data_1ff1_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ff1 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.259 0.552 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.98 161.79 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.489 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -118.1 178.1 1.12 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.0 110.663 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.3 Cg_endo -73.26 -35.75 4.76 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.191 1.627 . . . . 0.0 110.15 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -26.16 37.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 72.8 m-20 -81.47 -38.84 25.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.936 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 71' ' ' ALA . 8.2 tptp -69.84 -20.49 63.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.57 71.02 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 9.3 ptpt -75.25 -25.37 57.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.6 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.0 m-30 -71.72 -36.77 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.59 -9.85 58.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.746 -0.596 . . . . 0.0 110.318 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.42 -33.92 15.05 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.571 HG23 ' CE1' ' A' ' 70' ' ' PHE . 16.4 mt -77.29 -36.46 24.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.564 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.92 -40.0 79.33 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.692 0.758 . . . . 0.0 109.112 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.495 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -86.91 0.9 54.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.658 -0.651 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -6.18 55.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 108.996 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.6 mt -107.1 -9.99 16.02 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.8 92.05 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 121.195 0.521 . . . . 0.0 109.61 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -73.34 153.4 50.56 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.421 1.748 . . . . 0.0 110.994 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.53 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 94.1 t -121.58 114.13 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.74 . . . . 0.0 109.188 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 52.14 19.8 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.786 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.5 38.23 4.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.4 m-85 -150.43 147.32 27.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.878 -1.366 . . . . 0.0 112.639 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.602 HD13 ' CE2' ' A' ' 70' ' ' PHE . 10.3 mt -118.83 137.69 53.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ASP . 67.1 p -89.31 145.58 25.28 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.014 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.496 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.82 -27.54 0.18 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.1 t0 -61.52 -27.26 68.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -1.01 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 29.6 mttp -96.44 -32.85 12.12 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.096 -1.002 . . . . 0.0 108.551 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 70' ' ' PHE . 60.6 t -79.6 -50.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.188 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.07 -53.66 3.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.913 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -65.97 -36.07 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 N-CA-C 109.174 -1.125 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 24' ' ' LEU . 2.6 t -64.09 -32.42 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.529 ' CD1' HG13 ' A' ' 36' ' ' VAL . 60.9 mt -86.3 -25.77 25.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.625 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 62.7 mt -77.03 -11.7 59.84 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.306 -0.871 . . . . 0.0 109.44 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 63.2 t-20 -86.49 -8.86 57.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.024 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.487 ' OG ' HG13 ' A' ' 77' ' ' VAL . 0.9 OUTLIER -81.23 6.65 13.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.984 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.7 tptt 65.69 11.3 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -0.99 . . . . 0.0 109.553 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 46' ' ' PRO . 16.2 mt -95.18 152.55 39.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.843 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -73.53 168.98 23.39 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.965 1.508 . . . . 0.0 110.669 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' B' ' 111' ' ' PHE . 10.4 t -65.81 -10.54 10.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -30.56 58.93 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.243 -0.911 . . . . 0.0 108.958 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 16.1 mm -83.03 -40.32 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.585 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 10.9 mt -72.82 -30.23 63.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.98 -25.02 76.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -100.7 -31.71 11.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.833 -0.804 . . . . 0.0 110.043 179.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.532 ' CG1' HG22 ' A' ' 77' ' ' VAL . 25.6 t -72.08 -34.05 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.336 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 3.3 t-105 -73.25 -51.98 15.67 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.802 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.5 mm-40 -51.6 -58.25 6.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.951 -1.093 . . . . 0.0 110.088 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 5.5 mt -61.32 -14.54 27.82 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.872 179.087 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.517 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 2.9 t -94.03 -31.76 14.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.538 -0.726 . . . . 0.0 109.699 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 3.0 t0 -72.56 86.75 1.19 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.482 -0.762 . . . . 0.0 110.159 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.552 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.3 mm -65.94 -30.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 5.2 m-20 -99.01 -16.17 18.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.0 109.89 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 92.3 m-70 55.33 48.32 19.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.529 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 7.8 p30 -122.4 26.49 8.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 72.44 32.72 61.9 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.08 161.76 42.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.246 . . . . 0.0 111.082 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.529 HD13 ' CE3' ' A' ' 54' ' ' TRP . 14.1 mt -136.99 99.91 4.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.568 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 3.6 p30 -71.05 168.14 17.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.914 -1.116 . . . . 0.0 110.237 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' ASP . 15.7 ptt180 -38.56 -46.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.538 -0.726 . . . . 0.0 111.269 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.49 -35.48 63.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 110.57 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 57.4 mt-10 -75.79 -42.32 50.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.44 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.602 ' CE2' HD13 ' A' ' 31' ' ' LEU . 8.5 t80 -65.93 -19.91 66.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.413 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . . . -75.7 -46.6 30.28 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.568 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 86.2 t -59.04 -29.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.543 0.687 . . . . 0.0 109.881 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -89.86 -4.08 57.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.441 -0.787 . . . . 0.0 111.18 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.6 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.3 mmt -85.11 -48.32 9.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.907 -1.121 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.596 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -73.02 -31.62 64.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.596 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 6.1 mt -62.66 -24.13 67.46 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.532 HG22 ' CG1' ' A' ' 53' ' ' VAL . 58.9 t -91.04 -47.84 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.483 0.658 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -68.1 -31.96 71.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 110.689 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 93.3 m -83.2 -11.12 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.371 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.78 6.43 4.54 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.917 1.483 . . . . 0.0 111.126 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 65.2 m-85 . . . . . 0 N--CA 1.497 1.879 0 O-C-N 120.998 -1.064 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.325 0.583 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.75 136.59 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.977 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.511 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.9 mttp -96.81 178.93 1.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.822 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.78 -36.42 13.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.841 1.443 . . . . 0.0 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 3.7 pt-20 -74.8 -28.73 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.922 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.462 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 20.6 m-20 -82.3 -36.04 27.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 0.0 108.958 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -75.0 -15.29 60.66 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.514 -0.742 . . . . 0.0 109.027 178.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.1 -40.19 39.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.611 -0.681 . . . . 0.0 109.181 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.9 ptpt -74.73 -22.02 59.04 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 9.5 m-30 -75.22 -34.41 61.45 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.08 -11.33 60.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.421 0.629 . . . . 0.0 110.107 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -91.28 -29.28 17.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.576 HG23 ' CE1' ' A' ' 70' ' ' PHE . 36.3 mt -85.1 -33.71 8.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.74 -33.74 66.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 t70 -89.48 -6.12 56.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.616 -0.677 . . . . 0.0 109.951 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.73 -8.15 59.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 108.627 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.589 ' O ' ' CB ' ' A' ' 25' ' ' SER . 5.0 mt -104.66 -15.38 15.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 85.12 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 CA-C-O 121.157 0.503 . . . . 0.0 110.039 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 52.2 Cg_endo -79.76 157.87 24.6 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.343 1.707 . . . . 0.0 111.055 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.4 t -125.47 109.74 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 65.91 15.32 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 -178.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.5 36.75 6.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 75.2 m-85 -141.58 146.65 36.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.246 . . . . 0.0 111.847 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.1 mt -118.04 136.29 53.64 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -86.79 145.39 26.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.458 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.7 -26.05 0.38 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.7 t70 -67.19 -20.52 65.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.37 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.8 mttp -100.22 -36.54 9.26 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.019 -1.05 . . . . 0.0 108.194 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.492 HG13 ' CD1' ' A' ' 40' ' ' LEU . 86.9 t -75.61 -46.39 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.163 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.577 ' HG3' ' CZ ' ' B' ' 111' ' ' PHE . 12.0 tttt -39.06 -53.91 3.49 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.999 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.45 -37.0 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.463 1.244 . . . . 0.0 109.379 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.488 ' CG2' HD11 ' A' ' 24' ' ' LEU . 2.8 t -60.68 -34.63 59.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 53.9 mt -86.69 -26.39 24.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.5 -0.75 . . . . 0.0 109.584 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.462 HD13 ' CG ' ' A' ' 37' ' ' LYS . 36.8 mt -75.57 -17.09 60.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.81 -6.69 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.852 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.48 ' OG ' ' HB2' ' A' ' 45' ' ' LEU . 3.4 p -82.83 11.86 5.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 43' ' ' SER . 13.7 tttp 64.26 15.16 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.547 HD11 ' CB ' ' A' ' 80' ' ' ALA . 20.0 mt -100.66 153.3 37.81 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.88 169.82 21.42 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 124.216 1.64 . . . . 0.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 47' ' ' VAL . 3.6 t -69.15 -6.23 5.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.49 -31.46 42.3 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.249 -0.907 . . . . 0.0 109.207 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 12.1 mm -82.63 -39.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 11.1 mt -70.14 -28.38 65.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -71.87 -24.3 76.8 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.486 ' O ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.39 -32.02 10.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.777 -0.837 . . . . 0.0 110.208 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.551 ' CG1' HG23 ' A' ' 77' ' ' VAL . 4.9 t -72.41 -36.35 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.486 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.579 ' CD1' ' HB3' ' B' ' 109' ' ' ASN . 2.5 t-105 -68.78 -49.58 57.42 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.012 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.6 mt-10 -52.61 -57.08 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.901 -1.125 . . . . 0.0 110.186 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.486 HD11 ' O ' ' A' ' 52' ' ' ARG . 2.5 mt -61.45 -14.46 28.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.797 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 17.8 m -92.56 -38.64 11.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 109.371 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 10.7 t0 -70.21 85.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.442 -0.786 . . . . 0.0 109.924 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 26.8 mm -61.68 -27.63 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.899 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 49.9 p30 -108.97 -13.26 14.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.909 -1.119 . . . . 0.0 111.104 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 3.7 m170 63.07 44.68 5.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 13.0 p-10 -111.9 29.61 7.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.904 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 60.73 34.04 85.1 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.5 mtt -150.83 161.04 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -1.14 . . . . 0.0 111.127 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 31' ' ' LEU . 7.0 mt -128.21 104.82 7.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.754 . . . . 0.0 109.615 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.587 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -68.71 167.75 14.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.224 -0.922 . . . . 0.0 110.344 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.518 ' CG ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -46.18 -40.96 12.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.428 -0.795 . . . . 0.0 110.519 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 -25.82 31.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.064 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.68 -46.04 27.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.702 0.763 . . . . 0.0 109.261 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CE1' HG23 ' A' ' 20' ' ' ILE . 28.5 t80 -64.45 -16.43 62.41 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.56 -47.37 22.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.442 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.14 -24.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.603 -0.685 . . . . 0.0 109.594 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -89.89 -6.65 55.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -0.753 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.557 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.9 mmt -84.97 -48.21 9.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.003 -1.06 . . . . 0.0 110.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.514 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.1 p90 -75.97 -22.28 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.514 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 11.0 mt -73.89 -22.8 59.59 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.551 HG23 ' CG1' ' A' ' 53' ' ' VAL . 53.9 t -91.91 -60.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.448 0.642 . . . . 0.0 109.308 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.55 -19.29 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 110.722 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.45 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 4.2 m -85.01 -18.01 35.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.173 -0.954 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.547 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.429 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.579 ' HB3' ' CD1' ' A' ' 54' ' ' TRP . 50.7 p30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -79.06 11.06 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.101 1.58 . . . . 0.0 110.98 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 37' ' ' LYS . 48.8 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.935 -1.103 . . . . 0.0 110.266 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.376 0.608 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 137.6 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 110.376 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.493 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -94.63 174.49 3.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 37.9 Cg_endo -66.39 -32.7 40.17 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.795 1.418 . . . . 0.0 109.838 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.482 ' OE2' ' HG2' ' A' ' 11' ' ' PRO . 7.4 mm-40 -75.91 -33.47 59.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-20 -78.73 -40.5 33.38 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.5 tptp -69.63 -17.94 63.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.104 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -72.92 -41.47 64.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.51 -20.84 49.88 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -78.05 -34.23 50.52 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.96 -12.3 59.73 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.301 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.63 -32.38 13.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.588 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 21.5 mt -77.69 -30.92 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -71.28 -38.47 71.82 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.605 0.717 . . . . 0.0 109.141 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t70 -91.01 -4.19 56.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 110.115 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t -79.24 -11.66 59.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 108.742 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.648 ' O ' ' CB ' ' A' ' 25' ' ' SER . 8.9 mt -97.68 -56.09 2.61 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 142.46 97.19 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.7 Cg_endo -74.15 147.68 38.28 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 124.259 1.663 . . . . 0.0 110.726 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.0 t -118.49 99.15 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 109.107 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.8 t30 56.78 17.04 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.408 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 106.03 33.69 3.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 66' ' ' ASP . 75.6 m-85 -150.67 141.69 23.0 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -1.164 . . . . 0.0 112.106 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 70' ' ' PHE . 10.3 mt -110.59 141.81 43.28 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.492 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 99.4 p -89.7 147.54 23.8 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.998 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.8 -27.37 0.55 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' SER . 64.5 t0 -66.44 -25.75 66.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -1.05 . . . . 0.0 110.145 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttt -94.06 -33.08 13.53 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.014 -1.054 . . . . 0.0 108.533 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' CD1' ' A' ' 65' ' ' LEU . 90.8 t -82.05 -47.93 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.552 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -39.56 -53.65 4.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.637 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -66.34 -35.28 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.136 1.071 . . . . 0.0 109.468 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.588 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.6 -26.67 40.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.612 -0.68 . . . . 0.0 109.207 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.543 ' CD2' HG21 ' A' ' 77' ' ' VAL . 36.5 mt -95.66 -28.54 14.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 50' ' ' LEU . 79.2 mt -71.07 -15.11 62.51 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.86 -11.09 58.5 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.883 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.572 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 1.8 p -81.74 7.96 11.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.55 12.43 5.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.509 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.565 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 13.9 mt -88.56 156.39 50.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.953 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.9 Cg_endo -74.1 166.65 29.09 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.93 1.49 . . . . 0.0 109.386 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' B' ' 111' ' ' PHE . 3.5 t -66.55 -7.07 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.535 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -78.62 -31.9 47.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.185 -0.947 . . . . 0.0 109.392 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.562 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 6.9 mm -82.77 -41.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 46' ' ' PRO . 10.7 mt -67.43 -29.99 69.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.34 -23.81 77.16 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.469 ' O ' HD13 ' A' ' 56' ' ' LEU . 24.6 ttp180 -102.16 -33.13 9.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.966 -0.726 . . . . 0.0 111.06 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.537 ' CG1' HG22 ' A' ' 77' ' ' VAL . 17.2 t -67.16 -41.12 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.658 -1.276 . . . . 0.0 108.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.7 t-105 -62.55 -50.9 69.49 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.551 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 19.2 mt-10 -51.52 -59.05 4.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.82 -15.13 39.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 108.712 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.515 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 34.8 m -91.05 -30.49 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.237 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.43 97.38 4.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 109.595 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 24.9 mm -71.02 -38.44 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 110.375 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 9.8 p30 -99.34 -13.39 19.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 1.8 m-70 60.48 41.45 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.851 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 6.5 p-10 -96.79 13.27 29.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 0.0 109.565 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.53 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 78.63 22.15 67.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.53 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.29 161.35 41.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.302 -1.117 . . . . 0.0 109.573 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.54 ' CD1' HG12 ' A' ' 36' ' ' VAL . 5.8 mt -121.05 116.46 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.049 -1.032 . . . . 0.0 110.272 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.567 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -76.39 172.75 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -52.8 -34.37 53.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.559 -0.713 . . . . 0.0 110.847 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 28.0 m-20 -87.15 -31.56 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 31.4 mt-10 -78.13 -38.96 42.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 108.692 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.588 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 42.9 t80 -63.38 -29.27 70.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -64.8 -47.51 77.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.531 -0.73 . . . . 0.0 110.154 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.438 HG11 HD12 ' A' ' 76' ' ' LEU . 58.5 t -60.84 -19.26 19.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.515 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -89.6 -13.26 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 111.444 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 mmm -85.6 -41.84 14.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.696 -1.253 . . . . 0.0 110.553 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.4 p90 -77.57 -25.17 49.81 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.525 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 7.2 mt -70.96 -22.0 62.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.572 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 49.7 t -91.78 -61.52 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -48.88 -21.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.639 -0.663 . . . . 0.0 111.325 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.1 m -84.66 -14.65 47.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 110.123 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.565 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.574 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 20.8 t-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.895 0.379 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 109' ' ' ASN . 54.4 Cg_endo -85.55 12.57 3.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.07 1.563 . . . . 0.0 111.334 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.552 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 48.3 m-85 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 120.791 -1.193 . . . . 0.0 110.745 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.315 0.578 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.477 HG23 ' CD2' ' A' ' 75' ' ' PHE . 8.5 t -91.79 156.0 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.793 . . . . 0.0 109.239 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.495 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mmmt -108.72 167.39 9.25 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.878 -1.139 . . . . 0.0 110.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -69.4 -31.91 21.16 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.008 1.531 . . . . 0.0 109.811 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.85 -32.79 40.53 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.23 -34.7 49.11 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 28.6 tptp -72.46 -18.61 61.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.486 -0.759 . . . . 0.0 109.047 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.76 -42.8 60.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.593 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.0 ptpt -75.58 -25.29 56.93 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -72.96 -37.55 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.874 0.845 . . . . 0.0 108.732 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -79.5 -8.16 58.95 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.376 0.607 . . . . 0.0 110.339 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.59 -33.38 12.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 75.1 mt -76.63 -33.13 21.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -66.97 -38.57 86.32 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.7 t70 -90.97 -2.57 57.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -80.91 -12.58 59.38 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.65 ' O ' ' CB ' ' A' ' 25' ' ' SER . 6.4 mt -95.63 -54.36 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.65 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 6.7 p 142.55 90.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -75.14 150.94 38.28 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 124.057 1.556 . . . . 0.0 110.914 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -127.07 108.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.1 t30 57.28 21.93 7.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.996 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.438 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.08 38.91 5.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 82.6 m-85 -150.43 151.64 33.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.089 -1.242 . . . . 0.0 111.866 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.595 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.2 mt -122.17 140.61 52.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.475 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 19.3 p -90.42 141.64 28.54 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.855 -1.153 . . . . 0.0 110.343 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.539 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.28 -27.75 0.27 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -61.5 -28.29 69.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.969 . . . . 0.0 110.066 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 14.8 mttt -96.52 -32.93 12.03 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.221 -0.924 . . . . 0.0 108.816 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.552 ' CG1' HD12 ' A' ' 65' ' ' LEU . 92.1 t -77.03 -44.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 110.007 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 67.5 tttt -40.76 -56.75 3.64 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.7 Cg_endo -65.37 -34.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.494 1.26 . . . . 0.0 109.769 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -62.82 -35.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.792 . . . . 0.0 109.7 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.569 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 34.6 mt -85.37 -29.12 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.972 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.446 HD23 HD13 ' A' ' 50' ' ' LEU . 43.2 mt -71.6 -14.12 61.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.018 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.47 -12.34 60.0 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.755 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.528 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 59.8 p -81.38 3.78 23.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.421 -0.799 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.3 ttmt 68.63 16.25 9.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.54 HD23 ' HD2' ' A' ' 46' ' ' PRO . 15.5 mt -95.66 152.91 39.45 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.001 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.5 Cg_endo -74.04 175.03 11.41 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.973 1.512 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 47' ' ' VAL . 25.2 t -70.85 -7.09 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -32.24 37.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.582 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.8 mm -83.18 -36.86 13.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 108.742 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.569 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 29.5 mt -75.08 -26.48 59.36 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.24 -24.96 76.42 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.499 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 3.4 mtm180 -100.74 -31.68 11.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.905 -0.762 . . . . 0.0 109.897 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 77' ' ' VAL . 5.7 t -71.1 -37.34 66.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.556 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 3.0 t-105 -71.11 -50.1 37.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.44 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.568 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 9.4 mm-40 -56.96 -54.65 44.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 110.221 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.499 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 4.9 mt -62.78 -10.91 14.62 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.426 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 3.8 m -98.16 -37.71 9.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.77 . . . . 0.0 110.015 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -69.01 87.07 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.953 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.512 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 43.5 mm -57.82 -28.37 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 110.395 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.59 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 51.1 p-10 -112.04 1.29 16.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.554 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 9.3 p80 39.58 51.98 2.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.341 -0.849 . . . . 0.0 110.511 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 15.4 p-10 -112.33 24.79 12.17 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 71.13 31.15 66.73 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.75 161.82 42.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -1.227 . . . . 0.0 111.466 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.552 HD12 ' CG1' ' A' ' 36' ' ' VAL . 9.9 mt -125.73 105.52 9.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.482 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.565 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 4.7 t0 -69.02 163.71 24.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.86 -1.15 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -42.63 -36.47 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.763 . . . . 0.0 110.199 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.424 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -82.75 -34.27 27.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 17.7 mt-10 -74.98 -42.6 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' CD2' HD11 ' A' ' 31' ' ' LEU . 32.6 t80 -59.84 -26.95 66.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -72.25 -51.31 21.53 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.174 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.483 HG11 ' HA ' ' A' ' 57' ' ' SER . 53.7 t -55.46 -26.76 19.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.543 0.687 . . . . 0.0 109.518 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -89.85 -3.21 58.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.557 -0.714 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.0 mmt -90.15 -43.43 10.46 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.664 -1.273 . . . . 0.0 109.834 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' CD1' ' C ' ' A' ' 75' ' ' PHE . 1.9 p90 -79.26 -19.01 51.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 53' ' ' VAL . 4.6 mt -78.85 -23.24 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 73' ' ' ALA . 5.8 t -90.59 -37.16 9.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.627 -0.671 . . . . 0.0 109.65 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -80.05 -24.02 40.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 56.3 m -83.22 -18.74 38.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.224 -0.922 . . . . 0.0 109.188 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.409 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.843 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.568 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 43.1 t-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.687 0.28 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.77 17.39 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.949 1.499 . . . . 0.0 111.28 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 65.2 m-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.892 -1.13 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.376 0.608 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.6 t -97.71 138.53 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.525 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.97 175.53 2.68 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.525 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -37.03 19.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -72.54 -25.16 61.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 109.575 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -82.79 -40.09 20.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -71.73 -17.61 62.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -72.45 -45.8 57.91 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -74.48 -28.99 61.26 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.603 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.6 m-30 -68.02 -33.73 75.14 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 9.4 t70 -77.34 -9.32 58.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.662 -0.649 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.38 -30.76 14.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.461 ' CG2' ' CE2' ' A' ' 70' ' ' PHE . 61.5 mt -81.16 -32.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.616 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -73.43 -38.18 65.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.2 t70 -85.64 -1.25 56.95 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.411 0.624 . . . . 0.0 109.787 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 t -88.47 -9.33 52.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.212 -0.93 . . . . 0.0 108.895 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.621 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.4 mt -100.67 -8.09 23.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 88.31 94.75 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 46.6 Cg_endo -72.0 151.09 55.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.346 1.708 . . . . 0.0 111.022 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -121.6 97.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.0 t30 63.67 14.96 8.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.858 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.82 33.26 4.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 92.0 m-85 -149.92 154.69 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.161 -1.199 . . . . 0.0 111.827 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.605 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 10.0 mt -120.03 159.97 23.71 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' LYS . 13.4 p -104.28 142.15 35.04 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.904 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.28 -25.22 0.71 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.4 t70 -71.86 -23.57 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.605 -0.938 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttp -93.06 -36.8 12.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 HG13 ' CD1' ' A' ' 40' ' ' LEU . 90.1 t -78.11 -40.46 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.473 0.654 . . . . 0.0 109.765 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 6.3 tttp -40.71 -55.98 4.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 111.089 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.6 -35.01 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.574 1.302 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 35' ' ' LYS . 2.7 t -59.87 -36.19 65.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.56 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 23.2 mt -84.29 -25.73 29.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.913 . . . . 0.0 109.456 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD22 HD13 ' A' ' 50' ' ' LEU . 53.9 mt -71.92 -15.31 62.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.06 -10.22 59.72 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.464 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.487 ' CB ' HG11 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -81.13 8.6 8.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.842 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 43' ' ' SER . 4.3 tttt 65.6 15.83 10.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.462 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.544 HD11 ' CG2' ' A' ' 49' ' ' ILE . 14.1 mt -95.91 151.25 38.22 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 110.331 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.586 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.9 Cg_endo -75.54 -178.34 4.21 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.986 1.519 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.1 t -78.53 -0.68 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.47 -32.88 20.58 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.586 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.3 mm -83.22 -38.6 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.591 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 38.6 mt -72.91 -26.3 61.37 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 109.201 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.24 -23.03 78.29 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.484 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 3.3 mtm180 -100.38 -32.25 10.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.885 -0.774 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 76' ' ' LEU . 22.5 t -70.26 -36.32 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.015 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.31 -50.62 37.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mt-10 -56.82 -57.55 11.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.484 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -58.22 -16.94 15.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.48 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.539 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 1.9 t -92.12 -35.87 13.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -72.97 98.36 2.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 110.217 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.524 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 49.0 mm -71.93 -28.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.005 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -112.0 -15.26 13.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 109.656 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 91.7 m-70 59.68 47.77 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.558 -0.714 . . . . 0.0 111.298 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 1.3 m-20 -98.04 26.06 5.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 108.635 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.477 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 63.4 29.77 75.57 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 31' ' ' LEU . 7.9 mtt -150.56 160.74 43.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.995 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.509 ' CD1' HG11 ' A' ' 36' ' ' VAL . 11.9 mt -129.48 100.68 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 69' ' ' GLU . 2.3 p30 -69.6 160.61 31.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.616 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.7 ptp85 -35.36 -43.2 0.23 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.656 -0.653 . . . . 0.0 112.032 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -81.47 -35.79 30.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.963 -1.085 . . . . 0.0 110.298 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 13.7 tt0 -71.15 -43.26 67.89 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.478 ' CG ' ' HB2' ' A' ' 21' ' ' PHE . 58.4 t80 -63.1 -19.58 64.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.55 -42.7 67.54 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 109.693 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.39 -31.79 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.671 0.748 . . . . 0.0 109.722 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -87.58 0.25 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.757 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.574 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.4 mmt -89.8 -44.54 9.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.67 -1.269 . . . . 0.0 109.961 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.548 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.2 p90 -77.09 -22.34 52.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.548 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.2 mt -76.99 -22.95 52.35 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.461 0.648 . . . . 0.0 109.54 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 73' ' ' ALA . 5.4 t -91.34 -38.59 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.438 -0.789 . . . . 0.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.47 -22.71 61.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.467 -0.771 . . . . 0.0 110.676 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -83.15 -16.13 47.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.167 -0.958 . . . . 0.0 109.967 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.203 -0.936 . . . . 0.0 109.089 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.439 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 34.0 t-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.504 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 47.6 Cg_endo -72.19 -23.96 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.89 1.468 . . . . 0.0 110.545 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.629 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 45.0 m-85 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.501 0.667 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 60.3 t -100.75 131.57 48.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.545 -0.722 . . . . 0.0 109.596 179.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -89.65 -179.04 1.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.95 -35.67 14.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.816 1.429 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -73.28 -26.78 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.504 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -82.21 -39.43 23.11 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.31 -13.49 61.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 11' ' ' PRO . . . -78.69 -40.37 34.02 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.15 -23.65 43.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -78.7 -33.15 47.09 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 47.7 t0 -79.69 -7.79 58.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.682 -0.636 . . . . 0.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.27 12.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.405 ' CG2' HG22 ' A' ' 39' ' ' VAL . 40.2 mt -76.88 -31.51 19.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.566 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.19 -37.7 66.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.3 t70 -89.67 3.72 51.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.453 0.644 . . . . 0.0 109.71 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -5.95 53.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 108.868 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.38 -4.95 16.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 82.73 94.55 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.0 Cg_endo -73.29 148.57 43.88 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.224 1.644 . . . . 0.0 110.496 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 92.6 t -115.46 102.2 13.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 3.3 t30 61.15 16.36 7.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.419 -0.801 . . . . 0.0 109.661 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 100.07 35.56 4.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 76.3 m-85 -150.53 143.5 24.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.923 -1.339 . . . . 0.0 112.279 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.4 mt -113.93 137.53 51.56 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' C ' ' A' ' 33' ' ' GLY . 47.3 p -83.8 140.52 32.0 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.332 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.94 -28.44 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 37.9 t0 -62.34 -23.81 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.935 . . . . 0.0 110.559 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 43.0 mttp -97.93 -35.76 10.37 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.515 HG13 ' CD1' ' A' ' 65' ' ' LEU . 85.1 t -75.64 -37.76 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.023 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.653 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 ttmt -45.08 -51.36 24.14 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 111.133 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.2 Cg_endo -68.21 -33.57 24.16 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.254 1.133 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 1.8 t -61.6 -31.26 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.515 -0.741 . . . . 0.0 110.215 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.566 ' CD1' ' CZ ' ' B' ' 111' ' ' PHE . 18.9 mt -91.69 -23.8 19.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.076 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 57.8 mt -74.77 -13.46 60.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 109.383 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 2.1 p-10 -87.07 -1.02 57.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.322 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 5.1 p -90.58 12.69 18.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.615 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 65.93 15.63 10.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.079 -1.013 . . . . 0.0 109.925 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' CB ' ' A' ' 80' ' ' ALA . 15.7 mt -100.11 151.83 37.63 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.624 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.8 Cg_endo -76.89 172.87 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.206 1.635 . . . . 0.0 110.178 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -69.96 -4.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.659 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -82.04 -30.11 31.58 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 109.209 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.585 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.9 mm -85.54 -36.82 11.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.928 0.87 . . . . 0.0 108.896 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.626 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 15.7 mt -76.85 -27.96 55.3 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.413 0.625 . . . . 0.0 109.523 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.98 -24.92 75.03 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -101.05 -31.46 11.07 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.979 -0.718 . . . . 0.0 110.182 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 77' ' ' VAL . 15.0 t -72.06 -36.77 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.9 t-105 -64.38 -51.39 63.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.743 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 1.9 mm-40 -49.09 -61.41 2.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.326 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.6 mt -59.88 -16.58 30.25 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.858 179.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.522 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 17.7 m -90.55 -28.96 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' TRP . 27.9 t0 -76.4 101.6 5.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.788 -0.57 . . . . 0.0 109.64 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 18.3 mm -88.49 -17.23 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.562 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' OE2' ' A' ' 69' ' ' GLU . 3.3 m-20 -104.07 -10.08 18.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.63 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 2.8 m170 52.38 49.1 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 34.8 p-10 -128.46 14.14 6.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.932 -1.105 . . . . 0.0 110.177 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 79.4 32.61 37.78 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 18.6 mtp -150.8 161.07 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.188 -1.184 . . . . 0.0 110.747 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.515 ' CD1' HG13 ' A' ' 36' ' ' VAL . 7.7 mt -126.94 107.48 10.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -69.63 166.55 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 109.432 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.549 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.6 ptp85 -45.88 -42.17 12.23 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.139 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 63.4 m-20 -76.14 -36.63 58.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.827 . . . . 0.0 110.097 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 35.5 mt-10 -71.66 -46.34 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.997 . . . . 0.0 108.92 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.585 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 29.7 t80 -55.4 -30.95 61.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.44 -49.18 74.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.305 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.6 t -58.03 -22.47 19.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.044 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.522 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.34 -8.5 50.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 111.94 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 10.3 mmm -88.8 -41.2 12.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.617 -1.302 . . . . 0.0 110.527 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.58 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -78.9 -29.17 44.17 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.911 -1.118 . . . . 0.0 108.189 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.6 mt -66.75 -27.12 67.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.601 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 25.6 t -90.74 -19.91 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 110.032 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.91 -24.11 22.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.373 -0.83 . . . . 0.0 109.703 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.5 m -84.09 -16.74 42.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 108.598 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.551 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.553 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 44.9 Cg_endo -80.96 7.19 5.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.686 1.361 . . . . 0.0 109.714 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.653 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 96.6 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.311 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.256 0.551 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.61 139.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.17 -178.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.893 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -71.41 -34.73 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.849 1.447 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HG3' ' OD1' ' A' ' 13' ' ' ASP . 7.3 pt-20 -76.81 -27.88 55.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -84.7 -30.11 25.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -82.33 -19.67 38.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 0.0 109.005 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.42 -37.63 60.3 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.588 ' CG ' ' CD1' ' A' ' 17' ' ' TYR . 4.4 ptmt -74.27 -23.44 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD2' ' HB2' ' A' ' 74' ' ' MET . 10.3 m-30 -76.76 -35.67 57.56 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -72.31 -10.01 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 110.387 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.37 -35.88 14.15 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -76.23 -33.68 24.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.633 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -71.53 -40.55 70.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 t70 -85.75 4.51 36.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.664 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -9.41 43.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.61 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.1 mt -102.86 -9.3 20.03 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 87.2 91.28 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.222 0 CA-C-O 121.542 0.687 . . . . 0.0 109.153 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 Cg_endo -74.29 150.21 41.5 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.174 1.618 . . . . 0.0 110.75 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 35.3 t -119.18 112.37 37.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.3 t30 57.37 16.91 3.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 96.0 36.18 5.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.2 m-85 -147.16 146.1 29.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 112.097 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.6 mt -115.06 139.33 49.96 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -83.39 143.4 30.33 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.133 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.34 -25.93 0.87 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.8 m-20 -69.13 -22.93 63.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.641 -0.917 . . . . 0.0 110.349 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 32' ' ' SER . 65.1 mttm -94.91 -35.28 12.08 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.561 HG21 ' CE2' ' A' ' 70' ' ' PHE . 84.8 t -77.43 -39.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.741 0.782 . . . . 0.0 109.371 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.543 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 8.7 tttp -41.51 -55.13 5.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.715 -0.616 . . . . 0.0 110.721 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.29 -35.03 25.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.568 1.299 . . . . 0.0 110.034 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -61.38 -33.17 55.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.121 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 46.7 mt -87.44 -26.81 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.34 -13.72 60.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.81 . . . . 0.0 109.035 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -85.92 -10.93 54.41 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.554 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.487 ' OG ' HG11 ' A' ' 77' ' ' VAL . 3.2 m -78.18 4.84 11.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.606 -0.683 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' SER . 11.4 tttm 68.29 8.26 6.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.79 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.577 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 16.9 mt -92.1 155.09 43.23 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.4 Cg_endo -74.97 168.88 23.86 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.125 1.592 . . . . 0.0 109.734 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.542 ' CG1' ' HB3' ' B' ' 111' ' ' PHE . 10.3 t -68.03 -7.28 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.519 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.7 -32.47 53.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.338 -0.852 . . . . 0.0 109.313 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.5 mm -81.29 -40.56 18.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.55 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -69.92 -29.15 66.24 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.548 0.689 . . . . 0.0 109.373 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.21 -23.56 77.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.447 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.08 -29.86 11.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.723 -0.869 . . . . 0.0 110.211 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 77' ' ' VAL . 22.0 t -73.86 -37.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.747 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.5 t-105 -66.57 -48.69 68.82 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.4 mt-10 -56.48 -57.33 12.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.447 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.9 mt -61.35 -15.16 33.36 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.445 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 14.2 m -94.18 -25.59 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 109.832 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 2.5 t0 -76.99 85.09 3.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.537 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 40.3 mm -61.75 -30.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.888 . . . . 0.0 110.828 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 4.8 p30 -109.9 -13.9 14.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.01 -1.056 . . . . 0.0 110.683 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 16.9 m-70 60.48 46.18 9.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.5 p-10 -103.62 22.49 14.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.481 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 68.0 26.7 73.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 22.7 mtp -150.61 161.44 42.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -1.198 . . . . 0.0 110.375 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.531 ' CD1' HG12 ' A' ' 36' ' ' VAL . 11.5 mt -125.67 99.39 5.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 0.0 109.035 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 51.5 p30 -71.16 166.97 20.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.832 -1.167 . . . . 0.0 110.315 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.633 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -38.13 -45.39 0.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 0.0 112.149 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.95 -42.29 57.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.07 -1.019 . . . . 0.0 110.963 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.537 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 56.8 mt-10 -70.67 -44.45 67.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.117 -0.989 . . . . 0.0 109.02 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 13.2 t80 -57.31 -22.76 44.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.21 -46.91 38.89 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.76 0.791 . . . . 0.0 109.336 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 95.4 t -59.83 -25.17 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.437 0.637 . . . . 0.0 109.93 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.539 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.25 -6.11 55.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 111.179 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.595 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.5 mmt -85.89 -46.19 10.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 110.071 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.525 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.5 p90 -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.525 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.4 mt -66.23 -24.21 66.56 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.533 HG22 ' CG1' ' A' ' 53' ' ' VAL . 69.8 t -91.57 -57.8 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -49.71 -22.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.652 -0.655 . . . . 0.0 111.622 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -85.48 -11.75 53.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.842 -1.161 . . . . 0.0 110.434 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.577 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.535 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 22.5 t-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.94 6.2 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 111.847 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 73.0 m-85 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 120.793 -1.192 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.71 159.68 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.49 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mptt -115.68 177.87 1.1 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 110.422 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.28 -34.46 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.057 1.556 . . . . 0.0 109.869 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.43 -26.77 46.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.023 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.1 m-20 -81.5 -31.76 32.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -75.95 -12.61 60.18 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -0.805 . . . . 0.0 108.987 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.37 -40.33 21.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.07 -27.33 60.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -72.1 -34.83 68.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.9 OUTLIER -73.34 -10.15 59.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.75 -0.594 . . . . 0.0 110.15 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.5 -32.05 15.72 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.475 HG21 ' HE2' ' A' ' 74' ' ' MET 0.251 60.3 mt -82.41 -35.36 12.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.565 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.84 -37.5 70.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 14.4 t70 -88.62 1.98 54.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.39 -6.82 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 108.722 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.604 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -107.5 -8.49 16.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.692 -0.63 . . . . 0.0 109.435 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 85.38 95.67 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -72.26 147.77 48.26 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.205 1.634 . . . . 0.0 110.407 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -112.54 96.38 4.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 109.094 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 66.1 9.96 6.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.514 -0.741 . . . . 0.0 109.397 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 108.58 28.93 4.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 30.4 m-85 -140.98 141.43 34.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.251 . . . . 0.0 111.95 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 6.7 mt -112.61 139.59 48.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.513 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 20.9 p -92.43 144.88 24.92 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.288 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.33 -27.66 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . 54.2 m-20 -63.32 -26.23 68.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.461 -1.023 . . . . 0.0 109.972 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 16.5 mttt -95.21 -35.97 11.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.593 HG22 ' CE2' ' A' ' 70' ' ' PHE . 94.6 t -77.63 -48.81 23.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.233 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.596 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 31.9 tttm -35.5 -56.1 1.06 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.846 -0.534 . . . . 0.0 111.252 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.9 Cg_endo -67.02 -35.79 24.49 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.496 1.261 . . . . 0.0 110.073 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 24' ' ' LEU . 2.6 t -63.28 -31.93 54.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.988 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.544 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 18.3 mt -89.36 -25.52 21.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.087 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD22 HD12 ' A' ' 50' ' ' LEU . 41.8 mt -74.73 -12.52 60.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.078 -1.014 . . . . 0.0 109.049 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -84.05 -8.04 59.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.476 ' CB ' HG11 ' A' ' 77' ' ' VAL . 1.0 OUTLIER -84.54 15.32 3.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 110.217 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 21.13 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 109.996 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.564 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 14.6 mt -99.7 153.11 37.94 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.583 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.67 178.66 7.11 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.998 1.525 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' HB3' ' B' ' 111' ' ' PHE . 2.9 t -75.78 -2.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.331 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.83 -34.3 24.7 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.351 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.583 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.2 mm -80.73 -40.43 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 122.033 0.92 . . . . 0.0 108.522 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 32.8 mt -71.44 -27.55 63.35 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.83 -25.39 75.62 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.539 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 7.9 mtm-85 -101.28 -31.34 11.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.829 . . . . 0.0 109.829 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 57' ' ' SER . 7.5 t -67.7 -36.79 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.217 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.572 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -75.57 -51.63 12.45 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.809 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 41.0 mt-10 -57.7 -55.97 27.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.0 109.218 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 13.9 mt -59.55 -16.78 27.31 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 5.0 t -94.43 -25.5 16.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.7 t0 -73.73 98.95 3.02 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.234 0.54 . . . . 0.0 109.732 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 20.9 mm -86.61 -36.78 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 110.171 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -96.87 -12.32 23.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 40.4 m170 58.34 45.39 17.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 111.18 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 17.9 p-10 -107.22 28.91 7.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.599 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 61.24 30.37 73.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.513 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 86.7 mtp -151.96 160.21 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -1.106 . . . . 0.0 110.696 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.572 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 12.8 mt -116.1 103.82 10.94 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.54 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -68.83 156.18 38.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.868 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.524 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -35.89 -40.12 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.567 -0.708 . . . . 0.0 111.037 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.524 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 9.5 t0 -81.5 -34.46 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.154 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.54 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 18.2 mt-10 -73.91 -42.77 60.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.593 ' CE2' HG22 ' A' ' 36' ' ' VAL . 15.6 t80 -59.35 -22.49 61.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -73.7 -48.91 28.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.828 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 59.5 t -58.06 -27.98 32.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.361 -0.837 . . . . 0.0 109.452 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' A' ' 57' ' ' SER . . . -91.5 -7.04 51.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.484 -0.76 . . . . 0.0 111.465 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.569 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.9 mmt -82.26 -50.18 9.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.688 -1.257 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.6 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 1.7 p90 -71.72 -33.91 69.14 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.6 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.1 mt -58.72 -22.06 56.62 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.515 ' CG2' HG12 ' A' ' 53' ' ' VAL . 47.0 t -91.28 -64.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -55.18 -18.87 6.55 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.497 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.2 m -85.19 -10.88 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.05 -1.031 . . . . 0.0 109.586 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.564 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.229 -0.92 . . . . 0.0 109.184 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 13.5 t-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 -20.55 21.99 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.079 1.568 . . . . 0.0 110.68 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.599 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 80.7 m-85 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.218 0.532 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.533 HG21 ' CD2' ' A' ' 75' ' ' PHE . 40.7 t -87.01 157.16 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 21.7 mmtm -110.56 166.22 11.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.4 Cg_endo -68.29 -33.98 22.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.863 1.454 . . . . 0.0 109.669 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.52 -27.46 58.74 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 77.8 m-20 -81.38 -41.54 21.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 12.8 tptp -65.58 -25.21 67.31 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.068 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 -45.24 76.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.532 -0.73 . . . . 0.0 109.062 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.6 ptpt -73.53 -28.69 62.02 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 13' ' ' ASP . 8.0 m-30 -67.66 -37.62 82.64 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.71 -12.78 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.468 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.84 -30.98 15.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.458 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 26.1 mt -81.46 -32.65 11.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -72.23 -36.99 69.26 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t70 -89.02 1.43 55.55 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.681 -0.637 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.68 -8.32 54.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.912 . . . . 0.0 109.086 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 2.1 mt -107.57 -7.0 16.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 79.81 95.76 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -75.62 152.21 37.69 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.165 1.613 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.0 t -118.44 114.93 46.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 27.0 t30 57.4 18.39 4.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.208 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.37 37.95 5.76 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.0 m-85 -150.5 148.3 28.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.183 . . . . 0.0 111.902 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.0 mt -113.37 134.82 54.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.493 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 34.4 p -83.21 147.55 27.95 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.87 -26.34 1.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 32' ' ' SER . 20.6 t70 -64.45 -24.08 67.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.634 -0.921 . . . . 0.0 109.972 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.8 mttt -98.8 -32.12 11.52 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.531 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 92.3 t -83.05 -46.21 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.028 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.1 tttt -41.18 -50.18 8.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 43.3 Cg_endo -69.36 -35.45 13.79 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.231 1.122 . . . . 0.0 109.243 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 t -62.43 -36.47 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.458 0.647 . . . . 0.0 109.526 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.547 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 42.3 mt -83.21 -21.58 33.39 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.384 -0.822 . . . . 0.0 109.65 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.466 HD12 ' HG2' ' A' ' 37' ' ' LYS . 34.2 mt -79.04 -13.21 59.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.533 -0.73 . . . . 0.0 109.324 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 5.7 t30 -89.98 -3.77 57.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.051 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.577 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 94.6 p -86.11 16.85 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 16.06 6.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.709 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' A' ' 80' ' ' ALA . 16.3 mt -100.4 152.52 37.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -76.46 168.75 23.21 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.116 1.587 . . . . 0.0 110.173 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' B' ' 111' ' ' PHE . 9.6 t -68.7 -5.86 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.386 -0.821 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.23 -32.78 38.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.214 -0.928 . . . . 0.0 109.446 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.574 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.9 mm -82.47 -41.46 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 14.6 mt -68.09 -28.12 67.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.47 -24.57 76.68 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.46 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.8 ttm180 -101.62 -31.63 10.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 77' ' ' VAL . 24.2 t -69.29 -37.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 3.8 t-105 -67.6 -51.88 44.99 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.758 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 8.6 mt-10 -51.06 -59.99 3.57 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.16 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.0 mt -62.07 -13.16 23.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.647 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.521 ' HA ' HG12 ' A' ' 72' ' ' VAL . 4.3 m -93.82 -27.2 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.551 -0.718 . . . . 0.0 110.147 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.3 t0 -79.25 70.67 5.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.006 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.493 HG21 HD13 ' A' ' 59' ' ' ILE . 46.2 mm -47.25 -33.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 12.5 m-20 -94.0 -25.41 17.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 110.122 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 25.5 m-70 64.62 45.27 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 2.7 p30 -110.89 0.62 17.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 110.549 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.557 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 96.27 18.99 29.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.557 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.73 161.86 40.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.211 -1.17 . . . . 0.0 109.889 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.497 HD11 ' CG1' ' A' ' 36' ' ' VAL . 15.9 mt -119.11 116.24 25.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.232 -0.918 . . . . 0.0 110.194 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 10.8 t0 -71.15 168.79 16.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 0.0 110.047 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptt180 -53.48 -37.27 62.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.933 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.465 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.0 m-20 -85.16 -29.83 24.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.097 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -74.4 -46.59 39.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.562 0.696 . . . . 0.0 109.166 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.568 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 50.2 t80 -59.11 -22.53 60.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -67.16 -50.1 62.34 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.963 0.887 . . . . 0.0 109.544 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 57' ' ' SER . 54.2 t -57.19 -26.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.568 0.699 . . . . 0.0 110.105 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HA ' ' OG ' ' A' ' 57' ' ' SER . . . -85.11 -7.08 59.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.788 . . . . 0.0 111.694 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.58 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 7.2 mmm -89.95 -40.4 12.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.614 -1.304 . . . . 0.0 110.233 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CD2' HG21 ' A' ' 9' ' ' VAL . 1.9 p90 -77.24 -19.21 56.93 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.239 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HB3' HG12 ' A' ' 53' ' ' VAL . 5.3 mt -77.54 -24.95 49.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.577 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 72.5 t -91.11 -34.7 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.637 -0.664 . . . . 0.0 110.133 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.63 -26.09 59.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.794 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.18 -15.92 55.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.534 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 0.0 108.936 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 51' ' ' GLY . 9.8 t-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.553 0.215 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.31 -10.23 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.982 1.517 . . . . 0.0 110.758 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 88.8 m-85 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.171 -0.955 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.441 0.639 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -97.26 126.78 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.535 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -95.52 -178.54 0.79 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.889 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.6 Cg_endo -66.38 -37.09 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.644 1.339 . . . . 0.0 109.781 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.64 -33.83 76.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.037 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 46.8 m-20 -82.86 -41.49 18.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -68.23 -15.71 63.68 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.67 -39.0 20.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.443 -0.785 . . . . 0.0 109.245 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -81.63 -20.77 39.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.589 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -81.35 -36.32 29.83 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.475 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 7.0 t70 -76.07 -8.64 57.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.207 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.23 -31.63 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.493 HG22 ' CE1' ' A' ' 70' ' ' PHE . 33.9 mt -79.84 -34.78 15.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.607 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -66.91 -34.17 77.2 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t0 -91.23 -7.56 50.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.394 -0.816 . . . . 0.0 110.011 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -77.45 -14.54 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 108.792 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.656 ' O ' ' CB ' ' A' ' 25' ' ' SER . 12.7 mt -92.91 -55.38 3.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.656 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 m 140.36 97.15 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.473 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 52.5 Cg_endo -74.73 149.64 38.37 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 123.828 1.436 . . . . 0.0 110.951 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -125.76 106.05 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.2 t30 58.0 18.12 4.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.388 -0.82 . . . . 0.0 109.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 97.17 36.04 5.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 82.9 m-85 -150.78 143.74 24.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.093 -1.239 . . . . 0.0 111.969 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.587 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.0 mt -111.2 137.32 49.05 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.83 141.27 33.59 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.139 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.543 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.64 -27.53 0.33 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 24.7 t70 -64.77 -27.98 69.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -1.034 . . . . 0.0 110.319 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 77.2 mttt -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.538 ' CG1' HD13 ' A' ' 40' ' ' LEU . 77.1 t -74.97 -41.65 45.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.484 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.4 mtpt -36.67 -56.77 1.3 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.795 -0.566 . . . . 0.0 110.914 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -67.3 -35.5 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.919 1.483 . . . . 0.0 110.007 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -61.26 -27.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 36' ' ' VAL . 20.0 mt -97.94 -33.52 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 0.0 110.432 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 14.0 mt -73.11 -9.14 58.41 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.171 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -89.3 -9.01 52.15 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.882 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 45' ' ' LEU . 16.3 p -81.67 5.55 17.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.448 -0.782 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 43' ' ' SER . 6.1 ttpt 66.98 19.1 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.931 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.518 HD23 ' HD2' ' A' ' 46' ' ' PRO . 15.7 mt -100.36 156.47 35.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.0 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.549 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -75.44 167.98 25.48 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.123 1.591 . . . . 0.0 110.233 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.35 -8.0 7.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.346 -0.846 . . . . 0.0 109.219 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.22 -31.63 60.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.549 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.5 mm -83.2 -37.19 13.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.812 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.574 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 8.5 mt -74.19 -26.25 60.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.533 0.682 . . . . 0.0 109.371 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -69.94 -29.06 71.07 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.5 mtm180 -101.66 -31.88 10.6 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.251 -0.558 . . . . 0.0 110.462 179.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' ILE . 5.6 t -64.57 -55.48 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.195 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.567 ' CE3' HD11 ' A' ' 65' ' ' LEU . 2.0 t-105 -57.87 -52.18 66.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -45.46 -66.29 0.42 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.577 0.703 . . . . 0.0 110.689 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 3.8 mt -60.54 -16.83 41.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.528 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 t -89.34 -14.61 35.28 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' TRP . 2.1 t0 -93.31 83.27 4.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.507 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 31.9 mm -53.44 -38.84 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.374 -0.829 . . . . 0.0 110.804 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.525 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 4.8 p30 -103.72 -20.6 13.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 110.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 19.8 m-70 67.19 42.12 2.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.4 p30 -95.67 1.05 53.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.406 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 94.25 25.12 17.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 23.2 mtp -152.76 161.79 42.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -1.204 . . . . 0.0 111.17 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.567 HD11 ' CE3' ' A' ' 54' ' ' TRP . 21.9 mt -127.12 112.73 15.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 109.618 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 1.6 t70 -72.25 172.99 9.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.104 -0.998 . . . . 0.0 110.079 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.607 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.82 -41.58 64.33 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.202 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -81.15 -36.04 30.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 109.822 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 1.8 tt0 -72.02 -46.31 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.807 . . . . 0.0 108.945 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.594 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 16.8 t80 -59.32 -17.37 28.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -72.69 -43.66 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.835 0.826 . . . . 0.0 109.35 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.475 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 41.8 t -60.02 -26.05 34.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.498 0.666 . . . . 0.0 109.55 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' ' CB ' ' A' ' 57' ' ' SER . . . -90.31 -6.33 55.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 111.315 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.586 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.2 mmt -83.64 -49.01 9.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.0 109.986 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.576 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.4 p90 -73.97 -28.48 61.51 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.2 mt -66.28 -22.21 66.29 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.51 ' CG2' HG13 ' A' ' 53' ' ' VAL . 54.5 t -91.68 -45.45 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.642 -0.661 . . . . 0.0 110.164 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -75.52 -23.37 56.69 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.573 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 88.6 m -84.3 -19.74 33.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.601 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.496 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 14.7 t-20 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.541 ' HB2' ' CG ' ' A' ' 37' ' ' LYS . 47.8 Cg_endo -75.05 -1.47 11.27 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.837 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 86.8 m-85 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.104 -0.998 . . . . 0.0 110.096 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.484 0.659 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -93.92 146.47 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.568 -0.707 . . . . 0.0 109.531 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mttp -103.56 175.27 2.3 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 110.421 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.3 -33.82 22.92 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.101 1.579 . . . . 0.0 109.708 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -75.45 -36.5 60.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.612 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -77.74 -36.36 50.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.408 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.5 tmtt? -72.26 -14.97 61.9 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.212 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -76.44 -42.35 44.33 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.18 -21.79 60.61 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -77.79 -34.78 52.06 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.13 -8.35 56.82 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.616 . . . . 0.0 109.968 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.73 14.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.555 HG22 ' CE1' ' A' ' 70' ' ' PHE . 18.1 mt -78.29 -29.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.592 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -74.54 -32.46 62.45 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.562 0.696 . . . . 0.0 109.215 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -90.28 -5.52 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 0.0 109.866 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -82.7 -10.75 58.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.108 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.0 mt -103.15 -13.99 16.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 88.78 101.46 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.468 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.3 Cg_endo -72.53 152.2 53.9 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 124.348 1.709 . . . . 0.0 111.256 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 91.3 t -127.97 109.49 19.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 18.2 t30 57.47 24.07 9.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 84.77 40.62 8.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.491 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 87.7 m-85 -152.62 153.55 33.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.255 . . . . 0.0 111.749 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.592 HD13 ' CE2' ' A' ' 70' ' ' PHE . 6.7 mt -121.8 147.15 46.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' ASP . 58.8 p -95.16 143.21 26.77 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.288 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.6 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.87 -26.37 0.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 16.4 t0 -67.76 -26.04 65.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 0.0 110.134 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 84.7 mttt -91.1 -36.17 14.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 70' ' ' PHE . 68.2 t -75.76 -50.04 24.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.09 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HG3' ' CZ ' ' B' ' 111' ' ' PHE . 4.1 ttpt -34.61 -56.23 0.84 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.743 -0.598 . . . . 0.0 111.013 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -64.92 -33.51 51.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.326 1.172 . . . . 0.0 109.936 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 36' ' ' VAL . 2.6 t -67.56 -29.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.731 . . . . 0.0 110.002 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 24.7 mt -88.55 -27.1 21.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.148 -0.97 . . . . 0.0 110.204 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD12 ' CG ' ' A' ' 37' ' ' LYS . 19.8 mt -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -73.03 -13.77 61.28 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.611 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.533 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 1.4 p -80.25 7.4 9.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.463 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 43' ' ' SER . 14.4 tptt 64.65 8.64 4.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.0 110.561 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.536 HD22 ' HD2' ' A' ' 46' ' ' PRO . 17.2 mt -88.75 153.72 50.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.3 Cg_endo -73.51 176.75 8.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.696 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.548 HG11 ' O ' ' A' ' 47' ' ' VAL . 1.9 t -71.04 -10.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.83 -32.58 57.68 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.563 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.2 mm -81.98 -38.94 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.892 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 26.7 mt -74.98 -29.69 60.97 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.517 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.77 -25.09 75.38 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 8.5 ttm180 -101.05 -34.49 9.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.007 -0.702 . . . . 0.0 110.475 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.527 ' CG1' ' CG2' ' A' ' 77' ' ' VAL . 15.3 t -66.46 -41.76 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.774 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.6 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.0 t-105 -65.17 -51.87 58.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.702 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.0 mm-40 -50.9 -55.46 17.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.949 -1.094 . . . . 0.0 110.01 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 2.5 mt -64.38 -12.78 46.15 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.538 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 38.5 m -94.39 -35.85 12.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.757 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' TRP . 17.3 t0 -72.26 92.9 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.544 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 8.9 mm -72.55 -33.64 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.608 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 6.7 m-20 -92.43 -4.22 54.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.439 -0.788 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 28.9 p80 38.73 54.98 1.98 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.649 . . . . 0.0 110.644 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 62' ' ' ASP . 36.7 p-10 -125.77 18.34 7.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 108.793 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.45 32.77 45.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.7 mtp -150.86 161.79 42.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 111.578 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.481 HD11 ' CZ3' ' A' ' 54' ' ' TRP . 25.1 mt -135.42 110.4 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.022 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 27.1 t0 -70.0 169.32 13.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.087 -1.008 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.592 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 12.1 ptt180 -49.06 -41.98 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 109.952 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -80.85 -35.92 32.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.152 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HG3' ' CG1' ' A' ' 59' ' ' ILE . 1.7 tt0 -68.51 -55.35 12.0 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.915 0.864 . . . . 0.0 108.731 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CE2' HD13 ' A' ' 31' ' ' LEU . 23.2 t80 -50.01 -24.72 2.78 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -64.58 -49.1 72.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.669 0.747 . . . . 0.0 110.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.452 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 16.8 t -56.78 -25.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.571 -0.706 . . . . 0.0 110.178 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.538 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -88.19 -8.37 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 112.016 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.599 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 8.7 mmm -89.87 -30.35 17.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.375 -1.453 . . . . 0.0 110.147 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -85.52 -21.14 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.981 -1.074 . . . . 0.0 109.008 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.523 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.1 mt -83.53 -19.53 35.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 0.0 109.561 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 43' ' ' SER . 9.8 t -92.21 -44.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -70.28 -36.53 74.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 80.6 m -82.71 -8.52 59.59 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 109.58 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.512 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 122.145 0.974 . . . . 0.0 109.174 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.518 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 12.5 t-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.675 0.274 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.518 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.7 Cg_endo -74.93 -7.37 19.15 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.986 1.519 . . . . 0.0 111.076 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.589 ' CZ ' ' HG3' ' A' ' 37' ' ' LYS . 69.5 m-85 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.964 -1.085 . . . . 0.0 110.329 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.51 HG11 ' N ' ' A' ' 10' ' ' LYS . 41.0 t -98.41 152.9 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.841 . . . . 0.0 109.824 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.541 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -112.93 178.48 0.96 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.216 -0.927 . . . . 0.0 109.972 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.2 Cg_endo -71.78 -35.86 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.961 1.506 . . . . 0.0 109.772 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -73.21 -30.5 63.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 0.0 109.215 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -78.81 -43.79 24.52 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 13.5 tptp -65.32 -17.46 64.53 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -41.96 34.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.6 ptmt -79.27 -23.1 43.84 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.0 m-30 -75.43 -35.84 60.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 52.9 t0 -77.66 -9.04 58.76 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.46 -35.2 13.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.543 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -76.75 -32.96 21.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.589 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -73.5 -39.22 64.99 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.7 t70 -86.65 4.23 41.3 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -91.88 -10.93 37.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 108.938 179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.615 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -100.57 -6.95 24.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.79 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.1 Cg_endo -76.1 152.5 35.84 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.486 1.782 . . . . 0.0 110.852 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.4 t -117.72 108.38 24.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.171 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 17.4 t30 57.96 16.22 3.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 109.644 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.88 4.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 80.5 m-85 -145.96 146.24 30.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.266 . . . . 0.0 111.959 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.593 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.7 mt -117.46 139.73 50.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.483 ' OG ' ' HG3' ' A' ' 35' ' ' LYS . 79.9 p -84.42 139.91 31.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.574 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.08 -28.21 0.74 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.1 t0 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.635 -0.92 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HG3' ' OG ' ' A' ' 32' ' ' SER . 10.6 mttm -95.94 -33.91 12.0 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 70' ' ' PHE . 89.7 t -76.94 -42.28 32.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.533 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 23.2 ttmt -42.34 -49.68 12.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.6 Cg_endo -69.56 -33.65 16.91 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.099 1.052 . . . . 0.0 109.44 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.577 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -63.97 -35.38 73.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.437 0.637 . . . . 0.0 109.601 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.562 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 25.4 mt -87.89 -23.39 23.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.396 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.2 mt -74.03 -14.44 61.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 109.18 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -85.31 -3.66 58.9 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.122 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.589 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -85.9 15.3 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.527 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.24 13.23 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -0.994 . . . . 0.0 109.757 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.545 HD11 ' CB ' ' A' ' 80' ' ' ALA . 13.7 mt -100.23 153.95 37.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 0.0 110.717 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.597 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.8 Cg_endo -78.45 -179.09 5.13 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.137 1.598 . . . . 0.0 110.12 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.529 HG11 ' O ' ' A' ' 47' ' ' VAL . 10.8 t -78.47 -3.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -82.28 -35.5 27.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.259 -0.901 . . . . 0.0 109.439 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.597 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.4 mm -80.67 -38.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 33.9 mt -73.69 -25.99 60.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.84 -25.55 74.66 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 9.4 ttm180 -101.42 -31.98 10.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.98 -0.718 . . . . 0.0 110.135 179.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' ILE . 10.0 t -71.06 -34.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.526 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.585 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 2.5 t-105 -67.83 -53.18 28.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.127 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 11.5 mt-10 -45.92 -58.92 3.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.025 -1.047 . . . . 0.0 110.004 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . . . . . . . . . 2.8 mt -62.15 -18.32 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 108.61 179.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 45.9 t -87.78 -24.21 23.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t0 -102.78 72.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.715 -0.616 . . . . 0.0 109.584 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.448 ' O ' HG23 ' A' ' 59' ' ' ILE . 4.6 mt -60.62 -19.79 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.857 . . . . 0.0 110.718 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 46.9 p-10 -99.34 -18.16 17.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.919 -1.113 . . . . 0.0 109.481 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 20.9 m-70 58.59 46.83 14.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.441 -0.787 . . . . 0.0 110.985 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.459 ' OD2' ' OD2' ' A' ' 60' ' ' ASP . 48.7 p-10 -106.37 21.03 18.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 108.777 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 64.97 32.71 85.13 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 1.9 mmt -147.59 162.15 39.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.971 . . . . 0.0 110.849 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.585 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 12.7 mt -132.26 99.55 4.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.544 -0.723 . . . . 0.0 109.339 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.2 p30 -72.31 164.77 25.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.671 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.517 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.3 ptm180 -38.76 -43.82 0.95 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 111.601 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 12.3 m-20 -80.26 -33.47 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.992 . . . . 0.0 110.347 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.476 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 18.3 mt-10 -76.92 -48.1 19.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -0.91 . . . . 0.0 108.852 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.589 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 27.0 t80 -59.33 -18.42 38.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -73.6 -54.0 9.19 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.032 0.92 . . . . 0.0 109.263 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.561 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 59.6 t -53.09 -22.66 4.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 110.039 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.533 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -86.14 -17.16 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 111.713 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 8.7 mmm -82.17 -42.16 19.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.363 -1.461 . . . . 0.0 110.731 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.569 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -76.93 -18.44 58.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 108.773 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 7.2 mt -81.63 -24.76 36.16 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.631 0.729 . . . . 0.0 109.186 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 12.1 t -90.92 -34.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.597 -0.689 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 -29.57 64.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.383 -0.823 . . . . 0.0 110.843 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.97 -17.04 57.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.138 -0.976 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.545 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.498 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.01 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 6.6 t-20 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.503 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 43.7 Cg_endo -72.96 -40.67 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.843 1.444 . . . . 0.0 110.98 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 47.2 m-85 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.044 -1.035 . . . . 0.0 110.554 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.659 0.742 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -89.92 124.98 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -74.91 162.7 72.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 110.674 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.441 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 38.3 Cg_endo -67.42 -29.92 37.07 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.118 1.589 . . . . 0.0 108.747 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.69 -20.86 35.33 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.8 m-20 -85.24 -42.72 14.41 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -69.1 -20.44 64.07 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.533 -0.73 . . . . 0.0 109.157 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -74.32 -43.73 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.558 -0.714 . . . . 0.0 109.175 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.7 ptmt -73.65 -29.08 62.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.3 m-30 -67.45 -37.22 82.64 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.26 -10.4 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.685 -0.634 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.425 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -92.76 -31.94 14.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 28.3 mt -81.26 -28.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -75.8 -38.54 58.1 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.0 t0 -87.78 -0.33 56.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.66 -0.65 . . . . 0.0 109.881 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 1.7 m -89.73 -3.83 58.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 108.884 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -110.41 -8.94 14.63 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.0 t 83.79 98.4 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.3 Cg_endo -72.33 151.35 54.03 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.613 1.849 . . . . 0.0 110.812 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 50.2 t -122.93 104.67 14.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.7 t30 58.25 22.44 9.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 109.734 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 91.89 37.12 6.14 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 89.8 m-85 -151.16 151.62 32.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -1.182 . . . . 0.0 111.737 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.9 mt -119.0 151.36 38.35 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 35' ' ' LYS . 97.4 p -97.38 143.97 27.6 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.883 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.59 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.43 -27.65 0.16 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 1.2 m-20 -66.59 -30.59 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -1.075 . . . . 0.0 110.264 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.0 mttt -85.09 -35.79 21.59 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.582 HG22 ' CE2' ' A' ' 70' ' ' PHE . 55.7 t -80.06 -45.18 22.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.462 0.648 . . . . 0.0 110.316 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 5.2 tttt -40.65 -54.29 5.23 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.69 . . . . 0.0 110.789 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -67.01 -33.46 32.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.253 1.133 . . . . 0.0 109.796 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.489 HG23 HD13 ' A' ' 24' ' ' LEU . 2.3 t -66.7 -28.9 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.728 -0.607 . . . . 0.0 109.506 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.565 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 84.7 mt -88.05 -27.18 22.16 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 110.168 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.9 mt -73.81 -12.76 60.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.378 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 33.0 p-10 -80.09 -5.15 55.4 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.433 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -89.69 13.94 12.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.373 -0.83 . . . . 0.0 110.598 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.51 13.63 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.542 HD22 ' HD2' ' A' ' 46' ' ' PRO . 16.2 mt -94.9 154.19 39.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.022 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.6 174.39 12.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.096 1.577 . . . . 0.0 110.652 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 6.8 t -71.95 -4.27 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.529 -0.732 . . . . 0.0 109.389 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.59 -35.4 27.12 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.218 -0.927 . . . . 0.0 109.449 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.579 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.8 mm -79.79 -38.69 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.837 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 27.8 mt -70.41 -27.24 64.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.389 0.614 . . . . 0.0 109.403 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.507 ' HA2' ' ND2' ' B' ' 109' ' ' ASN . . . -70.25 -24.03 76.92 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.502 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 1.6 ttm180 -101.54 -31.47 10.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.761 -0.846 . . . . 0.0 110.896 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.553 ' CG1' HG22 ' A' ' 77' ' ' VAL . 12.5 t -68.32 -39.36 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.965 -1.085 . . . . 0.0 109.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.59 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.64 -50.29 58.68 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.57 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 51.2 mt-10 -49.32 -56.81 8.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.056 -1.027 . . . . 0.0 109.956 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.502 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -60.48 -16.2 34.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.731 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 66.2 m -93.02 -31.27 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.463 -0.773 . . . . 0.0 109.149 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 36.0 t0 -89.58 98.39 11.74 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.78 -22.22 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 111.076 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 58.7 p-10 -90.76 -16.54 28.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 110.067 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.0 m170 66.23 42.85 2.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.371 -0.83 . . . . 0.0 110.639 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 23.3 p-10 -111.72 17.22 20.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 109.602 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.465 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 64.55 34.8 90.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 40.9 mtp -150.78 162.03 41.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.087 -1.243 . . . . 0.0 110.805 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.532 ' CD1' HG12 ' A' ' 36' ' ' VAL . 9.4 mt -126.22 106.27 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.735 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 2.3 t70 -69.86 172.12 8.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.29 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.568 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -51.81 -34.74 41.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 111.048 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.81 -34.56 19.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.04 -1.038 . . . . 0.0 110.019 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 25.1 mt-10 -76.89 -38.94 52.6 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.582 ' CE2' HG22 ' A' ' 36' ' ' VAL . 38.6 t80 -63.01 -28.97 70.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.9 -51.49 64.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.995 0.902 . . . . 0.0 109.663 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.409 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 41.9 t -52.7 -28.03 12.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.494 0.664 . . . . 0.0 110.452 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.534 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -84.04 -13.61 52.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.319 -0.863 . . . . 0.0 111.862 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.1 mmm -85.82 -32.84 21.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.503 -1.373 . . . . 0.0 111.146 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.409 ' CE2' ' O ' ' A' ' 72' ' ' VAL . 4.4 p90 -84.47 -18.2 36.63 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.123 . . . . 0.0 108.675 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' A' ' 53' ' ' VAL . 4.4 mt -83.9 -13.74 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.553 HG22 ' CG1' ' A' ' 53' ' ' VAL . 52.0 t -91.22 -47.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.49 -0.756 . . . . 0.0 110.261 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -71.21 -29.89 65.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.279 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 31.2 t -82.09 -10.1 59.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.165 -0.959 . . . . 0.0 109.323 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.498 ' HB3' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 122.186 0.994 . . . . 0.0 109.02 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 16.1 t-20 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.5 -36.6 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.918 1.483 . . . . 0.0 110.713 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 95.5 m-85 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.047 -1.033 . . . . 0.0 110.037 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.51 0.671 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.5 137.8 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.414 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -95.74 173.37 4.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -70.99 -33.77 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.219 1.642 . . . . 0.0 109.993 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -27.48 39.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.3 m-20 -79.72 -40.03 29.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 22.4 tptp -72.31 -20.77 61.44 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.472 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.32 71.11 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.0 ptpt -74.84 -30.31 61.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.7 m-30 -64.86 -40.94 95.94 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.4 -8.67 56.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.281 0.562 . . . . 0.0 110.432 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -95.33 -33.81 12.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 36.0 mt -79.68 -27.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -75.83 -39.17 57.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 20.7 t0 -87.36 0.02 56.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.814 -0.553 . . . . 0.0 110.05 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.96 -7.55 53.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.628 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.9 mt -105.59 -14.38 15.3 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.1 t 90.68 97.2 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.65 151.75 41.79 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.62 1.853 . . . . 0.0 110.701 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.8 t -118.13 104.68 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.57 -0.706 . . . . 0.0 109.17 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 5.0 t30 58.56 15.02 3.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.787 . . . . 0.0 109.678 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.9 32.24 3.89 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -150.07 148.92 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.966 -1.314 . . . . 0.0 112.017 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 10.2 mt -114.41 136.39 53.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -82.0 141.56 33.14 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.811 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.482 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.51 -27.56 0.84 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.4 t0 -63.66 -23.53 67.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.549 -0.971 . . . . 0.0 110.05 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 11.9 mttm -98.52 -35.64 10.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.585 HG23 ' CE2' ' A' ' 70' ' ' PHE . 99.2 t -76.93 -42.16 32.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.569 0.7 . . . . 0.0 110.132 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.616 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 18.6 tttt -41.63 -53.94 7.06 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 111.346 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.31 -34.99 19.78 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.433 1.228 . . . . 0.0 109.907 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.512 ' CG2' HD12 ' A' ' 24' ' ' LEU . 2.7 t -60.57 -26.14 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.847 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 23.9 mt -96.9 -28.66 14.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.064 -1.022 . . . . 0.0 110.274 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 62.7 mt -69.66 -17.27 63.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.629 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.36 -6.68 58.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.575 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.475 ' OG ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -85.49 14.18 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 110.13 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 58.71 16.17 4.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.903 . . . . 0.0 110.2 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.547 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 15.9 mt -96.55 153.39 38.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 110.019 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.7 Cg_endo -76.02 176.32 10.19 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.112 1.585 . . . . 0.0 109.897 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.4 t -73.85 -3.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 46' ' ' PRO . 5.7 m-20 -81.11 -33.83 33.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.395 -0.816 . . . . 0.0 109.12 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.574 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.0 mm -82.73 -40.04 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.554 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 21.9 mt -73.32 -28.99 62.38 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -66.1 -24.24 71.71 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.561 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.47 -39.66 7.43 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.011 -0.7 . . . . 0.0 109.878 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.546 HG13 ' CG2' ' A' ' 77' ' ' VAL . 5.8 t -57.35 -45.41 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.041 -1.037 . . . . 0.0 109.751 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.533 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 4.3 t-105 -63.3 -53.14 57.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.336 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 85.7 mt-10 -54.87 -48.42 72.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.313 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.561 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 7.8 mt -62.4 -22.88 66.49 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 41.7 t -89.62 -30.13 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.506 0.67 . . . . 0.0 109.291 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -74.43 79.71 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.449 HG12 ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -60.43 -36.44 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.011 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.2 p30 -103.49 -20.09 14.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 33.2 m-70 69.41 41.8 1.26 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 2.7 p-10 -91.97 9.86 31.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.949 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.425 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 80.4 24.66 58.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 50.9 mtp -152.95 160.48 43.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.534 ' CD2' ' OG ' ' A' ' 57' ' ' SER . 13.6 mt -119.28 100.5 7.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.1 p30 -69.52 159.2 33.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.064 -1.022 . . . . 0.0 110.313 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.4 ptp180 -35.77 -43.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 111.251 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.488 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 35.8 t70 -75.89 -36.46 59.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.339 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.469 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 85.0 mt-10 -76.62 -43.11 39.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.004 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CE2' HD12 ' A' ' 31' ' ' LEU . 22.1 t80 -59.54 -20.52 56.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.13 -49.83 22.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.8 t -58.31 -24.75 25.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.351 0.596 . . . . 0.0 110.259 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 57' ' ' SER . . . -88.27 -9.38 53.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.349 -0.845 . . . . 0.0 111.282 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.579 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 3.3 mmt -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.924 -1.11 . . . . 0.0 110.361 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.553 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.3 p90 -77.41 -26.72 51.93 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.256 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.553 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 14.3 mt -69.03 -23.02 64.02 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.546 ' CG2' HG13 ' A' ' 53' ' ' VAL . 57.6 t -92.3 -63.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.49 0.662 . . . . 0.0 109.555 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -47.17 -27.93 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.554 -0.716 . . . . 0.0 111.637 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.473 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.5 m -80.65 -16.16 54.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.84 -1.162 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.547 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 121.366 -0.833 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.461 ' OD1' ' HD2' ' B' ' 110' ' ' PRO . 48.1 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.716 0.293 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.461 ' HD2' ' OD1' ' B' ' 109' ' ' ASN . 46.6 Cg_endo -75.88 -28.4 7.81 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.938 1.494 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 64.8 m-85 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.035 -1.041 . . . . 0.0 110.023 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.425 0.631 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 t -92.84 128.38 44.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.485 -0.759 . . . . 0.0 109.373 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.4 mttp -84.35 164.79 41.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.107 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.64 -30.24 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.933 1.491 . . . . 0.0 109.476 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -85.13 -25.3 27.57 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.575 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -77.59 -41.72 37.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 1.5 tmtt? -69.39 -23.63 63.75 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.071 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.76 93.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -38.81 65.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.3 m-30 -60.63 -21.98 63.3 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -90.35 -12.09 38.71 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.78 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -91.52 -33.38 15.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.526 HG23 ' CZ ' ' A' ' 70' ' ' PHE 0.253 41.2 mt -78.38 -29.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -76.81 -39.73 50.41 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.672 0.748 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.8 t70 -86.44 1.98 49.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.583 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -90.24 -10.27 44.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.086 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.3 mt -105.44 -12.93 15.8 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.1 t 87.24 96.2 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -75.49 152.38 38.45 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.509 1.794 . . . . 0.0 110.933 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 26.3 t -116.65 107.8 23.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 7.6 t30 58.76 15.13 3.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.348 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.94 32.26 4.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -144.32 149.5 36.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.0 111.859 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.588 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.8 mt -117.17 138.95 51.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 14.0 p -85.86 141.08 29.87 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.069 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.438 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.33 -26.71 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 29.1 t70 -61.25 -28.53 69.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -1.093 . . . . 0.0 109.736 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 46.8 mttm -94.11 -33.2 13.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.242 -0.911 . . . . 0.0 108.579 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.563 HG13 ' CD1' ' A' ' 65' ' ' LEU . 79.6 t -79.67 -44.3 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.463 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.578 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 25.2 tttt -40.2 -54.02 4.84 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.889 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -66.83 -36.44 23.68 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 109.683 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.585 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -59.74 -37.59 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.557 -0.714 . . . . 0.0 109.607 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.555 ' CD1' HG12 ' A' ' 36' ' ' VAL . 34.9 mt -83.89 -29.02 27.52 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.411 -0.806 . . . . 0.0 109.845 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.405 HD12 ' CG ' ' A' ' 37' ' ' LYS . 29.4 mt -74.01 -12.48 60.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.399 -0.813 . . . . 0.0 109.512 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -90.27 -4.98 56.82 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.125 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.526 ' CB ' HG11 ' A' ' 77' ' ' VAL . 60.5 p -84.13 8.87 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.2 OUTLIER 66.77 7.65 5.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.09 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.519 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 18.8 mt -93.18 155.87 40.72 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.3 Cg_endo -74.55 167.78 26.33 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.204 1.634 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 17.5 t -66.63 -7.78 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 47.4 t0 -77.33 -30.94 54.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.552 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.1 mm -84.69 -36.61 11.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.974 0.892 . . . . 0.0 108.943 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 11.5 mt -75.51 -25.59 57.38 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -75.6 -25.03 68.63 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.1 ttm180 -100.81 -29.67 12.12 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 49' ' ' ILE . 17.0 t -69.67 -51.03 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.565 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 1.5 t-105 -59.86 -53.63 55.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -45.43 -65.7 0.5 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.924 0.869 . . . . 0.0 110.12 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.418 HD12 ' O ' ' A' ' 52' ' ' ARG . 22.2 mt -56.76 -18.27 12.07 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.538 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 3.3 t -91.66 -17.29 25.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t70 -94.87 82.43 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.312 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -87.0 -20.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 110.892 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 5.8 p30 -94.52 -21.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 25.0 m-70 70.86 40.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.465 -0.772 . . . . 0.0 110.673 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 32.1 p-10 -101.89 15.13 29.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' MET . . . 62.29 31.85 80.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 74.8 mtp -154.41 161.29 41.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.366 -1.079 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 9.0 mt -116.9 101.11 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 109.344 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.5 p30 -69.67 160.85 30.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 110.339 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.511 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.8 ptt85 -33.88 -45.41 0.19 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.826 -0.546 . . . . 0.0 111.604 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -78.1 -41.25 35.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.437 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' OE2' ' OD2' ' A' ' 60' ' ' ASP . 44.8 mt-10 -67.77 -48.1 67.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.316 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.585 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 10.2 t80 -57.88 -17.88 19.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -75.37 -53.73 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.431 -0.793 . . . . 0.0 109.506 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 55.4 t -55.39 -27.13 20.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 179.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -90.25 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.815 . . . . 0.0 110.816 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.613 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.5 mmt -87.15 -50.02 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.662 -1.274 . . . . 0.0 110.066 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 4.2 p90 -74.51 -27.71 60.67 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.5 ' HB3' HG22 ' A' ' 53' ' ' VAL . 7.5 mt -62.95 -30.52 71.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 73' ' ' ALA . 18.0 t -91.17 -23.8 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.896 -0.503 . . . . 0.0 109.942 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.43 -21.29 23.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.449 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -84.59 -18.23 36.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.519 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.076 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.482 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 1.1 t-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.502 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.5 Cg_endo -82.51 21.15 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.87 1.458 . . . . 0.0 111.056 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 78.8 m-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.954 -1.092 . . . . 0.0 110.071 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.278 0.561 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 10' ' ' LYS . 49.3 t -106.13 157.91 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mttt -108.15 170.56 5.4 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.1 Cg_endo -66.17 -32.69 42.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.665 1.35 . . . . 0.0 109.915 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.6 mt-10 -70.07 -32.03 69.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.454 -0.779 . . . . 0.0 109.402 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.4 m-20 -77.04 -40.94 44.52 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 8.2 tptm -65.3 -15.87 62.97 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.681 0.753 . . . . 0.0 109.073 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 -27.44 39.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 1.8 mtpt -90.72 -38.11 13.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.9 m-30 -66.18 -27.07 67.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.1 t70 -89.42 -12.72 39.45 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.06 -28.24 17.28 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 24' ' ' LEU 0.255 54.0 mt -82.91 -35.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -70.74 -39.44 73.31 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.751 0.786 . . . . 0.0 108.949 178.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -87.35 -1.65 58.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.801 -0.562 . . . . 0.0 110.121 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 8.5 t -87.0 -11.37 50.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.01 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.0 mt -100.45 -10.7 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.72 97.08 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -74.9 149.52 37.31 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.308 1.688 . . . . 0.0 110.752 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.6 t -118.13 108.83 25.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 25.5 t30 58.91 22.29 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.583 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 87.62 39.56 7.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.518 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 90.6 m-85 -151.16 154.6 37.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.305 -1.115 . . . . 0.0 111.615 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 70' ' ' PHE . 10.8 mt -123.07 137.21 54.99 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.506 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 1.3 p -91.62 147.32 23.09 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.954 -1.091 . . . . 0.0 110.404 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -41.72 -27.93 0.37 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.458 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 13.3 t70 -62.09 -25.72 67.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.996 . . . . 0.0 110.411 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.7 mttp -101.64 -28.41 12.52 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.04 -1.037 . . . . 0.0 108.856 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 40' ' ' LEU . 91.6 t -83.81 -48.47 17.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.487 -0.758 . . . . 0.0 110.755 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.5 ttpp -41.53 -51.26 8.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.8 Cg_endo -67.83 -32.63 29.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.142 1.075 . . . . 0.0 109.575 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -66.92 -36.61 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.686 -0.634 . . . . 0.0 109.62 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CD1' HG13 ' A' ' 36' ' ' VAL . 58.0 mt -82.33 -25.43 33.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.812 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.448 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 39.4 mt -74.51 -11.56 60.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.12 -10.33 57.87 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.078 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.591 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -81.71 8.91 8.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 43' ' ' SER . 1.3 ttmt 64.04 11.11 5.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 110.124 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.54 HD22 ' HD2' ' A' ' 46' ' ' PRO . 14.5 mt -88.84 154.14 49.99 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.016 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.571 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.4 Cg_endo -75.0 172.32 16.61 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.946 1.498 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.539 HG13 ' CA ' ' B' ' 111' ' ' PHE . 5.9 t -70.21 -5.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 109.725 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -80.73 -33.09 35.43 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.234 -0.917 . . . . 0.0 109.386 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.571 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.7 mm -81.5 -39.9 17.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.567 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 19.7 mt -70.01 -28.64 65.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.54 -24.45 75.21 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.51 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 7.9 ttm-85 -101.99 -33.99 9.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.905 -0.762 . . . . 0.0 110.888 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.568 ' CG1' ' CG2' ' A' ' 77' ' ' VAL . 22.7 t -67.84 -36.22 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.846 -1.159 . . . . 0.0 109.264 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.1 t-105 -68.32 -49.88 57.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.281 -0.967 . . . . 0.0 109.435 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.5 mt-10 -56.01 -56.33 22.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.466 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.51 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -59.38 -15.67 18.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.101 -1.0 . . . . 0.0 108.54 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 28.5 t -94.22 -30.99 14.3 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -85.42 98.22 10.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.692 -0.63 . . . . 0.0 110.08 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.3 mt -96.15 -21.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.917 -179.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -95.28 -13.98 24.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 24.1 m170 61.4 44.4 9.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.415 -0.803 . . . . 0.0 110.787 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 20.8 p-10 -106.83 18.56 21.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.135 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.523 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 61.49 30.42 74.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.523 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 3.3 mmm -148.97 161.07 42.65 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.327 -1.102 . . . . 0.0 109.255 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.55 HD11 ' CG1' ' A' ' 36' ' ' VAL . 8.9 mt -111.86 107.81 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.852 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -68.21 148.99 50.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.131 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.549 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -39.57 -37.82 0.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.381 -0.824 . . . . 0.0 110.259 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.37 -36.62 53.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 85.9 mt-10 -73.04 -51.21 19.01 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CD2' HD11 ' A' ' 31' ' ' LEU . 27.2 t80 -50.0 -25.94 3.82 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -69.74 -54.58 13.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.071 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.547 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 52.4 t -53.65 -22.65 6.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 109.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.506 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -89.24 -14.78 35.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.275 -0.89 . . . . 0.0 111.937 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.558 ' HA ' ' CE ' ' A' ' 74' ' ' MET . 7.3 mmm -81.77 -41.07 21.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.411 -1.431 . . . . 0.0 110.491 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.566 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 p90 -76.79 -25.52 53.41 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.297 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.9 mt -72.35 -27.49 62.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.514 0.673 . . . . 0.0 109.267 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.591 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 33.3 t -91.59 -21.84 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.658 -0.652 . . . . 0.0 110.524 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 -22.08 22.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 26.7 m -83.74 -17.4 41.37 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.473 -0.767 . . . . 0.0 109.481 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.539 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.377 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' B' ' 111' ' ' PHE . 24.6 t-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.63 27.62 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.891 1.469 . . . . 0.0 111.869 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 62.6 m-85 . . . . . 0 N--CA 1.497 1.875 0 O-C-N 120.726 -1.234 . . . . 0.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.492 0.663 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.633 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 22.9 t -96.02 112.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.601 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.534 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -88.28 -177.53 0.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.955 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -70.12 -37.44 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.748 1.394 . . . . 0.0 109.789 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.7 pt-20 -70.94 -30.22 66.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.8 m-20 -77.89 -42.44 33.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -65.38 -33.82 76.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.48 62.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -72.31 -26.97 62.16 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.0 m-30 -74.03 -36.31 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.756 0.789 . . . . 0.0 109.147 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.9 t70 -74.69 -9.1 58.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.796 -0.565 . . . . 0.0 110.618 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.75 -32.26 13.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.583 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 72.5 mt -80.06 -31.46 13.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.606 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -72.9 -41.96 64.08 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.7 t70 -86.46 3.33 44.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 110.069 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.56 -7.49 50.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.182 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 2.2 mt -106.34 -8.85 17.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 83.06 92.2 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.7 Cg_endo -72.76 151.09 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.303 1.686 . . . . 0.0 111.134 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 75.3 t -122.52 104.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 67.66 22.61 8.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.387 -0.821 . . . . 0.0 108.962 -178.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 83.84 37.84 11.17 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 82.6 m-85 -148.7 147.27 28.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 111.513 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 15.5 mt -114.59 132.84 56.21 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.0 p -76.72 144.39 39.35 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.56 -27.09 0.28 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.9 t70 -66.41 -28.15 68.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.512 -0.993 . . . . 0.0 110.477 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.5 mttp -90.84 -35.74 14.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.996 -1.065 . . . . 0.0 108.223 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.519 ' CG1' HD13 ' A' ' 65' ' ' LEU . 94.9 t -77.66 -45.11 28.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.625 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 tttt -37.84 -54.63 2.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.708 -0.62 . . . . 0.0 110.951 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.8 Cg_endo -67.05 -34.68 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.495 1.261 . . . . 0.0 110.028 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.604 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.1 t -61.99 -27.01 41.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 110.117 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.599 ' CD1' ' CZ ' ' B' ' 111' ' ' PHE . 24.1 mt -94.16 -29.03 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 37' ' ' LYS . 8.8 mt -74.84 -15.28 60.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.92 -1.112 . . . . 0.0 108.96 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -13.57 59.66 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.944 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.581 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 27.4 p -82.87 11.7 5.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 0.0 110.326 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 12.21 4.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.561 HD13 ' CB ' ' A' ' 80' ' ' ALA . 16.0 mt -87.04 155.66 55.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.7 Cg_endo -77.4 168.95 22.03 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.026 1.54 . . . . 0.0 109.548 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -69.77 -4.34 3.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 -30.74 39.2 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.311 -0.868 . . . . 0.0 109.103 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.558 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 11.4 mm -85.35 -36.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.882 0.848 . . . . 0.0 108.884 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.592 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -77.31 -26.17 51.98 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.16 -26.91 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.624 ' CZ ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.96 -36.93 8.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 122.039 -0.683 . . . . 0.0 110.566 179.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 76' ' ' LEU . 6.8 t -59.73 -41.44 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.044 -1.035 . . . . 0.0 110.128 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.6 t-105 -66.98 -51.64 52.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.929 -1.107 . . . . 0.0 109.716 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.6 mt-10 -52.3 -59.92 3.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 110.481 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.624 ' CD1' ' CZ ' ' A' ' 52' ' ' ARG . 1.2 mt -59.95 -30.14 68.88 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.751 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.546 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 44.3 t -75.29 -29.76 60.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.327 -0.858 . . . . 0.0 108.809 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -70.42 62.41 0.24 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.578 -0.701 . . . . 0.0 109.54 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.513 HG23 HD11 ' A' ' 59' ' ' ILE . 43.4 mm -43.21 -33.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.992 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 1.6 m-20 -99.85 -20.7 16.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 44.3 m-70 59.33 38.47 23.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.6 -1.34 44.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 99.1 20.74 17.33 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.6 mtp -153.26 161.3 42.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.593 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.519 HD13 ' CG1' ' A' ' 36' ' ' VAL . 12.6 mt -118.98 107.07 13.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.58 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.5 p30 -75.15 160.67 30.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.886 -1.134 . . . . 0.0 109.706 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.606 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ppt_? -36.88 -46.33 0.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.671 -0.643 . . . . 0.0 111.741 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 1.7 t70 -72.75 -38.87 67.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.096 -1.002 . . . . 0.0 110.268 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.505 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 50.7 mt-10 -71.33 -46.63 60.16 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 108.791 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.604 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 26.7 t80 -59.03 -18.6 36.13 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.463 ' HB3' ' HE2' ' A' ' 14' ' ' LYS . . . -76.01 -50.57 14.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.1 t -59.89 -24.21 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.586 -0.696 . . . . 0.0 109.679 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.36 -4.99 56.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.289 -0.882 . . . . 0.0 110.877 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.553 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.5 mmt -84.44 -46.21 11.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.633 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 2.1 p90 -76.01 -29.36 58.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 53' ' ' VAL . 4.5 mt -60.42 -27.8 67.76 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.581 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 77.2 t -92.55 -41.89 13.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.624 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.39 -29.22 59.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.355 -0.841 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 82.6 m -80.83 -11.82 59.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.561 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.247 -0.908 . . . . 0.0 108.554 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 18.2 t-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.583 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -76.19 -29.36 6.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.096 1.577 . . . . 0.0 111.207 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 40.3 m-85 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.018 -1.051 . . . . 0.0 110.7 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.329 0.585 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.449 HG12 ' HB3' ' A' ' 13' ' ' ASP . 39.8 t -99.46 127.37 52.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.602 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.502 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -83.79 175.35 4.79 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.8 Cg_endo -67.71 -34.91 23.48 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.885 1.466 . . . . 0.0 109.412 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.09 -28.11 61.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.437 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -82.21 -38.86 23.94 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 8.2 tttt -70.43 -18.46 63.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -72.42 -44.93 61.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.1 ptmm? -73.66 -18.24 61.05 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -83.33 -28.6 28.91 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -84.98 -9.68 57.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.695 -0.628 . . . . 0.0 110.452 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.82 -31.73 15.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.583 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 95.5 mt -80.82 -37.6 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -66.27 -33.89 76.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -90.0 -6.44 55.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.638 -0.664 . . . . 0.0 109.806 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 t -83.46 -9.77 58.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 108.93 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.7 mt -104.69 -11.53 16.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 84.37 99.59 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.017 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -76.06 152.37 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.149 1.605 . . . . 0.0 110.727 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 51.0 t -121.52 106.65 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.088 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.4 t30 60.62 17.58 7.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.296 -0.877 . . . . 0.0 109.306 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 95.43 36.02 5.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 81.8 m-85 -150.38 144.42 25.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 111.964 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 70' ' ' PHE . 8.6 mt -109.07 143.33 38.54 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.499 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 60.3 p -92.01 144.6 25.28 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.293 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -42.9 -26.21 0.43 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -69.8 -23.85 63.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.939 . . . . 0.0 110.383 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 12.9 mttp -93.69 -35.01 13.03 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.549 HG12 ' CD1' ' A' ' 40' ' ' LEU . 95.7 t -75.94 -39.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.967 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.82 -56.65 3.0 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.233 -0.917 . . . . 0.0 110.95 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.3 Cg_endo -65.92 -32.85 44.29 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.675 1.355 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 4.6 t -65.18 -30.04 49.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.921 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.639 ' CD1' ' CZ ' ' B' ' 111' ' ' PHE . 22.5 mt -93.05 -36.24 12.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 6.6 mt -70.88 -14.18 62.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.109 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -78.81 -13.93 59.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.459 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.521 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.8 OUTLIER -79.18 6.15 10.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.648 -0.658 . . . . 0.0 110.263 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.2 ttpt 67.39 15.7 9.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD13 ' CB ' ' A' ' 80' ' ' ALA . 16.1 mt -96.7 154.38 38.43 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.6 178.92 6.96 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 109.957 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -75.35 -1.96 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.44 -32.84 23.85 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.231 -0.918 . . . . 0.0 109.326 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.581 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.2 mm -84.85 -35.77 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.989 0.9 . . . . 0.0 108.735 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.541 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 25.3 mt -79.76 -23.37 42.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.07 -24.78 75.12 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.467 ' O ' HD13 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -101.28 -30.55 11.45 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.85 -0.794 . . . . 0.0 110.087 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.54 ' CG1' HG23 ' A' ' 77' ' ' VAL . 24.6 t -69.25 -38.47 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.228 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.583 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.8 t-105 -65.93 -50.79 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.08 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.7 mt-10 -56.84 -57.45 12.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.292 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.467 HD13 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -59.87 -15.13 18.87 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.042 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.557 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 30.3 t -94.78 -36.76 11.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' OD1' ' CE2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -74.65 89.75 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 111.01 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 15.7 mm -60.74 -32.24 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.13 -0.981 . . . . 0.0 109.384 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.0 109.693 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 30.1 p80 40.74 40.54 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.424 0.63 . . . . 0.0 110.57 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.51 0.43 57.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.323 -0.86 . . . . 0.0 109.042 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.541 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 101.62 18.85 17.27 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.541 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.5 mmm -146.89 160.85 41.81 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.148 -1.207 . . . . 0.0 109.818 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.518 ' CD2' ' HG2' ' A' ' 69' ' ' GLU . 12.4 mt -120.05 110.3 16.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.222 -0.924 . . . . 0.0 110.036 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 9.1 t70 -69.38 169.56 12.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.116 -0.99 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.4 ptm180 -51.31 -40.34 58.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 3.1 t70 -81.11 -28.85 35.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.252 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 4.8 tt0 -74.51 -44.74 49.9 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.617 0.723 . . . . 0.0 109.198 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.583 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 44.2 t80 -62.6 -18.56 62.43 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.37 -49.05 24.32 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.938 0.875 . . . . 0.0 109.145 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.513 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 30.2 t -55.6 -30.75 27.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.469 0.652 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.09 -4.32 57.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.795 . . . . 0.0 111.759 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.578 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmt -85.39 -44.18 13.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.642 -1.287 . . . . 0.0 109.984 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 6.2 p90 -79.19 -23.13 44.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 53' ' ' VAL . 4.3 mt -72.75 -25.41 61.19 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.54 HG23 ' CG1' ' A' ' 53' ' ' VAL . 44.6 t -89.93 -44.75 15.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.5 -27.86 65.55 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.04 -15.16 58.61 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.042 -1.036 . . . . 0.0 109.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.553 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 20.3 t-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.571 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 47.5 Cg_endo -73.8 -25.46 14.49 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.953 1.502 . . . . 0.0 110.982 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.639 ' CZ ' ' CD1' ' A' ' 40' ' ' LEU . 71.5 m-85 . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.992 -1.067 . . . . 0.0 110.509 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.365 0.602 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 75' ' ' PHE . 44.0 t -95.79 155.0 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.621 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -90.17 163.96 29.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 109.923 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.64 -30.17 23.24 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.011 1.532 . . . . 0.0 109.683 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.3 mt-10 -86.68 -18.63 30.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.475 0.655 . . . . 0.0 109.462 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.577 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 3.6 m-20 -79.94 -43.98 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.518 ' HD3' ' CB ' ' A' ' 71' ' ' ALA . 7.2 tptp -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.72 74.92 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -78.04 -44.54 26.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 6.2 m-30 -54.73 -24.65 23.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.3 -14.57 40.5 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.527 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.87 -29.69 15.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 24' ' ' LEU 0.252 51.1 mt -80.03 -32.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 177.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.639 0.733 . . . . 0.0 109.204 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -90.41 -8.56 50.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.71 -0.619 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -13.72 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 108.867 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.66 ' O ' ' CB ' ' A' ' 25' ' ' SER . 10.9 mt -93.68 -54.53 3.6 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.66 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 m 137.54 96.41 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.479 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -71.45 146.59 50.4 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 123.948 1.499 . . . . 0.0 110.541 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 20.8 t -116.76 97.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 1.5 t30 60.56 11.32 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 110.79 33.49 2.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 82.3 m-85 -150.68 150.04 30.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.181 -1.188 . . . . 0.0 112.228 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.592 HD12 ' CD2' ' A' ' 70' ' ' PHE . 9.0 mt -117.28 136.08 53.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 34' ' ' ASP . 91.0 p -85.2 141.32 30.23 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.261 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -40.45 -27.93 0.17 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -62.43 -26.61 68.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -1.034 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.426 ' O ' HG21 ' A' ' 39' ' ' VAL . 53.2 mttt -96.53 -31.81 12.59 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.106 -0.996 . . . . 0.0 108.481 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 40' ' ' LEU . 99.0 t -82.36 -46.88 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.208 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -42.79 -53.74 9.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.75 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -65.81 -34.03 41.46 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 109.288 -1.081 . . . . 0.0 109.288 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.484 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.47 -30.43 49.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.493 0.663 . . . . 0.0 109.54 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 88.4 mt -86.72 -24.45 25.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.439 -0.788 . . . . 0.0 110.31 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD1' ' HD3' ' A' ' 37' ' ' LYS . 19.4 mt -79.31 -13.57 59.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.54 -6.88 58.77 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.829 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.06 12.1 6.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 109.934 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 64.71 17.77 11.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 109.98 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.553 HD23 ' HD2' ' A' ' 46' ' ' PRO . 15.1 mt -100.38 149.78 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.446 -0.784 . . . . 0.0 110.627 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.587 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.8 Cg_endo -75.88 175.34 11.44 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.059 1.557 . . . . 0.0 109.97 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' B' ' 111' ' ' PHE . 2.4 t -72.39 -2.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.25 -32.11 24.62 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.268 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.587 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.6 mm -84.35 -36.5 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.557 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 20.1 mt -75.62 -27.35 58.42 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.69 -24.06 75.37 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.478 ' O ' HD11 ' A' ' 56' ' ' LEU . 5.7 ttm105 -101.16 -33.96 9.89 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.942 -0.74 . . . . 0.0 109.935 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.536 ' CG1' HG23 ' A' ' 77' ' ' VAL . 38.0 t -69.26 -44.29 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.954 -1.091 . . . . 0.0 109.418 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.0 t-105 -60.78 -45.99 92.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.322 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 4.7 mm-40 -58.41 -55.81 30.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.243 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.478 HD11 ' O ' ' A' ' 52' ' ' ARG . 3.8 mt -62.36 -14.42 39.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 108.575 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 73' ' ' ALA . 1.4 t -95.14 -29.52 14.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.348 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.549 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 6.0 t0 -77.58 82.15 4.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.097 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.499 HG23 HD11 ' A' ' 59' ' ' ILE . 38.3 mm -57.89 -35.41 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 15.8 m-20 -96.84 -18.76 19.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 86.5 m-70 57.34 48.82 14.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.988 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -115.58 23.89 12.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.459 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 72.98 27.83 67.92 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.0 mtt -151.17 160.94 43.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.47 HD22 ' OG ' ' A' ' 57' ' ' SER . 10.9 mt -125.75 110.03 13.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.922 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.5 t70 -69.55 168.51 14.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.0 109.357 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.578 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.3 ptt180 -50.74 -39.47 52.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.523 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 37.7 m-20 -79.78 -33.08 40.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.228 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.481 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 33.5 mt-10 -73.53 -42.99 61.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CD2' HD12 ' A' ' 31' ' ' LEU . 35.9 t80 -58.62 -27.38 64.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.518 ' CB ' ' HD3' ' A' ' 14' ' ' LYS . . . -66.89 -46.86 73.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 110.092 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 61.6 t -58.62 -25.67 29.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.611 0.72 . . . . 0.0 109.86 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -89.67 -9.0 51.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.818 . . . . 0.0 112.186 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 4.4 mmm -85.47 -44.1 13.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.602 -1.311 . . . . 0.0 110.386 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.565 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -76.67 -26.83 55.24 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.31 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.565 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.3 mt -69.41 -23.99 63.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 61.8 t -91.4 -46.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.807 -0.558 . . . . 0.0 109.626 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.33 -28.71 68.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.7 -0.625 . . . . 0.0 110.908 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . 0.43 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 5.9 t -80.45 -14.96 57.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.171 -0.956 . . . . 0.0 109.969 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.541 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.3 -1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.068 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.477 ' ND2' ' HG2' ' A' ' 55' ' ' GLU . 42.9 t-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.57 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -75.88 9.74 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.832 1.438 . . . . 0.0 111.632 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 98.9 m-85 . . . . . 0 N--CA 1.499 1.979 0 O-C-N 120.778 -1.201 . . . . 0.0 110.366 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.412 0.625 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 46.3 t -101.23 134.92 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.777 . . . . 0.0 110.055 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -91.79 -179.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.385 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.7 Cg_endo -69.47 -36.47 11.53 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.941 1.495 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.77 -27.12 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 109.957 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 13.0 m-20 -80.93 -38.12 28.38 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.242 -0.911 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 2.2 tttt -77.13 -21.27 54.44 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.948 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.92 -39.35 87.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.72 -24.47 58.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 12.3 m-30 -76.96 -32.2 57.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -11.7 60.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.682 -0.636 . . . . 0.0 110.029 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.6 -31.61 17.49 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.584 HG21 ' CE1' ' A' ' 70' ' ' PHE . 25.6 mt -81.47 -37.0 15.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -68.26 -34.71 76.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.8 t0 -90.49 -4.63 56.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.626 -0.672 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 25.8 t -85.99 -4.91 59.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -0.97 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.612 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -109.47 -14.96 14.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.1 t 91.22 101.24 0.02 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.237 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' PRO . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -76.03 154.19 37.55 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.416 1.745 . . . . 0.0 110.607 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 94.3 t -122.6 102.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.497 -0.752 . . . . 0.0 109.306 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.4 t30 58.06 18.65 5.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 100.91 36.46 3.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 29' ' ' GLY . 86.9 m-85 -153.28 145.44 23.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.848 -1.384 . . . . 0.0 112.003 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.561 HD12 ' CD2' ' A' ' 70' ' ' PHE . 10.1 mt -113.65 138.47 50.15 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.497 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 96.5 p -88.64 146.86 24.85 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.21 -26.11 0.32 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 32' ' ' SER . 56.9 m-20 -63.82 -26.13 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -1.024 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.7 mttt -96.17 -35.75 11.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.091 -1.006 . . . . 0.0 108.507 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.525 HG13 ' CD1' ' A' ' 65' ' ' LEU . 63.0 t -79.18 -41.35 22.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.156 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 3.1 ttpt -41.31 -55.39 5.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.652 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.3 Cg_endo -67.85 -34.72 23.21 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.559 1.294 . . . . 0.0 109.935 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.603 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.1 t -59.71 -34.16 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 109.839 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 20.5 mt -88.77 -27.25 21.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.804 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 61.1 mt -71.99 -12.26 61.16 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 109.128 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -87.72 -4.52 58.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.989 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.493 ' OG ' HG13 ' A' ' 77' ' ' VAL . 1.2 m -86.04 8.62 19.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 13.14 4.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.095 -1.003 . . . . 0.0 109.747 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.566 HD12 ' CG2' ' A' ' 49' ' ' ILE . 16.9 mt -95.56 156.42 37.51 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.9 Cg_endo -73.26 167.64 26.81 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 124.141 1.6 . . . . 0.0 109.888 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' B' ' 111' ' ' PHE . 1.2 t -65.11 -9.32 7.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.263 -0.898 . . . . 0.0 109.321 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.3 m-20 -76.58 -30.46 57.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.344 -0.848 . . . . 0.0 109.214 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG2' HD12 ' A' ' 45' ' ' LEU . 13.4 mm -84.58 -38.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 122.002 0.906 . . . . 0.0 108.78 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . 0.565 ' HB2' ' CD1' ' B' ' 111' ' ' PHE . 10.6 mt -78.5 -26.86 46.04 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.57 0.7 . . . . 0.0 109.252 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . 0.514 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -81.18 -24.21 57.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.689 ' NH2' ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -101.24 -26.16 13.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.147 -0.619 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 49' ' ' ILE . 12.6 t -75.77 -43.23 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.774 -1.204 . . . . 0.0 107.869 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 1.5 t-105 -55.28 -49.04 73.12 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.442 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.0 mm-40 -53.75 -54.89 31.77 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 0.0 109.781 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.689 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 8.2 mt -61.37 -15.85 40.48 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 108.718 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 31.8 m -94.07 -38.96 10.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.583 -0.698 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 54' ' ' TRP . 4.8 t0 -60.94 100.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 110.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.526 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -83.48 -20.82 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.451 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 19.5 m-20 -105.35 -16.31 14.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.438 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' HIS . . . . . 0.45 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 6.9 m170 60.57 43.84 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.973 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 10.5 p30 -112.84 -6.82 13.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.527 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.526 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 100.95 23.39 9.88 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' MET . . . . . 0.526 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.0 mmm -147.57 161.16 41.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.222 -1.164 . . . . 0.0 109.374 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.525 ' CD1' HG13 ' A' ' 36' ' ' VAL . 7.9 mt -121.36 107.76 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.083 -1.011 . . . . 0.0 110.325 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 61.0 t0 -69.61 169.29 13.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.96 -1.088 . . . . 0.0 110.114 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.1 ptt180 -50.56 -37.83 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.505 -0.747 . . . . 0.0 109.976 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.416 ' OD2' ' HG3' ' A' ' 67' ' ' ARG . 9.2 m-20 -78.65 -32.86 47.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.64 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 39.3 mt-10 -76.71 -41.64 44.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.349 -0.844 . . . . 0.0 109.045 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 9.3 t80 -61.21 -25.38 67.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.526 -0.734 . . . . 0.0 109.242 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.59 -47.08 64.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.794 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' VAL . . . . . 0.606 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 92.0 t -61.29 -23.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.526 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.45 -2.95 57.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 110.835 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' MET . . . . . 0.606 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 16.1 mmt -89.59 -46.21 8.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.929 -1.107 . . . . 0.0 109.658 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.64 ' CD2' ' CG2' ' A' ' 9' ' ' VAL . 2.0 p90 -77.61 -17.91 57.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.244 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 53' ' ' VAL . 9.6 mt -77.07 -26.5 53.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.493 HG13 ' OG ' ' A' ' 43' ' ' SER . 79.6 t -91.87 -50.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.386 0.612 . . . . 0.0 109.773 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -33.52 70.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.607 -0.683 . . . . 0.0 111.54 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.6 m -77.48 -14.46 59.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.008 -1.057 . . . . 0.0 109.592 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.507 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' ASN . . . . . 0.518 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 5.4 t-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.749 0.309 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' PRO . . . . . 0.518 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.5 Cg_endo -74.87 -21.52 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.93 1.49 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 111' ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 85.4 m-85 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.097 -1.002 . . . . 0.0 110.003 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.546 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -84.3 121.08 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.535 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.01 -27.43 0.13 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 110.245 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.546 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.1 t -96.98 161.79 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.489 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -118.1 178.1 1.12 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.0 110.663 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.489 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.3 Cg_endo -73.26 -35.75 4.76 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.191 1.627 . . . . 0.0 110.15 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -26.16 37.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 72.8 m-20 -81.47 -38.84 25.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.936 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.417 ' HD3' ' HB3' ' A' ' 71' ' ' ALA . 8.2 tptp -69.84 -20.49 63.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.57 71.02 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.588 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 9.3 ptpt -75.25 -25.37 57.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.6 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.0 m-30 -71.72 -36.77 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -74.59 -9.85 58.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.746 -0.596 . . . . 0.0 110.318 -179.717 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.42 -33.92 15.05 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.571 HG23 ' CE1' ' A' ' 70' ' ' PHE . 16.4 mt -77.29 -36.46 24.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.564 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.92 -40.0 79.33 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.692 0.758 . . . . 0.0 109.112 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.495 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -86.91 0.9 54.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.658 -0.651 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -6.18 55.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 108.996 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.592 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.6 mt -107.1 -9.99 16.02 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.8 92.05 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 121.195 0.521 . . . . 0.0 109.61 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -73.34 153.4 50.56 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.421 1.748 . . . . 0.0 110.994 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.53 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 94.1 t -121.58 114.13 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.74 . . . . 0.0 109.188 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 52.14 19.8 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.786 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.5 38.23 4.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.4 m-85 -150.43 147.32 27.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.878 -1.366 . . . . 0.0 112.639 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.602 HD13 ' CE2' ' A' ' 70' ' ' PHE . 10.3 mt -118.83 137.69 53.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ASP . 67.1 p -89.31 145.58 25.28 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.014 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.496 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.82 -27.54 0.18 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.1 t0 -61.52 -27.26 68.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -1.01 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 29.6 mttp -96.44 -32.85 12.12 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.096 -1.002 . . . . 0.0 108.551 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.576 HG21 ' CD2' ' A' ' 70' ' ' PHE . 60.6 t -79.6 -50.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.188 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.07 -53.66 3.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.913 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -65.97 -36.07 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 N-CA-C 109.174 -1.125 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 24' ' ' LEU . 2.6 t -64.09 -32.42 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.529 ' CD1' HG13 ' A' ' 36' ' ' VAL . 60.9 mt -86.3 -25.77 25.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.625 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 62.7 mt -77.03 -11.7 59.84 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.306 -0.871 . . . . 0.0 109.44 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 63.2 t-20 -86.49 -8.86 57.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.024 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.534 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -81.23 6.65 13.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.984 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.7 tptt 65.69 11.3 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -0.99 . . . . 0.0 109.553 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.545 HD23 ' HD2' ' A' ' 46' ' ' PRO . 16.2 mt -95.18 152.55 39.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.843 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -73.53 168.98 23.39 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.965 1.508 . . . . 0.0 110.669 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.538 ' CG1' ' HB3' ' B' ' 111' ' ' PHE . 10.4 t -65.81 -10.54 10.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -30.56 58.93 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.243 -0.911 . . . . 0.0 108.958 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 16.1 mm -83.03 -40.32 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.585 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 10.9 mt -72.82 -30.23 63.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.98 -25.02 76.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.542 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 0.1 OUTLIER -100.7 -31.71 11.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.833 -0.804 . . . . 0.0 110.043 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.532 ' CG1' HG22 ' A' ' 77' ' ' VAL . 25.6 t -72.08 -34.05 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.336 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CZ2' ' O ' ' B' ' 108' ' ' THR . 3.3 t-105 -73.25 -51.98 15.67 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.802 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.483 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.5 mm-40 -51.6 -58.25 6.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.951 -1.093 . . . . 0.0 110.088 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 5.5 mt -61.32 -14.54 27.82 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.872 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.517 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 2.9 t -94.03 -31.76 14.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.538 -0.726 . . . . 0.0 109.699 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 3.0 t0 -72.56 86.75 1.19 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.482 -0.762 . . . . 0.0 110.159 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.552 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.3 mm -65.94 -30.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 5.2 m-20 -99.01 -16.17 18.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.0 109.89 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.408 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 92.3 m-70 55.33 48.32 19.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.529 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 7.8 p30 -122.4 26.49 8.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.446 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 72.44 32.72 61.9 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.497 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.08 161.76 42.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.246 . . . . 0.0 111.082 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.529 HD13 ' CE3' ' A' ' 54' ' ' TRP . 14.1 mt -136.99 99.91 4.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.568 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 3.6 p30 -71.05 168.14 17.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.914 -1.116 . . . . 0.0 110.237 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' ASP . 15.7 ptt180 -38.56 -46.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.538 -0.726 . . . . 0.0 111.269 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.49 -35.48 63.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 110.57 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.552 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 57.4 mt-10 -75.79 -42.32 50.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.44 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.602 ' CE2' HD13 ' A' ' 31' ' ' LEU . 8.5 t80 -65.93 -19.91 66.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.413 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.417 ' HB3' ' HD3' ' A' ' 14' ' ' LYS . . . -75.7 -46.6 30.28 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.568 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.54 HG12 ' CG ' ' A' ' 94' ' ' LEU . 86.2 t -59.04 -29.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.543 0.687 . . . . 0.0 109.881 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.517 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -89.86 -4.08 57.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.441 -0.787 . . . . 0.0 111.18 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.6 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.3 mmt -85.11 -48.32 9.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.907 -1.121 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.606 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 3.6 p90 -73.02 -31.62 64.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.596 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 6.1 mt -62.66 -24.13 67.46 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.532 HG22 ' CG1' ' A' ' 53' ' ' VAL . 58.9 t -91.04 -47.84 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.483 0.658 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.537 ' HA ' ' CD1' ' A' ' 81' ' ' LEU . 2.3 m-85 -68.1 -31.96 71.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.525 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 93.3 m -83.2 -11.12 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.474 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -84.88 -14.35 48.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.537 ' CD1' ' HA ' ' A' ' 78' ' ' TYR . 2.2 mt -92.26 -51.47 5.15 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.377 0.608 . . . . 0.0 110.731 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.4 18.56 15.97 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.911 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 0.4 OUTLIER -127.17 -76.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.429 -1.419 . . . . 0.0 111.881 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.521 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.7 mt-10 -158.83 -178.46 0.91 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.521 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 44.2 Cg_endo -71.97 171.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 124.006 1.529 . . . . 0.0 110.387 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.477 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 11.0 t -117.43 125.31 28.23 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.575 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.489 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 50.7 Cg_endo -85.68 -177.69 2.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.895 1.471 . . . . 0.0 109.871 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.542 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 39.2 mtm -111.38 16.43 20.84 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.491 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 67.7 m -107.32 105.22 15.07 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.153 . . . . 0.0 111.956 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -54.63 106.96 0.74 Allowed Pre-proline 0 C--N 1.293 -1.852 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.279 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.1 Cg_endo -66.71 143.1 66.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.862 1.454 . . . . 0.0 110.638 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.87 -8.81 24.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.248 1.657 . . . . 0.0 111.109 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.444 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -97.96 23.72 7.76 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.654 179.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.606 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 0.6 OUTLIER -152.31 19.87 0.65 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.899 0.857 . . . . 0.0 109.894 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.422 HG23 ' HD2' ' A' ' 96' ' ' PRO . 11.0 p -118.02 131.85 23.97 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.072 . . . . 0.0 110.373 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.422 ' HD2' HG23 ' A' ' 95' ' ' VAL . 43.6 Cg_endo -70.07 147.19 60.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.931 1.49 . . . . 0.0 110.201 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.02 -1.18 9.63 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.571 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.05 -17.37 52.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.659 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.503 ' CD ' HG22 ' A' ' 59' ' ' ILE . 8.4 ttpp -89.67 0.16 57.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.436 -0.79 . . . . 0.0 109.541 179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.422 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 10.0 ptp180 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.417 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.45 ' O ' ' HB ' ' B' ' 108' ' ' THR . 17.6 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.189 0.519 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.57 ' O ' ' CZ2' ' A' ' 54' ' ' TRP . 1.8 t 179.04 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.581 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 -121.4 120.89 28.73 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 110.551 -179.702 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.78 6.43 4.54 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.917 1.483 . . . . 0.0 111.126 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.585 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 65.2 m-85 -128.33 20.67 6.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.998 -1.064 . . . . 0.0 110.333 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.122 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.484 0.95 0 N-CA-C 110.672 -0.549 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.455 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -93.03 128.13 38.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.562 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -41.32 -33.29 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 110.347 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.455 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 32.3 t -90.75 136.59 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.977 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.511 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.9 mttp -96.81 178.93 1.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.822 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.511 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.78 -36.42 13.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.841 1.443 . . . . 0.0 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.462 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 3.7 pt-20 -74.8 -28.73 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.922 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.462 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 20.6 m-20 -82.3 -36.04 27.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 0.0 108.958 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.454 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -75.0 -15.29 60.66 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.514 -0.742 . . . . 0.0 109.027 178.849 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.1 -40.19 39.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.611 -0.681 . . . . 0.0 109.181 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.516 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.9 ptpt -74.73 -22.02 59.04 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.557 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 9.5 m-30 -75.22 -34.41 61.45 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.08 -11.33 60.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.421 0.629 . . . . 0.0 110.107 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -91.28 -29.28 17.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.576 HG23 ' CE1' ' A' ' 70' ' ' PHE . 36.3 mt -85.1 -33.71 8.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -72.74 -33.74 66.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.507 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 t70 -89.48 -6.12 56.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.616 -0.677 . . . . 0.0 109.951 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.73 -8.15 59.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 108.627 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.589 ' O ' ' CB ' ' A' ' 25' ' ' SER . 5.0 mt -104.66 -15.38 15.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 85.12 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 CA-C-O 121.157 0.503 . . . . 0.0 110.039 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 52.2 Cg_endo -79.76 157.87 24.6 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.343 1.707 . . . . 0.0 111.055 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.4 t -125.47 109.74 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.505 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.5 OUTLIER 65.91 15.32 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 -178.379 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.5 36.75 6.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 75.2 m-85 -141.58 146.65 36.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.246 . . . . 0.0 111.847 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.1 mt -118.04 136.29 53.64 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -86.79 145.39 26.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.458 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.7 -26.05 0.38 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.7 t70 -67.19 -20.52 65.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.37 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.501 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.8 mttp -100.22 -36.54 9.26 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.019 -1.05 . . . . 0.0 108.194 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.492 HG13 ' CD1' ' A' ' 40' ' ' LEU . 86.9 t -75.61 -46.39 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.163 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.577 ' HG3' ' CZ ' ' B' ' 111' ' ' PHE . 12.0 tttt -39.06 -53.91 3.49 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.999 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.54 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.45 -37.0 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.463 1.244 . . . . 0.0 109.379 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.488 ' CG2' HD11 ' A' ' 24' ' ' LEU . 2.8 t -60.68 -34.63 59.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.541 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 53.9 mt -86.69 -26.39 24.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.5 -0.75 . . . . 0.0 109.584 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.462 HD13 ' CG ' ' A' ' 37' ' ' LYS . 36.8 mt -75.57 -17.09 60.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.81 -6.69 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.852 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.513 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 3.4 p -82.83 11.86 5.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HB3' ' O ' ' A' ' 43' ' ' SER . 13.7 tttp 64.26 15.16 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.547 HD11 ' CB ' ' A' ' 80' ' ' ALA . 20.0 mt -100.66 153.3 37.81 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.567 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.88 169.82 21.42 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 124.216 1.64 . . . . 0.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.509 ' O ' HG13 ' A' ' 47' ' ' VAL . 3.6 t -69.15 -6.23 5.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.49 -31.46 42.3 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.249 -0.907 . . . . 0.0 109.207 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 12.1 mm -82.63 -39.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.574 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 11.1 mt -70.14 -28.38 65.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.466 ' O ' ' HG3' ' A' ' 55' ' ' GLU . . . -71.87 -24.3 76.8 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.563 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -101.39 -32.02 10.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.777 -0.837 . . . . 0.0 110.208 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.551 ' CG1' HG23 ' A' ' 77' ' ' VAL . 4.9 t -72.41 -36.35 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.486 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.579 ' CD1' ' HB3' ' B' ' 109' ' ' ASN . 2.5 t-105 -68.78 -49.58 57.42 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.012 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.6 mt-10 -52.61 -57.08 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.901 -1.125 . . . . 0.0 110.186 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.552 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.5 mt -61.45 -14.46 28.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.797 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.535 ' O ' ' CG ' ' A' ' 69' ' ' GLU . 17.8 m -92.56 -38.64 11.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 109.371 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 10.7 t0 -70.21 85.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.442 -0.786 . . . . 0.0 109.924 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 26.8 mm -61.68 -27.63 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.899 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 49.9 p30 -108.97 -13.26 14.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.909 -1.119 . . . . 0.0 111.104 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 3.7 m170 63.07 44.68 5.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.461 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 13.0 p-10 -111.9 29.61 7.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.904 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.474 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 60.73 34.04 85.1 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.488 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.5 mtt -150.83 161.04 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -1.14 . . . . 0.0 111.127 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' N ' ' O ' ' A' ' 31' ' ' LEU . 7.0 mt -128.21 104.82 7.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.754 . . . . 0.0 109.615 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.587 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -68.71 167.75 14.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.224 -0.922 . . . . 0.0 110.344 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.518 ' CG ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -46.18 -40.96 12.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.428 -0.795 . . . . 0.0 110.519 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 -25.82 31.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.064 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.68 -46.04 27.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.702 0.763 . . . . 0.0 109.261 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.576 ' CE1' HG23 ' A' ' 20' ' ' ILE . 28.5 t80 -64.45 -16.43 62.41 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -76.56 -47.37 22.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.442 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 57.6 t -60.14 -24.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.603 -0.685 . . . . 0.0 109.594 179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.527 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -89.89 -6.65 55.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -0.753 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.557 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.9 mmt -84.97 -48.21 9.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.003 -1.06 . . . . 0.0 110.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.632 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.1 p90 -75.97 -22.28 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.514 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 11.0 mt -73.89 -22.8 59.59 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.565 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 53.9 t -91.91 -60.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.448 0.642 . . . . 0.0 109.308 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.55 -19.29 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 110.722 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 4.2 m -85.01 -18.01 35.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.173 -0.954 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.547 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -87.8 -11.67 47.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.429 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.574 HD13 ' N ' ' A' ' 81' ' ' LEU . 6.4 mp -90.69 -41.06 11.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.755 0.788 . . . . 0.0 109.174 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 3.5 tt0 -71.83 -53.25 13.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.631 -0.668 . . . . 0.0 109.645 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.468 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 177.73 -25.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.85 . . . . 0.0 111.448 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.475 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.3 OUTLIER -70.16 115.12 31.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 0.0 111.576 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.92 179.18 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.776 1.408 . . . . 0.0 109.174 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.468 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 58.9 t -123.31 124.85 26.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.778 -1.201 . . . . 0.0 111.096 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.485 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 47.4 Cg_endo -86.88 -176.23 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.949 1.499 . . . . 0.0 109.198 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.563 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 8.3 mtp -114.9 15.62 17.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.217 . . . . 0.0 110.549 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 58.3 m -113.25 100.9 8.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.189 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.57 107.48 0.88 Allowed Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.466 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.542 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.1 Cg_endo -66.56 158.38 55.97 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.897 1.472 . . . . 0.0 110.61 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.63 -16.6 26.84 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.088 1.573 . . . . 0.0 111.017 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.452 ' C ' HD21 ' A' ' 94' ' ' LEU . . . -87.67 0.9 55.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.086 -1.009 . . . . 0.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.632 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 3.6 mm? -108.65 -5.29 16.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.325 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.9 t -92.76 108.83 34.84 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.0 110.799 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.484 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 48.1 Cg_endo -77.34 176.13 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.042 1.548 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.484 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 43.5 Cg_endo -71.27 -8.96 24.51 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.747 1.393 . . . . 0.0 110.099 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -69.09 -16.75 63.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.648 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.437 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 12.3 tptp -89.1 0.72 56.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 0.0 109.376 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.412 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.264 0.554 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 21.7 p -109.77 -27.85 9.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 110.346 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.579 ' HB3' ' CD1' ' A' ' 54' ' ' TRP . 50.7 p30 -65.75 161.77 50.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.565 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -79.06 11.06 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.101 1.58 . . . . 0.0 110.98 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.577 ' CZ ' ' HG3' ' A' ' 37' ' ' LYS . 48.8 m-85 -131.95 43.14 3.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.935 -1.103 . . . . 0.0 110.266 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.409 HD11 ' O ' ' B' ' 111' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.427 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.466 -0.628 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.558 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.2 t90 -86.78 127.35 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.871 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.577 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . . . -43.89 -30.16 0.65 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.267 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.558 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.9 t -91.22 137.6 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.493 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -94.63 174.49 3.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.493 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 37.9 Cg_endo -66.39 -32.7 40.17 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.795 1.418 . . . . 0.0 109.838 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.482 ' OE2' ' HG2' ' A' ' 11' ' ' PRO . 7.4 mm-40 -75.91 -33.47 59.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-20 -78.73 -40.5 33.38 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.416 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.5 tptp -69.63 -17.94 63.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.104 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -72.92 -41.47 64.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -78.51 -20.84 49.88 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.584 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -78.05 -34.23 50.52 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.96 -12.3 59.73 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.301 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.63 -32.38 13.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.588 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 21.5 mt -77.69 -30.92 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.3 OUTLIER -71.28 -38.47 71.82 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.605 0.717 . . . . 0.0 109.141 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t70 -91.01 -4.19 56.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 110.115 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t -79.24 -11.66 59.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 108.742 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.648 ' O ' ' CB ' ' A' ' 25' ' ' SER . 8.9 mt -97.68 -56.09 2.61 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 142.46 97.19 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.7 Cg_endo -74.15 147.68 38.28 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 124.259 1.663 . . . . 0.0 110.726 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.471 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.0 t -118.49 99.15 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 109.107 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.471 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.8 t30 56.78 17.04 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.408 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 106.03 33.69 3.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 66' ' ' ASP . 75.6 m-85 -150.67 141.69 23.0 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -1.164 . . . . 0.0 112.106 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.568 HD13 ' CD2' ' A' ' 70' ' ' PHE . 10.3 mt -110.59 141.81 43.28 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.492 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 99.4 p -89.7 147.54 23.8 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.998 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.8 -27.37 0.55 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' SER . 64.5 t0 -66.44 -25.75 66.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -1.05 . . . . 0.0 110.145 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttt -94.06 -33.08 13.53 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.014 -1.054 . . . . 0.0 108.533 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.54 HG12 ' CD1' ' A' ' 65' ' ' LEU . 90.8 t -82.05 -47.93 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.552 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -39.56 -53.65 4.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.637 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -66.34 -35.28 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.136 1.071 . . . . 0.0 109.468 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.588 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.2 t -61.6 -26.67 40.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.612 -0.68 . . . . 0.0 109.207 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.543 ' CD2' HG21 ' A' ' 77' ' ' VAL . 36.5 mt -95.66 -28.54 14.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.473 HD21 HD13 ' A' ' 50' ' ' LEU . 79.2 mt -71.07 -15.11 62.51 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.86 -11.09 58.5 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.883 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.572 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 1.8 p -81.74 7.96 11.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.55 12.43 5.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.509 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.565 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 13.9 mt -88.56 156.39 50.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.953 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.9 Cg_endo -74.1 166.65 29.09 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.93 1.49 . . . . 0.0 109.386 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.534 HG11 ' HB3' ' B' ' 111' ' ' PHE . 3.5 t -66.55 -7.07 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.535 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -78.62 -31.9 47.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.185 -0.947 . . . . 0.0 109.392 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.562 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 6.9 mm -82.77 -41.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.494 ' HG ' ' O ' ' A' ' 46' ' ' PRO . 10.7 mt -67.43 -29.99 69.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.34 -23.81 77.16 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' CD ' ' CG ' ' A' ' 88' ' ' MET . 24.6 ttp180 -102.16 -33.13 9.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.966 -0.726 . . . . 0.0 111.06 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.537 ' CG1' HG22 ' A' ' 77' ' ' VAL . 17.2 t -67.16 -41.12 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.658 -1.276 . . . . 0.0 108.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.7 t-105 -62.55 -50.9 69.49 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.551 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 19.2 mt-10 -51.52 -59.05 4.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.566 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.3 mt -61.82 -15.13 39.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 108.712 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.515 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 34.8 m -91.05 -30.49 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.237 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.43 97.38 4.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 109.595 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.527 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 24.9 mm -71.02 -38.44 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 110.375 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 9.8 p30 -99.34 -13.39 19.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 1.8 m-70 60.48 41.45 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.851 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 6.5 p-10 -96.79 13.27 29.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 0.0 109.565 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.53 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 78.63 22.15 67.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.53 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.29 161.35 41.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.302 -1.117 . . . . 0.0 109.573 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.54 ' CD1' HG12 ' A' ' 36' ' ' VAL . 5.8 mt -121.05 116.46 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.049 -1.032 . . . . 0.0 110.272 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.567 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -76.39 172.75 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.47 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -52.8 -34.37 53.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.559 -0.713 . . . . 0.0 110.847 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.47 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 28.0 m-20 -87.15 -31.56 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.527 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 31.4 mt-10 -78.13 -38.96 42.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 108.692 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.588 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 42.9 t80 -63.38 -29.27 70.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -64.8 -47.51 77.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.531 -0.73 . . . . 0.0 110.154 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.439 HG13 HD12 ' A' ' 94' ' ' LEU . 58.5 t -60.84 -19.26 19.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.515 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -89.6 -13.26 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 111.444 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.581 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 mmm -85.6 -41.84 14.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.696 -1.253 . . . . 0.0 110.553 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.665 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 3.4 p90 -77.57 -25.17 49.81 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.525 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 7.2 mt -70.96 -22.0 62.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.572 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 49.7 t -91.78 -61.52 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -48.88 -21.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.639 -0.663 . . . . 0.0 111.325 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLU . 20.1 m -84.66 -14.65 47.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.565 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -89.08 -14.19 36.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.574 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 6.4 mp -90.26 -38.18 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.743 0.782 . . . . 0.0 109.049 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.412 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.6 OUTLIER -69.12 -57.57 5.23 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.558 0.694 . . . . 0.0 109.483 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.48 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 2.2 tttt 177.26 -21.8 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.592 -0.692 . . . . 0.0 111.037 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 79' ' ' CYS . 8.4 mm-40 -73.16 118.81 71.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.966 -1.084 . . . . 0.0 111.091 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.87 169.67 20.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.715 1.376 . . . . 0.0 109.494 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.473 ' O ' ' NE ' ' A' ' 52' ' ' ARG . 34.0 t -112.77 122.55 35.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.854 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.497 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 47.8 Cg_endo -86.13 171.79 7.67 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.878 1.462 . . . . 0.0 109.006 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.554 ' CG ' ' CD ' ' A' ' 52' ' ' ARG . 35.0 mtm -106.01 17.97 22.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.0 -1.063 . . . . 0.0 110.056 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 45.1 m -113.48 99.65 7.92 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.751 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.566 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -55.28 107.17 0.8 Allowed Pre-proline 0 C--N 1.293 -1.863 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.437 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.559 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.3 Cg_endo -65.83 159.14 50.2 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.028 1.541 . . . . 0.0 110.86 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.36 -24.76 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.098 1.578 . . . . 0.0 111.46 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.458 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -82.33 3.48 27.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.06 . . . . 0.0 109.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.665 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 4.3 mm? -108.0 -5.97 16.82 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.4 -0.813 . . . . 0.0 110.282 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.411 ' CG1' ' HB3' ' A' ' 99' ' ' LYS . 51.1 t -99.98 121.89 52.52 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 110.238 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.49 170.61 15.85 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.889 1.468 . . . . 0.0 110.129 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.84 -8.23 23.14 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.452 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 t -76.07 -17.6 59.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.411 ' HB3' ' CG1' ' A' ' 95' ' ' VAL . 4.8 tptp -89.8 0.5 56.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.302 -0.873 . . . . 0.0 109.429 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.206 0.527 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 25.9 p -99.77 -19.91 16.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.359 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 20.8 t-20 -92.67 137.13 24.39 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.957 . . . . 0.0 110.633 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' B' ' 109' ' ' ASN . 54.4 Cg_endo -85.55 12.57 3.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.07 1.563 . . . . 0.0 111.334 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.552 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 48.3 m-85 -126.63 -12.96 6.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.791 -1.193 . . . . 0.0 110.745 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.16 179.757 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.484 0.921 0 N-CA-C 110.599 -0.577 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.581 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 -77.48 125.31 29.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.499 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -42.99 -29.15 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.766 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.581 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 8.5 t -91.79 156.0 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.793 . . . . 0.0 109.239 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.495 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mmmt -108.72 167.39 9.25 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.878 -1.139 . . . . 0.0 110.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.495 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -69.4 -31.91 21.16 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.008 1.531 . . . . 0.0 109.811 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.85 -32.79 40.53 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.23 -34.7 49.11 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 28.6 tptp -72.46 -18.61 61.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.486 -0.759 . . . . 0.0 109.047 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.76 -42.8 60.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.593 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.0 ptpt -75.58 -25.29 56.93 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.593 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -72.96 -37.55 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.874 0.845 . . . . 0.0 108.732 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -79.5 -8.16 58.95 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.376 0.607 . . . . 0.0 110.339 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.59 -33.38 12.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.445 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 75.1 mt -76.63 -33.13 21.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CE1' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -66.97 -38.57 86.32 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.711 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.7 t70 -90.97 -2.57 57.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -80.91 -12.58 59.38 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.65 ' O ' ' CB ' ' A' ' 25' ' ' SER . 6.4 mt -95.63 -54.36 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.65 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 6.7 p 142.55 90.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.577 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -75.14 150.94 38.28 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 124.057 1.556 . . . . 0.0 110.914 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.482 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -127.07 108.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.482 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.1 t30 57.28 21.93 7.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.996 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.438 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.08 38.91 5.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 82.6 m-85 -150.43 151.64 33.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.089 -1.242 . . . . 0.0 111.866 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.595 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.2 mt -122.17 140.61 52.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.475 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 19.3 p -90.42 141.64 28.54 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.855 -1.153 . . . . 0.0 110.343 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.539 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.28 -27.75 0.27 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -61.5 -28.29 69.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.969 . . . . 0.0 110.066 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 14.8 mttt -96.52 -32.93 12.03 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.221 -0.924 . . . . 0.0 108.816 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.552 ' CG1' HD12 ' A' ' 65' ' ' LEU . 92.1 t -77.03 -44.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 110.007 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.539 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 67.5 tttt -40.76 -56.75 3.64 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.7 Cg_endo -65.37 -34.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.494 1.26 . . . . 0.0 109.769 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.473 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -62.82 -35.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.792 . . . . 0.0 109.7 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.569 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 34.6 mt -85.37 -29.12 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.972 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.446 HD23 HD13 ' A' ' 50' ' ' LEU . 43.2 mt -71.6 -14.12 61.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.018 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.47 -12.34 60.0 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.755 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.528 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 59.8 p -81.38 3.78 23.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.421 -0.799 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.3 ttmt 68.63 16.25 9.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.54 HD23 ' HD2' ' A' ' 46' ' ' PRO . 15.5 mt -95.66 152.91 39.45 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.001 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.582 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.5 Cg_endo -74.04 175.03 11.41 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.973 1.512 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.518 ' O ' HG11 ' A' ' 47' ' ' VAL . 25.2 t -70.85 -7.09 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -32.24 37.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.582 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.8 mm -83.18 -36.86 13.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 108.742 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.569 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 29.5 mt -75.08 -26.48 59.36 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.477 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.24 -24.96 76.42 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.532 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 3.4 mtm180 -100.74 -31.68 11.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.905 -0.762 . . . . 0.0 109.897 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.527 HG12 ' CG2' ' A' ' 77' ' ' VAL . 5.7 t -71.1 -37.34 66.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.556 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 3.0 t-105 -71.11 -50.1 37.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.44 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.568 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 9.4 mm-40 -56.96 -54.65 44.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 110.221 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.593 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 4.9 mt -62.78 -10.91 14.62 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.426 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 3.8 m -98.16 -37.71 9.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.77 . . . . 0.0 110.015 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -69.01 87.07 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.953 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 43.5 mm -57.82 -28.37 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 110.395 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.59 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 51.1 p-10 -112.04 1.29 16.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.554 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 9.3 p80 39.58 51.98 2.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.341 -0.849 . . . . 0.0 110.511 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 15.4 p-10 -112.33 24.79 12.17 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.454 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 71.13 31.15 66.73 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.75 161.82 42.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -1.227 . . . . 0.0 111.466 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.552 HD12 ' CG1' ' A' ' 36' ' ' VAL . 9.9 mt -125.73 105.52 9.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.482 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.565 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 4.7 t0 -69.02 163.71 24.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.86 -1.15 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -42.63 -36.47 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.763 . . . . 0.0 110.199 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' OD1' ' CH2' ' A' ' 7' ' ' TRP . 0.4 OUTLIER -82.75 -34.27 27.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.519 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 17.7 mt-10 -74.98 -42.6 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' CD2' HD11 ' A' ' 31' ' ' LEU . 32.6 t80 -59.84 -26.95 66.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -72.25 -51.31 21.53 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.174 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.538 ' CG1' HD13 ' A' ' 94' ' ' LEU . 53.7 t -55.46 -26.76 19.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.543 0.687 . . . . 0.0 109.518 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.545 ' O ' HG22 ' A' ' 77' ' ' VAL . . . -89.85 -3.21 58.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.557 -0.714 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.582 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.0 mmt -90.15 -43.43 10.46 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.664 -1.273 . . . . 0.0 109.834 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 p90 -79.26 -19.01 51.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.428 ' HB3' HG21 ' A' ' 53' ' ' VAL . 4.6 mt -78.85 -23.24 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.551 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 5.8 t -90.59 -37.16 9.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.627 -0.671 . . . . 0.0 109.65 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -80.05 -24.02 40.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.5 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 56.3 m -83.22 -18.74 38.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.224 -0.922 . . . . 0.0 109.188 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.514 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -77.25 -15.73 59.33 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.843 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.551 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -92.31 -50.68 5.53 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.72 -0.612 . . . . 0.0 111.49 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' OE1' ' CA ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -118.53 -2.49 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.314 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -103.99 -74.37 0.64 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.506 -1.371 . . . . 0.0 111.378 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 mt-10 -160.36 179.44 1.34 Allowed Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.993 -1.067 . . . . 0.0 110.254 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.494 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 42.8 Cg_endo -70.72 171.79 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.807 1.425 . . . . 0.0 109.836 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.05 127.06 27.16 Favored Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 110.514 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.508 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 47.1 Cg_endo -85.12 -170.61 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.995 1.523 . . . . 0.0 109.182 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.532 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 4.9 mtm -116.95 10.45 14.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.063 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.43 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 56.7 p -114.47 98.69 7.05 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.656 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.593 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -52.39 107.09 0.75 Allowed Pre-proline 0 C--N 1.287 -2.145 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.425 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.518 ' HG2' HD23 ' A' ' 94' ' ' LEU . 39.1 Cg_endo -66.78 146.27 77.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.643 1.338 . . . . 0.0 110.273 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.28 -5.01 14.85 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.278 1.673 . . . . 0.0 111.024 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.72 -1.89 44.58 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 72' ' ' VAL . 0.2 OUTLIER -145.52 36.19 1.08 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.939 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.3 t -126.66 132.27 24.25 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.968 -1.082 . . . . 0.0 110.738 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.45 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.1 Cg_endo -72.79 174.51 11.71 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.01 1.531 . . . . 0.0 110.048 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.9 Cg_endo -72.62 179.84 4.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.836 1.44 . . . . 0.0 110.695 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 77.43 -45.52 0.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.769 -0.582 . . . . 0.0 110.251 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 40.0 tptt -88.51 9.36 24.04 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 108.672 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.209 0.528 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.44 ' O ' ' C ' ' B' ' 109' ' ' ASN . 9.4 t -149.55 -136.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.99 . . . . 0.0 110.213 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.568 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 43.1 t-20 -41.53 116.6 1.58 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.951 . . . . 0.0 110.283 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.77 17.39 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.949 1.499 . . . . 0.0 111.28 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.551 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 65.2 m-85 -139.63 31.83 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.892 -1.13 . . . . 0.0 110.283 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.156 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.933 0 N-CA-C 110.644 -0.56 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.578 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.1 t90 -58.98 125.32 23.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HB2' ' CD1' ' A' ' 94' ' ' LEU . . . -41.31 -26.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 54.6 t -97.71 138.53 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.525 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.97 175.53 2.68 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.525 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -37.03 19.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.555 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -72.54 -25.16 61.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 109.575 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -82.79 -40.09 20.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.407 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -71.73 -17.61 62.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -72.45 -45.8 57.91 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -74.48 -28.99 61.26 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.603 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.6 m-30 -68.02 -33.73 75.14 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.407 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 9.4 t70 -77.34 -9.32 58.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.662 -0.649 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.38 -30.76 14.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.461 HD12 ' SD ' ' A' ' 74' ' ' MET . 61.5 mt -81.16 -32.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.616 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -73.43 -38.18 65.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.643 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 2.2 t70 -85.64 -1.25 56.95 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.411 0.624 . . . . 0.0 109.787 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 t -88.47 -9.33 52.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.212 -0.93 . . . . 0.0 108.895 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.621 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.4 mt -100.67 -8.09 23.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 88.31 94.75 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 46.6 Cg_endo -72.0 151.09 55.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.346 1.708 . . . . 0.0 111.022 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -121.6 97.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.511 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.0 t30 63.67 14.96 8.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.858 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.82 33.26 4.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.414 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 92.0 m-85 -149.92 154.69 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.161 -1.199 . . . . 0.0 111.827 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.605 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 10.0 mt -120.03 159.97 23.71 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' LYS . 13.4 p -104.28 142.15 35.04 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.904 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.584 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.28 -25.22 0.71 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.4 t70 -71.86 -23.57 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.605 -0.938 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.491 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttp -93.06 -36.8 12.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 HG13 ' CD1' ' A' ' 40' ' ' LEU . 90.1 t -78.11 -40.46 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.473 0.654 . . . . 0.0 109.765 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.629 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 6.3 tttp -40.71 -55.98 4.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 111.089 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.6 -35.01 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.574 1.302 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.474 HG21 ' O ' ' A' ' 35' ' ' LYS . 2.7 t -59.87 -36.19 65.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.56 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 23.2 mt -84.29 -25.73 29.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.913 . . . . 0.0 109.456 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD22 HD13 ' A' ' 50' ' ' LEU . 53.9 mt -71.92 -15.31 62.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.06 -10.22 59.72 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.464 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.487 ' CB ' HG11 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -81.13 8.6 8.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.842 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 43' ' ' SER . 4.3 tttt 65.6 15.83 10.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.462 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.544 HD11 ' CG2' ' A' ' 49' ' ' ILE . 14.1 mt -95.91 151.25 38.22 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 110.331 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.586 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.9 Cg_endo -75.54 -178.34 4.21 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.986 1.519 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.501 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.1 t -78.53 -0.68 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.47 -32.88 20.58 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.586 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.3 mm -83.22 -38.6 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.591 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 38.6 mt -72.91 -26.3 61.37 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 109.201 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.511 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.24 -23.03 78.29 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.493 ' HD3' ' HG2' ' A' ' 88' ' ' MET . 3.3 mtm180 -100.38 -32.25 10.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.885 -0.774 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.468 HG21 ' HB3' ' A' ' 76' ' ' LEU . 22.5 t -70.26 -36.32 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.015 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.584 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.31 -50.62 37.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mt-10 -56.82 -57.55 11.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.511 ' CD2' ' C ' ' A' ' 89' ' ' SER . 4.5 mt -58.22 -16.94 15.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.48 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.539 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 1.9 t -92.12 -35.87 13.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -72.97 98.36 2.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 110.217 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.524 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 49.0 mm -71.93 -28.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.005 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.499 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -112.0 -15.26 13.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 109.656 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.499 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 91.7 m-70 59.68 47.77 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.558 -0.714 . . . . 0.0 111.298 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 1.3 m-20 -98.04 26.06 5.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 108.635 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.477 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 63.4 29.77 75.57 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 31' ' ' LEU . 7.9 mtt -150.56 160.74 43.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.995 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.509 ' CD1' HG11 ' A' ' 36' ' ' VAL . 11.9 mt -129.48 100.68 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.469 ' OD2' ' HB2' ' A' ' 69' ' ' GLU . 2.3 p30 -69.6 160.61 31.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.616 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.7 ptp85 -35.36 -43.2 0.23 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.656 -0.653 . . . . 0.0 112.032 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.412 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -81.47 -35.79 30.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.963 -1.085 . . . . 0.0 110.298 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 13.7 tt0 -71.15 -43.26 67.89 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.478 ' CG ' ' HB2' ' A' ' 21' ' ' PHE . 58.4 t80 -63.1 -19.58 64.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.469 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.55 -42.7 67.54 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 109.693 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.39 -31.79 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.671 0.748 . . . . 0.0 109.722 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 77' ' ' VAL . . . -87.58 0.25 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.757 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.574 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.4 mmt -89.8 -44.54 9.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.67 -1.269 . . . . 0.0 109.961 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.633 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 5.2 p90 -77.09 -22.34 52.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.548 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.2 mt -76.99 -22.95 52.35 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.461 0.648 . . . . 0.0 109.54 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.553 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 5.4 t -91.34 -38.59 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.438 -0.789 . . . . 0.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.47 -22.71 61.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.467 -0.771 . . . . 0.0 110.676 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -83.15 -16.13 47.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.167 -0.958 . . . . 0.0 109.967 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.533 ' HB2' ' CD1' ' A' ' 45' ' ' LEU . . . -88.77 -9.62 51.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.203 -0.936 . . . . 0.0 109.089 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.558 ' N ' HD22 ' A' ' 81' ' ' LEU . 2.3 mt -90.62 -43.26 10.28 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.724 0.774 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 4.9 mm-40 -71.64 -53.04 14.92 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.068 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.7 ttpp 178.01 -27.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -63.88 115.05 15.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 110.913 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.8 165.57 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.934 1.492 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.491 HG11 ' HB3' ' A' ' 52' ' ' ARG . 54.7 t -115.16 120.69 36.34 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 111.037 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.461 ' O ' HD13 ' A' ' 56' ' ' LEU . 54.1 Cg_endo -84.71 -166.24 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.91 1.479 . . . . 0.0 109.55 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.493 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -118.41 9.02 12.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 109.794 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.529 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -99.25 116.21 30.92 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.641 -177.889 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.573 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.2 OUTLIER -103.1 84.82 0.74 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.8 Cg_endo -63.73 173.37 4.69 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.496 1.464 . . . . 0.0 111.751 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.47 ' O ' HG23 ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.82 -12.87 33.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.213 1.638 . . . . 0.0 110.733 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.431 ' C ' HD21 ' A' ' 94' ' ' LEU . . . -76.68 -9.16 58.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.084 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.633 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 4.1 mm? -106.42 -13.44 15.36 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.563 -0.711 . . . . 0.0 110.297 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.476 HG22 ' NE ' ' A' ' 100' ' ' ARG . 5.3 m -83.26 134.25 46.15 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.3 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.463 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.2 Cg_endo -71.0 174.49 10.51 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.255 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 43.5 Cg_endo -69.78 -12.16 32.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.037 1.546 . . . . 0.0 110.107 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 -19.85 62.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.83 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.418 ' C ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -89.31 0.82 56.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.421 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' N ' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 110.09 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.22 0.534 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.507 ' O ' ' CZ2' ' A' ' 54' ' ' TRP . 1.1 p -54.17 -70.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.439 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 34.0 t-20 -101.48 118.88 58.96 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.426 -0.796 . . . . 0.0 109.857 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.504 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 47.6 Cg_endo -72.19 -23.96 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.89 1.468 . . . . 0.0 110.545 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.629 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 45.0 m-85 -88.9 -38.38 14.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.306 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 110.411 -0.65 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' VAL . 11.9 t90 -56.08 129.5 40.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.669 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.584 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -37.71 -30.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' N ' ' O ' ' A' ' 7' ' ' TRP . 60.3 t -100.75 131.57 48.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.545 -0.722 . . . . 0.0 109.596 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.531 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -89.65 -179.04 1.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.531 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.95 -35.67 14.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.816 1.429 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -73.28 -26.78 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 179.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.504 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.1 OUTLIER -82.21 -39.43 23.11 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 0.0 OUTLIER -72.31 -13.49 61.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 11' ' ' PRO . . . -78.69 -40.37 34.02 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.15 -23.65 43.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.473 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -78.7 -33.15 47.09 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 47.7 t0 -79.69 -7.79 58.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.682 -0.636 . . . . 0.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.27 12.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.405 ' CG2' HG22 ' A' ' 39' ' ' VAL . 40.2 mt -76.88 -31.51 19.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.566 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.19 -37.7 66.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.3 t70 -89.67 3.72 51.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.453 0.644 . . . . 0.0 109.71 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -5.95 53.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 108.868 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.38 -4.95 16.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 82.73 94.55 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.528 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.0 Cg_endo -73.29 148.57 43.88 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.224 1.644 . . . . 0.0 110.496 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.475 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 92.6 t -115.46 102.2 13.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 3.3 t30 61.15 16.36 7.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.419 -0.801 . . . . 0.0 109.661 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 100.07 35.56 4.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 76.3 m-85 -150.53 143.5 24.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.923 -1.339 . . . . 0.0 112.279 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.4 mt -113.93 137.53 51.56 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' C ' ' A' ' 33' ' ' GLY . 47.3 p -83.8 140.52 32.0 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.332 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.504 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.94 -28.44 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 37.9 t0 -62.34 -23.81 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.935 . . . . 0.0 110.559 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 43.0 mttp -97.93 -35.76 10.37 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.515 HG13 ' CD1' ' A' ' 65' ' ' LEU . 85.1 t -75.64 -37.76 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.023 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.653 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 ttmt -45.08 -51.36 24.14 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 111.133 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.2 Cg_endo -68.21 -33.57 24.16 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.254 1.133 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 1.8 t -61.6 -31.26 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.515 -0.741 . . . . 0.0 110.215 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.566 ' CD1' ' CZ ' ' B' ' 111' ' ' PHE . 18.9 mt -91.69 -23.8 19.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.076 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 57.8 mt -74.77 -13.46 60.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 109.383 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 2.1 p-10 -87.07 -1.02 57.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.322 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 5.1 p -90.58 12.69 18.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.615 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 65.93 15.63 10.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.079 -1.013 . . . . 0.0 109.925 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.537 HD12 ' CB ' ' A' ' 80' ' ' ALA . 15.7 mt -100.11 151.83 37.63 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.624 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.585 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.8 Cg_endo -76.89 172.87 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.206 1.635 . . . . 0.0 110.178 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.481 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -69.96 -4.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.659 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -82.04 -30.11 31.58 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 109.209 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.585 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.9 mm -85.54 -36.82 11.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.928 0.87 . . . . 0.0 108.896 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.626 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 15.7 mt -76.85 -27.96 55.3 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.413 0.625 . . . . 0.0 109.523 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.467 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.98 -24.92 75.03 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.553 ' NE ' ' HG2' ' A' ' 88' ' ' MET . 17.5 ttm180 -101.05 -31.46 11.07 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.979 -0.718 . . . . 0.0 110.182 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.526 ' CG1' HG21 ' A' ' 77' ' ' VAL . 15.0 t -72.06 -36.77 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.9 t-105 -64.38 -51.39 63.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.743 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 1.9 mm-40 -49.09 -61.41 2.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.326 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.545 HD22 ' CA ' ' A' ' 90' ' ' LEU . 2.6 mt -59.88 -16.58 30.25 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.858 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.522 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 17.7 m -90.55 -28.96 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' TRP . 27.9 t0 -76.4 101.6 5.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.788 -0.57 . . . . 0.0 109.64 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 18.3 mm -88.49 -17.23 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.562 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' OE2' ' A' ' 69' ' ' GLU . 3.3 m-20 -104.07 -10.08 18.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.63 ' N ' ' CD2' ' A' ' 61' ' ' HIS . 2.8 m170 52.38 49.1 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 34.8 p-10 -128.46 14.14 6.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.932 -1.105 . . . . 0.0 110.177 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 79.4 32.61 37.78 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 18.6 mtp -150.8 161.07 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.188 -1.184 . . . . 0.0 110.747 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.515 ' CD1' HG13 ' A' ' 36' ' ' VAL . 7.7 mt -126.94 107.48 10.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -69.63 166.55 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 109.432 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.549 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.6 ptp85 -45.88 -42.17 12.23 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.139 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 63.4 m-20 -76.14 -36.63 58.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.827 . . . . 0.0 110.097 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 35.5 mt-10 -71.66 -46.34 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.997 . . . . 0.0 108.92 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.585 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 29.7 t80 -55.4 -30.95 61.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.508 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.44 -49.18 74.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.305 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 49.6 t -58.03 -22.47 19.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.044 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.522 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -90.34 -8.5 50.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 111.94 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.596 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 10.3 mmm -88.8 -41.2 12.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.617 -1.302 . . . . 0.0 110.527 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.654 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 2.7 p90 -78.9 -29.17 44.17 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.911 -1.118 . . . . 0.0 108.189 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.58 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.6 mt -66.75 -27.12 67.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.601 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 25.6 t -90.74 -19.91 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 110.032 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.91 -24.11 22.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.373 -0.83 . . . . 0.0 109.703 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.555 ' CA ' ' HB2' ' A' ' 83' ' ' LYS . 1.5 m -84.09 -16.74 42.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.537 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -83.26 -11.48 57.73 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 108.598 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 77' ' ' VAL . 10.0 mt -90.99 -41.84 10.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.77 -0.581 . . . . 0.0 110.468 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 2.2 tt0 -131.44 -3.21 3.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.439 -0.904 . . . . 0.0 112.216 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.555 ' HB2' ' CA ' ' A' ' 79' ' ' CYS . 5.2 mmmt -111.42 -86.88 0.54 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.276 -1.515 . . . . 0.0 111.474 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.516 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 4.1 pt-20 -145.84 170.82 7.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.915 . . . . 0.0 110.119 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 84' ' ' GLU . 40.9 Cg_endo -68.58 -160.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.705 1.371 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.496 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 99.0 t -133.65 132.29 21.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.936 -1.102 . . . . 0.0 110.899 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.0 Cg_endo -84.84 176.57 6.02 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.94 1.495 . . . . 0.0 109.273 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.553 ' HG2' ' NE ' ' A' ' 52' ' ' ARG . 13.4 mtt -103.79 15.48 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.882 -1.136 . . . . 0.0 110.524 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.458 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 25.7 m -115.9 100.62 8.12 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.238 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' CA ' HD22 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -55.76 108.11 1.09 Allowed Pre-proline 0 C--N 1.29 -2.014 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.464 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.495 ' HG2' ' CD2' ' A' ' 94' ' ' LEU . 38.9 Cg_endo -66.73 161.09 43.4 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.946 1.498 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.61 -21.16 29.89 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.833 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.465 ' C ' HD21 ' A' ' 94' ' ' LEU . . . -83.96 -1.08 53.93 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.147 -0.971 . . . . 0.0 109.602 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.654 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 4.2 mm? -113.33 16.05 19.09 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.356 -0.84 . . . . 0.0 111.021 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 3.9 m -114.74 137.9 23.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.871 -1.143 . . . . 0.0 110.993 -179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.482 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 40.5 Cg_endo -68.56 174.84 7.83 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.158 1.609 . . . . 0.0 110.077 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.482 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 43.9 Cg_endo -70.52 -22.78 28.1 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.938 1.494 . . . . 0.0 110.767 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.2 p -78.0 -7.63 57.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.531 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -6.7 51.19 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.366 -0.834 . . . . 0.0 109.434 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.473 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.097 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.488 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' B' ' 107' ' ' SER . 7.9 p 51.69 47.39 24.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.581 ' ND2' ' CD2' ' B' ' 112' ' ' LEU . 0.9 OUTLIER -76.89 156.17 82.6 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.34 -0.85 . . . . 0.0 109.589 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.553 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 44.9 Cg_endo -80.96 7.19 5.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.686 1.361 . . . . 0.0 109.714 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.653 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 96.6 m-85 -120.65 -16.07 8.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.311 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.581 ' CD2' ' ND2' ' B' ' 109' ' ' ASN . 1.5 pp . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.991 . . . . 0.0 110.333 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.484 0.922 0 N-CA-C 110.492 -0.619 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.494 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 13.1 t90 -92.34 125.76 37.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.18 -0.95 . . . . 0.0 110.398 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.438 ' HB3' ' HA ' ' A' ' 94' ' ' LEU . . . -44.68 -26.82 0.42 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 44.2 t -105.61 139.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.17 -178.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.893 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -71.41 -34.73 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.849 1.447 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.425 ' HG3' ' OD1' ' A' ' 13' ' ' ASP . 7.3 pt-20 -76.81 -27.88 55.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -84.7 -30.11 25.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -82.33 -19.67 38.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 0.0 109.005 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.42 -37.63 60.3 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.588 ' CG ' ' CD1' ' A' ' 17' ' ' TYR . 4.4 ptmt -74.27 -23.44 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD2' ' HB2' ' A' ' 74' ' ' MET . 10.3 m-30 -76.76 -35.67 57.56 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -72.31 -10.01 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 110.387 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.37 -35.88 14.15 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.582 HG23 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -76.23 -33.68 24.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.633 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -71.53 -40.55 70.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.488 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 t70 -85.75 4.51 36.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.664 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -9.41 43.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.61 ' O ' ' CB ' ' A' ' 25' ' ' SER . 1.1 mt -102.86 -9.3 20.03 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 87.2 91.28 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.222 0 CA-C-O 121.542 0.687 . . . . 0.0 109.153 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.524 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 Cg_endo -74.29 150.21 41.5 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.174 1.618 . . . . 0.0 110.75 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 35.3 t -119.18 112.37 37.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.3 t30 57.37 16.91 3.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 96.0 36.18 5.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.2 m-85 -147.16 146.1 29.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 112.097 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.609 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.6 mt -115.06 139.33 49.96 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -83.39 143.4 30.33 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.133 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.522 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.34 -25.93 0.87 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.8 m-20 -69.13 -22.93 63.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.641 -0.917 . . . . 0.0 110.349 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 32' ' ' SER . 65.1 mttm -94.91 -35.28 12.08 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG21 ' CE2' ' A' ' 70' ' ' PHE . 84.8 t -77.43 -39.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.741 0.782 . . . . 0.0 109.371 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.543 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 8.7 tttp -41.51 -55.13 5.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.715 -0.616 . . . . 0.0 110.721 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.543 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.29 -35.03 25.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.568 1.299 . . . . 0.0 110.034 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -61.38 -33.17 55.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.121 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 46.7 mt -87.44 -26.81 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.34 -13.72 60.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.81 . . . . 0.0 109.035 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -85.92 -10.93 54.41 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.554 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.487 ' OG ' HG11 ' A' ' 77' ' ' VAL . 3.2 m -78.18 4.84 11.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.606 -0.683 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' SER . 11.4 tttm 68.29 8.26 6.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.79 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.577 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 16.9 mt -92.1 155.09 43.23 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.566 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.4 Cg_endo -74.97 168.88 23.86 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.125 1.592 . . . . 0.0 109.734 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.542 ' CG1' ' HB3' ' B' ' 111' ' ' PHE . 10.3 t -68.03 -7.28 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.519 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.7 -32.47 53.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.338 -0.852 . . . . 0.0 109.313 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.5 mm -81.29 -40.56 18.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.55 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -69.92 -29.15 66.24 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.548 0.689 . . . . 0.0 109.373 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.523 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.21 -23.56 77.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.562 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -101.08 -29.86 11.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.723 -0.869 . . . . 0.0 110.211 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 77' ' ' VAL . 22.0 t -73.86 -37.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.747 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.5 t-105 -66.57 -48.69 68.82 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.457 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.4 mt-10 -56.48 -57.33 12.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.603 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.9 mt -61.35 -15.16 33.36 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.445 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.539 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 14.2 m -94.18 -25.59 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 109.832 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 2.5 t0 -76.99 85.09 3.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.537 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 40.3 mm -61.75 -30.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.888 . . . . 0.0 110.828 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 4.8 p30 -109.9 -13.9 14.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.01 -1.056 . . . . 0.0 110.683 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 16.9 m-70 60.48 46.18 9.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.5 p-10 -103.62 22.49 14.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.481 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 68.0 26.7 73.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.515 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 22.7 mtp -150.61 161.44 42.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -1.198 . . . . 0.0 110.375 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.531 ' CD1' HG12 ' A' ' 36' ' ' VAL . 11.5 mt -125.67 99.39 5.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 0.0 109.035 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 51.5 p30 -71.16 166.97 20.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.832 -1.167 . . . . 0.0 110.315 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.633 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -38.13 -45.39 0.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 0.0 112.149 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -74.95 -42.29 57.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.07 -1.019 . . . . 0.0 110.963 -178.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.537 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 56.8 mt-10 -70.67 -44.45 67.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.117 -0.989 . . . . 0.0 109.02 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 13.2 t80 -57.31 -22.76 44.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.21 -46.91 38.89 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.76 0.791 . . . . 0.0 109.336 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.508 HG13 HD23 ' A' ' 94' ' ' LEU . 95.4 t -59.83 -25.17 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.437 0.637 . . . . 0.0 109.93 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.539 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.25 -6.11 55.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 111.179 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.595 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.5 mmt -85.89 -46.19 10.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 110.071 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.581 ' CE1' HD21 ' A' ' 94' ' ' LEU . 5.5 p90 -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.525 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.4 mt -66.23 -24.21 66.56 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.56 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 69.8 t -91.57 -57.8 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -49.71 -22.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.652 -0.655 . . . . 0.0 111.622 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -85.48 -11.75 53.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.842 -1.161 . . . . 0.0 110.434 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.577 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -90.19 -17.02 28.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.535 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.612 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 5.6 mp -90.51 -39.74 12.41 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.338 -0.851 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -70.89 -61.05 1.91 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.809 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 8.6 tptt 177.5 68.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.715 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.501 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -177.54 107.0 0.22 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.715 -1.241 . . . . 0.0 110.825 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -66.39 -178.73 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.92 1.484 . . . . 0.0 110.188 179.64 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.488 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 76.8 t -120.77 130.16 24.98 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 110.861 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.48 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 51.0 Cg_endo -86.06 -170.46 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.026 1.54 . . . . 0.0 109.796 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.562 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 36.9 mtm -115.23 14.14 16.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.099 -1.001 . . . . 0.0 110.363 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.492 ' N ' HD23 ' A' ' 56' ' ' LEU . 22.8 m -112.29 103.46 11.6 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.815 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.603 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -53.34 107.92 0.97 Allowed Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.515 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 36.9 Cg_endo -64.82 143.47 80.09 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.777 1.409 . . . . 0.0 110.731 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 2.22 5.62 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.399 1.736 . . . . 0.0 111.978 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -105.55 -16.63 14.66 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.581 HD21 ' CE1' ' A' ' 75' ' ' PHE . 1.0 OUTLIER -92.52 -16.24 26.0 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.414 0.626 . . . . 0.0 109.507 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.498 ' CG1' ' CB ' ' A' ' 99' ' ' LYS . 57.8 t -74.48 139.19 74.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 110.535 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.478 ' HD2' HG11 ' A' ' 95' ' ' VAL . 45.4 Cg_endo -71.78 172.13 15.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.043 1.549 . . . . 0.0 110.474 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.2 -17.38 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.982 1.517 . . . . 0.0 110.47 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -10.91 60.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.096 -1.003 . . . . 0.0 109.693 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -89.56 -4.78 57.72 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.421 -0.8 . . . . 0.0 109.438 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.12 0.486 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 139.16 43.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.544 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 22.5 t-20 -127.12 139.2 34.45 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 0.0 110.199 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.94 6.2 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 111.847 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.543 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 73.0 m-85 -125.2 -33.38 2.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.793 -1.192 . . . . 0.0 110.285 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.511 HD11 ' CA ' ' A' ' 51' ' ' GLY . 1.1 mp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.149 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.485 0.994 0 N-CA-C 110.22 -0.723 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.413 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.3 t90 -113.48 133.47 55.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 110.292 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.609 ' HB1' HD11 ' A' ' 94' ' ' LEU . . . -44.37 -35.01 2.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.461 -0.775 . . . . 0.0 110.952 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.1 t -86.71 159.68 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.49 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mptt -115.68 177.87 1.1 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 110.422 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.28 -34.46 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.057 1.556 . . . . 0.0 109.869 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.43 -26.77 46.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.023 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.477 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.1 m-20 -81.5 -31.76 32.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.422 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -75.95 -12.61 60.18 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -0.805 . . . . 0.0 108.987 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.37 -40.33 21.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.07 -27.33 60.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -72.1 -34.83 68.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.9 OUTLIER -73.34 -10.15 59.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.75 -0.594 . . . . 0.0 110.15 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.5 -32.05 15.72 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.475 HG21 ' HE2' ' A' ' 74' ' ' MET 0.251 60.3 mt -82.41 -35.36 12.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.565 ' HA ' ' CD1' ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.84 -37.5 70.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.469 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 14.4 t70 -88.62 1.98 54.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.39 -6.82 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 108.722 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.604 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -107.5 -8.49 16.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.692 -0.63 . . . . 0.0 109.435 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 85.38 95.67 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -72.26 147.77 48.26 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.205 1.634 . . . . 0.0 110.407 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.514 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -112.54 96.38 4.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 109.094 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.514 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 66.1 9.96 6.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.514 -0.741 . . . . 0.0 109.397 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 108.58 28.93 4.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 30.4 m-85 -140.98 141.43 34.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.251 . . . . 0.0 111.95 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.604 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 6.7 mt -112.61 139.59 48.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.513 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 20.9 p -92.43 144.88 24.92 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.288 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.524 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.33 -27.66 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . 54.2 m-20 -63.32 -26.23 68.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.461 -1.023 . . . . 0.0 109.972 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 16.5 mttt -95.21 -35.97 11.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.593 HG22 ' CE2' ' A' ' 70' ' ' PHE . 94.6 t -77.63 -48.81 23.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.233 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.596 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 31.9 tttm -35.5 -56.1 1.06 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.846 -0.534 . . . . 0.0 111.252 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.524 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.9 Cg_endo -67.02 -35.79 24.49 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.496 1.261 . . . . 0.0 110.073 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.476 HG22 HD11 ' A' ' 24' ' ' LEU . 2.6 t -63.28 -31.93 54.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.988 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.544 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 18.3 mt -89.36 -25.52 21.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.087 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD22 HD12 ' A' ' 50' ' ' LEU . 41.8 mt -74.73 -12.52 60.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.078 -1.014 . . . . 0.0 109.049 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -84.05 -8.04 59.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.541 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 1.0 OUTLIER -84.54 15.32 3.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 110.217 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 21.13 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 109.996 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.564 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 14.6 mt -99.7 153.11 37.94 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.583 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.67 178.66 7.11 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.998 1.525 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.517 HG12 ' HB3' ' B' ' 111' ' ' PHE . 2.9 t -75.78 -2.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.331 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.83 -34.3 24.7 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.351 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.583 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 10.2 mm -80.73 -40.43 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 122.033 0.92 . . . . 0.0 108.522 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.599 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 32.8 mt -71.44 -27.55 63.35 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.83 -25.39 75.62 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.539 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 7.9 mtm-85 -101.28 -31.34 11.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.829 . . . . 0.0 109.829 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.532 ' O ' ' CB ' ' A' ' 57' ' ' SER . 7.5 t -67.7 -36.79 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.217 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.572 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -75.57 -51.63 12.45 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.809 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 41.0 mt-10 -57.7 -55.97 27.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.0 109.218 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 52' ' ' ARG . 13.9 mt -59.55 -16.78 27.31 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.532 ' CB ' ' O ' ' A' ' 53' ' ' VAL . 5.0 t -94.43 -25.5 16.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.7 t0 -73.73 98.95 3.02 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.234 0.54 . . . . 0.0 109.732 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 20.9 mm -86.61 -36.78 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 110.171 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -96.87 -12.32 23.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 40.4 m170 58.34 45.39 17.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 111.18 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 17.9 p-10 -107.22 28.91 7.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.599 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 61.24 30.37 73.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.513 ' HG2' ' HA ' ' A' ' 32' ' ' SER . 86.7 mtp -151.96 160.21 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -1.106 . . . . 0.0 110.696 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.572 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 12.8 mt -116.1 103.82 10.94 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.54 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -68.83 156.18 38.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.868 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.524 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -35.89 -40.12 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.567 -0.708 . . . . 0.0 111.037 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.524 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 9.5 t0 -81.5 -34.46 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.154 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.54 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 18.2 mt-10 -73.91 -42.77 60.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.593 ' CE2' HG22 ' A' ' 36' ' ' VAL . 15.6 t80 -59.35 -22.49 61.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.486 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -73.7 -48.91 28.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.828 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.519 ' O ' ' CD1' ' A' ' 76' ' ' LEU . 59.5 t -58.06 -27.98 32.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.361 -0.837 . . . . 0.0 109.452 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' CB ' ' HB2' ' A' ' 57' ' ' SER . . . -91.5 -7.04 51.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.484 -0.76 . . . . 0.0 111.465 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.569 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.9 mmt -82.26 -50.18 9.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.688 -1.257 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.643 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 1.7 p90 -71.72 -33.91 69.14 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.6 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 7.1 mt -58.72 -22.06 56.62 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.564 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 47.0 t -91.28 -64.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -55.18 -18.87 6.55 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 59.2 m -85.19 -10.88 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.05 -1.031 . . . . 0.0 109.586 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.564 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -89.72 -19.7 24.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.229 -0.92 . . . . 0.0 109.184 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.616 ' CD1' ' N ' ' A' ' 81' ' ' LEU . 5.4 mp -90.8 -38.46 12.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.447 -0.783 . . . . 0.0 109.951 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.526 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -68.74 -61.6 1.74 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.067 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.526 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.74 35.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.157 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -140.37 107.99 6.69 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.75 -1.219 . . . . 0.0 110.864 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.76 -166.12 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.979 1.515 . . . . 0.0 110.28 179.599 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.513 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 51.0 t -125.02 148.45 60.15 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 48.2 Cg_endo -83.11 -162.3 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.007 1.53 . . . . 0.0 109.78 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 10.2 mtp -123.26 11.64 9.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 111.582 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' LEU . 5.2 t -162.86 20.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.524 -1.36 . . . . 0.0 112.03 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.525 ' CD1' ' O ' ' A' ' 56' ' ' LEU . 2.5 mt 59.94 120.78 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.431 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.037 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.56 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.4 Cg_endo -67.4 170.92 12.54 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.962 1.506 . . . . 0.0 109.415 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.75 -18.68 28.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.649 1.342 . . . . 0.0 111.833 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.481 ' O ' HD21 ' A' ' 94' ' ' LEU . . . -95.04 8.95 41.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.823 -1.173 . . . . 0.0 110.498 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.643 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 4.6 mm? -118.95 30.87 6.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.918 -1.114 . . . . 0.0 111.628 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -136.17 146.09 54.9 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 121.078 -1.013 . . . . 0.0 109.337 179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.37 172.24 6.82 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.064 1.56 . . . . 0.0 109.95 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 42.4 Cg_endo -68.93 -5.3 15.3 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.922 1.485 . . . . 0.0 110.887 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -91.62 -30.92 16.09 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.015 -1.053 . . . . 0.0 109.282 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 14.76 28.3 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.522 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 1.1 mmt85 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.475 -0.766 . . . . 0.0 110.563 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.2 0.524 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 6.3 t -115.39 -3.74 12.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.418 ' OD1' HD21 ' B' ' 112' ' ' LEU . 13.5 t-20 -126.96 138.13 32.03 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 -20.55 21.99 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.079 1.568 . . . . 0.0 110.68 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.599 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 80.7 m-85 -98.46 23.3 8.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.418 HD21 ' OD1' ' B' ' 109' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 109.816 -0.878 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.469 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.4 t90 -92.6 126.62 37.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.366 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.518 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -41.47 -31.22 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 110.438 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.533 HG21 ' CD2' ' A' ' 75' ' ' PHE . 40.7 t -87.01 157.16 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.474 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 21.7 mmtm -110.56 166.22 11.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.474 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.4 Cg_endo -68.29 -33.98 22.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.863 1.454 . . . . 0.0 109.669 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.52 -27.46 58.74 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 77.8 m-20 -81.38 -41.54 21.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 12.8 tptp -65.58 -25.21 67.31 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.068 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 -45.24 76.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.532 -0.73 . . . . 0.0 109.062 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.561 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.6 ptpt -73.53 -28.69 62.02 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 13' ' ' ASP . 8.0 m-30 -67.66 -37.62 82.64 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.71 -12.78 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.468 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.84 -30.98 15.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.458 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 26.1 mt -81.46 -32.65 11.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.58 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -72.23 -36.99 69.26 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.493 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t70 -89.02 1.43 55.55 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.681 -0.637 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.68 -8.32 54.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.912 . . . . 0.0 109.086 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 2.1 mt -107.57 -7.0 16.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 79.81 95.76 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.652 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.561 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -75.62 152.21 37.69 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.165 1.613 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.0 t -118.44 114.93 46.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 27.0 t30 57.4 18.39 4.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.208 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.37 37.95 5.76 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.0 m-85 -150.5 148.3 28.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.183 . . . . 0.0 111.902 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.58 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 12.0 mt -113.37 134.82 54.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.493 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 34.4 p -83.21 147.55 27.95 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.87 -26.34 1.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 32' ' ' SER . 20.6 t70 -64.45 -24.08 67.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.634 -0.921 . . . . 0.0 109.972 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.8 mttt -98.8 -32.12 11.52 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.531 ' HA ' ' HB ' ' A' ' 39' ' ' VAL . 92.3 t -83.05 -46.21 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.028 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.1 tttt -41.18 -50.18 8.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 43.3 Cg_endo -69.36 -35.45 13.79 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.231 1.122 . . . . 0.0 109.243 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 t -62.43 -36.47 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.458 0.647 . . . . 0.0 109.526 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.547 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 42.3 mt -83.21 -21.58 33.39 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.384 -0.822 . . . . 0.0 109.65 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.466 HD12 ' HG2' ' A' ' 37' ' ' LYS . 34.2 mt -79.04 -13.21 59.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.533 -0.73 . . . . 0.0 109.324 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 5.7 t30 -89.98 -3.77 57.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.051 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.577 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 94.6 p -86.11 16.85 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 16.06 6.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.709 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.534 HD11 ' CB ' ' A' ' 80' ' ' ALA . 16.3 mt -100.4 152.52 37.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -76.46 168.75 23.21 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.116 1.587 . . . . 0.0 110.173 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.543 HG12 ' HB3' ' B' ' 111' ' ' PHE . 9.6 t -68.7 -5.86 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.386 -0.821 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.23 -32.78 38.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.214 -0.928 . . . . 0.0 109.446 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.574 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.9 mm -82.47 -41.46 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.562 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 14.6 mt -68.09 -28.12 67.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.47 -24.57 76.68 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.542 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 7.8 ttm180 -101.62 -31.63 10.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.51 HG12 HG23 ' A' ' 77' ' ' VAL . 24.2 t -69.29 -37.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 3.8 t-105 -67.6 -51.88 44.99 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.758 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.471 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 8.6 mt-10 -51.06 -59.99 3.57 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.16 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.611 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.0 mt -62.07 -13.16 23.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.647 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.521 ' HA ' HG12 ' A' ' 72' ' ' VAL . 4.3 m -93.82 -27.2 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.551 -0.718 . . . . 0.0 110.147 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.3 t0 -79.25 70.67 5.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.006 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.493 HD13 HG21 ' A' ' 59' ' ' ILE . 46.2 mm -47.25 -33.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 12.5 m-20 -94.0 -25.41 17.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 110.122 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.455 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 25.5 m-70 64.62 45.27 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 2.7 p30 -110.89 0.62 17.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 110.549 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.557 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 96.27 18.99 29.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.557 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.73 161.86 40.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.211 -1.17 . . . . 0.0 109.889 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.497 HD11 ' CG1' ' A' ' 36' ' ' VAL . 15.9 mt -119.11 116.24 25.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.232 -0.918 . . . . 0.0 110.194 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 10.8 t0 -71.15 168.79 16.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 0.0 110.047 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.58 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptt180 -53.48 -37.27 62.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.933 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.465 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.0 m-20 -85.16 -29.83 24.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.097 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.489 ' HG2' ' O ' ' A' ' 57' ' ' SER . 0.5 OUTLIER -74.4 -46.59 39.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.562 0.696 . . . . 0.0 109.166 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.568 ' CE1' ' SD ' ' A' ' 74' ' ' MET . 50.2 t80 -59.11 -22.53 60.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.416 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -67.16 -50.1 62.34 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.963 0.887 . . . . 0.0 109.544 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 57' ' ' SER . 54.2 t -57.19 -26.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.568 0.699 . . . . 0.0 110.105 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.504 ' HA ' ' OG ' ' A' ' 57' ' ' SER . . . -85.11 -7.08 59.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.788 . . . . 0.0 111.694 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.58 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 7.2 mmm -89.95 -40.4 12.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.614 -1.304 . . . . 0.0 110.233 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CD2' HG21 ' A' ' 9' ' ' VAL . 1.9 p90 -77.24 -19.21 56.93 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.239 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HB3' HG12 ' A' ' 53' ' ' VAL . 5.3 mt -77.54 -24.95 49.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.577 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 72.5 t -91.11 -34.7 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.637 -0.664 . . . . 0.0 110.133 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.63 -26.09 59.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.794 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.3 m -80.18 -15.92 55.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.534 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -88.13 -8.88 54.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 0.0 108.936 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.571 ' N ' HD22 ' A' ' 81' ' ' LEU . 2.5 mt -89.97 -44.85 9.6 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.787 0.803 . . . . 0.0 109.337 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.93 -52.45 24.43 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.001 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.41 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.22 -27.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.211 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 79' ' ' CYS . 1.2 mt-10 -67.18 112.2 9.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.173 -0.954 . . . . 0.0 111.143 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 42.5 Cg_endo -69.94 -176.13 1.43 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.814 1.428 . . . . 0.0 109.636 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.474 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 61.1 t -128.73 120.73 20.72 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.887 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.528 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 49.1 Cg_endo -84.69 -179.92 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.974 1.513 . . . . 0.0 109.122 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.542 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 43.1 mtp -105.86 11.72 31.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.512 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.4 p -110.87 104.34 12.94 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.023 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -54.89 104.99 0.47 Allowed Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.15 179.099 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.535 ' HD2' HD21 ' A' ' 94' ' ' LEU . 42.3 Cg_endo -67.85 143.98 63.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.654 1.344 . . . . 0.0 110.729 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.93 -5.58 17.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.198 1.63 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -87.39 -4.36 59.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.505 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.535 HD21 ' HD2' ' A' ' 91' ' ' PRO . 0.1 OUTLIER -122.63 -1.81 8.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.655 -0.653 . . . . 0.0 109.787 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.453 HG22 ' O ' ' A' ' 91' ' ' PRO . 64.8 t -93.73 135.86 24.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.39 -0.819 . . . . 0.0 110.715 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.32 162.03 42.71 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.096 1.577 . . . . 0.0 110.09 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.74 -3.32 12.43 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.894 1.47 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 t -79.85 -30.56 40.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.469 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 22.3 tptt -94.02 13.82 21.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.22 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 95' ' ' VAL . 4.8 mtm180 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.436 ' O ' ' N ' ' B' ' 109' ' ' ASN . 5.2 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.225 0.536 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.51 ' O ' ' NE1' ' A' ' 54' ' ' TRP . 73.1 p -63.43 80.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 0.0 109.881 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.507 ' ND2' ' O ' ' A' ' 51' ' ' GLY . 9.8 t-20 -114.63 123.41 32.23 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.582 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.31 -10.23 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.982 1.517 . . . . 0.0 110.758 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.562 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 88.8 m-85 -99.65 -32.64 10.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.171 -0.955 . . . . 0.0 110.233 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.446 HD12 ' CG ' ' B' ' 109' ' ' ASN . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.172 -179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.484 0.948 0 N-CA-C 110.524 -0.606 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.576 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.4 t90 -51.79 123.73 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.237 -0.914 . . . . 0.0 110.07 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.519 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -44.82 -25.21 0.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.682 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.576 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 51.2 t -97.26 126.78 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.535 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -95.52 -178.54 0.79 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.889 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.535 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.6 Cg_endo -66.38 -37.09 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.644 1.339 . . . . 0.0 109.781 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -66.64 -33.83 76.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.037 179.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 46.8 m-20 -82.86 -41.49 18.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.476 ' HE3' ' O ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -68.23 -15.71 63.68 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.817 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -83.67 -39.0 20.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.443 -0.785 . . . . 0.0 109.245 179.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.589 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -81.63 -20.77 39.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.589 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -81.35 -36.32 29.83 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.475 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 7.0 t70 -76.07 -8.64 57.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.207 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.23 -31.63 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.493 HG22 ' CE1' ' A' ' 70' ' ' PHE . 33.9 mt -79.84 -34.78 15.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.607 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -66.91 -34.17 77.2 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.433 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t0 -91.23 -7.56 50.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.394 -0.816 . . . . 0.0 110.011 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.482 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -77.45 -14.54 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 108.792 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.656 ' O ' ' CB ' ' A' ' 25' ' ' SER . 12.7 mt -92.91 -55.38 3.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.656 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 m 140.36 97.15 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.473 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 52.5 Cg_endo -74.73 149.64 38.37 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 123.828 1.436 . . . . 0.0 110.951 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -125.76 106.05 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.2 t30 58.0 18.12 4.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.388 -0.82 . . . . 0.0 109.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 97.17 36.04 5.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.486 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 82.9 m-85 -150.78 143.74 24.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.093 -1.239 . . . . 0.0 111.969 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.587 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.0 mt -111.2 137.32 49.05 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.83 141.27 33.59 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.139 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.543 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.64 -27.53 0.33 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 24.7 t70 -64.77 -27.98 69.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -1.034 . . . . 0.0 110.319 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.494 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 77.2 mttt -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.538 ' CG1' HD13 ' A' ' 40' ' ' LEU . 77.1 t -74.97 -41.65 45.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.484 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.546 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 3.4 mtpt -36.67 -56.77 1.3 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.795 -0.566 . . . . 0.0 110.914 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -67.3 -35.5 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.919 1.483 . . . . 0.0 110.007 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.594 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -61.26 -27.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.538 HD13 ' CG1' ' A' ' 36' ' ' VAL . 20.0 mt -97.94 -33.52 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 0.0 110.432 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.466 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 14.0 mt -73.11 -9.14 58.41 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.171 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -89.3 -9.01 52.15 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.882 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.502 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 16.3 p -81.67 5.55 17.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.448 -0.782 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 43' ' ' SER . 6.1 ttpt 66.98 19.1 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.931 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.518 HD23 ' HD2' ' A' ' 46' ' ' PRO . 15.7 mt -100.36 156.47 35.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.0 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.549 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -75.44 167.98 25.48 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.123 1.591 . . . . 0.0 110.233 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.35 -8.0 7.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.346 -0.846 . . . . 0.0 109.219 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.22 -31.63 60.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.549 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.5 mm -83.2 -37.19 13.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.812 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.574 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 8.5 mt -74.19 -26.25 60.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.533 0.682 . . . . 0.0 109.371 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -69.94 -29.06 71.07 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.436 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . 2.5 mtm180 -101.66 -31.88 10.6 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.251 -0.558 . . . . 0.0 110.462 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' N ' ' O ' ' A' ' 49' ' ' ILE . 5.6 t -64.57 -55.48 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.195 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.567 ' CE3' HD11 ' A' ' 65' ' ' LEU . 2.0 t-105 -57.87 -52.18 66.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -45.46 -66.29 0.42 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.577 0.703 . . . . 0.0 110.689 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.541 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.8 mt -60.54 -16.83 41.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.528 ' CB ' ' HB1' ' A' ' 73' ' ' ALA . 3.0 t -89.34 -14.61 35.28 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' TRP . 2.1 t0 -93.31 83.27 4.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.507 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 31.9 mm -53.44 -38.84 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.374 -0.829 . . . . 0.0 110.804 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.525 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 4.8 p30 -103.72 -20.6 13.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 110.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 19.8 m-70 67.19 42.12 2.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.4 p30 -95.67 1.05 53.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.406 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 94.25 25.12 17.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 23.2 mtp -152.76 161.79 42.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -1.204 . . . . 0.0 111.17 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.567 HD11 ' CE3' ' A' ' 54' ' ' TRP . 21.9 mt -127.12 112.73 15.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 109.618 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.486 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 1.6 t70 -72.25 172.99 9.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.104 -0.998 . . . . 0.0 110.079 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.607 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.82 -41.58 64.33 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.202 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.448 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -81.15 -36.04 30.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 109.822 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 1.8 tt0 -72.02 -46.31 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.807 . . . . 0.0 108.945 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.594 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 16.8 t80 -59.32 -17.37 28.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -72.69 -43.66 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.835 0.826 . . . . 0.0 109.35 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.475 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 41.8 t -60.02 -26.05 34.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.498 0.666 . . . . 0.0 109.55 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.528 ' HB1' ' CB ' ' A' ' 57' ' ' SER . . . -90.31 -6.33 55.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 111.315 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.586 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.2 mmt -83.64 -49.01 9.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.0 109.986 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.625 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 5.4 p90 -73.97 -28.48 61.51 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 10.2 mt -66.28 -22.21 66.29 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.541 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 54.5 t -91.68 -45.45 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.642 -0.661 . . . . 0.0 110.164 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.46 ' HA ' HD11 ' A' ' 81' ' ' LEU . 4.8 m-85 -75.52 -23.37 56.69 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.573 -179.839 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.543 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 88.6 m -84.3 -19.74 33.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.601 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.506 ' HA ' ' O ' ' A' ' 84' ' ' GLU . . . -77.74 -14.27 59.65 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.541 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -92.29 -51.37 5.19 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.653 -0.654 . . . . 0.0 111.377 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -118.09 -14.34 9.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.417 -0.913 . . . . 0.0 113.007 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.543 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -108.58 -86.4 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.178 -1.576 . . . . 0.0 112.071 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' CYS . 33.9 mm-40 -131.54 155.01 82.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 110.738 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.19 -159.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.223 1.644 . . . . 0.0 110.51 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 52' ' ' ARG . 70.9 t -132.8 124.78 18.95 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.537 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.519 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 48.7 Cg_endo -84.49 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.825 1.434 . . . . 0.0 108.518 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.506 ' SD ' ' N ' ' A' ' 88' ' ' MET . 0.0 OUTLIER -123.63 3.9 8.92 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.581 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.479 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 67.5 m -110.02 97.46 6.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.789 -1.165 . . . . 0.0 112.264 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.541 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -51.4 106.2 0.62 Allowed Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.524 178.056 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 89' ' ' SER . 43.3 Cg_endo -71.91 161.97 43.31 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.044 1.549 . . . . 0.0 110.952 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.62 -13.65 22.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 124.094 1.576 . . . . 0.0 110.791 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.07 -5.02 55.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.214 -0.929 . . . . 0.0 109.286 179.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.625 ' CD1' ' CZ ' ' A' ' 75' ' ' PHE . 3.8 mm? -102.72 -19.2 14.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.403 -0.811 . . . . 0.0 110.112 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.88 116.02 28.38 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 110.479 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.488 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 49.2 Cg_endo -78.02 176.0 10.5 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.042 1.548 . . . . 0.0 110.26 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 39.7 Cg_endo -66.47 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.876 1.461 . . . . 0.0 110.015 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -24.98 68.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -89.21 9.18 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.421 -0.8 . . . . 0.0 109.281 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.52 -0.737 . . . . 0.0 109.598 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.287 0.565 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.416 HG23 ' HB3' ' A' ' 61' ' ' HIS . 0.6 OUTLIER -159.42 38.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.814 179.884 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 14.7 t-20 -120.85 130.83 24.67 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 110.204 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.541 ' HB2' ' CG ' ' A' ' 37' ' ' LYS . 47.8 Cg_endo -75.05 -1.47 11.27 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.837 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.574 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 86.8 m-85 -113.67 22.67 13.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.104 -0.998 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 179.885 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.482 0.815 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.56 ' CZ3' ' HG3' ' A' ' 14' ' ' LYS . 12.2 t90 -81.44 121.51 26.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 0.0 110.019 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.57 ' CB ' ' CD1' ' A' ' 94' ' ' LEU . . . -40.98 -29.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.484 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 84.9 t -93.92 146.47 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.568 -0.707 . . . . 0.0 109.531 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.488 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mttp -103.56 175.27 2.3 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 110.421 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.3 -33.82 22.92 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.101 1.579 . . . . 0.0 109.708 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -75.45 -36.5 60.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.612 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -77.74 -36.36 50.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.56 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 tmtt? -72.26 -14.97 61.9 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.212 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -76.44 -42.35 44.33 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.18 -21.79 60.61 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CE1' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -77.79 -34.78 52.06 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.13 -8.35 56.82 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.616 . . . . 0.0 109.968 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.73 14.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.555 HG22 ' CE1' ' A' ' 70' ' ' PHE . 18.1 mt -78.29 -29.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.592 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.0 OUTLIER -74.54 -32.46 62.45 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.562 0.696 . . . . 0.0 109.215 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.459 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -90.28 -5.52 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 0.0 109.866 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -82.7 -10.75 58.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.108 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.609 ' O ' ' CB ' ' A' ' 25' ' ' SER . 4.0 mt -103.15 -13.99 16.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 88.78 101.46 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.468 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.3 Cg_endo -72.53 152.2 53.9 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 124.348 1.709 . . . . 0.0 111.256 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.479 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 91.3 t -127.97 109.49 19.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.479 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 18.2 t30 57.47 24.07 9.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 84.77 40.62 8.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.491 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 87.7 m-85 -152.62 153.55 33.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.255 . . . . 0.0 111.749 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.592 HD13 ' CE2' ' A' ' 70' ' ' PHE . 6.7 mt -121.8 147.15 46.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 35' ' ' LYS . 58.8 p -95.16 143.21 26.77 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.288 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.6 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.87 -26.37 0.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 16.4 t0 -67.76 -26.04 65.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 0.0 110.134 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 84.7 mttt -91.1 -36.17 14.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.588 HG21 ' CE2' ' A' ' 70' ' ' PHE . 68.2 t -75.76 -50.04 24.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.09 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HG3' ' CZ ' ' B' ' 111' ' ' PHE . 4.1 ttpt -34.61 -56.23 0.84 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.743 -0.598 . . . . 0.0 111.013 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.537 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -64.92 -33.51 51.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.326 1.172 . . . . 0.0 109.936 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.534 ' N ' ' O ' ' A' ' 36' ' ' VAL . 2.6 t -67.56 -29.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.731 . . . . 0.0 110.002 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.525 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 24.7 mt -88.55 -27.1 21.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.148 -0.97 . . . . 0.0 110.204 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD12 ' CG ' ' A' ' 37' ' ' LYS . 19.8 mt -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -73.03 -13.77 61.28 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.611 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.533 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 1.4 p -80.25 7.4 9.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.463 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.469 ' HB3' ' O ' ' A' ' 43' ' ' SER . 14.4 tptt 64.65 8.64 4.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.0 110.561 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.536 HD22 ' HD2' ' A' ' 46' ' ' PRO . 17.2 mt -88.75 153.72 50.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.563 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.3 Cg_endo -73.51 176.75 8.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.696 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.548 ' O ' HG11 ' A' ' 47' ' ' VAL . 1.9 t -71.04 -10.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.83 -32.58 57.68 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.563 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.2 mm -81.98 -38.94 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.892 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.525 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 26.7 mt -74.98 -29.69 60.97 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.517 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.77 -25.09 75.38 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.528 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 8.5 ttm180 -101.05 -34.49 9.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.007 -0.702 . . . . 0.0 110.475 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.527 ' CG1' ' CG2' ' A' ' 77' ' ' VAL . 15.3 t -66.46 -41.76 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.774 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.6 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.0 t-105 -65.17 -51.87 58.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.702 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.472 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.0 mm-40 -50.9 -55.46 17.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.949 -1.094 . . . . 0.0 110.01 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.547 HD23 ' CA ' ' A' ' 90' ' ' LEU . 2.5 mt -64.38 -12.78 46.15 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.538 ' OG ' ' CA ' ' A' ' 73' ' ' ALA . 38.5 m -94.39 -35.85 12.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.757 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' TRP . 17.3 t0 -72.26 92.9 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.544 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 8.9 mm -72.55 -33.64 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.608 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 6.7 m-20 -92.43 -4.22 54.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.439 -0.788 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 28.9 p80 38.73 54.98 1.98 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.649 . . . . 0.0 110.644 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 36.7 p-10 -125.77 18.34 7.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 108.793 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.441 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.45 32.77 45.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.525 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.7 mtp -150.86 161.79 42.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 111.578 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.481 HD11 ' CZ3' ' A' ' 54' ' ' TRP . 25.1 mt -135.42 110.4 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.022 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 27.1 t0 -70.0 169.32 13.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.087 -1.008 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.592 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 12.1 ptt180 -49.06 -41.98 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 109.952 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 0.4 OUTLIER -80.85 -35.92 32.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.152 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.544 ' HG3' ' CG1' ' A' ' 59' ' ' ILE . 1.7 tt0 -68.51 -55.35 12.0 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.915 0.864 . . . . 0.0 108.731 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CE2' HD13 ' A' ' 31' ' ' LEU . 23.2 t80 -50.01 -24.72 2.78 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.496 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -64.58 -49.1 72.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.669 0.747 . . . . 0.0 110.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.452 ' O ' ' CE2' ' A' ' 75' ' ' PHE . 16.8 t -56.78 -25.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.571 -0.706 . . . . 0.0 110.178 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.538 ' CA ' ' OG ' ' A' ' 57' ' ' SER . . . -88.19 -8.37 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 112.016 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.599 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 8.7 mmm -89.87 -30.35 17.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.375 -1.453 . . . . 0.0 110.147 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -85.52 -21.14 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.981 -1.074 . . . . 0.0 109.008 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.523 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.1 mt -83.53 -19.53 35.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 0.0 109.561 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.533 ' CG1' ' HB3' ' A' ' 43' ' ' SER . 9.8 t -92.21 -44.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.552 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 1.4 m-85 -70.28 -36.53 74.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 80.6 m -82.71 -8.52 59.59 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 109.58 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.59 ' CB ' ' CG2' ' A' ' 86' ' ' VAL . . . -91.61 -30.39 16.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.145 0.974 . . . . 0.0 109.174 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.552 ' CD2' ' HA ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -90.53 -22.84 21.12 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 1.7 tp10 -72.33 -58.92 3.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.015 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.465 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.6 tttt -178.4 47.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.483 -0.761 . . . . 0.0 110.341 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 2.9 tt0 -147.76 142.01 16.22 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.94 . . . . 0.0 110.281 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -78.53 152.44 26.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.042 1.548 . . . . 0.0 110.407 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.59 ' CG2' ' CB ' ' A' ' 80' ' ' ALA . 40.5 t -115.49 112.22 43.6 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 110.615 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -83.57 178.05 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.825 1.434 . . . . 0.0 110.025 179.639 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.496 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -101.42 10.03 40.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.531 ' C ' ' CD2' ' A' ' 56' ' ' LEU . 0.9 OUTLIER -94.82 117.27 29.87 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.817 -178.04 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.588 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -104.36 85.44 1.11 Allowed Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.523 ' HD2' ' CD2' ' A' ' 94' ' ' LEU . 39.8 Cg_endo -65.29 173.69 5.96 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.672 1.354 . . . . 0.0 111.094 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 42.5 Cg_endo -68.45 -6.73 18.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.228 1.646 . . . . 0.0 110.905 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.46 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -77.72 -13.69 59.83 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.402 179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.57 ' CD1' ' CB ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -99.98 -10.61 21.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.453 HG11 ' HD2' ' A' ' 99' ' ' LYS . 79.3 t -89.16 129.95 46.01 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.463 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 47.5 Cg_endo -73.82 174.54 12.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.872 1.459 . . . . 0.0 110.111 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.1 Cg_endo -71.05 -8.5 23.72 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.765 1.402 . . . . 0.0 110.439 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -27.28 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.86 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.453 ' HD2' HG11 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -89.55 9.25 27.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.401 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.37 -0.832 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.468 ' O ' ' OG1' ' B' ' 108' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.245 0.545 . . . . 0.0 110.125 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.468 ' OG1' ' O ' ' B' ' 107' ' ' SER . 80.4 p 43.61 61.46 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.209 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.518 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 12.5 t-20 -115.46 129.18 25.33 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 110.289 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.518 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.7 Cg_endo -74.93 -7.37 19.15 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.986 1.519 . . . . 0.0 111.076 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.589 ' CZ ' ' HG3' ' A' ' 37' ' ' LYS . 69.5 m-85 -117.35 14.29 14.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.964 -1.085 . . . . 0.0 110.329 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.472 ' HB2' ' OD1' ' B' ' 109' ' ' ASN . 27.1 mt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 7' ' ' TRP . 47.4 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 CA-C-O 121.563 0.568 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.569 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.4 t90 -41.17 121.63 1.62 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.504 -0.748 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -43.1 -24.88 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.371 -0.831 . . . . 0.0 110.007 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.569 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 41.0 t -98.41 152.9 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.841 . . . . 0.0 109.824 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.541 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -112.93 178.48 0.96 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.216 -0.927 . . . . 0.0 109.972 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.541 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.2 Cg_endo -71.78 -35.86 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.961 1.506 . . . . 0.0 109.772 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -73.21 -30.5 63.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 0.0 109.215 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -78.81 -43.79 24.52 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.462 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 13.5 tptp -65.32 -17.46 64.53 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -41.96 34.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.559 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.6 ptmt -79.27 -23.1 43.84 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.559 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.0 m-30 -75.43 -35.84 60.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.47 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 52.9 t0 -77.66 -9.04 58.76 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.46 -35.2 13.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.543 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -76.75 -32.96 21.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.589 ' HB2' ' CD1' ' A' ' 70' ' ' PHE . 0.1 OUTLIER -73.5 -39.22 64.99 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.489 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.7 t70 -86.65 4.23 41.3 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -91.88 -10.93 37.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 108.938 179.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.615 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.6 OUTLIER -100.57 -6.95 24.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.79 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.1 Cg_endo -76.1 152.5 35.84 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.486 1.782 . . . . 0.0 110.852 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.4 t -117.72 108.38 24.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.171 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 17.4 t30 57.96 16.22 3.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 109.644 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.88 4.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.457 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 80.5 m-85 -145.96 146.24 30.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.266 . . . . 0.0 111.959 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.593 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.7 mt -117.46 139.73 50.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.483 ' OG ' ' HG3' ' A' ' 35' ' ' LYS . 79.9 p -84.42 139.91 31.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.574 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.08 -28.21 0.74 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.1 t0 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.635 -0.92 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.483 ' HG3' ' OG ' ' A' ' 32' ' ' SER . 10.6 mttm -95.94 -33.91 12.0 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.578 HG21 ' CD2' ' A' ' 70' ' ' PHE . 89.7 t -76.94 -42.28 32.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.533 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.597 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 23.2 ttmt -42.34 -49.68 12.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.6 Cg_endo -69.56 -33.65 16.91 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.099 1.052 . . . . 0.0 109.44 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.577 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -63.97 -35.38 73.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.437 0.637 . . . . 0.0 109.601 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.562 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 25.4 mt -87.89 -23.39 23.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.396 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.2 mt -74.03 -14.44 61.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 109.18 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -85.31 -3.66 58.9 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.122 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.589 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -85.9 15.3 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.527 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.24 13.23 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -0.994 . . . . 0.0 109.757 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.545 HD11 ' CB ' ' A' ' 80' ' ' ALA . 13.7 mt -100.23 153.95 37.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 0.0 110.717 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.597 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.8 Cg_endo -78.45 -179.09 5.13 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.137 1.598 . . . . 0.0 110.12 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' O ' HG11 ' A' ' 47' ' ' VAL . 10.8 t -78.47 -3.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -82.28 -35.5 27.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.259 -0.901 . . . . 0.0 109.439 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.597 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.4 mm -80.67 -38.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.598 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 33.9 mt -73.69 -25.99 60.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.522 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.84 -25.55 74.66 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.473 ' HD3' ' SD ' ' A' ' 88' ' ' MET . 9.4 ttm180 -101.42 -31.98 10.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.98 -0.718 . . . . 0.0 110.135 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.491 ' N ' ' O ' ' A' ' 49' ' ' ILE . 10.0 t -71.06 -34.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.526 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.585 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 2.5 t-105 -67.83 -53.18 28.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.127 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 11.5 mt-10 -45.92 -58.92 3.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.025 -1.047 . . . . 0.0 110.004 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.586 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 2.8 mt -62.15 -18.32 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 108.61 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 45.9 t -87.78 -24.21 23.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t0 -102.78 72.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.715 -0.616 . . . . 0.0 109.584 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.493 ' CG1' HD12 ' A' ' 90' ' ' LEU . 4.6 mt -60.62 -19.79 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.857 . . . . 0.0 110.718 -179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 46.9 p-10 -99.34 -18.16 17.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.919 -1.113 . . . . 0.0 109.481 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 20.9 m-70 58.59 46.83 14.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.441 -0.787 . . . . 0.0 110.985 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.458 ' OD2' ' OD2' ' A' ' 60' ' ' ASP . 48.7 p-10 -106.37 21.03 18.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 108.777 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.509 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 64.97 32.71 85.13 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.509 ' HG2' ' O ' ' A' ' 63' ' ' GLY . 1.9 mmt -147.59 162.15 39.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.971 . . . . 0.0 110.849 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.585 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 12.7 mt -132.26 99.55 4.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.544 -0.723 . . . . 0.0 109.339 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.2 p30 -72.31 164.77 25.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.671 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.517 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.3 ptm180 -38.76 -43.82 0.95 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 111.601 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 12.3 m-20 -80.26 -33.47 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.992 . . . . 0.0 110.347 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.476 ' CG ' ' OD2' ' A' ' 66' ' ' ASP . 18.3 mt-10 -76.92 -48.1 19.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -0.91 . . . . 0.0 108.852 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.589 ' CD1' ' HB2' ' A' ' 21' ' ' PHE . 27.0 t80 -59.33 -18.42 38.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -73.6 -54.0 9.19 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.032 0.92 . . . . 0.0 109.263 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.561 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 59.6 t -53.09 -22.66 4.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 110.039 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.533 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -86.14 -17.16 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 111.713 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 8.7 mmm -82.17 -42.16 19.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.363 -1.461 . . . . 0.0 110.731 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.569 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -76.93 -18.44 58.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 108.773 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.569 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 7.2 mt -81.63 -24.76 36.16 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.631 0.729 . . . . 0.0 109.186 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.589 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 12.1 t -90.92 -34.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.597 -0.689 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 -29.57 64.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.383 -0.823 . . . . 0.0 110.843 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.2 m -77.97 -17.04 57.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.138 -0.976 . . . . 0.0 109.613 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.545 ' CB ' HD11 ' A' ' 45' ' ' LEU . . . -88.31 -5.82 58.12 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.01 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.564 ' N ' HD22 ' A' ' 81' ' ' LEU . 3.1 mt -90.36 -44.51 9.62 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.641 0.734 . . . . 0.0 109.029 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.483 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 1.7 mt-10 -70.9 -53.74 13.98 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.409 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.4 ttpt 178.41 -29.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 110.907 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.476 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 2.5 mt-10 -63.07 110.11 3.17 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.639 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 42.6 Cg_endo -69.15 175.3 7.78 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.918 1.483 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.444 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 49.7 t -122.06 125.3 26.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 110.688 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.471 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 46.4 Cg_endo -85.76 -178.88 3.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.875 1.46 . . . . 0.0 108.831 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.473 ' SD ' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -111.88 12.98 20.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.05 -1.031 . . . . 0.0 110.324 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.8 m -105.4 104.88 14.7 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.959 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.586 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 1.9 mt -52.35 106.22 0.63 Allowed Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.013 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.529 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.7 Cg_endo -70.47 142.72 45.5 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.747 1.393 . . . . 0.0 110.556 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.58 -1.57 9.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.787 1.658 . . . . 0.0 111.795 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.422 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -99.82 -10.15 22.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.564 ' CD1' ' C ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -110.74 -14.99 13.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.554 0.692 . . . . 0.0 110.191 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 54.3 t -87.7 137.46 31.96 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.901 -1.124 . . . . 0.0 111.099 -179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.99 156.05 42.99 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.122 1.591 . . . . 0.0 110.178 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.515 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 49.2 Cg_endo -76.39 -2.34 12.53 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.981 1.516 . . . . 0.0 110.987 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.4 p -84.7 -30.9 24.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 110.186 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.474 ' HG2' HG21 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -89.78 7.32 37.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.608 179.327 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.515 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 110.096 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.202 0.525 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 13.7 t -102.35 -15.17 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.067 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 6.6 t-20 -46.22 148.77 1.45 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.979 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.503 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 43.7 Cg_endo -72.96 -40.67 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.843 1.444 . . . . 0.0 110.98 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.598 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 47.2 m-85 -67.65 -39.27 84.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.044 -1.035 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 4.3 mt . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.037 . . . . 0.0 110.248 -179.969 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.483 0.862 0 N-CA-C 110.275 -0.702 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.526 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.1 t90 -47.24 126.68 9.69 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.544 ' CB ' ' CB ' ' A' ' 94' ' ' LEU . . . -40.42 -28.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.526 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 3.6 t -89.92 124.98 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 1.5 mttm -74.91 162.7 72.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 110.674 -178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.441 ' O ' ' HB1' ' A' ' 15' ' ' ALA . 38.3 Cg_endo -67.42 -29.92 37.07 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.118 1.589 . . . . 0.0 108.747 178.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.69 -20.86 35.33 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.8 m-20 -85.24 -42.72 14.41 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 5.5 tttt -69.1 -20.44 64.07 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.533 -0.73 . . . . 0.0 109.157 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -74.32 -43.73 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.558 -0.714 . . . . 0.0 109.175 179.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.7 ptmt -73.65 -29.08 62.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.3 m-30 -67.45 -37.22 82.64 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.26 -10.4 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.685 -0.634 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.425 ' O ' ' OG ' ' A' ' 23' ' ' SER . . . -92.76 -31.94 14.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.567 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.473 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 28.3 mt -81.26 -28.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.568 ' CD2' ' HA ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -75.8 -38.54 58.1 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.666 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.0 t0 -87.78 -0.33 56.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.66 -0.65 . . . . 0.0 109.881 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.425 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 1.7 m -89.73 -3.83 58.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 108.884 178.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -110.41 -8.94 14.63 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.0 t 83.79 98.4 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.526 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.3 Cg_endo -72.33 151.35 54.03 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.613 1.849 . . . . 0.0 110.812 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 50.2 t -122.93 104.67 14.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.7 t30 58.25 22.44 9.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 109.734 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 91.89 37.12 6.14 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 89.8 m-85 -151.16 151.62 32.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -1.182 . . . . 0.0 111.737 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 9.9 mt -119.0 151.36 38.35 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 35' ' ' LYS . 97.4 p -97.38 143.97 27.6 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.883 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.59 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.43 -27.65 0.16 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 1.2 m-20 -66.59 -30.59 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -1.075 . . . . 0.0 110.264 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.0 mttt -85.09 -35.79 21.59 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.582 HG22 ' CE2' ' A' ' 70' ' ' PHE . 55.7 t -80.06 -45.18 22.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.462 0.648 . . . . 0.0 110.316 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.599 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 5.2 tttt -40.65 -54.29 5.23 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.69 . . . . 0.0 110.789 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.551 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -67.01 -33.46 32.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.253 1.133 . . . . 0.0 109.796 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.489 HG23 HD13 ' A' ' 24' ' ' LEU . 2.3 t -66.7 -28.9 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.728 -0.607 . . . . 0.0 109.506 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.565 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 84.7 mt -88.05 -27.18 22.16 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 110.168 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 23.9 mt -73.81 -12.76 60.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.378 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 33.0 p-10 -80.09 -5.15 55.4 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.433 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -89.69 13.94 12.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.373 -0.83 . . . . 0.0 110.598 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.51 13.63 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.542 HD22 ' HD2' ' A' ' 46' ' ' PRO . 16.2 mt -94.9 154.19 39.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.022 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.579 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.6 174.39 12.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.096 1.577 . . . . 0.0 110.652 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 6.8 t -71.95 -4.27 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.529 -0.732 . . . . 0.0 109.389 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.59 -35.4 27.12 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.218 -0.927 . . . . 0.0 109.449 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.579 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 7.8 mm -79.79 -38.69 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.837 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 27.8 mt -70.41 -27.24 64.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.389 0.614 . . . . 0.0 109.403 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.507 ' HA2' ' ND2' ' B' ' 109' ' ' ASN . . . -70.25 -24.03 76.92 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' CG ' ' HG2' ' A' ' 88' ' ' MET . 1.6 ttm180 -101.54 -31.47 10.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.761 -0.846 . . . . 0.0 110.896 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.553 ' CG1' HG22 ' A' ' 77' ' ' VAL . 12.5 t -68.32 -39.36 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.965 -1.085 . . . . 0.0 109.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.59 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.64 -50.29 58.68 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.57 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 51.2 mt-10 -49.32 -56.81 8.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.056 -1.027 . . . . 0.0 109.956 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.516 ' CD2' ' C ' ' A' ' 89' ' ' SER . 2.6 mt -60.48 -16.2 34.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.731 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 66.2 m -93.02 -31.27 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.463 -0.773 . . . . 0.0 109.149 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 36.0 t0 -89.58 98.39 11.74 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.78 -22.22 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 111.076 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 58.7 p-10 -90.76 -16.54 28.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 110.067 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.0 m170 66.23 42.85 2.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.371 -0.83 . . . . 0.0 110.639 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.441 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 23.3 p-10 -111.72 17.22 20.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 109.602 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.465 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 64.55 34.8 90.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.518 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 40.9 mtp -150.78 162.03 41.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.087 -1.243 . . . . 0.0 110.805 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.532 ' CD1' HG12 ' A' ' 36' ' ' VAL . 9.4 mt -126.22 106.27 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.735 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.5 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 2.3 t70 -69.86 172.12 8.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.29 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.568 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -51.81 -34.74 41.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 111.048 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.449 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 11.6 m-20 -86.81 -34.56 19.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.04 -1.038 . . . . 0.0 110.019 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.462 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 25.1 mt-10 -76.89 -38.94 52.6 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.582 ' CE2' HG22 ' A' ' 36' ' ' VAL . 38.6 t80 -63.01 -28.97 70.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.485 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.9 -51.49 64.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.995 0.902 . . . . 0.0 109.663 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.524 HG11 ' CD1' ' A' ' 94' ' ' LEU . 41.9 t -52.7 -28.03 12.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.494 0.664 . . . . 0.0 110.452 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.534 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -84.04 -13.61 52.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.319 -0.863 . . . . 0.0 111.862 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.1 mmm -85.82 -32.84 21.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.503 -1.373 . . . . 0.0 111.146 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.445 ' CE2' HD13 ' A' ' 94' ' ' LEU . 4.4 p90 -84.47 -18.2 36.63 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.123 . . . . 0.0 108.675 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.473 ' HB3' HG23 ' A' ' 53' ' ' VAL . 4.4 mt -83.9 -13.74 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.553 HG22 ' CG1' ' A' ' 53' ' ' VAL . 52.0 t -91.22 -47.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.49 -0.756 . . . . 0.0 110.261 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.56 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 8.2 m-85 -71.21 -29.89 65.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.279 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 31.2 t -82.09 -10.1 59.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.165 -0.959 . . . . 0.0 109.323 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.523 ' HB1' ' CG2' ' A' ' 86' ' ' VAL . . . -92.38 -35.76 13.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.186 0.994 . . . . 0.0 109.02 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.56 ' CD2' ' HA ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -90.57 -18.7 24.76 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.714 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.468 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 6.3 tt0 -69.94 -60.35 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.168 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.46 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 11.0 tttp -177.1 43.2 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.582 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 mt-10 -158.51 145.59 13.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.905 . . . . 0.0 110.298 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.0 -179.71 5.26 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.842 1.443 . . . . 0.0 109.596 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.523 ' CG2' ' HB1' ' A' ' 80' ' ' ALA . 92.7 t -131.22 117.28 16.84 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.963 -1.086 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.472 ' O ' HD12 ' A' ' 56' ' ' LEU . 50.5 Cg_endo -84.47 162.09 12.78 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.869 1.457 . . . . 0.0 109.551 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.554 ' HG2' ' CG ' ' A' ' 52' ' ' ARG . 22.4 mtm -89.99 17.2 7.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.163 -0.961 . . . . 0.0 110.117 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -98.56 114.9 27.51 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.705 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.545 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -103.18 84.76 0.74 Allowed Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.8 Cg_endo -64.57 165.48 20.37 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.776 1.409 . . . . 0.0 111.169 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.31 -6.99 20.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.437 1.756 . . . . 0.0 110.655 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.464 ' O ' ' HB1' ' A' ' 8' ' ' ALA . . . -72.83 -15.97 61.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.118 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.544 ' CB ' ' CB ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -132.47 40.26 3.3 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.897 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.47 HG22 ' O ' ' A' ' 91' ' ' PRO . 72.8 t -109.53 136.92 20.22 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 110.116 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.449 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 47.4 Cg_endo -72.81 170.11 20.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.502 . . . . 0.0 110.544 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.62 -18.96 14.99 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.172 1.617 . . . . 0.0 110.559 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.26 -23.66 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.122 -0.986 . . . . 0.0 110.172 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -90.49 8.82 31.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.399 -0.813 . . . . 0.0 110.432 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.519 ' C ' ' CG2' ' B' ' 108' ' ' THR . 14.6 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.093 0.473 . . . . 0.0 110.02 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.519 ' CG2' ' C ' ' B' ' 107' ' ' SER . 0.0 OUTLIER 34.67 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.326 0.584 . . . . 0.0 110.852 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.529 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 16.1 t-20 -125.23 145.6 51.2 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 110.098 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.5 -36.6 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.918 1.483 . . . . 0.0 110.713 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.599 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 95.5 m-85 -71.5 -5.21 31.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.047 -1.033 . . . . 0.0 110.037 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.352 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.561 -0.592 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.533 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.6 t90 -52.7 125.72 17.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 110.016 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.538 ' CB ' ' HB3' ' A' ' 94' ' ' LEU . . . -43.53 -26.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.533 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 13.2 t -92.5 137.8 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.414 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -95.74 173.37 4.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.414 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -70.99 -33.77 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.219 1.642 . . . . 0.0 109.993 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -27.48 39.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.3 m-20 -79.72 -40.03 29.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.477 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 22.4 tptp -72.31 -20.77 61.44 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.472 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.32 71.11 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.0 ptpt -74.84 -30.31 61.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.7 m-30 -64.86 -40.94 95.94 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.4 -8.67 56.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.281 0.562 . . . . 0.0 110.432 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -95.33 -33.81 12.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' A' ' 24' ' ' LEU . 36.0 mt -79.68 -27.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.595 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.1 OUTLIER -75.83 -39.17 57.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.447 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 20.7 t0 -87.36 0.02 56.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.814 -0.553 . . . . 0.0 110.05 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.96 -7.55 53.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.628 ' O ' ' CB ' ' A' ' 25' ' ' SER . 3.9 mt -105.59 -14.38 15.3 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.1 t 90.68 97.2 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.65 151.75 41.79 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.62 1.853 . . . . 0.0 110.701 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.484 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.8 t -118.13 104.68 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.57 -0.706 . . . . 0.0 109.17 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.484 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 5.0 t30 58.56 15.02 3.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.787 . . . . 0.0 109.678 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.9 32.24 3.89 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -150.07 148.92 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.966 -1.314 . . . . 0.0 112.017 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 10.2 mt -114.41 136.39 53.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -82.0 141.56 33.14 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.811 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.482 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.51 -27.56 0.84 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' C ' ' A' ' 32' ' ' SER . 22.4 t0 -63.66 -23.53 67.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.549 -0.971 . . . . 0.0 110.05 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 11.9 mttm -98.52 -35.64 10.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.585 HG23 ' CE2' ' A' ' 70' ' ' PHE . 99.2 t -76.93 -42.16 32.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.569 0.7 . . . . 0.0 110.132 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.616 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 18.6 tttt -41.63 -53.94 7.06 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 111.346 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.31 -34.99 19.78 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.433 1.228 . . . . 0.0 109.907 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.512 ' CG2' HD12 ' A' ' 24' ' ' LEU . 2.7 t -60.57 -26.14 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.847 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.55 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 23.9 mt -96.9 -28.66 14.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.064 -1.022 . . . . 0.0 110.274 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.465 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 62.7 mt -69.66 -17.27 63.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.629 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.36 -6.68 58.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.575 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.475 ' OG ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -85.49 14.18 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 110.13 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 58.71 16.17 4.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.903 . . . . 0.0 110.2 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.547 ' CD1' ' CB ' ' A' ' 80' ' ' ALA . 15.9 mt -96.55 153.39 38.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 110.019 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.574 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.7 Cg_endo -76.02 176.32 10.19 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.112 1.585 . . . . 0.0 109.897 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.494 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.4 t -73.85 -3.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.448 ' OD2' ' HB2' ' A' ' 46' ' ' PRO . 5.7 m-20 -81.11 -33.83 33.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.395 -0.816 . . . . 0.0 109.12 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.574 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.0 mm -82.73 -40.04 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.554 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 21.9 mt -73.32 -28.99 62.38 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -66.1 -24.24 71.71 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.561 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.47 -39.66 7.43 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.011 -0.7 . . . . 0.0 109.878 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.546 HG13 ' CG2' ' A' ' 77' ' ' VAL . 5.8 t -57.35 -45.41 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.041 -1.037 . . . . 0.0 109.751 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.533 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 4.3 t-105 -63.3 -53.14 57.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.336 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.493 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 85.7 mt-10 -54.87 -48.42 72.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.313 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.57 ' CD1' ' CG1' ' A' ' 86' ' ' VAL . 7.8 mt -62.4 -22.88 66.49 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.534 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 41.7 t -89.62 -30.13 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.506 0.67 . . . . 0.0 109.291 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -74.43 79.71 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.449 HG12 ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -60.43 -36.44 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.011 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.491 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.2 p30 -103.49 -20.09 14.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 33.2 m-70 69.41 41.8 1.26 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 2.7 p-10 -91.97 9.86 31.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.949 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.425 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 80.4 24.66 58.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 50.9 mtp -152.95 160.48 43.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.534 ' CD2' ' OG ' ' A' ' 57' ' ' SER . 13.6 mt -119.28 100.5 7.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.1 p30 -69.52 159.2 33.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.064 -1.022 . . . . 0.0 110.313 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.4 ptp180 -35.77 -43.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 111.251 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.488 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 35.8 t70 -75.89 -36.46 59.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.339 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.469 ' HG3' ' OD2' ' A' ' 66' ' ' ASP . 85.0 mt-10 -76.62 -43.11 39.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.004 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.591 ' CE2' HD12 ' A' ' 31' ' ' LEU . 22.1 t80 -59.54 -20.52 56.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.472 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.13 -49.83 22.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.531 ' CG1' ' CD1' ' A' ' 94' ' ' LEU . 55.8 t -58.31 -24.75 25.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.351 0.596 . . . . 0.0 110.259 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.509 ' CB ' ' HB2' ' A' ' 57' ' ' SER . . . -88.27 -9.38 53.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.349 -0.845 . . . . 0.0 111.282 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.579 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 3.3 mmt -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.924 -1.11 . . . . 0.0 110.361 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.553 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.3 p90 -77.41 -26.72 51.93 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.256 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.553 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 14.3 mt -69.03 -23.02 64.02 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.576 ' O ' ' CD1' ' A' ' 81' ' ' LEU . 57.6 t -92.3 -63.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.49 0.662 . . . . 0.0 109.555 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -47.17 -27.93 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.554 -0.716 . . . . 0.0 111.637 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.5 m -80.65 -16.16 54.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.84 -1.162 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.547 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -84.3 -14.25 50.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.366 -0.833 . . . . 0.0 109.785 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.576 ' CD1' ' O ' ' A' ' 77' ' ' VAL . 6.4 mp -90.33 -42.26 11.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.758 0.79 . . . . 0.0 109.345 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.23 -55.42 10.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.73 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.65 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.269 -0.894 . . . . 0.0 111.799 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 79' ' ' CYS . 13.4 tt0 -79.84 113.57 38.93 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.909 -1.12 . . . . 0.0 111.378 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.62 -171.25 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.763 1.402 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.57 ' CG1' ' CD1' ' A' ' 56' ' ' LEU . 72.7 t -114.48 148.48 40.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.517 ' HD2' ' CG1' ' A' ' 86' ' ' VAL . 48.8 Cg_endo -77.66 -162.3 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.753 1.396 . . . . 0.0 110.08 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.414 ' HG2' ' O ' ' A' ' 88' ' ' MET . 3.1 ttt -108.39 -0.72 20.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 90' ' ' LEU . 23.2 t -171.3 28.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.799 -1.188 . . . . 0.0 111.248 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.584 ' O ' ' O ' ' A' ' 89' ' ' SER . 0.3 OUTLIER 46.04 123.14 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.943 0 CA-C-O 121.576 0.703 . . . . 0.0 111.494 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.54 ' O ' ' CD1' ' A' ' 90' ' ' LEU . 40.0 Cg_endo -66.9 164.79 28.31 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.274 1.144 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HA ' HG22 ' A' ' 95' ' ' VAL . 43.6 Cg_endo -69.99 -3.2 11.68 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.099 1.579 . . . . 0.0 111.478 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.14 -5.31 46.07 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.538 ' HB3' ' CB ' ' A' ' 8' ' ' ALA . 0.2 OUTLIER -141.95 42.33 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.93 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.547 ' CG2' HD13 ' A' ' 90' ' ' LEU . 48.4 t -119.91 130.98 24.57 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 110.544 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.447 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.6 Cg_endo -69.47 174.29 9.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.867 1.457 . . . . 0.0 109.946 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.533 ' O ' ' CB ' ' A' ' 98' ' ' SER . 43.0 Cg_endo -69.33 176.42 6.47 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.78 1.411 . . . . 0.0 110.772 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 74.57 -49.74 0.67 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.505 -0.747 . . . . 0.0 110.134 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.3 12.65 13.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 108.634 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.508 ' NE ' ' HA ' ' A' ' 97' ' ' PRO . 2.2 ptp180 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 110.376 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -85.93 -27.67 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.461 ' OD1' ' HD2' ' B' ' 110' ' ' PRO . 48.1 t-20 -105.91 129.14 25.08 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.601 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.461 ' HD2' ' OD1' ' B' ' 109' ' ' ASN . 46.6 Cg_endo -75.88 -28.4 7.81 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.938 1.494 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 64.8 m-85 -86.08 -1.78 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.035 -1.041 . . . . 0.0 110.023 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.189 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.91 0 N-CA-C 110.445 -0.637 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.55 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.0 t90 -81.46 120.39 24.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 110.124 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.521 ' HB2' ' HB3' ' A' ' 94' ' ' LEU . . . -39.77 -29.01 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.55 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 14.4 t -92.84 128.38 44.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.485 -0.759 . . . . 0.0 109.373 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.4 mttp -84.35 164.79 41.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.107 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.64 -30.24 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.933 1.491 . . . . 0.0 109.476 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -85.13 -25.3 27.57 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.575 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -77.59 -41.72 37.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 1.5 tmtt? -69.39 -23.63 63.75 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.071 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.76 93.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -38.81 65.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.3 m-30 -60.63 -21.98 63.3 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -90.35 -12.09 38.71 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.78 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.414 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -91.52 -33.38 15.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.575 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.526 HG23 ' CZ ' ' A' ' 70' ' ' PHE 0.253 41.2 mt -78.38 -29.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -76.81 -39.73 50.41 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.672 0.748 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.8 t70 -86.44 1.98 49.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.583 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.414 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -90.24 -10.27 44.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.086 179.064 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.3 mt -105.44 -12.93 15.8 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.1 t 87.24 96.2 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -75.49 152.38 38.45 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.509 1.794 . . . . 0.0 110.933 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 26.3 t -116.65 107.8 23.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 7.6 t30 58.76 15.13 3.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.348 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.94 32.26 4.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.571 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -144.32 149.5 36.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.0 111.859 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.588 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 8.8 mt -117.17 138.95 51.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 14.0 p -85.86 141.08 29.87 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.069 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.438 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.33 -26.71 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 29.1 t70 -61.25 -28.53 69.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -1.093 . . . . 0.0 109.736 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.503 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 46.8 mttm -94.11 -33.2 13.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.242 -0.911 . . . . 0.0 108.579 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.563 HG13 ' CD1' ' A' ' 65' ' ' LEU . 79.6 t -79.67 -44.3 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.463 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.578 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 25.2 tttt -40.2 -54.02 4.84 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.889 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.539 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -66.83 -36.44 23.68 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 109.683 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.585 HG13 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -59.74 -37.59 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.557 -0.714 . . . . 0.0 109.607 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.555 ' CD1' HG12 ' A' ' 36' ' ' VAL . 34.9 mt -83.89 -29.02 27.52 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.411 -0.806 . . . . 0.0 109.845 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.405 HD12 ' CG ' ' A' ' 37' ' ' LYS . 29.4 mt -74.01 -12.48 60.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.399 -0.813 . . . . 0.0 109.512 179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -90.27 -4.98 56.82 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.125 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.526 ' CB ' HG11 ' A' ' 77' ' ' VAL . 60.5 p -84.13 8.87 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.2 OUTLIER 66.77 7.65 5.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.09 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.536 ' HG ' ' CD2' ' A' ' 81' ' ' LEU . 18.8 mt -93.18 155.87 40.72 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.552 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.3 Cg_endo -74.55 167.78 26.33 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.204 1.634 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.55 ' CG1' ' O ' ' B' ' 111' ' ' PHE . 17.5 t -66.63 -7.78 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.4 t0 -77.33 -30.94 54.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.552 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 9.1 mm -84.69 -36.61 11.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.974 0.892 . . . . 0.0 108.943 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.6 ' HB3' ' CZ ' ' B' ' 111' ' ' PHE . 11.5 mt -75.51 -25.59 57.38 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -75.6 -25.03 68.63 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.484 ' HB3' HG13 ' A' ' 86' ' ' VAL . 1.1 ttm180 -100.81 -29.67 12.12 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 49' ' ' ILE . 17.0 t -69.67 -51.03 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.5 t-105 -59.86 -53.63 55.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -45.43 -65.7 0.5 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.924 0.869 . . . . 0.0 110.12 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 HD22 ' N ' ' A' ' 90' ' ' LEU . 22.2 mt -56.76 -18.27 12.07 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.538 ' OG ' ' CD2' ' A' ' 65' ' ' LEU . 3.3 t -91.66 -17.29 25.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t70 -94.87 82.43 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.312 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -87.0 -20.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 110.892 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 5.8 p30 -94.52 -21.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 25.0 m-70 70.86 40.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.465 -0.772 . . . . 0.0 110.673 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 32.1 p-10 -101.89 15.13 29.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.416 ' O ' ' CG ' ' A' ' 64' ' ' MET . . . 62.29 31.85 80.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.537 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 74.8 mtp -154.41 161.29 41.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.366 -1.079 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.565 ' HG ' ' CZ3' ' A' ' 54' ' ' TRP . 9.0 mt -116.9 101.11 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 109.344 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.571 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.5 p30 -69.67 160.85 30.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 110.339 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.511 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.8 ptt85 -33.88 -45.41 0.19 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.826 -0.546 . . . . 0.0 111.604 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -78.1 -41.25 35.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.437 -179.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' OE2' ' OD2' ' A' ' 60' ' ' ASP . 44.8 mt-10 -67.77 -48.1 67.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.316 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.585 ' CZ ' HG13 ' A' ' 39' ' ' VAL . 10.2 t80 -57.88 -17.88 19.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.408 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -75.37 -53.73 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.431 -0.793 . . . . 0.0 109.506 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.467 HG11 HD13 ' A' ' 94' ' ' LEU . 55.4 t -55.39 -27.13 20.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.548 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -90.25 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.815 . . . . 0.0 110.816 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.613 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.5 mmt -87.15 -50.02 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.662 -1.274 . . . . 0.0 110.066 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.467 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 4.2 p90 -74.51 -27.71 60.67 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.5 ' HB3' HG22 ' A' ' 53' ' ' VAL . 7.5 mt -62.95 -30.52 71.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.548 HG21 ' O ' ' A' ' 73' ' ' ALA . 18.0 t -91.17 -23.8 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.896 -0.503 . . . . 0.0 109.942 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.43 -21.29 23.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.449 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 84' ' ' GLU . 3.9 t -84.59 -18.23 36.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.519 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -81.34 -14.88 56.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.076 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.545 ' N ' HD23 ' A' ' 81' ' ' LEU . 5.7 mt -90.62 -39.71 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.677 0.751 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.523 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 8.1 tp10 -69.08 -51.37 39.43 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.968 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.523 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 178.19 -24.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.261 -0.976 . . . . 0.0 112.236 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.49 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 3.6 mm-40 -94.11 120.15 65.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.699 -1.251 . . . . 0.0 111.66 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.97 -157.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.937 1.493 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.484 HG13 ' HB3' ' A' ' 52' ' ' ARG . 25.5 t -118.51 147.22 41.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.481 ' HD2' HG11 ' A' ' 86' ' ' VAL . 44.6 Cg_endo -80.34 -159.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.889 1.468 . . . . 0.0 110.02 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.37 12.58 8.16 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 111.341 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.9 t -165.15 23.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.595 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.557 HD21 ' CD2' ' A' ' 94' ' ' LEU . 0.7 OUTLIER 55.55 115.21 0.01 OUTLIER Pre-proline 0 C--N 1.281 -2.393 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.379 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.494 ' HD2' HD23 ' A' ' 94' ' ' LEU . 41.8 Cg_endo -69.9 157.36 60.37 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.714 1.376 . . . . 0.0 109.563 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.5 -1.43 9.74 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.029 1.542 . . . . 0.0 111.208 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.463 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -84.35 0.42 49.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 110.0 -179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.557 ' CD2' HD21 ' A' ' 90' ' ' LEU . 0.2 OUTLIER -150.68 38.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.558 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.34 133.27 24.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.008 -1.058 . . . . 0.0 110.21 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.42 171.7 17.16 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.043 1.549 . . . . 0.0 110.548 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.91 -169.49 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 110.244 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER 76.21 -42.42 0.44 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.495 -0.753 . . . . 0.0 110.489 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 6.34 36.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.092 -1.005 . . . . 0.0 108.491 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.433 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.432 -0.792 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.283 0.563 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.503 ' O ' ' CE2' ' A' ' 54' ' ' TRP . 35.7 p -86.74 -28.29 23.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.153 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.502 ' OD1' ' N ' ' B' ' 112' ' ' LEU . 1.1 t-20 -114.43 115.59 44.53 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.502 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.5 Cg_endo -82.51 21.15 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.87 1.458 . . . . 0.0 111.056 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.6 ' CZ ' ' HB3' ' A' ' 50' ' ' LEU . 78.8 m-85 -130.78 17.03 5.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.954 -1.092 . . . . 0.0 110.071 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.502 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.909 -1.119 . . . . 0.0 110.102 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.464 -0.629 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.596 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 -47.47 125.83 8.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.53 ' CB ' ' CD2' ' A' ' 94' ' ' LEU . . . -41.59 -26.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 110.161 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.596 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 49.3 t -106.13 157.91 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.559 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mttt -108.15 170.56 5.4 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.559 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.1 Cg_endo -66.17 -32.69 42.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.665 1.35 . . . . 0.0 109.915 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.6 mt-10 -70.07 -32.03 69.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.454 -0.779 . . . . 0.0 109.402 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.4 m-20 -77.04 -40.94 44.52 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.491 ' O ' ' HG3' ' A' ' 14' ' ' LYS . 8.2 tptm -65.3 -15.87 62.97 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.681 0.753 . . . . 0.0 109.073 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 -27.44 39.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.471 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 1.8 mtpt -90.72 -38.11 13.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.9 m-30 -66.18 -27.07 67.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.483 ' CB ' ' O ' ' A' ' 14' ' ' LYS . 1.1 t70 -89.42 -12.72 39.45 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.47 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.06 -28.24 17.28 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 24' ' ' LEU 0.255 54.0 mt -82.91 -35.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -70.74 -39.44 73.31 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.751 0.786 . . . . 0.0 108.949 178.873 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.501 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -87.35 -1.65 58.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.801 -0.562 . . . . 0.0 110.121 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.47 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 8.5 t -87.0 -11.37 50.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.01 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.616 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.0 mt -100.45 -10.7 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.72 97.08 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -74.9 149.52 37.31 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.308 1.688 . . . . 0.0 110.752 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.6 t -118.13 108.83 25.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 25.5 t30 58.91 22.29 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.583 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 87.62 39.56 7.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.518 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 90.6 m-85 -151.16 154.6 37.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.305 -1.115 . . . . 0.0 111.615 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.578 HD11 ' CD2' ' A' ' 70' ' ' PHE . 10.8 mt -123.07 137.21 54.99 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.506 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 1.3 p -91.62 147.32 23.09 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.954 -1.091 . . . . 0.0 110.404 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -41.72 -27.93 0.37 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.458 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 13.3 t70 -62.09 -25.72 67.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.996 . . . . 0.0 110.411 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.485 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.7 mttp -101.64 -28.41 12.52 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.04 -1.037 . . . . 0.0 108.856 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.551 HG13 ' CD1' ' A' ' 40' ' ' LEU . 91.6 t -83.81 -48.47 17.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.487 -0.758 . . . . 0.0 110.755 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.559 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 4.5 ttpp -41.53 -51.26 8.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.8 Cg_endo -67.83 -32.63 29.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.142 1.075 . . . . 0.0 109.575 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.47 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -66.92 -36.61 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.686 -0.634 . . . . 0.0 109.62 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.551 ' CD1' HG13 ' A' ' 36' ' ' VAL . 58.0 mt -82.33 -25.43 33.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.812 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.448 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 39.4 mt -74.51 -11.56 60.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.12 -10.33 57.87 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.078 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.591 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -81.71 8.91 8.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 43' ' ' SER . 1.3 ttmt 64.04 11.11 5.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 110.124 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.54 HD22 ' HD2' ' A' ' 46' ' ' PRO . 14.5 mt -88.84 154.14 49.99 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.016 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.571 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.4 Cg_endo -75.0 172.32 16.61 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.946 1.498 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.539 HG13 ' CA ' ' B' ' 111' ' ' PHE . 5.9 t -70.21 -5.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 109.725 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -80.73 -33.09 35.43 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.234 -0.917 . . . . 0.0 109.386 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.571 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.7 mm -81.5 -39.9 17.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.567 ' HB3' ' CE2' ' B' ' 111' ' ' PHE . 19.7 mt -70.01 -28.64 65.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.492 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.54 -24.45 75.21 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.554 ' HD3' ' CG ' ' A' ' 88' ' ' MET . 7.9 ttm-85 -101.99 -33.99 9.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.905 -0.762 . . . . 0.0 110.888 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.568 ' CG1' ' CG2' ' A' ' 77' ' ' VAL . 22.7 t -67.84 -36.22 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.846 -1.159 . . . . 0.0 109.264 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.1 t-105 -68.32 -49.88 57.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.281 -0.967 . . . . 0.0 109.435 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.5 mt-10 -56.01 -56.33 22.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.466 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.548 HD23 ' CA ' ' A' ' 90' ' ' LEU . 2.6 mt -59.38 -15.67 18.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.101 -1.0 . . . . 0.0 108.54 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.488 ' O ' ' HB3' ' A' ' 69' ' ' GLU . 28.5 t -94.22 -30.99 14.3 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -85.42 98.22 10.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.692 -0.63 . . . . 0.0 110.08 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.505 ' CG1' HD22 ' A' ' 90' ' ' LEU . 3.3 mt -96.15 -21.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.917 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -95.28 -13.98 24.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.508 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 24.1 m170 61.4 44.4 9.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.415 -0.803 . . . . 0.0 110.787 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 20.8 p-10 -106.83 18.56 21.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.135 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.523 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 61.49 30.42 74.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.523 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 3.3 mmm -148.97 161.07 42.65 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.327 -1.102 . . . . 0.0 109.255 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.55 HD11 ' CG1' ' A' ' 36' ' ' VAL . 8.9 mt -111.86 107.81 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.852 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -68.21 148.99 50.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.131 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.549 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -39.57 -37.82 0.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.381 -0.824 . . . . 0.0 110.259 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -77.37 -36.62 53.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 85.9 mt-10 -73.04 -51.21 19.01 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.578 ' CD2' HD11 ' A' ' 31' ' ' LEU . 27.2 t80 -50.0 -25.94 3.82 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.533 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -69.74 -54.58 13.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.071 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.547 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 52.4 t -53.65 -22.65 6.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 109.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.506 ' O ' HG21 ' A' ' 77' ' ' VAL . . . -89.24 -14.78 35.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.275 -0.89 . . . . 0.0 111.937 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.558 ' CE ' ' HA ' ' A' ' 74' ' ' MET . 7.3 mmm -81.77 -41.07 21.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.411 -1.431 . . . . 0.0 110.491 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.654 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 3.4 p90 -76.79 -25.52 53.41 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.297 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.566 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.9 mt -72.35 -27.49 62.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.514 0.673 . . . . 0.0 109.267 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.591 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 33.3 t -91.59 -21.84 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.658 -0.652 . . . . 0.0 110.524 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 -22.08 22.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' GLU . 26.7 m -83.74 -17.4 41.37 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.473 -0.767 . . . . 0.0 109.481 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.539 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -86.11 -9.97 55.71 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 1.9 mt -90.86 -42.0 10.87 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.685 0.755 . . . . 0.0 109.699 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.432 ' O ' ' OE2' ' A' ' 82' ' ' GLU . 6.3 tp10 -69.67 -51.95 30.07 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.64 -0.663 . . . . 0.0 109.856 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.461 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.4 -26.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 111.441 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 4.6 tt0 -76.64 110.65 12.26 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.092 -1.005 . . . . 0.0 111.017 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 40.5 Cg_endo -67.18 -176.48 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 109.997 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.485 ' O ' ' HD2' ' A' ' 52' ' ' ARG . 12.1 t -133.06 121.74 16.98 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 111.345 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -84.8 -170.43 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 124.041 1.548 . . . . 0.0 109.564 178.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.554 ' CG ' ' HD3' ' A' ' 52' ' ' ARG . 5.1 mtm -106.31 15.78 25.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 110.164 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.546 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 1.9 m -100.08 115.01 28.78 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.118 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.577 ' O ' ' HG ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -99.89 87.93 0.79 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.546 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.2 Cg_endo -63.81 165.36 18.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.296 1.33 . . . . 0.0 111.48 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 -10.38 27.51 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.241 1.653 . . . . 0.0 110.813 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.54 -8.0 52.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.24 -0.912 . . . . 0.0 108.64 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.654 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 4.3 mt -114.89 2.59 14.35 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.632 -0.668 . . . . 0.0 110.024 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.5 t -99.89 123.47 47.28 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.391 -0.818 . . . . 0.0 110.696 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.452 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 42.6 Cg_endo -68.92 167.25 23.83 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.958 1.504 . . . . 0.0 109.641 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.446 ' HA ' ' NE ' ' A' ' 100' ' ' ARG . 43.6 Cg_endo -71.32 -2.18 10.82 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.651 1.343 . . . . 0.0 110.755 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 p -102.48 -20.54 14.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.106 -0.996 . . . . 0.0 109.212 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.452 ' HG3' ' HG2' ' A' ' 96' ' ' PRO . 0.1 OUTLIER -100.5 6.96 44.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 6.8 ptp180 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 110.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' SER . . . . . 0.409 ' O ' ' C ' ' B' ' 108' ' ' THR . 34.1 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.201 0.524 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' THR . . . . . 0.409 ' C ' ' O ' ' B' ' 107' ' ' SER . 7.3 p 41.93 38.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 0.0 110.098 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.49 ' OD1' ' HB2' ' B' ' 111' ' ' PHE . 24.6 t-20 -90.13 133.08 34.2 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.63 27.62 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.891 1.469 . . . . 0.0 111.869 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.567 ' CE2' ' HB3' ' A' ' 50' ' ' LEU . 62.6 m-85 -142.19 -56.97 0.45 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.726 -1.234 . . . . 0.0 110.33 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.291 -179.798 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.843 0 N-CA-C 110.289 -0.696 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.615 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -95.21 117.03 29.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.549 ' CB ' HD21 ' A' ' 94' ' ' LEU . . . -42.2 -28.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 110.463 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.633 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 22.9 t -96.02 112.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.601 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.534 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -88.28 -177.53 0.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.955 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.534 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -70.12 -37.44 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.748 1.394 . . . . 0.0 109.789 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.439 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.7 pt-20 -70.94 -30.22 66.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.8 m-20 -77.89 -42.44 33.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.556 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -65.38 -33.82 76.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.28 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.48 62.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.596 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -72.31 -26.97 62.16 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.596 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.0 m-30 -74.03 -36.31 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.756 0.789 . . . . 0.0 109.147 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.469 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.9 t70 -74.69 -9.1 58.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.796 -0.565 . . . . 0.0 110.618 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.75 -32.26 13.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.583 HG21 ' CZ ' ' A' ' 70' ' ' PHE . 72.5 mt -80.06 -31.46 13.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.606 ' CE2' ' N ' ' A' ' 67' ' ' ARG . 0.2 OUTLIER -72.9 -41.96 64.08 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.523 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.477 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.7 t70 -86.46 3.33 44.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 110.069 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.56 -7.49 50.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.182 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 31' ' ' LEU . 2.2 mt -106.34 -8.85 17.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 83.06 92.2 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.7 Cg_endo -72.76 151.09 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.303 1.686 . . . . 0.0 111.134 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.494 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 75.3 t -122.52 104.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.494 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 67.66 22.61 8.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.387 -0.821 . . . . 0.0 108.962 -178.316 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 83.84 37.84 11.17 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 82.6 m-85 -148.7 147.27 28.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 111.513 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.598 ' CD1' ' CD1' ' A' ' 24' ' ' LEU . 15.5 mt -114.59 132.84 56.21 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.0 p -76.72 144.39 39.35 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.56 -27.09 0.28 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.9 t70 -66.41 -28.15 68.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.512 -0.993 . . . . 0.0 110.477 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.5 mttp -90.84 -35.74 14.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.996 -1.065 . . . . 0.0 108.223 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.519 ' CG1' HD13 ' A' ' 65' ' ' LEU . 94.9 t -77.66 -45.11 28.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.625 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.631 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 tttt -37.84 -54.63 2.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.708 -0.62 . . . . 0.0 110.951 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.527 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.8 Cg_endo -67.05 -34.68 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.495 1.261 . . . . 0.0 110.028 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.604 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 2.1 t -61.99 -27.01 41.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 110.117 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.599 ' CD1' ' CZ ' ' B' ' 111' ' ' PHE . 24.1 mt -94.16 -29.03 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.493 HD12 ' O ' ' A' ' 37' ' ' LYS . 8.8 mt -74.84 -15.28 60.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.92 -1.112 . . . . 0.0 108.96 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -13.57 59.66 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.944 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.581 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 27.4 p -82.87 11.7 5.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 0.0 110.326 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 12.21 4.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.561 HD13 ' CB ' ' A' ' 80' ' ' ALA . 16.0 mt -87.04 155.66 55.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.558 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.7 Cg_endo -77.4 168.95 22.03 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.026 1.54 . . . . 0.0 109.548 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -69.77 -4.34 3.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 -30.74 39.2 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.311 -0.868 . . . . 0.0 109.103 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.558 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 11.4 mm -85.35 -36.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.882 0.848 . . . . 0.0 108.884 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.592 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -77.31 -26.17 51.98 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.539 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.16 -26.91 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.624 ' CZ ' ' CD1' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.96 -36.93 8.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 122.039 -0.683 . . . . 0.0 110.566 179.412 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 76' ' ' LEU . 6.8 t -59.73 -41.44 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.044 -1.035 . . . . 0.0 110.128 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.6 t-105 -66.98 -51.64 52.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.929 -1.107 . . . . 0.0 109.716 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.6 mt-10 -52.3 -59.92 3.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 110.481 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.624 ' CD1' ' CZ ' ' A' ' 52' ' ' ARG . 1.2 mt -59.95 -30.14 68.88 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.751 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.546 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 44.3 t -75.29 -29.76 60.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.327 -0.858 . . . . 0.0 108.809 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -70.42 62.41 0.24 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.578 -0.701 . . . . 0.0 109.54 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.513 HG23 HD11 ' A' ' 59' ' ' ILE . 43.4 mm -43.21 -33.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.992 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 1.6 m-20 -99.85 -20.7 16.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 44.3 m-70 59.33 38.47 23.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.6 -1.34 44.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 99.1 20.74 17.33 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.568 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.6 mtp -153.26 161.3 42.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.593 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.519 HD13 ' CG1' ' A' ' 36' ' ' VAL . 12.6 mt -118.98 107.07 13.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.58 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.5 p30 -75.15 160.67 30.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.886 -1.134 . . . . 0.0 109.706 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.606 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ppt_? -36.88 -46.33 0.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.671 -0.643 . . . . 0.0 111.741 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' OD1' ' NH1' ' A' ' 67' ' ' ARG . 1.7 t70 -72.75 -38.87 67.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.096 -1.002 . . . . 0.0 110.268 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.505 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 50.7 mt-10 -71.33 -46.63 60.16 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 108.791 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.604 ' CZ ' HG12 ' A' ' 39' ' ' VAL . 26.7 t80 -59.03 -18.6 36.13 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.463 ' HB3' ' HE2' ' A' ' 14' ' ' LYS . . . -76.01 -50.57 14.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.454 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.1 t -59.89 -24.21 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.586 -0.696 . . . . 0.0 109.679 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.546 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.36 -4.99 56.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.289 -0.882 . . . . 0.0 110.877 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.553 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.5 mmt -84.44 -46.21 11.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.668 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 2.1 p90 -76.01 -29.36 58.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.49 ' HB3' HG21 ' A' ' 53' ' ' VAL . 4.5 mt -60.42 -27.8 67.76 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.581 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 77.2 t -92.55 -41.89 13.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.624 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.39 -29.22 59.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.355 -0.841 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.481 ' O ' ' N ' ' A' ' 84' ' ' GLU . 82.6 m -80.83 -11.82 59.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.561 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . -84.96 -17.37 37.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.247 -0.908 . . . . 0.0 108.554 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.538 HD21 ' N ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -91.19 -39.36 12.16 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.891 0.853 . . . . 0.0 109.169 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.525 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -69.91 -53.93 15.7 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.854 -0.529 . . . . 0.0 110.076 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.525 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 178.93 -25.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.57 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.8 OUTLIER -77.63 110.62 13.37 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 -178.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.9 Cg_endo -75.79 -167.34 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.818 1.431 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.552 ' CG2' HG22 ' A' ' 49' ' ' ILE . 60.2 t -109.47 144.53 30.01 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.224 -0.922 . . . . 0.0 109.424 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.543 ' O ' ' CZ ' ' A' ' 52' ' ' ARG . 45.8 Cg_endo -84.95 -155.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.994 1.523 . . . . 0.0 110.552 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.47 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 20.8 mtp -124.24 3.01 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.334 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 90' ' ' LEU . 1.9 t -163.62 26.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.718 -1.239 . . . . 0.0 110.81 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' CD2' ' HB2' ' A' ' 94' ' ' LEU . 0.4 OUTLIER 52.42 113.96 0.01 OUTLIER Pre-proline 0 C--N 1.286 -2.174 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.722 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' CG ' HD12 ' A' ' 94' ' ' LEU . 47.0 Cg_endo -71.7 175.04 10.16 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.685 1.36 . . . . 0.0 109.348 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.424 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 52.8 Cg_endo -81.1 -7.29 13.11 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.839 1.442 . . . . 0.0 111.96 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.508 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -84.83 12.6 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.887 -1.133 . . . . 0.0 109.126 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.668 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 39.1 mt -133.41 -24.83 1.77 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.513 -0.742 . . . . 0.0 111.244 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 92' ' ' PRO . 4.6 m -93.67 148.86 36.16 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.485 ' O ' ' CB ' ' A' ' 100' ' ' ARG . 43.9 Cg_endo -69.75 171.51 14.32 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.247 1.656 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.491 ' HA ' ' HB3' ' A' ' 100' ' ' ARG . 46.5 Cg_endo -72.63 -14.23 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.108 1.583 . . . . 0.0 110.971 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -74.65 -54.3 7.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.999 -1.063 . . . . 0.0 110.022 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -89.32 18.12 5.48 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.371 -0.831 . . . . 0.0 108.789 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.491 ' HB3' ' HA ' ' A' ' 97' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.618 -0.676 . . . . 0.0 110.314 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.262 0.553 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 39.9 p -94.33 27.47 2.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.997 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.507 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 18.2 t-20 -60.42 137.77 92.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.583 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -76.19 -29.36 6.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.096 1.577 . . . . 0.0 111.207 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.631 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 40.3 m-85 -80.9 -35.85 31.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.018 -1.051 . . . . 0.0 110.7 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.504 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.149 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 N-CA-C 110.766 -0.513 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.575 ' CZ3' ' HG3' ' A' ' 14' ' ' LYS . 13.2 t90 -64.19 126.8 28.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.537 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.12 -28.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.145 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.463 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.8 t -99.46 127.37 52.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.602 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.502 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -83.79 175.35 4.79 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.8 Cg_endo -67.71 -34.91 23.48 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.885 1.466 . . . . 0.0 109.412 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.09 -28.11 61.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.437 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -82.21 -38.86 23.94 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.575 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 8.2 tttt -70.43 -18.46 63.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 11' ' ' PRO . . . -72.42 -44.93 61.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.607 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.1 ptmm? -73.66 -18.24 61.05 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.607 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -83.33 -28.6 28.91 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -84.98 -9.68 57.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.695 -0.628 . . . . 0.0 110.452 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.82 -31.73 15.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.583 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 95.5 mt -80.82 -37.6 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.942 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -66.27 -33.89 76.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.481 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -90.0 -6.44 55.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.638 -0.664 . . . . 0.0 109.806 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 t -83.46 -9.77 58.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 108.93 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.594 ' O ' ' CB ' ' A' ' 25' ' ' SER . 2.7 mt -104.69 -11.53 16.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 84.37 99.59 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.017 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -76.06 152.37 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.149 1.605 . . . . 0.0 110.727 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 51.0 t -121.52 106.65 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.088 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.4 t30 60.62 17.58 7.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.296 -0.877 . . . . 0.0 109.306 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 95.43 36.02 5.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 81.8 m-85 -150.38 144.42 25.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 111.964 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.538 HD11 ' CD1' ' A' ' 70' ' ' PHE . 8.6 mt -109.07 143.33 38.54 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.499 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 60.3 p -92.01 144.6 25.28 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.293 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -42.9 -26.21 0.43 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -69.8 -23.85 63.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.939 . . . . 0.0 110.383 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 12.9 mttp -93.69 -35.01 13.03 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.549 HG12 ' CD1' ' A' ' 40' ' ' LEU . 95.7 t -75.94 -39.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.967 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.531 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.82 -56.65 3.0 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.233 -0.917 . . . . 0.0 110.95 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.3 Cg_endo -65.92 -32.85 44.29 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.675 1.355 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.583 HG12 ' CZ ' ' A' ' 70' ' ' PHE . 4.6 t -65.18 -30.04 49.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.921 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.639 ' CD1' ' CZ ' ' B' ' 111' ' ' PHE . 22.5 mt -93.05 -36.24 12.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 37' ' ' LYS . 6.6 mt -70.88 -14.18 62.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.109 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . 0.466 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -78.81 -13.93 59.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.459 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.521 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.8 OUTLIER -79.18 6.15 10.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.648 -0.658 . . . . 0.0 110.263 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.2 ttpt 67.39 15.7 9.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD13 ' CB ' ' A' ' 80' ' ' ALA . 16.1 mt -96.7 154.38 38.43 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.6 178.92 6.96 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 109.957 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.511 HG11 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -75.35 -1.96 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -84.44 -32.84 23.85 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.231 -0.918 . . . . 0.0 109.326 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.581 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.2 mm -84.85 -35.77 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.989 0.9 . . . . 0.0 108.735 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.541 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 25.3 mt -79.76 -23.37 42.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.07 -24.78 75.12 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.525 ' HB3' ' CG1' ' A' ' 86' ' ' VAL . 1.0 OUTLIER -101.28 -30.55 11.45 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.85 -0.794 . . . . 0.0 110.087 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.54 ' CG1' HG23 ' A' ' 77' ' ' VAL . 24.6 t -69.25 -38.47 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.228 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.583 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.8 t-105 -65.93 -50.79 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.08 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.481 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.7 mt-10 -56.84 -57.45 12.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.292 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 4.5 mt -59.87 -15.13 18.87 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.042 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.557 ' CB ' ' HB3' ' A' ' 73' ' ' ALA . 30.3 t -94.78 -36.76 11.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' OD1' ' CE2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -74.65 89.75 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 111.01 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 15.7 mm -60.74 -32.24 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.13 -0.981 . . . . 0.0 109.384 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.0 109.693 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 30.1 p80 40.74 40.54 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.424 0.63 . . . . 0.0 110.57 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.51 0.43 57.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.323 -0.86 . . . . 0.0 109.042 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.541 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 101.62 18.85 17.27 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.541 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.5 mmm -146.89 160.85 41.81 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.148 -1.207 . . . . 0.0 109.818 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.518 ' CD2' ' HG2' ' A' ' 69' ' ' GLU . 12.4 mt -120.05 110.3 16.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.222 -0.924 . . . . 0.0 110.036 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 9.1 t70 -69.38 169.56 12.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.116 -0.99 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.562 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.4 ptm180 -51.31 -40.34 58.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 3.1 t70 -81.11 -28.85 35.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.252 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 4.8 tt0 -74.51 -44.74 49.9 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.617 0.723 . . . . 0.0 109.198 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.583 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 44.2 t80 -62.6 -18.56 62.43 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.37 -49.05 24.32 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.938 0.875 . . . . 0.0 109.145 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.554 ' CG1' ' CD1' ' A' ' 94' ' ' LEU . 30.2 t -55.6 -30.75 27.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.469 0.652 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.557 ' HB3' ' CB ' ' A' ' 57' ' ' SER . . . -90.09 -4.32 57.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.795 . . . . 0.0 111.759 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.578 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmt -85.39 -44.18 13.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.642 -1.287 . . . . 0.0 109.984 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 6.2 p90 -79.19 -23.13 44.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.461 ' HB3' HG21 ' A' ' 53' ' ' VAL . 4.3 mt -72.75 -25.41 61.19 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.554 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 44.6 t -89.93 -44.75 15.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . 0.45 ' O ' ' OE1' ' A' ' 82' ' ' GLU . 1.4 m-85 -69.5 -27.86 65.55 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.04 -15.16 58.61 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.042 -1.036 . . . . 0.0 109.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.553 ' CB ' HD13 ' A' ' 45' ' ' LEU . . . -91.05 -9.61 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.594 ' N ' ' CD2' ' A' ' 81' ' ' LEU . 1.3 mt -90.03 -34.44 15.95 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.71 0.767 . . . . 0.0 109.227 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -68.36 -60.06 2.73 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.385 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 176.73 70.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.352 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.534 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.2 mt-10 -172.79 136.05 0.77 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 111.392 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -77.92 -171.59 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.796 1.419 . . . . 0.0 110.189 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.525 ' CG1' ' HB3' ' A' ' 52' ' ' ARG . 43.7 t -130.47 131.65 23.49 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.72 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.524 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 50.1 Cg_endo -82.91 -168.64 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.52 ' HG2' ' HD3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -119.63 13.93 12.58 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.625 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 19.9 m -115.31 97.63 6.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -59.48 109.01 1.6 Allowed Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.851 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.488 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 38.9 Cg_endo -65.3 150.65 87.06 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.826 1.435 . . . . 0.0 111.966 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.33 -10.64 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.415 1.745 . . . . 0.0 111.406 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.68 -21.3 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.107 -0.996 . . . . 0.0 108.445 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.576 ' CD1' ' C ' ' A' ' 94' ' ' LEU . 0.0 OUTLIER -103.32 -5.47 22.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -93.01 144.6 28.65 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 0.0 110.938 -179.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.479 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 47.4 Cg_endo -75.85 174.94 11.97 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 124.24 1.653 . . . . 0.0 110.407 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 47.4 Cg_endo -72.89 -11.04 25.42 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.966 1.509 . . . . 0.0 110.59 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.8 m -77.13 -19.99 56.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 0.0 109.535 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.424 ' HG3' ' CG2' ' A' ' 59' ' ' ILE . 0.0 OUTLIER -88.96 2.13 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.487 -0.758 . . . . 0.0 109.531 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 179.828 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 25.0 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.231 0.539 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 57.3 p -62.1 -69.17 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.49 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 20.3 t-20 -94.09 131.66 31.1 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.481 -0.762 . . . . 0.0 110.029 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.571 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 47.5 Cg_endo -73.8 -25.46 14.49 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.953 1.502 . . . . 0.0 110.982 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.639 ' CZ ' ' CD1' ' A' ' 40' ' ' LEU . 71.5 m-85 -82.35 -46.72 13.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.992 -1.067 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . 0.489 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.41 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.717 -0.532 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.487 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -51.29 130.17 26.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.663 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.553 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.04 -26.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.564 HG21 ' CD2' ' A' ' 75' ' ' PHE . 44.0 t -95.79 155.0 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.621 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -90.17 163.96 29.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 109.923 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.64 -30.17 23.24 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.011 1.532 . . . . 0.0 109.683 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.47 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.3 mt-10 -86.68 -18.63 30.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.475 0.655 . . . . 0.0 109.462 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.577 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 3.6 m-20 -79.94 -43.98 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.518 ' HD3' ' CB ' ' A' ' 71' ' ' ALA . 7.2 tptp -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.72 74.92 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -78.04 -44.54 26.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 6.2 m-30 -54.73 -24.65 23.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.3 -14.57 40.5 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.527 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.87 -29.69 15.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.454 ' O ' ' HG ' ' A' ' 24' ' ' LEU 0.252 51.1 mt -80.03 -32.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 177.846 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.1 OUTLIER -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.639 0.733 . . . . 0.0 109.204 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -90.41 -8.56 50.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.71 -0.619 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -13.72 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 108.867 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.66 ' O ' ' CB ' ' A' ' 25' ' ' SER . 10.9 mt -93.68 -54.53 3.6 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.66 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 m 137.54 96.41 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.479 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -71.45 146.59 50.4 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 123.948 1.499 . . . . 0.0 110.541 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.507 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 20.8 t -116.76 97.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.507 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 1.5 t30 60.56 11.32 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 110.79 33.49 2.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 82.3 m-85 -150.68 150.04 30.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.181 -1.188 . . . . 0.0 112.228 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.592 HD12 ' CD2' ' A' ' 70' ' ' PHE . 9.0 mt -117.28 136.08 53.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 34' ' ' ASP . 91.0 p -85.2 141.32 30.23 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.261 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.48 ' O ' ' N ' ' A' ' 37' ' ' LYS . . . -40.45 -27.93 0.17 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -62.43 -26.61 68.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -1.034 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.426 ' O ' HG21 ' A' ' 39' ' ' VAL . 53.2 mttt -96.53 -31.81 12.59 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.106 -0.996 . . . . 0.0 108.481 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.539 HG11 ' CD1' ' A' ' 40' ' ' LEU . 99.0 t -82.36 -46.88 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.208 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.589 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -42.79 -53.74 9.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.75 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -65.81 -34.03 41.46 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 109.288 -1.081 . . . . 0.0 109.288 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.484 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.47 -30.43 49.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.493 0.663 . . . . 0.0 109.54 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.557 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 88.4 mt -86.72 -24.45 25.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.439 -0.788 . . . . 0.0 110.31 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD1' ' HD3' ' A' ' 37' ' ' LYS . 19.4 mt -79.31 -13.57 59.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.54 -6.88 58.77 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.829 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.06 12.1 6.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 109.934 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.464 ' HB3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 64.71 17.77 11.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 109.98 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.553 HD23 ' HD2' ' A' ' 46' ' ' PRO . 15.1 mt -100.38 149.78 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.446 -0.784 . . . . 0.0 110.627 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.587 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.8 Cg_endo -75.88 175.34 11.44 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.059 1.557 . . . . 0.0 109.97 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.513 HG11 ' HB3' ' B' ' 111' ' ' PHE . 2.4 t -72.39 -2.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.25 -32.11 24.62 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.268 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.587 ' CG1' ' HD2' ' A' ' 46' ' ' PRO . 8.6 mm -84.35 -36.5 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.557 ' CD2' ' HB3' ' A' ' 40' ' ' LEU . 20.1 mt -75.62 -27.35 58.42 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.525 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.69 -24.06 75.37 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.564 ' CD ' ' HG2' ' A' ' 88' ' ' MET . 5.7 ttm105 -101.16 -33.96 9.89 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.942 -0.74 . . . . 0.0 109.935 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.536 ' CG1' HG23 ' A' ' 77' ' ' VAL . 38.0 t -69.26 -44.29 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.954 -1.091 . . . . 0.0 109.418 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.0 t-105 -60.78 -45.99 92.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.322 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.477 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 4.7 mm-40 -58.41 -55.81 30.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.243 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 90' ' ' LEU . 3.8 mt -62.36 -14.42 39.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 108.575 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 73' ' ' ALA . 1.4 t -95.14 -29.52 14.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.348 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.549 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 6.0 t0 -77.58 82.15 4.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.097 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.499 HG23 HD11 ' A' ' 59' ' ' ILE . 38.3 mm -57.89 -35.41 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.484 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 15.8 m-20 -96.84 -18.76 19.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 86.5 m-70 57.34 48.82 14.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.988 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -115.58 23.89 12.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.459 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 72.98 27.83 67.92 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.0 mtt -151.17 160.94 43.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.47 HD22 ' OG ' ' A' ' 57' ' ' SER . 10.9 mt -125.75 110.03 13.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.922 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.5 t70 -69.55 168.51 14.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.0 109.357 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.578 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.3 ptt180 -50.74 -39.47 52.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.523 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 37.7 m-20 -79.78 -33.08 40.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.228 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.481 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 33.5 mt-10 -73.53 -42.99 61.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.592 ' CD2' HD12 ' A' ' 31' ' ' LEU . 35.9 t80 -58.62 -27.38 64.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.518 ' CB ' ' HD3' ' A' ' 14' ' ' LYS . . . -66.89 -46.86 73.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 110.092 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.542 ' CG1' HD11 ' A' ' 94' ' ' LEU . 61.6 t -58.62 -25.67 29.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.611 0.72 . . . . 0.0 109.86 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.477 ' HB3' ' OG ' ' A' ' 57' ' ' SER . . . -89.67 -9.0 51.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.818 . . . . 0.0 112.186 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 4.4 mmm -85.47 -44.1 13.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.602 -1.311 . . . . 0.0 110.386 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.576 ' CZ ' HD12 ' A' ' 94' ' ' LEU . 3.9 p90 -76.67 -26.83 55.24 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.31 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.565 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.3 mt -69.41 -23.99 63.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.588 ' CG1' ' CB ' ' A' ' 43' ' ' SER . 61.8 t -91.4 -46.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.807 -0.558 . . . . 0.0 109.626 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.33 -28.71 68.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.7 -0.625 . . . . 0.0 110.908 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 5.9 t -80.45 -14.96 57.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.171 -0.956 . . . . 0.0 109.969 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.541 ' CB ' HD12 ' A' ' 45' ' ' LEU . . . -90.34 -8.43 50.78 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.068 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 81' ' ' LEU . 1.3 mt -90.75 -44.62 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.585 -0.697 . . . . 0.0 109.933 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -72.34 -54.39 9.61 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.344 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 174.48 78.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.134 -0.979 . . . . 0.0 111.29 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -174.1 121.64 0.38 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.45 -1.406 . . . . 0.0 111.325 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.84 168.57 24.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.914 1.481 . . . . 0.0 110.161 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.523 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 69.6 t -124.7 127.72 25.1 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 110.98 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.506 ' O ' ' CD1' ' A' ' 56' ' ' LEU . 52.5 Cg_endo -86.76 157.11 8.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.939 1.494 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.564 ' HG2' ' CD ' ' A' ' 52' ' ' ARG . 1.3 mmt -84.77 14.32 4.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.906 -1.121 . . . . 0.0 110.462 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.511 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 10.8 m -111.87 103.63 11.89 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.88 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.577 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -65.57 108.69 2.31 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.76 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.519 ' HD2' HD23 ' A' ' 94' ' ' LEU . 39.2 Cg_endo -64.21 149.39 90.37 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.748 1.394 . . . . 0.0 111.553 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.14 -9.46 24.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.347 1.709 . . . . 0.0 110.957 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.515 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -92.45 20.59 6.06 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.576 HD12 ' CZ ' ' A' ' 75' ' ' PHE 0.252 0.2 OUTLIER -138.75 3.47 2.27 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.481 0.658 . . . . 0.0 109.879 -178.014 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 16.9 t -93.28 115.7 65.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.43 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 49.6 Cg_endo -77.96 173.14 14.45 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.938 1.494 . . . . 0.0 110.115 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.43 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.8 Cg_endo -71.49 92.06 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.021 1.537 . . . . 0.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t -154.37 -42.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -89.48 5.26 46.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 2.1 mmt85 . . . . . 0 N--CA 1.491 1.623 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.433 -179.761 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -139.18 6.64 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.477 ' ND2' ' HG2' ' A' ' 55' ' ' GLU . 42.9 t-20 -122.89 128.63 25.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.57 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -75.88 9.74 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.832 1.438 . . . . 0.0 111.632 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.589 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 98.9 m-85 -132.42 41.51 3.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.778 -1.201 . . . . 0.0 110.366 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.504 -0.614 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' TRP . . . . . 0.587 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.0 t90 -74.27 124.71 26.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.869 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.588 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -38.33 -30.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.695 -0.628 . . . . 0.0 110.789 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 46.3 t -101.23 134.92 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.777 . . . . 0.0 110.055 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -91.79 -179.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.385 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.7 Cg_endo -69.47 -36.47 11.53 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.941 1.495 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.77 -27.12 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 109.957 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 13.0 m-20 -80.93 -38.12 28.38 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.242 -0.911 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 2.2 tttt -77.13 -21.27 54.44 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.948 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.92 -39.35 87.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.59 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.72 -24.47 58.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.606 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 12.3 m-30 -76.96 -32.2 57.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -11.7 60.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.682 -0.636 . . . . 0.0 110.029 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.6 -31.61 17.49 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.584 HG21 ' CE1' ' A' ' 70' ' ' PHE . 25.6 mt -81.47 -37.0 15.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.59 ' CZ ' ' HB3' ' A' ' 26' ' ' PRO . 0.0 OUTLIER -68.26 -34.71 76.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.8 t0 -90.49 -4.63 56.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.626 -0.672 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . 0.412 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 25.8 t -85.99 -4.91 59.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -0.97 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.612 ' O ' ' CB ' ' A' ' 25' ' ' SER . 0.9 OUTLIER -109.47 -14.96 14.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.1 t 91.22 101.24 0.02 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.237 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.59 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -76.03 154.19 37.55 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.416 1.745 . . . . 0.0 110.607 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.487 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 94.3 t -122.6 102.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.497 -0.752 . . . . 0.0 109.306 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.4 t30 58.06 18.65 5.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 100.91 36.46 3.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 29' ' ' GLY . 86.9 m-85 -153.28 145.44 23.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.848 -1.384 . . . . 0.0 112.003 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.561 HD12 ' CD2' ' A' ' 70' ' ' PHE . 10.1 mt -113.65 138.47 50.15 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.497 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 96.5 p -88.64 146.86 24.85 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.21 -26.11 0.32 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 32' ' ' SER . 56.9 m-20 -63.82 -26.13 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -1.024 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.7 mttt -96.17 -35.75 11.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.091 -1.006 . . . . 0.0 108.507 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.525 HG13 ' CD1' ' A' ' 65' ' ' LEU . 63.0 t -79.18 -41.35 22.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.156 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.611 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 3.1 ttpt -41.31 -55.39 5.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.652 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.3 Cg_endo -67.85 -34.72 23.21 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.559 1.294 . . . . 0.0 109.935 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.603 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.1 t -59.71 -34.16 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 109.839 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . 0.556 ' HB3' ' CD2' ' A' ' 50' ' ' LEU . 20.5 mt -88.77 -27.25 21.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.804 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 61.1 mt -71.99 -12.26 61.16 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 109.128 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -87.72 -4.52 58.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.989 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.493 ' OG ' HG13 ' A' ' 77' ' ' VAL . 1.2 m -86.04 8.62 19.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 13.14 4.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.095 -1.003 . . . . 0.0 109.747 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.566 HD12 ' CG2' ' A' ' 49' ' ' ILE . 16.9 mt -95.56 156.42 37.51 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.9 Cg_endo -73.26 167.64 26.81 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 124.141 1.6 . . . . 0.0 109.888 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG11 ' HB3' ' B' ' 111' ' ' PHE . 1.2 t -65.11 -9.32 7.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.263 -0.898 . . . . 0.0 109.321 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.3 m-20 -76.58 -30.46 57.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.344 -0.848 . . . . 0.0 109.214 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.566 ' CG2' HD12 ' A' ' 45' ' ' LEU . 13.4 mm -84.58 -38.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 122.002 0.906 . . . . 0.0 108.78 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . 0.565 ' HB2' ' CD1' ' B' ' 111' ' ' PHE . 10.6 mt -78.5 -26.86 46.04 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.57 0.7 . . . . 0.0 109.252 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . 0.514 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -81.18 -24.21 57.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.793 ' NH1' HG13 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -101.24 -26.16 13.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.147 -0.619 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 49' ' ' ILE . 12.6 t -75.77 -43.23 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.774 -1.204 . . . . 0.0 107.869 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 1.5 t-105 -55.28 -49.04 73.12 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.442 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.0 mm-40 -53.75 -54.89 31.77 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 0.0 109.781 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.689 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 8.2 mt -61.37 -15.85 40.48 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 108.718 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.526 ' OG ' ' CB ' ' A' ' 73' ' ' ALA . 31.8 m -94.07 -38.96 10.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.583 -0.698 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.484 ' N ' ' O ' ' A' ' 54' ' ' TRP . 4.8 t0 -60.94 100.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 110.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.526 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -83.48 -20.82 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.451 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 19.5 m-20 -105.35 -16.31 14.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.438 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' HIS . . . . . 0.45 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 6.9 m170 60.57 43.84 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.973 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.433 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 10.5 p30 -112.84 -6.82 13.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.527 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.526 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 100.95 23.39 9.88 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' MET . . . . . 0.526 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.0 mmm -147.57 161.16 41.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.222 -1.164 . . . . 0.0 109.374 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.525 ' CD1' HG13 ' A' ' 36' ' ' VAL . 7.9 mt -121.36 107.76 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.083 -1.011 . . . . 0.0 110.325 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 61.0 t0 -69.61 169.29 13.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.96 -1.088 . . . . 0.0 110.114 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ARG . . . . . 0.583 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 8.1 ptt180 -50.56 -37.83 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.505 -0.747 . . . . 0.0 109.976 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.416 ' OD2' ' HG3' ' A' ' 67' ' ' ARG . 9.2 m-20 -78.65 -32.86 47.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.64 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.526 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 39.3 mt-10 -76.71 -41.64 44.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.349 -0.844 . . . . 0.0 109.045 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . 0.603 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 9.3 t80 -61.21 -25.38 67.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.526 -0.734 . . . . 0.0 109.242 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -69.59 -47.08 64.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.794 179.664 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' VAL . . . . . 0.606 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 92.0 t -61.29 -23.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.526 ' CB ' ' OG ' ' A' ' 57' ' ' SER . . . -90.45 -2.95 57.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 110.835 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' MET . . . . . 0.606 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 16.1 mmt -89.59 -46.21 8.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.929 -1.107 . . . . 0.0 109.658 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.641 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 2.0 p90 -77.61 -17.91 57.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.244 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.472 ' HB3' HG22 ' A' ' 53' ' ' VAL . 9.6 mt -77.07 -26.5 53.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.511 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 79.6 t -91.87 -50.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.386 0.612 . . . . 0.0 109.773 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -33.52 70.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.607 -0.683 . . . . 0.0 111.54 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' CYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 55.6 m -77.48 -14.46 59.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.008 -1.057 . . . . 0.0 109.592 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.507 ' CB ' ' CD1' ' A' ' 45' ' ' LEU . . . -88.67 -10.34 48.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.546 ' CD2' HD11 ' A' ' 45' ' ' LEU . 6.0 mt -90.88 -41.45 11.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 4.7 mm-40 -69.79 -52.34 26.04 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.836 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 175.65 -23.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.277 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 1.4 tt0 -59.45 131.66 88.09 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 111.179 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.95 148.12 27.63 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.105 1.581 . . . . 0.0 109.866 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' VAL . . . . . 0.793 HG13 ' NH1' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -98.95 111.65 61.17 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.011 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.568 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 48.0 Cg_endo -85.38 135.94 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.502 1.264 . . . . 0.0 109.665 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' MET . . . . . 0.483 ' HG3' ' HD2' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -62.84 -1.59 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.295 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.547 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.1 m -91.1 126.03 36.06 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.686 -1.206 . . . . 0.0 112.145 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' LEU . . . . . 0.589 ' CA ' HD23 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -103.25 85.23 0.83 Allowed Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.998 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HD3' ' O ' ' A' ' 89' ' ' SER . 42.2 Cg_endo -67.67 165.66 26.79 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.612 1.322 . . . . 0.0 110.699 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.99 -6.07 18.37 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.165 1.613 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.455 ' O ' ' CB ' ' A' ' 8' ' ' ALA . . . -76.72 -1.51 28.31 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 109.163 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.641 ' CD2' ' CZ ' ' A' ' 75' ' ' PHE . 3.6 mt -127.39 -0.96 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.679 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . 0.475 HG13 ' HD2' ' A' ' 96' ' ' PRO . 9.0 t -106.3 143.94 27.98 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 110.211 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.476 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 41.1 Cg_endo -67.2 174.9 6.37 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.062 1.559 . . . . 0.0 109.718 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 98' ' ' SER . 42.3 Cg_endo -68.54 170.79 14.27 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.844 1.444 . . . . 0.0 110.57 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 77.3 -46.15 0.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.314 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' NZ ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.22 9.45 22.94 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 108.801 179.079 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.8 . . . . 0.0 109.912 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.246 0.546 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 12.0 p -50.61 -33.16 21.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ASN . . . . . 0.518 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 5.4 t-20 -104.71 128.14 27.46 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . 0.518 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.5 Cg_endo -74.87 -21.52 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.93 1.49 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 37' ' ' LYS . 85.4 m-85 -83.85 -10.6 57.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.097 -1.002 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 41.8 mt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.105 -179.974 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.259 0.552 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.98 161.79 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.502 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -118.1 178.1 1.12 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.0 110.663 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.3 Cg_endo -73.26 -35.75 4.76 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.191 1.627 . . . . 0.0 110.15 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -26.16 37.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 72.8 m-20 -81.47 -38.84 25.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.936 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -69.84 -20.49 63.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.57 71.02 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 9.3 ptpt -75.25 -25.37 57.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.0 m-30 -71.72 -36.77 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -74.59 -9.85 58.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.746 -0.596 . . . . 0.0 110.318 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.42 -33.92 15.05 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.697 HD13 ' SD ' ' A' ' 74' ' ' MET . 16.4 mt -77.29 -36.46 24.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.756 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.92 -40.0 79.33 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.692 0.758 . . . . 0.0 109.112 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -86.91 0.9 54.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.658 -0.651 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -6.18 55.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 108.996 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.042 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -107.1 -9.99 16.02 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.8 92.05 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 121.195 0.521 . . . . 0.0 109.61 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -73.34 153.4 50.56 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.421 1.748 . . . . 0.0 110.994 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.58 114.13 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.74 . . . . 0.0 109.188 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.629 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 52.14 19.8 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.786 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.5 38.23 4.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.4 m-85 -150.43 147.32 27.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.878 -1.366 . . . . 0.0 112.639 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.042 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.3 mt -118.83 137.69 53.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ASP . 67.1 p -89.31 145.58 25.28 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.014 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.518 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.82 -27.54 0.18 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.1 t0 -61.52 -27.26 68.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -1.01 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' HB3' HD13 ' A' ' 24' ' ' LEU . 29.6 mttp -96.44 -32.85 12.12 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.096 -1.002 . . . . 0.0 108.551 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.082 HG11 HD12 ' A' ' 65' ' ' LEU . 60.6 t -79.6 -50.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.188 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.07 -53.66 3.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.913 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -65.97 -36.07 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 N-CA-C 109.174 -1.125 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.09 -32.42 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.012 ' HB3' HD22 ' A' ' 50' ' ' LEU . 60.9 mt -86.3 -25.77 25.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.625 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.518 HD21 ' HE1' ' B' ' 111' ' ' PHE . 62.7 mt -77.03 -11.7 59.84 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.306 -0.871 . . . . 0.0 109.44 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 63.2 t-20 -86.49 -8.86 57.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.024 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.441 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -81.23 6.65 13.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.984 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.7 tptt 65.69 11.3 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -0.99 . . . . 0.0 109.553 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.023 HD13 HG21 ' A' ' 49' ' ' ILE . 16.2 mt -95.18 152.55 39.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.843 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -73.53 168.98 23.39 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.965 1.508 . . . . 0.0 110.669 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' B' ' 111' ' ' PHE . 10.4 t -65.81 -10.54 10.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -30.56 58.93 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.243 -0.911 . . . . 0.0 108.958 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.023 HG21 HD13 ' A' ' 45' ' ' LEU . 16.1 mm -83.03 -40.32 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.012 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -72.82 -30.23 63.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.98 -25.02 76.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.799 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -100.7 -31.71 11.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.833 -0.804 . . . . 0.0 110.043 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 77' ' ' VAL . 25.6 t -72.08 -34.05 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.336 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.558 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 3.3 t-105 -73.25 -51.98 15.67 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.802 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.5 mm-40 -51.6 -58.25 6.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.951 -1.093 . . . . 0.0 110.088 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.799 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.5 mt -61.32 -14.54 27.82 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.872 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.963 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.9 t -94.03 -31.76 14.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.538 -0.726 . . . . 0.0 109.699 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 3.0 t0 -72.56 86.75 1.19 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.482 -0.762 . . . . 0.0 110.159 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.568 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.3 mm -65.94 -30.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 5.2 m-20 -99.01 -16.17 18.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.0 109.89 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.406 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 92.3 m-70 55.33 48.32 19.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.529 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 7.8 p30 -122.4 26.49 8.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 72.44 32.72 61.9 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.08 161.76 42.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.246 . . . . 0.0 111.082 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.082 HD12 HG11 ' A' ' 36' ' ' VAL . 14.1 mt -136.99 99.91 4.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 3.6 p30 -71.05 168.14 17.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.914 -1.116 . . . . 0.0 110.237 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' ASP . 15.7 ptt180 -38.56 -46.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.538 -0.726 . . . . 0.0 111.269 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.49 -35.48 63.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 110.57 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 57.4 mt-10 -75.79 -42.32 50.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.44 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 1.015 ' CD2' HD12 ' A' ' 31' ' ' LEU . 8.5 t80 -65.93 -19.91 66.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.413 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.7 -46.6 30.28 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.568 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 86.2 t -59.04 -29.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.543 0.687 . . . . 0.0 109.881 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.963 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.86 -4.08 57.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.441 -0.787 . . . . 0.0 111.18 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.697 ' SD ' HD13 ' A' ' 20' ' ' ILE . 9.3 mmt -85.11 -48.32 9.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.907 -1.121 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -73.02 -31.62 64.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.694 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.1 mt -62.66 -24.13 67.46 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.781 HG23 HG11 ' A' ' 53' ' ' VAL . 58.9 t -91.04 -47.84 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.483 0.658 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -68.1 -31.96 71.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 110.689 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 93.3 m -83.2 -11.12 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.371 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.78 6.43 4.54 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.917 1.483 . . . . 0.0 111.126 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.895 ' HB3' HG13 ' A' ' 47' ' ' VAL . 65.2 m-85 . . . . . 0 N--CA 1.497 1.879 0 O-C-N 120.998 -1.064 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.325 0.583 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.75 136.59 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.977 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.523 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.9 mttp -96.81 178.93 1.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.822 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.78 -36.42 13.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.841 1.443 . . . . 0.0 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 3.7 pt-20 -74.8 -28.73 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.922 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 20.6 m-20 -82.3 -36.04 27.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 0.0 108.958 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -75.0 -15.29 60.66 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.514 -0.742 . . . . 0.0 109.027 178.849 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.1 -40.19 39.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.611 -0.681 . . . . 0.0 109.181 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.9 ptpt -74.73 -22.02 59.04 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 9.5 m-30 -75.22 -34.41 61.45 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.08 -11.33 60.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.421 0.629 . . . . 0.0 110.107 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -91.28 -29.28 17.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.683 HG22 ' CE1' ' A' ' 70' ' ' PHE . 36.3 mt -85.1 -33.71 8.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.767 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.74 -33.74 66.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.561 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 t70 -89.48 -6.12 56.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.616 -0.677 . . . . 0.0 109.951 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.73 -8.15 59.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 108.627 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.119 HD12 HD13 ' A' ' 31' ' ' LEU . 5.0 mt -104.66 -15.38 15.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 85.12 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 CA-C-O 121.157 0.503 . . . . 0.0 110.039 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 52.2 Cg_endo -79.76 157.87 24.6 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.343 1.707 . . . . 0.0 111.055 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.4 t -125.47 109.74 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.5 OUTLIER 65.91 15.32 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 -178.379 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.5 36.75 6.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 75.2 m-85 -141.58 146.65 36.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.246 . . . . 0.0 111.847 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.119 HD13 HD12 ' A' ' 24' ' ' LEU . 9.1 mt -118.04 136.29 53.64 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -86.79 145.39 26.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.7 -26.05 0.38 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.7 t70 -67.19 -20.52 65.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.37 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.8 mttp -100.22 -36.54 9.26 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.019 -1.05 . . . . 0.0 108.194 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.675 HG12 ' CD1' ' A' ' 40' ' ' LEU . 86.9 t -75.61 -46.39 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.163 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.583 ' HG3' ' CZ ' ' B' ' 111' ' ' PHE . 12.0 tttt -39.06 -53.91 3.49 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.999 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.45 -37.0 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.463 1.244 . . . . 0.0 109.379 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.878 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.8 t -60.68 -34.63 59.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.033 ' HB3' HD22 ' A' ' 50' ' ' LEU . 53.9 mt -86.69 -26.39 24.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.5 -0.75 . . . . 0.0 109.584 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD12 ' HG2' ' A' ' 37' ' ' LYS . 36.8 mt -75.57 -17.09 60.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.81 -6.69 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.852 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 45' ' ' LEU . 3.4 p -82.83 11.86 5.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 43' ' ' SER . 13.7 tttp 64.26 15.16 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.061 HD11 ' HB3' ' A' ' 80' ' ' ALA . 20.0 mt -100.66 153.3 37.81 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.88 169.82 21.42 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 124.216 1.64 . . . . 0.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.808 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.6 t -69.15 -6.23 5.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.49 -31.46 42.3 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.249 -0.907 . . . . 0.0 109.207 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.842 HG13 HD22 ' A' ' 45' ' ' LEU . 12.1 mm -82.63 -39.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.033 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -70.14 -28.38 65.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.87 -24.3 76.8 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 1.004 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.39 -32.02 10.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.777 -0.837 . . . . 0.0 110.208 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.75 HG11 ' CG2' ' A' ' 77' ' ' VAL . 4.9 t -72.41 -36.35 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.486 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CD1' ' HB3' ' B' ' 109' ' ' ASN . 2.5 t-105 -68.78 -49.58 57.42 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.012 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.6 mt-10 -52.61 -57.08 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.901 -1.125 . . . . 0.0 110.186 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.004 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.5 mt -61.45 -14.46 28.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.797 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.725 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.8 m -92.56 -38.64 11.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 109.371 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 61' ' ' HIS . 10.7 t0 -70.21 85.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.442 -0.786 . . . . 0.0 109.924 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 26.8 mm -61.68 -27.63 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.899 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 49.9 p30 -108.97 -13.26 14.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.909 -1.119 . . . . 0.0 111.104 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.531 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.9 m-70 63.07 44.68 5.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 13.0 p-10 -111.9 29.61 7.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.904 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 60.73 34.04 85.1 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.5 mtt -150.83 161.04 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -1.14 . . . . 0.0 111.127 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.656 ' CD1' HG11 ' A' ' 36' ' ' VAL . 7.0 mt -128.21 104.82 7.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.754 . . . . 0.0 109.615 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.587 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -68.71 167.75 14.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.224 -0.922 . . . . 0.0 110.344 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.521 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -46.18 -40.96 12.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.428 -0.795 . . . . 0.0 110.519 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 -25.82 31.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.064 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.68 -46.04 27.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.702 0.763 . . . . 0.0 109.261 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 28.5 t80 -64.45 -16.43 62.41 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -76.56 -47.37 22.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.442 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 76' ' ' LEU . 57.6 t -60.14 -24.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.603 -0.685 . . . . 0.0 109.594 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.89 -6.65 55.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -0.753 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.581 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.9 mmt -84.97 -48.21 9.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.003 -1.06 . . . . 0.0 110.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.1 p90 -75.97 -22.28 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.523 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 11.0 mt -73.89 -22.8 59.59 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.75 ' CG2' HG11 ' A' ' 53' ' ' VAL . 53.9 t -91.91 -60.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.448 0.642 . . . . 0.0 109.308 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.55 -19.29 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 110.722 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 4.2 m -85.01 -18.01 35.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.173 -0.954 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.061 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.429 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.606 ' HB3' ' CD1' ' A' ' 54' ' ' TRP . 50.7 p30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -79.06 11.06 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.101 1.58 . . . . 0.0 110.98 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.808 ' HB3' HG13 ' A' ' 47' ' ' VAL . 48.8 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.935 -1.103 . . . . 0.0 110.266 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.376 0.608 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 137.6 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 110.376 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -94.63 174.49 3.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HG2' ' OE2' ' A' ' 12' ' ' GLU . 37.9 Cg_endo -66.39 -32.7 40.17 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.795 1.418 . . . . 0.0 109.838 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' OE2' ' HG2' ' A' ' 11' ' ' PRO . 7.4 mm-40 -75.91 -33.47 59.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-20 -78.73 -40.5 33.38 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.5 tptp -69.63 -17.94 63.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.104 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.47 64.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.673 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.51 -20.84 49.88 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -78.05 -34.23 50.52 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.96 -12.3 59.73 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.301 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.63 -32.38 13.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.717 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.5 mt -77.69 -30.92 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.667 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -71.28 -38.47 71.82 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.605 0.717 . . . . 0.0 109.141 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t70 -91.01 -4.19 56.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 110.115 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t -79.24 -11.66 59.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 108.742 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.976 HD12 HD13 ' A' ' 31' ' ' LEU . 8.9 mt -97.68 -56.09 2.61 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 142.46 97.19 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.7 Cg_endo -74.15 147.68 38.28 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 124.259 1.663 . . . . 0.0 110.726 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.0 t -118.49 99.15 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 109.107 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.8 t30 56.78 17.04 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.408 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 106.03 33.69 3.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 66' ' ' ASP . 75.6 m-85 -150.67 141.69 23.0 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -1.164 . . . . 0.0 112.106 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.976 HD13 HD12 ' A' ' 24' ' ' LEU . 10.3 mt -110.59 141.81 43.28 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.45 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 99.4 p -89.7 147.54 23.8 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.998 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.8 -27.37 0.55 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' SER . 64.5 t0 -66.44 -25.75 66.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -1.05 . . . . 0.0 110.145 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttt -94.06 -33.08 13.53 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.014 -1.054 . . . . 0.0 108.533 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 65' ' ' LEU . 90.8 t -82.05 -47.93 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -39.56 -53.65 4.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.637 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -66.34 -35.28 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.136 1.071 . . . . 0.0 109.468 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 24' ' ' LEU . 2.2 t -61.6 -26.67 40.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.612 -0.68 . . . . 0.0 109.207 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.996 ' HB3' HD22 ' A' ' 50' ' ' LEU . 36.5 mt -95.66 -28.54 14.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 79.2 mt -71.07 -15.11 62.51 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.86 -11.09 58.5 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.883 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.572 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 1.8 p -81.74 7.96 11.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.55 12.43 5.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.509 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.9 mt -88.56 156.39 50.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.953 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.9 Cg_endo -74.1 166.65 29.09 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.93 1.49 . . . . 0.0 109.386 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.834 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.5 t -66.55 -7.07 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.535 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -78.62 -31.9 47.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.185 -0.947 . . . . 0.0 109.392 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.928 HG13 HD22 ' A' ' 45' ' ' LEU . 6.9 mm -82.77 -41.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.7 mt -67.43 -29.99 69.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.34 -23.81 77.16 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 56' ' ' LEU . 24.6 ttp180 -102.16 -33.13 9.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.966 -0.726 . . . . 0.0 111.06 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.963 HG11 HG23 ' A' ' 77' ' ' VAL . 17.2 t -67.16 -41.12 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.658 -1.276 . . . . 0.0 108.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.7 t-105 -62.55 -50.9 69.49 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.551 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 19.2 mt-10 -51.52 -59.05 4.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.82 -15.13 39.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 108.712 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.739 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 34.8 m -91.05 -30.49 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.237 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.43 97.38 4.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 109.595 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.529 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 24.9 mm -71.02 -38.44 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 110.375 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 9.8 p30 -99.34 -13.39 19.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 3.6 m80 60.48 41.45 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.851 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 6.5 p-10 -96.79 13.27 29.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 0.0 109.565 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.551 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 78.63 22.15 67.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.551 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.29 161.35 41.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.302 -1.117 . . . . 0.0 109.573 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' HA ' ' A' ' 70' ' ' PHE . 5.8 mt -121.05 116.46 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.049 -1.032 . . . . 0.0 110.272 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.573 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -76.39 172.75 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -52.8 -34.37 53.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.559 -0.713 . . . . 0.0 110.847 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 28.0 m-20 -87.15 -31.56 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 31.4 mt-10 -78.13 -38.96 42.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 108.692 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.951 ' CD2' HD12 ' A' ' 31' ' ' LEU . 42.9 t80 -63.38 -29.27 70.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -64.8 -47.51 77.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.531 -0.73 . . . . 0.0 110.154 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' O ' HD12 ' A' ' 76' ' ' LEU . 58.5 t -60.84 -19.26 19.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.6 -13.26 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 111.444 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 mmm -85.6 -41.84 14.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.696 -1.253 . . . . 0.0 110.553 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.4 p90 -77.57 -25.17 49.81 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 7.2 mt -70.96 -22.0 62.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.963 HG23 HG11 ' A' ' 53' ' ' VAL . 49.7 t -91.78 -61.52 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -48.88 -21.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.639 -0.663 . . . . 0.0 111.325 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.1 m -84.66 -14.65 47.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 110.123 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.991 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.574 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.509 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 20.8 t-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.895 0.379 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 109' ' ' ASN . 54.4 Cg_endo -85.55 12.57 3.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.07 1.563 . . . . 0.0 111.334 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.834 ' HB3' HG13 ' A' ' 47' ' ' VAL . 48.3 m-85 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 120.791 -1.193 . . . . 0.0 110.745 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.315 0.578 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 8.5 t -91.79 156.0 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.793 . . . . 0.0 109.239 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mmmt -108.72 167.39 9.25 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.878 -1.139 . . . . 0.0 110.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -69.4 -31.91 21.16 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.008 1.531 . . . . 0.0 109.811 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.85 -32.79 40.53 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.23 -34.7 49.11 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 28.6 tptp -72.46 -18.61 61.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.486 -0.759 . . . . 0.0 109.047 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.76 -42.8 60.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.0 ptpt -75.58 -25.29 56.93 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -72.96 -37.55 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.874 0.845 . . . . 0.0 108.732 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -79.5 -8.16 58.95 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.376 0.607 . . . . 0.0 110.339 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.59 -33.38 12.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 70' ' ' PHE . 75.1 mt -76.63 -33.13 21.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.74 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -66.97 -38.57 86.32 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.711 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.7 t70 -90.97 -2.57 57.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -80.91 -12.58 59.38 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.989 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -95.63 -54.36 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.65 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 6.7 p 142.55 90.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -75.14 150.94 38.28 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 124.057 1.556 . . . . 0.0 110.914 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -127.07 108.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.1 t30 57.28 21.93 7.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.996 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.438 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.08 38.91 5.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 82.6 m-85 -150.43 151.64 33.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.089 -1.242 . . . . 0.0 111.866 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.989 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.2 mt -122.17 140.61 52.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 19.3 p -90.42 141.64 28.54 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.855 -1.153 . . . . 0.0 110.343 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.558 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.28 -27.75 0.27 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -61.5 -28.29 69.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.969 . . . . 0.0 110.066 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 14.8 mttt -96.52 -32.93 12.03 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.221 -0.924 . . . . 0.0 108.816 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.755 ' CG1' HD12 ' A' ' 65' ' ' LEU . 92.1 t -77.03 -44.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 110.007 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 67.5 tttt -40.76 -56.75 3.64 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.7 Cg_endo -65.37 -34.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.494 1.26 . . . . 0.0 109.769 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -62.82 -35.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.792 . . . . 0.0 109.7 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.113 ' HB3' HD22 ' A' ' 50' ' ' LEU . 34.6 mt -85.37 -29.12 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.972 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.659 HD21 ' HE1' ' B' ' 111' ' ' PHE . 43.2 mt -71.6 -14.12 61.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.018 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.47 -12.34 60.0 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.755 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.549 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 59.8 p -81.38 3.78 23.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.421 -0.799 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.3 ttmt 68.63 16.25 9.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.934 HD22 HG13 ' A' ' 49' ' ' ILE . 15.5 mt -95.66 152.91 39.45 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.001 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.575 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.5 Cg_endo -74.04 175.03 11.41 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.973 1.512 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' HD1' ' B' ' 111' ' ' PHE . 25.2 t -70.85 -7.09 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -32.24 37.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.934 HG13 HD22 ' A' ' 45' ' ' LEU . 9.8 mm -83.18 -36.86 13.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 108.742 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.113 HD22 ' HB3' ' A' ' 40' ' ' LEU . 29.5 mt -75.08 -26.48 59.36 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.24 -24.96 76.42 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.964 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.4 mtm180 -100.74 -31.68 11.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.905 -0.762 . . . . 0.0 109.897 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.029 HG11 HG23 ' A' ' 77' ' ' VAL . 5.7 t -71.1 -37.34 66.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.0 t-105 -71.11 -50.1 37.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.44 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.568 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 9.4 mm-40 -56.96 -54.65 44.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 110.221 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.964 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.9 mt -62.78 -10.91 14.62 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.426 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.755 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.8 m -98.16 -37.71 9.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.77 . . . . 0.0 110.015 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -69.01 87.07 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.953 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.512 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 43.5 mm -57.82 -28.37 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 110.395 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.59 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 51.1 p-10 -112.04 1.29 16.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.554 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 9.3 p80 39.58 51.98 2.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.341 -0.849 . . . . 0.0 110.511 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 15.4 p-10 -112.33 24.79 12.17 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 71.13 31.15 66.73 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.75 161.82 42.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -1.227 . . . . 0.0 111.466 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' CG1' ' A' ' 36' ' ' VAL . 9.9 mt -125.73 105.52 9.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.482 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.565 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 4.7 t0 -69.02 163.71 24.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.86 -1.15 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -42.63 -36.47 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.763 . . . . 0.0 110.199 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -82.75 -34.27 27.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 17.7 mt-10 -74.98 -42.6 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.877 ' CD2' HD12 ' A' ' 31' ' ' LEU . 32.6 t80 -59.84 -26.95 66.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -72.25 -51.31 21.53 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.174 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.475 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 53.7 t -55.46 -26.76 19.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.543 0.687 . . . . 0.0 109.518 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.755 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.85 -3.21 58.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.557 -0.714 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.606 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.0 mmt -90.15 -43.43 10.46 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.664 -1.273 . . . . 0.0 109.834 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' CD1' ' C ' ' A' ' 75' ' ' PHE . 1.9 p90 -79.26 -19.01 51.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 4.6 mt -78.85 -23.24 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.029 HG23 HG11 ' A' ' 53' ' ' VAL . 5.8 t -90.59 -37.16 9.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.627 -0.671 . . . . 0.0 109.65 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -80.05 -24.02 40.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 56.3 m -83.22 -18.74 38.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.224 -0.922 . . . . 0.0 109.188 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.751 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.843 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.568 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 43.1 t-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.687 0.28 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.77 17.39 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.949 1.499 . . . . 0.0 111.28 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.714 ' HD1' HG22 ' A' ' 47' ' ' VAL . 65.2 m-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.892 -1.13 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.376 0.608 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.6 t -97.71 138.53 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.97 175.53 2.68 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -37.03 19.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.556 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -72.54 -25.16 61.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 109.575 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -82.79 -40.09 20.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -71.73 -17.61 62.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.8 57.91 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.63 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -74.48 -28.99 61.26 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.63 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.6 m-30 -68.02 -33.73 75.14 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 9.4 t70 -77.34 -9.32 58.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.662 -0.649 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.38 -30.76 14.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.81 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 61.5 mt -81.16 -32.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.43 -38.18 65.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.643 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.2 t70 -85.64 -1.25 56.95 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.411 0.624 . . . . 0.0 109.787 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 t -88.47 -9.33 52.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.212 -0.93 . . . . 0.0 108.895 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.102 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.4 mt -100.67 -8.09 23.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 88.31 94.75 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 46.6 Cg_endo -72.0 151.09 55.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.346 1.708 . . . . 0.0 111.022 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -121.6 97.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 22.0 t-20 63.67 14.96 8.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.858 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.82 33.26 4.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 92.0 m-85 -149.92 154.69 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.161 -1.199 . . . . 0.0 111.827 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.102 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.0 mt -120.03 159.97 23.71 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' LYS . 13.4 p -104.28 142.15 35.04 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.904 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.28 -25.22 0.71 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.4 t70 -71.86 -23.57 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.605 -0.938 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttp -93.06 -36.8 12.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 90.1 t -78.11 -40.46 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.473 0.654 . . . . 0.0 109.765 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.669 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 6.3 tttp -40.71 -55.98 4.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 111.089 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.6 -35.01 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.574 1.302 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.745 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -59.87 -36.19 65.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.039 ' HB3' HD22 ' A' ' 50' ' ' LEU . 23.2 mt -84.29 -25.73 29.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.913 . . . . 0.0 109.456 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 38' ' ' PRO . 53.9 mt -71.92 -15.31 62.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.06 -10.22 59.72 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.464 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.515 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -81.13 8.6 8.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.842 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 43' ' ' SER . 4.3 tttt 65.6 15.83 10.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.462 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.041 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.1 mt -95.91 151.25 38.22 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 110.331 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.9 Cg_endo -75.54 -178.34 4.21 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.986 1.519 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.1 t -78.53 -0.68 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.47 -32.88 20.58 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.955 HG13 HD22 ' A' ' 45' ' ' LEU . 8.3 mm -83.22 -38.6 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.039 HD22 ' HB3' ' A' ' 40' ' ' LEU . 38.6 mt -72.91 -26.3 61.37 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 109.201 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.24 -23.03 78.29 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.975 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.3 mtm180 -100.38 -32.25 10.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.885 -0.774 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.001 HG11 HG23 ' A' ' 77' ' ' VAL . 22.5 t -70.26 -36.32 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.015 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.604 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.31 -50.62 37.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mt-10 -56.82 -57.55 11.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.975 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -58.22 -16.94 15.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.48 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.014 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t -92.12 -35.87 13.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -72.97 98.36 2.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 110.217 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.524 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 49.0 mm -71.93 -28.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.005 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -112.0 -15.26 13.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 109.656 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 91.7 m-70 59.68 47.77 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.558 -0.714 . . . . 0.0 111.298 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 1.3 m-20 -98.04 26.06 5.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 108.635 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 63.4 29.77 75.57 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 31' ' ' LEU . 7.9 mtt -150.56 160.74 43.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.995 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 11.9 mt -129.48 100.68 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 69' ' ' GLU . 2.3 p30 -69.6 160.61 31.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.616 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.7 ptp85 -35.36 -43.2 0.23 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.656 -0.653 . . . . 0.0 112.032 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.47 -35.79 30.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.963 -1.085 . . . . 0.0 110.298 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 13.7 tt0 -71.15 -43.26 67.89 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.81 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 58.4 t80 -63.1 -19.58 64.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.55 -42.7 67.54 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 109.693 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.39 -31.79 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.671 0.748 . . . . 0.0 109.722 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -87.58 0.25 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.757 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.4 mmt -89.8 -44.54 9.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.67 -1.269 . . . . 0.0 109.961 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.2 p90 -77.09 -22.34 52.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.2 mt -76.99 -22.95 52.35 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.461 0.648 . . . . 0.0 109.54 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.001 HG23 HG11 ' A' ' 53' ' ' VAL . 5.4 t -91.34 -38.59 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.438 -0.789 . . . . 0.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.47 -22.71 61.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.467 -0.771 . . . . 0.0 110.676 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -83.15 -16.13 47.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.167 -0.958 . . . . 0.0 109.967 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.041 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.203 -0.936 . . . . 0.0 109.089 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.465 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 34.0 t-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.52 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 47.6 Cg_endo -72.19 -23.96 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.89 1.468 . . . . 0.0 110.545 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.936 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 45.0 m-85 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.501 0.667 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 13' ' ' ASP . 60.3 t -100.75 131.57 48.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.545 -0.722 . . . . 0.0 109.596 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -89.65 -179.04 1.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.95 -35.67 14.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.816 1.429 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 3.8 pt-20 -73.28 -26.78 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' HB3' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.21 -39.43 23.11 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -72.31 -13.49 61.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.69 -40.37 34.02 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.15 -23.65 43.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.473 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -78.7 -33.15 47.09 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 47.7 t0 -79.69 -7.79 58.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.682 -0.636 . . . . 0.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.27 12.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.805 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 40.2 mt -76.88 -31.51 19.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.19 -37.7 66.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.3 t70 -89.67 3.72 51.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.453 0.644 . . . . 0.0 109.71 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -5.95 53.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 108.868 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.043 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.38 -4.95 16.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 82.73 94.55 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.0 Cg_endo -73.29 148.57 43.88 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.224 1.644 . . . . 0.0 110.496 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 92.6 t -115.46 102.2 13.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 22.6 t-20 61.15 16.36 7.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.419 -0.801 . . . . 0.0 109.661 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 100.07 35.56 4.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 76.3 m-85 -150.53 143.5 24.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.923 -1.339 . . . . 0.0 112.279 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.043 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.4 mt -113.93 137.53 51.56 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' C ' ' A' ' 33' ' ' GLY . 47.3 p -83.8 140.52 32.0 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.332 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.94 -28.44 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 37.9 t0 -62.34 -23.81 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.935 . . . . 0.0 110.559 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 43.0 mttp -97.93 -35.76 10.37 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 85.1 t -75.64 -37.76 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.023 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 ttmt -45.08 -51.36 24.14 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 111.133 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 37' ' ' LYS . 41.2 Cg_endo -68.21 -33.57 24.16 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.254 1.133 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.633 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 1.8 t -61.6 -31.26 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.515 -0.741 . . . . 0.0 110.215 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.123 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.9 mt -91.69 -23.8 19.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.076 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 57.8 mt -74.77 -13.46 60.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 109.383 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 2.1 p-10 -87.07 -1.02 57.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.322 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 5.1 p -90.58 12.69 18.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.615 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 65.93 15.63 10.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.079 -1.013 . . . . 0.0 109.925 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.078 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.7 mt -100.11 151.83 37.63 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.624 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.8 Cg_endo -76.89 172.87 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.206 1.635 . . . . 0.0 110.178 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -69.96 -4.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.659 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -82.04 -30.11 31.58 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 109.209 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.941 HG13 HD22 ' A' ' 45' ' ' LEU . 8.9 mm -85.54 -36.82 11.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.928 0.87 . . . . 0.0 108.896 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.123 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -76.85 -27.96 55.3 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.413 0.625 . . . . 0.0 109.523 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.98 -24.92 75.03 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.805 ' O ' HD12 ' A' ' 56' ' ' LEU . 17.5 ttm180 -101.05 -31.46 11.07 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.979 -0.718 . . . . 0.0 110.182 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.943 HG11 HG23 ' A' ' 77' ' ' VAL . 15.0 t -72.06 -36.77 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.9 t-105 -64.38 -51.39 63.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.743 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.502 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 1.9 mm-40 -49.09 -61.41 2.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.326 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -59.88 -16.58 30.25 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.858 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.772 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.7 m -90.55 -28.96 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' TRP . 27.9 t0 -76.4 101.6 5.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.788 -0.57 . . . . 0.0 109.64 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 18.3 mm -88.49 -17.23 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.562 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' OE2' ' A' ' 69' ' ' GLU . 3.3 m-20 -104.07 -10.08 18.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.411 ' ND1' ' N ' ' A' ' 61' ' ' HIS . 1.4 m-70 52.38 49.1 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 34.8 p-10 -128.46 14.14 6.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.932 -1.105 . . . . 0.0 110.177 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 79.4 32.61 37.78 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.49 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 18.6 mtp -150.8 161.07 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.188 -1.184 . . . . 0.0 110.747 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 7.7 mt -126.94 107.48 10.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -69.63 166.55 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 109.432 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.549 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.6 ptp85 -45.88 -42.17 12.23 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.139 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 63.4 m-20 -76.14 -36.63 58.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.827 . . . . 0.0 110.097 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 35.5 mt-10 -71.66 -46.34 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.997 . . . . 0.0 108.92 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.885 ' CD2' HD12 ' A' ' 31' ' ' LEU . 29.7 t80 -55.4 -30.95 61.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.44 -49.18 74.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.305 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 76' ' ' LEU . 49.6 t -58.03 -22.47 19.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.772 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.34 -8.5 50.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 111.94 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 10.3 mmm -88.8 -41.2 12.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.617 -1.302 . . . . 0.0 110.527 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.589 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -78.9 -29.17 44.17 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.911 -1.118 . . . . 0.0 108.189 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.66 ' HB3' HG13 ' A' ' 53' ' ' VAL . 7.6 mt -66.75 -27.12 67.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.943 HG23 HG11 ' A' ' 53' ' ' VAL . 25.6 t -90.74 -19.91 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 110.032 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.91 -24.11 22.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.373 -0.83 . . . . 0.0 109.703 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.5 m -84.09 -16.74 42.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.078 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 108.598 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.993 HD21 ' N ' ' B' ' 109' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.562 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 44.9 Cg_endo -80.96 7.19 5.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.686 1.361 . . . . 0.0 109.714 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 1.02 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 96.6 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.311 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.256 0.551 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.61 139.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.17 -178.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.893 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -71.41 -34.73 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.849 1.447 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HG3' ' OD1' ' A' ' 13' ' ' ASP . 7.3 pt-20 -76.81 -27.88 55.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -84.7 -30.11 25.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -82.33 -19.67 38.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 0.0 109.005 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.42 -37.63 60.3 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.4 ptmt -74.27 -23.44 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.3 m-30 -76.76 -35.67 57.56 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -72.31 -10.01 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 110.387 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.37 -35.88 14.15 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.683 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -76.23 -33.68 24.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.753 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.53 -40.55 70.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 t70 -85.75 4.51 36.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.664 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -9.41 43.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.026 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.1 mt -102.86 -9.3 20.03 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 87.2 91.28 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.222 0 CA-C-O 121.542 0.687 . . . . 0.0 109.153 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 Cg_endo -74.29 150.21 41.5 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.174 1.618 . . . . 0.0 110.75 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 35.3 t -119.18 112.37 37.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 8.3 t-20 57.37 16.91 3.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 96.0 36.18 5.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.619 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.2 m-85 -147.16 146.1 29.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 112.097 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.026 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.6 mt -115.06 139.33 49.96 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -83.39 143.4 30.33 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.133 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.34 -25.93 0.87 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.8 m-20 -69.13 -22.93 63.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.641 -0.917 . . . . 0.0 110.349 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HE3' ' HG ' ' A' ' 25' ' ' SER . 65.1 mttm -94.91 -35.28 12.08 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.062 HG11 HD12 ' A' ' 65' ' ' LEU . 84.8 t -77.43 -39.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.741 0.782 . . . . 0.0 109.371 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 8.7 tttp -41.51 -55.13 5.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.715 -0.616 . . . . 0.0 110.721 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.29 -35.03 25.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.568 1.299 . . . . 0.0 110.034 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.811 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -61.38 -33.17 55.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.121 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.976 ' HB3' HD22 ' A' ' 50' ' ' LEU . 46.7 mt -87.44 -26.81 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.34 -13.72 60.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.81 . . . . 0.0 109.035 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -85.92 -10.93 54.41 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.554 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.519 ' OG ' HG11 ' A' ' 77' ' ' VAL . 3.2 m -78.18 4.84 11.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.606 -0.683 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' SER . 11.4 tttm 68.29 8.26 6.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.79 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.03 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.9 mt -92.1 155.09 43.23 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.4 Cg_endo -74.97 168.88 23.86 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.125 1.592 . . . . 0.0 109.734 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' B' ' 111' ' ' PHE . 10.3 t -68.03 -7.28 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.519 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.7 -32.47 53.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.338 -0.852 . . . . 0.0 109.313 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.874 HG21 HD13 ' A' ' 45' ' ' LEU . 10.5 mm -81.29 -40.56 18.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.976 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -69.92 -29.15 66.24 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.548 0.689 . . . . 0.0 109.373 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.21 -23.56 77.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.922 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.08 -29.86 11.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.723 -0.869 . . . . 0.0 110.211 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.831 HG11 HG23 ' A' ' 77' ' ' VAL . 22.0 t -73.86 -37.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.747 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.5 t-105 -66.57 -48.69 68.82 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.4 mt-10 -56.48 -57.33 12.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.9 mt -61.35 -15.16 33.36 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.445 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.821 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 14.2 m -94.18 -25.59 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 109.832 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.567 ' OD2' ' CE2' ' A' ' 54' ' ' TRP . 2.5 t0 -76.99 85.09 3.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.557 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 40.3 mm -61.75 -30.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.888 . . . . 0.0 110.828 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 4.8 p30 -109.9 -13.9 14.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.01 -1.056 . . . . 0.0 110.683 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.512 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 18.4 m80 60.48 46.18 9.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.5 p-10 -103.62 22.49 14.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 68.0 26.7 73.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 22.7 mtp -150.61 161.44 42.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -1.198 . . . . 0.0 110.375 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.062 HD12 HG11 ' A' ' 36' ' ' VAL . 11.5 mt -125.67 99.39 5.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 0.0 109.035 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.619 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 51.5 p30 -71.16 166.97 20.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.832 -1.167 . . . . 0.0 110.315 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.633 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -38.13 -45.39 0.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 0.0 112.149 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 31.2 t70 -74.95 -42.29 57.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.07 -1.019 . . . . 0.0 110.963 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.557 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 56.8 mt-10 -70.67 -44.45 67.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.117 -0.989 . . . . 0.0 109.02 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 13.2 t80 -57.31 -22.76 44.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -74.21 -46.91 38.89 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.76 0.791 . . . . 0.0 109.336 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 76' ' ' LEU . 95.4 t -59.83 -25.17 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.437 0.637 . . . . 0.0 109.93 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.821 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.25 -6.11 55.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 111.179 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.613 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.5 mmt -85.89 -46.19 10.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 110.071 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.5 p90 -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.4 mt -66.23 -24.21 66.56 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.831 HG23 HG11 ' A' ' 53' ' ' VAL . 69.8 t -91.57 -57.8 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -49.71 -22.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.652 -0.655 . . . . 0.0 111.622 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -85.48 -11.75 53.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.842 -1.161 . . . . 0.0 110.434 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.03 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.535 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 22.5 t-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.94 6.2 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 111.847 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.821 ' HB3' HG13 ' A' ' 47' ' ' VAL . 73.0 m-85 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 120.793 -1.192 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.71 159.68 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.5 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mptt -115.68 177.87 1.1 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 110.422 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.28 -34.46 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.057 1.556 . . . . 0.0 109.869 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.43 -26.77 46.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.023 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.1 m-20 -81.5 -31.76 32.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -75.95 -12.61 60.18 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -0.805 . . . . 0.0 108.987 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.37 -40.33 21.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.07 -27.33 60.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -72.1 -34.83 68.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.9 OUTLIER -73.34 -10.15 59.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.75 -0.594 . . . . 0.0 110.15 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.5 -32.05 15.72 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.646 HG22 ' CE1' ' A' ' 70' ' ' PHE 0.251 60.3 mt -82.41 -35.36 12.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.84 -37.5 70.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 14.4 t70 -88.62 1.98 54.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.39 -6.82 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 108.722 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.044 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -107.5 -8.49 16.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.692 -0.63 . . . . 0.0 109.435 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 85.38 95.67 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -72.26 147.77 48.26 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.205 1.634 . . . . 0.0 110.407 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -112.54 96.38 4.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 109.094 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 66.1 9.96 6.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.514 -0.741 . . . . 0.0 109.397 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 108.58 28.93 4.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 30.4 m-85 -140.98 141.43 34.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.251 . . . . 0.0 111.95 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.044 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.7 mt -112.61 139.59 48.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 20.9 p -92.43 144.88 24.92 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.288 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.33 -27.66 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . 54.2 m-20 -63.32 -26.23 68.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.461 -1.023 . . . . 0.0 109.972 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 16.5 mttt -95.21 -35.97 11.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.871 HG12 HD11 ' A' ' 40' ' ' LEU . 94.6 t -77.63 -48.81 23.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.233 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.64 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 31.9 tttm -35.5 -56.1 1.06 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.846 -0.534 . . . . 0.0 111.252 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.9 Cg_endo -67.02 -35.79 24.49 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.496 1.261 . . . . 0.0 110.073 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.684 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -63.28 -31.93 54.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.988 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.091 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.3 mt -89.36 -25.52 21.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.087 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD11 ' HG3' ' A' ' 37' ' ' LYS . 41.8 mt -74.73 -12.52 60.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.078 -1.014 . . . . 0.0 109.049 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -84.05 -8.04 59.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.481 ' CB ' HG13 ' A' ' 77' ' ' VAL . 1.0 OUTLIER -84.54 15.32 3.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 110.217 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 21.13 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 109.996 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.6 mt -99.7 153.11 37.94 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.67 178.66 7.11 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.998 1.525 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.9 t -75.78 -2.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.331 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.83 -34.3 24.7 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.351 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.948 HG13 HD22 ' A' ' 45' ' ' LEU . 10.2 mm -80.73 -40.43 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 122.033 0.92 . . . . 0.0 108.522 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.091 HD22 ' HB3' ' A' ' 40' ' ' LEU . 32.8 mt -71.44 -27.55 63.35 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.83 -25.39 75.62 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.854 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.9 mtm-85 -101.28 -31.34 11.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.829 . . . . 0.0 109.829 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.634 HG11 ' CG2' ' A' ' 77' ' ' VAL . 7.5 t -67.7 -36.79 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.217 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.578 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -75.57 -51.63 12.45 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.809 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 41.0 mt-10 -57.7 -55.97 27.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.0 109.218 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 52' ' ' ARG . 13.9 mt -59.55 -16.78 27.31 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.981 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 5.0 t -94.43 -25.5 16.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.7 t0 -73.73 98.95 3.02 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.234 0.54 . . . . 0.0 109.732 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 20.9 mm -86.61 -36.78 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 110.171 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -96.87 -12.32 23.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 1.8 m-70 58.34 45.39 17.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 111.18 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 17.9 p-10 -107.22 28.91 7.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.599 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 61.24 30.37 73.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.521 ' HE2' ' HB3' ' A' ' 30' ' ' PHE . 86.7 mtp -151.96 160.21 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -1.106 . . . . 0.0 110.696 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.85 HD12 HG11 ' A' ' 36' ' ' VAL . 12.8 mt -116.1 103.82 10.94 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.547 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -68.83 156.18 38.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.868 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -35.89 -40.12 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.567 -0.708 . . . . 0.0 111.037 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 9.5 t0 -81.5 -34.46 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.154 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.547 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 18.2 mt-10 -73.91 -42.77 60.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.961 ' CD2' HD12 ' A' ' 31' ' ' LEU . 15.6 t80 -59.35 -22.49 61.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -73.7 -48.91 28.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.828 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.822 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.5 t -58.06 -27.98 32.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.361 -0.837 . . . . 0.0 109.452 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.981 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -91.5 -7.04 51.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.484 -0.76 . . . . 0.0 111.465 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.9 mmt -82.26 -50.18 9.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.688 -1.257 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.614 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 1.7 p90 -71.72 -33.91 69.14 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.822 HD12 ' O ' ' A' ' 72' ' ' VAL . 7.1 mt -58.72 -22.06 56.62 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 73' ' ' ALA . 47.0 t -91.28 -64.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -55.18 -18.87 6.55 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.2 m -85.19 -10.88 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.05 -1.031 . . . . 0.0 109.586 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.008 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.229 -0.92 . . . . 0.0 109.184 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 13.5 t-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 -20.55 21.99 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.079 1.568 . . . . 0.0 110.68 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.655 ' HE2' HD12 ' A' ' 40' ' ' LEU . 80.7 m-85 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.218 0.532 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' A' ' 75' ' ' PHE . 40.7 t -87.01 157.16 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 21.7 mmtm -110.56 166.22 11.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.4 Cg_endo -68.29 -33.98 22.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.863 1.454 . . . . 0.0 109.669 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.52 -27.46 58.74 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 77.8 m-20 -81.38 -41.54 21.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 12.8 tptp -65.58 -25.21 67.31 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.068 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 -45.24 76.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.532 -0.73 . . . . 0.0 109.062 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.6 ptpt -73.53 -28.69 62.02 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 13' ' ' ASP . 8.0 m-30 -67.66 -37.62 82.64 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.71 -12.78 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.468 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.84 -30.98 15.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.823 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 26.1 mt -81.46 -32.65 11.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.23 -36.99 69.26 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t70 -89.02 1.43 55.55 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.681 -0.637 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.68 -8.32 54.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.912 . . . . 0.0 109.086 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.08 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.1 mt -107.57 -7.0 16.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 79.81 95.76 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.652 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -75.62 152.21 37.69 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.165 1.613 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.0 t -118.44 114.93 46.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 27.0 t30 57.4 18.39 4.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.208 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.37 37.95 5.76 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.0 m-85 -150.5 148.3 28.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.183 . . . . 0.0 111.902 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.08 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.0 mt -113.37 134.82 54.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.451 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 34.4 p -83.21 147.55 27.95 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.87 -26.34 1.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 32' ' ' SER . 20.6 t70 -64.45 -24.08 67.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.634 -0.921 . . . . 0.0 109.972 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.8 mttt -98.8 -32.12 11.52 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 40' ' ' LEU . 92.3 t -83.05 -46.21 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.028 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.1 tttt -41.18 -50.18 8.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 43.3 Cg_endo -69.36 -35.45 13.79 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.231 1.122 . . . . 0.0 109.243 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 t -62.43 -36.47 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.458 0.647 . . . . 0.0 109.526 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.059 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.3 mt -83.21 -21.58 33.39 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.384 -0.822 . . . . 0.0 109.65 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 38' ' ' PRO . 34.2 mt -79.04 -13.21 59.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.533 -0.73 . . . . 0.0 109.324 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' OD1' ' O ' ' A' ' 42' ' ' ASN . 5.7 t30 -89.98 -3.77 57.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.051 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.577 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 94.6 p -86.11 16.85 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 16.06 6.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.709 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.066 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.3 mt -100.4 152.52 37.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -76.46 168.75 23.21 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.116 1.587 . . . . 0.0 110.173 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.792 HG13 ' HB3' ' B' ' 111' ' ' PHE . 9.6 t -68.7 -5.86 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.386 -0.821 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.23 -32.78 38.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.214 -0.928 . . . . 0.0 109.446 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.833 HG13 HD22 ' A' ' 45' ' ' LEU . 7.9 mm -82.47 -41.46 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.059 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.6 mt -68.09 -28.12 67.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.47 -24.57 76.68 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.835 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.8 ttm180 -101.62 -31.63 10.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.745 HG11 ' CG2' ' A' ' 77' ' ' VAL . 24.2 t -69.29 -37.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 3.8 t-105 -67.6 -51.88 44.99 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.758 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 8.6 mt-10 -51.06 -59.99 3.57 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.16 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.0 mt -62.07 -13.16 23.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.647 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 4.3 m -93.82 -27.2 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.551 -0.718 . . . . 0.0 110.147 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.3 t0 -79.25 70.67 5.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.006 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG12 ' HG2' ' A' ' 69' ' ' GLU . 46.2 mm -47.25 -33.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 12.5 m-20 -94.0 -25.41 17.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 110.122 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 25.5 m-70 64.62 45.27 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 2.7 p30 -110.89 0.62 17.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 110.549 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.579 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 96.27 18.99 29.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.579 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.73 161.86 40.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.211 -1.17 . . . . 0.0 109.889 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.655 HD12 HG11 ' A' ' 36' ' ' VAL . 15.9 mt -119.11 116.24 25.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.232 -0.918 . . . . 0.0 110.194 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 10.8 t0 -71.15 168.79 16.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 0.0 110.047 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptt180 -53.48 -37.27 62.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.933 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.0 m-20 -85.16 -29.83 24.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.097 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.555 ' OE1' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -74.4 -46.59 39.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.562 0.696 . . . . 0.0 109.166 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.823 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 50.2 t80 -59.11 -22.53 60.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.16 -50.1 62.34 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.963 0.887 . . . . 0.0 109.544 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.489 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 54.2 t -57.19 -26.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.568 0.699 . . . . 0.0 110.105 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -85.11 -7.08 59.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.788 . . . . 0.0 111.694 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.595 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 7.2 mmm -89.95 -40.4 12.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.614 -1.304 . . . . 0.0 110.233 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.515 ' CD1' ' C ' ' A' ' 75' ' ' PHE . 1.9 p90 -77.24 -19.21 56.93 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.239 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.3 mt -77.54 -24.95 49.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.745 ' CG2' HG11 ' A' ' 53' ' ' VAL . 72.5 t -91.11 -34.7 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.637 -0.664 . . . . 0.0 110.133 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.63 -26.09 59.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.794 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.18 -15.92 55.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.066 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 0.0 108.936 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.527 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 9.8 t-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.553 0.215 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.31 -10.23 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.982 1.517 . . . . 0.0 110.758 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.792 ' HB3' HG13 ' A' ' 47' ' ' VAL . 88.8 m-85 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.171 -0.955 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.441 0.639 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -97.26 126.78 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -95.52 -178.54 0.79 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.889 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.6 Cg_endo -66.38 -37.09 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.644 1.339 . . . . 0.0 109.781 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 10' ' ' LYS . 12.7 pt-20 -66.64 -33.83 76.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.037 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 46.8 m-20 -82.86 -41.49 18.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -68.23 -15.71 63.68 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -83.67 -39.0 20.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.443 -0.785 . . . . 0.0 109.245 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -81.63 -20.77 39.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -81.35 -36.32 29.83 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.516 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 7.0 t70 -76.07 -8.64 57.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.207 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.23 -31.63 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.517 HD13 ' SD ' ' A' ' 74' ' ' MET . 33.9 mt -79.84 -34.78 15.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.759 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.91 -34.17 77.2 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t0 -91.23 -7.56 50.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.394 -0.816 . . . . 0.0 110.011 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -77.45 -14.54 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 108.792 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.084 HD12 ' CD1' ' A' ' 31' ' ' LEU . 12.7 mt -92.91 -55.38 3.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.656 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 m 140.36 97.15 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.473 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 52.5 Cg_endo -74.73 149.64 38.37 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 123.828 1.436 . . . . 0.0 110.951 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -125.76 106.05 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.2 t30 58.0 18.12 4.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.388 -0.82 . . . . 0.0 109.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 97.17 36.04 5.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 82.9 m-85 -150.78 143.74 24.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.093 -1.239 . . . . 0.0 111.969 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.084 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.0 mt -111.2 137.32 49.05 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.83 141.27 33.59 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.139 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.64 -27.53 0.33 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 24.7 t70 -64.77 -27.98 69.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -1.034 . . . . 0.0 110.319 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 77.2 mttt -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.857 ' CG1' HD11 ' A' ' 40' ' ' LEU . 77.1 t -74.97 -41.65 45.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.484 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.562 ' CG ' ' HB2' ' B' ' 110' ' ' PRO . 3.4 mtpt -36.67 -56.77 1.3 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.795 -0.566 . . . . 0.0 110.914 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -67.3 -35.5 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.919 1.483 . . . . 0.0 110.007 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.7 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -61.26 -27.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.926 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.0 mt -97.94 -33.52 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 0.0 110.432 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 37' ' ' LYS . 14.0 mt -73.11 -9.14 58.41 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.171 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -89.3 -9.01 52.15 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.882 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.474 ' OG ' ' HB2' ' A' ' 45' ' ' LEU . 16.3 p -81.67 5.55 17.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.448 -0.782 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 43' ' ' SER . 6.1 ttpt 66.98 19.1 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.931 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.884 HD22 HG13 ' A' ' 49' ' ' ILE . 15.7 mt -100.36 156.47 35.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.0 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -75.44 167.98 25.48 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.123 1.591 . . . . 0.0 110.233 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.699 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.35 -8.0 7.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.346 -0.846 . . . . 0.0 109.219 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.22 -31.63 60.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.884 HG13 HD22 ' A' ' 45' ' ' LEU . 8.5 mm -83.2 -37.19 13.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.812 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.926 HD22 ' HB3' ' A' ' 40' ' ' LEU . 8.5 mt -74.19 -26.25 60.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.533 0.682 . . . . 0.0 109.371 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -69.94 -29.06 71.07 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.794 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.5 mtm180 -101.66 -31.88 10.6 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.251 -0.558 . . . . 0.0 110.462 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 77' ' ' VAL . 5.6 t -64.57 -55.48 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.195 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.559 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.0 t-105 -57.87 -52.18 66.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -45.46 -66.29 0.42 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.577 0.703 . . . . 0.0 110.689 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.8 mt -60.54 -16.83 41.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.953 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.0 t -89.34 -14.61 35.28 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' TRP . 2.1 t0 -93.31 83.27 4.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.507 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 31.9 mm -53.44 -38.84 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.374 -0.829 . . . . 0.0 110.804 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 4.8 p30 -103.72 -20.6 13.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 110.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.473 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 12.5 m80 67.19 42.12 2.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.4 p30 -95.67 1.05 53.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 94.25 25.12 17.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 23.2 mtp -152.76 161.79 42.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -1.204 . . . . 0.0 111.17 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 36' ' ' VAL . 21.9 mt -127.12 112.73 15.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 109.618 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.6 t70 -72.25 172.99 9.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.104 -0.998 . . . . 0.0 110.079 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.607 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.82 -41.58 64.33 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.202 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -81.15 -36.04 30.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 109.822 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 1.8 tt0 -72.02 -46.31 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.807 . . . . 0.0 108.945 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.961 ' CD2' HD12 ' A' ' 31' ' ' LEU . 16.8 t80 -59.32 -17.37 28.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -72.69 -43.66 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.835 0.826 . . . . 0.0 109.35 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.628 ' O ' HD12 ' A' ' 76' ' ' LEU . 41.8 t -60.02 -26.05 34.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.498 0.666 . . . . 0.0 109.55 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.953 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.31 -6.33 55.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 111.315 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.61 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.2 mmt -83.64 -49.01 9.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.0 109.986 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.4 p90 -73.97 -28.48 61.51 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 72' ' ' VAL . 10.2 mt -66.28 -22.21 66.29 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 73' ' ' ALA . 54.5 t -91.68 -45.45 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.642 -0.661 . . . . 0.0 110.164 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -75.52 -23.37 56.69 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.573 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 88.6 m -84.3 -19.74 33.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.601 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.72 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 14.7 t-20 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.562 ' HB2' ' CG ' ' A' ' 37' ' ' LYS . 47.8 Cg_endo -75.05 -1.47 11.27 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.837 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.699 ' O ' HG13 ' A' ' 47' ' ' VAL . 86.8 m-85 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.104 -0.998 . . . . 0.0 110.096 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.484 0.659 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -93.92 146.47 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.568 -0.707 . . . . 0.0 109.531 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mttp -103.56 175.27 2.3 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 110.421 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.3 -33.82 22.92 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.101 1.579 . . . . 0.0 109.708 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -75.45 -36.5 60.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.612 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -77.74 -36.36 50.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.5 tmtt? -72.26 -14.97 61.9 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.212 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.44 -42.35 44.33 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.621 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.18 -21.79 60.61 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CE1' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -77.79 -34.78 52.06 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.13 -8.35 56.82 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.616 . . . . 0.0 109.968 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.73 14.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.67 HG22 ' CE1' ' A' ' 70' ' ' PHE . 18.1 mt -78.29 -29.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.763 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -74.54 -32.46 62.45 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.562 0.696 . . . . 0.0 109.215 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -90.28 -5.52 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 0.0 109.866 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -82.7 -10.75 58.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.108 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.067 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.0 mt -103.15 -13.99 16.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 88.78 101.46 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.468 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.3 Cg_endo -72.53 152.2 53.9 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 124.348 1.709 . . . . 0.0 111.256 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 91.3 t -127.97 109.49 19.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.7 t-20 57.47 24.07 9.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 84.77 40.62 8.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.491 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 87.7 m-85 -152.62 153.55 33.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.255 . . . . 0.0 111.749 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.067 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.7 mt -121.8 147.15 46.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' ASP . 58.8 p -95.16 143.21 26.77 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.288 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.621 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.87 -26.37 0.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 16.4 t0 -67.76 -26.04 65.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 0.0 110.134 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 84.7 mttt -91.1 -36.17 14.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.942 HG21 HD12 ' A' ' 65' ' ' LEU . 68.2 t -75.76 -50.04 24.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.09 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.604 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 4.1 ttpt -34.61 -56.23 0.84 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.743 -0.598 . . . . 0.0 111.013 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -64.92 -33.51 51.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.326 1.172 . . . . 0.0 109.936 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.751 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -67.56 -29.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.731 . . . . 0.0 110.002 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.03 ' HB3' HD22 ' A' ' 50' ' ' LEU . 24.7 mt -88.55 -27.1 21.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.148 -0.97 . . . . 0.0 110.204 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 38' ' ' PRO . 19.8 mt -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -73.03 -13.77 61.28 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.611 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.555 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 1.4 p -80.25 7.4 9.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.463 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 43' ' ' SER . 14.4 tptt 64.65 8.64 4.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.0 110.561 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.062 HD13 HG21 ' A' ' 49' ' ' ILE . 17.2 mt -88.75 153.72 50.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.3 Cg_endo -73.51 176.75 8.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.696 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.838 HG22 ' HD1' ' B' ' 111' ' ' PHE . 1.9 t -71.04 -10.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.83 -32.58 57.68 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 1.062 HG21 HD13 ' A' ' 45' ' ' LEU . 8.2 mm -81.98 -38.94 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.892 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.03 HD22 ' HB3' ' A' ' 40' ' ' LEU . 26.7 mt -74.98 -29.69 60.97 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.77 -25.09 75.38 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.847 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.5 ttm180 -101.05 -34.49 9.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.007 -0.702 . . . . 0.0 110.475 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.066 HG11 ' CG2' ' A' ' 77' ' ' VAL . 15.3 t -66.46 -41.76 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.774 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.621 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.0 t-105 -65.17 -51.87 58.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.702 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.0 mm-40 -50.9 -55.46 17.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.949 -1.094 . . . . 0.0 110.01 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.5 mt -64.38 -12.78 46.15 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.854 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 38.5 m -94.39 -35.85 12.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.757 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' TRP . 17.3 t0 -72.26 92.9 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.569 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 8.9 mm -72.55 -33.64 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.608 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 6.7 m-20 -92.43 -4.22 54.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.439 -0.788 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 28.9 p80 38.73 54.98 1.98 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.649 . . . . 0.0 110.644 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 36.7 p-10 -125.77 18.34 7.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 108.793 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.45 32.77 45.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.7 mtp -150.86 161.79 42.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 111.578 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.942 HD12 HG21 ' A' ' 36' ' ' VAL . 25.1 mt -135.42 110.4 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.022 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 27.1 t0 -70.0 169.32 13.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.087 -1.008 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 12.1 ptt180 -49.06 -41.98 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 109.952 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.743 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -80.85 -35.92 32.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.152 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.569 ' HG3' ' CG1' ' A' ' 59' ' ' ILE . 1.7 tt0 -68.51 -55.35 12.0 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.915 0.864 . . . . 0.0 108.731 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 23.2 t80 -50.01 -24.72 2.78 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -64.58 -49.1 72.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.669 0.747 . . . . 0.0 110.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.48 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 16.8 t -56.78 -25.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.571 -0.706 . . . . 0.0 110.178 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.854 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.19 -8.37 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 112.016 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 8.7 mmm -89.87 -30.35 17.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.375 -1.453 . . . . 0.0 110.147 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -85.52 -21.14 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.981 -1.074 . . . . 0.0 109.008 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 5.1 mt -83.53 -19.53 35.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 0.0 109.561 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.066 ' CG2' HG11 ' A' ' 53' ' ' VAL . 9.8 t -92.21 -44.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -70.28 -36.53 74.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 80.6 m -82.71 -8.52 59.59 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 109.58 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 122.145 0.974 . . . . 0.0 109.174 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.526 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 12.5 t-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.675 0.274 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.526 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.7 Cg_endo -74.93 -7.37 19.15 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.986 1.519 . . . . 0.0 111.076 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.838 ' HD1' HG22 ' A' ' 47' ' ' VAL . 69.5 m-85 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.964 -1.085 . . . . 0.0 110.329 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -98.41 152.9 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.841 . . . . 0.0 109.824 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -112.93 178.48 0.96 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.216 -0.927 . . . . 0.0 109.972 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.2 Cg_endo -71.78 -35.86 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.961 1.506 . . . . 0.0 109.772 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -73.21 -30.5 63.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 0.0 109.215 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -78.81 -43.79 24.52 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 13.5 tptp -65.32 -17.46 64.53 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -41.96 34.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.6 ptmt -79.27 -23.1 43.84 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.0 m-30 -75.43 -35.84 60.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 52.9 t0 -77.66 -9.04 58.76 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.46 -35.2 13.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.692 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -76.75 -32.96 21.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.742 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.5 -39.22 64.99 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.7 t70 -86.65 4.23 41.3 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.88 -10.93 37.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 108.938 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.972 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -100.57 -6.95 24.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.79 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.1 Cg_endo -76.1 152.5 35.84 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.486 1.782 . . . . 0.0 110.852 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.4 t -117.72 108.38 24.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.171 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 17.4 t30 57.96 16.22 3.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 109.644 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.88 4.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 80.5 m-85 -145.96 146.24 30.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.266 . . . . 0.0 111.959 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.972 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.7 mt -117.46 139.73 50.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 35' ' ' LYS . 79.9 p -84.42 139.91 31.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.08 -28.21 0.74 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.1 t0 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.635 -0.92 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 10.6 mttm -95.94 -33.91 12.0 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.047 HG11 HD12 ' A' ' 65' ' ' LEU . 89.7 t -76.94 -42.28 32.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.533 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.645 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 23.2 ttmt -42.34 -49.68 12.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.6 Cg_endo -69.56 -33.65 16.91 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.099 1.052 . . . . 0.0 109.44 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.773 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -63.97 -35.38 73.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.437 0.637 . . . . 0.0 109.601 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.065 ' HB3' HD22 ' A' ' 50' ' ' LEU . 25.4 mt -87.89 -23.39 23.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.396 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.2 mt -74.03 -14.44 61.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 109.18 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -85.31 -3.66 58.9 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.122 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.589 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -85.9 15.3 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.527 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.24 13.23 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -0.994 . . . . 0.0 109.757 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.069 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.7 mt -100.23 153.95 37.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 0.0 110.717 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.599 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.8 Cg_endo -78.45 -179.09 5.13 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.137 1.598 . . . . 0.0 110.12 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.815 HG22 ' HD1' ' B' ' 111' ' ' PHE . 10.8 t -78.47 -3.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -82.28 -35.5 27.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.259 -0.901 . . . . 0.0 109.439 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.774 HG13 HD22 ' A' ' 45' ' ' LEU . 9.4 mm -80.67 -38.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.065 HD22 ' HB3' ' A' ' 40' ' ' LEU . 33.9 mt -73.69 -25.99 60.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.84 -25.55 74.66 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.806 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.4 ttm180 -101.42 -31.98 10.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.98 -0.718 . . . . 0.0 110.135 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.015 HG11 HG23 ' A' ' 77' ' ' VAL . 10.0 t -71.06 -34.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.526 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.5 t-105 -67.83 -53.18 28.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.127 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 11.5 mt-10 -45.92 -58.92 3.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.025 -1.047 . . . . 0.0 110.004 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.8 mt -62.15 -18.32 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 108.61 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 1.042 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 45.9 t -87.78 -24.21 23.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t0 -102.78 72.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.715 -0.616 . . . . 0.0 109.584 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -60.62 -19.79 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.857 . . . . 0.0 110.718 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 46.9 p-10 -99.34 -18.16 17.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.919 -1.113 . . . . 0.0 109.481 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.511 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 36.0 m80 58.59 46.83 14.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.441 -0.787 . . . . 0.0 110.985 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 64' ' ' MET . 48.7 p-10 -106.37 21.03 18.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 108.777 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 64.97 32.71 85.13 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 1.9 mmt -147.59 162.15 39.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.971 . . . . 0.0 110.849 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.047 HD12 HG11 ' A' ' 36' ' ' VAL . 12.7 mt -132.26 99.55 4.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.544 -0.723 . . . . 0.0 109.339 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.2 p30 -72.31 164.77 25.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.671 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.517 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.3 ptm180 -38.76 -43.82 0.95 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 111.601 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 12.3 m-20 -80.26 -33.47 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.992 . . . . 0.0 110.347 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE1' ' HA ' ' A' ' 58' ' ' ASP . 18.3 mt-10 -76.92 -48.1 19.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -0.91 . . . . 0.0 108.852 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.917 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.0 t80 -59.33 -18.42 38.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -73.6 -54.0 9.19 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.032 0.92 . . . . 0.0 109.263 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.561 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 59.6 t -53.09 -22.66 4.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 110.039 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.14 -17.16 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 111.713 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 8.7 mmm -82.17 -42.16 19.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.363 -1.461 . . . . 0.0 110.731 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -76.93 -18.44 58.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 108.773 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 53' ' ' VAL . 7.2 mt -81.63 -24.76 36.16 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.631 0.729 . . . . 0.0 109.186 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.015 HG23 HG11 ' A' ' 53' ' ' VAL . 12.1 t -90.92 -34.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.597 -0.689 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 -29.57 64.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.383 -0.823 . . . . 0.0 110.843 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.97 -17.04 57.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.138 -0.976 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.069 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.498 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.01 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 6.6 t-20 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.506 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 43.7 Cg_endo -72.96 -40.67 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.843 1.444 . . . . 0.0 110.98 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.815 ' HD1' HG22 ' A' ' 47' ' ' VAL . 47.2 m-85 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.044 -1.035 . . . . 0.0 110.554 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.659 0.742 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -89.92 124.98 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HB2' ' CG ' ' A' ' 13' ' ' ASP . 1.5 mttm -74.91 162.7 72.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 110.674 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.42 -29.92 37.07 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.118 1.589 . . . . 0.0 108.747 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.69 -20.86 35.33 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.8 m-20 -85.24 -42.72 14.41 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -69.1 -20.44 64.07 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.533 -0.73 . . . . 0.0 109.157 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.32 -43.73 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.558 -0.714 . . . . 0.0 109.175 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.7 ptmt -73.65 -29.08 62.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.3 m-30 -67.45 -37.22 82.64 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.26 -10.4 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.685 -0.634 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.76 -31.94 14.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.748 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 28.3 mt -81.26 -28.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.807 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.8 -38.54 58.1 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.666 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.0 t0 -87.78 -0.33 56.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.66 -0.65 . . . . 0.0 109.881 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -89.73 -3.83 58.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 108.884 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.086 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -110.41 -8.94 14.63 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.0 t 83.79 98.4 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.3 Cg_endo -72.33 151.35 54.03 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.613 1.849 . . . . 0.0 110.812 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 50.2 t -122.93 104.67 14.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.7 t30 58.25 22.44 9.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 109.734 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 91.89 37.12 6.14 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 89.8 m-85 -151.16 151.62 32.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -1.182 . . . . 0.0 111.737 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.086 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.9 mt -119.0 151.36 38.35 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 35' ' ' LYS . 97.4 p -97.38 143.97 27.6 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.883 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.608 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.43 -27.65 0.16 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 1.2 m-20 -66.59 -30.59 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -1.075 . . . . 0.0 110.264 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.0 mttt -85.09 -35.79 21.59 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.871 HG11 HD12 ' A' ' 65' ' ' LEU . 55.7 t -80.06 -45.18 22.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.462 0.648 . . . . 0.0 110.316 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.644 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 5.2 tttt -40.65 -54.29 5.23 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.69 . . . . 0.0 110.789 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -67.01 -33.46 32.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.253 1.133 . . . . 0.0 109.796 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.7 -28.9 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.728 -0.607 . . . . 0.0 109.506 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.098 ' HB3' HD22 ' A' ' 50' ' ' LEU . 84.7 mt -88.05 -27.18 22.16 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 110.168 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 38' ' ' PRO . 23.9 mt -73.81 -12.76 60.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.378 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 33.0 p-10 -80.09 -5.15 55.4 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.433 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -89.69 13.94 12.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.373 -0.83 . . . . 0.0 110.598 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.51 13.63 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.895 HD22 HG13 ' A' ' 49' ' ' ILE . 16.2 mt -94.9 154.19 39.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.022 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.6 174.39 12.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.096 1.577 . . . . 0.0 110.652 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' B' ' 111' ' ' PHE . 6.8 t -71.95 -4.27 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.529 -0.732 . . . . 0.0 109.389 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.59 -35.4 27.12 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.218 -0.927 . . . . 0.0 109.449 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.895 HG13 HD22 ' A' ' 45' ' ' LEU . 7.8 mm -79.79 -38.69 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.837 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.098 HD22 ' HB3' ' A' ' 40' ' ' LEU . 27.8 mt -70.41 -27.24 64.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.389 0.614 . . . . 0.0 109.403 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.25 -24.03 76.92 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.963 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.6 ttm180 -101.54 -31.47 10.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.761 -0.846 . . . . 0.0 110.896 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.787 HG11 ' CG2' ' A' ' 77' ' ' VAL . 12.5 t -68.32 -39.36 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.965 -1.085 . . . . 0.0 109.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.64 -50.29 58.68 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.57 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 51.2 mt-10 -49.32 -56.81 8.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.056 -1.027 . . . . 0.0 109.956 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.963 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -60.48 -16.2 34.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.731 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.792 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 66.2 m -93.02 -31.27 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.463 -0.773 . . . . 0.0 109.149 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 36.0 t0 -89.58 98.39 11.74 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.78 -22.22 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 111.076 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 58.7 p-10 -90.76 -16.54 28.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 110.067 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.0 m170 66.23 42.85 2.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.371 -0.83 . . . . 0.0 110.639 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 23.3 p-10 -111.72 17.22 20.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 109.602 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 64.55 34.8 90.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 40.9 mtp -150.78 162.03 41.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.087 -1.243 . . . . 0.0 110.805 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.871 HD12 HG11 ' A' ' 36' ' ' VAL . 9.4 mt -126.22 106.27 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.735 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 2.3 t70 -69.86 172.12 8.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.29 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -51.81 -34.74 41.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 111.048 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.81 -34.56 19.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.04 -1.038 . . . . 0.0 110.019 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 57' ' ' SER . 25.1 mt-10 -76.89 -38.94 52.6 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.965 ' CD2' HD12 ' A' ' 31' ' ' LEU . 38.6 t80 -63.01 -28.97 70.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.9 -51.49 64.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.995 0.902 . . . . 0.0 109.663 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 41.9 t -52.7 -28.03 12.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.494 0.664 . . . . 0.0 110.452 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.792 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -84.04 -13.61 52.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.319 -0.863 . . . . 0.0 111.862 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.1 mmm -85.82 -32.84 21.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.503 -1.373 . . . . 0.0 111.146 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 72' ' ' VAL . 4.4 p90 -84.47 -18.2 36.63 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.123 . . . . 0.0 108.675 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.497 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.4 mt -83.9 -13.74 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.787 ' CG2' HG11 ' A' ' 53' ' ' VAL . 52.0 t -91.22 -47.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.49 -0.756 . . . . 0.0 110.261 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -71.21 -29.89 65.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.279 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 31.2 t -82.09 -10.1 59.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.165 -0.959 . . . . 0.0 109.323 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 49' ' ' ILE . . . . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 122.186 0.994 . . . . 0.0 109.02 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 16.1 t-20 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.5 -36.6 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.918 1.483 . . . . 0.0 110.713 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.709 ' HB3' HG13 ' A' ' 47' ' ' VAL . 95.5 m-85 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.047 -1.033 . . . . 0.0 110.037 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.51 0.671 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.5 137.8 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -95.74 173.37 4.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -70.99 -33.77 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.219 1.642 . . . . 0.0 109.993 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -27.48 39.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.3 m-20 -79.72 -40.03 29.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 22.4 tptp -72.31 -20.77 61.44 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.472 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.32 71.11 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.0 ptpt -74.84 -30.31 61.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.636 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.7 m-30 -64.86 -40.94 95.94 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.4 -8.67 56.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.281 0.562 . . . . 0.0 110.432 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -95.33 -33.81 12.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.63 HG22 ' CE1' ' A' ' 70' ' ' PHE . 36.0 mt -79.68 -27.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.83 -39.17 57.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.7 t0 -87.36 0.02 56.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.814 -0.553 . . . . 0.0 110.05 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.96 -7.55 53.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.11 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.9 mt -105.59 -14.38 15.3 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.1 t 90.68 97.2 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.65 151.75 41.79 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.62 1.853 . . . . 0.0 110.701 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.8 t -118.13 104.68 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.57 -0.706 . . . . 0.0 109.17 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 5.0 t30 58.56 15.02 3.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.787 . . . . 0.0 109.678 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.9 32.24 3.89 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -150.07 148.92 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.966 -1.314 . . . . 0.0 112.017 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.11 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.2 mt -114.41 136.39 53.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -82.0 141.56 33.14 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.811 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.51 -27.56 0.84 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.4 t0 -63.66 -23.53 67.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.549 -0.971 . . . . 0.0 110.05 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 11.9 mttm -98.52 -35.64 10.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.052 HG11 HD12 ' A' ' 65' ' ' LEU . 99.2 t -76.93 -42.16 32.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.569 0.7 . . . . 0.0 110.132 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.648 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 18.6 tttt -41.63 -53.94 7.06 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 111.346 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.31 -34.99 19.78 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.433 1.228 . . . . 0.0 109.907 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.792 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -60.57 -26.14 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.847 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.066 ' HB3' HD22 ' A' ' 50' ' ' LEU . 23.9 mt -96.9 -28.66 14.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.064 -1.022 . . . . 0.0 110.274 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 62.7 mt -69.66 -17.27 63.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.629 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.36 -6.68 58.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.575 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.471 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -85.49 14.18 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 110.13 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 58.71 16.17 4.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.903 . . . . 0.0 110.2 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.037 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.9 mt -96.55 153.39 38.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 110.019 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.7 Cg_endo -76.02 176.32 10.19 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.112 1.585 . . . . 0.0 109.897 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.4 t -73.85 -3.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 46' ' ' PRO . 5.7 m-20 -81.11 -33.83 33.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.395 -0.816 . . . . 0.0 109.12 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.96 HG13 HD22 ' A' ' 45' ' ' LEU . 9.0 mm -82.73 -40.04 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.066 HD22 ' HB3' ' A' ' 40' ' ' LEU . 21.9 mt -73.32 -28.99 62.38 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.613 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -66.1 -24.24 71.71 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.659 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.47 -39.66 7.43 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.011 -0.7 . . . . 0.0 109.878 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.804 HG11 ' CG2' ' A' ' 77' ' ' VAL . 5.8 t -57.35 -45.41 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.041 -1.037 . . . . 0.0 109.751 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 58' ' ' ASP . 4.3 t-105 -63.3 -53.14 57.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.336 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 85.7 mt-10 -54.87 -48.42 72.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.313 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 52' ' ' ARG . 7.8 mt -62.4 -22.88 66.49 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.913 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 41.7 t -89.62 -30.13 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.506 0.67 . . . . 0.0 109.291 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -74.43 79.71 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -60.43 -36.44 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.011 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.2 p30 -103.49 -20.09 14.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 16.4 m80 69.41 41.8 1.26 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 2.7 p-10 -91.97 9.86 31.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.949 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 80.4 24.66 58.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 50.9 mtp -152.95 160.48 43.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 1.052 HD12 HG11 ' A' ' 36' ' ' VAL . 13.6 mt -119.28 100.5 7.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.1 p30 -69.52 159.2 33.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.064 -1.022 . . . . 0.0 110.313 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.4 ptp180 -35.77 -43.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 111.251 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 35.8 t70 -75.89 -36.46 59.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.339 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HG2' HG12 ' A' ' 59' ' ' ILE . 85.0 mt-10 -76.62 -43.11 39.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.004 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.967 ' CD2' HD12 ' A' ' 31' ' ' LEU . 22.1 t80 -59.54 -20.52 56.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.13 -49.83 22.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.425 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 55.8 t -58.31 -24.75 25.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.351 0.596 . . . . 0.0 110.259 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.27 -9.38 53.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.349 -0.845 . . . . 0.0 111.282 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 3.3 mmt -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.924 -1.11 . . . . 0.0 110.361 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.3 p90 -77.41 -26.72 51.93 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.256 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB3' HG22 ' A' ' 53' ' ' VAL . 14.3 mt -69.03 -23.02 64.02 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.804 ' CG2' HG11 ' A' ' 53' ' ' VAL . 57.6 t -92.3 -63.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.49 0.662 . . . . 0.0 109.555 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -47.17 -27.93 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.554 -0.716 . . . . 0.0 111.637 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.5 m -80.65 -16.16 54.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.84 -1.162 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.037 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 121.366 -0.833 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.452 ' OD1' ' HD2' ' B' ' 110' ' ' PRO . 48.1 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.716 0.293 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' B' ' 109' ' ' ASN . 46.6 Cg_endo -75.88 -28.4 7.81 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.938 1.494 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.738 ' CE2' HD12 ' A' ' 40' ' ' LEU . 64.8 m-85 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.035 -1.041 . . . . 0.0 110.023 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.425 0.631 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 t -92.84 128.38 44.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.485 -0.759 . . . . 0.0 109.373 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.4 mttp -84.35 164.79 41.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.107 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.64 -30.24 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.933 1.491 . . . . 0.0 109.476 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -85.13 -25.3 27.57 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.575 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -77.59 -41.72 37.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 1.5 tmtt? -69.39 -23.63 63.75 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.071 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.76 93.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -38.81 65.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.3 m-30 -60.63 -21.98 63.3 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -90.35 -12.09 38.71 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.78 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.52 -33.38 15.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 41.2 mt -78.38 -29.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.864 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.81 -39.73 50.41 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.672 0.748 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.8 t70 -86.44 1.98 49.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.583 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.24 -10.27 44.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.086 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.089 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.3 mt -105.44 -12.93 15.8 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.1 t 87.24 96.2 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -75.49 152.38 38.45 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.509 1.794 . . . . 0.0 110.933 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 26.3 t -116.65 107.8 23.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.9 t-20 58.76 15.13 3.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.348 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.94 32.26 4.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -144.32 149.5 36.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.0 111.859 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.089 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.8 mt -117.17 138.95 51.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 14.0 p -85.86 141.08 29.87 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.069 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.451 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.33 -26.71 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 29.1 t70 -61.25 -28.53 69.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -1.093 . . . . 0.0 109.736 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.579 ' HB3' HD13 ' A' ' 24' ' ' LEU . 46.8 mttm -94.11 -33.2 13.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.242 -0.911 . . . . 0.0 108.579 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.625 HG12 HD11 ' A' ' 40' ' ' LEU . 79.6 t -79.67 -44.3 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.463 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.595 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 25.2 tttt -40.2 -54.02 4.84 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.889 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -66.83 -36.44 23.68 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 109.683 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -59.74 -37.59 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.557 -0.714 . . . . 0.0 109.607 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.996 ' HB3' HD22 ' A' ' 50' ' ' LEU . 34.9 mt -83.89 -29.02 27.52 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.411 -0.806 . . . . 0.0 109.845 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -74.01 -12.48 60.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.399 -0.813 . . . . 0.0 109.512 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -90.27 -4.98 56.82 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.125 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.582 ' CB ' HG13 ' A' ' 77' ' ' VAL . 60.5 p -84.13 8.87 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.2 OUTLIER 66.77 7.65 5.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.09 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 1.04 HD11 ' HB3' ' A' ' 80' ' ' ALA . 18.8 mt -93.18 155.87 40.72 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.3 Cg_endo -74.55 167.78 26.33 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.204 1.634 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' B' ' 111' ' ' PHE . 17.5 t -66.63 -7.78 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' OD1' ' O ' ' A' ' 48' ' ' ASP . 47.4 t0 -77.33 -30.94 54.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.831 HG13 HD22 ' A' ' 45' ' ' LEU . 9.1 mm -84.69 -36.61 11.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.974 0.892 . . . . 0.0 108.943 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.5 mt -75.51 -25.59 57.38 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -75.6 -25.03 68.63 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.1 ttm180 -100.81 -29.67 12.12 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.014 HG11 HG23 ' A' ' 77' ' ' VAL . 17.0 t -69.67 -51.03 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 1.5 t-105 -59.86 -53.63 55.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -45.43 -65.7 0.5 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.924 0.869 . . . . 0.0 110.12 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 52' ' ' ARG . 22.2 mt -56.76 -18.27 12.07 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.997 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.3 t -91.66 -17.29 25.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t70 -94.87 82.43 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.312 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.46 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 26.5 mt -87.0 -20.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 110.892 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 5.8 p30 -94.52 -21.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.532 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 15.2 m80 70.86 40.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.465 -0.772 . . . . 0.0 110.673 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 32.1 p-10 -101.89 15.13 29.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 62.29 31.85 80.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 74.8 mtp -154.41 161.29 41.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.366 -1.079 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 ' OG ' ' A' ' 57' ' ' SER . 9.0 mt -116.9 101.11 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 109.344 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.5 p30 -69.67 160.85 30.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 110.339 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.511 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.8 ptt85 -33.88 -45.41 0.19 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.826 -0.546 . . . . 0.0 111.604 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 22.6 m-20 -78.1 -41.25 35.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.437 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 44.8 mt-10 -67.77 -48.1 67.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.316 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.846 ' CD2' HD12 ' A' ' 31' ' ' LEU . 10.2 t80 -57.88 -17.88 19.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -75.37 -53.73 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.431 -0.793 . . . . 0.0 109.506 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.494 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.4 t -55.39 -27.13 20.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.25 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.815 . . . . 0.0 110.816 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.5 mmt -87.15 -50.02 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.662 -1.274 . . . . 0.0 110.066 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 4.2 p90 -74.51 -27.71 60.67 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.504 ' HA ' HD23 ' A' ' 76' ' ' LEU . 7.5 mt -62.95 -30.52 71.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.014 HG23 HG11 ' A' ' 53' ' ' VAL . 18.0 t -91.17 -23.8 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.896 -0.503 . . . . 0.0 109.942 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.43 -21.29 23.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.449 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -84.59 -18.23 36.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 1.04 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.076 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.482 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 1.1 t-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.505 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.5 Cg_endo -82.51 21.15 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.87 1.458 . . . . 0.0 111.056 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.916 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 78.8 m-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.954 -1.092 . . . . 0.0 110.071 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.278 0.561 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.3 t -106.13 157.91 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.587 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mttt -108.15 170.56 5.4 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.1 Cg_endo -66.17 -32.69 42.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.665 1.35 . . . . 0.0 109.915 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.6 mt-10 -70.07 -32.03 69.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.454 -0.779 . . . . 0.0 109.402 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.4 m-20 -77.04 -40.94 44.52 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 8.2 tptm -65.3 -15.87 62.97 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.681 0.753 . . . . 0.0 109.073 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 -27.44 39.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 1.8 mtpt -90.72 -38.11 13.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.9 m-30 -66.18 -27.07 67.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 1.1 t70 -89.42 -12.72 39.45 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.06 -28.24 17.28 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.773 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.255 54.0 mt -82.91 -35.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.738 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.74 -39.44 73.31 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.751 0.786 . . . . 0.0 108.949 178.873 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -87.35 -1.65 58.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.801 -0.562 . . . . 0.0 110.121 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 8.5 t -87.0 -11.37 50.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.01 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.975 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.0 mt -100.45 -10.7 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.72 97.08 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -74.9 149.52 37.31 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.308 1.688 . . . . 0.0 110.752 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.6 t -118.13 108.83 25.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 25.5 t30 58.91 22.29 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.583 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 87.62 39.56 7.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.54 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 90.6 m-85 -151.16 154.6 37.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.305 -1.115 . . . . 0.0 111.615 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.975 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.8 mt -123.07 137.21 54.99 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.494 ' CA ' ' SD ' ' A' ' 64' ' ' MET . 1.3 p -91.62 147.32 23.09 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.954 -1.091 . . . . 0.0 110.404 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -41.72 -27.93 0.37 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 13.3 t70 -62.09 -25.72 67.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.996 . . . . 0.0 110.411 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.7 mttp -101.64 -28.41 12.52 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.04 -1.037 . . . . 0.0 108.856 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.743 ' CG1' HD12 ' A' ' 65' ' ' LEU . 91.6 t -83.81 -48.47 17.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.487 -0.758 . . . . 0.0 110.755 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.59 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 4.5 ttpp -41.53 -51.26 8.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.8 Cg_endo -67.83 -32.63 29.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.142 1.075 . . . . 0.0 109.575 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -66.92 -36.61 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.686 -0.634 . . . . 0.0 109.62 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.088 ' HB3' HD22 ' A' ' 50' ' ' LEU . 58.0 mt -82.33 -25.43 33.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.812 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 39.4 mt -74.51 -11.56 60.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.12 -10.33 57.87 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.078 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.591 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -81.71 8.91 8.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 43' ' ' SER . 1.3 ttmt 64.04 11.11 5.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 110.124 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.952 HD22 HG13 ' A' ' 49' ' ' ILE . 14.5 mt -88.84 154.14 49.99 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.016 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.4 Cg_endo -75.0 172.32 16.61 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.946 1.498 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.708 HG22 ' HD1' ' B' ' 111' ' ' PHE . 5.9 t -70.21 -5.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 109.725 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -80.73 -33.09 35.43 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.234 -0.917 . . . . 0.0 109.386 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.952 HG13 HD22 ' A' ' 45' ' ' LEU . 8.7 mm -81.5 -39.9 17.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.088 HD22 ' HB3' ' A' ' 40' ' ' LEU . 19.7 mt -70.01 -28.64 65.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.54 -24.45 75.21 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 1.003 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.9 ttm-85 -101.99 -33.99 9.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.905 -0.762 . . . . 0.0 110.888 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 1.107 HG11 ' CG2' ' A' ' 77' ' ' VAL . 22.7 t -67.84 -36.22 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.846 -1.159 . . . . 0.0 109.264 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.1 t-105 -68.32 -49.88 57.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.281 -0.967 . . . . 0.0 109.435 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.5 mt-10 -56.01 -56.33 22.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.466 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.003 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -59.38 -15.67 18.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.101 -1.0 . . . . 0.0 108.54 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.867 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 28.5 t -94.22 -30.99 14.3 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -85.42 98.22 10.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.692 -0.63 . . . . 0.0 110.08 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' A' ' 69' ' ' GLU . 3.3 mt -96.15 -21.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.917 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -95.28 -13.98 24.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 24.1 m170 61.4 44.4 9.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.415 -0.803 . . . . 0.0 110.787 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 20.8 p-10 -106.83 18.56 21.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.135 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.542 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 61.49 30.42 74.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.542 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 3.3 mmm -148.97 161.07 42.65 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.327 -1.102 . . . . 0.0 109.255 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.743 HD12 ' CG1' ' A' ' 36' ' ' VAL . 8.9 mt -111.86 107.81 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.852 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -68.21 148.99 50.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.131 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -39.57 -37.82 0.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.381 -0.824 . . . . 0.0 110.259 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -77.37 -36.62 53.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 85.9 mt-10 -73.04 -51.21 19.01 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.866 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.2 t80 -50.0 -25.94 3.82 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -69.74 -54.58 13.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.071 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.547 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 52.4 t -53.65 -22.65 6.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 109.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.867 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.24 -14.78 35.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.275 -0.89 . . . . 0.0 111.937 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.539 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.3 mmm -81.77 -41.07 21.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.411 -1.431 . . . . 0.0 110.491 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 p90 -76.79 -25.52 53.41 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.297 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HB3' HG22 ' A' ' 53' ' ' VAL . 5.9 mt -72.35 -27.49 62.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.514 0.673 . . . . 0.0 109.267 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.107 ' CG2' HG11 ' A' ' 53' ' ' VAL . 33.3 t -91.59 -21.84 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.658 -0.652 . . . . 0.0 110.524 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 -22.08 22.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 26.7 m -83.74 -17.4 41.37 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.473 -0.767 . . . . 0.0 109.481 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.917 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.377 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.504 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 24.6 t-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.63 27.62 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.891 1.469 . . . . 0.0 111.869 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.708 ' HD1' HG22 ' A' ' 47' ' ' VAL . 62.6 m-85 . . . . . 0 N--CA 1.497 1.875 0 O-C-N 120.726 -1.234 . . . . 0.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.492 0.663 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.66 HG13 ' HE2' ' A' ' 17' ' ' TYR . 22.9 t -96.02 112.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.601 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.551 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -88.28 -177.53 0.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.955 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -70.12 -37.44 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.748 1.394 . . . . 0.0 109.789 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.7 pt-20 -70.94 -30.22 66.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.8 m-20 -77.89 -42.44 33.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.686 ' CE ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -65.38 -33.82 76.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.28 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.48 62.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -72.31 -26.97 62.16 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' HE2' HG13 ' A' ' 9' ' ' VAL . 10.0 m-30 -74.03 -36.31 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.756 0.789 . . . . 0.0 109.147 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.9 t70 -74.69 -9.1 58.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.796 -0.565 . . . . 0.0 110.618 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.75 -32.26 13.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.668 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 72.5 mt -80.06 -31.46 13.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.761 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -72.9 -41.96 64.08 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.523 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.7 t70 -86.46 3.33 44.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 110.069 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.56 -7.49 50.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.182 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.072 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.2 mt -106.34 -8.85 17.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 83.06 92.2 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.7 Cg_endo -72.76 151.09 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.303 1.686 . . . . 0.0 111.134 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 75.3 t -122.52 104.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 67.66 22.61 8.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.387 -0.821 . . . . 0.0 108.962 -178.316 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 83.84 37.84 11.17 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 82.6 m-85 -148.7 147.27 28.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 111.513 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.072 ' CD1' HD12 ' A' ' 24' ' ' LEU . 15.5 mt -114.59 132.84 56.21 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.0 p -76.72 144.39 39.35 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.56 -27.09 0.28 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.9 t70 -66.41 -28.15 68.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.512 -0.993 . . . . 0.0 110.477 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.5 mttp -90.84 -35.74 14.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.996 -1.065 . . . . 0.0 108.223 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.812 HG11 HD12 ' A' ' 65' ' ' LEU . 94.9 t -77.66 -45.11 28.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.625 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.671 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 tttt -37.84 -54.63 2.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.708 -0.62 . . . . 0.0 110.951 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.618 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.8 Cg_endo -67.05 -34.68 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.495 1.261 . . . . 0.0 110.028 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.678 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.1 t -61.99 -27.01 41.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 110.117 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.092 ' HB3' HD22 ' A' ' 50' ' ' LEU . 24.1 mt -94.16 -29.03 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.662 HD11 ' HG3' ' A' ' 37' ' ' LYS . 8.8 mt -74.84 -15.28 60.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.92 -1.112 . . . . 0.0 108.96 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -13.57 59.66 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.944 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.581 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 27.4 p -82.87 11.7 5.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 0.0 110.326 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 12.21 4.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.0 mt -87.04 155.66 55.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.7 Cg_endo -77.4 168.95 22.03 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.026 1.54 . . . . 0.0 109.548 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -69.77 -4.34 3.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 -30.74 39.2 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.311 -0.868 . . . . 0.0 109.103 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.795 HG13 HD22 ' A' ' 45' ' ' LEU . 11.4 mm -85.35 -36.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.882 0.848 . . . . 0.0 108.884 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.092 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -77.31 -26.17 51.98 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.16 -26.91 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 1.026 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.96 -36.93 8.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 122.039 -0.683 . . . . 0.0 110.566 179.412 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 49' ' ' ILE . 6.8 t -59.73 -41.44 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.044 -1.035 . . . . 0.0 110.128 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.6 t-105 -66.98 -51.64 52.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.929 -1.107 . . . . 0.0 109.716 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.6 mt-10 -52.3 -59.92 3.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 110.481 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 1.026 HD11 ' CZ ' ' A' ' 52' ' ' ARG . 1.2 mt -59.95 -30.14 68.88 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.751 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.971 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 44.3 t -75.29 -29.76 60.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.327 -0.858 . . . . 0.0 108.809 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -70.42 62.41 0.24 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.578 -0.701 . . . . 0.0 109.54 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.518 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 43.4 mm -43.21 -33.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.992 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 1.6 m-20 -99.85 -20.7 16.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 33.0 m80 59.33 38.47 23.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.6 -1.34 44.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 99.1 20.74 17.33 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.6 mtp -153.26 161.3 42.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.593 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.812 HD12 HG11 ' A' ' 36' ' ' VAL . 12.6 mt -118.98 107.07 13.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.5 p30 -75.15 160.67 30.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.886 -1.134 . . . . 0.0 109.706 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.606 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ppt_? -36.88 -46.33 0.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.671 -0.643 . . . . 0.0 111.741 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 1.7 t70 -72.75 -38.87 67.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.096 -1.002 . . . . 0.0 110.268 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 50.7 mt-10 -71.33 -46.63 60.16 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 108.791 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.96 ' CD2' HD12 ' A' ' 31' ' ' LEU . 26.7 t80 -59.03 -18.6 36.13 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.686 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . . . -76.01 -50.57 14.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.545 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.1 t -59.89 -24.21 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.586 -0.696 . . . . 0.0 109.679 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.36 -4.99 56.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.289 -0.882 . . . . 0.0 110.877 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.578 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.5 mmt -84.44 -46.21 11.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.657 ' CD2' HG22 ' A' ' 9' ' ' VAL . 2.1 p90 -76.01 -29.36 58.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 72' ' ' VAL . 4.5 mt -60.42 -27.8 67.76 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' ALA . 77.2 t -92.55 -41.89 13.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.624 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.39 -29.22 59.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.355 -0.841 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 82.6 m -80.83 -11.82 59.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.799 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.247 -0.908 . . . . 0.0 108.554 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.515 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 18.2 t-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.598 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -76.19 -29.36 6.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.096 1.577 . . . . 0.0 111.207 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 1.034 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 40.3 m-85 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.018 -1.051 . . . . 0.0 110.7 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.329 0.585 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 13' ' ' ASP . 39.8 t -99.46 127.37 52.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.602 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.523 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -83.79 175.35 4.79 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.8 Cg_endo -67.71 -34.91 23.48 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.885 1.466 . . . . 0.0 109.412 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.09 -28.11 61.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.437 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -82.21 -38.86 23.94 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 8.2 tttt -70.43 -18.46 63.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.42 -44.93 61.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.1 ptmm? -73.66 -18.24 61.05 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.637 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -83.33 -28.6 28.91 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -84.98 -9.68 57.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.695 -0.628 . . . . 0.0 110.452 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.82 -31.73 15.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 95.5 mt -80.82 -37.6 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.942 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -66.27 -33.89 76.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.52 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -90.0 -6.44 55.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.638 -0.664 . . . . 0.0 109.806 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 t -83.46 -9.77 58.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 108.93 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.819 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.7 mt -104.69 -11.53 16.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 84.37 99.59 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.017 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -76.06 152.37 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.149 1.605 . . . . 0.0 110.727 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 51.0 t -121.52 106.65 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.088 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 19.8 t-20 60.62 17.58 7.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.296 -0.877 . . . . 0.0 109.306 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 95.43 36.02 5.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 81.8 m-85 -150.38 144.42 25.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 111.964 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.822 HD12 ' CD1' ' A' ' 70' ' ' PHE . 8.6 mt -109.07 143.33 38.54 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.458 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 60.3 p -92.01 144.6 25.28 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.293 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -42.9 -26.21 0.43 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -69.8 -23.85 63.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.939 . . . . 0.0 110.383 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 12.9 mttp -93.69 -35.01 13.03 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 40' ' ' LEU . 95.7 t -75.94 -39.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.967 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.571 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -39.82 -56.65 3.0 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.233 -0.917 . . . . 0.0 110.95 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.3 Cg_endo -65.92 -32.85 44.29 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.675 1.355 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.882 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.6 t -65.18 -30.04 49.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.921 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 1.059 HD12 ' CZ ' ' B' ' 111' ' ' PHE . 22.5 mt -93.05 -36.24 12.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 37' ' ' LYS . 6.6 mt -70.88 -14.18 62.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.109 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -78.81 -13.93 59.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.459 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.521 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.8 OUTLIER -79.18 6.15 10.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.648 -0.658 . . . . 0.0 110.263 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.2 ttpt 67.39 15.7 9.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.973 HD22 HG13 ' A' ' 49' ' ' ILE . 16.1 mt -96.7 154.38 38.43 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.6 178.92 6.96 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 109.957 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -75.35 -1.96 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' OD1' HD13 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -84.44 -32.84 23.85 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.231 -0.918 . . . . 0.0 109.326 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.973 HG13 HD22 ' A' ' 45' ' ' LEU . 8.2 mm -84.85 -35.77 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.989 0.9 . . . . 0.0 108.735 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 1.057 HD22 ' HB3' ' A' ' 40' ' ' LEU . 25.3 mt -79.76 -23.37 42.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.618 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.07 -24.78 75.12 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.933 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -101.28 -30.55 11.45 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.85 -0.794 . . . . 0.0 110.087 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.946 HG11 HG23 ' A' ' 77' ' ' VAL . 24.6 t -69.25 -38.47 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.228 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.583 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.8 t-105 -65.93 -50.79 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.08 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.7 mt-10 -56.84 -57.45 12.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.292 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -59.87 -15.13 18.87 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.042 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.961 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 30.3 t -94.78 -36.76 11.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' OD1' ' CE2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -74.65 89.75 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 111.01 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 15.7 mm -60.74 -32.24 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.13 -0.981 . . . . 0.0 109.384 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.0 109.693 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 30.1 p80 40.74 40.54 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.424 0.63 . . . . 0.0 110.57 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.51 0.43 57.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.323 -0.86 . . . . 0.0 109.042 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.56 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 101.62 18.85 17.27 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.56 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.5 mmm -146.89 160.85 41.81 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.148 -1.207 . . . . 0.0 109.818 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.648 HD12 HG11 ' A' ' 36' ' ' VAL . 12.4 mt -120.05 110.3 16.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.222 -0.924 . . . . 0.0 110.036 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 9.1 t70 -69.38 169.56 12.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.116 -0.99 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.4 ptm180 -51.31 -40.34 58.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 3.1 t70 -81.11 -28.85 35.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.252 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 4.8 tt0 -74.51 -44.74 49.9 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.617 0.723 . . . . 0.0 109.198 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.882 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 44.2 t80 -62.6 -18.56 62.43 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.37 -49.05 24.32 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.938 0.875 . . . . 0.0 109.145 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.513 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 30.2 t -55.6 -30.75 27.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.469 0.652 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.961 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.09 -4.32 57.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.795 . . . . 0.0 111.759 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.604 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmt -85.39 -44.18 13.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.642 -1.287 . . . . 0.0 109.984 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 6.2 p90 -79.19 -23.13 44.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.652 ' HB3' HG13 ' A' ' 53' ' ' VAL . 4.3 mt -72.75 -25.41 61.19 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.946 HG23 HG11 ' A' ' 53' ' ' VAL . 44.6 t -89.93 -44.75 15.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.5 -27.86 65.55 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.04 -15.16 58.61 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.042 -1.036 . . . . 0.0 109.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.71 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 20.3 t-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.582 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 47.5 Cg_endo -73.8 -25.46 14.49 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.953 1.502 . . . . 0.0 110.982 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 1.059 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 71.5 m-85 . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.992 -1.067 . . . . 0.0 110.509 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.365 0.602 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG22 ' CD2' ' A' ' 75' ' ' PHE . 44.0 t -95.79 155.0 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.621 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -90.17 163.96 29.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 109.923 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.64 -30.17 23.24 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.011 1.532 . . . . 0.0 109.683 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.3 mt-10 -86.68 -18.63 30.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.475 0.655 . . . . 0.0 109.462 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.577 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 3.6 m-20 -79.94 -43.98 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 71' ' ' ALA . 7.2 tptp -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.72 74.92 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -78.04 -44.54 26.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 6.2 m-30 -54.73 -24.65 23.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.3 -14.57 40.5 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.527 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.87 -29.69 15.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.252 51.1 mt -80.03 -32.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 177.846 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.69 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.639 0.733 . . . . 0.0 109.204 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -90.41 -8.56 50.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.71 -0.619 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -13.72 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 108.867 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 1.003 HD12 ' CD1' ' A' ' 31' ' ' LEU . 10.9 mt -93.68 -54.53 3.6 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.66 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 m 137.54 96.41 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.479 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -71.45 146.59 50.4 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 123.948 1.499 . . . . 0.0 110.541 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 20.8 t -116.76 97.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 1.5 t30 60.56 11.32 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 110.79 33.49 2.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 82.3 m-85 -150.68 150.04 30.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.181 -1.188 . . . . 0.0 112.228 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 1.003 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.0 mt -117.28 136.08 53.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 34' ' ' ASP . 91.0 p -85.2 141.32 30.23 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.261 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.45 -27.93 0.17 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -62.43 -26.61 68.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -1.034 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 53.2 mttt -96.53 -31.81 12.59 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.106 -0.996 . . . . 0.0 108.481 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 65' ' ' LEU . 99.0 t -82.36 -46.88 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.208 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.625 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -42.79 -53.74 9.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.75 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -65.81 -34.03 41.46 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 109.288 -1.081 . . . . 0.0 109.288 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.47 -30.43 49.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.493 0.663 . . . . 0.0 109.54 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.997 ' HB3' HD22 ' A' ' 50' ' ' LEU . 88.4 mt -86.72 -24.45 25.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.439 -0.788 . . . . 0.0 110.31 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD1' ' HD3' ' A' ' 37' ' ' LYS . 19.4 mt -79.31 -13.57 59.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.54 -6.88 58.77 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.829 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.06 12.1 6.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 109.934 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 64.71 17.77 11.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 109.98 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.904 HD22 HG13 ' A' ' 49' ' ' ILE . 15.1 mt -100.38 149.78 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.446 -0.784 . . . . 0.0 110.627 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.8 Cg_endo -75.88 175.34 11.44 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.059 1.557 . . . . 0.0 109.97 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.79 HG22 ' HD1' ' B' ' 111' ' ' PHE . 2.4 t -72.39 -2.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.25 -32.11 24.62 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.268 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.904 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -84.35 -36.5 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.997 HD22 ' HB3' ' A' ' 40' ' ' LEU . 20.1 mt -75.62 -27.35 58.42 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.69 -24.06 75.37 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.826 ' O ' HD12 ' A' ' 56' ' ' LEU . 5.7 ttm105 -101.16 -33.96 9.89 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.942 -0.74 . . . . 0.0 109.935 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 HG23 ' A' ' 77' ' ' VAL . 38.0 t -69.26 -44.29 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.954 -1.091 . . . . 0.0 109.418 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.0 t-105 -60.78 -45.99 92.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.322 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 4.7 mm-40 -58.41 -55.81 30.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.243 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.8 mt -62.36 -14.42 39.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 108.575 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.932 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.4 t -95.14 -29.52 14.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.348 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.58 82.15 4.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.097 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.482 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 38.3 mm -57.89 -35.41 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 15.8 m-20 -96.84 -18.76 19.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 86.5 m-70 57.34 48.82 14.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.988 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -115.58 23.89 12.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 72.98 27.83 67.92 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.0 mtt -151.17 160.94 43.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.741 HD12 HG11 ' A' ' 36' ' ' VAL . 10.9 mt -125.75 110.03 13.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.922 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.5 t70 -69.55 168.51 14.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.0 109.357 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.3 ptt180 -50.74 -39.47 52.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.523 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 37.7 m-20 -79.78 -33.08 40.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.228 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 33.5 mt-10 -73.53 -42.99 61.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.884 ' CD2' HD12 ' A' ' 31' ' ' LEU . 35.9 t80 -58.62 -27.38 64.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.567 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . . . -66.89 -46.86 73.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 110.092 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' HE2' ' A' ' 75' ' ' PHE . 61.6 t -58.62 -25.67 29.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.611 0.72 . . . . 0.0 109.86 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.67 -9.0 51.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.818 . . . . 0.0 112.186 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 4.4 mmm -85.47 -44.1 13.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.602 -1.311 . . . . 0.0 110.386 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.573 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -76.67 -26.83 55.24 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.31 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.573 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.3 mt -69.41 -23.99 63.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.848 HG23 HG11 ' A' ' 53' ' ' VAL . 61.8 t -91.4 -46.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.807 -0.558 . . . . 0.0 109.626 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.33 -28.71 68.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.7 -0.625 . . . . 0.0 110.908 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 5.9 t -80.45 -14.96 57.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.171 -0.956 . . . . 0.0 109.969 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.3 -1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.068 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' A' ' 55' ' ' GLU . 42.9 t-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.574 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -75.88 9.74 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.832 1.438 . . . . 0.0 111.632 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.79 ' HD1' HG22 ' A' ' 47' ' ' VAL . 98.9 m-85 . . . . . 0 N--CA 1.499 1.979 0 O-C-N 120.778 -1.201 . . . . 0.0 110.366 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.412 0.625 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 46.3 t -101.23 134.92 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.777 . . . . 0.0 110.055 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -91.79 -179.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.385 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.7 Cg_endo -69.47 -36.47 11.53 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.941 1.495 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.77 -27.12 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 109.957 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 13.0 m-20 -80.93 -38.12 28.38 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.242 -0.911 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 2.2 tttt -77.13 -21.27 54.44 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.948 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -66.92 -39.35 87.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.72 -24.47 58.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 12.3 m-30 -76.96 -32.2 57.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -11.7 60.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.682 -0.636 . . . . 0.0 110.029 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.6 -31.61 17.49 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.655 HG22 ' CE1' ' A' ' 70' ' ' PHE . 25.6 mt -81.47 -37.0 15.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.758 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.26 -34.71 76.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.8 t0 -90.49 -4.63 56.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.626 -0.672 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 25.8 t -85.99 -4.91 59.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -0.97 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.874 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.47 -14.96 14.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.1 t 91.22 101.24 0.02 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.237 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -76.03 154.19 37.55 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.416 1.745 . . . . 0.0 110.607 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 94.3 t -122.6 102.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.497 -0.752 . . . . 0.0 109.306 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.4 t30 58.06 18.65 5.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 100.91 36.46 3.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 29' ' ' GLY . 86.9 m-85 -153.28 145.44 23.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.848 -1.384 . . . . 0.0 112.003 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.898 HD12 ' CD2' ' A' ' 70' ' ' PHE . 10.1 mt -113.65 138.47 50.15 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.5 p -88.64 146.86 24.85 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.21 -26.11 0.32 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 32' ' ' SER . 56.9 m-20 -63.82 -26.13 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -1.024 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.7 mttt -96.17 -35.75 11.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.091 -1.006 . . . . 0.0 108.507 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.914 HG11 HD12 ' A' ' 65' ' ' LEU . 63.0 t -79.18 -41.35 22.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.156 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 3.1 ttpt -41.31 -55.39 5.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.652 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.3 Cg_endo -67.85 -34.72 23.21 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.559 1.294 . . . . 0.0 109.935 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.861 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.1 t -59.71 -34.16 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 109.839 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.966 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.5 mt -88.77 -27.25 21.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.804 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 61.1 mt -71.99 -12.26 61.16 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 109.128 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -87.72 -4.52 58.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.989 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.467 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 1.2 m -86.04 8.62 19.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 13.14 4.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.095 -1.003 . . . . 0.0 109.747 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.996 HD13 HG21 ' A' ' 49' ' ' ILE . 16.9 mt -95.56 156.42 37.51 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HG2' HG12 ' A' ' 49' ' ' ILE . 43.9 Cg_endo -73.26 167.64 26.81 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 124.141 1.6 . . . . 0.0 109.888 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.642 HG22 ' HD1' ' B' ' 111' ' ' PHE . 1.2 t -65.11 -9.32 7.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.263 -0.898 . . . . 0.0 109.321 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.3 m-20 -76.58 -30.46 57.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.344 -0.848 . . . . 0.0 109.214 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.996 HG21 HD13 ' A' ' 45' ' ' LEU . 13.4 mm -84.58 -38.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 122.002 0.906 . . . . 0.0 108.78 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.966 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.6 mt -78.5 -26.86 46.04 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.57 0.7 . . . . 0.0 109.252 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -81.18 -24.21 57.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.689 ' NH2' ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -101.24 -26.16 13.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.147 -0.619 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.794 HG11 HG23 ' A' ' 77' ' ' VAL . 12.6 t -75.77 -43.23 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.774 -1.204 . . . . 0.0 107.869 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 1.5 t-105 -55.28 -49.04 73.12 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.442 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.0 mm-40 -53.75 -54.89 31.77 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 0.0 109.781 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.689 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 8.2 mt -61.37 -15.85 40.48 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 108.718 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.832 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 31.8 m -94.07 -38.96 10.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.583 -0.698 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 54' ' ' TRP . 4.8 t0 -60.94 100.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 110.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.531 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -83.48 -20.82 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 19.5 m-20 -105.35 -16.31 14.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.438 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 5.7 m-70 60.57 43.84 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.973 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 10.5 p30 -112.84 -6.82 13.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.527 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.549 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 100.95 23.39 9.88 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' MET . . . . . 0.549 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.0 mmm -147.57 161.16 41.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.222 -1.164 . . . . 0.0 109.374 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.914 HD12 HG11 ' A' ' 36' ' ' VAL . 7.9 mt -121.36 107.76 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.083 -1.011 . . . . 0.0 110.325 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 61.0 t0 -69.61 169.29 13.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.96 -1.088 . . . . 0.0 110.114 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.1 ptt180 -50.56 -37.83 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.505 -0.747 . . . . 0.0 109.976 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' OD2' ' HG3' ' A' ' 67' ' ' ARG . 9.2 m-20 -78.65 -32.86 47.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.64 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 39.3 mt-10 -76.71 -41.64 44.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.349 -0.844 . . . . 0.0 109.045 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' PHE . . . . . 0.898 ' CD2' HD12 ' A' ' 31' ' ' LEU . 9.3 t80 -61.21 -25.38 67.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.526 -0.734 . . . . 0.0 109.242 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -69.59 -47.08 64.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.794 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' VAL . . . . . 0.651 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 92.0 t -61.29 -23.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.45 -2.95 57.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 110.835 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 16.1 mmt -89.59 -46.21 8.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.929 -1.107 . . . . 0.0 109.658 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.651 ' CE2' ' HA ' ' A' ' 72' ' ' VAL . 2.0 p90 -77.61 -17.91 57.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.244 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.597 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.6 mt -77.07 -26.5 53.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.794 HG23 HG11 ' A' ' 53' ' ' VAL . 79.6 t -91.87 -50.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.386 0.612 . . . . 0.0 109.773 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -33.52 70.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.607 -0.683 . . . . 0.0 111.54 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.6 m -77.48 -14.46 59.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.008 -1.057 . . . . 0.0 109.592 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.954 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' ASN . . . . . 0.529 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 5.4 t-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.749 0.309 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.5 Cg_endo -74.87 -21.52 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.93 1.49 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 111' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 85.4 m-85 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.097 -1.002 . . . . 0.0 110.003 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.555 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -84.3 121.08 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.01 -27.43 0.13 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 110.245 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.555 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.1 t -96.98 161.79 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.502 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -118.1 178.1 1.12 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.0 110.663 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.3 Cg_endo -73.26 -35.75 4.76 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.191 1.627 . . . . 0.0 110.15 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -26.16 37.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 72.8 m-20 -81.47 -38.84 25.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.936 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -69.84 -20.49 63.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.57 71.02 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 9.3 ptpt -75.25 -25.37 57.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.0 m-30 -71.72 -36.77 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -74.59 -9.85 58.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.746 -0.596 . . . . 0.0 110.318 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.42 -33.92 15.05 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.697 HD13 ' SD ' ' A' ' 74' ' ' MET . 16.4 mt -77.29 -36.46 24.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.756 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.92 -40.0 79.33 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.692 0.758 . . . . 0.0 109.112 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -86.91 0.9 54.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.658 -0.651 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -6.18 55.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 108.996 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.042 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -107.1 -9.99 16.02 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.8 92.05 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 121.195 0.521 . . . . 0.0 109.61 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -73.34 153.4 50.56 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.421 1.748 . . . . 0.0 110.994 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 94.1 t -121.58 114.13 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.74 . . . . 0.0 109.188 179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.629 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 0.1 OUTLIER 52.14 19.8 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.786 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.5 38.23 4.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.4 m-85 -150.43 147.32 27.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.878 -1.366 . . . . 0.0 112.639 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.042 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.3 mt -118.83 137.69 53.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ASP . 67.1 p -89.31 145.58 25.28 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.014 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.518 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.82 -27.54 0.18 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.1 t0 -61.52 -27.26 68.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -1.01 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' HB3' HD13 ' A' ' 24' ' ' LEU . 29.6 mttp -96.44 -32.85 12.12 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.096 -1.002 . . . . 0.0 108.551 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.082 HG11 HD12 ' A' ' 65' ' ' LEU . 60.6 t -79.6 -50.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.188 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.07 -53.66 3.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.913 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -65.97 -36.07 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 N-CA-C 109.174 -1.125 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.09 -32.42 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.012 ' HB3' HD22 ' A' ' 50' ' ' LEU . 60.9 mt -86.3 -25.77 25.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.625 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.518 HD21 ' HE1' ' B' ' 111' ' ' PHE . 62.7 mt -77.03 -11.7 59.84 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.306 -0.871 . . . . 0.0 109.44 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 63.2 t-20 -86.49 -8.86 57.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.024 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.534 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -81.23 6.65 13.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.984 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.7 tptt 65.69 11.3 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -0.99 . . . . 0.0 109.553 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.023 HD13 HG21 ' A' ' 49' ' ' ILE . 16.2 mt -95.18 152.55 39.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.843 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -73.53 168.98 23.39 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.965 1.508 . . . . 0.0 110.669 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' B' ' 111' ' ' PHE . 10.4 t -65.81 -10.54 10.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -30.56 58.93 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.243 -0.911 . . . . 0.0 108.958 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.023 HG21 HD13 ' A' ' 45' ' ' LEU . 16.1 mm -83.03 -40.32 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.012 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -72.82 -30.23 63.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.98 -25.02 76.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.799 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -100.7 -31.71 11.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.833 -0.804 . . . . 0.0 110.043 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 77' ' ' VAL . 25.6 t -72.08 -34.05 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.336 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CZ2' ' O ' ' B' ' 108' ' ' THR . 3.3 t-105 -73.25 -51.98 15.67 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.802 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.5 mm-40 -51.6 -58.25 6.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.951 -1.093 . . . . 0.0 110.088 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.799 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.5 mt -61.32 -14.54 27.82 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.872 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.963 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.9 t -94.03 -31.76 14.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.538 -0.726 . . . . 0.0 109.699 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 3.0 t0 -72.56 86.75 1.19 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.482 -0.762 . . . . 0.0 110.159 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.568 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.3 mm -65.94 -30.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 5.2 m-20 -99.01 -16.17 18.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.0 109.89 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.406 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 92.3 m-70 55.33 48.32 19.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.529 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 7.8 p30 -122.4 26.49 8.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 72.44 32.72 61.9 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.08 161.76 42.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.246 . . . . 0.0 111.082 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.082 HD12 HG11 ' A' ' 36' ' ' VAL . 14.1 mt -136.99 99.91 4.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 3.6 p30 -71.05 168.14 17.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.914 -1.116 . . . . 0.0 110.237 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' ASP . 15.7 ptt180 -38.56 -46.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.538 -0.726 . . . . 0.0 111.269 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.49 -35.48 63.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 110.57 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 57.4 mt-10 -75.79 -42.32 50.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.44 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 1.015 ' CD2' HD12 ' A' ' 31' ' ' LEU . 8.5 t80 -65.93 -19.91 66.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.413 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.7 -46.6 30.28 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.568 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.906 HG13 HD11 ' A' ' 94' ' ' LEU . 86.2 t -59.04 -29.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.543 0.687 . . . . 0.0 109.881 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.963 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.86 -4.08 57.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.441 -0.787 . . . . 0.0 111.18 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.697 ' SD ' HD13 ' A' ' 20' ' ' ILE . 9.3 mmt -85.11 -48.32 9.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.907 -1.121 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -73.02 -31.62 64.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.694 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.1 mt -62.66 -24.13 67.46 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.781 HG23 HG11 ' A' ' 53' ' ' VAL . 58.9 t -91.04 -47.84 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.483 0.658 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.921 ' HA ' HD12 ' A' ' 81' ' ' LEU . 2.3 m-85 -68.1 -31.96 71.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 93.3 m -83.2 -11.12 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.88 -14.35 48.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.921 HD12 ' HA ' ' A' ' 78' ' ' TYR . 2.2 mt -92.26 -51.47 5.15 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.377 0.608 . . . . 0.0 110.731 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.4 18.56 15.97 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.911 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.4 OUTLIER -127.17 -76.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.429 -1.419 . . . . 0.0 111.881 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.7 mt-10 -158.83 -178.46 0.91 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 44.2 Cg_endo -71.97 171.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 124.006 1.529 . . . . 0.0 110.387 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.63 HG13 HD22 ' A' ' 76' ' ' LEU . 11.0 t -117.43 125.31 28.23 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.575 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.69 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -85.68 -177.69 2.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.895 1.471 . . . . 0.0 109.871 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.706 ' C ' HD21 ' A' ' 56' ' ' LEU . 39.2 mtm -111.38 16.43 20.84 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 67.7 m -107.32 105.22 15.07 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.153 . . . . 0.0 111.956 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -54.63 106.96 0.74 Allowed Pre-proline 0 C--N 1.293 -1.852 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.279 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 38.1 Cg_endo -66.71 143.1 66.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.862 1.454 . . . . 0.0 110.638 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.87 -8.81 24.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.248 1.657 . . . . 0.0 111.109 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.96 23.72 7.76 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.654 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.906 HD11 HG13 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -152.31 19.87 0.65 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.899 0.857 . . . . 0.0 109.894 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.479 ' O ' HG13 ' A' ' 95' ' ' VAL . 11.0 p -118.02 131.85 23.97 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.072 . . . . 0.0 110.373 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.07 147.19 60.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.931 1.49 . . . . 0.0 110.201 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.02 -1.18 9.63 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.571 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.05 -17.37 52.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.659 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -89.67 0.16 57.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.436 -0.79 . . . . 0.0 109.541 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.427 ' O ' ' HG3' ' A' ' 100' ' ' ARG . 10.0 ptp180 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.417 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' B' ' 108' ' ' THR . 17.6 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.189 0.519 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.57 ' O ' ' CZ2' ' A' ' 54' ' ' TRP . 1.8 t 179.04 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.581 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.413 ' ND2' HD13 ' B' ' 112' ' ' LEU . 51.4 t-20 -121.4 120.89 28.73 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 110.551 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.78 6.43 4.54 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.917 1.483 . . . . 0.0 111.126 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.895 ' HB3' HG13 ' A' ' 47' ' ' VAL . 65.2 m-85 -128.33 20.67 6.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.998 -1.064 . . . . 0.0 110.333 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.413 HD13 ' ND2' ' B' ' 109' ' ' ASN . 1.1 tp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.122 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.484 0.95 0 N-CA-C 110.672 -0.549 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.465 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -93.03 128.13 38.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -41.32 -33.29 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 110.347 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 32.3 t -90.75 136.59 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.977 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.9 mttp -96.81 178.93 1.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.822 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.78 -36.42 13.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.841 1.443 . . . . 0.0 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 3.7 pt-20 -74.8 -28.73 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.922 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 20.6 m-20 -82.3 -36.04 27.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 0.0 108.958 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -75.0 -15.29 60.66 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.514 -0.742 . . . . 0.0 109.027 178.849 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.1 -40.19 39.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.611 -0.681 . . . . 0.0 109.181 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.9 ptpt -74.73 -22.02 59.04 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 9.5 m-30 -75.22 -34.41 61.45 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.08 -11.33 60.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.421 0.629 . . . . 0.0 110.107 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -91.28 -29.28 17.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.683 HG22 ' CE1' ' A' ' 70' ' ' PHE . 36.3 mt -85.1 -33.71 8.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.767 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.74 -33.74 66.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.561 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 t70 -89.48 -6.12 56.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.616 -0.677 . . . . 0.0 109.951 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.73 -8.15 59.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 108.627 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.119 HD12 HD13 ' A' ' 31' ' ' LEU . 5.0 mt -104.66 -15.38 15.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 85.12 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 CA-C-O 121.157 0.503 . . . . 0.0 110.039 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 52.2 Cg_endo -79.76 157.87 24.6 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.343 1.707 . . . . 0.0 111.055 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.4 t -125.47 109.74 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.5 OUTLIER 65.91 15.32 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 -178.379 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.5 36.75 6.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 75.2 m-85 -141.58 146.65 36.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.246 . . . . 0.0 111.847 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.119 HD13 HD12 ' A' ' 24' ' ' LEU . 9.1 mt -118.04 136.29 53.64 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -86.79 145.39 26.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.7 -26.05 0.38 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.7 t70 -67.19 -20.52 65.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.37 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.8 mttp -100.22 -36.54 9.26 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.019 -1.05 . . . . 0.0 108.194 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.675 HG12 ' CD1' ' A' ' 40' ' ' LEU . 86.9 t -75.61 -46.39 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.163 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.583 ' HG3' ' CZ ' ' B' ' 111' ' ' PHE . 12.0 tttt -39.06 -53.91 3.49 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.999 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.45 -37.0 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.463 1.244 . . . . 0.0 109.379 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.878 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.8 t -60.68 -34.63 59.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.033 ' HB3' HD22 ' A' ' 50' ' ' LEU . 53.9 mt -86.69 -26.39 24.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.5 -0.75 . . . . 0.0 109.584 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD12 ' HG2' ' A' ' 37' ' ' LYS . 36.8 mt -75.57 -17.09 60.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.81 -6.69 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.852 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.718 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.4 p -82.83 11.86 5.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 43' ' ' SER . 13.7 tttp 64.26 15.16 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.061 HD11 ' HB3' ' A' ' 80' ' ' ALA . 20.0 mt -100.66 153.3 37.81 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.88 169.82 21.42 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 124.216 1.64 . . . . 0.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.808 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.6 t -69.15 -6.23 5.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.49 -31.46 42.3 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.249 -0.907 . . . . 0.0 109.207 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.842 HG13 HD22 ' A' ' 45' ' ' LEU . 12.1 mm -82.63 -39.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.033 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -70.14 -28.38 65.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.87 -24.3 76.8 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 1.004 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.39 -32.02 10.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.777 -0.837 . . . . 0.0 110.208 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.75 HG11 ' CG2' ' A' ' 77' ' ' VAL . 4.9 t -72.41 -36.35 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.486 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CD1' ' HB3' ' B' ' 109' ' ' ASN . 2.5 t-105 -68.78 -49.58 57.42 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.012 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.6 mt-10 -52.61 -57.08 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.901 -1.125 . . . . 0.0 110.186 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.004 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.5 mt -61.45 -14.46 28.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.797 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.725 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.8 m -92.56 -38.64 11.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 109.371 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.506 ' OD2' ' HA ' ' A' ' 61' ' ' HIS . 10.7 t0 -70.21 85.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.442 -0.786 . . . . 0.0 109.924 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 26.8 mm -61.68 -27.63 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.899 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 49.9 p30 -108.97 -13.26 14.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.909 -1.119 . . . . 0.0 111.104 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.531 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.9 m-70 63.07 44.68 5.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 13.0 p-10 -111.9 29.61 7.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.904 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 60.73 34.04 85.1 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.5 mtt -150.83 161.04 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -1.14 . . . . 0.0 111.127 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.656 ' CD1' HG11 ' A' ' 36' ' ' VAL . 7.0 mt -128.21 104.82 7.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.754 . . . . 0.0 109.615 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.587 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -68.71 167.75 14.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.224 -0.922 . . . . 0.0 110.344 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.521 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -46.18 -40.96 12.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.428 -0.795 . . . . 0.0 110.519 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 -25.82 31.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.064 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.68 -46.04 27.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.702 0.763 . . . . 0.0 109.261 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 28.5 t80 -64.45 -16.43 62.41 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -76.56 -47.37 22.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.442 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 76' ' ' LEU . 57.6 t -60.14 -24.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.603 -0.685 . . . . 0.0 109.594 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.89 -6.65 55.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -0.753 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.581 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.9 mmt -84.97 -48.21 9.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.003 -1.06 . . . . 0.0 110.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.1 p90 -75.97 -22.28 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.523 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 11.0 mt -73.89 -22.8 59.59 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.75 ' CG2' HG11 ' A' ' 53' ' ' VAL . 53.9 t -91.91 -60.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.448 0.642 . . . . 0.0 109.308 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.55 -19.29 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 110.722 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 4.2 m -85.01 -18.01 35.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.173 -0.954 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.061 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.8 -11.67 47.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.429 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.718 HD21 ' O ' ' A' ' 43' ' ' SER . 6.4 mp -90.69 -41.06 11.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.755 0.788 . . . . 0.0 109.174 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 3.5 tt0 -71.83 -53.25 13.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.631 -0.668 . . . . 0.0 109.645 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 177.73 -25.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.85 . . . . 0.0 111.448 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -70.16 115.12 31.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 0.0 111.576 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.92 179.18 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.776 1.408 . . . . 0.0 109.174 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG21 ' CG2' ' A' ' 53' ' ' VAL . 58.9 t -123.31 124.85 26.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.778 -1.201 . . . . 0.0 111.096 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.733 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.4 Cg_endo -86.88 -176.23 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.949 1.499 . . . . 0.0 109.198 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.685 ' C ' HD21 ' A' ' 56' ' ' LEU . 8.3 mtp -114.9 15.62 17.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.217 . . . . 0.0 110.549 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.554 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.3 m -113.25 100.9 8.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.189 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.652 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.57 107.48 0.88 Allowed Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.466 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.566 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.1 Cg_endo -66.56 158.38 55.97 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.897 1.472 . . . . 0.0 110.61 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.63 -16.6 26.84 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.088 1.573 . . . . 0.0 111.017 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.605 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -87.67 0.9 55.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.086 -1.009 . . . . 0.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.781 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.6 mm? -108.65 -5.29 16.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.325 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.9 t -92.76 108.83 34.84 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.0 110.799 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 48.1 Cg_endo -77.34 176.13 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.042 1.548 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.495 ' HA ' ' HD2' ' A' ' 100' ' ' ARG . 43.5 Cg_endo -71.27 -8.96 24.51 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.747 1.393 . . . . 0.0 110.099 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -69.09 -16.75 63.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.648 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.417 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 12.3 tptp -89.1 0.72 56.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 0.0 109.376 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.495 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.264 0.554 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 21.7 p -109.77 -27.85 9.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 110.346 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.606 ' HB3' ' CD1' ' A' ' 54' ' ' TRP . 50.7 p30 -65.75 161.77 50.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.565 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -79.06 11.06 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.101 1.58 . . . . 0.0 110.98 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.808 ' HB3' HG13 ' A' ' 47' ' ' VAL . 48.8 m-85 -131.95 43.14 3.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.935 -1.103 . . . . 0.0 110.266 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.508 HD12 ' O ' ' B' ' 111' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.427 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.466 -0.628 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.567 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.2 t90 -86.78 127.35 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.871 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.778 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -43.89 -30.16 0.65 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.267 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.567 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.9 t -91.22 137.6 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -94.63 174.49 3.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HG2' ' OE2' ' A' ' 12' ' ' GLU . 37.9 Cg_endo -66.39 -32.7 40.17 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.795 1.418 . . . . 0.0 109.838 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' OE2' ' HG2' ' A' ' 11' ' ' PRO . 7.4 mm-40 -75.91 -33.47 59.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-20 -78.73 -40.5 33.38 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.5 tptp -69.63 -17.94 63.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.104 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.47 64.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.673 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.51 -20.84 49.88 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -78.05 -34.23 50.52 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.96 -12.3 59.73 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.301 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.63 -32.38 13.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.717 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.5 mt -77.69 -30.92 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.667 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -71.28 -38.47 71.82 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.605 0.717 . . . . 0.0 109.141 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t70 -91.01 -4.19 56.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 110.115 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t -79.24 -11.66 59.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 108.742 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.976 HD12 HD13 ' A' ' 31' ' ' LEU . 8.9 mt -97.68 -56.09 2.61 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 142.46 97.19 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.7 Cg_endo -74.15 147.68 38.28 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 124.259 1.663 . . . . 0.0 110.726 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.0 t -118.49 99.15 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 109.107 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.8 t30 56.78 17.04 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.408 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 106.03 33.69 3.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 75.6 m-85 -150.67 141.69 23.0 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -1.164 . . . . 0.0 112.106 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.976 HD13 HD12 ' A' ' 24' ' ' LEU . 10.3 mt -110.59 141.81 43.28 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.45 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 99.4 p -89.7 147.54 23.8 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.998 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.8 -27.37 0.55 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' SER . 64.5 t0 -66.44 -25.75 66.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -1.05 . . . . 0.0 110.145 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttt -94.06 -33.08 13.53 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.014 -1.054 . . . . 0.0 108.533 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 65' ' ' LEU . 90.8 t -82.05 -47.93 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -39.56 -53.65 4.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.637 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -66.34 -35.28 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.136 1.071 . . . . 0.0 109.468 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 24' ' ' LEU . 2.2 t -61.6 -26.67 40.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.612 -0.68 . . . . 0.0 109.207 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.996 ' HB3' HD22 ' A' ' 50' ' ' LEU . 36.5 mt -95.66 -28.54 14.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 79.2 mt -71.07 -15.11 62.51 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.86 -11.09 58.5 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.883 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.631 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.8 p -81.74 7.96 11.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.55 12.43 5.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.509 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.9 mt -88.56 156.39 50.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.953 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.9 Cg_endo -74.1 166.65 29.09 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.93 1.49 . . . . 0.0 109.386 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.834 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.5 t -66.55 -7.07 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.535 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -78.62 -31.9 47.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.185 -0.947 . . . . 0.0 109.392 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.928 HG13 HD22 ' A' ' 45' ' ' LEU . 6.9 mm -82.77 -41.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.7 mt -67.43 -29.99 69.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.34 -23.81 77.16 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 56' ' ' LEU . 24.6 ttp180 -102.16 -33.13 9.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.966 -0.726 . . . . 0.0 111.06 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.963 HG11 HG23 ' A' ' 77' ' ' VAL . 17.2 t -67.16 -41.12 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.658 -1.276 . . . . 0.0 108.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.565 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.7 t-105 -62.55 -50.9 69.49 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.551 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 19.2 mt-10 -51.52 -59.05 4.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.82 -15.13 39.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 108.712 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.739 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 34.8 m -91.05 -30.49 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.237 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.43 97.38 4.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 109.595 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.529 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 24.9 mm -71.02 -38.44 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 110.375 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 9.8 p30 -99.34 -13.39 19.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 1.8 m-70 60.48 41.45 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.851 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 6.5 p-10 -96.79 13.27 29.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 0.0 109.565 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.551 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 78.63 22.15 67.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.551 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.29 161.35 41.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.302 -1.117 . . . . 0.0 109.573 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' HA ' ' A' ' 70' ' ' PHE . 5.8 mt -121.05 116.46 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.049 -1.032 . . . . 0.0 110.272 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.573 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -76.39 172.75 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -52.8 -34.37 53.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.559 -0.713 . . . . 0.0 110.847 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 28.0 m-20 -87.15 -31.56 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 31.4 mt-10 -78.13 -38.96 42.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 108.692 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.951 ' CD2' HD12 ' A' ' 31' ' ' LEU . 42.9 t80 -63.38 -29.27 70.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -64.8 -47.51 77.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.531 -0.73 . . . . 0.0 110.154 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 94' ' ' LEU . 58.5 t -60.84 -19.26 19.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.6 -13.26 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 111.444 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 mmm -85.6 -41.84 14.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.696 -1.253 . . . . 0.0 110.553 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.812 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.4 p90 -77.57 -25.17 49.81 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 7.2 mt -70.96 -22.0 62.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.963 HG23 HG11 ' A' ' 53' ' ' VAL . 49.7 t -91.78 -61.52 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -48.88 -21.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.639 -0.663 . . . . 0.0 111.325 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLU . 20.1 m -84.66 -14.65 47.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.991 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.08 -14.19 36.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.574 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.4 mp -90.26 -38.18 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.743 0.782 . . . . 0.0 109.049 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.6 OUTLIER -69.12 -57.57 5.23 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.558 0.694 . . . . 0.0 109.483 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 2.2 tttt 177.26 -21.8 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.592 -0.692 . . . . 0.0 111.037 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 79' ' ' CYS . 8.4 mm-40 -73.16 118.81 71.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.966 -1.084 . . . . 0.0 111.091 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.87 169.67 20.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.715 1.376 . . . . 0.0 109.494 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.53 HG21 ' CG2' ' A' ' 49' ' ' ILE . 34.0 t -112.77 122.55 35.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.854 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.67 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.8 Cg_endo -86.13 171.79 7.67 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.878 1.462 . . . . 0.0 109.006 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.706 ' C ' HD21 ' A' ' 56' ' ' LEU . 35.0 mtm -106.01 17.97 22.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.0 -1.063 . . . . 0.0 110.056 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.527 ' N ' HD21 ' A' ' 56' ' ' LEU . 45.1 m -113.48 99.65 7.92 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.751 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -55.28 107.17 0.8 Allowed Pre-proline 0 C--N 1.293 -1.863 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.437 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.3 Cg_endo -65.83 159.14 50.2 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.028 1.541 . . . . 0.0 110.86 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.36 -24.76 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.098 1.578 . . . . 0.0 111.46 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.537 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -82.33 3.48 27.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.06 . . . . 0.0 109.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.812 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 4.3 mm? -108.0 -5.97 16.82 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.4 -0.813 . . . . 0.0 110.282 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 99' ' ' LYS . 51.1 t -99.98 121.89 52.52 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 110.238 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.49 170.61 15.85 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.889 1.468 . . . . 0.0 110.129 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.84 -8.23 23.14 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.452 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 t -76.07 -17.6 59.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' CE ' HG22 ' A' ' 59' ' ' ILE . 4.8 tptp -89.8 0.5 56.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.302 -0.873 . . . . 0.0 109.429 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.206 0.527 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 25.9 p -99.77 -19.91 16.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.359 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.509 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 20.8 t-20 -92.67 137.13 24.39 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.957 . . . . 0.0 110.633 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 109' ' ' ASN . 54.4 Cg_endo -85.55 12.57 3.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.07 1.563 . . . . 0.0 111.334 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.834 ' HB3' HG13 ' A' ' 47' ' ' VAL . 48.3 m-85 -126.63 -12.96 6.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.791 -1.193 . . . . 0.0 110.745 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.16 179.757 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.484 0.921 0 N-CA-C 110.599 -0.577 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.589 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 -77.48 125.31 29.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -42.99 -29.15 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.766 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 8.5 t -91.79 156.0 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.793 . . . . 0.0 109.239 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mmmt -108.72 167.39 9.25 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.878 -1.139 . . . . 0.0 110.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -69.4 -31.91 21.16 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.008 1.531 . . . . 0.0 109.811 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.85 -32.79 40.53 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.23 -34.7 49.11 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 28.6 tptp -72.46 -18.61 61.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.486 -0.759 . . . . 0.0 109.047 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.76 -42.8 60.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.0 ptpt -75.58 -25.29 56.93 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -72.96 -37.55 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.874 0.845 . . . . 0.0 108.732 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -79.5 -8.16 58.95 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.376 0.607 . . . . 0.0 110.339 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.59 -33.38 12.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 70' ' ' PHE . 75.1 mt -76.63 -33.13 21.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.74 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -66.97 -38.57 86.32 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.711 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.7 t70 -90.97 -2.57 57.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -80.91 -12.58 59.38 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.989 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -95.63 -54.36 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.65 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 6.7 p 142.55 90.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -75.14 150.94 38.28 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 124.057 1.556 . . . . 0.0 110.914 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -127.07 108.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.1 t30 57.28 21.93 7.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.996 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.438 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.08 38.91 5.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 82.6 m-85 -150.43 151.64 33.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.089 -1.242 . . . . 0.0 111.866 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.989 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.2 mt -122.17 140.61 52.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 19.3 p -90.42 141.64 28.54 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.855 -1.153 . . . . 0.0 110.343 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.558 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.28 -27.75 0.27 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -61.5 -28.29 69.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.969 . . . . 0.0 110.066 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 14.8 mttt -96.52 -32.93 12.03 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.221 -0.924 . . . . 0.0 108.816 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.755 HG11 HD12 ' A' ' 65' ' ' LEU . 92.1 t -77.03 -44.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 110.007 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 67.5 tttt -40.76 -56.75 3.64 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.7 Cg_endo -65.37 -34.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.494 1.26 . . . . 0.0 109.769 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -62.82 -35.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.792 . . . . 0.0 109.7 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.113 ' HB3' HD22 ' A' ' 50' ' ' LEU . 34.6 mt -85.37 -29.12 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.972 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.659 HD21 ' HE1' ' B' ' 111' ' ' PHE . 43.2 mt -71.6 -14.12 61.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.018 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.47 -12.34 60.0 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.755 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.981 ' O ' HD21 ' A' ' 81' ' ' LEU . 59.8 p -81.38 3.78 23.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.421 -0.799 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.3 ttmt 68.63 16.25 9.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.934 HD22 HG13 ' A' ' 49' ' ' ILE . 15.5 mt -95.66 152.91 39.45 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.001 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.575 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.5 Cg_endo -74.04 175.03 11.41 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.973 1.512 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' HD1' ' B' ' 111' ' ' PHE . 25.2 t -70.85 -7.09 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -32.24 37.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.934 HG13 HD22 ' A' ' 45' ' ' LEU . 9.8 mm -83.18 -36.86 13.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 108.742 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.113 HD22 ' HB3' ' A' ' 40' ' ' LEU . 29.5 mt -75.08 -26.48 59.36 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.24 -24.96 76.42 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.964 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.4 mtm180 -100.74 -31.68 11.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.905 -0.762 . . . . 0.0 109.897 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.029 HG11 HG23 ' A' ' 77' ' ' VAL . 5.7 t -71.1 -37.34 66.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.0 t-105 -71.11 -50.1 37.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.44 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.568 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 9.4 mm-40 -56.96 -54.65 44.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 110.221 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.964 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.9 mt -62.78 -10.91 14.62 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.426 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.755 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.8 m -98.16 -37.71 9.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.77 . . . . 0.0 110.015 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -69.01 87.07 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.953 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 43.5 mm -57.82 -28.37 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 110.395 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.59 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 51.1 p-10 -112.04 1.29 16.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.554 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 9.3 p80 39.58 51.98 2.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.341 -0.849 . . . . 0.0 110.511 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 15.4 p-10 -112.33 24.79 12.17 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 71.13 31.15 66.73 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.75 161.82 42.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -1.227 . . . . 0.0 111.466 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 HG11 ' A' ' 36' ' ' VAL . 9.9 mt -125.73 105.52 9.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.482 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.565 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 4.7 t0 -69.02 163.71 24.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.86 -1.15 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -42.63 -36.47 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.763 . . . . 0.0 110.199 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -82.75 -34.27 27.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 17.7 mt-10 -74.98 -42.6 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.877 ' CD2' HD12 ' A' ' 31' ' ' LEU . 32.6 t80 -59.84 -26.95 66.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -72.25 -51.31 21.53 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.174 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.071 HG13 HD11 ' A' ' 94' ' ' LEU . 53.7 t -55.46 -26.76 19.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.543 0.687 . . . . 0.0 109.518 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.755 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.85 -3.21 58.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.557 -0.714 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.606 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.0 mmt -90.15 -43.43 10.46 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.664 -1.273 . . . . 0.0 109.834 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.774 ' CE2' HD13 ' A' ' 94' ' ' LEU . 1.9 p90 -79.26 -19.01 51.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 4.6 mt -78.85 -23.24 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.029 HG23 HG11 ' A' ' 53' ' ' VAL . 5.8 t -90.59 -37.16 9.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.627 -0.671 . . . . 0.0 109.65 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -80.05 -24.02 40.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 56.3 m -83.22 -18.74 38.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.224 -0.922 . . . . 0.0 109.188 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.751 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.25 -15.73 59.33 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.843 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.986 HD12 ' O ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -92.31 -50.68 5.53 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.72 -0.612 . . . . 0.0 111.49 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' OE1' ' CA ' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -118.53 -2.49 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.314 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -103.99 -74.37 0.64 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.506 -1.371 . . . . 0.0 111.378 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 mt-10 -160.36 179.44 1.34 Allowed Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.993 -1.067 . . . . 0.0 110.254 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 42.8 Cg_endo -70.72 171.79 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.807 1.425 . . . . 0.0 109.836 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.05 127.06 27.16 Favored Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 110.514 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.848 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.1 Cg_endo -85.12 -170.61 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.995 1.523 . . . . 0.0 109.182 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.903 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.9 mtm -116.95 10.45 14.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.063 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.617 ' N ' HD21 ' A' ' 56' ' ' LEU . 56.7 p -114.47 98.69 7.05 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.656 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.65 HD11 ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -52.39 107.09 0.75 Allowed Pre-proline 0 C--N 1.287 -2.145 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.425 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.962 ' HG2' HD23 ' A' ' 94' ' ' LEU . 39.1 Cg_endo -66.78 146.27 77.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.643 1.338 . . . . 0.0 110.273 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.28 -5.01 14.85 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.278 1.673 . . . . 0.0 111.024 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.72 -1.89 44.58 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.071 HD11 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -145.52 36.19 1.08 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.939 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.3 t -126.66 132.27 24.25 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.968 -1.082 . . . . 0.0 110.738 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.454 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.1 Cg_endo -72.79 174.51 11.71 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.01 1.531 . . . . 0.0 110.048 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.9 Cg_endo -72.62 179.84 4.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.836 1.44 . . . . 0.0 110.695 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 77.43 -45.52 0.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.769 -0.582 . . . . 0.0 110.251 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 40.0 tptt -88.51 9.36 24.04 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 108.672 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.209 0.528 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.525 HG23 ' N ' ' B' ' 109' ' ' ASN . 9.4 t -149.55 -136.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.99 . . . . 0.0 110.213 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.568 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 43.1 t-20 -41.53 116.6 1.58 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.951 . . . . 0.0 110.283 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.77 17.39 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.949 1.499 . . . . 0.0 111.28 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.714 ' HD1' HG22 ' A' ' 47' ' ' VAL . 65.2 m-85 -139.63 31.83 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.892 -1.13 . . . . 0.0 110.283 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.156 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.933 0 N-CA-C 110.644 -0.56 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.1 t90 -58.98 125.32 23.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.712 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.31 -26.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 54.6 t -97.71 138.53 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.97 175.53 2.68 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -37.03 19.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.556 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -72.54 -25.16 61.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 109.575 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -82.79 -40.09 20.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -71.73 -17.61 62.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.8 57.91 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.63 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -74.48 -28.99 61.26 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.63 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.6 m-30 -68.02 -33.73 75.14 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 9.4 t70 -77.34 -9.32 58.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.662 -0.649 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.38 -30.76 14.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.81 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 61.5 mt -81.16 -32.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.43 -38.18 65.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.643 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.2 t70 -85.64 -1.25 56.95 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.411 0.624 . . . . 0.0 109.787 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 t -88.47 -9.33 52.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.212 -0.93 . . . . 0.0 108.895 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.102 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.4 mt -100.67 -8.09 23.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 88.31 94.75 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 46.6 Cg_endo -72.0 151.09 55.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.346 1.708 . . . . 0.0 111.022 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -121.6 97.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 22.0 t-20 63.67 14.96 8.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.858 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.82 33.26 4.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 92.0 m-85 -149.92 154.69 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.161 -1.199 . . . . 0.0 111.827 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.102 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.0 mt -120.03 159.97 23.71 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' LYS . 13.4 p -104.28 142.15 35.04 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.904 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.28 -25.22 0.71 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.4 t70 -71.86 -23.57 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.605 -0.938 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttp -93.06 -36.8 12.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 90.1 t -78.11 -40.46 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.473 0.654 . . . . 0.0 109.765 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.669 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 6.3 tttp -40.71 -55.98 4.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 111.089 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.6 -35.01 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.574 1.302 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.745 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -59.87 -36.19 65.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.039 ' HB3' HD22 ' A' ' 50' ' ' LEU . 23.2 mt -84.29 -25.73 29.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.913 . . . . 0.0 109.456 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 38' ' ' PRO . 53.9 mt -71.92 -15.31 62.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.06 -10.22 59.72 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.464 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.743 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -81.13 8.6 8.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.842 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 43' ' ' SER . 4.3 tttt 65.6 15.83 10.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.462 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.041 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.1 mt -95.91 151.25 38.22 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 110.331 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.9 Cg_endo -75.54 -178.34 4.21 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.986 1.519 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.1 t -78.53 -0.68 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.47 -32.88 20.58 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.955 HG13 HD22 ' A' ' 45' ' ' LEU . 8.3 mm -83.22 -38.6 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.039 HD22 ' HB3' ' A' ' 40' ' ' LEU . 38.6 mt -72.91 -26.3 61.37 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 109.201 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.24 -23.03 78.29 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.975 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.3 mtm180 -100.38 -32.25 10.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.885 -0.774 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.001 HG11 HG23 ' A' ' 77' ' ' VAL . 22.5 t -70.26 -36.32 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.015 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.604 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.31 -50.62 37.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mt-10 -56.82 -57.55 11.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.975 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -58.22 -16.94 15.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.48 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.014 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t -92.12 -35.87 13.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -72.97 98.36 2.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 110.217 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.524 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 49.0 mm -71.93 -28.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.005 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -112.0 -15.26 13.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 109.656 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 91.7 m-70 59.68 47.77 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.558 -0.714 . . . . 0.0 111.298 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 1.3 m-20 -98.04 26.06 5.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 108.635 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 63.4 29.77 75.57 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 31' ' ' LEU . 7.9 mtt -150.56 160.74 43.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.995 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 11.9 mt -129.48 100.68 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 69' ' ' GLU . 2.3 p30 -69.6 160.61 31.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.616 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.7 ptp85 -35.36 -43.2 0.23 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.656 -0.653 . . . . 0.0 112.032 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.47 -35.79 30.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.963 -1.085 . . . . 0.0 110.298 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 13.7 tt0 -71.15 -43.26 67.89 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.81 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 58.4 t80 -63.1 -19.58 64.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.55 -42.7 67.54 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 109.693 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HD12 ' A' ' 94' ' ' LEU . 56.3 t -62.39 -31.79 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.671 0.748 . . . . 0.0 109.722 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -87.58 0.25 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.757 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.4 mmt -89.8 -44.54 9.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.67 -1.269 . . . . 0.0 109.961 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.762 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 5.2 p90 -77.09 -22.34 52.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.2 mt -76.99 -22.95 52.35 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.461 0.648 . . . . 0.0 109.54 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.001 HG23 HG11 ' A' ' 53' ' ' VAL . 5.4 t -91.34 -38.59 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.438 -0.789 . . . . 0.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.47 -22.71 61.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.467 -0.771 . . . . 0.0 110.676 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -83.15 -16.13 47.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.167 -0.958 . . . . 0.0 109.967 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.041 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.77 -9.62 51.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.203 -0.936 . . . . 0.0 109.089 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 43' ' ' SER . 2.3 mt -90.62 -43.26 10.28 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.724 0.774 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 4.9 mm-40 -71.64 -53.04 14.92 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.068 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.7 ttpp 178.01 -27.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -63.88 115.05 15.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 110.913 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.8 165.57 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.934 1.492 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.456 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 54.7 t -115.16 120.69 36.34 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 111.037 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.453 ' O ' HD11 ' A' ' 56' ' ' LEU . 54.1 Cg_endo -84.71 -166.24 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.91 1.479 . . . . 0.0 109.55 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.952 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.41 9.02 12.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 109.794 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.568 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -99.25 116.21 30.92 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.641 -177.889 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -103.1 84.82 0.74 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.8 Cg_endo -63.73 173.37 4.69 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.496 1.464 . . . . 0.0 111.751 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.82 -12.87 33.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.213 1.638 . . . . 0.0 110.733 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.59 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -76.68 -9.16 58.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.084 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.762 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 4.1 mm? -106.42 -13.44 15.36 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.563 -0.711 . . . . 0.0 110.297 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 92' ' ' PRO . 5.3 m -83.26 134.25 46.15 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.3 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.2 Cg_endo -71.0 174.49 10.51 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.255 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 43.5 Cg_endo -69.78 -12.16 32.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.037 1.546 . . . . 0.0 110.107 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 -19.85 62.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.83 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -89.31 0.82 56.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.421 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' N ' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 110.09 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.22 0.534 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.507 ' O ' ' CZ2' ' A' ' 54' ' ' TRP . 1.1 p -54.17 -70.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.465 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 34.0 t-20 -101.48 118.88 58.96 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.426 -0.796 . . . . 0.0 109.857 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.52 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 47.6 Cg_endo -72.19 -23.96 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.89 1.468 . . . . 0.0 110.545 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.936 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 45.0 m-85 -88.9 -38.38 14.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.306 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 110.411 -0.65 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' VAL . 11.9 t90 -56.08 129.5 40.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.669 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.849 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -37.71 -30.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 13' ' ' ASP . 60.3 t -100.75 131.57 48.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.545 -0.722 . . . . 0.0 109.596 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.547 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -89.65 -179.04 1.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.95 -35.67 14.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.816 1.429 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 3.8 pt-20 -73.28 -26.78 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' HB3' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.21 -39.43 23.11 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -72.31 -13.49 61.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.69 -40.37 34.02 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.15 -23.65 43.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.473 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -78.7 -33.15 47.09 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 47.7 t0 -79.69 -7.79 58.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.682 -0.636 . . . . 0.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.27 12.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.805 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 40.2 mt -76.88 -31.51 19.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.19 -37.7 66.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.3 t70 -89.67 3.72 51.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.453 0.644 . . . . 0.0 109.71 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -5.95 53.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 108.868 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.043 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.38 -4.95 16.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 82.73 94.55 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.0 Cg_endo -73.29 148.57 43.88 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.224 1.644 . . . . 0.0 110.496 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 92.6 t -115.46 102.2 13.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.488 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 22.6 t-20 61.15 16.36 7.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.419 -0.801 . . . . 0.0 109.661 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 100.07 35.56 4.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 76.3 m-85 -150.53 143.5 24.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.923 -1.339 . . . . 0.0 112.279 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.043 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.4 mt -113.93 137.53 51.56 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' C ' ' A' ' 33' ' ' GLY . 47.3 p -83.8 140.52 32.0 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.332 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.94 -28.44 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 37.9 t0 -62.34 -23.81 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.935 . . . . 0.0 110.559 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 43.0 mttp -97.93 -35.76 10.37 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 85.1 t -75.64 -37.76 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.023 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 ttmt -45.08 -51.36 24.14 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 111.133 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 37' ' ' LYS . 41.2 Cg_endo -68.21 -33.57 24.16 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.254 1.133 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.633 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 1.8 t -61.6 -31.26 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.515 -0.741 . . . . 0.0 110.215 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.123 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.9 mt -91.69 -23.8 19.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.076 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 57.8 mt -74.77 -13.46 60.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 109.383 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 2.1 p-10 -87.07 -1.02 57.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.322 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.654 ' O ' HD22 ' A' ' 81' ' ' LEU . 5.1 p -90.58 12.69 18.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.615 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 65.93 15.63 10.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.079 -1.013 . . . . 0.0 109.925 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.078 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.7 mt -100.11 151.83 37.63 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.624 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.8 Cg_endo -76.89 172.87 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.206 1.635 . . . . 0.0 110.178 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -69.96 -4.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.659 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -82.04 -30.11 31.58 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 109.209 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.941 HG13 HD22 ' A' ' 45' ' ' LEU . 8.9 mm -85.54 -36.82 11.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.928 0.87 . . . . 0.0 108.896 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.123 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -76.85 -27.96 55.3 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.413 0.625 . . . . 0.0 109.523 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.98 -24.92 75.03 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.805 ' O ' HD12 ' A' ' 56' ' ' LEU . 17.5 ttm180 -101.05 -31.46 11.07 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.979 -0.718 . . . . 0.0 110.182 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.943 HG11 HG23 ' A' ' 77' ' ' VAL . 15.0 t -72.06 -36.77 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.9 t-105 -64.38 -51.39 63.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.743 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 1.9 mm-40 -49.09 -61.41 2.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.326 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 87' ' ' PRO . 2.6 mt -59.88 -16.58 30.25 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.858 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.772 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.7 m -90.55 -28.96 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' TRP . 27.9 t0 -76.4 101.6 5.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.788 -0.57 . . . . 0.0 109.64 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 18.3 mm -88.49 -17.23 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.562 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' OE2' ' A' ' 69' ' ' GLU . 3.3 m-20 -104.07 -10.08 18.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.411 ' ND1' ' N ' ' A' ' 61' ' ' HIS . 1.4 m-70 52.38 49.1 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 34.8 p-10 -128.46 14.14 6.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.932 -1.105 . . . . 0.0 110.177 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 79.4 32.61 37.78 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.49 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 18.6 mtp -150.8 161.07 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.188 -1.184 . . . . 0.0 110.747 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 7.7 mt -126.94 107.48 10.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -69.63 166.55 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 109.432 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.549 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.6 ptp85 -45.88 -42.17 12.23 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.139 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 63.4 m-20 -76.14 -36.63 58.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.827 . . . . 0.0 110.097 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 35.5 mt-10 -71.66 -46.34 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.997 . . . . 0.0 108.92 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.885 ' CD2' HD12 ' A' ' 31' ' ' LEU . 29.7 t80 -55.4 -30.95 61.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.44 -49.18 74.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.305 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 76' ' ' LEU . 49.6 t -58.03 -22.47 19.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.772 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.34 -8.5 50.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 111.94 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 10.3 mmm -88.8 -41.2 12.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.617 -1.302 . . . . 0.0 110.527 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.673 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.7 p90 -78.9 -29.17 44.17 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.911 -1.118 . . . . 0.0 108.189 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.66 ' HB3' HG13 ' A' ' 53' ' ' VAL . 7.6 mt -66.75 -27.12 67.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.943 HG23 HG11 ' A' ' 53' ' ' VAL . 25.6 t -90.74 -19.91 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 110.032 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.91 -24.11 22.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.373 -0.83 . . . . 0.0 109.703 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.562 ' CA ' ' HB2' ' A' ' 83' ' ' LYS . 1.5 m -84.09 -16.74 42.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.078 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -83.26 -11.48 57.73 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 108.598 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 43' ' ' SER . 10.0 mt -90.99 -41.84 10.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.77 -0.581 . . . . 0.0 110.468 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 2.2 tt0 -131.44 -3.21 3.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.439 -0.904 . . . . 0.0 112.216 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 79' ' ' CYS . 5.2 mmmt -111.42 -86.88 0.54 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.276 -1.515 . . . . 0.0 111.474 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 4.1 pt-20 -145.84 170.82 7.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.915 . . . . 0.0 110.119 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 84' ' ' GLU . 40.9 Cg_endo -68.58 -160.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.705 1.371 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.631 HG21 ' CG2' ' A' ' 53' ' ' VAL . 99.0 t -133.65 132.29 21.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.936 -1.102 . . . . 0.0 110.899 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.906 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.0 Cg_endo -84.84 176.57 6.02 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.94 1.495 . . . . 0.0 109.273 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.58 ' HG2' ' NE ' ' A' ' 52' ' ' ARG . 13.4 mtt -103.79 15.48 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.882 -1.136 . . . . 0.0 110.524 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.531 ' N ' HD21 ' A' ' 56' ' ' LEU . 25.7 m -115.9 100.62 8.12 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.238 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.653 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -55.76 108.11 1.09 Allowed Pre-proline 0 C--N 1.29 -2.014 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.464 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.668 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.9 Cg_endo -66.73 161.09 43.4 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.946 1.498 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.492 ' O ' HG22 ' A' ' 95' ' ' VAL . 45.1 Cg_endo -70.61 -21.16 29.89 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.833 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.747 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -83.96 -1.08 53.93 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.147 -0.971 . . . . 0.0 109.602 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.849 HD13 ' HB3' ' A' ' 8' ' ' ALA . 4.2 mm? -113.33 16.05 19.09 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.356 -0.84 . . . . 0.0 111.021 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 92' ' ' PRO . 3.9 m -114.74 137.9 23.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.871 -1.143 . . . . 0.0 110.993 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 40.5 Cg_endo -68.56 174.84 7.83 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.158 1.609 . . . . 0.0 110.077 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 43.9 Cg_endo -70.52 -22.78 28.1 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.938 1.494 . . . . 0.0 110.767 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.2 p -78.0 -7.63 57.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.531 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -6.7 51.19 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.366 -0.834 . . . . 0.0 109.434 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.097 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.488 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 7.9 p 51.69 47.39 24.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.581 ' ND2' ' CD2' ' B' ' 112' ' ' LEU . 0.9 OUTLIER -76.89 156.17 82.6 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.34 -0.85 . . . . 0.0 109.589 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.562 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 44.9 Cg_endo -80.96 7.19 5.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.686 1.361 . . . . 0.0 109.714 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 1.02 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 96.6 m-85 -120.65 -16.07 8.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.311 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.581 ' CD2' ' ND2' ' B' ' 109' ' ' ASN . 1.5 pp . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.991 . . . . 0.0 110.333 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.484 0.922 0 N-CA-C 110.492 -0.619 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.511 ' HA ' ' O ' ' A' ' 93' ' ' ALA . 13.1 t90 -92.34 125.76 37.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.18 -0.95 . . . . 0.0 110.398 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 94' ' ' LEU . . . -44.68 -26.82 0.42 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 44.2 t -105.61 139.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.17 -178.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.893 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -71.41 -34.73 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.849 1.447 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HG3' ' OD1' ' A' ' 13' ' ' ASP . 7.3 pt-20 -76.81 -27.88 55.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -84.7 -30.11 25.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -82.33 -19.67 38.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 0.0 109.005 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.42 -37.63 60.3 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.4 ptmt -74.27 -23.44 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.3 m-30 -76.76 -35.67 57.56 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -72.31 -10.01 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 110.387 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.37 -35.88 14.15 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.683 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -76.23 -33.68 24.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.753 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.53 -40.55 70.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 t70 -85.75 4.51 36.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.664 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -9.41 43.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.026 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.1 mt -102.86 -9.3 20.03 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 87.2 91.28 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.222 0 CA-C-O 121.542 0.687 . . . . 0.0 109.153 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 Cg_endo -74.29 150.21 41.5 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.174 1.618 . . . . 0.0 110.75 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 35.3 t -119.18 112.37 37.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 8.3 t-20 57.37 16.91 3.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 96.0 36.18 5.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.619 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.2 m-85 -147.16 146.1 29.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 112.097 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.026 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.6 mt -115.06 139.33 49.96 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -83.39 143.4 30.33 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.133 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.34 -25.93 0.87 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.8 m-20 -69.13 -22.93 63.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.641 -0.917 . . . . 0.0 110.349 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HE3' ' HG ' ' A' ' 25' ' ' SER . 65.1 mttm -94.91 -35.28 12.08 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.062 HG11 HD12 ' A' ' 65' ' ' LEU . 84.8 t -77.43 -39.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.741 0.782 . . . . 0.0 109.371 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 8.7 tttp -41.51 -55.13 5.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.715 -0.616 . . . . 0.0 110.721 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.29 -35.03 25.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.568 1.299 . . . . 0.0 110.034 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.811 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -61.38 -33.17 55.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.121 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.976 ' HB3' HD22 ' A' ' 50' ' ' LEU . 46.7 mt -87.44 -26.81 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.34 -13.72 60.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.81 . . . . 0.0 109.035 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -85.92 -10.93 54.41 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.554 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.572 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.2 m -78.18 4.84 11.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.606 -0.683 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' SER . 11.4 tttm 68.29 8.26 6.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.79 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.03 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.9 mt -92.1 155.09 43.23 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.4 Cg_endo -74.97 168.88 23.86 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.125 1.592 . . . . 0.0 109.734 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' B' ' 111' ' ' PHE . 10.3 t -68.03 -7.28 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.519 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.7 -32.47 53.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.338 -0.852 . . . . 0.0 109.313 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.874 HG21 HD13 ' A' ' 45' ' ' LEU . 10.5 mm -81.29 -40.56 18.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.976 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -69.92 -29.15 66.24 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.548 0.689 . . . . 0.0 109.373 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.21 -23.56 77.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.922 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.08 -29.86 11.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.723 -0.869 . . . . 0.0 110.211 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.831 HG11 HG23 ' A' ' 77' ' ' VAL . 22.0 t -73.86 -37.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.747 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.573 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.5 t-105 -66.57 -48.69 68.82 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.4 mt-10 -56.48 -57.33 12.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.9 mt -61.35 -15.16 33.36 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.445 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.821 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 14.2 m -94.18 -25.59 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 109.832 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.567 ' OD2' ' CE2' ' A' ' 54' ' ' TRP . 2.5 t0 -76.99 85.09 3.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.557 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 40.3 mm -61.75 -30.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.888 . . . . 0.0 110.828 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 4.8 p30 -109.9 -13.9 14.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.01 -1.056 . . . . 0.0 110.683 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.512 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 18.4 m80 60.48 46.18 9.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.5 p-10 -103.62 22.49 14.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 68.0 26.7 73.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 22.7 mtp -150.61 161.44 42.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -1.198 . . . . 0.0 110.375 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.062 HD12 HG11 ' A' ' 36' ' ' VAL . 11.5 mt -125.67 99.39 5.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 0.0 109.035 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.619 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 51.5 p30 -71.16 166.97 20.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.832 -1.167 . . . . 0.0 110.315 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.633 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -38.13 -45.39 0.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 0.0 112.149 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 31.2 t70 -74.95 -42.29 57.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.07 -1.019 . . . . 0.0 110.963 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.557 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 56.8 mt-10 -70.67 -44.45 67.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.117 -0.989 . . . . 0.0 109.02 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 13.2 t80 -57.31 -22.76 44.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -74.21 -46.91 38.89 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.76 0.791 . . . . 0.0 109.336 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.971 ' CG1' HD11 ' A' ' 94' ' ' LEU . 95.4 t -59.83 -25.17 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.437 0.637 . . . . 0.0 109.93 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.821 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.25 -6.11 55.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 111.179 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.613 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.5 mmt -85.89 -46.19 10.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 110.071 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.5 p90 -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.4 mt -66.23 -24.21 66.56 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.831 HG23 HG11 ' A' ' 53' ' ' VAL . 69.8 t -91.57 -57.8 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -49.71 -22.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.652 -0.655 . . . . 0.0 111.622 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -85.48 -11.75 53.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.842 -1.161 . . . . 0.0 110.434 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.03 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.19 -17.02 28.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.535 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.868 HD12 ' N ' ' A' ' 81' ' ' LEU . 5.6 mp -90.51 -39.74 12.41 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.338 -0.851 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -70.89 -61.05 1.91 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.809 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 8.6 tptt 177.5 68.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.715 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -177.54 107.0 0.22 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.715 -1.241 . . . . 0.0 110.825 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 40.3 Cg_endo -66.39 -178.73 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.92 1.484 . . . . 0.0 110.188 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.597 HG21 ' CG2' ' A' ' 53' ' ' VAL . 76.8 t -120.77 130.16 24.98 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 110.861 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.704 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.0 Cg_endo -86.06 -170.46 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.026 1.54 . . . . 0.0 109.796 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.659 ' C ' HD21 ' A' ' 56' ' ' LEU . 36.9 mtm -115.23 14.14 16.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.099 -1.001 . . . . 0.0 110.363 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.492 ' N ' HD21 ' A' ' 56' ' ' LEU . 22.8 m -112.29 103.46 11.6 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.815 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.744 ' CD2' HD12 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -53.34 107.92 0.97 Allowed Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 36.9 Cg_endo -64.82 143.47 80.09 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.777 1.409 . . . . 0.0 110.731 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 2.22 5.62 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.399 1.736 . . . . 0.0 111.978 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -105.55 -16.63 14.66 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.971 HD11 ' CG1' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -92.52 -16.24 26.0 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.414 0.626 . . . . 0.0 109.507 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 91' ' ' PRO . 57.8 t -74.48 139.19 74.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 110.535 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.78 172.13 15.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.043 1.549 . . . . 0.0 110.474 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.2 -17.38 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.982 1.517 . . . . 0.0 110.47 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -10.91 60.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.096 -1.003 . . . . 0.0 109.693 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -89.56 -4.78 57.72 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.421 -0.8 . . . . 0.0 109.438 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.12 0.486 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 139.16 43.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.544 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' B' ' 112' ' ' LEU . 22.5 t-20 -127.12 139.2 34.45 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 0.0 110.199 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.94 6.2 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 111.847 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.821 ' HB3' HG13 ' A' ' 47' ' ' VAL . 73.0 m-85 -125.2 -33.38 2.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.793 -1.192 . . . . 0.0 110.285 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 1.1 mp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.149 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.485 0.994 0 N-CA-C 110.22 -0.723 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.422 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.3 t90 -113.48 133.47 55.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 110.292 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.772 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -44.37 -35.01 2.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.461 -0.775 . . . . 0.0 110.952 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.1 t -86.71 159.68 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mptt -115.68 177.87 1.1 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 110.422 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.28 -34.46 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.057 1.556 . . . . 0.0 109.869 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.43 -26.77 46.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.023 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.1 m-20 -81.5 -31.76 32.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -75.95 -12.61 60.18 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -0.805 . . . . 0.0 108.987 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.37 -40.33 21.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.07 -27.33 60.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -72.1 -34.83 68.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.9 OUTLIER -73.34 -10.15 59.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.75 -0.594 . . . . 0.0 110.15 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.5 -32.05 15.72 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.646 HG22 ' CE1' ' A' ' 70' ' ' PHE 0.251 60.3 mt -82.41 -35.36 12.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.84 -37.5 70.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 14.4 t70 -88.62 1.98 54.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.39 -6.82 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 108.722 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.044 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -107.5 -8.49 16.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.692 -0.63 . . . . 0.0 109.435 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 85.38 95.67 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -72.26 147.77 48.26 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.205 1.634 . . . . 0.0 110.407 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -112.54 96.38 4.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 109.094 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 66.1 9.96 6.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.514 -0.741 . . . . 0.0 109.397 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 108.58 28.93 4.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 30.4 m-85 -140.98 141.43 34.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.251 . . . . 0.0 111.95 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.044 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.7 mt -112.61 139.59 48.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 20.9 p -92.43 144.88 24.92 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.288 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.33 -27.66 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . 54.2 m-20 -63.32 -26.23 68.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.461 -1.023 . . . . 0.0 109.972 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 16.5 mttt -95.21 -35.97 11.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.871 HG12 HD11 ' A' ' 40' ' ' LEU . 94.6 t -77.63 -48.81 23.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.233 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.64 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 31.9 tttm -35.5 -56.1 1.06 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.846 -0.534 . . . . 0.0 111.252 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.9 Cg_endo -67.02 -35.79 24.49 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.496 1.261 . . . . 0.0 110.073 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.684 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -63.28 -31.93 54.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.988 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.091 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.3 mt -89.36 -25.52 21.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.087 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD11 ' HG3' ' A' ' 37' ' ' LYS . 41.8 mt -74.73 -12.52 60.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.078 -1.014 . . . . 0.0 109.049 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -84.05 -8.04 59.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.794 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -84.54 15.32 3.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 110.217 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 21.13 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 109.996 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.6 mt -99.7 153.11 37.94 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.67 178.66 7.11 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.998 1.525 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.9 t -75.78 -2.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.331 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.83 -34.3 24.7 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.351 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.948 HG13 HD22 ' A' ' 45' ' ' LEU . 10.2 mm -80.73 -40.43 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 122.033 0.92 . . . . 0.0 108.522 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.091 HD22 ' HB3' ' A' ' 40' ' ' LEU . 32.8 mt -71.44 -27.55 63.35 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.83 -25.39 75.62 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.854 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.9 mtm-85 -101.28 -31.34 11.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.829 . . . . 0.0 109.829 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.634 HG11 ' CG2' ' A' ' 77' ' ' VAL . 7.5 t -67.7 -36.79 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.217 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.578 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -75.57 -51.63 12.45 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.809 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 41.0 mt-10 -57.7 -55.97 27.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.0 109.218 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.855 ' O ' HD11 ' A' ' 90' ' ' LEU . 13.9 mt -59.55 -16.78 27.31 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.981 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 5.0 t -94.43 -25.5 16.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.7 t0 -73.73 98.95 3.02 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.234 0.54 . . . . 0.0 109.732 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 20.9 mm -86.61 -36.78 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 110.171 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -96.87 -12.32 23.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 1.8 m-70 58.34 45.39 17.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 111.18 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 17.9 p-10 -107.22 28.91 7.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.599 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 61.24 30.37 73.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.521 ' HE2' ' HB3' ' A' ' 30' ' ' PHE . 86.7 mtp -151.96 160.21 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -1.106 . . . . 0.0 110.696 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.85 HD12 HG11 ' A' ' 36' ' ' VAL . 12.8 mt -116.1 103.82 10.94 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.547 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -68.83 156.18 38.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.868 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -35.89 -40.12 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.567 -0.708 . . . . 0.0 111.037 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 9.5 t0 -81.5 -34.46 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.154 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.547 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 18.2 mt-10 -73.91 -42.77 60.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.961 ' CD2' HD12 ' A' ' 31' ' ' LEU . 15.6 t80 -59.35 -22.49 61.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -73.7 -48.91 28.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.828 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.822 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.5 t -58.06 -27.98 32.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.361 -0.837 . . . . 0.0 109.452 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.981 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -91.5 -7.04 51.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.484 -0.76 . . . . 0.0 111.465 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.9 mmt -82.26 -50.18 9.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.688 -1.257 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.643 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 1.7 p90 -71.72 -33.91 69.14 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.822 HD12 ' O ' ' A' ' 72' ' ' VAL . 7.1 mt -58.72 -22.06 56.62 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 73' ' ' ALA . 47.0 t -91.28 -64.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -55.18 -18.87 6.55 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 59.2 m -85.19 -10.88 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.05 -1.031 . . . . 0.0 109.586 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.008 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.72 -19.7 24.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.229 -0.92 . . . . 0.0 109.184 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.876 HD12 ' N ' ' A' ' 81' ' ' LEU . 5.4 mp -90.8 -38.46 12.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.447 -0.783 . . . . 0.0 109.951 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -68.74 -61.6 1.74 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.067 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.74 35.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.157 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -140.37 107.99 6.69 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.75 -1.219 . . . . 0.0 110.864 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 43.9 Cg_endo -70.76 -166.12 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.979 1.515 . . . . 0.0 110.28 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.527 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 51.0 t -125.02 148.45 60.15 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 48.2 Cg_endo -83.11 -162.3 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.007 1.53 . . . . 0.0 109.78 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 10.2 mtp -123.26 11.64 9.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 111.582 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' LEU . 5.2 t -162.86 20.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.524 -1.36 . . . . 0.0 112.03 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.855 HD11 ' O ' ' A' ' 56' ' ' LEU . 2.5 mt 59.94 120.78 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.431 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.037 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.812 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.4 Cg_endo -67.4 170.92 12.54 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.962 1.506 . . . . 0.0 109.415 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.75 -18.68 28.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.649 1.342 . . . . 0.0 111.833 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.842 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -95.04 8.95 41.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.823 -1.173 . . . . 0.0 110.498 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.842 HD22 ' C ' ' A' ' 93' ' ' ALA . 4.6 mm? -118.95 30.87 6.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.918 -1.114 . . . . 0.0 111.628 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.48 HG13 HD13 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -136.17 146.09 54.9 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 121.078 -1.013 . . . . 0.0 109.337 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.37 172.24 6.82 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.064 1.56 . . . . 0.0 109.95 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 42.4 Cg_endo -68.93 -5.3 15.3 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.922 1.485 . . . . 0.0 110.887 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -91.62 -30.92 16.09 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.015 -1.053 . . . . 0.0 109.282 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 14.76 28.3 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.563 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 1.1 mmt85 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.475 -0.766 . . . . 0.0 110.563 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.2 0.524 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 6.3 t -115.39 -3.74 12.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.545 ' OD1' HD23 ' B' ' 112' ' ' LEU . 13.5 t-20 -126.96 138.13 32.03 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 -20.55 21.99 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.079 1.568 . . . . 0.0 110.68 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.655 ' HE2' HD12 ' A' ' 40' ' ' LEU . 80.7 m-85 -98.46 23.3 8.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.545 HD23 ' OD1' ' B' ' 109' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 109.816 -0.878 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.479 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.4 t90 -92.6 126.62 37.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.366 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -41.47 -31.22 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 110.438 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' A' ' 75' ' ' PHE . 40.7 t -87.01 157.16 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 21.7 mmtm -110.56 166.22 11.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.4 Cg_endo -68.29 -33.98 22.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.863 1.454 . . . . 0.0 109.669 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.52 -27.46 58.74 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 77.8 m-20 -81.38 -41.54 21.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 12.8 tptp -65.58 -25.21 67.31 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.068 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 -45.24 76.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.532 -0.73 . . . . 0.0 109.062 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.6 ptpt -73.53 -28.69 62.02 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 13' ' ' ASP . 8.0 m-30 -67.66 -37.62 82.64 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.71 -12.78 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.468 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.84 -30.98 15.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.823 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 26.1 mt -81.46 -32.65 11.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.23 -36.99 69.26 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t70 -89.02 1.43 55.55 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.681 -0.637 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.68 -8.32 54.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.912 . . . . 0.0 109.086 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.08 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.1 mt -107.57 -7.0 16.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 79.81 95.76 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.652 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -75.62 152.21 37.69 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.165 1.613 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.0 t -118.44 114.93 46.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 27.0 t30 57.4 18.39 4.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.208 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.37 37.95 5.76 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.0 m-85 -150.5 148.3 28.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.183 . . . . 0.0 111.902 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.08 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.0 mt -113.37 134.82 54.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.451 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 34.4 p -83.21 147.55 27.95 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.87 -26.34 1.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 32' ' ' SER . 20.6 t70 -64.45 -24.08 67.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.634 -0.921 . . . . 0.0 109.972 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.8 mttt -98.8 -32.12 11.52 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 40' ' ' LEU . 92.3 t -83.05 -46.21 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.028 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.1 tttt -41.18 -50.18 8.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 43.3 Cg_endo -69.36 -35.45 13.79 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.231 1.122 . . . . 0.0 109.243 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 t -62.43 -36.47 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.458 0.647 . . . . 0.0 109.526 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.059 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.3 mt -83.21 -21.58 33.39 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.384 -0.822 . . . . 0.0 109.65 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 38' ' ' PRO . 34.2 mt -79.04 -13.21 59.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.533 -0.73 . . . . 0.0 109.324 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 5.7 t30 -89.98 -3.77 57.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.051 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.577 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 94.6 p -86.11 16.85 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 16.06 6.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.709 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.066 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.3 mt -100.4 152.52 37.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -76.46 168.75 23.21 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.116 1.587 . . . . 0.0 110.173 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.792 HG13 ' HB3' ' B' ' 111' ' ' PHE . 9.6 t -68.7 -5.86 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.386 -0.821 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.23 -32.78 38.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.214 -0.928 . . . . 0.0 109.446 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.833 HG13 HD22 ' A' ' 45' ' ' LEU . 7.9 mm -82.47 -41.46 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.059 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.6 mt -68.09 -28.12 67.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.47 -24.57 76.68 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.835 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.8 ttm180 -101.62 -31.63 10.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.745 HG11 ' CG2' ' A' ' 77' ' ' VAL . 24.2 t -69.29 -37.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 3.8 t-105 -67.6 -51.88 44.99 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.758 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 8.6 mt-10 -51.06 -59.99 3.57 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.16 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.0 mt -62.07 -13.16 23.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.647 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 4.3 m -93.82 -27.2 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.551 -0.718 . . . . 0.0 110.147 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.3 t0 -79.25 70.67 5.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.006 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG12 ' HG2' ' A' ' 69' ' ' GLU . 46.2 mm -47.25 -33.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 12.5 m-20 -94.0 -25.41 17.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 110.122 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 25.5 m-70 64.62 45.27 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 2.7 p30 -110.89 0.62 17.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 110.549 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.579 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 96.27 18.99 29.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.579 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.73 161.86 40.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.211 -1.17 . . . . 0.0 109.889 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.655 HD12 HG11 ' A' ' 36' ' ' VAL . 15.9 mt -119.11 116.24 25.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.232 -0.918 . . . . 0.0 110.194 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 10.8 t0 -71.15 168.79 16.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 0.0 110.047 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptt180 -53.48 -37.27 62.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.933 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.0 m-20 -85.16 -29.83 24.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.097 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.555 ' OE1' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -74.4 -46.59 39.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.562 0.696 . . . . 0.0 109.166 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.823 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 50.2 t80 -59.11 -22.53 60.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.16 -50.1 62.34 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.963 0.887 . . . . 0.0 109.544 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.073 HG13 HD11 ' A' ' 94' ' ' LEU . 54.2 t -57.19 -26.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.568 0.699 . . . . 0.0 110.105 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -85.11 -7.08 59.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.788 . . . . 0.0 111.694 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.595 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 7.2 mmm -89.95 -40.4 12.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.614 -1.304 . . . . 0.0 110.233 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.856 ' CE2' HD13 ' A' ' 94' ' ' LEU . 1.9 p90 -77.24 -19.21 56.93 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.239 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.3 mt -77.54 -24.95 49.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.745 ' CG2' HG11 ' A' ' 53' ' ' VAL . 72.5 t -91.11 -34.7 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.637 -0.664 . . . . 0.0 110.133 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.411 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 1.8 m-85 -74.63 -26.09 59.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.794 . . . . 0.0 110.386 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.3 m -80.18 -15.92 55.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.066 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.13 -8.88 54.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 0.0 108.936 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.71 ' N ' HD23 ' A' ' 81' ' ' LEU . 2.5 mt -89.97 -44.85 9.6 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.787 0.803 . . . . 0.0 109.337 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.93 -52.45 24.43 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.001 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.22 -27.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.211 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 79' ' ' CYS . 1.2 mt-10 -67.18 112.2 9.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.173 -0.954 . . . . 0.0 111.143 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 42.5 Cg_endo -69.94 -176.13 1.43 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.814 1.428 . . . . 0.0 109.636 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG13 HD22 ' A' ' 76' ' ' LEU . 61.1 t -128.73 120.73 20.72 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.887 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.709 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.1 Cg_endo -84.69 -179.92 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.974 1.513 . . . . 0.0 109.122 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 43.1 mtp -105.86 11.72 31.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.509 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.4 p -110.87 104.34 12.94 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.023 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -54.89 104.99 0.47 Allowed Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.15 179.099 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' HD2' HD23 ' A' ' 94' ' ' LEU . 42.3 Cg_endo -67.85 143.98 63.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.654 1.344 . . . . 0.0 110.729 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.93 -5.58 17.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.198 1.63 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -87.39 -4.36 59.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.505 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.073 HD11 HG13 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -122.63 -1.81 8.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.655 -0.653 . . . . 0.0 109.787 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.429 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 64.8 t -93.73 135.86 24.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.39 -0.819 . . . . 0.0 110.715 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.32 162.03 42.71 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.096 1.577 . . . . 0.0 110.09 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.74 -3.32 12.43 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.894 1.47 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 t -79.85 -30.56 40.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 99' ' ' LYS . 22.3 tptt -94.02 13.82 21.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.22 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 95' ' ' VAL . 4.8 mtm180 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.436 ' O ' ' N ' ' B' ' 109' ' ' ASN . 5.2 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.225 0.536 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.51 ' O ' ' NE1' ' A' ' 54' ' ' TRP . 73.1 p -63.43 80.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 0.0 109.881 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.527 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 9.8 t-20 -114.63 123.41 32.23 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.582 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.31 -10.23 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.982 1.517 . . . . 0.0 110.758 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.792 ' HB3' HG13 ' A' ' 47' ' ' VAL . 88.8 m-85 -99.65 -32.64 10.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.171 -0.955 . . . . 0.0 110.233 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.172 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.484 0.948 0 N-CA-C 110.524 -0.606 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.586 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.4 t90 -51.79 123.73 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.237 -0.914 . . . . 0.0 110.07 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -44.82 -25.21 0.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.682 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 51.2 t -97.26 126.78 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -95.52 -178.54 0.79 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.889 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.6 Cg_endo -66.38 -37.09 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.644 1.339 . . . . 0.0 109.781 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 10' ' ' LYS . 12.7 pt-20 -66.64 -33.83 76.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.037 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 46.8 m-20 -82.86 -41.49 18.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -68.23 -15.71 63.68 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -83.67 -39.0 20.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.443 -0.785 . . . . 0.0 109.245 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -81.63 -20.77 39.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -81.35 -36.32 29.83 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.516 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 7.0 t70 -76.07 -8.64 57.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.207 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.23 -31.63 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.517 HD13 ' SD ' ' A' ' 74' ' ' MET . 33.9 mt -79.84 -34.78 15.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.759 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.91 -34.17 77.2 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t0 -91.23 -7.56 50.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.394 -0.816 . . . . 0.0 110.011 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -77.45 -14.54 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 108.792 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.084 HD12 ' CD1' ' A' ' 31' ' ' LEU . 12.7 mt -92.91 -55.38 3.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.656 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 m 140.36 97.15 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.473 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 52.5 Cg_endo -74.73 149.64 38.37 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 123.828 1.436 . . . . 0.0 110.951 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -125.76 106.05 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.2 t30 58.0 18.12 4.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.388 -0.82 . . . . 0.0 109.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 97.17 36.04 5.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 82.9 m-85 -150.78 143.74 24.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.093 -1.239 . . . . 0.0 111.969 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.084 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.0 mt -111.2 137.32 49.05 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.83 141.27 33.59 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.139 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.64 -27.53 0.33 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 24.7 t70 -64.77 -27.98 69.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -1.034 . . . . 0.0 110.319 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 77.2 mttt -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.857 ' CG1' HD11 ' A' ' 40' ' ' LEU . 77.1 t -74.97 -41.65 45.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.484 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.562 ' CG ' ' HB2' ' B' ' 110' ' ' PRO . 3.4 mtpt -36.67 -56.77 1.3 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.795 -0.566 . . . . 0.0 110.914 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -67.3 -35.5 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.919 1.483 . . . . 0.0 110.007 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.7 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -61.26 -27.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.926 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.0 mt -97.94 -33.52 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 0.0 110.432 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 37' ' ' LYS . 14.0 mt -73.11 -9.14 58.41 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.171 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -89.3 -9.01 52.15 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.882 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 1.008 ' O ' HD21 ' A' ' 81' ' ' LEU . 16.3 p -81.67 5.55 17.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.448 -0.782 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 43' ' ' SER . 6.1 ttpt 66.98 19.1 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.931 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.884 HD22 HG13 ' A' ' 49' ' ' ILE . 15.7 mt -100.36 156.47 35.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.0 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -75.44 167.98 25.48 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.123 1.591 . . . . 0.0 110.233 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.699 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.35 -8.0 7.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.346 -0.846 . . . . 0.0 109.219 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.22 -31.63 60.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.884 HG13 HD22 ' A' ' 45' ' ' LEU . 8.5 mm -83.2 -37.19 13.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.812 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.926 HD22 ' HB3' ' A' ' 40' ' ' LEU . 8.5 mt -74.19 -26.25 60.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.533 0.682 . . . . 0.0 109.371 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -69.94 -29.06 71.07 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.794 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.5 mtm180 -101.66 -31.88 10.6 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.251 -0.558 . . . . 0.0 110.462 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.75 ' CG2' HG21 ' A' ' 86' ' ' VAL . 5.6 t -64.57 -55.48 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.195 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.559 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.0 t-105 -57.87 -52.18 66.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -45.46 -66.29 0.42 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.577 0.703 . . . . 0.0 110.689 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.937 HD11 ' O ' ' A' ' 87' ' ' PRO . 3.8 mt -60.54 -16.83 41.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.953 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.0 t -89.34 -14.61 35.28 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' TRP . 2.1 t0 -93.31 83.27 4.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.507 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 31.9 mm -53.44 -38.84 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.374 -0.829 . . . . 0.0 110.804 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 4.8 p30 -103.72 -20.6 13.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 110.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.473 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 12.5 m80 67.19 42.12 2.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.4 p30 -95.67 1.05 53.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 94.25 25.12 17.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 23.2 mtp -152.76 161.79 42.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -1.204 . . . . 0.0 111.17 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 36' ' ' VAL . 21.9 mt -127.12 112.73 15.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 109.618 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.6 t70 -72.25 172.99 9.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.104 -0.998 . . . . 0.0 110.079 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.607 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.82 -41.58 64.33 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.202 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -81.15 -36.04 30.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 109.822 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 1.8 tt0 -72.02 -46.31 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.807 . . . . 0.0 108.945 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.961 ' CD2' HD12 ' A' ' 31' ' ' LEU . 16.8 t80 -59.32 -17.37 28.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -72.69 -43.66 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.835 0.826 . . . . 0.0 109.35 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.929 HG13 HD12 ' A' ' 94' ' ' LEU . 41.8 t -60.02 -26.05 34.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.498 0.666 . . . . 0.0 109.55 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.953 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.31 -6.33 55.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 111.315 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.61 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.2 mmt -83.64 -49.01 9.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.0 109.986 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.006 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 5.4 p90 -73.97 -28.48 61.51 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 72' ' ' VAL . 10.2 mt -66.28 -22.21 66.29 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.984 ' O ' HD12 ' A' ' 81' ' ' LEU . 54.5 t -91.68 -45.45 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.642 -0.661 . . . . 0.0 110.164 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -75.52 -23.37 56.69 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.573 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 88.6 m -84.3 -19.74 33.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.601 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.72 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.74 -14.27 59.65 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.008 HD21 ' O ' ' A' ' 43' ' ' SER . 1.0 OUTLIER -92.29 -51.37 5.19 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.653 -0.654 . . . . 0.0 111.377 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -118.09 -14.34 9.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.417 -0.913 . . . . 0.0 113.007 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -108.58 -86.4 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.178 -1.576 . . . . 0.0 112.071 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' CYS . 33.9 mm-40 -131.54 155.01 82.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 110.738 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.19 -159.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.223 1.644 . . . . 0.0 110.51 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.75 HG21 ' CG2' ' A' ' 53' ' ' VAL . 70.9 t -132.8 124.78 18.95 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.537 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.937 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.7 Cg_endo -84.49 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.825 1.434 . . . . 0.0 108.518 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.75 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -123.63 3.9 8.92 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.581 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.593 ' N ' HD21 ' A' ' 56' ' ' LEU . 67.5 m -110.02 97.46 6.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.789 -1.165 . . . . 0.0 112.264 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.724 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -51.4 106.2 0.62 Allowed Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.524 178.056 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.766 ' HG2' HD23 ' A' ' 94' ' ' LEU . 43.3 Cg_endo -71.91 161.97 43.31 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.044 1.549 . . . . 0.0 110.952 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.62 -13.65 22.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 124.094 1.576 . . . . 0.0 110.791 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.498 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -80.07 -5.02 55.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.214 -0.929 . . . . 0.0 109.286 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.006 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.8 mm? -102.72 -19.2 14.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.403 -0.811 . . . . 0.0 110.112 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.88 116.02 28.38 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 110.479 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 49.2 Cg_endo -78.02 176.0 10.5 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.042 1.548 . . . . 0.0 110.26 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 39.7 Cg_endo -66.47 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.876 1.461 . . . . 0.0 110.015 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -24.98 68.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -89.21 9.18 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.421 -0.8 . . . . 0.0 109.281 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.52 -0.737 . . . . 0.0 109.598 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.287 0.565 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.42 38.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.814 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 14.7 t-20 -120.85 130.83 24.67 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 110.204 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.562 ' HB2' ' CG ' ' A' ' 37' ' ' LYS . 47.8 Cg_endo -75.05 -1.47 11.27 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.837 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.699 ' O ' HG13 ' A' ' 47' ' ' VAL . 86.8 m-85 -113.67 22.67 13.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.104 -0.998 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 179.885 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.482 0.815 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.563 ' CZ3' ' HG3' ' A' ' 14' ' ' LYS . 12.2 t90 -81.44 121.51 26.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 0.0 110.019 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.586 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -40.98 -29.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 84.9 t -93.92 146.47 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.568 -0.707 . . . . 0.0 109.531 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mttp -103.56 175.27 2.3 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 110.421 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.3 -33.82 22.92 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.101 1.579 . . . . 0.0 109.708 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -75.45 -36.5 60.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.612 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -77.74 -36.36 50.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.563 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 tmtt? -72.26 -14.97 61.9 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.212 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.44 -42.35 44.33 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.621 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.18 -21.79 60.61 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CE1' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -77.79 -34.78 52.06 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.13 -8.35 56.82 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.616 . . . . 0.0 109.968 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.73 14.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.67 HG22 ' CE1' ' A' ' 70' ' ' PHE . 18.1 mt -78.29 -29.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.763 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -74.54 -32.46 62.45 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.562 0.696 . . . . 0.0 109.215 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -90.28 -5.52 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 0.0 109.866 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -82.7 -10.75 58.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.108 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.067 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.0 mt -103.15 -13.99 16.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 88.78 101.46 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.468 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.3 Cg_endo -72.53 152.2 53.9 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 124.348 1.709 . . . . 0.0 111.256 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 91.3 t -127.97 109.49 19.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.7 t-20 57.47 24.07 9.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 84.77 40.62 8.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.491 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 87.7 m-85 -152.62 153.55 33.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.255 . . . . 0.0 111.749 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.067 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.7 mt -121.8 147.15 46.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 35' ' ' LYS . 58.8 p -95.16 143.21 26.77 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.288 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.621 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.87 -26.37 0.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 16.4 t0 -67.76 -26.04 65.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 0.0 110.134 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 84.7 mttt -91.1 -36.17 14.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.942 HG21 HD12 ' A' ' 65' ' ' LEU . 68.2 t -75.76 -50.04 24.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.09 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.604 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 4.1 ttpt -34.61 -56.23 0.84 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.743 -0.598 . . . . 0.0 111.013 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -64.92 -33.51 51.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.326 1.172 . . . . 0.0 109.936 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.751 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -67.56 -29.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.731 . . . . 0.0 110.002 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.03 ' HB3' HD22 ' A' ' 50' ' ' LEU . 24.7 mt -88.55 -27.1 21.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.148 -0.97 . . . . 0.0 110.204 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 38' ' ' PRO . 19.8 mt -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -73.03 -13.77 61.28 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.611 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.555 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 1.4 p -80.25 7.4 9.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.463 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 43' ' ' SER . 14.4 tptt 64.65 8.64 4.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.0 110.561 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.062 HD13 HG21 ' A' ' 49' ' ' ILE . 17.2 mt -88.75 153.72 50.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.3 Cg_endo -73.51 176.75 8.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.696 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.838 HG22 ' HD1' ' B' ' 111' ' ' PHE . 1.9 t -71.04 -10.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.83 -32.58 57.68 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 1.062 HG21 HD13 ' A' ' 45' ' ' LEU . 8.2 mm -81.98 -38.94 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.892 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.03 HD22 ' HB3' ' A' ' 40' ' ' LEU . 26.7 mt -74.98 -29.69 60.97 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.77 -25.09 75.38 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.847 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.5 ttm180 -101.05 -34.49 9.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.007 -0.702 . . . . 0.0 110.475 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.066 HG11 ' CG2' ' A' ' 77' ' ' VAL . 15.3 t -66.46 -41.76 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.774 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.621 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.0 t-105 -65.17 -51.87 58.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.702 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.0 mm-40 -50.9 -55.46 17.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.949 -1.094 . . . . 0.0 110.01 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.929 HD21 ' C ' ' A' ' 88' ' ' MET . 2.5 mt -64.38 -12.78 46.15 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.854 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 38.5 m -94.39 -35.85 12.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.757 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' TRP . 17.3 t0 -72.26 92.9 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.569 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 8.9 mm -72.55 -33.64 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.608 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 6.7 m-20 -92.43 -4.22 54.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.439 -0.788 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 28.9 p80 38.73 54.98 1.98 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.649 . . . . 0.0 110.644 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 36.7 p-10 -125.77 18.34 7.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 108.793 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.45 32.77 45.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.7 mtp -150.86 161.79 42.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 111.578 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.942 HD12 HG21 ' A' ' 36' ' ' VAL . 25.1 mt -135.42 110.4 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.022 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 27.1 t0 -70.0 169.32 13.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.087 -1.008 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 12.1 ptt180 -49.06 -41.98 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 109.952 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.743 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -80.85 -35.92 32.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.152 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.569 ' HG3' ' CG1' ' A' ' 59' ' ' ILE . 1.7 tt0 -68.51 -55.35 12.0 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.915 0.864 . . . . 0.0 108.731 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 23.2 t80 -50.01 -24.72 2.78 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -64.58 -49.1 72.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.669 0.747 . . . . 0.0 110.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.48 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 16.8 t -56.78 -25.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.571 -0.706 . . . . 0.0 110.178 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.854 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.19 -8.37 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 112.016 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 8.7 mmm -89.87 -30.35 17.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.375 -1.453 . . . . 0.0 110.147 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -85.52 -21.14 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.981 -1.074 . . . . 0.0 109.008 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 5.1 mt -83.53 -19.53 35.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 0.0 109.561 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.066 ' CG2' HG11 ' A' ' 53' ' ' VAL . 9.8 t -92.21 -44.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.707 ' HA ' HD23 ' A' ' 81' ' ' LEU . 1.4 m-85 -70.28 -36.53 74.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 80.6 m -82.71 -8.52 59.59 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 109.58 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.59 ' CB ' ' CG2' ' A' ' 86' ' ' VAL . . . -91.61 -30.39 16.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.145 0.974 . . . . 0.0 109.174 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -90.53 -22.84 21.12 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.509 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 1.7 tp10 -72.33 -58.92 3.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.015 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.6 tttt -178.4 47.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.483 -0.761 . . . . 0.0 110.341 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 2.9 tt0 -147.76 142.01 16.22 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.94 . . . . 0.0 110.281 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.414 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 49.6 Cg_endo -78.53 152.44 26.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.042 1.548 . . . . 0.0 110.407 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.685 HG21 ' CG2' ' A' ' 49' ' ' ILE . 40.5 t -115.49 112.22 43.6 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 110.615 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.612 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -83.57 178.05 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.825 1.434 . . . . 0.0 110.025 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.929 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.42 10.03 40.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.555 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -94.82 117.27 29.87 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.817 -178.04 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.715 HD12 ' C ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -104.36 85.44 1.11 Allowed Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.652 ' HD2' HD23 ' A' ' 94' ' ' LEU . 39.8 Cg_endo -65.29 173.69 5.96 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.672 1.354 . . . . 0.0 111.094 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 42.5 Cg_endo -68.45 -6.73 18.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.228 1.646 . . . . 0.0 110.905 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.72 -13.69 59.83 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.402 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.652 HD23 ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -99.98 -10.61 21.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.3 t -89.16 129.95 46.01 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.471 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 47.5 Cg_endo -73.82 174.54 12.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.872 1.459 . . . . 0.0 110.111 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.1 Cg_endo -71.05 -8.5 23.72 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.765 1.402 . . . . 0.0 110.439 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -27.28 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.86 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.55 9.25 27.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.37 -0.832 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.412 ' O ' ' C ' ' B' ' 108' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.245 0.545 . . . . 0.0 110.125 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.412 ' C ' ' O ' ' B' ' 107' ' ' SER . 80.4 p 43.61 61.46 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.209 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.526 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 12.5 t-20 -115.46 129.18 25.33 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 110.289 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.526 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.7 Cg_endo -74.93 -7.37 19.15 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.986 1.519 . . . . 0.0 111.076 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.838 ' HD1' HG22 ' A' ' 47' ' ' VAL . 69.5 m-85 -117.35 14.29 14.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.964 -1.085 . . . . 0.0 110.329 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 27.1 mt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 7' ' ' TRP . 47.4 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 CA-C-O 121.563 0.568 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.846 ' HE1' HD22 ' A' ' 94' ' ' LEU . 12.4 t90 -41.17 121.63 1.62 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.504 -0.748 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -43.1 -24.88 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.371 -0.831 . . . . 0.0 110.007 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 41.0 t -98.41 152.9 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.841 . . . . 0.0 109.824 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -112.93 178.48 0.96 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.216 -0.927 . . . . 0.0 109.972 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.2 Cg_endo -71.78 -35.86 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.961 1.506 . . . . 0.0 109.772 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -73.21 -30.5 63.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 0.0 109.215 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -78.81 -43.79 24.52 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 13.5 tptp -65.32 -17.46 64.53 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -41.96 34.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.6 ptmt -79.27 -23.1 43.84 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.0 m-30 -75.43 -35.84 60.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 52.9 t0 -77.66 -9.04 58.76 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.46 -35.2 13.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.692 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -76.75 -32.96 21.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.742 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.5 -39.22 64.99 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.7 t70 -86.65 4.23 41.3 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.88 -10.93 37.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 108.938 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.972 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -100.57 -6.95 24.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.79 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.1 Cg_endo -76.1 152.5 35.84 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.486 1.782 . . . . 0.0 110.852 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.4 t -117.72 108.38 24.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.171 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 17.4 t30 57.96 16.22 3.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 109.644 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.88 4.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 80.5 m-85 -145.96 146.24 30.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.266 . . . . 0.0 111.959 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.972 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.7 mt -117.46 139.73 50.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 35' ' ' LYS . 79.9 p -84.42 139.91 31.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.08 -28.21 0.74 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.1 t0 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.635 -0.92 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 10.6 mttm -95.94 -33.91 12.0 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.047 HG11 HD12 ' A' ' 65' ' ' LEU . 89.7 t -76.94 -42.28 32.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.533 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.645 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 23.2 ttmt -42.34 -49.68 12.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.6 Cg_endo -69.56 -33.65 16.91 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.099 1.052 . . . . 0.0 109.44 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.773 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -63.97 -35.38 73.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.437 0.637 . . . . 0.0 109.601 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.065 ' HB3' HD22 ' A' ' 50' ' ' LEU . 25.4 mt -87.89 -23.39 23.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.396 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.2 mt -74.03 -14.44 61.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 109.18 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -85.31 -3.66 58.9 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.122 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.635 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -85.9 15.3 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.527 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.24 13.23 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -0.994 . . . . 0.0 109.757 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.069 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.7 mt -100.23 153.95 37.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 0.0 110.717 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.599 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.8 Cg_endo -78.45 -179.09 5.13 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.137 1.598 . . . . 0.0 110.12 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.815 HG22 ' HD1' ' B' ' 111' ' ' PHE . 10.8 t -78.47 -3.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -82.28 -35.5 27.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.259 -0.901 . . . . 0.0 109.439 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.774 HG13 HD22 ' A' ' 45' ' ' LEU . 9.4 mm -80.67 -38.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.065 HD22 ' HB3' ' A' ' 40' ' ' LEU . 33.9 mt -73.69 -25.99 60.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.84 -25.55 74.66 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.806 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.4 ttm180 -101.42 -31.98 10.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.98 -0.718 . . . . 0.0 110.135 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.015 HG11 HG23 ' A' ' 77' ' ' VAL . 10.0 t -71.06 -34.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.526 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.5 t-105 -67.83 -53.18 28.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.127 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 11.5 mt-10 -45.92 -58.92 3.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.025 -1.047 . . . . 0.0 110.004 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.8 mt -62.15 -18.32 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 108.61 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 1.042 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 45.9 t -87.78 -24.21 23.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t0 -102.78 72.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.715 -0.616 . . . . 0.0 109.584 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -60.62 -19.79 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.857 . . . . 0.0 110.718 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 46.9 p-10 -99.34 -18.16 17.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.919 -1.113 . . . . 0.0 109.481 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.511 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 36.0 m80 58.59 46.83 14.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.441 -0.787 . . . . 0.0 110.985 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 64' ' ' MET . 48.7 p-10 -106.37 21.03 18.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 108.777 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 64.97 32.71 85.13 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 1.9 mmt -147.59 162.15 39.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.971 . . . . 0.0 110.849 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.047 HD12 HG11 ' A' ' 36' ' ' VAL . 12.7 mt -132.26 99.55 4.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.544 -0.723 . . . . 0.0 109.339 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.2 p30 -72.31 164.77 25.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.671 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.517 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.3 ptm180 -38.76 -43.82 0.95 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 111.601 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 12.3 m-20 -80.26 -33.47 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.992 . . . . 0.0 110.347 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE1' ' HA ' ' A' ' 58' ' ' ASP . 18.3 mt-10 -76.92 -48.1 19.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -0.91 . . . . 0.0 108.852 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.917 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.0 t80 -59.33 -18.42 38.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -73.6 -54.0 9.19 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.032 0.92 . . . . 0.0 109.263 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.879 HG22 HD21 ' A' ' 94' ' ' LEU . 59.6 t -53.09 -22.66 4.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 110.039 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.14 -17.16 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 111.713 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 8.7 mmm -82.17 -42.16 19.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.363 -1.461 . . . . 0.0 110.731 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -76.93 -18.44 58.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 108.773 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 86' ' ' VAL . 7.2 mt -81.63 -24.76 36.16 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.631 0.729 . . . . 0.0 109.186 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.015 HG23 HG11 ' A' ' 53' ' ' VAL . 12.1 t -90.92 -34.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.597 -0.689 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.444 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -71.87 -29.57 64.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.383 -0.823 . . . . 0.0 110.843 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.2 m -77.97 -17.04 57.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.138 -0.976 . . . . 0.0 109.613 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.069 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.31 -5.82 58.12 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.01 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.675 ' N ' HD23 ' A' ' 81' ' ' LEU . 3.1 mt -90.36 -44.51 9.62 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.641 0.734 . . . . 0.0 109.029 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 1.7 mt-10 -70.9 -53.74 13.98 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.409 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.4 ttpt 178.41 -29.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 110.907 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 79' ' ' CYS . 2.5 mt-10 -63.07 110.11 3.17 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.639 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 42.6 Cg_endo -69.15 175.3 7.78 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.918 1.483 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.658 HG11 ' CG2' ' A' ' 53' ' ' VAL . 49.7 t -122.06 125.3 26.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 110.688 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.656 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.4 Cg_endo -85.76 -178.88 3.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.875 1.46 . . . . 0.0 108.831 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.742 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -111.88 12.98 20.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.05 -1.031 . . . . 0.0 110.324 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.8 m -105.4 104.88 14.7 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.959 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.645 HD22 ' CG2' ' A' ' 95' ' ' VAL . 1.9 mt -52.35 106.22 0.63 Allowed Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.013 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.7 Cg_endo -70.47 142.72 45.5 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.747 1.393 . . . . 0.0 110.556 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.58 -1.57 9.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.787 1.658 . . . . 0.0 111.795 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -99.82 -10.15 22.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.971 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -110.74 -14.99 13.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.554 0.692 . . . . 0.0 110.191 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.645 ' CG2' HD22 ' A' ' 90' ' ' LEU . 54.3 t -87.7 137.46 31.96 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.901 -1.124 . . . . 0.0 111.099 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.99 156.05 42.99 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.122 1.591 . . . . 0.0 110.178 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.577 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 49.2 Cg_endo -76.39 -2.34 12.53 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.981 1.516 . . . . 0.0 110.987 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.4 p -84.7 -30.9 24.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 110.186 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.78 7.32 37.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.608 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 110.096 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.202 0.525 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 13.7 t -102.35 -15.17 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.067 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.6 ' CB ' HD12 ' B' ' 112' ' ' LEU . 6.6 t-20 -46.22 148.77 1.45 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.979 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.506 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 43.7 Cg_endo -72.96 -40.67 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.843 1.444 . . . . 0.0 110.98 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.815 ' HD1' HG22 ' A' ' 47' ' ' VAL . 47.2 m-85 -67.65 -39.27 84.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.044 -1.035 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.6 HD12 ' CB ' ' B' ' 109' ' ' ASN . 4.3 mt . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.037 . . . . 0.0 110.248 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.483 0.862 0 N-CA-C 110.275 -0.702 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.57 ' CD1' ' HA ' ' A' ' 94' ' ' LEU . 10.1 t90 -47.24 126.68 9.69 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.767 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -40.42 -28.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.532 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 3.6 t -89.92 124.98 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HB2' ' CG ' ' A' ' 13' ' ' ASP . 1.5 mttm -74.91 162.7 72.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 110.674 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.42 -29.92 37.07 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.118 1.589 . . . . 0.0 108.747 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.69 -20.86 35.33 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.8 m-20 -85.24 -42.72 14.41 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 5.5 tttt -69.1 -20.44 64.07 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.533 -0.73 . . . . 0.0 109.157 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.32 -43.73 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.558 -0.714 . . . . 0.0 109.175 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.7 ptmt -73.65 -29.08 62.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.3 m-30 -67.45 -37.22 82.64 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.26 -10.4 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.685 -0.634 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.76 -31.94 14.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.748 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 28.3 mt -81.26 -28.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.807 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.8 -38.54 58.1 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.666 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.0 t0 -87.78 -0.33 56.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.66 -0.65 . . . . 0.0 109.881 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -89.73 -3.83 58.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 108.884 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.086 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -110.41 -8.94 14.63 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.0 t 83.79 98.4 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.3 Cg_endo -72.33 151.35 54.03 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.613 1.849 . . . . 0.0 110.812 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 50.2 t -122.93 104.67 14.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.7 t30 58.25 22.44 9.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 109.734 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 91.89 37.12 6.14 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 89.8 m-85 -151.16 151.62 32.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -1.182 . . . . 0.0 111.737 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.086 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.9 mt -119.0 151.36 38.35 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 35' ' ' LYS . 97.4 p -97.38 143.97 27.6 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.883 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.608 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.43 -27.65 0.16 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 1.2 m-20 -66.59 -30.59 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -1.075 . . . . 0.0 110.264 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.0 mttt -85.09 -35.79 21.59 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.871 HG11 HD12 ' A' ' 65' ' ' LEU . 55.7 t -80.06 -45.18 22.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.462 0.648 . . . . 0.0 110.316 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.644 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 5.2 tttt -40.65 -54.29 5.23 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.69 . . . . 0.0 110.789 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -67.01 -33.46 32.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.253 1.133 . . . . 0.0 109.796 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.7 -28.9 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.728 -0.607 . . . . 0.0 109.506 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.098 ' HB3' HD22 ' A' ' 50' ' ' LEU . 84.7 mt -88.05 -27.18 22.16 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 110.168 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 38' ' ' PRO . 23.9 mt -73.81 -12.76 60.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.378 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 33.0 p-10 -80.09 -5.15 55.4 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.433 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -89.69 13.94 12.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.373 -0.83 . . . . 0.0 110.598 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.51 13.63 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.895 HD22 HG13 ' A' ' 49' ' ' ILE . 16.2 mt -94.9 154.19 39.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.022 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.6 174.39 12.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.096 1.577 . . . . 0.0 110.652 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' B' ' 111' ' ' PHE . 6.8 t -71.95 -4.27 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.529 -0.732 . . . . 0.0 109.389 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.59 -35.4 27.12 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.218 -0.927 . . . . 0.0 109.449 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.895 HG13 HD22 ' A' ' 45' ' ' LEU . 7.8 mm -79.79 -38.69 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.837 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.098 HD22 ' HB3' ' A' ' 40' ' ' LEU . 27.8 mt -70.41 -27.24 64.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.389 0.614 . . . . 0.0 109.403 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.25 -24.03 76.92 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.963 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.6 ttm180 -101.54 -31.47 10.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.761 -0.846 . . . . 0.0 110.896 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.787 HG11 ' CG2' ' A' ' 77' ' ' VAL . 12.5 t -68.32 -39.36 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.965 -1.085 . . . . 0.0 109.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.64 -50.29 58.68 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.57 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 51.2 mt-10 -49.32 -56.81 8.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.056 -1.027 . . . . 0.0 109.956 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.963 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -60.48 -16.2 34.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.731 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.792 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 66.2 m -93.02 -31.27 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.463 -0.773 . . . . 0.0 109.149 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 36.0 t0 -89.58 98.39 11.74 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.78 -22.22 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 111.076 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 58.7 p-10 -90.76 -16.54 28.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 110.067 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.0 m170 66.23 42.85 2.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.371 -0.83 . . . . 0.0 110.639 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 23.3 p-10 -111.72 17.22 20.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 109.602 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 64.55 34.8 90.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 40.9 mtp -150.78 162.03 41.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.087 -1.243 . . . . 0.0 110.805 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.871 HD12 HG11 ' A' ' 36' ' ' VAL . 9.4 mt -126.22 106.27 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.735 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 2.3 t70 -69.86 172.12 8.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.29 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -51.81 -34.74 41.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 111.048 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 11.6 m-20 -86.81 -34.56 19.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.04 -1.038 . . . . 0.0 110.019 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 57' ' ' SER . 25.1 mt-10 -76.89 -38.94 52.6 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.965 ' CD2' HD12 ' A' ' 31' ' ' LEU . 38.6 t80 -63.01 -28.97 70.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.9 -51.49 64.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.995 0.902 . . . . 0.0 109.663 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.928 HG13 ' CD1' ' A' ' 94' ' ' LEU . 41.9 t -52.7 -28.03 12.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.494 0.664 . . . . 0.0 110.452 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.792 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -84.04 -13.61 52.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.319 -0.863 . . . . 0.0 111.862 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.1 mmm -85.82 -32.84 21.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.503 -1.373 . . . . 0.0 111.146 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.769 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 4.4 p90 -84.47 -18.2 36.63 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.123 . . . . 0.0 108.675 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.497 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.4 mt -83.9 -13.74 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.787 ' CG2' HG11 ' A' ' 53' ' ' VAL . 52.0 t -91.22 -47.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.49 -0.756 . . . . 0.0 110.261 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 8.2 m-85 -71.21 -29.89 65.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.279 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 31.2 t -82.09 -10.1 59.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.165 -0.959 . . . . 0.0 109.323 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 49' ' ' ILE . . . -92.38 -35.76 13.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.186 0.994 . . . . 0.0 109.02 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.576 ' CD2' ' HA ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -90.57 -18.7 24.76 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.714 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 6.3 tt0 -69.94 -60.35 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.168 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 11.0 tttp -177.1 43.2 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.582 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 mt-10 -158.51 145.59 13.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.905 . . . . 0.0 110.298 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.0 -179.71 5.26 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.842 1.443 . . . . 0.0 109.596 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 80' ' ' ALA . 92.7 t -131.22 117.28 16.84 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.963 -1.086 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.5 Cg_endo -84.47 162.09 12.78 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.869 1.457 . . . . 0.0 109.551 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.898 ' C ' HD21 ' A' ' 56' ' ' LEU . 22.4 mtm -89.99 17.2 7.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.163 -0.961 . . . . 0.0 110.117 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.579 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -98.56 114.9 27.51 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.705 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.873 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -103.18 84.76 0.74 Allowed Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.8 Cg_endo -64.57 165.48 20.37 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.776 1.409 . . . . 0.0 111.169 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.31 -6.99 20.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.437 1.756 . . . . 0.0 110.655 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.83 -15.97 61.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.118 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.928 ' CD1' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -132.47 40.26 3.3 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.897 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.706 HG22 HD11 ' A' ' 90' ' ' LEU . 72.8 t -109.53 136.92 20.22 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 110.116 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 47.4 Cg_endo -72.81 170.11 20.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.502 . . . . 0.0 110.544 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.62 -18.96 14.99 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.172 1.617 . . . . 0.0 110.559 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.26 -23.66 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.122 -0.986 . . . . 0.0 110.172 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -90.49 8.82 31.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.399 -0.813 . . . . 0.0 110.432 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.519 ' C ' ' CG2' ' B' ' 108' ' ' THR . 14.6 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.093 0.473 . . . . 0.0 110.02 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.519 ' CG2' ' C ' ' B' ' 107' ' ' SER . 0.0 OUTLIER 34.67 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.326 0.584 . . . . 0.0 110.852 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 16.1 t-20 -125.23 145.6 51.2 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 110.098 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.5 -36.6 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.918 1.483 . . . . 0.0 110.713 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.709 ' HB3' HG13 ' A' ' 47' ' ' VAL . 95.5 m-85 -71.5 -5.21 31.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.047 -1.033 . . . . 0.0 110.037 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.352 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.561 -0.592 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.54 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.6 t90 -52.7 125.72 17.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 110.016 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -43.53 -26.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.54 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 13.2 t -92.5 137.8 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -95.74 173.37 4.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -70.99 -33.77 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.219 1.642 . . . . 0.0 109.993 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -27.48 39.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.3 m-20 -79.72 -40.03 29.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 22.4 tptp -72.31 -20.77 61.44 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.472 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.32 71.11 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.0 ptpt -74.84 -30.31 61.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.636 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.7 m-30 -64.86 -40.94 95.94 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.4 -8.67 56.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.281 0.562 . . . . 0.0 110.432 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -95.33 -33.81 12.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.63 HG22 ' CE1' ' A' ' 70' ' ' PHE . 36.0 mt -79.68 -27.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.83 -39.17 57.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.7 t0 -87.36 0.02 56.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.814 -0.553 . . . . 0.0 110.05 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.96 -7.55 53.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.11 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.9 mt -105.59 -14.38 15.3 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.1 t 90.68 97.2 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.65 151.75 41.79 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.62 1.853 . . . . 0.0 110.701 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.8 t -118.13 104.68 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.57 -0.706 . . . . 0.0 109.17 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 5.0 t30 58.56 15.02 3.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.787 . . . . 0.0 109.678 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.9 32.24 3.89 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -150.07 148.92 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.966 -1.314 . . . . 0.0 112.017 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.11 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.2 mt -114.41 136.39 53.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -82.0 141.56 33.14 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.811 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.51 -27.56 0.84 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' C ' ' A' ' 32' ' ' SER . 22.4 t0 -63.66 -23.53 67.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.549 -0.971 . . . . 0.0 110.05 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 11.9 mttm -98.52 -35.64 10.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.052 HG11 HD12 ' A' ' 65' ' ' LEU . 99.2 t -76.93 -42.16 32.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.569 0.7 . . . . 0.0 110.132 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.648 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 18.6 tttt -41.63 -53.94 7.06 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 111.346 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.31 -34.99 19.78 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.433 1.228 . . . . 0.0 109.907 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.792 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -60.57 -26.14 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.847 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.066 ' HB3' HD22 ' A' ' 50' ' ' LEU . 23.9 mt -96.9 -28.66 14.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.064 -1.022 . . . . 0.0 110.274 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 62.7 mt -69.66 -17.27 63.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.629 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.36 -6.68 58.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.575 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.471 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -85.49 14.18 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 110.13 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 58.71 16.17 4.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.903 . . . . 0.0 110.2 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.037 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.9 mt -96.55 153.39 38.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 110.019 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.7 Cg_endo -76.02 176.32 10.19 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.112 1.585 . . . . 0.0 109.897 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.4 t -73.85 -3.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 46' ' ' PRO . 5.7 m-20 -81.11 -33.83 33.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.395 -0.816 . . . . 0.0 109.12 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.96 HG13 HD22 ' A' ' 45' ' ' LEU . 9.0 mm -82.73 -40.04 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.066 HD22 ' HB3' ' A' ' 40' ' ' LEU . 21.9 mt -73.32 -28.99 62.38 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.613 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -66.1 -24.24 71.71 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.659 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.47 -39.66 7.43 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.011 -0.7 . . . . 0.0 109.878 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.804 HG11 ' CG2' ' A' ' 77' ' ' VAL . 5.8 t -57.35 -45.41 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.041 -1.037 . . . . 0.0 109.751 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 58' ' ' ASP . 4.3 t-105 -63.3 -53.14 57.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.336 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 85.7 mt-10 -54.87 -48.42 72.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.313 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 52' ' ' ARG . 7.8 mt -62.4 -22.88 66.49 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.913 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 41.7 t -89.62 -30.13 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.506 0.67 . . . . 0.0 109.291 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -74.43 79.71 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -60.43 -36.44 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.011 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.2 p30 -103.49 -20.09 14.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 16.4 m80 69.41 41.8 1.26 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 2.7 p-10 -91.97 9.86 31.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.949 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 80.4 24.66 58.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 50.9 mtp -152.95 160.48 43.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 1.052 HD12 HG11 ' A' ' 36' ' ' VAL . 13.6 mt -119.28 100.5 7.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.1 p30 -69.52 159.2 33.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.064 -1.022 . . . . 0.0 110.313 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.4 ptp180 -35.77 -43.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 111.251 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 35.8 t70 -75.89 -36.46 59.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.339 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HG2' HG12 ' A' ' 59' ' ' ILE . 85.0 mt-10 -76.62 -43.11 39.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.004 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.967 ' CD2' HD12 ' A' ' 31' ' ' LEU . 22.1 t80 -59.54 -20.52 56.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.13 -49.83 22.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.939 HG13 ' CD1' ' A' ' 94' ' ' LEU . 55.8 t -58.31 -24.75 25.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.351 0.596 . . . . 0.0 110.259 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -88.27 -9.38 53.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.349 -0.845 . . . . 0.0 111.282 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 3.3 mmt -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.924 -1.11 . . . . 0.0 110.361 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.749 ' CE2' HD13 ' A' ' 94' ' ' LEU . 3.3 p90 -77.41 -26.72 51.93 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.256 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB3' HG22 ' A' ' 53' ' ' VAL . 14.3 mt -69.03 -23.02 64.02 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.804 ' CG2' HG11 ' A' ' 53' ' ' VAL . 57.6 t -92.3 -63.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.49 0.662 . . . . 0.0 109.555 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.435 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.7 m-85 -47.17 -27.93 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.554 -0.716 . . . . 0.0 111.637 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.5 m -80.65 -16.16 54.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.84 -1.162 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.037 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.3 -14.25 50.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.366 -0.833 . . . . 0.0 109.785 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.4 mp -90.33 -42.26 11.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.758 0.79 . . . . 0.0 109.345 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.23 -55.42 10.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.73 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.65 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.269 -0.894 . . . . 0.0 111.799 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 79' ' ' CYS . 13.4 tt0 -79.84 113.57 38.93 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.909 -1.12 . . . . 0.0 111.378 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.62 -171.25 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.763 1.402 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.68 HG13 ' HD2' ' A' ' 87' ' ' PRO . 72.7 t -114.48 148.48 40.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.68 ' HD2' HG13 ' A' ' 86' ' ' VAL . 48.8 Cg_endo -77.66 -162.3 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.753 1.396 . . . . 0.0 110.08 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 88' ' ' MET . 3.1 ttt -108.39 -0.72 20.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 90' ' ' LEU . 23.2 t -171.3 28.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.799 -1.188 . . . . 0.0 111.248 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.953 HD11 HG22 ' A' ' 95' ' ' VAL . 0.3 OUTLIER 46.04 123.14 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.943 0 CA-C-O 121.576 0.703 . . . . 0.0 111.494 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.754 ' O ' HD12 ' A' ' 90' ' ' LEU . 40.0 Cg_endo -66.9 164.79 28.31 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.274 1.144 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.99 -3.2 11.68 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.099 1.579 . . . . 0.0 111.478 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.14 -5.31 46.07 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.939 ' CD1' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -141.95 42.33 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.93 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.953 HG22 HD11 ' A' ' 90' ' ' LEU . 48.4 t -119.91 130.98 24.57 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 110.544 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.46 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.6 Cg_endo -69.47 174.29 9.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.867 1.457 . . . . 0.0 109.946 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 43.0 Cg_endo -69.33 176.42 6.47 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.78 1.411 . . . . 0.0 110.772 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 74.57 -49.74 0.67 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.505 -0.747 . . . . 0.0 110.134 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.3 12.65 13.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 108.634 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 2.2 ptp180 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 110.376 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -85.93 -27.67 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.452 ' OD1' ' HD2' ' B' ' 110' ' ' PRO . 48.1 t-20 -105.91 129.14 25.08 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.601 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' B' ' 109' ' ' ASN . 46.6 Cg_endo -75.88 -28.4 7.81 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.938 1.494 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.738 ' CE2' HD12 ' A' ' 40' ' ' LEU . 64.8 m-85 -86.08 -1.78 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.035 -1.041 . . . . 0.0 110.023 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.189 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.91 0 N-CA-C 110.445 -0.637 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.557 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.0 t90 -81.46 120.39 24.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 110.124 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.68 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -39.77 -29.01 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.557 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 14.4 t -92.84 128.38 44.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.485 -0.759 . . . . 0.0 109.373 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.4 mttp -84.35 164.79 41.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.107 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.64 -30.24 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.933 1.491 . . . . 0.0 109.476 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -85.13 -25.3 27.57 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.575 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -77.59 -41.72 37.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 1.5 tmtt? -69.39 -23.63 63.75 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.071 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.76 93.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -38.81 65.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.3 m-30 -60.63 -21.98 63.3 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -90.35 -12.09 38.71 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.78 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.52 -33.38 15.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 41.2 mt -78.38 -29.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.864 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.81 -39.73 50.41 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.672 0.748 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.8 t70 -86.44 1.98 49.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.583 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.24 -10.27 44.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.086 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.089 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.3 mt -105.44 -12.93 15.8 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.1 t 87.24 96.2 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -75.49 152.38 38.45 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.509 1.794 . . . . 0.0 110.933 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 26.3 t -116.65 107.8 23.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 6.9 t-20 58.76 15.13 3.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.348 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.94 32.26 4.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -144.32 149.5 36.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.0 111.859 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.089 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.8 mt -117.17 138.95 51.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 14.0 p -85.86 141.08 29.87 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.069 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.451 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.33 -26.71 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 29.1 t70 -61.25 -28.53 69.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -1.093 . . . . 0.0 109.736 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.579 ' HB3' HD13 ' A' ' 24' ' ' LEU . 46.8 mttm -94.11 -33.2 13.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.242 -0.911 . . . . 0.0 108.579 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.625 HG12 HD11 ' A' ' 40' ' ' LEU . 79.6 t -79.67 -44.3 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.463 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.595 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 25.2 tttt -40.2 -54.02 4.84 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.889 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -66.83 -36.44 23.68 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 109.683 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -59.74 -37.59 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.557 -0.714 . . . . 0.0 109.607 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.996 ' HB3' HD22 ' A' ' 50' ' ' LEU . 34.9 mt -83.89 -29.02 27.52 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.411 -0.806 . . . . 0.0 109.845 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -74.01 -12.48 60.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.399 -0.813 . . . . 0.0 109.512 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -90.27 -4.98 56.82 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.125 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.582 ' CB ' HG13 ' A' ' 77' ' ' VAL . 60.5 p -84.13 8.87 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.2 OUTLIER 66.77 7.65 5.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.09 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 1.04 HD11 ' HB3' ' A' ' 80' ' ' ALA . 18.8 mt -93.18 155.87 40.72 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.3 Cg_endo -74.55 167.78 26.33 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.204 1.634 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' B' ' 111' ' ' PHE . 17.5 t -66.63 -7.78 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.4 t0 -77.33 -30.94 54.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.831 HG13 HD22 ' A' ' 45' ' ' LEU . 9.1 mm -84.69 -36.61 11.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.974 0.892 . . . . 0.0 108.943 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.5 mt -75.51 -25.59 57.38 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -75.6 -25.03 68.63 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.1 ttm180 -100.81 -29.67 12.12 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.014 HG11 HG23 ' A' ' 77' ' ' VAL . 17.0 t -69.67 -51.03 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 1.5 t-105 -59.86 -53.63 55.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -45.43 -65.7 0.5 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.924 0.869 . . . . 0.0 110.12 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.731 HD22 ' N ' ' A' ' 90' ' ' LEU . 22.2 mt -56.76 -18.27 12.07 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.997 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.3 t -91.66 -17.29 25.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t70 -94.87 82.43 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.312 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.46 ' O ' ' CE1' ' A' ' 61' ' ' HIS . 26.5 mt -87.0 -20.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 110.892 -178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.532 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 5.8 p30 -94.52 -21.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.532 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 15.2 m80 70.86 40.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.465 -0.772 . . . . 0.0 110.673 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 32.1 p-10 -101.89 15.13 29.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 62.29 31.85 80.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 74.8 mtp -154.41 161.29 41.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.366 -1.079 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 ' OG ' ' A' ' 57' ' ' SER . 9.0 mt -116.9 101.11 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 109.344 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.5 p30 -69.67 160.85 30.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 110.339 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.511 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.8 ptt85 -33.88 -45.41 0.19 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.826 -0.546 . . . . 0.0 111.604 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 22.6 m-20 -78.1 -41.25 35.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.437 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 44.8 mt-10 -67.77 -48.1 67.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.316 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.846 ' CD2' HD12 ' A' ' 31' ' ' LEU . 10.2 t80 -57.88 -17.88 19.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -75.37 -53.73 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.431 -0.793 . . . . 0.0 109.506 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 1.04 HG13 HD11 ' A' ' 94' ' ' LEU . 55.4 t -55.39 -27.13 20.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.25 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.815 . . . . 0.0 110.816 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.5 mmt -87.15 -50.02 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.662 -1.274 . . . . 0.0 110.066 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.859 ' CE2' HD13 ' A' ' 94' ' ' LEU . 4.2 p90 -74.51 -27.71 60.67 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.51 HD22 HG22 ' A' ' 86' ' ' VAL . 7.5 mt -62.95 -30.52 71.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.014 HG23 HG11 ' A' ' 53' ' ' VAL . 18.0 t -91.17 -23.8 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.896 -0.503 . . . . 0.0 109.942 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.43 -21.29 23.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.449 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 84' ' ' GLU . 3.9 t -84.59 -18.23 36.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 1.04 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -81.34 -14.88 56.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.076 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.572 HD21 ' CD1' ' A' ' 45' ' ' LEU . 5.7 mt -90.62 -39.71 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.677 0.751 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 8.1 tp10 -69.08 -51.37 39.43 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.968 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 178.19 -24.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.261 -0.976 . . . . 0.0 112.236 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 79' ' ' CYS . 3.6 mm-40 -94.11 120.15 65.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.699 -1.251 . . . . 0.0 111.66 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.97 -157.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.937 1.493 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG13 ' HD2' ' A' ' 87' ' ' PRO . 25.5 t -118.51 147.22 41.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.652 ' HD2' HG13 ' A' ' 86' ' ' VAL . 44.6 Cg_endo -80.34 -159.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.889 1.468 . . . . 0.0 110.02 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.37 12.58 8.16 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 111.341 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.9 t -165.15 23.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.595 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.791 HD23 HD21 ' A' ' 94' ' ' LEU . 0.7 OUTLIER 55.55 115.21 0.01 OUTLIER Pre-proline 0 C--N 1.281 -2.393 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.379 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.722 ' HG2' HD23 ' A' ' 94' ' ' LEU . 41.8 Cg_endo -69.9 157.36 60.37 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.714 1.376 . . . . 0.0 109.563 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.5 -1.43 9.74 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.029 1.542 . . . . 0.0 111.208 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.35 0.42 49.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 110.0 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.04 HD11 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -150.68 38.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.558 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.34 133.27 24.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.008 -1.058 . . . . 0.0 110.21 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.42 171.7 17.16 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.043 1.549 . . . . 0.0 110.548 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.91 -169.49 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 110.244 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER 76.21 -42.42 0.44 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.495 -0.753 . . . . 0.0 110.489 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 6.34 36.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.092 -1.005 . . . . 0.0 108.491 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.432 -0.792 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.283 0.563 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.503 ' O ' ' CE2' ' A' ' 54' ' ' TRP . 35.7 p -86.74 -28.29 23.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.153 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.548 ' CG ' HD23 ' B' ' 112' ' ' LEU . 1.1 t-20 -114.43 115.59 44.53 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.505 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.5 Cg_endo -82.51 21.15 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.87 1.458 . . . . 0.0 111.056 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.916 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 78.8 m-85 -130.78 17.03 5.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.954 -1.092 . . . . 0.0 110.071 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.548 HD23 ' CG ' ' B' ' 109' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.909 -1.119 . . . . 0.0 110.102 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.464 -0.629 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.609 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 -47.47 125.83 8.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.734 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -41.59 -26.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 110.161 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 49.3 t -106.13 157.91 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.587 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mttt -108.15 170.56 5.4 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.1 Cg_endo -66.17 -32.69 42.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.665 1.35 . . . . 0.0 109.915 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.6 mt-10 -70.07 -32.03 69.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.454 -0.779 . . . . 0.0 109.402 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.4 m-20 -77.04 -40.94 44.52 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 8.2 tptm -65.3 -15.87 62.97 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.681 0.753 . . . . 0.0 109.073 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 -27.44 39.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 1.8 mtpt -90.72 -38.11 13.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.9 m-30 -66.18 -27.07 67.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 1.1 t70 -89.42 -12.72 39.45 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.06 -28.24 17.28 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.773 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.255 54.0 mt -82.91 -35.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.738 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.74 -39.44 73.31 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.751 0.786 . . . . 0.0 108.949 178.873 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -87.35 -1.65 58.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.801 -0.562 . . . . 0.0 110.121 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 8.5 t -87.0 -11.37 50.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.01 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.975 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.0 mt -100.45 -10.7 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.72 97.08 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -74.9 149.52 37.31 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.308 1.688 . . . . 0.0 110.752 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.6 t -118.13 108.83 25.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 25.5 t30 58.91 22.29 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.583 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 87.62 39.56 7.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.54 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 90.6 m-85 -151.16 154.6 37.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.305 -1.115 . . . . 0.0 111.615 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.975 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.8 mt -123.07 137.21 54.99 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.494 ' CA ' ' SD ' ' A' ' 64' ' ' MET . 1.3 p -91.62 147.32 23.09 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.954 -1.091 . . . . 0.0 110.404 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -41.72 -27.93 0.37 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 13.3 t70 -62.09 -25.72 67.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.996 . . . . 0.0 110.411 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.7 mttp -101.64 -28.41 12.52 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.04 -1.037 . . . . 0.0 108.856 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.743 ' CG1' HD12 ' A' ' 65' ' ' LEU . 91.6 t -83.81 -48.47 17.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.487 -0.758 . . . . 0.0 110.755 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.59 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 4.5 ttpp -41.53 -51.26 8.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.8 Cg_endo -67.83 -32.63 29.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.142 1.075 . . . . 0.0 109.575 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -66.92 -36.61 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.686 -0.634 . . . . 0.0 109.62 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.088 ' HB3' HD22 ' A' ' 50' ' ' LEU . 58.0 mt -82.33 -25.43 33.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.812 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 39.4 mt -74.51 -11.56 60.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.12 -10.33 57.87 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.078 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.591 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -81.71 8.91 8.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 43' ' ' SER . 1.3 ttmt 64.04 11.11 5.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 110.124 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.952 HD22 HG13 ' A' ' 49' ' ' ILE . 14.5 mt -88.84 154.14 49.99 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.016 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.4 Cg_endo -75.0 172.32 16.61 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.946 1.498 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.708 HG22 ' HD1' ' B' ' 111' ' ' PHE . 5.9 t -70.21 -5.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 109.725 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -80.73 -33.09 35.43 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.234 -0.917 . . . . 0.0 109.386 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.952 HG13 HD22 ' A' ' 45' ' ' LEU . 8.7 mm -81.5 -39.9 17.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.088 HD22 ' HB3' ' A' ' 40' ' ' LEU . 19.7 mt -70.01 -28.64 65.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.54 -24.45 75.21 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 1.003 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.9 ttm-85 -101.99 -33.99 9.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.905 -0.762 . . . . 0.0 110.888 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 1.107 HG11 ' CG2' ' A' ' 77' ' ' VAL . 22.7 t -67.84 -36.22 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.846 -1.159 . . . . 0.0 109.264 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.568 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.1 t-105 -68.32 -49.88 57.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.281 -0.967 . . . . 0.0 109.435 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.5 mt-10 -56.01 -56.33 22.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.466 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.003 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -59.38 -15.67 18.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.101 -1.0 . . . . 0.0 108.54 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.867 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 28.5 t -94.22 -30.99 14.3 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -85.42 98.22 10.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.692 -0.63 . . . . 0.0 110.08 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' A' ' 69' ' ' GLU . 3.3 mt -96.15 -21.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.917 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -95.28 -13.98 24.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 24.1 m170 61.4 44.4 9.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.415 -0.803 . . . . 0.0 110.787 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 20.8 p-10 -106.83 18.56 21.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.135 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.542 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 61.49 30.42 74.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.542 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 3.3 mmm -148.97 161.07 42.65 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.327 -1.102 . . . . 0.0 109.255 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.743 HD12 ' CG1' ' A' ' 36' ' ' VAL . 8.9 mt -111.86 107.81 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.852 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -68.21 148.99 50.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.131 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -39.57 -37.82 0.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.381 -0.824 . . . . 0.0 110.259 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -77.37 -36.62 53.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 85.9 mt-10 -73.04 -51.21 19.01 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.866 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.2 t80 -50.0 -25.94 3.82 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -69.74 -54.58 13.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.071 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.58 HG13 HD22 ' A' ' 94' ' ' LEU . 52.4 t -53.65 -22.65 6.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 109.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.867 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.24 -14.78 35.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.275 -0.89 . . . . 0.0 111.937 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.539 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.3 mmm -81.77 -41.07 21.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.411 -1.431 . . . . 0.0 110.491 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.654 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 3.4 p90 -76.79 -25.52 53.41 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.297 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.957 HD22 HG13 ' A' ' 86' ' ' VAL . 5.9 mt -72.35 -27.49 62.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.514 0.673 . . . . 0.0 109.267 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.107 ' CG2' HG11 ' A' ' 53' ' ' VAL . 33.3 t -91.59 -21.84 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.658 -0.652 . . . . 0.0 110.524 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 -22.08 22.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' GLU . 26.7 m -83.74 -17.4 41.37 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.473 -0.767 . . . . 0.0 109.481 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.917 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.11 -9.97 55.71 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.806 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.9 mt -90.86 -42.0 10.87 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.685 0.755 . . . . 0.0 109.699 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.432 ' O ' ' OE2' ' A' ' 82' ' ' GLU . 6.3 tp10 -69.67 -51.95 30.07 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.64 -0.663 . . . . 0.0 109.856 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.4 -26.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 111.441 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 79' ' ' CYS . 4.6 tt0 -76.64 110.65 12.26 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.092 -1.005 . . . . 0.0 111.017 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 40.5 Cg_endo -67.18 -176.48 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 109.997 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.957 HG13 HD22 ' A' ' 76' ' ' LEU . 12.1 t -133.06 121.74 16.98 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 111.345 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.596 ' O ' HD11 ' A' ' 56' ' ' LEU . 55.0 Cg_endo -84.8 -170.43 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 124.041 1.548 . . . . 0.0 109.564 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.699 ' C ' HD21 ' A' ' 56' ' ' LEU . 5.1 mtm -106.31 15.78 25.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 110.164 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.585 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 1.9 m -100.08 115.01 28.78 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.118 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.755 HD12 ' C ' ' A' ' 90' ' ' LEU . 0.1 OUTLIER -99.89 87.93 0.79 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.818 ' HG2' HD12 ' A' ' 94' ' ' LEU . 38.2 Cg_endo -63.81 165.36 18.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.296 1.33 . . . . 0.0 111.48 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 -10.38 27.51 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.241 1.653 . . . . 0.0 110.813 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.54 -8.0 52.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.24 -0.912 . . . . 0.0 108.64 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.818 HD12 ' HG2' ' A' ' 91' ' ' PRO . 4.3 mt -114.89 2.59 14.35 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.632 -0.668 . . . . 0.0 110.024 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.5 t -99.89 123.47 47.28 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.391 -0.818 . . . . 0.0 110.696 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 42.6 Cg_endo -68.92 167.25 23.83 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.958 1.504 . . . . 0.0 109.641 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.486 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 43.6 Cg_endo -71.32 -2.18 10.82 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.651 1.343 . . . . 0.0 110.755 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 p -102.48 -20.54 14.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.106 -0.996 . . . . 0.0 109.212 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.509 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -100.5 6.96 44.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 6.8 ptp180 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 110.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 107' ' ' SER . . . . . 0.409 ' O ' ' C ' ' B' ' 108' ' ' THR . 34.1 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.201 0.524 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 108' ' ' THR . . . . . 0.409 ' C ' ' O ' ' B' ' 107' ' ' SER . 7.3 p 41.93 38.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 0.0 110.098 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.504 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 24.6 t-20 -90.13 133.08 34.2 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.63 27.62 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.891 1.469 . . . . 0.0 111.869 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.708 ' HD1' HG22 ' A' ' 47' ' ' VAL . 62.6 m-85 -142.19 -56.97 0.45 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.726 -1.234 . . . . 0.0 110.33 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.291 -179.798 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.843 0 N-CA-C 110.289 -0.696 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.627 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -95.21 117.03 29.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.715 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -42.2 -28.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 110.463 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.66 HG13 ' HE2' ' A' ' 17' ' ' TYR . 22.9 t -96.02 112.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.601 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.551 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -88.28 -177.53 0.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.955 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -70.12 -37.44 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.748 1.394 . . . . 0.0 109.789 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.7 pt-20 -70.94 -30.22 66.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.8 m-20 -77.89 -42.44 33.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.686 ' CE ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -65.38 -33.82 76.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.28 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.48 62.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -72.31 -26.97 62.16 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' HE2' HG13 ' A' ' 9' ' ' VAL . 10.0 m-30 -74.03 -36.31 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.756 0.789 . . . . 0.0 109.147 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.9 t70 -74.69 -9.1 58.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.796 -0.565 . . . . 0.0 110.618 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.75 -32.26 13.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.668 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 72.5 mt -80.06 -31.46 13.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.761 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -72.9 -41.96 64.08 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.523 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.7 t70 -86.46 3.33 44.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 110.069 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.56 -7.49 50.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.182 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.072 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.2 mt -106.34 -8.85 17.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 83.06 92.2 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.7 Cg_endo -72.76 151.09 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.303 1.686 . . . . 0.0 111.134 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 75.3 t -122.52 104.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 67.66 22.61 8.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.387 -0.821 . . . . 0.0 108.962 -178.316 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 83.84 37.84 11.17 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 82.6 m-85 -148.7 147.27 28.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 111.513 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.072 ' CD1' HD12 ' A' ' 24' ' ' LEU . 15.5 mt -114.59 132.84 56.21 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.0 p -76.72 144.39 39.35 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.56 -27.09 0.28 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.9 t70 -66.41 -28.15 68.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.512 -0.993 . . . . 0.0 110.477 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.5 mttp -90.84 -35.74 14.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.996 -1.065 . . . . 0.0 108.223 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.812 HG11 HD12 ' A' ' 65' ' ' LEU . 94.9 t -77.66 -45.11 28.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.625 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.671 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 tttt -37.84 -54.63 2.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.708 -0.62 . . . . 0.0 110.951 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.618 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.8 Cg_endo -67.05 -34.68 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.495 1.261 . . . . 0.0 110.028 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.678 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.1 t -61.99 -27.01 41.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 110.117 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.092 ' HB3' HD22 ' A' ' 50' ' ' LEU . 24.1 mt -94.16 -29.03 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.662 HD11 ' HG3' ' A' ' 37' ' ' LYS . 8.8 mt -74.84 -15.28 60.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.92 -1.112 . . . . 0.0 108.96 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -13.57 59.66 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.944 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.581 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 27.4 p -82.87 11.7 5.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 0.0 110.326 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 12.21 4.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.0 mt -87.04 155.66 55.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.7 Cg_endo -77.4 168.95 22.03 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.026 1.54 . . . . 0.0 109.548 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -69.77 -4.34 3.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 -30.74 39.2 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.311 -0.868 . . . . 0.0 109.103 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.795 HG13 HD22 ' A' ' 45' ' ' LEU . 11.4 mm -85.35 -36.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.882 0.848 . . . . 0.0 108.884 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.092 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -77.31 -26.17 51.98 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.16 -26.91 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 1.026 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.96 -36.93 8.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 122.039 -0.683 . . . . 0.0 110.566 179.412 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 49' ' ' ILE . 6.8 t -59.73 -41.44 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.044 -1.035 . . . . 0.0 110.128 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.6 t-105 -66.98 -51.64 52.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.929 -1.107 . . . . 0.0 109.716 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.6 mt-10 -52.3 -59.92 3.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 110.481 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 1.026 HD11 ' CZ ' ' A' ' 52' ' ' ARG . 1.2 mt -59.95 -30.14 68.88 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.751 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.971 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 44.3 t -75.29 -29.76 60.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.327 -0.858 . . . . 0.0 108.809 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -70.42 62.41 0.24 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.578 -0.701 . . . . 0.0 109.54 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.518 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 43.4 mm -43.21 -33.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.992 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 1.6 m-20 -99.85 -20.7 16.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.438 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 33.0 m80 59.33 38.47 23.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.6 -1.34 44.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 99.1 20.74 17.33 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.6 mtp -153.26 161.3 42.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.593 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.812 HD12 HG11 ' A' ' 36' ' ' VAL . 12.6 mt -118.98 107.07 13.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.5 p30 -75.15 160.67 30.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.886 -1.134 . . . . 0.0 109.706 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.606 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ppt_? -36.88 -46.33 0.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.671 -0.643 . . . . 0.0 111.741 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 1.7 t70 -72.75 -38.87 67.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.096 -1.002 . . . . 0.0 110.268 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 50.7 mt-10 -71.33 -46.63 60.16 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 108.791 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.96 ' CD2' HD12 ' A' ' 31' ' ' LEU . 26.7 t80 -59.03 -18.6 36.13 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.686 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . . . -76.01 -50.57 14.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.545 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.1 t -59.89 -24.21 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.586 -0.696 . . . . 0.0 109.679 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.36 -4.99 56.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.289 -0.882 . . . . 0.0 110.877 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.578 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.5 mmt -84.44 -46.21 11.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.175 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 2.1 p90 -76.01 -29.36 58.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 72' ' ' VAL . 4.5 mt -60.42 -27.8 67.76 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' ALA . 77.2 t -92.55 -41.89 13.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.624 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.39 -29.22 59.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.355 -0.841 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 82.6 m -80.83 -11.82 59.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.799 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.96 -17.37 37.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.247 -0.908 . . . . 0.0 108.554 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.677 ' N ' HD23 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -91.19 -39.36 12.16 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.891 0.853 . . . . 0.0 109.169 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -69.91 -53.93 15.7 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.854 -0.529 . . . . 0.0 110.076 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 178.93 -25.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.57 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -77.63 110.62 13.37 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 -178.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.9 Cg_endo -75.79 -167.34 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.818 1.431 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG21 HG23 ' A' ' 49' ' ' ILE . 60.2 t -109.47 144.53 30.01 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.224 -0.922 . . . . 0.0 109.424 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HG3' ' HD3' ' A' ' 91' ' ' PRO . 45.8 Cg_endo -84.95 -155.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.994 1.523 . . . . 0.0 110.552 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 20.8 mtp -124.24 3.01 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.334 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.503 ' N ' HH22 ' A' ' 52' ' ' ARG . 1.9 t -163.62 26.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.718 -1.239 . . . . 0.0 110.81 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.653 HD22 HG13 ' A' ' 95' ' ' VAL . 0.4 OUTLIER 52.42 113.96 0.01 OUTLIER Pre-proline 0 C--N 1.286 -2.174 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.722 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.866 ' HD2' HD12 ' A' ' 94' ' ' LEU . 47.0 Cg_endo -71.7 175.04 10.16 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.685 1.36 . . . . 0.0 109.348 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 52.8 Cg_endo -81.1 -7.29 13.11 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.839 1.442 . . . . 0.0 111.96 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.722 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -84.83 12.6 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.887 -1.133 . . . . 0.0 109.126 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.175 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 39.1 mt -133.41 -24.83 1.77 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.513 -0.742 . . . . 0.0 111.244 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.653 HG13 HD22 ' A' ' 90' ' ' LEU . 4.6 m -93.67 148.86 36.16 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.505 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 43.9 Cg_endo -69.75 171.51 14.32 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.247 1.656 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' A' ' 100' ' ' ARG . 46.5 Cg_endo -72.63 -14.23 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.108 1.583 . . . . 0.0 110.971 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -74.65 -54.3 7.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.999 -1.063 . . . . 0.0 110.022 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -89.32 18.12 5.48 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.371 -0.831 . . . . 0.0 108.789 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' A' ' 97' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.618 -0.676 . . . . 0.0 110.314 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.262 0.553 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 39.9 p -94.33 27.47 2.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.997 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.515 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 18.2 t-20 -60.42 137.77 92.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.598 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -76.19 -29.36 6.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.096 1.577 . . . . 0.0 111.207 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 1.034 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 40.3 m-85 -80.9 -35.85 31.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.018 -1.051 . . . . 0.0 110.7 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.149 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 N-CA-C 110.766 -0.513 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.816 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.2 t90 -64.19 126.8 28.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.12 -28.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.145 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.473 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.8 t -99.46 127.37 52.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.602 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -83.79 175.35 4.79 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.8 Cg_endo -67.71 -34.91 23.48 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.885 1.466 . . . . 0.0 109.412 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.09 -28.11 61.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.437 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -82.21 -38.86 23.94 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 8.2 tttt -70.43 -18.46 63.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.42 -44.93 61.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.1 ptmm? -73.66 -18.24 61.05 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.637 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -83.33 -28.6 28.91 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -84.98 -9.68 57.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.695 -0.628 . . . . 0.0 110.452 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.82 -31.73 15.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 95.5 mt -80.82 -37.6 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.942 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -66.27 -33.89 76.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.52 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -90.0 -6.44 55.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.638 -0.664 . . . . 0.0 109.806 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 t -83.46 -9.77 58.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 108.93 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.819 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.7 mt -104.69 -11.53 16.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 84.37 99.59 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.017 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -76.06 152.37 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.149 1.605 . . . . 0.0 110.727 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 51.0 t -121.52 106.65 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.088 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 19.8 t-20 60.62 17.58 7.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.296 -0.877 . . . . 0.0 109.306 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 95.43 36.02 5.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 81.8 m-85 -150.38 144.42 25.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 111.964 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.822 HD12 ' CD1' ' A' ' 70' ' ' PHE . 8.6 mt -109.07 143.33 38.54 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.458 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 60.3 p -92.01 144.6 25.28 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.293 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -42.9 -26.21 0.43 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -69.8 -23.85 63.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.939 . . . . 0.0 110.383 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 12.9 mttp -93.69 -35.01 13.03 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 40' ' ' LEU . 95.7 t -75.94 -39.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.967 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.571 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -39.82 -56.65 3.0 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.233 -0.917 . . . . 0.0 110.95 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.3 Cg_endo -65.92 -32.85 44.29 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.675 1.355 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.882 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.6 t -65.18 -30.04 49.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.921 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 1.059 HD12 ' CZ ' ' B' ' 111' ' ' PHE . 22.5 mt -93.05 -36.24 12.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 37' ' ' LYS . 6.6 mt -70.88 -14.18 62.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.109 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -78.81 -13.93 59.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.459 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.715 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -79.18 6.15 10.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.648 -0.658 . . . . 0.0 110.263 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.2 ttpt 67.39 15.7 9.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.973 HD22 HG13 ' A' ' 49' ' ' ILE . 16.1 mt -96.7 154.38 38.43 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.6 178.92 6.96 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 109.957 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -75.35 -1.96 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' OD1' HD13 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -84.44 -32.84 23.85 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.231 -0.918 . . . . 0.0 109.326 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.973 HG13 HD22 ' A' ' 45' ' ' LEU . 8.2 mm -84.85 -35.77 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.989 0.9 . . . . 0.0 108.735 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 1.057 HD22 ' HB3' ' A' ' 40' ' ' LEU . 25.3 mt -79.76 -23.37 42.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.618 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.07 -24.78 75.12 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.933 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -101.28 -30.55 11.45 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.85 -0.794 . . . . 0.0 110.087 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.946 HG11 HG23 ' A' ' 77' ' ' VAL . 24.6 t -69.25 -38.47 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.228 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.583 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.8 t-105 -65.93 -50.79 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.08 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.7 mt-10 -56.84 -57.45 12.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.292 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -59.87 -15.13 18.87 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.042 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.961 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 30.3 t -94.78 -36.76 11.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' OD1' ' CE2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -74.65 89.75 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 111.01 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.901 HG23 ' HG3' ' A' ' 99' ' ' LYS . 15.7 mm -60.74 -32.24 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.13 -0.981 . . . . 0.0 109.384 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.0 109.693 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 30.1 p80 40.74 40.54 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.424 0.63 . . . . 0.0 110.57 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.51 0.43 57.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.323 -0.86 . . . . 0.0 109.042 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.56 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 101.62 18.85 17.27 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.56 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.5 mmm -146.89 160.85 41.81 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.148 -1.207 . . . . 0.0 109.818 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.648 HD12 HG11 ' A' ' 36' ' ' VAL . 12.4 mt -120.05 110.3 16.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.222 -0.924 . . . . 0.0 110.036 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 9.1 t70 -69.38 169.56 12.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.116 -0.99 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.4 ptm180 -51.31 -40.34 58.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 3.1 t70 -81.11 -28.85 35.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.252 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 4.8 tt0 -74.51 -44.74 49.9 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.617 0.723 . . . . 0.0 109.198 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.882 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 44.2 t80 -62.6 -18.56 62.43 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.37 -49.05 24.32 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.938 0.875 . . . . 0.0 109.145 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.989 ' CG1' HD11 ' A' ' 94' ' ' LEU . 30.2 t -55.6 -30.75 27.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.469 0.652 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.961 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.09 -4.32 57.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.795 . . . . 0.0 111.759 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.604 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmt -85.39 -44.18 13.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.642 -1.287 . . . . 0.0 109.984 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 6.2 p90 -79.19 -23.13 44.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.652 ' HB3' HG13 ' A' ' 53' ' ' VAL . 4.3 mt -72.75 -25.41 61.19 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.946 HG23 HG11 ' A' ' 53' ' ' VAL . 44.6 t -89.93 -44.75 15.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TYR . . . . . 0.474 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 1.4 m-85 -69.5 -27.86 65.55 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.04 -15.16 58.61 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.042 -1.036 . . . . 0.0 109.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.71 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -91.05 -9.61 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.841 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.3 mt -90.03 -34.44 15.95 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.71 0.767 . . . . 0.0 109.227 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -68.36 -60.06 2.73 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.385 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 176.73 70.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.352 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.2 mt-10 -172.79 136.05 0.77 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 111.392 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -77.92 -171.59 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.796 1.419 . . . . 0.0 110.189 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 52' ' ' ARG . 43.7 t -130.47 131.65 23.49 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.72 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.909 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.1 Cg_endo -82.91 -168.64 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.767 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -119.63 13.93 12.58 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.625 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.684 ' N ' HD21 ' A' ' 56' ' ' LEU . 19.9 m -115.31 97.63 6.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.92 HD11 HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -59.48 109.01 1.6 Allowed Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.851 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 38.9 Cg_endo -65.3 150.65 87.06 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.826 1.435 . . . . 0.0 111.966 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.33 -10.64 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.415 1.745 . . . . 0.0 111.406 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.68 -21.3 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.107 -0.996 . . . . 0.0 108.445 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.989 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -103.32 -5.47 22.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.92 HG23 HD11 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -93.01 144.6 28.65 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 0.0 110.938 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 95' ' ' VAL . 47.4 Cg_endo -75.85 174.94 11.97 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 124.24 1.653 . . . . 0.0 110.407 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 47.4 Cg_endo -72.89 -11.04 25.42 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.966 1.509 . . . . 0.0 110.59 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.8 m -77.13 -19.99 56.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 0.0 109.535 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.901 ' HG3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -88.96 2.13 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.487 -0.758 . . . . 0.0 109.531 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 179.828 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 25.0 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.231 0.539 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 57.3 p -62.1 -69.17 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' B' ' 112' ' ' LEU . 20.3 t-20 -94.09 131.66 31.1 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.481 -0.762 . . . . 0.0 110.029 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.582 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 47.5 Cg_endo -73.8 -25.46 14.49 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.953 1.502 . . . . 0.0 110.982 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 1.059 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 71.5 m-85 -82.35 -46.72 13.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.992 -1.067 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.41 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.717 -0.532 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.496 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -51.29 130.17 26.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.663 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.04 -26.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG22 ' CD2' ' A' ' 75' ' ' PHE . 44.0 t -95.79 155.0 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.621 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -90.17 163.96 29.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 109.923 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.64 -30.17 23.24 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.011 1.532 . . . . 0.0 109.683 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.3 mt-10 -86.68 -18.63 30.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.475 0.655 . . . . 0.0 109.462 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.577 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 3.6 m-20 -79.94 -43.98 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 71' ' ' ALA . 7.2 tptp -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.72 74.92 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -78.04 -44.54 26.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 6.2 m-30 -54.73 -24.65 23.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.3 -14.57 40.5 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.527 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.87 -29.69 15.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.252 51.1 mt -80.03 -32.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 177.846 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.69 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.639 0.733 . . . . 0.0 109.204 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -90.41 -8.56 50.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.71 -0.619 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -13.72 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 108.867 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 1.003 HD12 ' CD1' ' A' ' 31' ' ' LEU . 10.9 mt -93.68 -54.53 3.6 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.66 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 m 137.54 96.41 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.479 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -71.45 146.59 50.4 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 123.948 1.499 . . . . 0.0 110.541 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 20.8 t -116.76 97.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 1.5 t30 60.56 11.32 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 110.79 33.49 2.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 82.3 m-85 -150.68 150.04 30.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.181 -1.188 . . . . 0.0 112.228 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 1.003 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.0 mt -117.28 136.08 53.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 34' ' ' ASP . 91.0 p -85.2 141.32 30.23 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.261 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.45 -27.93 0.17 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -62.43 -26.61 68.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -1.034 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 53.2 mttt -96.53 -31.81 12.59 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.106 -0.996 . . . . 0.0 108.481 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 65' ' ' LEU . 99.0 t -82.36 -46.88 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.208 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.625 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -42.79 -53.74 9.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.75 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -65.81 -34.03 41.46 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 109.288 -1.081 . . . . 0.0 109.288 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.47 -30.43 49.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.493 0.663 . . . . 0.0 109.54 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.997 ' HB3' HD22 ' A' ' 50' ' ' LEU . 88.4 mt -86.72 -24.45 25.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.439 -0.788 . . . . 0.0 110.31 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD1' ' HD3' ' A' ' 37' ' ' LYS . 19.4 mt -79.31 -13.57 59.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.54 -6.88 58.77 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.829 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.06 12.1 6.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 109.934 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 64.71 17.77 11.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 109.98 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.904 HD22 HG13 ' A' ' 49' ' ' ILE . 15.1 mt -100.38 149.78 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.446 -0.784 . . . . 0.0 110.627 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.8 Cg_endo -75.88 175.34 11.44 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.059 1.557 . . . . 0.0 109.97 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.79 HG22 ' HD1' ' B' ' 111' ' ' PHE . 2.4 t -72.39 -2.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.25 -32.11 24.62 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.268 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.904 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -84.35 -36.5 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.997 HD22 ' HB3' ' A' ' 40' ' ' LEU . 20.1 mt -75.62 -27.35 58.42 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.69 -24.06 75.37 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.826 ' O ' HD12 ' A' ' 56' ' ' LEU . 5.7 ttm105 -101.16 -33.96 9.89 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.942 -0.74 . . . . 0.0 109.935 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 HG23 ' A' ' 77' ' ' VAL . 38.0 t -69.26 -44.29 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.954 -1.091 . . . . 0.0 109.418 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 2.0 t-105 -60.78 -45.99 92.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.322 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 4.7 mm-40 -58.41 -55.81 30.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.243 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.8 mt -62.36 -14.42 39.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 108.575 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.932 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.4 t -95.14 -29.52 14.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.348 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.58 82.15 4.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.097 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.482 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 38.3 mm -57.89 -35.41 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 15.8 m-20 -96.84 -18.76 19.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 86.5 m-70 57.34 48.82 14.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.988 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -115.58 23.89 12.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 72.98 27.83 67.92 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.0 mtt -151.17 160.94 43.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.741 HD12 HG11 ' A' ' 36' ' ' VAL . 10.9 mt -125.75 110.03 13.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.922 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.5 t70 -69.55 168.51 14.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.0 109.357 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.3 ptt180 -50.74 -39.47 52.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.523 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 37.7 m-20 -79.78 -33.08 40.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.228 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 33.5 mt-10 -73.53 -42.99 61.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.884 ' CD2' HD12 ' A' ' 31' ' ' LEU . 35.9 t80 -58.62 -27.38 64.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.567 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . . . -66.89 -46.86 73.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 110.092 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.946 HG13 HD11 ' A' ' 94' ' ' LEU . 61.6 t -58.62 -25.67 29.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.611 0.72 . . . . 0.0 109.86 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.67 -9.0 51.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.818 . . . . 0.0 112.186 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 4.4 mmm -85.47 -44.1 13.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.602 -1.311 . . . . 0.0 110.386 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.573 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -76.67 -26.83 55.24 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.31 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.573 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.3 mt -69.41 -23.99 63.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.848 HG23 HG11 ' A' ' 53' ' ' VAL . 61.8 t -91.4 -46.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.807 -0.558 . . . . 0.0 109.626 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.33 -28.71 68.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.7 -0.625 . . . . 0.0 110.908 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 5.9 t -80.45 -14.96 57.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.171 -0.956 . . . . 0.0 109.969 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.34 -8.43 50.78 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.068 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.806 ' N ' HD23 ' A' ' 81' ' ' LEU . 1.3 mt -90.75 -44.62 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.585 -0.697 . . . . 0.0 109.933 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -72.34 -54.39 9.61 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.344 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 174.48 78.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.134 -0.979 . . . . 0.0 111.29 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -174.1 121.64 0.38 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.45 -1.406 . . . . 0.0 111.325 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.84 168.57 24.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.914 1.481 . . . . 0.0 110.161 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 0.523 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 69.6 t -124.7 127.72 25.1 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 110.98 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.724 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.5 Cg_endo -86.76 157.11 8.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.939 1.494 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.737 ' C ' HD21 ' A' ' 56' ' ' LEU . 1.3 mmt -84.77 14.32 4.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.906 -1.121 . . . . 0.0 110.462 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.556 ' N ' HD21 ' A' ' 56' ' ' LEU . 10.8 m -111.87 103.63 11.89 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.88 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.732 HD12 HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.57 108.69 2.31 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.76 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 89' ' ' SER . 39.2 Cg_endo -64.21 149.39 90.37 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.748 1.394 . . . . 0.0 111.553 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.14 -9.46 24.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.347 1.709 . . . . 0.0 110.957 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -92.45 20.59 6.06 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.946 HD11 HG13 ' A' ' 72' ' ' VAL 0.252 0.2 OUTLIER -138.75 3.47 2.27 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.481 0.658 . . . . 0.0 109.879 -178.014 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.663 HG22 HD11 ' A' ' 90' ' ' LEU . 16.9 t -93.28 115.7 65.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 49.6 Cg_endo -77.96 173.14 14.45 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.938 1.494 . . . . 0.0 110.115 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 44.8 Cg_endo -71.49 92.06 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.021 1.537 . . . . 0.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t -154.37 -42.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -89.48 5.26 46.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 2.1 mmt85 . . . . . 0 N--CA 1.491 1.623 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.433 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -139.18 6.64 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' A' ' 55' ' ' GLU . 42.9 t-20 -122.89 128.63 25.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.574 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -75.88 9.74 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.832 1.438 . . . . 0.0 111.632 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.79 ' HD1' HG22 ' A' ' 47' ' ' VAL . 98.9 m-85 -132.42 41.51 3.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.778 -1.201 . . . . 0.0 110.366 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.504 -0.614 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.0 t90 -74.27 124.71 26.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.869 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 1.033 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -38.33 -30.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.695 -0.628 . . . . 0.0 110.789 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 46.3 t -101.23 134.92 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.777 . . . . 0.0 110.055 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -91.79 -179.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.385 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.7 Cg_endo -69.47 -36.47 11.53 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.941 1.495 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.77 -27.12 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 109.957 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 13.0 m-20 -80.93 -38.12 28.38 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.242 -0.911 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 2.2 tttt -77.13 -21.27 54.44 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.948 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -66.92 -39.35 87.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.72 -24.47 58.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 12.3 m-30 -76.96 -32.2 57.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -11.7 60.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.682 -0.636 . . . . 0.0 110.029 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.6 -31.61 17.49 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.655 HG22 ' CE1' ' A' ' 70' ' ' PHE . 25.6 mt -81.47 -37.0 15.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.758 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.26 -34.71 76.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.8 t0 -90.49 -4.63 56.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.626 -0.672 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 25.8 t -85.99 -4.91 59.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -0.97 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.874 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.47 -14.96 14.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.1 t 91.22 101.24 0.02 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.237 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -76.03 154.19 37.55 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.416 1.745 . . . . 0.0 110.607 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 94.3 t -122.6 102.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.497 -0.752 . . . . 0.0 109.306 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.4 t30 58.06 18.65 5.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 100.91 36.46 3.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 29' ' ' GLY . 86.9 m-85 -153.28 145.44 23.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.848 -1.384 . . . . 0.0 112.003 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.898 HD12 ' CD2' ' A' ' 70' ' ' PHE . 10.1 mt -113.65 138.47 50.15 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.5 p -88.64 146.86 24.85 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.21 -26.11 0.32 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 32' ' ' SER . 56.9 m-20 -63.82 -26.13 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -1.024 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.7 mttt -96.17 -35.75 11.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.091 -1.006 . . . . 0.0 108.507 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.914 HG11 HD12 ' A' ' 65' ' ' LEU . 63.0 t -79.18 -41.35 22.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.156 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 3.1 ttpt -41.31 -55.39 5.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.652 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.3 Cg_endo -67.85 -34.72 23.21 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.559 1.294 . . . . 0.0 109.935 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.861 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.1 t -59.71 -34.16 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 109.839 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.966 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.5 mt -88.77 -27.25 21.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.804 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 61.1 mt -71.99 -12.26 61.16 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 109.128 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -87.72 -4.52 58.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.989 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' HD22 ' A' ' 81' ' ' LEU . 1.2 m -86.04 8.62 19.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 13.14 4.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.095 -1.003 . . . . 0.0 109.747 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.996 HD13 HG21 ' A' ' 49' ' ' ILE . 16.9 mt -95.56 156.42 37.51 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HG2' HG12 ' A' ' 49' ' ' ILE . 43.9 Cg_endo -73.26 167.64 26.81 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 124.141 1.6 . . . . 0.0 109.888 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.642 HG22 ' HD1' ' B' ' 111' ' ' PHE . 1.2 t -65.11 -9.32 7.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.263 -0.898 . . . . 0.0 109.321 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.3 m-20 -76.58 -30.46 57.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.344 -0.848 . . . . 0.0 109.214 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.996 HG21 HD13 ' A' ' 45' ' ' LEU . 13.4 mm -84.58 -38.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 122.002 0.906 . . . . 0.0 108.78 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.966 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.6 mt -78.5 -26.86 46.04 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.57 0.7 . . . . 0.0 109.252 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -81.18 -24.21 57.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 1.079 ' NH2' HG12 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -101.24 -26.16 13.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.147 -0.619 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.794 HG11 HG23 ' A' ' 77' ' ' VAL . 12.6 t -75.77 -43.23 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.774 -1.204 . . . . 0.0 107.869 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' CD1' ' C ' ' A' ' 54' ' ' TRP . 1.5 t-105 -55.28 -49.04 73.12 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.442 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.0 mm-40 -53.75 -54.89 31.77 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 0.0 109.781 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 90' ' ' LEU . 8.2 mt -61.37 -15.85 40.48 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 108.718 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.832 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 31.8 m -94.07 -38.96 10.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.583 -0.698 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 54' ' ' TRP . 4.8 t0 -60.94 100.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 110.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.531 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -83.48 -20.82 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 19.5 m-20 -105.35 -16.31 14.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.438 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' HIS . . . . . 0.414 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 5.7 m-70 60.57 43.84 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.973 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 10.5 p30 -112.84 -6.82 13.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.527 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.549 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 100.95 23.39 9.88 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' MET . . . . . 0.549 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.0 mmm -147.57 161.16 41.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.222 -1.164 . . . . 0.0 109.374 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.914 HD12 HG11 ' A' ' 36' ' ' VAL . 7.9 mt -121.36 107.76 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.083 -1.011 . . . . 0.0 110.325 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 61.0 t0 -69.61 169.29 13.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.96 -1.088 . . . . 0.0 110.114 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.1 ptt180 -50.56 -37.83 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.505 -0.747 . . . . 0.0 109.976 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' OD2' ' HG3' ' A' ' 67' ' ' ARG . 9.2 m-20 -78.65 -32.86 47.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.64 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 39.3 mt-10 -76.71 -41.64 44.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.349 -0.844 . . . . 0.0 109.045 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' PHE . . . . . 0.898 ' CD2' HD12 ' A' ' 31' ' ' LEU . 9.3 t80 -61.21 -25.38 67.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.526 -0.734 . . . . 0.0 109.242 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -69.59 -47.08 64.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.794 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' VAL . . . . . 0.651 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 92.0 t -61.29 -23.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.45 -2.95 57.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 110.835 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 16.1 mmt -89.59 -46.21 8.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.929 -1.107 . . . . 0.0 109.658 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 1.177 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 2.0 p90 -77.61 -17.91 57.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.244 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.597 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.6 mt -77.07 -26.5 53.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.794 HG23 HG11 ' A' ' 53' ' ' VAL . 79.6 t -91.87 -50.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.386 0.612 . . . . 0.0 109.773 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -33.52 70.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.607 -0.683 . . . . 0.0 111.54 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 55.6 m -77.48 -14.46 59.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.008 -1.057 . . . . 0.0 109.592 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.954 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.67 -10.34 48.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' N ' HD23 ' A' ' 81' ' ' LEU . 6.0 mt -90.88 -41.45 11.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 4.7 mm-40 -69.79 -52.34 26.04 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.836 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 175.65 -23.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.277 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 1.4 tt0 -59.45 131.66 88.09 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 111.179 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.95 148.12 27.63 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.105 1.581 . . . . 0.0 109.866 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' VAL . . . . . 1.079 HG12 ' NH2' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -98.95 111.65 61.17 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.011 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.568 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 48.0 Cg_endo -85.38 135.94 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.502 1.264 . . . . 0.0 109.665 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' MET . . . . . 0.686 ' O ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.84 -1.59 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.295 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.589 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.1 m -91.1 126.03 36.06 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.686 -1.206 . . . . 0.0 112.145 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' LEU . . . . . 0.858 HD11 HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -103.25 85.23 0.83 Allowed Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.998 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 89' ' ' SER . 42.2 Cg_endo -67.67 165.66 26.79 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.612 1.322 . . . . 0.0 110.699 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.99 -6.07 18.37 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.165 1.613 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -76.72 -1.51 28.31 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 109.163 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 1.177 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 3.6 mt -127.39 -0.96 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.679 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' VAL . . . . . 0.858 HG23 HD11 ' A' ' 90' ' ' LEU . 9.0 t -106.3 143.94 27.98 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 110.211 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.501 ' HD2' HG13 ' A' ' 95' ' ' VAL . 41.1 Cg_endo -67.2 174.9 6.37 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.062 1.559 . . . . 0.0 109.718 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 98' ' ' SER . 42.3 Cg_endo -68.54 170.79 14.27 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.844 1.444 . . . . 0.0 110.57 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 77.3 -46.15 0.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.314 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' NZ ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.22 9.45 22.94 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 108.801 179.079 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.8 . . . . 0.0 109.912 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.246 0.546 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 12.0 p -50.61 -33.16 21.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' B' ' 112' ' ' LEU . 5.4 t-20 -104.71 128.14 27.46 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.5 Cg_endo -74.87 -21.52 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.93 1.49 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 111' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 85.4 m-85 -83.85 -10.6 57.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.097 -1.002 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 112' ' ' LEU . . . . . 0.542 HD12 ' OD1' ' B' ' 109' ' ' ASN . 41.8 mt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.259 0.552 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 25.1 t -96.98 161.79 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.502 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -118.1 178.1 1.12 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.0 110.663 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.3 Cg_endo -73.26 -35.75 4.76 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.191 1.627 . . . . 0.0 110.15 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -26.16 37.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 72.8 m-20 -81.47 -38.84 25.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.936 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -69.84 -20.49 63.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.57 71.02 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 9.3 ptpt -75.25 -25.37 57.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.0 m-30 -71.72 -36.77 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -74.59 -9.85 58.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.746 -0.596 . . . . 0.0 110.318 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.42 -33.92 15.05 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.697 HD13 ' SD ' ' A' ' 74' ' ' MET . 16.4 mt -77.29 -36.46 24.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.756 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.92 -40.0 79.33 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.692 0.758 . . . . 0.0 109.112 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -86.91 0.9 54.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.658 -0.651 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -6.18 55.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 108.996 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.042 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -107.1 -9.99 16.02 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.8 92.05 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 121.195 0.521 . . . . 0.0 109.61 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -73.34 153.4 50.56 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.421 1.748 . . . . 0.0 110.994 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.53 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 94.1 t -121.58 114.13 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.74 . . . . 0.0 109.188 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 52.14 19.8 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.786 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.5 38.23 4.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.4 m-85 -150.43 147.32 27.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.878 -1.366 . . . . 0.0 112.639 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.042 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.3 mt -118.83 137.69 53.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ASP . 67.1 p -89.31 145.58 25.28 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.014 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.518 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.82 -27.54 0.18 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.1 t0 -61.52 -27.26 68.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -1.01 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.553 ' HB3' HD13 ' A' ' 24' ' ' LEU . 29.6 mttp -96.44 -32.85 12.12 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.096 -1.002 . . . . 0.0 108.551 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.082 HG11 HD12 ' A' ' 65' ' ' LEU . 60.6 t -79.6 -50.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.188 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.07 -53.66 3.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.913 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -65.97 -36.07 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 N-CA-C 109.174 -1.125 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.09 -32.42 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.012 ' HB3' HD22 ' A' ' 50' ' ' LEU . 60.9 mt -86.3 -25.77 25.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.625 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.518 HD21 ' HE1' ' B' ' 111' ' ' PHE . 62.7 mt -77.03 -11.7 59.84 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.306 -0.871 . . . . 0.0 109.44 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 63.2 t-20 -86.49 -8.86 57.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.024 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.441 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 0.9 OUTLIER -81.23 6.65 13.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.984 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.7 tptt 65.69 11.3 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -0.99 . . . . 0.0 109.553 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.023 HD13 HG21 ' A' ' 49' ' ' ILE . 16.2 mt -95.18 152.55 39.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.843 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -73.53 168.98 23.39 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.965 1.508 . . . . 0.0 110.669 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' B' ' 111' ' ' PHE . 10.4 t -65.81 -10.54 10.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -30.56 58.93 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.243 -0.911 . . . . 0.0 108.958 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.023 HG21 HD13 ' A' ' 45' ' ' LEU . 16.1 mm -83.03 -40.32 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.012 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -72.82 -30.23 63.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.98 -25.02 76.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.799 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -100.7 -31.71 11.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.833 -0.804 . . . . 0.0 110.043 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 77' ' ' VAL . 25.6 t -72.08 -34.05 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.336 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.558 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.3 t-105 -73.25 -51.98 15.67 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.802 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.5 mm-40 -51.6 -58.25 6.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.951 -1.093 . . . . 0.0 110.088 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.799 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.5 mt -61.32 -14.54 27.82 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.872 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.963 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.9 t -94.03 -31.76 14.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.538 -0.726 . . . . 0.0 109.699 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 3.0 t0 -72.56 86.75 1.19 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.482 -0.762 . . . . 0.0 110.159 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.568 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.3 mm -65.94 -30.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 5.2 m-20 -99.01 -16.17 18.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.0 109.89 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.406 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 92.3 m-70 55.33 48.32 19.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.529 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 7.8 p30 -122.4 26.49 8.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 72.44 32.72 61.9 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.08 161.76 42.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.246 . . . . 0.0 111.082 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.082 HD12 HG11 ' A' ' 36' ' ' VAL . 14.1 mt -136.99 99.91 4.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 3.6 p30 -71.05 168.14 17.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.914 -1.116 . . . . 0.0 110.237 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' ASP . 15.7 ptt180 -38.56 -46.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.538 -0.726 . . . . 0.0 111.269 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.49 -35.48 63.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 110.57 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 57.4 mt-10 -75.79 -42.32 50.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.44 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 1.015 ' CD2' HD12 ' A' ' 31' ' ' LEU . 8.5 t80 -65.93 -19.91 66.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.413 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.7 -46.6 30.28 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.568 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.459 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 86.2 t -59.04 -29.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.543 0.687 . . . . 0.0 109.881 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.963 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.86 -4.08 57.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.441 -0.787 . . . . 0.0 111.18 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.697 ' SD ' HD13 ' A' ' 20' ' ' ILE . 9.3 mmt -85.11 -48.32 9.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.907 -1.121 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -73.02 -31.62 64.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.694 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.1 mt -62.66 -24.13 67.46 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.781 HG23 HG11 ' A' ' 53' ' ' VAL . 58.9 t -91.04 -47.84 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.483 0.658 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 -68.1 -31.96 71.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 110.689 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 93.3 m -83.2 -11.12 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.371 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.093 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . . . . . . . . . 51.4 t-20 . . . . . 0 N--CA 1.492 1.666 0 CA-C-O 120.706 0.288 . . . . 0.0 110.551 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.78 6.43 4.54 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.917 1.483 . . . . 0.0 111.126 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.895 ' HB3' HG13 ' A' ' 47' ' ' VAL . 65.2 m-85 . . . . . 0 N--CA 1.497 1.879 0 O-C-N 120.998 -1.064 . . . . 0.0 110.333 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.325 0.583 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 32.3 t -90.75 136.59 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.977 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.523 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.9 mttp -96.81 178.93 1.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.822 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.78 -36.42 13.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.841 1.443 . . . . 0.0 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 3.7 pt-20 -74.8 -28.73 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.922 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 20.6 m-20 -82.3 -36.04 27.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 0.0 108.958 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -75.0 -15.29 60.66 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.514 -0.742 . . . . 0.0 109.027 178.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.1 -40.19 39.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.611 -0.681 . . . . 0.0 109.181 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.9 ptpt -74.73 -22.02 59.04 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 9.5 m-30 -75.22 -34.41 61.45 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.08 -11.33 60.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.421 0.629 . . . . 0.0 110.107 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -91.28 -29.28 17.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.683 HG22 ' CE1' ' A' ' 70' ' ' PHE . 36.3 mt -85.1 -33.71 8.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.767 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.74 -33.74 66.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.561 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 t70 -89.48 -6.12 56.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.616 -0.677 . . . . 0.0 109.951 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.73 -8.15 59.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 108.627 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.119 HD12 HD13 ' A' ' 31' ' ' LEU . 5.0 mt -104.66 -15.38 15.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 85.12 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 CA-C-O 121.157 0.503 . . . . 0.0 110.039 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 52.2 Cg_endo -79.76 157.87 24.6 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.343 1.707 . . . . 0.0 111.055 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.4 t -125.47 109.74 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.5 OUTLIER 65.91 15.32 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 -178.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.5 36.75 6.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 75.2 m-85 -141.58 146.65 36.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.246 . . . . 0.0 111.847 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.119 HD13 HD12 ' A' ' 24' ' ' LEU . 9.1 mt -118.04 136.29 53.64 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -86.79 145.39 26.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.7 -26.05 0.38 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.7 t70 -67.19 -20.52 65.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.37 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.8 mttp -100.22 -36.54 9.26 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.019 -1.05 . . . . 0.0 108.194 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.675 HG12 ' CD1' ' A' ' 40' ' ' LEU . 86.9 t -75.61 -46.39 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.163 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.583 ' HG3' ' CZ ' ' B' ' 111' ' ' PHE . 12.0 tttt -39.06 -53.91 3.49 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.999 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.45 -37.0 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.463 1.244 . . . . 0.0 109.379 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.878 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.8 t -60.68 -34.63 59.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.033 ' HB3' HD22 ' A' ' 50' ' ' LEU . 53.9 mt -86.69 -26.39 24.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.5 -0.75 . . . . 0.0 109.584 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.507 HD12 ' HG2' ' A' ' 37' ' ' LYS . 36.8 mt -75.57 -17.09 60.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.81 -6.69 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.852 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.476 ' OG ' ' HB2' ' A' ' 45' ' ' LEU . 3.4 p -82.83 11.86 5.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 43' ' ' SER . 13.7 tttp 64.26 15.16 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.061 HD11 ' HB3' ' A' ' 80' ' ' ALA . 20.0 mt -100.66 153.3 37.81 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.88 169.82 21.42 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 124.216 1.64 . . . . 0.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.808 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.6 t -69.15 -6.23 5.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.49 -31.46 42.3 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.249 -0.907 . . . . 0.0 109.207 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.842 HG13 HD22 ' A' ' 45' ' ' LEU . 12.1 mm -82.63 -39.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.033 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -70.14 -28.38 65.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.87 -24.3 76.8 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 1.004 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.39 -32.02 10.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.777 -0.837 . . . . 0.0 110.208 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.75 HG11 ' CG2' ' A' ' 77' ' ' VAL . 4.9 t -72.41 -36.35 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.486 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CD1' ' HB3' ' B' ' 109' ' ' ASN . 2.5 t-105 -68.78 -49.58 57.42 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.012 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.6 mt-10 -52.61 -57.08 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.901 -1.125 . . . . 0.0 110.186 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.004 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.5 mt -61.45 -14.46 28.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.797 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.725 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.8 m -92.56 -38.64 11.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 109.371 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 10.7 t0 -70.21 85.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.442 -0.786 . . . . 0.0 109.924 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 26.8 mm -61.68 -27.63 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.899 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 49.9 p30 -108.97 -13.26 14.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.909 -1.119 . . . . 0.0 111.104 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 3.7 m170 63.07 44.68 5.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 13.0 p-10 -111.9 29.61 7.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.904 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 60.73 34.04 85.1 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.5 mtt -150.83 161.04 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -1.14 . . . . 0.0 111.127 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.656 ' CD1' HG11 ' A' ' 36' ' ' VAL . 7.0 mt -128.21 104.82 7.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.754 . . . . 0.0 109.615 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.587 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -68.71 167.75 14.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.224 -0.922 . . . . 0.0 110.344 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.521 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -46.18 -40.96 12.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.428 -0.795 . . . . 0.0 110.519 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 -25.82 31.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.064 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.68 -46.04 27.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.702 0.763 . . . . 0.0 109.261 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 28.5 t80 -64.45 -16.43 62.41 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -76.56 -47.37 22.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.442 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 76' ' ' LEU . 57.6 t -60.14 -24.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.603 -0.685 . . . . 0.0 109.594 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.89 -6.65 55.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -0.753 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.581 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.9 mmt -84.97 -48.21 9.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.003 -1.06 . . . . 0.0 110.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.523 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.1 p90 -75.97 -22.28 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.523 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 11.0 mt -73.89 -22.8 59.59 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.75 ' CG2' HG11 ' A' ' 53' ' ' VAL . 53.9 t -91.91 -60.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.448 0.642 . . . . 0.0 109.308 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.55 -19.29 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 110.722 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 4.2 m -85.01 -18.01 35.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.173 -0.954 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.061 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.429 179.516 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.606 ' HB3' ' CD1' ' A' ' 54' ' ' TRP . 50.7 p30 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 120.8 0.333 . . . . 0.0 110.565 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -79.06 11.06 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.101 1.58 . . . . 0.0 110.98 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.808 ' HB3' HG13 ' A' ' 47' ' ' VAL . 48.8 m-85 . . . . . 0 N--CA 1.493 1.717 0 O-C-N 120.935 -1.103 . . . . 0.0 110.266 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 121.376 0.608 . . . . 0.0 110.267 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 137.6 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 110.376 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -94.63 174.49 3.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HG2' ' OE2' ' A' ' 12' ' ' GLU . 37.9 Cg_endo -66.39 -32.7 40.17 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.795 1.418 . . . . 0.0 109.838 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' OE2' ' HG2' ' A' ' 11' ' ' PRO . 7.4 mm-40 -75.91 -33.47 59.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-20 -78.73 -40.5 33.38 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.5 tptp -69.63 -17.94 63.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.104 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.47 64.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.673 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.51 -20.84 49.88 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -78.05 -34.23 50.52 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.96 -12.3 59.73 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.301 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.63 -32.38 13.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.717 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.5 mt -77.69 -30.92 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.667 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -71.28 -38.47 71.82 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.605 0.717 . . . . 0.0 109.141 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t70 -91.01 -4.19 56.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 110.115 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t -79.24 -11.66 59.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 108.742 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.976 HD12 HD13 ' A' ' 31' ' ' LEU . 8.9 mt -97.68 -56.09 2.61 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 142.46 97.19 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.7 Cg_endo -74.15 147.68 38.28 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 124.259 1.663 . . . . 0.0 110.726 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.0 t -118.49 99.15 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 109.107 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.8 t30 56.78 17.04 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.408 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 106.03 33.69 3.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 66' ' ' ASP . 75.6 m-85 -150.67 141.69 23.0 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -1.164 . . . . 0.0 112.106 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.976 HD13 HD12 ' A' ' 24' ' ' LEU . 10.3 mt -110.59 141.81 43.28 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.45 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 99.4 p -89.7 147.54 23.8 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.998 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.8 -27.37 0.55 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' SER . 64.5 t0 -66.44 -25.75 66.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -1.05 . . . . 0.0 110.145 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttt -94.06 -33.08 13.53 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.014 -1.054 . . . . 0.0 108.533 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 65' ' ' LEU . 90.8 t -82.05 -47.93 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -39.56 -53.65 4.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.637 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -66.34 -35.28 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.136 1.071 . . . . 0.0 109.468 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 24' ' ' LEU . 2.2 t -61.6 -26.67 40.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.612 -0.68 . . . . 0.0 109.207 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.996 ' HB3' HD22 ' A' ' 50' ' ' LEU . 36.5 mt -95.66 -28.54 14.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 79.2 mt -71.07 -15.11 62.51 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.86 -11.09 58.5 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.883 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.572 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 1.8 p -81.74 7.96 11.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.55 12.43 5.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.509 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.9 mt -88.56 156.39 50.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.953 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.9 Cg_endo -74.1 166.65 29.09 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.93 1.49 . . . . 0.0 109.386 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.834 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.5 t -66.55 -7.07 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.535 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -78.62 -31.9 47.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.185 -0.947 . . . . 0.0 109.392 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.928 HG13 HD22 ' A' ' 45' ' ' LEU . 6.9 mm -82.77 -41.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.7 mt -67.43 -29.99 69.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.34 -23.81 77.16 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 56' ' ' LEU . 24.6 ttp180 -102.16 -33.13 9.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.966 -0.726 . . . . 0.0 111.06 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.963 HG11 HG23 ' A' ' 77' ' ' VAL . 17.2 t -67.16 -41.12 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.658 -1.276 . . . . 0.0 108.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.565 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.7 t-105 -62.55 -50.9 69.49 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.551 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 19.2 mt-10 -51.52 -59.05 4.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.82 -15.13 39.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 108.712 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.739 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 34.8 m -91.05 -30.49 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.237 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.43 97.38 4.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 109.595 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.529 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 24.9 mm -71.02 -38.44 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 110.375 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 9.8 p30 -99.34 -13.39 19.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 1.8 m-70 60.48 41.45 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.851 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.471 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 6.5 p-10 -96.79 13.27 29.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 0.0 109.565 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.551 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 78.63 22.15 67.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.551 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.29 161.35 41.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.302 -1.117 . . . . 0.0 109.573 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' HA ' ' A' ' 70' ' ' PHE . 5.8 mt -121.05 116.46 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.049 -1.032 . . . . 0.0 110.272 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.573 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -76.39 172.75 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -52.8 -34.37 53.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.559 -0.713 . . . . 0.0 110.847 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 28.0 m-20 -87.15 -31.56 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 31.4 mt-10 -78.13 -38.96 42.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 108.692 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.951 ' CD2' HD12 ' A' ' 31' ' ' LEU . 42.9 t80 -63.38 -29.27 70.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -64.8 -47.51 77.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.531 -0.73 . . . . 0.0 110.154 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.451 ' O ' HD12 ' A' ' 76' ' ' LEU . 58.5 t -60.84 -19.26 19.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.6 -13.26 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 111.444 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 mmm -85.6 -41.84 14.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.696 -1.253 . . . . 0.0 110.553 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.534 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.4 p90 -77.57 -25.17 49.81 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 7.2 mt -70.96 -22.0 62.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.963 HG23 HG11 ' A' ' 53' ' ' VAL . 49.7 t -91.78 -61.52 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -48.88 -21.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.639 -0.663 . . . . 0.0 111.325 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 20.1 m -84.66 -14.65 47.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 110.123 -179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.991 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.574 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.509 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 20.8 t-20 . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 120.895 0.379 . . . . 0.0 110.633 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 109' ' ' ASN . 54.4 Cg_endo -85.55 12.57 3.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.07 1.563 . . . . 0.0 111.334 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.834 ' HB3' HG13 ' A' ' 47' ' ' VAL . 48.3 m-85 . . . . . 0 N--CA 1.495 1.825 0 O-C-N 120.791 -1.193 . . . . 0.0 110.745 -179.675 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.315 0.578 . . . . 0.0 109.766 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 8.5 t -91.79 156.0 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.793 . . . . 0.0 109.239 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mmmt -108.72 167.39 9.25 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.878 -1.139 . . . . 0.0 110.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -69.4 -31.91 21.16 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.008 1.531 . . . . 0.0 109.811 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.85 -32.79 40.53 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.23 -34.7 49.11 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 28.6 tptp -72.46 -18.61 61.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.486 -0.759 . . . . 0.0 109.047 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.76 -42.8 60.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.0 ptpt -75.58 -25.29 56.93 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -72.96 -37.55 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.874 0.845 . . . . 0.0 108.732 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -79.5 -8.16 58.95 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.376 0.607 . . . . 0.0 110.339 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.59 -33.38 12.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 70' ' ' PHE . 75.1 mt -76.63 -33.13 21.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.74 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -66.97 -38.57 86.32 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.7 t70 -90.97 -2.57 57.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -80.91 -12.58 59.38 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.989 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -95.63 -54.36 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.65 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 6.7 p 142.55 90.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -75.14 150.94 38.28 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 124.057 1.556 . . . . 0.0 110.914 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -127.07 108.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.1 t30 57.28 21.93 7.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.996 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.438 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.08 38.91 5.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 82.6 m-85 -150.43 151.64 33.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.089 -1.242 . . . . 0.0 111.866 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.989 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.2 mt -122.17 140.61 52.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 19.3 p -90.42 141.64 28.54 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.855 -1.153 . . . . 0.0 110.343 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.558 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.28 -27.75 0.27 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -61.5 -28.29 69.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.969 . . . . 0.0 110.066 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 14.8 mttt -96.52 -32.93 12.03 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.221 -0.924 . . . . 0.0 108.816 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.755 ' CG1' HD12 ' A' ' 65' ' ' LEU . 92.1 t -77.03 -44.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 110.007 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 67.5 tttt -40.76 -56.75 3.64 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.7 Cg_endo -65.37 -34.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.494 1.26 . . . . 0.0 109.769 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -62.82 -35.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.792 . . . . 0.0 109.7 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.113 ' HB3' HD22 ' A' ' 50' ' ' LEU . 34.6 mt -85.37 -29.12 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.972 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.659 HD21 ' HE1' ' B' ' 111' ' ' PHE . 43.2 mt -71.6 -14.12 61.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.018 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.47 -12.34 60.0 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.755 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.549 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 59.8 p -81.38 3.78 23.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.421 -0.799 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.3 ttmt 68.63 16.25 9.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.934 HD22 HG13 ' A' ' 49' ' ' ILE . 15.5 mt -95.66 152.91 39.45 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.001 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.575 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.5 Cg_endo -74.04 175.03 11.41 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.973 1.512 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' HD1' ' B' ' 111' ' ' PHE . 25.2 t -70.85 -7.09 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -32.24 37.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.934 HG13 HD22 ' A' ' 45' ' ' LEU . 9.8 mm -83.18 -36.86 13.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 108.742 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.113 HD22 ' HB3' ' A' ' 40' ' ' LEU . 29.5 mt -75.08 -26.48 59.36 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.24 -24.96 76.42 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.964 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.4 mtm180 -100.74 -31.68 11.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.905 -0.762 . . . . 0.0 109.897 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.029 HG11 HG23 ' A' ' 77' ' ' VAL . 5.7 t -71.1 -37.34 66.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.0 t-105 -71.11 -50.1 37.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.44 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.568 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 9.4 mm-40 -56.96 -54.65 44.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 110.221 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.964 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.9 mt -62.78 -10.91 14.62 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.426 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.755 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.8 m -98.16 -37.71 9.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.77 . . . . 0.0 110.015 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -69.01 87.07 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.953 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.512 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 43.5 mm -57.82 -28.37 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 110.395 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.59 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 51.1 p-10 -112.04 1.29 16.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.554 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 9.3 p80 39.58 51.98 2.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.341 -0.849 . . . . 0.0 110.511 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 15.4 p-10 -112.33 24.79 12.17 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 71.13 31.15 66.73 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.75 161.82 42.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -1.227 . . . . 0.0 111.466 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' CG1' ' A' ' 36' ' ' VAL . 9.9 mt -125.73 105.52 9.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.482 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.565 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 4.7 t0 -69.02 163.71 24.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.86 -1.15 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -42.63 -36.47 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.763 . . . . 0.0 110.199 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -82.75 -34.27 27.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 17.7 mt-10 -74.98 -42.6 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.877 ' CD2' HD12 ' A' ' 31' ' ' LEU . 32.6 t80 -59.84 -26.95 66.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -72.25 -51.31 21.53 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.174 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.475 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 53.7 t -55.46 -26.76 19.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.543 0.687 . . . . 0.0 109.518 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.755 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.85 -3.21 58.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.557 -0.714 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.606 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.0 mmt -90.15 -43.43 10.46 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.664 -1.273 . . . . 0.0 109.834 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.5 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 p90 -79.26 -19.01 51.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 4.6 mt -78.85 -23.24 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.029 HG23 HG11 ' A' ' 53' ' ' VAL . 5.8 t -90.59 -37.16 9.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.627 -0.671 . . . . 0.0 109.65 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -80.05 -24.02 40.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 56.3 m -83.22 -18.74 38.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.224 -0.922 . . . . 0.0 109.188 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.751 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.335 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.843 179.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.568 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 43.1 t-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 120.687 0.28 . . . . 0.0 110.283 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.77 17.39 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.949 1.499 . . . . 0.0 111.28 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.714 ' HD1' HG22 ' A' ' 47' ' ' VAL . 65.2 m-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.892 -1.13 . . . . 0.0 110.283 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.663 0 CA-C-O 121.376 0.608 . . . . 0.0 110.255 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.6 t -97.71 138.53 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.97 175.53 2.68 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -37.03 19.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.556 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -72.54 -25.16 61.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 109.575 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -82.79 -40.09 20.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -71.73 -17.61 62.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.8 57.91 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.63 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -74.48 -28.99 61.26 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.63 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.6 m-30 -68.02 -33.73 75.14 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 9.4 t70 -77.34 -9.32 58.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.662 -0.649 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.38 -30.76 14.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.81 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 61.5 mt -81.16 -32.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.43 -38.18 65.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.2 t70 -85.64 -1.25 56.95 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.411 0.624 . . . . 0.0 109.787 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 t -88.47 -9.33 52.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.212 -0.93 . . . . 0.0 108.895 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.102 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.4 mt -100.67 -8.09 23.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 88.31 94.75 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 46.6 Cg_endo -72.0 151.09 55.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.346 1.708 . . . . 0.0 111.022 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -121.6 97.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.0 t30 63.67 14.96 8.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.858 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.82 33.26 4.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 92.0 m-85 -149.92 154.69 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.161 -1.199 . . . . 0.0 111.827 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.102 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.0 mt -120.03 159.97 23.71 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' LYS . 13.4 p -104.28 142.15 35.04 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.904 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.28 -25.22 0.71 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.4 t70 -71.86 -23.57 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.605 -0.938 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttp -93.06 -36.8 12.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 90.1 t -78.11 -40.46 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.473 0.654 . . . . 0.0 109.765 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.669 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 6.3 tttp -40.71 -55.98 4.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 111.089 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.6 -35.01 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.574 1.302 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.745 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -59.87 -36.19 65.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.039 ' HB3' HD22 ' A' ' 50' ' ' LEU . 23.2 mt -84.29 -25.73 29.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.913 . . . . 0.0 109.456 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 38' ' ' PRO . 53.9 mt -71.92 -15.31 62.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.06 -10.22 59.72 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.464 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.515 ' CB ' HG13 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -81.13 8.6 8.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.842 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 43' ' ' SER . 4.3 tttt 65.6 15.83 10.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.462 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.041 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.1 mt -95.91 151.25 38.22 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 110.331 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.9 Cg_endo -75.54 -178.34 4.21 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.986 1.519 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.1 t -78.53 -0.68 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.47 -32.88 20.58 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.955 HG13 HD22 ' A' ' 45' ' ' LEU . 8.3 mm -83.22 -38.6 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.039 HD22 ' HB3' ' A' ' 40' ' ' LEU . 38.6 mt -72.91 -26.3 61.37 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 109.201 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.24 -23.03 78.29 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.975 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.3 mtm180 -100.38 -32.25 10.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.885 -0.774 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.001 HG11 HG23 ' A' ' 77' ' ' VAL . 22.5 t -70.26 -36.32 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.015 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.604 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.31 -50.62 37.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mt-10 -56.82 -57.55 11.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.975 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -58.22 -16.94 15.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.48 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.014 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t -92.12 -35.87 13.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -72.97 98.36 2.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 110.217 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.524 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 49.0 mm -71.93 -28.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.005 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -112.0 -15.26 13.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 109.656 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 91.7 m-70 59.68 47.77 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.558 -0.714 . . . . 0.0 111.298 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 1.3 m-20 -98.04 26.06 5.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 108.635 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.483 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 63.4 29.77 75.57 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 31' ' ' LEU . 7.9 mtt -150.56 160.74 43.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.995 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 11.9 mt -129.48 100.68 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 69' ' ' GLU . 2.3 p30 -69.6 160.61 31.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.616 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.7 ptp85 -35.36 -43.2 0.23 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.656 -0.653 . . . . 0.0 112.032 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.47 -35.79 30.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.963 -1.085 . . . . 0.0 110.298 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 13.7 tt0 -71.15 -43.26 67.89 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.81 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 58.4 t80 -63.1 -19.58 64.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.55 -42.7 67.54 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 109.693 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . . . . . . . . . 56.3 t -62.39 -31.79 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.671 0.748 . . . . 0.0 109.722 179.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -87.58 0.25 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.757 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.4 mmt -89.8 -44.54 9.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.67 -1.269 . . . . 0.0 109.961 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.557 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.2 p90 -77.09 -22.34 52.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.557 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.2 mt -76.99 -22.95 52.35 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.461 0.648 . . . . 0.0 109.54 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.001 HG23 HG11 ' A' ' 53' ' ' VAL . 5.4 t -91.34 -38.59 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.438 -0.789 . . . . 0.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.47 -22.71 61.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.467 -0.771 . . . . 0.0 110.676 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.457 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -83.15 -16.13 47.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.167 -0.958 . . . . 0.0 109.967 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.041 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.413 0 O-C-N 121.203 -0.936 . . . . 0.0 109.089 179.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.465 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 34.0 t-20 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.857 -0.423 . . . . 0.0 109.857 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.52 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 47.6 Cg_endo -72.19 -23.96 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.89 1.468 . . . . 0.0 110.545 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.936 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 45.0 m-85 . . . . . 0 N--CA 1.495 1.783 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.733 0 CA-C-O 121.501 0.667 . . . . 0.0 110.219 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 13' ' ' ASP . 60.3 t -100.75 131.57 48.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.545 -0.722 . . . . 0.0 109.596 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.547 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -89.65 -179.04 1.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.95 -35.67 14.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.816 1.429 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 3.8 pt-20 -73.28 -26.78 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.541 ' HB3' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.21 -39.43 23.11 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -72.31 -13.49 61.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.69 -40.37 34.02 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.15 -23.65 43.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -78.7 -33.15 47.09 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 47.7 t0 -79.69 -7.79 58.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.682 -0.636 . . . . 0.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.27 12.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.805 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 40.2 mt -76.88 -31.51 19.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.19 -37.7 66.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.3 t70 -89.67 3.72 51.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.453 0.644 . . . . 0.0 109.71 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -5.95 53.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 108.868 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.043 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.38 -4.95 16.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 82.73 94.55 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.0 Cg_endo -73.29 148.57 43.88 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.224 1.644 . . . . 0.0 110.496 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 92.6 t -115.46 102.2 13.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 28' ' ' ASN . 3.3 t30 61.15 16.36 7.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.419 -0.801 . . . . 0.0 109.661 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 100.07 35.56 4.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 76.3 m-85 -150.53 143.5 24.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.923 -1.339 . . . . 0.0 112.279 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.043 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.4 mt -113.93 137.53 51.56 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' C ' ' A' ' 33' ' ' GLY . 47.3 p -83.8 140.52 32.0 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.332 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.521 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.94 -28.44 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 37.9 t0 -62.34 -23.81 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.935 . . . . 0.0 110.559 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 43.0 mttp -97.93 -35.76 10.37 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 85.1 t -75.64 -37.76 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.023 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 ttmt -45.08 -51.36 24.14 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 111.133 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 37' ' ' LYS . 41.2 Cg_endo -68.21 -33.57 24.16 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.254 1.133 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.633 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 1.8 t -61.6 -31.26 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.515 -0.741 . . . . 0.0 110.215 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.123 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.9 mt -91.69 -23.8 19.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.076 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 57.8 mt -74.77 -13.46 60.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 109.383 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 2.1 p-10 -87.07 -1.02 57.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.322 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.601 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 5.1 p -90.58 12.69 18.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.615 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 65.93 15.63 10.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.079 -1.013 . . . . 0.0 109.925 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.078 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.7 mt -100.11 151.83 37.63 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.624 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.8 Cg_endo -76.89 172.87 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.206 1.635 . . . . 0.0 110.178 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -69.96 -4.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.659 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -82.04 -30.11 31.58 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 109.209 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.941 HG13 HD22 ' A' ' 45' ' ' LEU . 8.9 mm -85.54 -36.82 11.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.928 0.87 . . . . 0.0 108.896 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.123 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -76.85 -27.96 55.3 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.413 0.625 . . . . 0.0 109.523 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.98 -24.92 75.03 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.805 ' O ' HD12 ' A' ' 56' ' ' LEU . 17.5 ttm180 -101.05 -31.46 11.07 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.979 -0.718 . . . . 0.0 110.182 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.943 HG11 HG23 ' A' ' 77' ' ' VAL . 15.0 t -72.06 -36.77 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.9 t-105 -64.38 -51.39 63.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.743 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 1.9 mm-40 -49.09 -61.41 2.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.326 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -59.88 -16.58 30.25 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.858 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.772 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.7 m -90.55 -28.96 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' TRP . 27.9 t0 -76.4 101.6 5.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.788 -0.57 . . . . 0.0 109.64 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 18.3 mm -88.49 -17.23 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.562 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' OE2' ' A' ' 69' ' ' GLU . 3.3 m-20 -104.07 -10.08 18.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.63 ' CD2' ' N ' ' A' ' 61' ' ' HIS . 2.8 m170 52.38 49.1 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 34.8 p-10 -128.46 14.14 6.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.932 -1.105 . . . . 0.0 110.177 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 79.4 32.61 37.78 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.49 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 18.6 mtp -150.8 161.07 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.188 -1.184 . . . . 0.0 110.747 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 7.7 mt -126.94 107.48 10.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -69.63 166.55 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 109.432 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.549 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.6 ptp85 -45.88 -42.17 12.23 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.139 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.544 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 63.4 m-20 -76.14 -36.63 58.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.827 . . . . 0.0 110.097 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 35.5 mt-10 -71.66 -46.34 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.997 . . . . 0.0 108.92 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.885 ' CD2' HD12 ' A' ' 31' ' ' LEU . 29.7 t80 -55.4 -30.95 61.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.44 -49.18 74.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.305 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 76' ' ' LEU . 49.6 t -58.03 -22.47 19.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.772 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.34 -8.5 50.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 111.94 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 10.3 mmm -88.8 -41.2 12.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.617 -1.302 . . . . 0.0 110.527 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.589 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 2.7 p90 -78.9 -29.17 44.17 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.911 -1.118 . . . . 0.0 108.189 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.66 ' HB3' HG13 ' A' ' 53' ' ' VAL . 7.6 mt -66.75 -27.12 67.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.943 HG23 HG11 ' A' ' 53' ' ' VAL . 25.6 t -90.74 -19.91 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 110.032 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.91 -24.11 22.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.373 -0.83 . . . . 0.0 109.703 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.5 m -84.09 -16.74 42.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.078 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 108.598 178.817 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.551 ' N ' ' OD1' ' B' ' 109' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.562 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 44.9 Cg_endo -80.96 7.19 5.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.686 1.361 . . . . 0.0 109.714 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 1.02 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 96.6 m-85 . . . . . 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.311 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 121.256 0.551 . . . . 0.0 110.185 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 44.2 t -105.61 139.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.17 -178.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.893 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -71.41 -34.73 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.849 1.447 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HG3' ' OD1' ' A' ' 13' ' ' ASP . 7.3 pt-20 -76.81 -27.88 55.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -84.7 -30.11 25.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -82.33 -19.67 38.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 0.0 109.005 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.42 -37.63 60.3 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.4 ptmt -74.27 -23.44 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.3 m-30 -76.76 -35.67 57.56 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -72.31 -10.01 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 110.387 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.37 -35.88 14.15 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.683 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -76.23 -33.68 24.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.753 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.53 -40.55 70.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 t70 -85.75 4.51 36.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.664 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -9.41 43.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.026 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.1 mt -102.86 -9.3 20.03 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 87.2 91.28 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.222 0 CA-C-O 121.542 0.687 . . . . 0.0 109.153 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 Cg_endo -74.29 150.21 41.5 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.174 1.618 . . . . 0.0 110.75 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 35.3 t -119.18 112.37 37.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.3 t30 57.37 16.91 3.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 96.0 36.18 5.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.619 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.2 m-85 -147.16 146.1 29.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 112.097 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.026 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.6 mt -115.06 139.33 49.96 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -83.39 143.4 30.33 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.133 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.34 -25.93 0.87 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.8 m-20 -69.13 -22.93 63.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.641 -0.917 . . . . 0.0 110.349 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HE3' ' HG ' ' A' ' 25' ' ' SER . 65.1 mttm -94.91 -35.28 12.08 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.062 HG11 HD12 ' A' ' 65' ' ' LEU . 84.8 t -77.43 -39.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.741 0.782 . . . . 0.0 109.371 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 8.7 tttp -41.51 -55.13 5.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.715 -0.616 . . . . 0.0 110.721 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.29 -35.03 25.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.568 1.299 . . . . 0.0 110.034 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.811 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -61.38 -33.17 55.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.121 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.976 ' HB3' HD22 ' A' ' 50' ' ' LEU . 46.7 mt -87.44 -26.81 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.34 -13.72 60.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.81 . . . . 0.0 109.035 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -85.92 -10.93 54.41 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.554 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.519 ' OG ' HG11 ' A' ' 77' ' ' VAL . 3.2 m -78.18 4.84 11.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.606 -0.683 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' SER . 11.4 tttm 68.29 8.26 6.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.79 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.03 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.9 mt -92.1 155.09 43.23 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.4 Cg_endo -74.97 168.88 23.86 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.125 1.592 . . . . 0.0 109.734 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' B' ' 111' ' ' PHE . 10.3 t -68.03 -7.28 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.519 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.7 -32.47 53.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.338 -0.852 . . . . 0.0 109.313 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.874 HG21 HD13 ' A' ' 45' ' ' LEU . 10.5 mm -81.29 -40.56 18.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.976 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -69.92 -29.15 66.24 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.548 0.689 . . . . 0.0 109.373 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.21 -23.56 77.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.922 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.08 -29.86 11.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.723 -0.869 . . . . 0.0 110.211 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.831 HG11 HG23 ' A' ' 77' ' ' VAL . 22.0 t -73.86 -37.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.747 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.573 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.5 t-105 -66.57 -48.69 68.82 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.4 mt-10 -56.48 -57.33 12.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.9 mt -61.35 -15.16 33.36 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.445 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.821 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 14.2 m -94.18 -25.59 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 109.832 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.57 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 2.5 t0 -76.99 85.09 3.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.557 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 40.3 mm -61.75 -30.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.888 . . . . 0.0 110.828 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 4.8 p30 -109.9 -13.9 14.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.01 -1.056 . . . . 0.0 110.683 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 16.9 m-70 60.48 46.18 9.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.5 p-10 -103.62 22.49 14.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.494 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 68.0 26.7 73.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 22.7 mtp -150.61 161.44 42.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -1.198 . . . . 0.0 110.375 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.062 HD12 HG11 ' A' ' 36' ' ' VAL . 11.5 mt -125.67 99.39 5.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 0.0 109.035 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.619 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 51.5 p30 -71.16 166.97 20.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.832 -1.167 . . . . 0.0 110.315 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.633 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -38.13 -45.39 0.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 0.0 112.149 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 31.2 t70 -74.95 -42.29 57.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.07 -1.019 . . . . 0.0 110.963 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.557 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 56.8 mt-10 -70.67 -44.45 67.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.117 -0.989 . . . . 0.0 109.02 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 13.2 t80 -57.31 -22.76 44.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -74.21 -46.91 38.89 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.76 0.791 . . . . 0.0 109.336 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.747 ' O ' HD12 ' A' ' 76' ' ' LEU . 95.4 t -59.83 -25.17 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.437 0.637 . . . . 0.0 109.93 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.821 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.25 -6.11 55.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 111.179 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.613 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.5 mmt -85.89 -46.19 10.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 110.071 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.5 p90 -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.4 mt -66.23 -24.21 66.56 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.831 HG23 HG11 ' A' ' 53' ' ' VAL . 69.8 t -91.57 -57.8 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -49.71 -22.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.652 -0.655 . . . . 0.0 111.622 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -85.48 -11.75 53.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.842 -1.161 . . . . 0.0 110.434 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.03 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.535 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.479 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 22.5 t-20 . . . . . 0 N--CA 1.491 1.612 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.94 6.2 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 111.847 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.821 ' HB3' HG13 ' A' ' 47' ' ' VAL . 73.0 m-85 . . . . . 0 N--CA 1.496 1.871 0 O-C-N 120.793 -1.192 . . . . 0.0 110.285 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.386 0.612 . . . . 0.0 110.952 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.71 159.68 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.5 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mptt -115.68 177.87 1.1 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 110.422 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.28 -34.46 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.057 1.556 . . . . 0.0 109.869 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.43 -26.77 46.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.023 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.1 m-20 -81.5 -31.76 32.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -75.95 -12.61 60.18 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -0.805 . . . . 0.0 108.987 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.37 -40.33 21.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.07 -27.33 60.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -72.1 -34.83 68.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.9 OUTLIER -73.34 -10.15 59.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.75 -0.594 . . . . 0.0 110.15 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.5 -32.05 15.72 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.646 HG22 ' CE1' ' A' ' 70' ' ' PHE 0.251 60.3 mt -82.41 -35.36 12.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.84 -37.5 70.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.509 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 14.4 t70 -88.62 1.98 54.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.39 -6.82 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 108.722 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.044 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -107.5 -8.49 16.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.692 -0.63 . . . . 0.0 109.435 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 85.38 95.67 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -72.26 147.77 48.26 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.205 1.634 . . . . 0.0 110.407 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -112.54 96.38 4.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 109.094 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 66.1 9.96 6.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.514 -0.741 . . . . 0.0 109.397 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 108.58 28.93 4.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 30.4 m-85 -140.98 141.43 34.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.251 . . . . 0.0 111.95 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.044 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.7 mt -112.61 139.59 48.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 20.9 p -92.43 144.88 24.92 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.288 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.33 -27.66 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . 54.2 m-20 -63.32 -26.23 68.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.461 -1.023 . . . . 0.0 109.972 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 16.5 mttt -95.21 -35.97 11.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.871 HG12 HD11 ' A' ' 40' ' ' LEU . 94.6 t -77.63 -48.81 23.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.233 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.64 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 31.9 tttm -35.5 -56.1 1.06 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.846 -0.534 . . . . 0.0 111.252 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.9 Cg_endo -67.02 -35.79 24.49 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.496 1.261 . . . . 0.0 110.073 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.684 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -63.28 -31.93 54.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.988 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.091 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.3 mt -89.36 -25.52 21.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.087 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.475 HD11 ' HG3' ' A' ' 37' ' ' LYS . 41.8 mt -74.73 -12.52 60.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.078 -1.014 . . . . 0.0 109.049 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -84.05 -8.04 59.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.481 ' CB ' HG13 ' A' ' 77' ' ' VAL . 1.0 OUTLIER -84.54 15.32 3.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 110.217 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 21.13 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 109.996 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.6 mt -99.7 153.11 37.94 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.67 178.66 7.11 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.998 1.525 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.9 t -75.78 -2.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.331 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.83 -34.3 24.7 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.351 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.948 HG13 HD22 ' A' ' 45' ' ' LEU . 10.2 mm -80.73 -40.43 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 122.033 0.92 . . . . 0.0 108.522 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.091 HD22 ' HB3' ' A' ' 40' ' ' LEU . 32.8 mt -71.44 -27.55 63.35 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.83 -25.39 75.62 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.854 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.9 mtm-85 -101.28 -31.34 11.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.829 . . . . 0.0 109.829 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.634 HG11 ' CG2' ' A' ' 77' ' ' VAL . 7.5 t -67.7 -36.79 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.217 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.578 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -75.57 -51.63 12.45 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.809 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 41.0 mt-10 -57.7 -55.97 27.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.0 109.218 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 52' ' ' ARG . 13.9 mt -59.55 -16.78 27.31 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.981 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 5.0 t -94.43 -25.5 16.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.7 t0 -73.73 98.95 3.02 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.234 0.54 . . . . 0.0 109.732 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 20.9 mm -86.61 -36.78 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 110.171 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -96.87 -12.32 23.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 40.4 m170 58.34 45.39 17.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 111.18 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 17.9 p-10 -107.22 28.91 7.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.599 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.451 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 61.24 30.37 73.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.521 ' HE2' ' HB3' ' A' ' 30' ' ' PHE . 86.7 mtp -151.96 160.21 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -1.106 . . . . 0.0 110.696 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.85 HD12 HG11 ' A' ' 36' ' ' VAL . 12.8 mt -116.1 103.82 10.94 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.547 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -68.83 156.18 38.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.868 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -35.89 -40.12 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.567 -0.708 . . . . 0.0 111.037 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.543 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 9.5 t0 -81.5 -34.46 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.154 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.547 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 18.2 mt-10 -73.91 -42.77 60.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.961 ' CD2' HD12 ' A' ' 31' ' ' LEU . 15.6 t80 -59.35 -22.49 61.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -73.7 -48.91 28.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.828 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.822 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.5 t -58.06 -27.98 32.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.361 -0.837 . . . . 0.0 109.452 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.981 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -91.5 -7.04 51.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.484 -0.76 . . . . 0.0 111.465 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.9 mmt -82.26 -50.18 9.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.688 -1.257 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.614 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 1.7 p90 -71.72 -33.91 69.14 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.822 HD12 ' O ' ' A' ' 72' ' ' VAL . 7.1 mt -58.72 -22.06 56.62 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 73' ' ' ALA . 47.0 t -91.28 -64.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -55.18 -18.87 6.55 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 59.2 m -85.19 -10.88 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.05 -1.031 . . . . 0.0 109.586 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.008 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.229 -0.92 . . . . 0.0 109.184 179.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.416 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 13.5 t-20 . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 110.149 -0.315 . . . . 0.0 110.149 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 -20.55 21.99 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.079 1.568 . . . . 0.0 110.68 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.655 ' HE2' HD12 ' A' ' 40' ' ' LEU . 80.7 m-85 . . . . . 0 N--CA 1.495 1.775 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.682 0 CA-C-O 121.218 0.532 . . . . 0.0 110.438 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' A' ' 75' ' ' PHE . 40.7 t -87.01 157.16 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 21.7 mmtm -110.56 166.22 11.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.4 Cg_endo -68.29 -33.98 22.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.863 1.454 . . . . 0.0 109.669 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.52 -27.46 58.74 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 77.8 m-20 -81.38 -41.54 21.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 12.8 tptp -65.58 -25.21 67.31 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.068 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 -45.24 76.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.532 -0.73 . . . . 0.0 109.062 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.6 ptpt -73.53 -28.69 62.02 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 13' ' ' ASP . 8.0 m-30 -67.66 -37.62 82.64 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.71 -12.78 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.468 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.84 -30.98 15.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.823 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 26.1 mt -81.46 -32.65 11.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.23 -36.99 69.26 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t70 -89.02 1.43 55.55 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.681 -0.637 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.68 -8.32 54.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.912 . . . . 0.0 109.086 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.08 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.1 mt -107.57 -7.0 16.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 79.81 95.76 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -75.62 152.21 37.69 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.165 1.613 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.0 t -118.44 114.93 46.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 27.0 t30 57.4 18.39 4.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.208 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.37 37.95 5.76 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.0 m-85 -150.5 148.3 28.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.183 . . . . 0.0 111.902 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.08 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.0 mt -113.37 134.82 54.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.451 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 34.4 p -83.21 147.55 27.95 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.87 -26.34 1.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 32' ' ' SER . 20.6 t70 -64.45 -24.08 67.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.634 -0.921 . . . . 0.0 109.972 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.8 mttt -98.8 -32.12 11.52 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 40' ' ' LEU . 92.3 t -83.05 -46.21 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.028 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.1 tttt -41.18 -50.18 8.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 43.3 Cg_endo -69.36 -35.45 13.79 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.231 1.122 . . . . 0.0 109.243 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 t -62.43 -36.47 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.458 0.647 . . . . 0.0 109.526 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.059 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.3 mt -83.21 -21.58 33.39 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.384 -0.822 . . . . 0.0 109.65 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 38' ' ' PRO . 34.2 mt -79.04 -13.21 59.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.533 -0.73 . . . . 0.0 109.324 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 5.7 t30 -89.98 -3.77 57.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.051 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.577 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 94.6 p -86.11 16.85 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 16.06 6.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.709 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.066 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.3 mt -100.4 152.52 37.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -76.46 168.75 23.21 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.116 1.587 . . . . 0.0 110.173 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.792 HG13 ' HB3' ' B' ' 111' ' ' PHE . 9.6 t -68.7 -5.86 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.386 -0.821 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.23 -32.78 38.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.214 -0.928 . . . . 0.0 109.446 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.833 HG13 HD22 ' A' ' 45' ' ' LEU . 7.9 mm -82.47 -41.46 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.059 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.6 mt -68.09 -28.12 67.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.47 -24.57 76.68 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.835 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.8 ttm180 -101.62 -31.63 10.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.745 HG11 ' CG2' ' A' ' 77' ' ' VAL . 24.2 t -69.29 -37.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.57 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.8 t-105 -67.6 -51.88 44.99 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.758 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 8.6 mt-10 -51.06 -59.99 3.57 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.16 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.0 mt -62.07 -13.16 23.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.647 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 4.3 m -93.82 -27.2 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.551 -0.718 . . . . 0.0 110.147 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.3 t0 -79.25 70.67 5.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.006 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 HG12 ' HG2' ' A' ' 69' ' ' GLU . 46.2 mm -47.25 -33.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.478 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 12.5 m-20 -94.0 -25.41 17.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 110.122 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 25.5 m-70 64.62 45.27 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 2.7 p30 -110.89 0.62 17.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 110.549 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.579 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 96.27 18.99 29.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.579 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.73 161.86 40.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.211 -1.17 . . . . 0.0 109.889 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.655 HD12 HG11 ' A' ' 36' ' ' VAL . 15.9 mt -119.11 116.24 25.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.232 -0.918 . . . . 0.0 110.194 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 10.8 t0 -71.15 168.79 16.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 0.0 110.047 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptt180 -53.48 -37.27 62.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.933 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.487 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.0 m-20 -85.16 -29.83 24.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.097 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.555 ' OE1' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -74.4 -46.59 39.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.562 0.696 . . . . 0.0 109.166 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.823 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 50.2 t80 -59.11 -22.53 60.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.16 -50.1 62.34 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.963 0.887 . . . . 0.0 109.544 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.489 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 54.2 t -57.19 -26.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.568 0.699 . . . . 0.0 110.105 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -85.11 -7.08 59.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.788 . . . . 0.0 111.694 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.595 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 7.2 mmm -89.95 -40.4 12.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.614 -1.304 . . . . 0.0 110.233 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.515 ' C ' ' CD1' ' A' ' 75' ' ' PHE . 1.9 p90 -77.24 -19.21 56.93 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.239 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.3 mt -77.54 -24.95 49.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.745 ' CG2' HG11 ' A' ' 53' ' ' VAL . 72.5 t -91.11 -34.7 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.637 -0.664 . . . . 0.0 110.133 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -74.63 -26.09 59.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.794 . . . . 0.0 110.386 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.3 m -80.18 -15.92 55.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.066 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 0.0 108.936 178.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.527 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 9.8 t-20 . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 120.553 0.215 . . . . 0.0 110.582 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.31 -10.23 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.982 1.517 . . . . 0.0 110.758 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.792 ' HB3' HG13 ' A' ' 47' ' ' VAL . 88.8 m-85 . . . . . 0 N--CA 1.497 1.884 0 O-C-N 121.171 -0.955 . . . . 0.0 110.233 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 121.441 0.639 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 51.2 t -97.26 126.78 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -95.52 -178.54 0.79 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.889 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.6 Cg_endo -66.38 -37.09 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.644 1.339 . . . . 0.0 109.781 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 10' ' ' LYS . 12.7 pt-20 -66.64 -33.83 76.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.037 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 46.8 m-20 -82.86 -41.49 18.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -68.23 -15.71 63.68 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -83.67 -39.0 20.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.443 -0.785 . . . . 0.0 109.245 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -81.63 -20.77 39.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -81.35 -36.32 29.83 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.516 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 7.0 t70 -76.07 -8.64 57.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.207 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.23 -31.63 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.517 HD13 ' SD ' ' A' ' 74' ' ' MET . 33.9 mt -79.84 -34.78 15.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.759 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.91 -34.17 77.2 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t0 -91.23 -7.56 50.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.394 -0.816 . . . . 0.0 110.011 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -77.45 -14.54 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 108.792 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.084 HD12 ' CD1' ' A' ' 31' ' ' LEU . 12.7 mt -92.91 -55.38 3.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.656 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 m 140.36 97.15 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.473 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 52.5 Cg_endo -74.73 149.64 38.37 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 123.828 1.436 . . . . 0.0 110.951 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -125.76 106.05 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.2 t30 58.0 18.12 4.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.388 -0.82 . . . . 0.0 109.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 97.17 36.04 5.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 82.9 m-85 -150.78 143.74 24.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.093 -1.239 . . . . 0.0 111.969 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.084 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.0 mt -111.2 137.32 49.05 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.83 141.27 33.59 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.139 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.64 -27.53 0.33 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 24.7 t70 -64.77 -27.98 69.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -1.034 . . . . 0.0 110.319 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 77.2 mttt -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.857 ' CG1' HD11 ' A' ' 40' ' ' LEU . 77.1 t -74.97 -41.65 45.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.484 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.562 ' CG ' ' HB2' ' B' ' 110' ' ' PRO . 3.4 mtpt -36.67 -56.77 1.3 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.795 -0.566 . . . . 0.0 110.914 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -67.3 -35.5 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.919 1.483 . . . . 0.0 110.007 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.7 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -61.26 -27.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.926 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.0 mt -97.94 -33.52 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 0.0 110.432 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 37' ' ' LYS . 14.0 mt -73.11 -9.14 58.41 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.171 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -89.3 -9.01 52.15 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.882 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.474 ' OG ' ' HB2' ' A' ' 45' ' ' LEU . 16.3 p -81.67 5.55 17.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.448 -0.782 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 43' ' ' SER . 6.1 ttpt 66.98 19.1 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.931 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.884 HD22 HG13 ' A' ' 49' ' ' ILE . 15.7 mt -100.36 156.47 35.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.0 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -75.44 167.98 25.48 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.123 1.591 . . . . 0.0 110.233 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.699 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.35 -8.0 7.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.346 -0.846 . . . . 0.0 109.219 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.22 -31.63 60.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.884 HG13 HD22 ' A' ' 45' ' ' LEU . 8.5 mm -83.2 -37.19 13.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.812 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.926 HD22 ' HB3' ' A' ' 40' ' ' LEU . 8.5 mt -74.19 -26.25 60.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.533 0.682 . . . . 0.0 109.371 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -69.94 -29.06 71.07 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.794 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.5 mtm180 -101.66 -31.88 10.6 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.251 -0.558 . . . . 0.0 110.462 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.636 HG11 ' CG2' ' A' ' 77' ' ' VAL . 5.6 t -64.57 -55.48 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.195 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.559 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.0 t-105 -57.87 -52.18 66.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -45.46 -66.29 0.42 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.577 0.703 . . . . 0.0 110.689 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.794 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.8 mt -60.54 -16.83 41.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.953 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.0 t -89.34 -14.61 35.28 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' TRP . 2.1 t0 -93.31 83.27 4.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.507 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 31.9 mm -53.44 -38.84 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.374 -0.829 . . . . 0.0 110.804 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.525 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 4.8 p30 -103.72 -20.6 13.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 110.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 19.8 m-70 67.19 42.12 2.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.4 p30 -95.67 1.05 53.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 94.25 25.12 17.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 23.2 mtp -152.76 161.79 42.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -1.204 . . . . 0.0 111.17 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 36' ' ' VAL . 21.9 mt -127.12 112.73 15.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 109.618 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.497 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.6 t70 -72.25 172.99 9.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.104 -0.998 . . . . 0.0 110.079 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.607 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.82 -41.58 64.33 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.202 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -81.15 -36.04 30.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 109.822 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 1.8 tt0 -72.02 -46.31 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.807 . . . . 0.0 108.945 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.961 ' CD2' HD12 ' A' ' 31' ' ' LEU . 16.8 t80 -59.32 -17.37 28.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -72.69 -43.66 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.835 0.826 . . . . 0.0 109.35 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.628 ' O ' HD12 ' A' ' 76' ' ' LEU . 41.8 t -60.02 -26.05 34.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.498 0.666 . . . . 0.0 109.55 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.953 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.31 -6.33 55.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 111.315 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.61 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.2 mmt -83.64 -49.01 9.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.0 109.986 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.583 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.4 p90 -73.97 -28.48 61.51 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 72' ' ' VAL . 10.2 mt -66.28 -22.21 66.29 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.703 HG23 ' O ' ' A' ' 73' ' ' ALA . 54.5 t -91.68 -45.45 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.642 -0.661 . . . . 0.0 110.164 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -75.52 -23.37 56.69 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.573 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.481 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 88.6 m -84.3 -19.74 33.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.601 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.72 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 179.03 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 14.7 t-20 . . . . . 0 N--CA 1.488 1.455 0 N-CA-C 110.204 -0.295 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.562 ' HB2' ' CG ' ' A' ' 37' ' ' LYS . 47.8 Cg_endo -75.05 -1.47 11.27 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.837 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.699 ' O ' HG13 ' A' ' 47' ' ' VAL . 86.8 m-85 . . . . . 0 N--CA 1.492 1.67 0 O-C-N 121.104 -0.998 . . . . 0.0 110.096 179.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 121.484 0.659 . . . . 0.0 110.053 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 84.9 t -93.92 146.47 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.568 -0.707 . . . . 0.0 109.531 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mttp -103.56 175.27 2.3 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 110.421 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.3 -33.82 22.92 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.101 1.579 . . . . 0.0 109.708 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -75.45 -36.5 60.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.612 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -77.74 -36.36 50.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 1.5 tmtt? -72.26 -14.97 61.9 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.212 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.44 -42.35 44.33 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.621 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.18 -21.79 60.61 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CE1' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -77.79 -34.78 52.06 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.13 -8.35 56.82 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.616 . . . . 0.0 109.968 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.73 14.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.67 HG22 ' CE1' ' A' ' 70' ' ' PHE . 18.1 mt -78.29 -29.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.763 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -74.54 -32.46 62.45 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.562 0.696 . . . . 0.0 109.215 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -90.28 -5.52 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 0.0 109.866 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -82.7 -10.75 58.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.108 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.067 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.0 mt -103.15 -13.99 16.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 88.78 101.46 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.468 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.3 Cg_endo -72.53 152.2 53.9 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 124.348 1.709 . . . . 0.0 111.256 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 91.3 t -127.97 109.49 19.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 18.2 t30 57.47 24.07 9.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.491 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 84.77 40.62 8.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.491 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 87.7 m-85 -152.62 153.55 33.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.255 . . . . 0.0 111.749 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.067 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.7 mt -121.8 147.15 46.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' ASP . 58.8 p -95.16 143.21 26.77 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.288 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.621 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.87 -26.37 0.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 16.4 t0 -67.76 -26.04 65.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 0.0 110.134 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 84.7 mttt -91.1 -36.17 14.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.942 HG21 HD12 ' A' ' 65' ' ' LEU . 68.2 t -75.76 -50.04 24.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.09 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.604 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 4.1 ttpt -34.61 -56.23 0.84 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.743 -0.598 . . . . 0.0 111.013 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -64.92 -33.51 51.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.326 1.172 . . . . 0.0 109.936 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.751 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -67.56 -29.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.731 . . . . 0.0 110.002 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.03 ' HB3' HD22 ' A' ' 50' ' ' LEU . 24.7 mt -88.55 -27.1 21.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.148 -0.97 . . . . 0.0 110.204 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 38' ' ' PRO . 19.8 mt -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -73.03 -13.77 61.28 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.611 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.555 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 1.4 p -80.25 7.4 9.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.463 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 43' ' ' SER . 14.4 tptt 64.65 8.64 4.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.0 110.561 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.062 HD13 HG21 ' A' ' 49' ' ' ILE . 17.2 mt -88.75 153.72 50.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.3 Cg_endo -73.51 176.75 8.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.696 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.838 HG22 ' HD1' ' B' ' 111' ' ' PHE . 1.9 t -71.04 -10.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.83 -32.58 57.68 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 1.062 HG21 HD13 ' A' ' 45' ' ' LEU . 8.2 mm -81.98 -38.94 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.892 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.03 HD22 ' HB3' ' A' ' 40' ' ' LEU . 26.7 mt -74.98 -29.69 60.97 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.77 -25.09 75.38 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.847 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.5 ttm180 -101.05 -34.49 9.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.007 -0.702 . . . . 0.0 110.475 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.066 HG11 ' CG2' ' A' ' 77' ' ' VAL . 15.3 t -66.46 -41.76 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.774 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.621 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.0 t-105 -65.17 -51.87 58.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.702 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.0 mm-40 -50.9 -55.46 17.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.949 -1.094 . . . . 0.0 110.01 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.847 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.5 mt -64.38 -12.78 46.15 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.854 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 38.5 m -94.39 -35.85 12.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.757 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' TRP . 17.3 t0 -72.26 92.9 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.569 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 8.9 mm -72.55 -33.64 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.608 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 6.7 m-20 -92.43 -4.22 54.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.439 -0.788 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 28.9 p80 38.73 54.98 1.98 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.649 . . . . 0.0 110.644 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 36.7 p-10 -125.77 18.34 7.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 108.793 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.45 32.77 45.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.7 mtp -150.86 161.79 42.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 111.578 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.942 HD12 HG21 ' A' ' 36' ' ' VAL . 25.1 mt -135.42 110.4 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.022 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 27.1 t0 -70.0 169.32 13.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.087 -1.008 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 12.1 ptt180 -49.06 -41.98 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 109.952 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.743 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -80.85 -35.92 32.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.152 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.569 ' HG3' ' CG1' ' A' ' 59' ' ' ILE . 1.7 tt0 -68.51 -55.35 12.0 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.915 0.864 . . . . 0.0 108.731 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 23.2 t80 -50.01 -24.72 2.78 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -64.58 -49.1 72.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.669 0.747 . . . . 0.0 110.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.48 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 16.8 t -56.78 -25.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.571 -0.706 . . . . 0.0 110.178 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.854 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.19 -8.37 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 112.016 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 8.7 mmm -89.87 -30.35 17.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.375 -1.453 . . . . 0.0 110.147 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -85.52 -21.14 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.981 -1.074 . . . . 0.0 109.008 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 5.1 mt -83.53 -19.53 35.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 0.0 109.561 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.066 ' CG2' HG11 ' A' ' 53' ' ' VAL . 9.8 t -92.21 -44.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -70.28 -36.53 74.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 80.6 m -82.71 -8.52 59.59 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 109.58 179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.558 ' HB2' ' O ' ' A' ' 76' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 122.145 0.974 . . . . 0.0 109.174 179.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.526 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 12.5 t-20 . . . . . 0 N--CA 1.49 1.551 0 CA-C-O 120.675 0.274 . . . . 0.0 110.289 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.526 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.7 Cg_endo -74.93 -7.37 19.15 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.986 1.519 . . . . 0.0 111.076 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.838 ' HD1' HG22 ' A' ' 47' ' ' VAL . 69.5 m-85 . . . . . 0 N--CA 1.495 1.796 0 O-C-N 120.964 -1.085 . . . . 0.0 110.329 179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.43 0 CA-C-O 121.339 0.59 . . . . 0.0 110.007 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.0 t -98.41 152.9 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.841 . . . . 0.0 109.824 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -112.93 178.48 0.96 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.216 -0.927 . . . . 0.0 109.972 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.2 Cg_endo -71.78 -35.86 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.961 1.506 . . . . 0.0 109.772 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -73.21 -30.5 63.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 0.0 109.215 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -78.81 -43.79 24.52 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 13.5 tptp -65.32 -17.46 64.53 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -41.96 34.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.6 ptmt -79.27 -23.1 43.84 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.0 m-30 -75.43 -35.84 60.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 52.9 t0 -77.66 -9.04 58.76 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.46 -35.2 13.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.692 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -76.75 -32.96 21.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.742 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.5 -39.22 64.99 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.7 t70 -86.65 4.23 41.3 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.88 -10.93 37.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 108.938 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.972 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -100.57 -6.95 24.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.79 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.1 Cg_endo -76.1 152.5 35.84 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.486 1.782 . . . . 0.0 110.852 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.4 t -117.72 108.38 24.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.171 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 17.4 t30 57.96 16.22 3.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 109.644 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.88 4.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 80.5 m-85 -145.96 146.24 30.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.266 . . . . 0.0 111.959 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.972 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.7 mt -117.46 139.73 50.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 35' ' ' LYS . 79.9 p -84.42 139.91 31.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.08 -28.21 0.74 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.1 t0 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.635 -0.92 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 10.6 mttm -95.94 -33.91 12.0 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.047 HG11 HD12 ' A' ' 65' ' ' LEU . 89.7 t -76.94 -42.28 32.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.533 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.645 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 23.2 ttmt -42.34 -49.68 12.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.6 Cg_endo -69.56 -33.65 16.91 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.099 1.052 . . . . 0.0 109.44 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.773 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -63.97 -35.38 73.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.437 0.637 . . . . 0.0 109.601 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.065 ' HB3' HD22 ' A' ' 50' ' ' LEU . 25.4 mt -87.89 -23.39 23.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.396 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.2 mt -74.03 -14.44 61.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 109.18 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -85.31 -3.66 58.9 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.122 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.589 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.9 OUTLIER -85.9 15.3 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.527 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.24 13.23 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -0.994 . . . . 0.0 109.757 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.069 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.7 mt -100.23 153.95 37.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 0.0 110.717 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.599 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.8 Cg_endo -78.45 -179.09 5.13 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.137 1.598 . . . . 0.0 110.12 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.815 HG22 ' HD1' ' B' ' 111' ' ' PHE . 10.8 t -78.47 -3.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -82.28 -35.5 27.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.259 -0.901 . . . . 0.0 109.439 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.774 HG13 HD22 ' A' ' 45' ' ' LEU . 9.4 mm -80.67 -38.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.065 HD22 ' HB3' ' A' ' 40' ' ' LEU . 33.9 mt -73.69 -25.99 60.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.84 -25.55 74.66 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.806 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.4 ttm180 -101.42 -31.98 10.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.98 -0.718 . . . . 0.0 110.135 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.015 HG11 HG23 ' A' ' 77' ' ' VAL . 10.0 t -71.06 -34.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.526 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.5 t-105 -67.83 -53.18 28.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.127 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 11.5 mt-10 -45.92 -58.92 3.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.025 -1.047 . . . . 0.0 110.004 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.8 mt -62.15 -18.32 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 108.61 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 1.042 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 45.9 t -87.78 -24.21 23.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t0 -102.78 72.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.715 -0.616 . . . . 0.0 109.584 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -60.62 -19.79 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.857 . . . . 0.0 110.718 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 46.9 p-10 -99.34 -18.16 17.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.919 -1.113 . . . . 0.0 109.481 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 20.9 m-70 58.59 46.83 14.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.441 -0.787 . . . . 0.0 110.985 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 64' ' ' MET . 48.7 p-10 -106.37 21.03 18.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 108.777 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 64.97 32.71 85.13 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 1.9 mmt -147.59 162.15 39.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.971 . . . . 0.0 110.849 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.047 HD12 HG11 ' A' ' 36' ' ' VAL . 12.7 mt -132.26 99.55 4.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.544 -0.723 . . . . 0.0 109.339 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.2 p30 -72.31 164.77 25.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.671 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.517 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.3 ptm180 -38.76 -43.82 0.95 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 111.601 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 12.3 m-20 -80.26 -33.47 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.992 . . . . 0.0 110.347 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE1' ' HA ' ' A' ' 58' ' ' ASP . 18.3 mt-10 -76.92 -48.1 19.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -0.91 . . . . 0.0 108.852 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.917 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.0 t80 -59.33 -18.42 38.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -73.6 -54.0 9.19 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.032 0.92 . . . . 0.0 109.263 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.561 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 59.6 t -53.09 -22.66 4.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 110.039 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.14 -17.16 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 111.713 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 8.7 mmm -82.17 -42.16 19.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.363 -1.461 . . . . 0.0 110.731 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -76.93 -18.44 58.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 108.773 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.617 ' HB3' HG13 ' A' ' 53' ' ' VAL . 7.2 mt -81.63 -24.76 36.16 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.631 0.729 . . . . 0.0 109.186 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.015 HG23 HG11 ' A' ' 53' ' ' VAL . 12.1 t -90.92 -34.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.597 -0.689 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -71.87 -29.57 64.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.383 -0.823 . . . . 0.0 110.843 -179.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 1.2 m -77.97 -17.04 57.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.138 -0.976 . . . . 0.0 109.613 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.069 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.498 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.01 179.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.527 ' OD1' ' N ' ' B' ' 111' ' ' PHE . 6.6 t-20 . . . . . 0 N--CA 1.491 1.603 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.506 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 43.7 Cg_endo -72.96 -40.67 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.843 1.444 . . . . 0.0 110.98 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.815 ' HD1' HG22 ' A' ' 47' ' ' VAL . 47.2 m-85 . . . . . 0 N--CA 1.495 1.812 0 O-C-N 121.044 -1.035 . . . . 0.0 110.554 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 121.659 0.742 . . . . 0.0 109.306 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 3.6 t -89.92 124.98 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HB2' ' CG ' ' A' ' 13' ' ' ASP . 1.5 mttm -74.91 162.7 72.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 110.674 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.42 -29.92 37.07 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.118 1.589 . . . . 0.0 108.747 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.69 -20.86 35.33 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.8 m-20 -85.24 -42.72 14.41 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 5.5 tttt -69.1 -20.44 64.07 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.533 -0.73 . . . . 0.0 109.157 178.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.32 -43.73 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.558 -0.714 . . . . 0.0 109.175 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.7 ptmt -73.65 -29.08 62.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.3 m-30 -67.45 -37.22 82.64 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.26 -10.4 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.685 -0.634 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.76 -31.94 14.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.748 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 28.3 mt -81.26 -28.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.807 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.8 -38.54 58.1 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.452 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.0 t0 -87.78 -0.33 56.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.66 -0.65 . . . . 0.0 109.881 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -89.73 -3.83 58.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 108.884 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.086 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -110.41 -8.94 14.63 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.0 t 83.79 98.4 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.3 Cg_endo -72.33 151.35 54.03 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.613 1.849 . . . . 0.0 110.812 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 50.2 t -122.93 104.67 14.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.7 t30 58.25 22.44 9.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 109.734 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 91.89 37.12 6.14 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 89.8 m-85 -151.16 151.62 32.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -1.182 . . . . 0.0 111.737 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.086 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.9 mt -119.0 151.36 38.35 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 35' ' ' LYS . 97.4 p -97.38 143.97 27.6 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.883 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.608 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.43 -27.65 0.16 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.53 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 1.2 m-20 -66.59 -30.59 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -1.075 . . . . 0.0 110.264 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.0 mttt -85.09 -35.79 21.59 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.871 HG11 HD12 ' A' ' 65' ' ' LEU . 55.7 t -80.06 -45.18 22.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.462 0.648 . . . . 0.0 110.316 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.644 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 5.2 tttt -40.65 -54.29 5.23 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.69 . . . . 0.0 110.789 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -67.01 -33.46 32.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.253 1.133 . . . . 0.0 109.796 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.7 -28.9 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.728 -0.607 . . . . 0.0 109.506 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.098 ' HB3' HD22 ' A' ' 50' ' ' LEU . 84.7 mt -88.05 -27.18 22.16 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 110.168 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 38' ' ' PRO . 23.9 mt -73.81 -12.76 60.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.378 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 33.0 p-10 -80.09 -5.15 55.4 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.433 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -89.69 13.94 12.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.373 -0.83 . . . . 0.0 110.598 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.51 13.63 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.895 HD22 HG13 ' A' ' 49' ' ' ILE . 16.2 mt -94.9 154.19 39.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.022 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.6 174.39 12.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.096 1.577 . . . . 0.0 110.652 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' B' ' 111' ' ' PHE . 6.8 t -71.95 -4.27 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.529 -0.732 . . . . 0.0 109.389 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.59 -35.4 27.12 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.218 -0.927 . . . . 0.0 109.449 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.895 HG13 HD22 ' A' ' 45' ' ' LEU . 7.8 mm -79.79 -38.69 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.837 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.098 HD22 ' HB3' ' A' ' 40' ' ' LEU . 27.8 mt -70.41 -27.24 64.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.389 0.614 . . . . 0.0 109.403 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.25 -24.03 76.92 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.963 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.6 ttm180 -101.54 -31.47 10.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.761 -0.846 . . . . 0.0 110.896 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.787 HG11 ' CG2' ' A' ' 77' ' ' VAL . 12.5 t -68.32 -39.36 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.965 -1.085 . . . . 0.0 109.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.64 -50.29 58.68 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.57 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 51.2 mt-10 -49.32 -56.81 8.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.056 -1.027 . . . . 0.0 109.956 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.963 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -60.48 -16.2 34.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.731 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.792 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 66.2 m -93.02 -31.27 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.463 -0.773 . . . . 0.0 109.149 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 36.0 t0 -89.58 98.39 11.74 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.78 -22.22 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 111.076 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 58.7 p-10 -90.76 -16.54 28.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 110.067 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.0 m170 66.23 42.85 2.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.371 -0.83 . . . . 0.0 110.639 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 23.3 p-10 -111.72 17.22 20.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 109.602 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 64.55 34.8 90.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 40.9 mtp -150.78 162.03 41.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.087 -1.243 . . . . 0.0 110.805 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.871 HD12 HG11 ' A' ' 36' ' ' VAL . 9.4 mt -126.22 106.27 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.735 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 2.3 t70 -69.86 172.12 8.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.29 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -51.81 -34.74 41.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 111.048 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -86.81 -34.56 19.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.04 -1.038 . . . . 0.0 110.019 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 57' ' ' SER . 25.1 mt-10 -76.89 -38.94 52.6 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.965 ' CD2' HD12 ' A' ' 31' ' ' LEU . 38.6 t80 -63.01 -28.97 70.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.9 -51.49 64.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.995 0.902 . . . . 0.0 109.663 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.464 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 41.9 t -52.7 -28.03 12.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.494 0.664 . . . . 0.0 110.452 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.792 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -84.04 -13.61 52.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.319 -0.863 . . . . 0.0 111.862 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.1 mmm -85.82 -32.84 21.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.503 -1.373 . . . . 0.0 111.146 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.464 ' CE2' ' HA ' ' A' ' 72' ' ' VAL . 4.4 p90 -84.47 -18.2 36.63 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.123 . . . . 0.0 108.675 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.497 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.4 mt -83.9 -13.74 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.787 ' CG2' HG11 ' A' ' 53' ' ' VAL . 52.0 t -91.22 -47.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.49 -0.756 . . . . 0.0 110.261 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -71.21 -29.89 65.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.279 -179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 31.2 t -82.09 -10.1 59.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.165 -0.959 . . . . 0.0 109.323 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 49' ' ' ILE . . . . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 122.186 0.994 . . . . 0.0 109.02 179.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 16.1 t-20 . . . . . 0 N--CA 1.492 1.634 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.5 -36.6 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.918 1.483 . . . . 0.0 110.713 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.709 ' HB3' HG13 ' A' ' 47' ' ' VAL . 95.5 m-85 . . . . . 0 N--CA 1.494 1.742 0 O-C-N 121.047 -1.033 . . . . 0.0 110.037 179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.51 0.671 . . . . 0.0 109.682 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.2 t -92.5 137.8 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.162 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.423 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -95.74 173.37 4.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -70.99 -33.77 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.219 1.642 . . . . 0.0 109.993 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -27.48 39.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.3 m-20 -79.72 -40.03 29.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 22.4 tptp -72.31 -20.77 61.44 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.472 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.32 71.11 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.0 ptpt -74.84 -30.31 61.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.636 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.7 m-30 -64.86 -40.94 95.94 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.4 -8.67 56.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.281 0.562 . . . . 0.0 110.432 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -95.33 -33.81 12.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.63 HG22 ' CE1' ' A' ' 70' ' ' PHE . 36.0 mt -79.68 -27.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.83 -39.17 57.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.7 t0 -87.36 0.02 56.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.814 -0.553 . . . . 0.0 110.05 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.96 -7.55 53.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.11 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.9 mt -105.59 -14.38 15.3 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.1 t 90.68 97.2 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.65 151.75 41.79 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.62 1.853 . . . . 0.0 110.701 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.8 t -118.13 104.68 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.57 -0.706 . . . . 0.0 109.17 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 5.0 t30 58.56 15.02 3.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.787 . . . . 0.0 109.678 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.9 32.24 3.89 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -150.07 148.92 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.966 -1.314 . . . . 0.0 112.017 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.11 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.2 mt -114.41 136.39 53.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -82.0 141.56 33.14 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.811 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.498 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.51 -27.56 0.84 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.4 t0 -63.66 -23.53 67.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.549 -0.971 . . . . 0.0 110.05 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 11.9 mttm -98.52 -35.64 10.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.052 HG11 HD12 ' A' ' 65' ' ' LEU . 99.2 t -76.93 -42.16 32.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.569 0.7 . . . . 0.0 110.132 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.648 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 18.6 tttt -41.63 -53.94 7.06 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 111.346 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.31 -34.99 19.78 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.433 1.228 . . . . 0.0 109.907 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.792 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -60.57 -26.14 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.847 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.066 ' HB3' HD22 ' A' ' 50' ' ' LEU . 23.9 mt -96.9 -28.66 14.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.064 -1.022 . . . . 0.0 110.274 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 62.7 mt -69.66 -17.27 63.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.629 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.36 -6.68 58.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.575 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.471 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -85.49 14.18 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 110.13 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 58.71 16.17 4.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.903 . . . . 0.0 110.2 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.037 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.9 mt -96.55 153.39 38.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 110.019 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.7 Cg_endo -76.02 176.32 10.19 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.112 1.585 . . . . 0.0 109.897 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.4 t -73.85 -3.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 46' ' ' PRO . 5.7 m-20 -81.11 -33.83 33.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.395 -0.816 . . . . 0.0 109.12 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.96 HG13 HD22 ' A' ' 45' ' ' LEU . 9.0 mm -82.73 -40.04 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.066 HD22 ' HB3' ' A' ' 40' ' ' LEU . 21.9 mt -73.32 -28.99 62.38 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.613 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -66.1 -24.24 71.71 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.659 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.47 -39.66 7.43 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.011 -0.7 . . . . 0.0 109.878 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.804 HG11 ' CG2' ' A' ' 77' ' ' VAL . 5.8 t -57.35 -45.41 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.041 -1.037 . . . . 0.0 109.751 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 58' ' ' ASP . 4.3 t-105 -63.3 -53.14 57.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.336 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 85.7 mt-10 -54.87 -48.42 72.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.313 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 52' ' ' ARG . 7.8 mt -62.4 -22.88 66.49 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.913 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 41.7 t -89.62 -30.13 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.506 0.67 . . . . 0.0 109.291 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -74.43 79.71 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -60.43 -36.44 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.011 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.2 p30 -103.49 -20.09 14.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 33.2 m-70 69.41 41.8 1.26 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 2.7 p-10 -91.97 9.86 31.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.949 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 80.4 24.66 58.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 50.9 mtp -152.95 160.48 43.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 1.052 HD12 HG11 ' A' ' 36' ' ' VAL . 13.6 mt -119.28 100.5 7.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.1 p30 -69.52 159.2 33.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.064 -1.022 . . . . 0.0 110.313 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.595 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.4 ptp180 -35.77 -43.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 111.251 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 35.8 t70 -75.89 -36.46 59.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.339 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HG2' HG12 ' A' ' 59' ' ' ILE . 85.0 mt-10 -76.62 -43.11 39.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.004 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.967 ' CD2' HD12 ' A' ' 31' ' ' LEU . 22.1 t80 -59.54 -20.52 56.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.13 -49.83 22.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.425 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 55.8 t -58.31 -24.75 25.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.351 0.596 . . . . 0.0 110.259 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -88.27 -9.38 53.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.349 -0.845 . . . . 0.0 111.282 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 3.3 mmt -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.924 -1.11 . . . . 0.0 110.361 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.561 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.3 p90 -77.41 -26.72 51.93 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.256 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB3' HG22 ' A' ' 53' ' ' VAL . 14.3 mt -69.03 -23.02 64.02 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.804 ' CG2' HG11 ' A' ' 53' ' ' VAL . 57.6 t -92.3 -63.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.49 0.662 . . . . 0.0 109.555 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -47.17 -27.93 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.554 -0.716 . . . . 0.0 111.637 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 1.5 m -80.65 -16.16 54.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.84 -1.162 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.037 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.305 -1.333 0 O-C-N 121.366 -0.833 . . . . 0.0 109.785 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.452 ' OD1' ' HD2' ' B' ' 110' ' ' PRO . 48.1 t-20 . . . . . 0 N--CA 1.49 1.545 0 CA-C-O 120.716 0.293 . . . . 0.0 110.601 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' B' ' 109' ' ' ASN . 46.6 Cg_endo -75.88 -28.4 7.81 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.938 1.494 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.738 ' CE2' HD12 ' A' ' 40' ' ' LEU . 64.8 m-85 . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.035 -1.041 . . . . 0.0 110.023 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 121.425 0.631 . . . . 0.0 110.322 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.4 t -92.84 128.38 44.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.485 -0.759 . . . . 0.0 109.373 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.4 mttp -84.35 164.79 41.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.107 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.64 -30.24 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.933 1.491 . . . . 0.0 109.476 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -85.13 -25.3 27.57 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.575 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -77.59 -41.72 37.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 1.5 tmtt? -69.39 -23.63 63.75 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.071 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.76 93.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -38.81 65.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.3 m-30 -60.63 -21.98 63.3 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -90.35 -12.09 38.71 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.78 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.52 -33.38 15.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 41.2 mt -78.38 -29.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.864 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.81 -39.73 50.41 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.672 0.748 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.8 t70 -86.44 1.98 49.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.583 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.24 -10.27 44.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.086 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.089 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.3 mt -105.44 -12.93 15.8 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.1 t 87.24 96.2 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -75.49 152.38 38.45 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.509 1.794 . . . . 0.0 110.933 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 26.3 t -116.65 107.8 23.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 7.6 t30 58.76 15.13 3.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.348 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.94 32.26 4.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -144.32 149.5 36.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.0 111.859 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.089 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.8 mt -117.17 138.95 51.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 14.0 p -85.86 141.08 29.87 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.069 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.451 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.33 -26.71 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 29.1 t70 -61.25 -28.53 69.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -1.093 . . . . 0.0 109.736 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.579 ' HB3' HD13 ' A' ' 24' ' ' LEU . 46.8 mttm -94.11 -33.2 13.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.242 -0.911 . . . . 0.0 108.579 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.625 HG12 HD11 ' A' ' 40' ' ' LEU . 79.6 t -79.67 -44.3 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.463 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.595 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 25.2 tttt -40.2 -54.02 4.84 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.889 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -66.83 -36.44 23.68 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 109.683 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -59.74 -37.59 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.557 -0.714 . . . . 0.0 109.607 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.996 ' HB3' HD22 ' A' ' 50' ' ' LEU . 34.9 mt -83.89 -29.02 27.52 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.411 -0.806 . . . . 0.0 109.845 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -74.01 -12.48 60.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.399 -0.813 . . . . 0.0 109.512 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -90.27 -4.98 56.82 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.125 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.582 ' CB ' HG13 ' A' ' 77' ' ' VAL . 60.5 p -84.13 8.87 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.2 OUTLIER 66.77 7.65 5.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.09 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 1.04 HD11 ' HB3' ' A' ' 80' ' ' ALA . 18.8 mt -93.18 155.87 40.72 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.3 Cg_endo -74.55 167.78 26.33 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.204 1.634 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' B' ' 111' ' ' PHE . 17.5 t -66.63 -7.78 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.4 t0 -77.33 -30.94 54.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.831 HG13 HD22 ' A' ' 45' ' ' LEU . 9.1 mm -84.69 -36.61 11.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.974 0.892 . . . . 0.0 108.943 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.5 mt -75.51 -25.59 57.38 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -75.6 -25.03 68.63 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.586 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.1 ttm180 -100.81 -29.67 12.12 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.014 HG11 HG23 ' A' ' 77' ' ' VAL . 17.0 t -69.67 -51.03 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 1.5 t-105 -59.86 -53.63 55.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -45.43 -65.7 0.5 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.924 0.869 . . . . 0.0 110.12 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.586 HD12 ' O ' ' A' ' 52' ' ' ARG . 22.2 mt -56.76 -18.27 12.07 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.997 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.3 t -91.66 -17.29 25.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t70 -94.87 82.43 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.312 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -87.0 -20.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 110.892 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 5.8 p30 -94.52 -21.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 25.0 m-70 70.86 40.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.465 -0.772 . . . . 0.0 110.673 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 32.1 p-10 -101.89 15.13 29.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.427 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 62.29 31.85 80.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 74.8 mtp -154.41 161.29 41.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.366 -1.079 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 ' OG ' ' A' ' 57' ' ' SER . 9.0 mt -116.9 101.11 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 109.344 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.5 p30 -69.67 160.85 30.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 110.339 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.511 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.8 ptt85 -33.88 -45.41 0.19 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.826 -0.546 . . . . 0.0 111.604 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 22.6 m-20 -78.1 -41.25 35.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.437 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 44.8 mt-10 -67.77 -48.1 67.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.316 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.846 ' CD2' HD12 ' A' ' 31' ' ' LEU . 10.2 t80 -57.88 -17.88 19.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -75.37 -53.73 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.431 -0.793 . . . . 0.0 109.506 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.494 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.4 t -55.39 -27.13 20.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.25 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.815 . . . . 0.0 110.816 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.5 mmt -87.15 -50.02 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.662 -1.274 . . . . 0.0 110.066 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.485 ' O ' ' HB2' ' A' ' 79' ' ' CYS . 4.2 p90 -74.51 -27.71 60.67 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.504 HD23 ' HA ' ' A' ' 76' ' ' LEU . 7.5 mt -62.95 -30.52 71.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.014 HG23 HG11 ' A' ' 53' ' ' VAL . 18.0 t -91.17 -23.8 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.896 -0.503 . . . . 0.0 109.942 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.43 -21.29 23.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.449 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.485 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 3.9 t -84.59 -18.23 36.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 1.04 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.076 179.207 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.482 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 1.1 t-20 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 110.132 -0.321 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.505 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.5 Cg_endo -82.51 21.15 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.87 1.458 . . . . 0.0 111.056 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.916 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 78.8 m-85 . . . . . 0 N--CA 1.494 1.73 0 O-C-N 120.954 -1.092 . . . . 0.0 110.071 179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.278 0.561 . . . . 0.0 110.161 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 49.3 t -106.13 157.91 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.587 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mttt -108.15 170.56 5.4 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.1 Cg_endo -66.17 -32.69 42.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.665 1.35 . . . . 0.0 109.915 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.6 mt-10 -70.07 -32.03 69.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.454 -0.779 . . . . 0.0 109.402 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.4 m-20 -77.04 -40.94 44.52 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 8.2 tptm -65.3 -15.87 62.97 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.681 0.753 . . . . 0.0 109.073 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 -27.44 39.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 1.8 mtpt -90.72 -38.11 13.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.548 ' N ' ' CD1' ' A' ' 17' ' ' TYR . 4.9 m-30 -66.18 -27.07 67.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 1.1 t70 -89.42 -12.72 39.45 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.06 -28.24 17.28 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.773 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.255 54.0 mt -82.91 -35.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.738 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.74 -39.44 73.31 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.751 0.786 . . . . 0.0 108.949 178.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -87.35 -1.65 58.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.801 -0.562 . . . . 0.0 110.121 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 8.5 t -87.0 -11.37 50.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.01 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.975 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.0 mt -100.45 -10.7 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.72 97.08 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -74.9 149.52 37.31 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.308 1.688 . . . . 0.0 110.752 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.6 t -118.13 108.83 25.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 25.5 t30 58.91 22.29 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.583 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 87.62 39.56 7.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.54 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 90.6 m-85 -151.16 154.6 37.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.305 -1.115 . . . . 0.0 111.615 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.975 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.8 mt -123.07 137.21 54.99 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.494 ' CA ' ' SD ' ' A' ' 64' ' ' MET . 1.3 p -91.62 147.32 23.09 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.954 -1.091 . . . . 0.0 110.404 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -41.72 -27.93 0.37 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 13.3 t70 -62.09 -25.72 67.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.996 . . . . 0.0 110.411 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.7 mttp -101.64 -28.41 12.52 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.04 -1.037 . . . . 0.0 108.856 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.743 ' CG1' HD12 ' A' ' 65' ' ' LEU . 91.6 t -83.81 -48.47 17.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.487 -0.758 . . . . 0.0 110.755 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.59 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 4.5 ttpp -41.53 -51.26 8.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.8 Cg_endo -67.83 -32.63 29.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.142 1.075 . . . . 0.0 109.575 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -66.92 -36.61 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.686 -0.634 . . . . 0.0 109.62 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.088 ' HB3' HD22 ' A' ' 50' ' ' LEU . 58.0 mt -82.33 -25.43 33.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.812 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.464 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 39.4 mt -74.51 -11.56 60.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.12 -10.33 57.87 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.078 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.591 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -81.71 8.91 8.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 43' ' ' SER . 1.3 ttmt 64.04 11.11 5.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 110.124 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.952 HD22 HG13 ' A' ' 49' ' ' ILE . 14.5 mt -88.84 154.14 49.99 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.016 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.4 Cg_endo -75.0 172.32 16.61 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.946 1.498 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.708 HG22 ' HD1' ' B' ' 111' ' ' PHE . 5.9 t -70.21 -5.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 109.725 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -80.73 -33.09 35.43 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.234 -0.917 . . . . 0.0 109.386 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.952 HG13 HD22 ' A' ' 45' ' ' LEU . 8.7 mm -81.5 -39.9 17.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.088 HD22 ' HB3' ' A' ' 40' ' ' LEU . 19.7 mt -70.01 -28.64 65.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.54 -24.45 75.21 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 1.003 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.9 ttm-85 -101.99 -33.99 9.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.905 -0.762 . . . . 0.0 110.888 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 1.107 HG11 ' CG2' ' A' ' 77' ' ' VAL . 22.7 t -67.84 -36.22 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.846 -1.159 . . . . 0.0 109.264 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.568 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.1 t-105 -68.32 -49.88 57.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.281 -0.967 . . . . 0.0 109.435 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.5 mt-10 -56.01 -56.33 22.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.466 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.003 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -59.38 -15.67 18.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.101 -1.0 . . . . 0.0 108.54 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.867 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 28.5 t -94.22 -30.99 14.3 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -85.42 98.22 10.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.692 -0.63 . . . . 0.0 110.08 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' A' ' 69' ' ' GLU . 3.3 mt -96.15 -21.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.917 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -95.28 -13.98 24.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 24.1 m170 61.4 44.4 9.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.415 -0.803 . . . . 0.0 110.787 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 20.8 p-10 -106.83 18.56 21.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.135 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.542 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 61.49 30.42 74.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.542 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 3.3 mmm -148.97 161.07 42.65 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.327 -1.102 . . . . 0.0 109.255 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.743 HD12 ' CG1' ' A' ' 36' ' ' VAL . 8.9 mt -111.86 107.81 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.852 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.569 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -68.21 148.99 50.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.131 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -39.57 -37.82 0.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.381 -0.824 . . . . 0.0 110.259 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -77.37 -36.62 53.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 85.9 mt-10 -73.04 -51.21 19.01 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.866 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.2 t80 -50.0 -25.94 3.82 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -69.74 -54.58 13.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.071 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.547 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 52.4 t -53.65 -22.65 6.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 109.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.867 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.24 -14.78 35.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.275 -0.89 . . . . 0.0 111.937 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.539 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.3 mmm -81.77 -41.07 21.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.411 -1.431 . . . . 0.0 110.491 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.4 p90 -76.79 -25.52 53.41 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.297 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.585 ' HB3' HG22 ' A' ' 53' ' ' VAL . 5.9 mt -72.35 -27.49 62.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.514 0.673 . . . . 0.0 109.267 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.107 ' CG2' HG11 ' A' ' 53' ' ' VAL . 33.3 t -91.59 -21.84 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.658 -0.652 . . . . 0.0 110.524 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 -22.08 22.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 26.7 m -83.74 -17.4 41.37 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.473 -0.767 . . . . 0.0 109.481 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.917 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.377 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.504 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 24.6 t-20 . . . . . 0 N--CA 1.49 1.566 0 N-CA-C 110.162 -0.31 . . . . 0.0 110.162 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.63 27.62 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.891 1.469 . . . . 0.0 111.869 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.708 ' HD1' HG22 ' A' ' 47' ' ' VAL . 62.6 m-85 . . . . . 0 N--CA 1.497 1.875 0 O-C-N 120.726 -1.234 . . . . 0.0 110.33 179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.492 0.663 . . . . 0.0 110.463 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.66 HG13 ' HE2' ' A' ' 17' ' ' TYR . 22.9 t -96.02 112.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.601 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.551 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -88.28 -177.53 0.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.955 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -70.12 -37.44 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.748 1.394 . . . . 0.0 109.789 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.7 pt-20 -70.94 -30.22 66.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.8 m-20 -77.89 -42.44 33.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.686 ' CE ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -65.38 -33.82 76.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.48 62.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -72.31 -26.97 62.16 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.66 ' HE2' HG13 ' A' ' 9' ' ' VAL . 10.0 m-30 -74.03 -36.31 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.756 0.789 . . . . 0.0 109.147 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.9 t70 -74.69 -9.1 58.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.796 -0.565 . . . . 0.0 110.618 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.75 -32.26 13.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.668 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 72.5 mt -80.06 -31.46 13.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.761 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -72.9 -41.96 64.08 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.7 t70 -86.46 3.33 44.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 110.069 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.56 -7.49 50.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.182 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.072 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.2 mt -106.34 -8.85 17.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 83.06 92.2 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.7 Cg_endo -72.76 151.09 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.303 1.686 . . . . 0.0 111.134 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 75.3 t -122.52 104.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 67.66 22.61 8.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.387 -0.821 . . . . 0.0 108.962 -178.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 83.84 37.84 11.17 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 82.6 m-85 -148.7 147.27 28.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 111.513 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.072 ' CD1' HD12 ' A' ' 24' ' ' LEU . 15.5 mt -114.59 132.84 56.21 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.0 p -76.72 144.39 39.35 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.56 -27.09 0.28 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.9 t70 -66.41 -28.15 68.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.512 -0.993 . . . . 0.0 110.477 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.5 mttp -90.84 -35.74 14.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.996 -1.065 . . . . 0.0 108.223 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.812 HG11 HD12 ' A' ' 65' ' ' LEU . 94.9 t -77.66 -45.11 28.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.625 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.671 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 tttt -37.84 -54.63 2.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.708 -0.62 . . . . 0.0 110.951 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.618 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.8 Cg_endo -67.05 -34.68 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.495 1.261 . . . . 0.0 110.028 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.678 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.1 t -61.99 -27.01 41.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 110.117 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.092 ' HB3' HD22 ' A' ' 50' ' ' LEU . 24.1 mt -94.16 -29.03 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.662 HD11 ' HG3' ' A' ' 37' ' ' LYS . 8.8 mt -74.84 -15.28 60.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.92 -1.112 . . . . 0.0 108.96 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -13.57 59.66 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.944 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.581 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 27.4 p -82.87 11.7 5.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 0.0 110.326 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 12.21 4.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.0 mt -87.04 155.66 55.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.7 Cg_endo -77.4 168.95 22.03 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.026 1.54 . . . . 0.0 109.548 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -69.77 -4.34 3.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 -30.74 39.2 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.311 -0.868 . . . . 0.0 109.103 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.795 HG13 HD22 ' A' ' 45' ' ' LEU . 11.4 mm -85.35 -36.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.882 0.848 . . . . 0.0 108.884 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.092 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -77.31 -26.17 51.98 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.16 -26.91 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 1.026 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.96 -36.93 8.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 122.039 -0.683 . . . . 0.0 110.566 179.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 49' ' ' ILE . 6.8 t -59.73 -41.44 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.044 -1.035 . . . . 0.0 110.128 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.6 t-105 -66.98 -51.64 52.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.929 -1.107 . . . . 0.0 109.716 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.6 mt-10 -52.3 -59.92 3.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 110.481 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 1.026 HD11 ' CZ ' ' A' ' 52' ' ' ARG . 1.2 mt -59.95 -30.14 68.88 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.751 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.971 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 44.3 t -75.29 -29.76 60.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.327 -0.858 . . . . 0.0 108.809 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -70.42 62.41 0.24 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.578 -0.701 . . . . 0.0 109.54 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.518 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 43.4 mm -43.21 -33.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.992 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.443 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 1.6 m-20 -99.85 -20.7 16.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 44.3 m-70 59.33 38.47 23.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.6 -1.34 44.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 99.1 20.74 17.33 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.6 mtp -153.26 161.3 42.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.593 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.812 HD12 HG11 ' A' ' 36' ' ' VAL . 12.6 mt -118.98 107.07 13.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.5 p30 -75.15 160.67 30.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.886 -1.134 . . . . 0.0 109.706 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.606 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ppt_? -36.88 -46.33 0.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.671 -0.643 . . . . 0.0 111.741 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 1.7 t70 -72.75 -38.87 67.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.096 -1.002 . . . . 0.0 110.268 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 50.7 mt-10 -71.33 -46.63 60.16 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 108.791 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.96 ' CD2' HD12 ' A' ' 31' ' ' LEU . 26.7 t80 -59.03 -18.6 36.13 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.686 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . . . -76.01 -50.57 14.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.545 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.1 t -59.89 -24.21 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.586 -0.696 . . . . 0.0 109.679 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.36 -4.99 56.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.289 -0.882 . . . . 0.0 110.877 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.578 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.5 mmt -84.44 -46.21 11.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.657 ' CD2' HG22 ' A' ' 9' ' ' VAL . 2.1 p90 -76.01 -29.36 58.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 72' ' ' VAL . 4.5 mt -60.42 -27.8 67.76 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' ALA . 77.2 t -92.55 -41.89 13.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.624 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.39 -29.22 59.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.355 -0.841 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.461 ' SG ' ' O ' ' A' ' 75' ' ' PHE . 82.6 m -80.83 -11.82 59.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.799 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.247 -0.908 . . . . 0.0 108.554 178.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.515 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 18.2 t-20 . . . . . 0 N--CA 1.491 1.58 0 CA-C-O 120.843 0.354 . . . . 0.0 110.395 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.598 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -76.19 -29.36 6.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.096 1.577 . . . . 0.0 111.207 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 1.034 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 40.3 m-85 . . . . . 0 N--CA 1.496 1.84 0 O-C-N 121.018 -1.051 . . . . 0.0 110.7 -179.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.329 0.585 . . . . 0.0 110.145 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.422 HG13 ' HB3' ' A' ' 13' ' ' ASP . 39.8 t -99.46 127.37 52.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.602 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.523 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -83.79 175.35 4.79 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.8 Cg_endo -67.71 -34.91 23.48 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.885 1.466 . . . . 0.0 109.412 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.09 -28.11 61.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.437 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -82.21 -38.86 23.94 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 8.2 tttt -70.43 -18.46 63.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.42 -44.93 61.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.1 ptmm? -73.66 -18.24 61.05 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.637 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -83.33 -28.6 28.91 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -84.98 -9.68 57.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.695 -0.628 . . . . 0.0 110.452 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.82 -31.73 15.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 95.5 mt -80.82 -37.6 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -66.27 -33.89 76.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.52 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -90.0 -6.44 55.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.638 -0.664 . . . . 0.0 109.806 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 t -83.46 -9.77 58.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 108.93 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.819 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.7 mt -104.69 -11.53 16.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 84.37 99.59 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.017 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -76.06 152.37 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.149 1.605 . . . . 0.0 110.727 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 51.0 t -121.52 106.65 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.088 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.4 t30 60.62 17.58 7.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.296 -0.877 . . . . 0.0 109.306 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 95.43 36.02 5.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 81.8 m-85 -150.38 144.42 25.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 111.964 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.822 HD12 ' CD1' ' A' ' 70' ' ' PHE . 8.6 mt -109.07 143.33 38.54 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.458 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 60.3 p -92.01 144.6 25.28 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.293 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -42.9 -26.21 0.43 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -69.8 -23.85 63.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.939 . . . . 0.0 110.383 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 12.9 mttp -93.69 -35.01 13.03 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 40' ' ' LEU . 95.7 t -75.94 -39.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.967 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.571 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -39.82 -56.65 3.0 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.233 -0.917 . . . . 0.0 110.95 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.3 Cg_endo -65.92 -32.85 44.29 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.675 1.355 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.882 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.6 t -65.18 -30.04 49.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.921 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 1.059 HD12 ' CZ ' ' B' ' 111' ' ' PHE . 22.5 mt -93.05 -36.24 12.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 37' ' ' LYS . 6.6 mt -70.88 -14.18 62.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.109 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -78.81 -13.93 59.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.459 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.521 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.8 OUTLIER -79.18 6.15 10.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.648 -0.658 . . . . 0.0 110.263 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.2 ttpt 67.39 15.7 9.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.973 HD22 HG13 ' A' ' 49' ' ' ILE . 16.1 mt -96.7 154.38 38.43 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.6 178.92 6.96 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 109.957 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -75.35 -1.96 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' OD1' HD13 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -84.44 -32.84 23.85 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.231 -0.918 . . . . 0.0 109.326 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.973 HG13 HD22 ' A' ' 45' ' ' LEU . 8.2 mm -84.85 -35.77 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.989 0.9 . . . . 0.0 108.735 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 1.057 HD22 ' HB3' ' A' ' 40' ' ' LEU . 25.3 mt -79.76 -23.37 42.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.618 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.07 -24.78 75.12 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.933 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -101.28 -30.55 11.45 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.85 -0.794 . . . . 0.0 110.087 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.946 HG11 HG23 ' A' ' 77' ' ' VAL . 24.6 t -69.25 -38.47 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.228 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.583 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.8 t-105 -65.93 -50.79 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.08 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.7 mt-10 -56.84 -57.45 12.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.292 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -59.87 -15.13 18.87 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.042 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.961 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 30.3 t -94.78 -36.76 11.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.583 ' OD1' ' CE2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -74.65 89.75 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 111.01 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 15.7 mm -60.74 -32.24 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.13 -0.981 . . . . 0.0 109.384 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.0 109.693 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 30.1 p80 40.74 40.54 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.424 0.63 . . . . 0.0 110.57 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.51 0.43 57.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.323 -0.86 . . . . 0.0 109.042 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.56 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 101.62 18.85 17.27 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.56 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.5 mmm -146.89 160.85 41.81 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.148 -1.207 . . . . 0.0 109.818 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.648 HD12 HG11 ' A' ' 36' ' ' VAL . 12.4 mt -120.05 110.3 16.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.222 -0.924 . . . . 0.0 110.036 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 9.1 t70 -69.38 169.56 12.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.116 -0.99 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.4 ptm180 -51.31 -40.34 58.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 3.1 t70 -81.11 -28.85 35.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.252 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 4.8 tt0 -74.51 -44.74 49.9 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.617 0.723 . . . . 0.0 109.198 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.882 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 44.2 t80 -62.6 -18.56 62.43 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.37 -49.05 24.32 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.938 0.875 . . . . 0.0 109.145 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.513 ' O ' ' CE1' ' A' ' 75' ' ' PHE . 30.2 t -55.6 -30.75 27.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.469 0.652 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.961 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.09 -4.32 57.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.795 . . . . 0.0 111.759 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.604 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmt -85.39 -44.18 13.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.642 -1.287 . . . . 0.0 109.984 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 6.2 p90 -79.19 -23.13 44.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.652 ' HB3' HG13 ' A' ' 53' ' ' VAL . 4.3 mt -72.75 -25.41 61.19 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.946 HG23 HG11 ' A' ' 53' ' ' VAL . 44.6 t -89.93 -44.75 15.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -69.5 -27.86 65.55 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.798 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.04 -15.16 58.61 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.042 -1.036 . . . . 0.0 109.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.71 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.304 -1.407 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.181 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 20.3 t-20 . . . . . 0 N--CA 1.49 1.526 0 N-CA-C 110.029 -0.36 . . . . 0.0 110.029 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.582 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 47.5 Cg_endo -73.8 -25.46 14.49 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.953 1.502 . . . . 0.0 110.982 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 1.059 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 71.5 m-85 . . . . . 0 N--CA 1.495 1.82 0 O-C-N 120.992 -1.067 . . . . 0.0 110.509 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.732 0 CA-C-O 121.365 0.602 . . . . 0.0 110.324 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG22 ' CD2' ' A' ' 75' ' ' PHE . 44.0 t -95.79 155.0 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.621 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -90.17 163.96 29.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 109.923 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.64 -30.17 23.24 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.011 1.532 . . . . 0.0 109.683 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.3 mt-10 -86.68 -18.63 30.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.475 0.655 . . . . 0.0 109.462 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.577 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 3.6 m-20 -79.94 -43.98 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 71' ' ' ALA . 7.2 tptp -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.72 74.92 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -78.04 -44.54 26.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 6.2 m-30 -54.73 -24.65 23.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.3 -14.57 40.5 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.527 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.87 -29.69 15.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.252 51.1 mt -80.03 -32.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 177.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.69 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.639 0.733 . . . . 0.0 109.204 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -90.41 -8.56 50.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.71 -0.619 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -13.72 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 108.867 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 1.003 HD12 ' CD1' ' A' ' 31' ' ' LEU . 10.9 mt -93.68 -54.53 3.6 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.66 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 m 137.54 96.41 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.479 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -71.45 146.59 50.4 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 123.948 1.499 . . . . 0.0 110.541 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 20.8 t -116.76 97.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 1.5 t30 60.56 11.32 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 110.79 33.49 2.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 82.3 m-85 -150.68 150.04 30.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.181 -1.188 . . . . 0.0 112.228 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 1.003 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.0 mt -117.28 136.08 53.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 34' ' ' ASP . 91.0 p -85.2 141.32 30.23 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.261 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.45 -27.93 0.17 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -62.43 -26.61 68.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -1.034 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 53.2 mttt -96.53 -31.81 12.59 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.106 -0.996 . . . . 0.0 108.481 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 65' ' ' LEU . 99.0 t -82.36 -46.88 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.208 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.625 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -42.79 -53.74 9.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.75 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -65.81 -34.03 41.46 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 109.288 -1.081 . . . . 0.0 109.288 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.47 -30.43 49.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.493 0.663 . . . . 0.0 109.54 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.997 ' HB3' HD22 ' A' ' 50' ' ' LEU . 88.4 mt -86.72 -24.45 25.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.439 -0.788 . . . . 0.0 110.31 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD1' ' HD3' ' A' ' 37' ' ' LYS . 19.4 mt -79.31 -13.57 59.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.54 -6.88 58.77 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.829 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.06 12.1 6.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 109.934 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 64.71 17.77 11.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 109.98 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.904 HD22 HG13 ' A' ' 49' ' ' ILE . 15.1 mt -100.38 149.78 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.446 -0.784 . . . . 0.0 110.627 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.8 Cg_endo -75.88 175.34 11.44 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.059 1.557 . . . . 0.0 109.97 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.79 HG22 ' HD1' ' B' ' 111' ' ' PHE . 2.4 t -72.39 -2.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.25 -32.11 24.62 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.268 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.904 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -84.35 -36.5 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.997 HD22 ' HB3' ' A' ' 40' ' ' LEU . 20.1 mt -75.62 -27.35 58.42 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.69 -24.06 75.37 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.826 ' O ' HD12 ' A' ' 56' ' ' LEU . 5.7 ttm105 -101.16 -33.96 9.89 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.942 -0.74 . . . . 0.0 109.935 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 HG23 ' A' ' 77' ' ' VAL . 38.0 t -69.26 -44.29 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.954 -1.091 . . . . 0.0 109.418 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.0 t-105 -60.78 -45.99 92.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.322 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 4.7 mm-40 -58.41 -55.81 30.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.243 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.8 mt -62.36 -14.42 39.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 108.575 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.932 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.4 t -95.14 -29.52 14.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.348 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.58 82.15 4.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.097 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.482 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 38.3 mm -57.89 -35.41 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 15.8 m-20 -96.84 -18.76 19.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 86.5 m-70 57.34 48.82 14.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.988 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -115.58 23.89 12.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.47 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 72.98 27.83 67.92 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.0 mtt -151.17 160.94 43.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.741 HD12 HG11 ' A' ' 36' ' ' VAL . 10.9 mt -125.75 110.03 13.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.922 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.5 t70 -69.55 168.51 14.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.0 109.357 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.3 ptt180 -50.74 -39.47 52.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.523 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 37.7 m-20 -79.78 -33.08 40.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.228 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 33.5 mt-10 -73.53 -42.99 61.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.884 ' CD2' HD12 ' A' ' 31' ' ' LEU . 35.9 t80 -58.62 -27.38 64.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.567 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . . . -66.89 -46.86 73.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 110.092 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.41 ' HA ' ' HE2' ' A' ' 75' ' ' PHE . 61.6 t -58.62 -25.67 29.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.611 0.72 . . . . 0.0 109.86 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.67 -9.0 51.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.818 . . . . 0.0 112.186 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 4.4 mmm -85.47 -44.1 13.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.602 -1.311 . . . . 0.0 110.386 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.573 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -76.67 -26.83 55.24 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.31 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.573 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.3 mt -69.41 -23.99 63.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.848 HG23 HG11 ' A' ' 53' ' ' VAL . 61.8 t -91.4 -46.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.807 -0.558 . . . . 0.0 109.626 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.33 -28.71 68.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.7 -0.625 . . . . 0.0 110.908 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . 0.452 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 5.9 t -80.45 -14.96 57.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.171 -0.956 . . . . 0.0 109.969 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.3 -1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.068 179.183 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' A' ' 55' ' ' GLU . 42.9 t-20 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.574 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -75.88 9.74 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.832 1.438 . . . . 0.0 111.632 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.79 ' HD1' HG22 ' A' ' 47' ' ' VAL . 98.9 m-85 . . . . . 0 N--CA 1.499 1.979 0 O-C-N 120.778 -1.201 . . . . 0.0 110.366 179.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 121.412 0.625 . . . . 0.0 110.789 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.64 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 46.3 t -101.23 134.92 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.777 . . . . 0.0 110.055 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -91.79 -179.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.385 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.7 Cg_endo -69.47 -36.47 11.53 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.941 1.495 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.77 -27.12 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 109.957 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 13.0 m-20 -80.93 -38.12 28.38 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.242 -0.911 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 2.2 tttt -77.13 -21.27 54.44 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.948 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -66.92 -39.35 87.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.72 -24.47 58.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 12.3 m-30 -76.96 -32.2 57.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -11.7 60.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.682 -0.636 . . . . 0.0 110.029 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.6 -31.61 17.49 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.655 HG22 ' CE1' ' A' ' 70' ' ' PHE . 25.6 mt -81.47 -37.0 15.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.758 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.26 -34.71 76.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 22' ' ' ASP . 6.8 t0 -90.49 -4.63 56.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.626 -0.672 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 25.8 t -85.99 -4.91 59.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -0.97 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.874 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.47 -14.96 14.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.1 t 91.22 101.24 0.02 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.237 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -76.03 154.19 37.55 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.416 1.745 . . . . 0.0 110.607 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 94.3 t -122.6 102.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.497 -0.752 . . . . 0.0 109.306 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.4 t30 58.06 18.65 5.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 100.91 36.46 3.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 29' ' ' GLY . 86.9 m-85 -153.28 145.44 23.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.848 -1.384 . . . . 0.0 112.003 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.898 HD12 ' CD2' ' A' ' 70' ' ' PHE . 10.1 mt -113.65 138.47 50.15 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.5 p -88.64 146.86 24.85 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.21 -26.11 0.32 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 32' ' ' SER . 56.9 m-20 -63.82 -26.13 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -1.024 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.7 mttt -96.17 -35.75 11.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.091 -1.006 . . . . 0.0 108.507 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.914 HG11 HD12 ' A' ' 65' ' ' LEU . 63.0 t -79.18 -41.35 22.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.156 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 3.1 ttpt -41.31 -55.39 5.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.652 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.3 Cg_endo -67.85 -34.72 23.21 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.559 1.294 . . . . 0.0 109.935 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.861 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.1 t -59.71 -34.16 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 109.839 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.966 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.5 mt -88.77 -27.25 21.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.804 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 61.1 mt -71.99 -12.26 61.16 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 109.128 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -87.72 -4.52 58.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.989 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.467 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 1.2 m -86.04 8.62 19.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 13.14 4.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.095 -1.003 . . . . 0.0 109.747 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.996 HD13 HG21 ' A' ' 49' ' ' ILE . 16.9 mt -95.56 156.42 37.51 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HG2' HG12 ' A' ' 49' ' ' ILE . 43.9 Cg_endo -73.26 167.64 26.81 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 124.141 1.6 . . . . 0.0 109.888 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.642 HG22 ' HD1' ' B' ' 111' ' ' PHE . 1.2 t -65.11 -9.32 7.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.263 -0.898 . . . . 0.0 109.321 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.3 m-20 -76.58 -30.46 57.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.344 -0.848 . . . . 0.0 109.214 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.996 HG21 HD13 ' A' ' 45' ' ' LEU . 13.4 mm -84.58 -38.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 122.002 0.906 . . . . 0.0 108.78 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.966 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.6 mt -78.5 -26.86 46.04 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.57 0.7 . . . . 0.0 109.252 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -81.18 -24.21 57.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.689 ' NH2' ' CD1' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -101.24 -26.16 13.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.147 -0.619 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.794 HG11 HG23 ' A' ' 77' ' ' VAL . 12.6 t -75.77 -43.23 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.774 -1.204 . . . . 0.0 107.869 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' TRP . . . . . 0.563 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 1.5 t-105 -55.28 -49.04 73.12 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.442 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.0 mm-40 -53.75 -54.89 31.77 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 0.0 109.781 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.689 ' CD1' ' NH2' ' A' ' 52' ' ' ARG . 8.2 mt -61.37 -15.85 40.48 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 108.718 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.832 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 31.8 m -94.07 -38.96 10.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.583 -0.698 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 54' ' ' TRP . 4.8 t0 -60.94 100.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 110.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.531 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -83.48 -20.82 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 19.5 m-20 -105.35 -16.31 14.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.438 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' HIS . . . . . 0.45 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 6.9 m170 60.57 43.84 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.973 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 10.5 p30 -112.84 -6.82 13.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.527 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.549 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 100.95 23.39 9.88 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' MET . . . . . 0.549 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.0 mmm -147.57 161.16 41.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.222 -1.164 . . . . 0.0 109.374 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.914 HD12 HG11 ' A' ' 36' ' ' VAL . 7.9 mt -121.36 107.76 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.083 -1.011 . . . . 0.0 110.325 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 61.0 t0 -69.61 169.29 13.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.96 -1.088 . . . . 0.0 110.114 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.1 ptt180 -50.56 -37.83 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.505 -0.747 . . . . 0.0 109.976 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.439 ' OD2' ' HG3' ' A' ' 67' ' ' ARG . 9.2 m-20 -78.65 -32.86 47.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.64 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 39.3 mt-10 -76.71 -41.64 44.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.349 -0.844 . . . . 0.0 109.045 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . 0.898 ' CD2' HD12 ' A' ' 31' ' ' LEU . 9.3 t80 -61.21 -25.38 67.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.526 -0.734 . . . . 0.0 109.242 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -69.59 -47.08 64.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.794 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' VAL . . . . . 0.651 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 92.0 t -61.29 -23.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.45 -2.95 57.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 110.835 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 16.1 mmt -89.59 -46.21 8.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.929 -1.107 . . . . 0.0 109.658 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.651 ' CE2' ' HA ' ' A' ' 72' ' ' VAL . 2.0 p90 -77.61 -17.91 57.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.244 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.597 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.6 mt -77.07 -26.5 53.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.794 HG23 HG11 ' A' ' 53' ' ' VAL . 79.6 t -91.87 -50.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.386 0.612 . . . . 0.0 109.773 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -33.52 70.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.607 -0.683 . . . . 0.0 111.54 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 55.6 m -77.48 -14.46 59.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.008 -1.057 . . . . 0.0 109.592 -179.753 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.954 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . . . . . . 0 C--N 1.302 -1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 179.195 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' ASN . . . . . 0.529 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 5.4 t-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 120.749 0.309 . . . . 0.0 110.389 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.5 Cg_endo -74.87 -21.52 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.93 1.49 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 111' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 85.4 m-85 . . . . . 0 N--CA 1.494 1.733 0 O-C-N 121.097 -1.002 . . . . 0.0 110.003 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo . . . . . 0 N--CA 1.484 0.957 0 N-CA-C 110.542 -0.599 . . . . 0.0 110.542 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.555 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -84.3 121.08 27.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.364 -0.835 . . . . 0.0 109.801 179.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.542 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.01 -27.43 0.13 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.358 -0.839 . . . . 0.0 110.245 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.555 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 25.1 t -96.98 161.79 2.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.287 -0.883 . . . . 0.0 109.633 179.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.502 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.6 OUTLIER -118.1 178.1 1.12 Allowed Pre-proline 0 N--CA 1.49 1.557 0 O-C-N 121.061 -1.024 . . . . 0.0 110.663 -179.532 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.3 Cg_endo -73.26 -35.75 4.76 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.191 1.627 . . . . 0.0 110.15 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.63 -26.16 37.92 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.335 -0.853 . . . . 0.0 109.956 179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 72.8 m-20 -81.47 -38.84 25.74 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 108.936 179.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 8.2 tptp -69.84 -20.49 63.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.03 -43.57 71.02 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 9.3 ptpt -75.25 -25.37 57.99 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.628 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 8.0 m-30 -71.72 -36.77 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.6 OUTLIER -74.59 -9.85 58.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.746 -0.596 . . . . 0.0 110.318 -179.717 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.42 -33.92 15.05 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 178.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.697 HD13 ' SD ' ' A' ' 74' ' ' MET . 16.4 mt -77.29 -36.46 24.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 178.061 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.756 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -68.92 -40.0 79.33 Favored 'General case' 0 C--N 1.304 -1.386 0 CA-C-O 121.692 0.758 . . . . 0.0 109.112 178.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.549 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 4.2 t0 -86.91 0.9 54.24 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.658 -0.651 . . . . 0.0 110.184 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -89.99 -6.18 55.89 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.241 -0.912 . . . . 0.0 108.996 178.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.042 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -107.1 -9.99 16.02 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.592 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 84.8 92.05 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.202 0 CA-C-O 121.195 0.521 . . . . 0.0 109.61 -178.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.4 Cg_endo -73.34 153.4 50.56 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 124.421 1.748 . . . . 0.0 110.994 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.53 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 94.1 t -121.58 114.13 41.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.515 -0.74 . . . . 0.0 109.188 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 52.14 19.8 1.15 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.367 -0.833 . . . . 0.0 109.786 -178.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 96.5 38.23 4.55 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 179.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.4 m-85 -150.43 147.32 27.4 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.878 -1.366 . . . . 0.0 112.639 -179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.042 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.3 mt -118.83 137.69 53.24 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 177.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.494 ' O ' ' N ' ' A' ' 34' ' ' ASP . 67.1 p -89.31 145.58 25.28 Favored 'General case' 0 C--N 1.289 -2.027 0 C-N-CA 118.878 -1.129 . . . . 0.0 110.014 -179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.518 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.82 -27.54 0.18 Allowed Glycine 0 N--CA 1.494 2.537 0 N-CA-C 108.93 -1.668 . . . . 0.0 108.93 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.494 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.1 t0 -61.52 -27.26 68.48 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.484 -1.01 . . . . 0.0 110.224 179.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.553 ' HB3' HD13 ' A' ' 24' ' ' LEU . 29.6 mttp -96.44 -32.85 12.12 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.096 -1.002 . . . . 0.0 108.551 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.082 HG11 HD12 ' A' ' 65' ' ' LEU . 60.6 t -79.6 -50.24 18.31 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 C-N-CA 119.837 -0.745 . . . . 0.0 110.188 179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.563 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 0.0 OUTLIER -39.07 -53.66 3.59 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.439 -0.788 . . . . 0.0 110.913 -179.457 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.563 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.5 Cg_endo -65.97 -36.07 32.07 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 N-CA-C 109.174 -1.125 . . . . 0.0 109.174 179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.809 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -64.09 -32.42 57.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 109.025 -0.732 . . . . 0.0 109.025 178.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.012 ' HB3' HD22 ' A' ' 50' ' ' LEU . 60.9 mt -86.3 -25.77 25.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.272 -0.892 . . . . 0.0 109.625 179.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.518 HD21 ' HE1' ' B' ' 111' ' ' PHE . 62.7 mt -77.03 -11.7 59.84 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.306 -0.871 . . . . 0.0 109.44 179.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.423 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 63.2 t-20 -86.49 -8.86 57.23 Favored 'General case' 0 C--N 1.302 -1.47 0 C-N-CA 119.654 -0.818 . . . . 0.0 110.024 -179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.534 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -81.23 6.65 13.42 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.417 -0.802 . . . . 0.0 109.984 179.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.441 ' CB ' ' O ' ' A' ' 43' ' ' SER . 7.7 tptt 65.69 11.3 7.43 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.117 -0.99 . . . . 0.0 109.553 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.023 HD13 HG21 ' A' ' 49' ' ' ILE . 16.2 mt -95.18 152.55 39.51 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.35 -0.843 . . . . 0.0 110.011 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -73.53 168.98 23.39 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 123.965 1.508 . . . . 0.0 110.669 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.895 HG13 ' HB3' ' B' ' 111' ' ' PHE . 10.4 t -65.81 -10.54 10.69 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.358 0 O-C-N 121.612 -0.68 . . . . 0.0 109.244 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.86 -30.56 58.93 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.243 -0.911 . . . . 0.0 108.958 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.023 HG21 HD13 ' A' ' 45' ' ' LEU . 16.1 mm -83.03 -40.32 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.012 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.9 mt -72.82 -30.23 63.87 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.408 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.543 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.98 -25.02 76.11 Favored Glycine 0 N--CA 1.487 2.095 0 N-CA-C 107.59 -2.204 . . . . 0.0 107.59 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.799 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.1 OUTLIER -100.7 -31.71 11.07 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.833 -0.804 . . . . 0.0 110.043 179.365 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.781 HG11 HG23 ' A' ' 77' ' ' VAL . 25.6 t -72.08 -34.05 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 C-N-CA 118.948 -1.101 . . . . 0.0 108.336 179.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' CZ2' ' O ' ' B' ' 108' ' ' THR . 3.3 t-105 -73.25 -51.98 15.67 Favored 'General case' 0 C--N 1.302 -1.492 0 C-N-CA 119.632 -0.827 . . . . 0.0 109.802 179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 4.5 mm-40 -51.6 -58.25 6.86 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.951 -1.093 . . . . 0.0 110.088 -178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.799 HD12 ' O ' ' A' ' 52' ' ' ARG . 5.5 mt -61.32 -14.54 27.82 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.319 -0.952 . . . . 0.0 108.872 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.963 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 2.9 t -94.03 -31.76 14.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.538 -0.726 . . . . 0.0 109.699 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 3.0 t0 -72.56 86.75 1.19 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.482 -0.762 . . . . 0.0 110.159 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.568 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 26.3 mm -65.94 -30.25 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.15 -0.969 . . . . 0.0 110.148 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.456 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 5.2 m-20 -99.01 -16.17 18.8 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.222 -0.924 . . . . 0.0 109.89 179.733 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.406 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 92.3 m-70 55.33 48.32 19.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.427 -0.796 . . . . 0.0 110.529 179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.486 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 7.8 p30 -122.4 26.49 8.37 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.935 -1.103 . . . . 0.0 109.853 179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 72.44 32.72 61.9 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.349 -1.5 . . . . 0.0 109.349 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.08 161.76 42.13 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.082 -1.246 . . . . 0.0 111.082 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.082 HD12 HG11 ' A' ' 36' ' ' VAL . 14.1 mt -136.99 99.91 4.14 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.429 -0.794 . . . . 0.0 109.877 179.179 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 3.6 p30 -71.05 168.14 17.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.914 -1.116 . . . . 0.0 110.237 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.442 ' C ' ' O ' ' A' ' 66' ' ' ASP . 15.7 ptt180 -38.56 -46.09 1.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.538 -0.726 . . . . 0.0 111.269 -179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.49 -35.48 63.24 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.151 -0.968 . . . . 0.0 110.57 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.568 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 57.4 mt-10 -75.79 -42.32 50.42 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.149 -0.97 . . . . 0.0 109.44 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 1.015 ' CD2' HD12 ' A' ' 31' ' ' LEU . 8.5 t80 -65.93 -19.91 66.03 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 119.77 -0.772 . . . . 0.0 109.413 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -75.7 -46.6 30.28 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.582 -0.847 . . . . 0.0 109.568 179.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.906 HG13 HD11 ' A' ' 94' ' ' LEU . 86.2 t -59.04 -29.0 40.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.491 0 CA-C-O 121.543 0.687 . . . . 0.0 109.881 179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.963 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.86 -4.08 57.75 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.441 -0.787 . . . . 0.0 111.18 -179.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.697 ' SD ' HD13 ' A' ' 20' ' ' ILE . 9.3 mmt -85.11 -48.32 9.29 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.907 -1.121 . . . . 0.0 110.164 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.607 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.6 p90 -73.02 -31.62 64.58 Favored 'General case' 0 C--N 1.298 -1.642 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 178.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.694 ' HB3' HG13 ' A' ' 53' ' ' VAL . 6.1 mt -62.66 -24.13 67.46 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 178.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.781 HG23 HG11 ' A' ' 53' ' ' VAL . 58.9 t -91.04 -47.84 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 CA-C-O 121.483 0.658 . . . . 0.0 109.436 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.921 ' HA ' HD12 ' A' ' 81' ' ' LEU . 2.3 m-85 -68.1 -31.96 71.93 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.514 -0.741 . . . . 0.0 110.689 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.541 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 93.3 m -83.2 -11.12 58.17 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.305 -0.872 . . . . 0.0 109.984 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.549 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.88 -14.35 48.1 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.169 -0.957 . . . . 0.0 108.88 179.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.921 HD12 ' HA ' ' A' ' 78' ' ' TYR . 2.2 mt -92.26 -51.47 5.15 Favored 'General case' 0 C--N 1.304 -1.388 0 CA-C-O 121.377 0.608 . . . . 0.0 110.731 -179.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -115.4 18.56 15.97 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.517 -0.873 . . . . 0.0 111.911 -178.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.541 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.4 OUTLIER -127.17 -76.98 0.57 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.429 -1.419 . . . . 0.0 111.881 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' CB ' ' HD2' ' A' ' 85' ' ' PRO . 2.7 mt-10 -158.83 -178.46 0.91 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.94 -1.1 . . . . 0.0 110.767 -178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.537 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 44.2 Cg_endo -71.97 171.24 17.05 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 124.006 1.529 . . . . 0.0 110.387 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.63 HG13 HD22 ' A' ' 76' ' ' LEU . 11.0 t -117.43 125.31 28.23 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.22 -0.925 . . . . 0.0 110.575 -179.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.69 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -85.68 -177.69 2.69 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.895 1.471 . . . . 0.0 109.871 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.706 ' C ' HD21 ' A' ' 56' ' ' LEU . 39.2 mtm -111.38 16.43 20.84 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -0.974 . . . . 0.0 110.17 179.698 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 67.7 m -107.32 105.22 15.07 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 118.816 -1.153 . . . . 0.0 111.956 -177.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.592 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.6 OUTLIER -54.63 106.96 0.74 Allowed Pre-proline 0 C--N 1.293 -1.852 0 C-N-CA 119.754 -0.778 . . . . 0.0 109.279 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.51 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 38.1 Cg_endo -66.71 143.1 66.4 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.862 1.454 . . . . 0.0 110.638 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.87 -8.81 24.45 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 124.248 1.657 . . . . 0.0 111.109 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -97.96 23.72 7.76 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.252 -0.905 . . . . 0.0 108.654 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.906 HD11 HG13 ' A' ' 72' ' ' VAL . 0.6 OUTLIER -152.31 19.87 0.65 Allowed 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.899 0.857 . . . . 0.0 109.894 -178.58 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.479 HG13 ' O ' ' A' ' 95' ' ' VAL . 11.0 p -118.02 131.85 23.97 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.986 -1.072 . . . . 0.0 110.373 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.07 147.19 60.3 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.931 1.49 . . . . 0.0 110.201 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -72.02 -1.18 9.63 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.96 1.505 . . . . 0.0 110.571 -179.65 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -80.05 -17.37 52.91 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.16 -0.962 . . . . 0.0 109.659 179.577 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 ttpp -89.67 0.16 57.14 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.436 -0.79 . . . . 0.0 109.541 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.427 ' HG3' ' O ' ' A' ' 100' ' ' ARG . 10.0 ptp180 . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.328 -0.857 . . . . 0.0 110.417 179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.457 ' O ' ' HB ' ' B' ' 108' ' ' THR . 17.6 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 121.189 0.519 . . . . 0.0 110.233 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.57 ' O ' ' CZ2' ' A' ' 54' ' ' TRP . 1.8 t 179.04 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.15 -0.969 . . . . 0.0 110.581 179.845 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.413 ' ND2' HD13 ' B' ' 112' ' ' LEU . 51.4 t-20 -121.4 120.89 28.73 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.178 -0.951 . . . . 0.0 110.551 -179.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -77.78 6.43 4.54 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.917 1.483 . . . . 0.0 111.126 -179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.895 ' HB3' HG13 ' A' ' 47' ' ' VAL . 65.2 m-85 -128.33 20.67 6.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.998 -1.064 . . . . 0.0 110.333 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.413 HD13 ' ND2' ' B' ' 109' ' ' ASN . 1.1 tp . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.944 -1.027 . . . . 0.0 110.122 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.484 0.95 0 N-CA-C 110.672 -0.549 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.465 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -93.03 128.13 38.8 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.416 -0.802 . . . . 0.0 109.726 179.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.76 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -41.32 -33.29 0.38 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.357 -0.839 . . . . 0.0 110.347 -179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.465 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 32.3 t -90.75 136.59 23.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.409 -0.807 . . . . 0.0 109.977 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.9 mttp -96.81 178.93 1.23 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.231 -0.918 . . . . 0.0 109.822 -179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.78 -36.42 13.91 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 123.841 1.443 . . . . 0.0 110.324 -179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.471 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 3.7 pt-20 -74.8 -28.73 60.84 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.206 -0.934 . . . . 0.0 109.922 179.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 20.6 m-20 -82.3 -36.04 27.38 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.307 -0.871 . . . . 0.0 108.958 179.23 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.467 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -75.0 -15.29 60.66 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.514 -0.742 . . . . 0.0 109.027 178.849 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.1 -40.19 39.11 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.611 -0.681 . . . . 0.0 109.181 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.9 ptpt -74.73 -22.02 59.04 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 178.599 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 9.5 m-30 -75.22 -34.41 61.45 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 178.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.1 OUTLIER -73.08 -11.33 60.51 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.421 0.629 . . . . 0.0 110.107 179.918 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' SER . . . -91.28 -29.28 17.26 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 107.391 -1.337 . . . . 0.0 107.391 178.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.683 HG22 ' CE1' ' A' ' 70' ' ' PHE . 36.3 mt -85.1 -33.71 8.22 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 178.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.767 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -72.74 -33.74 66.57 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 178.854 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.561 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.9 t70 -89.48 -6.12 56.73 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.616 -0.677 . . . . 0.0 109.951 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.448 ' HB3' ' O ' ' A' ' 19' ' ' ALA . 0.0 OUTLIER -82.73 -8.15 59.61 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.902 . . . . 0.0 108.627 178.759 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.119 HD12 HD13 ' A' ' 31' ' ' LEU . 5.0 mt -104.66 -15.38 15.29 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.589 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 85.12 93.07 0.04 OUTLIER Pre-proline 0 N--CA 1.504 2.27 0 CA-C-O 121.157 0.503 . . . . 0.0 110.039 -179.348 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.591 ' HG3' ' CE1' ' A' ' 21' ' ' PHE . 52.2 Cg_endo -79.76 157.87 24.6 Favored 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 124.343 1.707 . . . . 0.0 111.055 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.51 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 24.4 t -125.47 109.74 22.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.51 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.5 OUTLIER 65.91 15.32 10.01 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.436 -0.79 . . . . 0.0 109.04 -178.379 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.466 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.5 36.75 6.07 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.696 -1.362 . . . . 0.0 109.696 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.587 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 75.2 m-85 -141.58 146.65 36.53 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.082 -1.246 . . . . 0.0 111.847 -179.68 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.119 HD13 HD12 ' A' ' 24' ' ' LEU . 9.1 mt -118.04 136.29 53.64 Favored 'General case' 0 C--N 1.299 -1.594 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 177.046 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 34' ' ' ASP . 0.1 OUTLIER -86.79 145.39 26.65 Favored 'General case' 0 C--N 1.287 -2.123 0 C-N-CA 119.006 -1.078 . . . . 0.0 110.005 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.7 -26.05 0.38 Allowed Glycine 0 N--CA 1.493 2.437 0 N-CA-C 108.924 -1.67 . . . . 0.0 108.924 179.327 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 34.7 t70 -67.19 -20.52 65.73 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.529 -0.983 . . . . 0.0 110.37 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.8 mttp -100.22 -36.54 9.26 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.019 -1.05 . . . . 0.0 108.194 179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.675 HG12 ' CD1' ' A' ' 40' ' ' LEU . 86.9 t -75.61 -46.39 36.8 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 C-N-CA 120.109 -0.637 . . . . 0.0 110.163 179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.583 ' HG3' ' CZ ' ' B' ' 111' ' ' PHE . 12.0 tttt -39.06 -53.91 3.49 Favored Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 121.431 -0.793 . . . . 0.0 110.999 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.554 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.45 -37.0 18.45 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 O-C-N 123.463 1.244 . . . . 0.0 109.379 179.59 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.878 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.8 t -60.68 -34.63 59.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.033 ' HB3' HD22 ' A' ' 50' ' ' LEU . 53.9 mt -86.69 -26.39 24.3 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.5 -0.75 . . . . 0.0 109.584 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.507 HD12 ' HG2' ' A' ' 37' ' ' LYS . 36.8 mt -75.57 -17.09 60.16 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -85.81 -6.69 59.06 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.852 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.718 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.4 p -82.83 11.86 5.52 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.336 -0.852 . . . . 0.0 109.987 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.462 ' HB3' ' O ' ' A' ' 43' ' ' SER . 13.7 tttp 64.26 15.16 9.22 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.311 -0.868 . . . . 0.0 110.073 -179.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.061 HD11 ' HB3' ' A' ' 80' ' ' ALA . 20.0 mt -100.66 153.3 37.81 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.203 -0.936 . . . . 0.0 110.802 -179.83 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.88 169.82 21.42 Favored 'Trans proline' 0 C--N 1.301 -1.956 0 O-C-N 124.216 1.64 . . . . 0.0 110.08 179.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.808 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.6 t -69.15 -6.23 5.9 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 O-C-N 121.337 -0.852 . . . . 0.0 109.508 -179.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -79.49 -31.46 42.3 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.249 -0.907 . . . . 0.0 109.207 179.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.842 HG13 HD22 ' A' ' 45' ' ' LEU . 12.1 mm -82.63 -39.81 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 N-CA-C 108.667 -0.864 . . . . 0.0 108.667 178.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.033 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.1 mt -70.14 -28.38 65.32 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.48 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.87 -24.3 76.8 Favored Glycine 0 N--CA 1.486 2.021 0 N-CA-C 107.64 -2.184 . . . . 0.0 107.64 179.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 1.004 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.39 -32.02 10.65 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.777 -0.837 . . . . 0.0 110.208 179.479 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.75 HG11 ' CG2' ' A' ' 77' ' ' VAL . 4.9 t -72.41 -36.35 54.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 C-N-CA 119.076 -1.05 . . . . 0.0 108.486 179.486 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.606 ' CD1' ' HB3' ' B' ' 109' ' ' ASN . 2.5 t-105 -68.78 -49.58 57.42 Favored 'General case' 0 C--N 1.299 -1.614 0 C-N-CA 119.674 -0.81 . . . . 0.0 110.012 179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.461 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 18.6 mt-10 -52.61 -57.08 11.18 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.901 -1.125 . . . . 0.0 110.186 -178.529 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.004 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.5 mt -61.45 -14.46 28.71 Favored 'General case' 0 C--N 1.299 -1.591 0 C-N-CA 119.358 -0.937 . . . . 0.0 108.797 179.022 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.725 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.8 m -92.56 -38.64 11.8 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.527 -0.733 . . . . 0.0 109.371 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 10.7 t0 -70.21 85.38 0.56 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.442 -0.786 . . . . 0.0 109.924 179.796 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 26.8 mm -61.68 -27.63 42.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.207 -0.933 . . . . 0.0 110.899 -179.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 49.9 p30 -108.97 -13.26 14.76 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.909 -1.119 . . . . 0.0 111.104 -179.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.565 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 3.7 m170 63.07 44.68 5.69 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.176 -0.953 . . . . 0.0 110.59 179.75 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.464 ' OD1' ' HB2' ' A' ' 64' ' ' MET . 13.0 p-10 -111.9 29.61 7.72 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.871 -1.143 . . . . 0.0 109.904 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 60.73 34.04 85.1 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.08 -1.608 . . . . 0.0 109.08 -179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.509 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 7.5 mtt -150.83 161.04 43.44 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.262 -1.14 . . . . 0.0 111.127 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.656 ' CD1' HG11 ' A' ' 36' ' ' VAL . 7.0 mt -128.21 104.82 7.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.494 -0.754 . . . . 0.0 109.615 178.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.587 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -68.71 167.75 14.65 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.224 -0.922 . . . . 0.0 110.344 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.521 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 0.1 OUTLIER -46.18 -40.96 12.0 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.428 -0.795 . . . . 0.0 110.519 -179.792 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -83.32 -25.82 31.15 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.249 -0.907 . . . . 0.0 109.064 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -76.68 -46.04 27.24 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.702 0.763 . . . . 0.0 109.261 179.368 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 28.5 t80 -64.45 -16.43 62.41 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.405 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -76.56 -47.37 22.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.445 -0.784 . . . . 0.0 109.442 179.454 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.5 ' O ' HD12 ' A' ' 76' ' ' LEU . 57.6 t -60.14 -24.93 31.8 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.603 -0.685 . . . . 0.0 109.594 179.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.725 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.89 -6.65 55.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.496 -0.753 . . . . 0.0 110.971 -179.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.581 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.9 mmt -84.97 -48.21 9.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.003 -1.06 . . . . 0.0 110.11 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.781 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.1 p90 -75.97 -22.28 56.09 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 108.22 -1.03 . . . . 0.0 108.22 179.096 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.523 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 11.0 mt -73.89 -22.8 59.59 Favored 'General case' 0 N--CA 1.485 1.324 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.75 ' CG2' HG11 ' A' ' 53' ' ' VAL . 53.9 t -91.91 -60.36 2.48 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.288 0 CA-C-O 121.448 0.642 . . . . 0.0 109.308 179.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -51.55 -19.29 1.41 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 110.722 179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.504 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 4.2 m -85.01 -18.01 35.75 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.173 -0.954 . . . . 0.0 110.296 -179.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.061 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -87.8 -11.67 47.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 121.134 -0.979 . . . . 0.0 109.429 179.516 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.718 HD21 ' O ' ' A' ' 43' ' ' SER . 6.4 mp -90.69 -41.06 11.51 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 121.755 0.788 . . . . 0.0 109.174 179.475 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' O ' ' HG3' ' A' ' 83' ' ' LYS . 3.5 tt0 -71.83 -53.25 13.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.631 -0.668 . . . . 0.0 109.645 179.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.451 ' HG3' ' O ' ' A' ' 82' ' ' GLU . 0.2 OUTLIER 177.73 -25.95 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.339 -0.85 . . . . 0.0 111.448 179.793 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.3 OUTLIER -70.16 115.12 31.04 Favored Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.133 -0.979 . . . . 0.0 111.576 -178.598 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.92 179.18 5.58 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.776 1.408 . . . . 0.0 109.174 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.546 HG21 ' CG2' ' A' ' 53' ' ' VAL . 58.9 t -123.31 124.85 26.28 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.778 -1.201 . . . . 0.0 111.096 -179.581 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.733 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.4 Cg_endo -86.88 -176.23 1.87 Allowed 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.949 1.499 . . . . 0.0 109.198 178.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.685 ' C ' HD21 ' A' ' 56' ' ' LEU . 8.3 mtp -114.9 15.62 17.32 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.752 -1.217 . . . . 0.0 110.549 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.554 ' N ' HD21 ' A' ' 56' ' ' LEU . 58.3 m -113.25 100.9 8.92 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 118.531 -1.268 . . . . 0.0 112.189 -178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.652 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -54.57 107.48 0.88 Allowed Pre-proline 0 C--N 1.293 -1.861 0 C-N-CA 119.913 -0.715 . . . . 0.0 109.466 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.566 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.1 Cg_endo -66.56 158.38 55.97 Favored 'Trans proline' 0 C--N 1.303 -1.839 0 O-C-N 123.897 1.472 . . . . 0.0 110.61 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.63 -16.6 26.84 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 124.088 1.573 . . . . 0.0 111.017 -179.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.605 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -87.67 0.9 55.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.086 -1.009 . . . . 0.0 109.731 179.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.781 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.6 mm? -108.65 -5.29 16.49 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.362 -0.836 . . . . 0.0 110.325 -179.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 19.9 t -92.76 108.83 34.84 Favored Pre-proline 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.0 110.799 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.495 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 48.1 Cg_endo -77.34 176.13 10.46 Favored 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 124.042 1.548 . . . . 0.0 110.011 179.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.495 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 43.5 Cg_endo -71.27 -8.96 24.51 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.747 1.393 . . . . 0.0 110.099 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -69.09 -16.75 63.75 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.232 -0.917 . . . . 0.0 109.648 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 12.3 tptp -89.1 0.72 56.48 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.419 -0.801 . . . . 0.0 109.376 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.495 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.528 0 O-C-N 121.332 -0.855 . . . . 0.0 109.981 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 3.1 m . . . . . 0 N--CA 1.493 1.692 0 CA-C-O 121.264 0.554 . . . . 0.0 110.227 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 21.7 p -109.77 -27.85 9.1 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.167 -0.958 . . . . 0.0 110.346 -179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.606 ' HB3' ' CD1' ' A' ' 54' ' ' TRP . 50.7 p30 -65.75 161.77 50.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.263 -0.898 . . . . 0.0 110.565 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -79.06 11.06 2.71 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 124.101 1.58 . . . . 0.0 110.98 -179.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.808 ' HB3' HG13 ' A' ' 47' ' ' VAL . 48.8 m-85 -131.95 43.14 3.07 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.935 -1.103 . . . . 0.0 110.266 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.508 HD12 ' O ' ' B' ' 111' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 117.997 -1.001 . . . . 0.0 110.427 179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.873 0 N-CA-C 110.466 -0.628 . . . . 0.0 110.466 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.567 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.2 t90 -86.78 127.35 35.0 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.284 -0.885 . . . . 0.0 109.871 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.778 ' HB2' ' CD2' ' A' ' 94' ' ' LEU . . . -43.89 -30.16 0.65 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.198 -0.939 . . . . 0.0 110.267 -179.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.567 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 42.9 t -91.22 137.6 21.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.339 -0.85 . . . . 0.0 110.376 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -94.63 174.49 3.6 Favored Pre-proline 0 N--CA 1.49 1.535 0 O-C-N 121.365 -0.834 . . . . 0.0 109.902 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.492 ' HG2' ' OE2' ' A' ' 12' ' ' GLU . 37.9 Cg_endo -66.39 -32.7 40.17 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.795 1.418 . . . . 0.0 109.838 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' OE2' ' HG2' ' A' ' 11' ' ' PRO . 7.4 mm-40 -75.91 -33.47 59.89 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.547 -0.72 . . . . 0.0 109.553 179.465 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.506 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.2 m-20 -78.73 -40.5 33.38 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.674 -0.861 . . . . 0.0 108.674 179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.475 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 7.5 tptp -69.63 -17.94 63.56 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.891 -0.724 . . . . 0.0 109.104 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.92 -41.47 64.52 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 179.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.673 ' O ' HD12 ' A' ' 20' ' ' ILE . 0.0 OUTLIER -78.51 -20.84 49.88 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 178.546 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.612 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.9 m-30 -78.05 -34.23 50.52 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -79.96 -12.3 59.73 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.41 -0.516 . . . . 0.0 110.301 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.63 -32.38 13.43 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 178.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.717 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.5 mt -77.69 -30.92 16.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 177.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.667 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -71.28 -38.47 71.82 Favored 'General case' 0 N--CA 1.486 1.349 0 CA-C-O 121.605 0.717 . . . . 0.0 109.141 179.135 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.496 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.2 t70 -91.01 -4.19 56.63 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.397 -0.814 . . . . 0.0 110.115 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.2 t -79.24 -11.66 59.96 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.288 -0.883 . . . . 0.0 108.742 179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.976 HD12 HD13 ' A' ' 31' ' ' LEU . 8.9 mt -97.68 -56.09 2.61 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.648 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 142.46 97.19 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.447 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.151 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.624 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.7 Cg_endo -74.15 147.68 38.28 Favored 'Trans proline' 0 C--N 1.297 -2.173 0 O-C-N 124.259 1.663 . . . . 0.0 110.726 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.467 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.0 t -118.49 99.15 7.41 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.539 0 O-C-N 121.479 -0.763 . . . . 0.0 109.107 179.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 10.8 t30 56.78 17.04 2.98 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.319 -0.863 . . . . 0.0 109.408 -178.901 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.432 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 106.03 33.69 3.41 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 66' ' ' ASP . 75.6 m-85 -150.67 141.69 23.0 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.221 -1.164 . . . . 0.0 112.106 -179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.976 HD13 HD12 ' A' ' 24' ' ' LEU . 10.3 mt -110.59 141.81 43.28 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 107.934 -1.136 . . . . 0.0 107.934 177.595 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.45 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 99.4 p -89.7 147.54 23.8 Favored 'General case' 0 C--N 1.292 -1.909 0 C-N-CA 118.749 -1.181 . . . . 0.0 109.998 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.8 -27.37 0.55 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.444 ' N ' ' O ' ' A' ' 32' ' ' SER . 64.5 t0 -66.44 -25.75 66.89 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.416 -1.05 . . . . 0.0 110.145 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttt -94.06 -33.08 13.53 Favored 'General case' 0 C--N 1.306 -1.304 0 O-C-N 121.014 -1.054 . . . . 0.0 108.533 178.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.719 HG21 ' HB2' ' A' ' 65' ' ' LEU . 90.8 t -82.05 -47.93 18.83 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.606 -0.684 . . . . 0.0 110.364 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.594 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.7 OUTLIER -39.56 -53.65 4.22 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.462 -0.774 . . . . 0.0 110.637 -179.367 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.559 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.6 Cg_endo -66.34 -35.28 32.11 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 O-C-N 123.136 1.071 . . . . 0.0 109.468 179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.673 HG21 HD11 ' A' ' 24' ' ' LEU . 2.2 t -61.6 -26.67 40.27 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.612 -0.68 . . . . 0.0 109.207 179.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.996 ' HB3' HD22 ' A' ' 50' ' ' LEU . 36.5 mt -95.66 -28.54 14.76 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.457 -0.777 . . . . 0.0 109.836 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.469 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 79.2 mt -71.07 -15.11 62.51 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.367 -0.833 . . . . 0.0 109.069 179.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 45.8 t30 -82.86 -11.09 58.5 Favored 'General case' 0 C--N 1.302 -1.488 0 C-N-CA 119.58 -0.848 . . . . 0.0 109.883 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.631 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.8 p -81.74 7.96 11.26 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.44 -0.788 . . . . 0.0 110.088 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HB2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 62.55 12.43 5.45 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.292 -0.88 . . . . 0.0 110.509 179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.9 mt -88.56 156.39 50.53 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.267 -0.896 . . . . 0.0 109.953 179.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.554 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 43.9 Cg_endo -74.1 166.65 29.09 Favored 'Trans proline' 0 C--N 1.302 -1.872 0 O-C-N 123.93 1.49 . . . . 0.0 109.386 178.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.834 HG13 ' HB3' ' B' ' 111' ' ' PHE . 3.5 t -66.55 -7.07 5.03 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 O-C-N 121.216 -0.927 . . . . 0.0 109.535 -179.862 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 7.4 m-20 -78.62 -31.9 47.18 Favored 'General case' 0 C--N 1.307 -1.28 0 O-C-N 121.185 -0.947 . . . . 0.0 109.392 179.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.928 HG13 HD22 ' A' ' 45' ' ' LEU . 6.9 mm -82.77 -41.81 17.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.7 mt -67.43 -29.99 69.62 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 179.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.532 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.34 -23.81 77.16 Favored Glycine 0 N--CA 1.483 1.826 0 N-CA-C 107.804 -2.118 . . . . 0.0 107.804 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.779 ' O ' HD12 ' A' ' 56' ' ' LEU . 24.6 ttp180 -102.16 -33.13 9.78 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.966 -0.726 . . . . 0.0 111.06 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.963 HG11 HG23 ' A' ' 77' ' ' VAL . 17.2 t -67.16 -41.12 86.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 120.658 -1.276 . . . . 0.0 108.882 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.565 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.7 t-105 -62.55 -50.9 69.49 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.306 -0.958 . . . . 0.0 109.551 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 19.2 mt-10 -51.52 -59.05 4.69 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.247 -0.908 . . . . 0.0 110.29 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.779 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.3 mt -61.82 -15.13 39.39 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.018 -1.051 . . . . 0.0 108.712 179.074 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.739 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 34.8 m -91.05 -30.49 16.74 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.577 -0.702 . . . . 0.0 109.237 179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.43 97.38 4.94 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.498 -0.751 . . . . 0.0 109.595 179.384 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.529 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 24.9 mm -71.02 -38.44 71.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.114 -0.991 . . . . 0.0 110.375 -179.567 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.481 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 9.8 p30 -99.34 -13.39 19.64 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.188 -0.945 . . . . 0.0 110.28 -179.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 1.8 m-70 60.48 41.45 15.78 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.339 -0.851 . . . . 0.0 110.267 -179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.471 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 6.5 p-10 -96.79 13.27 29.16 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.357 -0.84 . . . . 0.0 109.565 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.551 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 78.63 22.15 67.55 Favored Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.551 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.29 161.35 41.7 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.302 -1.117 . . . . 0.0 109.573 179.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.862 HD13 ' HA ' ' A' ' 70' ' ' PHE . 5.8 mt -121.05 116.46 25.08 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.049 -1.032 . . . . 0.0 110.272 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.573 ' HB2' ' CD1' ' A' ' 30' ' ' PHE . 1.0 OUTLIER -76.39 172.75 12.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.014 -1.054 . . . . 0.0 110.196 179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.479 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.1 OUTLIER -52.8 -34.37 53.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.559 -0.713 . . . . 0.0 110.847 -179.627 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.479 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 28.0 m-20 -87.15 -31.56 20.33 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.162 -0.961 . . . . 0.0 110.091 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.529 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 31.4 mt-10 -78.13 -38.96 42.6 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.316 -0.865 . . . . 0.0 108.692 179.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.951 ' CD2' HD12 ' A' ' 31' ' ' LEU . 42.9 t80 -63.38 -29.27 70.6 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.479 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -64.8 -47.51 77.8 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.531 -0.73 . . . . 0.0 110.154 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.545 HG13 HD12 ' A' ' 94' ' ' LEU . 58.5 t -60.84 -19.26 19.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.739 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.6 -13.26 37.56 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.288 -0.883 . . . . 0.0 111.444 -179.067 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 8.9 mmm -85.6 -41.84 14.87 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.696 -1.253 . . . . 0.0 110.553 -179.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.812 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 3.4 p90 -77.57 -25.17 49.81 Favored 'General case' 0 C--N 1.299 -1.623 0 C-N-CA 118.842 -1.143 . . . . 0.0 108.346 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.534 ' HG ' ' CE1' ' A' ' 75' ' ' PHE . 7.2 mt -70.96 -22.0 62.26 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.963 HG23 HG11 ' A' ' 53' ' ' VAL . 49.7 t -91.78 -61.52 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 179.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -48.88 -21.22 0.61 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.639 -0.663 . . . . 0.0 111.325 -179.584 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLU . 20.1 m -84.66 -14.65 47.91 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.999 -1.063 . . . . 0.0 110.123 -179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.991 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.08 -14.19 36.88 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.284 -0.885 . . . . 0.0 109.574 179.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.829 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.4 mp -90.26 -38.18 13.59 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.743 0.782 . . . . 0.0 109.049 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.417 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.6 OUTLIER -69.12 -57.57 5.23 Favored 'General case' 0 C--N 1.301 -1.527 0 CA-C-O 121.558 0.694 . . . . 0.0 109.483 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.494 ' HG3' ' O ' ' A' ' 83' ' ' LYS . 2.2 tttt 177.26 -21.8 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.592 -0.692 . . . . 0.0 111.037 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 79' ' ' CYS . 8.4 mm-40 -73.16 118.81 71.75 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 120.966 -1.084 . . . . 0.0 111.091 -178.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -71.87 169.67 20.68 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 123.715 1.376 . . . . 0.0 109.494 179.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.53 HG21 ' CG2' ' A' ' 49' ' ' ILE . 34.0 t -112.77 122.55 35.84 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.991 -1.068 . . . . 0.0 110.854 -179.561 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.67 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.8 Cg_endo -86.13 171.79 7.67 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.878 1.462 . . . . 0.0 109.006 179.128 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.706 ' C ' HD21 ' A' ' 56' ' ' LEU . 35.0 mtm -106.01 17.97 22.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.0 -1.063 . . . . 0.0 110.056 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.527 ' N ' HD21 ' A' ' 56' ' ' LEU . 45.1 m -113.48 99.65 7.92 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 118.895 -1.122 . . . . 0.0 111.751 -178.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.676 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.6 OUTLIER -55.28 107.17 0.8 Allowed Pre-proline 0 C--N 1.293 -1.863 0 C-N-CA 119.66 -0.816 . . . . 0.0 109.437 178.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' HG2' ' CG ' ' A' ' 94' ' ' LEU . 40.3 Cg_endo -65.83 159.14 50.2 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.028 1.541 . . . . 0.0 110.86 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -73.36 -24.76 16.18 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 124.098 1.578 . . . . 0.0 111.46 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.537 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -82.33 3.48 27.62 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.005 -1.06 . . . . 0.0 109.604 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.812 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 4.3 mm? -108.0 -5.97 16.82 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.4 -0.813 . . . . 0.0 110.282 -179.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.425 ' CG1' ' HB3' ' A' ' 99' ' ' LYS . 51.1 t -99.98 121.89 52.52 Favored Pre-proline 0 C--N 1.301 -1.503 0 O-C-N 121.394 -0.816 . . . . 0.0 110.238 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.49 170.61 15.85 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.889 1.468 . . . . 0.0 110.129 179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.84 -8.23 23.14 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.962 1.506 . . . . 0.0 110.452 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 13.1 t -76.07 -17.6 59.57 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.0 109.802 179.544 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.494 ' CE ' HG22 ' A' ' 59' ' ' ILE . 4.8 tptp -89.8 0.5 56.98 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.302 -0.873 . . . . 0.0 109.429 179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 O-C-N 121.328 -0.858 . . . . 0.0 109.935 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 5.1 t . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 121.206 0.527 . . . . 0.0 110.056 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 25.9 p -99.77 -19.91 16.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.213 -0.929 . . . . 0.0 110.359 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.509 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 20.8 t-20 -92.67 137.13 24.39 Favored Pre-proline 0 N--CA 1.493 1.68 0 O-C-N 121.168 -0.957 . . . . 0.0 110.633 -179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' B' ' 109' ' ' ASN . 54.4 Cg_endo -85.55 12.57 3.01 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.07 1.563 . . . . 0.0 111.334 -179.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.834 ' HB3' HG13 ' A' ' 47' ' ' VAL . 48.3 m-85 -126.63 -12.96 6.02 Favored 'General case' 0 N--CA 1.495 1.825 0 O-C-N 120.791 -1.193 . . . . 0.0 110.745 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 41.7 mt . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.16 179.757 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo . . . . . 0 N--CA 1.484 0.921 0 N-CA-C 110.599 -0.577 . . . . 0.0 110.599 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.589 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.4 t90 -77.48 125.31 29.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.242 -0.911 . . . . 0.0 109.637 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.836 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -42.99 -29.15 0.31 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.191 -0.943 . . . . 0.0 109.766 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.589 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 8.5 t -91.79 156.0 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.432 -0.793 . . . . 0.0 109.239 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.486 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 2.1 mmmt -108.72 167.39 9.25 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 120.878 -1.139 . . . . 0.0 110.606 -179.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.486 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -69.4 -31.91 21.16 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 124.008 1.531 . . . . 0.0 109.811 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.5 mm-40 -79.85 -32.79 40.53 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 0.3 OUTLIER -78.23 -34.7 49.11 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.926 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.451 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 28.6 tptp -72.46 -18.61 61.67 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.486 -0.759 . . . . 0.0 109.047 179.111 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.76 -42.8 60.58 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.619 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.0 ptpt -75.58 -25.29 56.93 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.271 -1.011 . . . . 0.0 108.271 178.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.619 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.2 m-30 -72.96 -37.55 67.06 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-O 121.874 0.845 . . . . 0.0 108.732 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -79.5 -8.16 58.95 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.376 0.607 . . . . 0.0 110.339 -179.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -95.59 -33.38 12.4 Favored 'General case' 0 C--N 1.301 -1.513 0 N-CA-C 107.203 -1.406 . . . . 0.0 107.203 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.598 HG22 ' CE1' ' A' ' 70' ' ' PHE . 75.1 mt -76.63 -33.13 21.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 177.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.74 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -66.97 -38.57 86.32 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 178.711 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.7 t70 -90.97 -2.57 57.69 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 109.802 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.5 t -80.91 -12.58 59.38 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.132 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.989 HD12 ' CD1' ' A' ' 31' ' ' LEU . 6.4 mt -95.63 -54.36 3.39 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.65 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 6.7 p 142.55 90.32 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.488 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HB3' ' CE1' ' A' ' 21' ' ' PHE . 48.3 Cg_endo -75.14 150.94 38.28 Favored 'Trans proline' 0 C--N 1.301 -1.961 0 O-C-N 124.057 1.556 . . . . 0.0 110.914 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.483 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 28.7 t -127.07 108.18 18.22 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 N-CA-C 109.162 -0.681 . . . . 0.0 109.162 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.483 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 9.1 t30 57.28 21.93 7.2 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.332 -0.855 . . . . 0.0 109.996 -179.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.438 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 93.08 38.91 5.29 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.958 -1.257 . . . . 0.0 109.958 179.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.565 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 82.6 m-85 -150.43 151.64 33.09 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.089 -1.242 . . . . 0.0 111.866 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.989 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.2 mt -122.17 140.61 52.36 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 107.638 -1.245 . . . . 0.0 107.638 177.538 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.48 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 19.3 p -90.42 141.64 28.54 Favored 'General case' 0 C--N 1.293 -1.853 0 O-C-N 120.855 -1.153 . . . . 0.0 110.343 -179.502 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.558 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.28 -27.75 0.27 Allowed Glycine 0 N--CA 1.492 2.409 0 N-CA-C 108.919 -1.672 . . . . 0.0 108.919 179.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.7 OUTLIER -61.5 -28.29 69.19 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.553 -0.969 . . . . 0.0 110.066 179.356 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.498 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 14.8 mttt -96.52 -32.93 12.03 Favored 'General case' 0 N--CA 1.485 1.305 0 O-C-N 121.221 -0.924 . . . . 0.0 108.816 179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.755 ' CG1' HD12 ' A' ' 65' ' ' LEU . 92.1 t -77.03 -44.0 31.68 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.464 -0.772 . . . . 0.0 110.007 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.549 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 67.5 tttt -40.76 -56.75 3.64 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.317 -0.864 . . . . 0.0 110.682 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.7 Cg_endo -65.37 -34.34 44.4 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 O-C-N 123.494 1.26 . . . . 0.0 109.769 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.533 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -62.82 -35.98 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.434 -0.792 . . . . 0.0 109.7 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.113 ' HB3' HD22 ' A' ' 50' ' ' LEU . 34.6 mt -85.37 -29.12 24.7 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.421 -0.799 . . . . 0.0 109.972 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.659 HD21 ' HE1' ' B' ' 111' ' ' PHE . 43.2 mt -71.6 -14.12 61.98 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.28 -0.887 . . . . 0.0 109.018 179.481 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 7.6 t30 -78.47 -12.34 60.0 Favored 'General case' 0 C--N 1.303 -1.436 0 C-N-CA 119.753 -0.779 . . . . 0.0 109.755 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.981 ' O ' HD21 ' A' ' 81' ' ' LEU . 59.8 p -81.38 3.78 23.15 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.421 -0.799 . . . . 0.0 110.109 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.3 ttmt 68.63 16.25 9.04 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.253 -0.904 . . . . 0.0 110.158 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.934 HD22 HG13 ' A' ' 49' ' ' ILE . 15.5 mt -95.66 152.91 39.45 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.317 -0.865 . . . . 0.0 110.001 179.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.575 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.5 Cg_endo -74.04 175.03 11.41 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.973 1.512 . . . . 0.0 110.524 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.714 HG22 ' HD1' ' B' ' 111' ' ' PHE . 25.2 t -70.85 -7.09 8.25 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.468 0 O-C-N 121.316 -0.865 . . . . 0.0 109.579 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -80.46 -32.24 37.23 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.331 -0.856 . . . . 0.0 109.569 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.934 HG13 HD22 ' A' ' 45' ' ' LEU . 9.8 mm -83.18 -36.86 13.18 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 O-C-N 121.291 -0.881 . . . . 0.0 108.742 178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.113 HD22 ' HB3' ' A' ' 40' ' ' LEU . 29.5 mt -75.08 -26.48 59.36 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 179.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.504 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.24 -24.96 76.42 Favored Glycine 0 N--CA 1.487 2.052 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.964 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.4 mtm180 -100.74 -31.68 11.08 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.905 -0.762 . . . . 0.0 109.897 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.029 HG11 HG23 ' A' ' 77' ' ' VAL . 5.7 t -71.1 -37.34 66.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 C-N-CA 119.101 -1.04 . . . . 0.0 108.95 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.565 ' O ' ' N ' ' A' ' 58' ' ' ASP . 3.0 t-105 -71.11 -50.1 37.24 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.172 -1.011 . . . . 0.0 109.44 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.568 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 9.4 mm-40 -56.96 -54.65 44.2 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.082 -1.011 . . . . 0.0 110.221 -178.491 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.964 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.9 mt -62.78 -10.91 14.62 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.037 -1.065 . . . . 0.0 108.426 178.059 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.755 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.8 m -98.16 -37.71 9.6 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.469 -0.77 . . . . 0.0 110.015 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -69.01 87.07 0.37 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.202 -0.936 . . . . 0.0 109.953 -179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.512 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 43.5 mm -57.82 -28.37 32.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.301 -0.874 . . . . 0.0 110.395 -179.652 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.59 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 51.1 p-10 -112.04 1.29 16.29 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.258 -0.901 . . . . 0.0 110.554 -179.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.59 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 9.3 p80 39.58 51.98 2.33 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.341 -0.849 . . . . 0.0 110.511 -179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.45 ' OD1' ' OD1' ' A' ' 60' ' ' ASP . 15.4 p-10 -112.33 24.79 12.17 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 178.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.471 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 71.13 31.15 66.73 Favored Glycine 0 N--CA 1.486 2.019 0 N-CA-C 108.795 -1.722 . . . . 0.0 108.795 -179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.51 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.0 mtp -151.75 161.82 42.03 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.114 -1.227 . . . . 0.0 111.466 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.755 HD12 ' CG1' ' A' ' 36' ' ' VAL . 9.9 mt -125.73 105.52 9.04 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.395 -0.815 . . . . 0.0 109.482 178.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.565 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 4.7 t0 -69.02 163.71 24.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.86 -1.15 . . . . 0.0 109.984 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.42 ' C ' ' O ' ' A' ' 66' ' ' ASP . 0.2 OUTLIER -42.63 -36.47 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.48 -0.763 . . . . 0.0 110.199 179.772 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.451 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -82.75 -34.27 27.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.427 -0.796 . . . . 0.0 109.905 179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.551 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 17.7 mt-10 -74.98 -42.6 57.25 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.263 -0.898 . . . . 0.0 108.971 179.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.877 ' CD2' HD12 ' A' ' 31' ' ' LEU . 32.6 t80 -59.84 -26.95 66.22 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 178.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.493 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -72.25 -51.31 21.53 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.754 0.788 . . . . 0.0 109.174 179.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.071 HG13 HD11 ' A' ' 94' ' ' LEU . 53.7 t -55.46 -26.76 19.81 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.543 0.687 . . . . 0.0 109.518 179.456 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.755 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.85 -3.21 58.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.557 -0.714 . . . . 0.0 110.726 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.606 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.0 mmt -90.15 -43.43 10.46 Favored 'General case' 0 C--N 1.3 -1.567 0 O-C-N 120.664 -1.273 . . . . 0.0 109.834 179.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.774 ' CE2' HD13 ' A' ' 94' ' ' LEU . 1.9 p90 -79.26 -19.01 51.63 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 108.21 -1.033 . . . . 0.0 108.21 178.677 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.405 ' HB2' ' O ' ' A' ' 72' ' ' VAL . 4.6 mt -78.85 -23.24 45.1 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.029 HG23 HG11 ' A' ' 53' ' ' VAL . 5.8 t -90.59 -37.16 9.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.393 0 O-C-N 121.627 -0.671 . . . . 0.0 109.65 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -80.05 -24.02 40.97 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.242 -0.911 . . . . 0.0 110.132 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 56.3 m -83.22 -18.74 38.18 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.224 -0.922 . . . . 0.0 109.188 179.21 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.751 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.25 -15.73 59.33 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.601 -0.84 . . . . 0.0 108.843 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.986 HD12 ' O ' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -92.31 -50.68 5.53 Favored 'General case' 0 C--N 1.305 -1.335 0 O-C-N 121.72 -0.612 . . . . 0.0 111.49 -179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' CA ' ' OE1' ' A' ' 82' ' ' GLU . 0.6 OUTLIER -118.53 -2.49 11.01 Favored 'General case' 0 N--CA 1.494 1.731 0 C-N-CA 119.387 -0.925 . . . . 0.0 112.314 -177.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.565 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.2 OUTLIER -103.99 -74.37 0.64 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.506 -1.371 . . . . 0.0 111.378 -179.31 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 2.7 mt-10 -160.36 179.44 1.34 Allowed Pre-proline 0 N--CA 1.494 1.756 0 O-C-N 120.993 -1.067 . . . . 0.0 110.254 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.502 ' HD2' ' CB ' ' A' ' 84' ' ' GLU . 42.8 Cg_endo -70.72 171.79 14.83 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.807 1.425 . . . . 0.0 109.836 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . . . . . . . . . 79.6 t -115.05 127.06 27.16 Favored Pre-proline 0 C--N 1.302 -1.488 0 O-C-N 121.133 -0.98 . . . . 0.0 110.514 -179.543 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.848 ' O ' HD11 ' A' ' 56' ' ' LEU . 47.1 Cg_endo -85.12 -170.61 0.79 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.995 1.523 . . . . 0.0 109.182 179.348 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.903 ' C ' HD21 ' A' ' 56' ' ' LEU . 4.9 mtm -116.95 10.45 14.05 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.998 -1.063 . . . . 0.0 109.896 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.617 ' N ' HD21 ' A' ' 56' ' ' LEU . 56.7 p -114.47 98.69 7.05 Favored 'General case' 0 C--N 1.298 -1.656 0 C-N-CA 118.79 -1.164 . . . . 0.0 111.656 -178.498 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.65 HD11 ' O ' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -52.39 107.09 0.75 Allowed Pre-proline 0 C--N 1.287 -2.145 0 C-N-CA 119.978 -0.689 . . . . 0.0 109.425 178.872 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.962 ' HG2' HD23 ' A' ' 94' ' ' LEU . 39.1 Cg_endo -66.78 146.27 77.85 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.643 1.338 . . . . 0.0 110.273 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.28 -5.01 14.85 Favored 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 124.278 1.673 . . . . 0.0 111.024 -179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.72 -1.89 44.58 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.363 -0.836 . . . . 0.0 109.421 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.071 HD11 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -145.52 36.19 1.08 Allowed 'General case' 0 C--N 1.307 -1.241 0 C-N-CA 119.282 -0.967 . . . . 0.0 110.939 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 55.3 t -126.66 132.27 24.25 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.968 -1.082 . . . . 0.0 110.738 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.454 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.1 Cg_endo -72.79 174.51 11.71 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 124.01 1.531 . . . . 0.0 110.048 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.531 ' O ' ' CB ' ' A' ' 98' ' ' SER . 44.9 Cg_endo -72.62 179.84 4.81 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.836 1.44 . . . . 0.0 110.695 -179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.531 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 77.43 -45.52 0.46 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.769 -0.582 . . . . 0.0 110.251 -179.266 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.459 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 40.0 tptt -88.51 9.36 24.04 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.134 -0.978 . . . . 0.0 108.672 178.684 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.681 0 O-C-N 121.297 -0.877 . . . . 0.0 110.367 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 10.6 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.209 0.528 . . . . 0.0 110.273 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.525 HG23 ' N ' ' B' ' 109' ' ' ASN . 9.4 t -149.55 -136.24 0.07 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.115 -0.99 . . . . 0.0 110.213 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.568 ' ND2' ' CG ' ' A' ' 55' ' ' GLU . 43.1 t-20 -41.53 116.6 1.58 Allowed Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.179 -0.951 . . . . 0.0 110.283 -179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -80.77 17.39 1.42 Allowed 'Trans proline' 0 C--N 1.309 -1.524 0 O-C-N 123.949 1.499 . . . . 0.0 111.28 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.714 ' HD1' HG22 ' A' ' 47' ' ' VAL . 65.2 m-85 -139.63 31.83 2.06 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.892 -1.13 . . . . 0.0 110.283 179.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 117.984 -1.007 . . . . 0.0 110.156 179.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo . . . . . 0 N--CA 1.484 0.933 0 N-CA-C 110.644 -0.56 . . . . 0.0 110.644 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.588 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.1 t90 -58.98 125.32 23.12 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.42 -0.8 . . . . 0.0 109.825 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.712 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -41.31 -26.95 0.07 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.378 -0.826 . . . . 0.0 110.255 -179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.588 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 54.6 t -97.71 138.53 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.314 -0.866 . . . . 0.0 110.18 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -95.97 175.53 2.68 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.21 -0.931 . . . . 0.0 109.792 179.982 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.9 Cg_endo -67.2 -37.03 19.48 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.838 1.441 . . . . 0.0 110.393 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.556 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -72.54 -25.16 61.27 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.141 -0.975 . . . . 0.0 109.575 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.562 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.6 OUTLIER -82.79 -40.09 20.9 Favored 'General case' 0 N--CA 1.487 1.395 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.435 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.6 OUTLIER -71.73 -17.61 62.2 Favored 'General case' 0 C--N 1.303 -1.452 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.659 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.45 -45.8 57.91 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.63 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -74.48 -28.99 61.26 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 178.662 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.63 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.6 m-30 -68.02 -33.73 75.14 Favored 'General case' 0 N--CA 1.489 1.477 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.435 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 9.4 t70 -77.34 -9.32 58.77 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.662 -0.649 . . . . 0.0 110.171 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.38 -30.76 14.93 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 178.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.81 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 61.5 mt -81.16 -32.59 12.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 177.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.708 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -73.43 -38.18 65.61 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 178.643 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.46 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.2 t70 -85.64 -1.25 56.95 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.411 0.624 . . . . 0.0 109.787 179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 2.8 t -88.47 -9.33 52.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.212 -0.93 . . . . 0.0 108.895 178.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.102 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.4 mt -100.67 -8.09 23.23 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 179.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.621 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 88.31 94.75 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.172 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -178.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 46.6 Cg_endo -72.0 151.09 55.74 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.346 1.708 . . . . 0.0 111.022 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.523 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 87.6 t -121.6 97.66 5.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 179.192 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.523 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.0 t30 63.67 14.96 8.58 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.527 -0.733 . . . . 0.0 109.858 -178.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 103.82 33.26 4.14 Favored Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.788 -1.325 . . . . 0.0 109.788 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.433 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 92.0 m-85 -149.92 154.69 38.71 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.161 -1.199 . . . . 0.0 111.827 -179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.102 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.0 mt -120.03 159.97 23.71 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 107.566 -1.272 . . . . 0.0 107.566 177.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.454 ' O ' ' N ' ' A' ' 35' ' ' LYS . 13.4 p -104.28 142.15 35.04 Favored 'General case' 0 C--N 1.293 -1.887 0 C-N-CA 118.769 -1.173 . . . . 0.0 109.904 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.604 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.28 -25.22 0.71 Allowed Glycine 0 N--CA 1.492 2.373 0 N-CA-C 108.565 -1.814 . . . . 0.0 108.565 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 32' ' ' SER . 7.4 t70 -71.86 -23.57 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.605 -0.938 . . . . 0.0 110.352 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 39.7 mttp -93.06 -36.8 12.5 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 179.069 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 90.1 t -78.11 -40.46 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 CA-C-O 121.473 0.654 . . . . 0.0 109.765 178.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.669 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 6.3 tttp -40.71 -55.98 4.14 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.31 -0.868 . . . . 0.0 111.089 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.6 -35.01 18.04 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.574 1.302 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.745 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -59.87 -36.19 65.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.403 -0.811 . . . . 0.0 109.621 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.039 ' HB3' HD22 ' A' ' 50' ' ' LEU . 23.2 mt -84.29 -25.73 29.09 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.238 -0.913 . . . . 0.0 109.456 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.47 HD12 ' HA ' ' A' ' 38' ' ' PRO . 53.9 mt -71.92 -15.31 62.09 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 179.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.8 m-20 -81.06 -10.22 59.72 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 119.885 -0.726 . . . . 0.0 109.464 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.743 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -81.13 8.6 8.36 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.842 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.435 ' CB ' ' O ' ' A' ' 43' ' ' SER . 4.3 tttt 65.6 15.83 10.22 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.279 -0.888 . . . . 0.0 109.462 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.041 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.1 mt -95.91 151.25 38.22 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.417 -0.802 . . . . 0.0 110.331 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.584 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.9 Cg_endo -75.54 -178.34 4.21 Favored 'Trans proline' 0 C--N 1.302 -1.889 0 O-C-N 123.986 1.519 . . . . 0.0 109.617 179.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.554 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.1 t -78.53 -0.68 3.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 O-C-N 121.21 -0.931 . . . . 0.0 109.521 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -86.47 -32.88 20.58 Favored 'General case' 0 N--CA 1.486 1.373 0 O-C-N 121.315 -0.865 . . . . 0.0 109.525 179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.955 HG13 HD22 ' A' ' 45' ' ' LEU . 8.3 mm -83.22 -38.6 14.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 N-CA-C 108.452 -0.944 . . . . 0.0 108.452 178.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.039 HD22 ' HB3' ' A' ' 40' ' ' LEU . 38.6 mt -72.91 -26.3 61.37 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.53 0.681 . . . . 0.0 109.201 179.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.548 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.24 -23.03 78.29 Favored Glycine 0 N--CA 1.486 1.976 0 N-CA-C 107.443 -2.263 . . . . 0.0 107.443 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.975 ' O ' HD12 ' A' ' 56' ' ' LEU . 3.3 mtm180 -100.38 -32.25 10.93 Favored 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.885 -0.774 . . . . 0.0 109.764 179.225 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.001 HG11 HG23 ' A' ' 77' ' ' VAL . 22.5 t -70.26 -36.32 66.85 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 119.062 -1.055 . . . . 0.0 109.015 179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.604 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.2 t-105 -70.31 -50.62 37.39 Favored 'General case' 0 C--N 1.304 -1.38 0 C-N-CA 119.434 -0.906 . . . . 0.0 109.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.7 mt-10 -56.82 -57.55 11.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.095 -1.003 . . . . 0.0 109.992 -178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.975 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -58.22 -16.94 15.66 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.303 -0.959 . . . . 0.0 108.48 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.014 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.9 t -92.12 -35.87 13.63 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.532 0.682 . . . . 0.0 109.905 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.546 ' OD2' ' CZ2' ' A' ' 54' ' ' TRP . 0.4 OUTLIER -72.97 98.36 2.48 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 110.217 -179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.524 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 49.0 mm -71.93 -28.99 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.156 -0.965 . . . . 0.0 110.005 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 0.0 OUTLIER -112.0 -15.26 13.33 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.327 -0.858 . . . . 0.0 109.656 179.757 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.495 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 91.7 m-70 59.68 47.77 10.15 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.558 -0.714 . . . . 0.0 111.298 179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.493 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 1.3 m-20 -98.04 26.06 5.57 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.179 -0.951 . . . . 0.0 108.635 178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.483 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 63.4 29.77 75.57 Favored Glycine 0 N--CA 1.484 1.875 0 N-CA-C 108.017 -2.033 . . . . 0.0 108.017 -178.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.518 ' CB ' ' O ' ' A' ' 31' ' ' LEU . 7.9 mtt -150.56 160.74 43.59 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.508 -0.995 . . . . 0.0 110.526 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 11.9 mt -129.48 100.68 5.64 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.388 -0.82 . . . . 0.0 109.412 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 69' ' ' GLU . 2.3 p30 -69.6 160.61 31.23 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.092 -1.005 . . . . 0.0 110.247 -179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.616 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.7 ptp85 -35.36 -43.2 0.23 Allowed 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.656 -0.653 . . . . 0.0 112.032 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.471 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.3 OUTLIER -81.47 -35.79 30.1 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.963 -1.085 . . . . 0.0 110.298 -179.472 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.524 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 13.7 tt0 -71.15 -43.26 67.89 Favored 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.427 -0.796 . . . . 0.0 109.18 179.469 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.81 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 58.4 t80 -63.1 -19.58 64.56 Favored 'General case' 0 C--N 1.302 -1.47 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -71.55 -42.7 67.54 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.487 0.661 . . . . 0.0 109.693 179.593 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.459 HG13 HD12 ' A' ' 94' ' ' LEU . 56.3 t -62.39 -31.79 52.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 CA-C-O 121.671 0.748 . . . . 0.0 109.722 179.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.014 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -87.58 0.25 55.88 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.38 -0.825 . . . . 0.0 110.757 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.598 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 9.4 mmt -89.8 -44.54 9.9 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.67 -1.269 . . . . 0.0 109.961 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.762 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 5.2 p90 -77.09 -22.34 52.92 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.265 -1.013 . . . . 0.0 108.265 178.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.557 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 5.2 mt -76.99 -22.95 52.35 Favored 'General case' 0 N--CA 1.487 1.385 0 CA-C-O 121.461 0.648 . . . . 0.0 109.54 179.064 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.001 HG23 HG11 ' A' ' 53' ' ' VAL . 5.4 t -91.34 -38.59 10.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.438 -0.789 . . . . 0.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -72.47 -22.71 61.03 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.467 -0.771 . . . . 0.0 110.676 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' GLU . 0.5 OUTLIER -83.15 -16.13 47.92 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.167 -0.958 . . . . 0.0 109.967 -179.9 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.041 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.77 -9.62 51.18 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.203 -0.936 . . . . 0.0 109.089 179.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.743 HD22 ' O ' ' A' ' 43' ' ' SER . 2.3 mt -90.62 -43.26 10.28 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 121.724 0.774 . . . . 0.0 109.535 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 4.9 mm-40 -71.64 -53.04 14.92 Favored 'General case' 0 C--N 1.3 -1.567 0 C-N-CA 119.999 -0.68 . . . . 0.0 110.068 -179.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 2.7 ttpp 178.01 -27.24 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.676 -0.81 . . . . 0.0 111.183 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -63.88 115.05 15.96 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.22 -0.925 . . . . 0.0 110.913 -178.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -69.8 165.57 30.58 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.934 1.492 . . . . 0.0 109.89 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.456 ' O ' ' NH1' ' A' ' 52' ' ' ARG . 54.7 t -115.16 120.69 36.34 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.183 -0.948 . . . . 0.0 111.037 -179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.453 ' O ' HD11 ' A' ' 56' ' ' LEU . 54.1 Cg_endo -84.71 -166.24 0.34 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.91 1.479 . . . . 0.0 109.55 179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.952 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -118.41 9.02 12.27 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.269 -0.894 . . . . 0.0 109.794 179.515 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.568 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -99.25 116.21 30.92 Favored 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.004 -1.078 . . . . 0.0 111.641 -177.889 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.806 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -103.1 84.82 0.74 Allowed Pre-proline 0 C--N 1.293 -1.878 0 N-CA-C 107.365 -1.346 . . . . 0.0 107.365 178.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.568 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.8 Cg_endo -63.73 173.37 4.69 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.496 1.464 . . . . 0.0 111.751 -178.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.775 ' O ' HG22 ' A' ' 95' ' ' VAL . 43.5 Cg_endo -69.82 -12.87 33.66 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 O-C-N 124.213 1.638 . . . . 0.0 110.733 -179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.59 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -76.68 -9.16 58.47 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.174 -0.954 . . . . 0.0 109.084 179.283 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.762 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 4.1 mm? -106.42 -13.44 15.36 Favored 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.563 -0.711 . . . . 0.0 110.297 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.775 HG22 ' O ' ' A' ' 92' ' ' PRO . 5.3 m -83.26 134.25 46.15 Favored Pre-proline 0 C--N 1.303 -1.438 0 O-C-N 121.252 -0.905 . . . . 0.0 110.3 -179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.474 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 44.2 Cg_endo -71.0 174.49 10.51 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.022 1.538 . . . . 0.0 110.255 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 43.5 Cg_endo -69.78 -12.16 32.28 Favored 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.037 1.546 . . . . 0.0 110.107 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.31 -19.85 62.26 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.242 -0.911 . . . . 0.0 109.83 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.444 ' C ' ' HD2' ' A' ' 100' ' ' ARG . 1.0 OUTLIER -89.31 0.82 56.52 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.333 -0.854 . . . . 0.0 109.421 179.219 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.526 ' N ' ' CD ' ' A' ' 100' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.397 -0.814 . . . . 0.0 110.09 179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.686 0 CA-C-O 121.22 0.534 . . . . 0.0 110.296 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.507 ' O ' ' CZ2' ' A' ' 54' ' ' TRP . 1.1 p -54.17 -70.99 0.08 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.284 -0.885 . . . . 0.0 109.947 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.465 ' ND2' ' HG3' ' A' ' 55' ' ' GLU . 34.0 t-20 -101.48 118.88 58.96 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.426 -0.796 . . . . 0.0 109.857 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.52 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 47.6 Cg_endo -72.19 -23.96 20.56 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.89 1.468 . . . . 0.0 110.545 -179.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.936 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 45.0 m-85 -88.9 -38.38 14.58 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.266 -0.896 . . . . 0.0 110.337 -179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.306 179.945 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.482 0.85 0 N-CA-C 110.411 -0.65 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.499 ' O ' ' N ' ' A' ' 9' ' ' VAL . 11.9 t90 -56.08 129.5 40.22 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.332 -0.855 . . . . 0.0 109.669 179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.849 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -37.71 -30.17 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.455 -0.778 . . . . 0.0 110.219 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.541 HG13 ' HB3' ' A' ' 13' ' ' ASP . 60.3 t -100.75 131.57 48.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 121.545 -0.722 . . . . 0.0 109.596 179.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.547 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.8 OUTLIER -89.65 -179.04 1.11 Allowed Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.232 -0.918 . . . . 0.0 110.203 -179.336 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.547 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 40.8 Cg_endo -68.95 -35.67 14.66 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.816 1.429 . . . . 0.0 109.903 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.403 ' HG2' ' N ' ' A' ' 13' ' ' ASP . 3.8 pt-20 -73.28 -26.78 61.23 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.303 -0.873 . . . . 0.0 109.764 179.388 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.541 ' HB3' HG13 ' A' ' 9' ' ' VAL . 0.1 OUTLIER -82.21 -39.43 23.11 Favored 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -72.31 -13.49 61.51 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 178.875 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -78.69 -40.37 34.02 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -79.15 -23.65 43.84 Favored 'General case' 0 C--N 1.305 -1.341 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.473 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.638 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -78.7 -33.15 47.09 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 47.7 t0 -79.69 -7.79 58.81 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.682 -0.636 . . . . 0.0 110.047 -179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.51 -36.27 12.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.805 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 40.2 mt -76.88 -31.51 19.14 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.19 -37.7 66.41 Favored 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 108.663 -0.866 . . . . 0.0 108.663 178.887 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.519 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 2.3 t70 -89.67 3.72 51.79 Favored 'General case' 0 N--CA 1.488 1.428 0 CA-C-O 121.453 0.644 . . . . 0.0 109.71 179.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -91.46 -5.95 53.46 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.313 -0.867 . . . . 0.0 108.868 178.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.043 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.38 -4.95 16.01 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 179.542 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.573 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 82.73 94.55 0.04 OUTLIER Pre-proline 0 N--CA 1.499 1.983 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 -178.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 48.0 Cg_endo -73.29 148.57 43.88 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.224 1.644 . . . . 0.0 110.496 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.488 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 92.6 t -115.46 102.2 13.41 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 O-C-N 121.545 -0.722 . . . . 0.0 109.299 179.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' O ' ' ND2' ' A' ' 28' ' ' ASN . 3.3 t30 61.15 16.36 7.12 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.419 -0.801 . . . . 0.0 109.661 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 100.07 35.56 4.47 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.755 -1.338 . . . . 0.0 109.755 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.577 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 76.3 m-85 -150.53 143.5 24.73 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.923 -1.339 . . . . 0.0 112.279 -179.627 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.043 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.4 mt -113.93 137.53 51.56 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 177.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.478 ' O ' ' C ' ' A' ' 33' ' ' GLY . 47.3 p -83.8 140.52 32.0 Favored 'General case' 0 C--N 1.29 -2.009 0 C-N-CA 118.666 -1.213 . . . . 0.0 109.332 179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.521 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.94 -28.44 0.23 Allowed Glycine 0 N--CA 1.494 2.54 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 37.9 t0 -62.34 -23.81 66.98 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.61 -0.935 . . . . 0.0 110.559 179.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.48 ' O ' ' HG2' ' A' ' 38' ' ' PRO . 43.0 mttp -97.93 -35.76 10.37 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.928 HG11 HD12 ' A' ' 65' ' ' LEU . 85.1 t -75.64 -37.76 37.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.511 0 C-N-CA 120.084 -0.646 . . . . 0.0 110.023 179.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.693 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 ttmt -45.08 -51.36 24.14 Favored Pre-proline 0 N--CA 1.489 1.523 0 O-C-N 121.252 -0.905 . . . . 0.0 111.133 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD3' ' HB3' ' A' ' 37' ' ' LYS . 41.2 Cg_endo -68.21 -33.57 24.16 Favored 'Trans proline' 0 C--N 1.31 -1.479 0 O-C-N 123.254 1.133 . . . . 0.0 109.917 179.546 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.633 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 1.8 t -61.6 -31.26 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.515 -0.741 . . . . 0.0 110.215 179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.123 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.9 mt -91.69 -23.8 19.69 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.076 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.474 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 57.8 mt -74.77 -13.46 60.59 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.28 -0.887 . . . . 0.0 109.383 179.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.452 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 2.1 p-10 -87.07 -1.02 57.57 Favored 'General case' 0 C--N 1.303 -1.443 0 C-N-CA 118.996 -1.082 . . . . 0.0 110.322 -179.441 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.654 ' O ' HD22 ' A' ' 81' ' ' LEU . 5.1 p -90.58 12.69 18.03 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.277 -0.89 . . . . 0.0 110.615 -179.702 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 65.93 15.63 10.14 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.079 -1.013 . . . . 0.0 109.925 -179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.078 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.7 mt -100.11 151.83 37.63 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.229 -0.919 . . . . 0.0 110.624 -179.669 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.8 Cg_endo -76.89 172.87 15.41 Favored 'Trans proline' 0 C--N 1.303 -1.859 0 O-C-N 124.206 1.635 . . . . 0.0 110.178 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.521 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.0 OUTLIER -69.96 -4.13 3.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 O-C-N 121.342 -0.849 . . . . 0.0 109.659 -179.993 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -82.04 -30.11 31.58 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.201 -0.937 . . . . 0.0 109.209 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.941 HG13 HD22 ' A' ' 45' ' ' LEU . 8.9 mm -85.54 -36.82 11.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 CA-C-O 121.928 0.87 . . . . 0.0 108.896 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.123 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -76.85 -27.96 55.3 Favored 'General case' 0 C--N 1.297 -1.694 0 CA-C-O 121.413 0.625 . . . . 0.0 109.523 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.98 -24.92 75.03 Favored Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.164 -2.374 . . . . 0.0 107.164 178.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.805 ' O ' HD12 ' A' ' 56' ' ' LEU . 17.5 ttm180 -101.05 -31.46 11.07 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.979 -0.718 . . . . 0.0 110.182 179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.943 HG11 HG23 ' A' ' 77' ' ' VAL . 15.0 t -72.06 -36.77 58.08 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 O-C-N 120.96 -1.087 . . . . 0.0 108.421 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.56 ' O ' ' N ' ' A' ' 58' ' ' ASP . 1.9 t-105 -64.38 -51.39 63.53 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.27 -0.972 . . . . 0.0 108.743 178.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.541 ' CG ' ' ND2' ' B' ' 109' ' ' ASN . 1.9 mm-40 -49.09 -61.41 2.09 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.088 -1.008 . . . . 0.0 110.326 -179.249 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.906 HD11 ' O ' ' A' ' 87' ' ' PRO . 2.6 mt -59.88 -16.58 30.25 Favored 'General case' 0 C--N 1.299 -1.61 0 C-N-CA 119.477 -0.889 . . . . 0.0 108.858 179.634 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.772 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 17.7 m -90.55 -28.96 18.14 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.79 -0.818 . . . . 0.0 108.79 178.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 54' ' ' TRP . 27.9 t0 -76.4 101.6 5.62 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.788 -0.57 . . . . 0.0 109.64 179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.507 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 18.3 mm -88.49 -17.23 8.5 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.154 -0.966 . . . . 0.0 110.562 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.409 ' CG ' ' OE2' ' A' ' 69' ' ' GLU . 3.3 m-20 -104.07 -10.08 18.3 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.148 -0.97 . . . . 0.0 110.374 -179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.63 ' N ' ' CD2' ' A' ' 61' ' ' HIS . 2.8 m170 52.38 49.1 21.22 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.0 110.208 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 34.8 p-10 -128.46 14.14 6.56 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.932 -1.105 . . . . 0.0 110.177 -179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 79.4 32.61 37.78 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.38 -1.488 . . . . 0.0 109.38 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.49 ' HG3' ' O ' ' A' ' 63' ' ' GLY . 18.6 mtp -150.8 161.07 43.36 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.188 -1.184 . . . . 0.0 110.747 -179.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.928 HD12 HG11 ' A' ' 36' ' ' VAL . 7.7 mt -126.94 107.48 10.11 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.288 -0.882 . . . . 0.0 110.09 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.577 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 12.4 t0 -69.63 166.55 18.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.947 -1.096 . . . . 0.0 109.432 179.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.549 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 4.6 ptp85 -45.88 -42.17 12.23 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.407 -0.808 . . . . 0.0 110.139 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.544 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 63.4 m-20 -76.14 -36.63 58.7 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.376 -0.827 . . . . 0.0 110.097 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.53 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 35.5 mt-10 -71.66 -46.34 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.106 -0.997 . . . . 0.0 108.92 179.253 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.885 ' CD2' HD12 ' A' ' 31' ' ' LEU . 29.7 t80 -55.4 -30.95 61.38 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 179.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.505 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.44 -49.18 74.7 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.487 -0.758 . . . . 0.0 110.305 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.487 ' O ' HD12 ' A' ' 76' ' ' LEU . 49.6 t -58.03 -22.47 19.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.47 -0.769 . . . . 0.0 110.044 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.772 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.34 -8.5 50.62 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.29 -0.881 . . . . 0.0 111.94 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.62 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 10.3 mmm -88.8 -41.2 12.65 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.617 -1.302 . . . . 0.0 110.527 -179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.673 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 2.7 p90 -78.9 -29.17 44.17 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.911 -1.118 . . . . 0.0 108.189 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.66 ' HB3' HG13 ' A' ' 53' ' ' VAL . 7.6 mt -66.75 -27.12 67.35 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 178.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.943 HG23 HG11 ' A' ' 53' ' ' VAL . 25.6 t -90.74 -19.91 7.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.744 -0.598 . . . . 0.0 110.032 179.552 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -88.91 -24.11 22.55 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.373 -0.83 . . . . 0.0 109.703 179.66 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.562 ' CA ' ' HB2' ' A' ' 83' ' ' LYS . 1.5 m -84.09 -16.74 42.6 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.404 -0.81 . . . . 0.0 109.541 179.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.078 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -83.26 -11.48 57.73 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.13 -0.981 . . . . 0.0 108.598 178.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.654 HD22 ' O ' ' A' ' 43' ' ' SER . 10.0 mt -90.99 -41.84 10.88 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.77 -0.581 . . . . 0.0 110.468 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.448 ' O ' ' CG ' ' A' ' 82' ' ' GLU . 2.2 tt0 -131.44 -3.21 3.82 Favored 'General case' 0 N--CA 1.493 1.723 0 C-N-CA 119.439 -0.904 . . . . 0.0 112.216 -178.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.562 ' HB2' ' CA ' ' A' ' 79' ' ' CYS . 5.2 mmmt -111.42 -86.88 0.54 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 120.276 -1.515 . . . . 0.0 111.474 -179.227 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.535 ' HB2' ' HD2' ' A' ' 85' ' ' PRO . 4.1 pt-20 -145.84 170.82 7.31 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.237 -0.915 . . . . 0.0 110.119 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 84' ' ' GLU . 40.9 Cg_endo -68.58 -160.32 0.06 OUTLIER 'Trans proline' 0 C--N 1.308 -1.594 0 O-C-N 123.705 1.371 . . . . 0.0 109.585 179.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.631 HG21 ' CG2' ' A' ' 53' ' ' VAL . 99.0 t -133.65 132.29 21.66 Favored Pre-proline 0 N--CA 1.49 1.552 0 O-C-N 120.936 -1.102 . . . . 0.0 110.899 -179.283 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.906 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.0 Cg_endo -84.84 176.57 6.02 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.94 1.495 . . . . 0.0 109.273 178.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.58 ' HG2' ' NE ' ' A' ' 52' ' ' ARG . 13.4 mtt -103.79 15.48 28.64 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.882 -1.136 . . . . 0.0 110.524 179.829 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.531 ' N ' HD21 ' A' ' 56' ' ' LEU . 25.7 m -115.9 100.62 8.12 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 118.327 -1.349 . . . . 0.0 112.238 -177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.653 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.5 OUTLIER -55.76 108.11 1.09 Allowed Pre-proline 0 C--N 1.29 -2.014 0 C-N-CA 119.998 -0.681 . . . . 0.0 109.464 178.168 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.668 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.9 Cg_endo -66.73 161.09 43.4 Favored 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.946 1.498 . . . . 0.0 110.619 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.492 ' O ' HG22 ' A' ' 95' ' ' VAL . 45.1 Cg_endo -70.61 -21.16 29.89 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.072 1.564 . . . . 0.0 110.833 -179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.747 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -83.96 -1.08 53.93 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.147 -0.971 . . . . 0.0 109.602 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.849 HD13 ' HB3' ' A' ' 8' ' ' ALA . 4.2 mm? -113.33 16.05 19.09 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.356 -0.84 . . . . 0.0 111.021 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.492 HG22 ' O ' ' A' ' 92' ' ' PRO . 3.9 m -114.74 137.9 23.0 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 120.871 -1.143 . . . . 0.0 110.993 -179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.49 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 40.5 Cg_endo -68.56 174.84 7.83 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.158 1.609 . . . . 0.0 110.077 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.49 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 43.9 Cg_endo -70.52 -22.78 28.1 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.938 1.494 . . . . 0.0 110.767 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 65.2 p -78.0 -7.63 57.11 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 120.999 -1.063 . . . . 0.0 109.531 179.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.83 -6.7 51.19 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.366 -0.834 . . . . 0.0 109.434 179.119 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.465 ' HD2' ' O ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 O-C-N 121.219 -0.925 . . . . 0.0 110.097 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.488 ' N ' ' OE1' ' A' ' 55' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.228 0.537 . . . . 0.0 110.152 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 7.9 p 51.69 47.39 24.88 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.399 -0.813 . . . . 0.0 110.313 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.581 ' ND2' ' CD2' ' B' ' 112' ' ' LEU . 0.9 OUTLIER -76.89 156.17 82.6 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.34 -0.85 . . . . 0.0 109.589 179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.562 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 44.9 Cg_endo -80.96 7.19 5.07 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.686 1.361 . . . . 0.0 109.714 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 1.02 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 96.6 m-85 -120.65 -16.07 8.32 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.261 -0.899 . . . . 0.0 110.311 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.581 ' CD2' ' ND2' ' B' ' 109' ' ' ASN . 1.5 pp . . . . . 0 N--CA 1.492 1.659 0 O-C-N 121.115 -0.991 . . . . 0.0 110.333 179.768 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo . . . . . 0 N--CA 1.484 0.922 0 N-CA-C 110.492 -0.619 . . . . 0.0 110.492 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.511 ' HA ' ' O ' ' A' ' 93' ' ' ALA . 13.1 t90 -92.34 125.76 37.14 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.18 -0.95 . . . . 0.0 110.398 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.469 ' HB3' ' HA ' ' A' ' 94' ' ' LEU . . . -44.68 -26.82 0.42 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.314 -0.866 . . . . 0.0 110.185 179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.502 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 44.2 t -105.61 139.52 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.3 -0.875 . . . . 0.0 110.234 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.574 ' CG ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -99.17 -178.37 0.69 Allowed Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.168 -0.957 . . . . 0.0 109.893 179.961 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -71.41 -34.73 9.22 Favored 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.849 1.447 . . . . 0.0 110.119 179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.449 ' HG3' ' OD1' ' A' ' 13' ' ' ASP . 7.3 pt-20 -76.81 -27.88 55.38 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.314 -0.867 . . . . 0.0 110.304 179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.556 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.8 OUTLIER -84.7 -30.11 25.05 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.782 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -82.33 -19.67 38.89 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.373 -0.829 . . . . 0.0 109.005 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -75.42 -37.63 60.3 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 4.4 ptmt -74.27 -23.44 59.12 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 10.3 m-30 -76.76 -35.67 57.56 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 25.0 t0 -72.31 -10.01 59.23 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.702 -0.624 . . . . 0.0 110.387 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.37 -35.88 14.15 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 107.432 -1.321 . . . . 0.0 107.432 178.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.683 HG22 ' CE1' ' A' ' 70' ' ' PHE . 21.4 mt -76.23 -33.68 24.45 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 N-CA-C 107.58 -1.267 . . . . 0.0 107.58 177.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.753 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.53 -40.55 70.02 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.54 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 21.4 t70 -85.75 4.51 36.49 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.609 -0.682 . . . . 0.0 109.664 179.323 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.9 -9.41 43.31 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.344 -0.848 . . . . 0.0 109.012 179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.026 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.1 mt -102.86 -9.3 20.03 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 179.285 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.61 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 p 87.2 91.28 0.04 OUTLIER Pre-proline 0 N--CA 1.503 2.222 0 CA-C-O 121.542 0.687 . . . . 0.0 109.153 -178.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.554 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.7 Cg_endo -74.29 150.21 41.5 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.174 1.618 . . . . 0.0 110.75 -178.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.486 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 35.3 t -119.18 112.37 37.26 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.486 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.3 t30 57.37 16.91 3.42 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.314 -0.866 . . . . 0.0 109.357 -178.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.449 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 96.0 36.18 5.32 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.619 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 79.2 m-85 -147.16 146.1 29.76 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.065 -1.256 . . . . 0.0 112.097 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.026 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.6 mt -115.06 139.33 49.96 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.9 -1.148 . . . . 0.0 107.9 177.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.463 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -83.39 143.4 30.33 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 118.861 -1.136 . . . . 0.0 110.133 -179.855 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.528 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -44.34 -25.93 0.87 Allowed Glycine 0 N--CA 1.491 2.318 0 N-CA-C 108.463 -1.855 . . . . 0.0 108.463 179.257 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.426 ' N ' ' O ' ' A' ' 32' ' ' SER . 43.8 m-20 -69.13 -22.93 63.93 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.641 -0.917 . . . . 0.0 110.349 179.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.551 ' HE3' ' HG ' ' A' ' 25' ' ' SER . 65.1 mttm -94.91 -35.28 12.08 Favored 'General case' 0 N--CA 1.485 1.279 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.062 HG11 HD12 ' A' ' 65' ' ' LEU . 84.8 t -77.43 -39.7 28.01 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 CA-C-O 121.741 0.782 . . . . 0.0 109.371 178.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.591 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 8.7 tttp -41.51 -55.13 5.79 Favored Pre-proline 0 N--CA 1.489 1.476 0 O-C-N 121.715 -0.616 . . . . 0.0 110.721 -179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.0 Cg_endo -67.29 -35.03 25.52 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 O-C-N 123.568 1.299 . . . . 0.0 110.034 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.811 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.4 t -61.38 -33.17 55.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.383 -0.823 . . . . 0.0 109.121 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.976 ' HB3' HD22 ' A' ' 50' ' ' LEU . 46.7 mt -87.44 -26.81 23.08 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.449 -0.782 . . . . 0.0 109.864 179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 42.0 mt -74.34 -13.72 60.79 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.405 -0.81 . . . . 0.0 109.035 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -85.92 -10.93 54.41 Favored 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.554 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.572 ' O ' HD21 ' A' ' 81' ' ' LEU . 3.2 m -78.18 4.84 11.55 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.606 -0.683 . . . . 0.0 109.965 179.72 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CB ' ' O ' ' A' ' 43' ' ' SER . 11.4 tttm 68.29 8.26 6.47 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.214 -0.929 . . . . 0.0 109.79 -179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.03 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.9 mt -92.1 155.09 43.23 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.362 -0.836 . . . . 0.0 110.424 -179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.4 Cg_endo -74.97 168.88 23.86 Favored 'Trans proline' 0 C--N 1.301 -1.931 0 O-C-N 124.125 1.592 . . . . 0.0 109.734 179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.821 HG13 ' HB3' ' B' ' 111' ' ' PHE . 10.3 t -68.03 -7.28 6.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.5 0 O-C-N 121.336 -0.853 . . . . 0.0 109.519 -179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.7 -32.47 53.01 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.338 -0.852 . . . . 0.0 109.313 179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.874 HG21 HD13 ' A' ' 45' ' ' LEU . 10.5 mm -81.29 -40.56 18.32 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 178.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.976 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.2 mt -69.92 -29.15 66.24 Favored 'General case' 0 C--N 1.299 -1.591 0 CA-C-O 121.548 0.689 . . . . 0.0 109.373 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -72.21 -23.56 77.77 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 108.183 -1.967 . . . . 0.0 108.183 179.573 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.922 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.08 -29.86 11.92 Favored 'General case' 0 C--N 1.3 -1.566 0 O-C-N 121.723 -0.869 . . . . 0.0 110.211 179.648 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.831 HG11 HG23 ' A' ' 77' ' ' VAL . 22.0 t -73.86 -37.35 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 C-N-CA 118.862 -1.135 . . . . 0.0 108.747 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.573 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.5 t-105 -66.57 -48.69 68.82 Favored 'General case' 0 C--N 1.303 -1.441 0 C-N-CA 119.263 -0.975 . . . . 0.0 109.471 178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 1.4 mt-10 -56.48 -57.33 12.8 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.09 -1.006 . . . . 0.0 109.92 -178.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.922 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.9 mt -61.35 -15.16 33.36 Favored 'General case' 0 C--N 1.299 -1.598 0 C-N-CA 119.311 -0.956 . . . . 0.0 108.445 178.595 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.821 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 14.2 m -94.18 -25.59 17.04 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.51 -0.744 . . . . 0.0 109.832 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.57 ' O ' ' CD2' ' A' ' 61' ' ' HIS . 2.5 t0 -76.99 85.09 3.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.415 -0.803 . . . . 0.0 109.917 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.557 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 40.3 mm -61.75 -30.31 48.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.548 0 O-C-N 121.278 -0.888 . . . . 0.0 110.828 -179.498 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 4.8 p30 -109.9 -13.9 14.36 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.01 -1.056 . . . . 0.0 110.683 -179.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 16.9 m-70 60.48 46.18 9.98 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.33 -0.856 . . . . 0.0 110.21 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 43.5 p-10 -103.62 22.49 14.26 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.241 -0.912 . . . . 0.0 109.404 179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.494 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 68.0 26.7 73.9 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.527 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 22.7 mtp -150.61 161.44 42.59 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.163 -1.198 . . . . 0.0 110.375 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.062 HD12 HG11 ' A' ' 36' ' ' VAL . 11.5 mt -125.67 99.39 5.97 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.317 -0.865 . . . . 0.0 109.035 178.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.619 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 51.5 p30 -71.16 166.97 20.35 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.832 -1.167 . . . . 0.0 110.315 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.633 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -38.13 -45.39 0.93 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.402 -0.811 . . . . 0.0 112.149 -179.051 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.457 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 31.2 t70 -74.95 -42.29 57.95 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.07 -1.019 . . . . 0.0 110.963 -178.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.557 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 56.8 mt-10 -70.67 -44.45 67.02 Favored 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.117 -0.989 . . . . 0.0 109.02 179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 13.2 t80 -57.31 -22.76 44.15 Favored 'General case' 0 C--N 1.301 -1.519 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.5 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -74.21 -46.91 38.89 Favored 'General case' 0 N--CA 1.49 1.57 0 CA-C-O 121.76 0.791 . . . . 0.0 109.336 179.43 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.971 ' CG1' HD11 ' A' ' 94' ' ' LEU . 95.4 t -59.83 -25.17 31.58 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.579 0 CA-C-O 121.437 0.637 . . . . 0.0 109.93 179.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.821 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.25 -6.11 55.57 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.434 -0.791 . . . . 0.0 111.179 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.613 ' HB2' ' CD2' ' A' ' 17' ' ' TYR . 4.5 mmt -85.89 -46.19 10.82 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.91 -1.119 . . . . 0.0 110.071 179.753 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.533 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 5.5 p90 -75.28 -28.23 59.69 Favored 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 108.09 -1.078 . . . . 0.0 108.09 178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.747 HD12 ' O ' ' A' ' 72' ' ' VAL . 5.4 mt -66.23 -24.21 66.56 Favored 'General case' 0 N--CA 1.486 1.357 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.831 HG23 HG11 ' A' ' 53' ' ' VAL . 69.8 t -91.57 -57.8 4.04 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.305 0 N-CA-C 109.179 -0.674 . . . . 0.0 109.179 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -49.71 -22.04 1.25 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.652 -0.655 . . . . 0.0 111.622 -179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.474 ' HB2' ' O ' ' A' ' 75' ' ' PHE . 0.5 OUTLIER -85.48 -11.75 53.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.842 -1.161 . . . . 0.0 110.434 -179.657 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.03 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.19 -17.02 28.32 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.278 -0.889 . . . . 0.0 109.535 179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.868 HD12 ' N ' ' A' ' 81' ' ' LEU . 5.6 mp -90.51 -39.74 12.41 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.338 -0.851 . . . . 0.0 109.766 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.3 OUTLIER -70.89 -61.05 1.91 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.551 -0.859 . . . . 0.0 109.809 179.842 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.52 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 8.6 tptt 177.5 68.72 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.838 0 C-N-CA 120.299 -0.561 . . . . 0.0 110.715 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.465 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 0.0 OUTLIER -177.54 107.0 0.22 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.715 -1.241 . . . . 0.0 110.825 179.899 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.444 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 40.3 Cg_endo -66.39 -178.73 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 123.92 1.484 . . . . 0.0 110.188 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.597 HG21 ' CG2' ' A' ' 53' ' ' VAL . 76.8 t -120.77 130.16 24.98 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.112 -0.992 . . . . 0.0 110.861 -179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.704 ' O ' HD11 ' A' ' 56' ' ' LEU . 51.0 Cg_endo -86.06 -170.46 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 124.026 1.54 . . . . 0.0 109.796 178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.659 ' C ' HD21 ' A' ' 56' ' ' LEU . 36.9 mtm -115.23 14.14 16.86 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.099 -1.001 . . . . 0.0 110.363 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.492 ' N ' HD21 ' A' ' 56' ' ' LEU . 22.8 m -112.29 103.46 11.6 Favored 'General case' 0 C--N 1.297 -1.693 0 C-N-CA 118.622 -1.231 . . . . 0.0 111.815 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.744 ' CD2' HD12 ' A' ' 94' ' ' LEU . 0.7 OUTLIER -53.34 107.92 0.97 Allowed Pre-proline 0 C--N 1.291 -1.966 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 178.551 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.548 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 36.9 Cg_endo -64.82 143.47 80.09 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.777 1.409 . . . . 0.0 110.731 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.86 2.22 5.62 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.399 1.736 . . . . 0.0 111.978 -178.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.511 ' O ' ' HA ' ' A' ' 7' ' ' TRP . . . -105.55 -16.63 14.66 Favored 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.971 HD11 ' CG1' ' A' ' 72' ' ' VAL . 1.0 OUTLIER -92.52 -16.24 26.0 Favored 'General case' 0 C--N 1.299 -1.587 0 CA-C-O 121.414 0.626 . . . . 0.0 109.507 179.698 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.519 HG23 ' O ' ' A' ' 91' ' ' PRO . 57.8 t -74.48 139.19 74.61 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.281 -0.887 . . . . 0.0 110.535 -179.582 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -71.78 172.13 15.09 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.043 1.549 . . . . 0.0 110.474 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.2 -17.38 27.84 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 123.982 1.517 . . . . 0.0 110.47 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -10.91 60.45 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.096 -1.003 . . . . 0.0 109.693 179.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.498 ' CB ' ' CG1' ' A' ' 95' ' ' VAL . 0.0 OUTLIER -89.56 -4.78 57.72 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.421 -0.8 . . . . 0.0 109.438 179.243 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.321 -0.862 . . . . 0.0 110.446 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.12 0.486 . . . . 0.0 110.284 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 15.3 t -135.79 139.16 43.3 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.18 -0.95 . . . . 0.0 110.544 -179.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.484 ' HB3' ' HB2' ' B' ' 112' ' ' LEU . 22.5 t-20 -127.12 139.2 34.45 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.275 -0.89 . . . . 0.0 110.199 179.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -76.94 6.2 4.39 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 111.847 -179.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.821 ' HB3' HG13 ' A' ' 47' ' ' VAL . 73.0 m-85 -125.2 -33.38 2.87 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.793 -1.192 . . . . 0.0 110.285 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.484 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 1.1 mp . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.149 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo . . . . . 0 N--CA 1.485 0.994 0 N-CA-C 110.22 -0.723 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.422 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 15.3 t90 -113.48 133.47 55.2 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.132 -0.98 . . . . 0.0 110.292 -179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.772 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -44.37 -35.01 2.19 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.461 -0.775 . . . . 0.0 110.952 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.422 ' HB ' ' CD2' ' A' ' 7' ' ' TRP . 70.1 t -86.71 159.68 3.1 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.412 -0.805 . . . . 0.0 110.055 -179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.5 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mptt -115.68 177.87 1.1 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.285 -0.884 . . . . 0.0 110.422 -179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.5 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.6 Cg_endo -70.28 -34.46 12.79 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.057 1.556 . . . . 0.0 109.869 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -78.43 -26.77 46.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.36 -0.838 . . . . 0.0 110.023 179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.483 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 1.1 m-20 -81.5 -31.76 32.73 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.205 -0.934 . . . . 0.0 108.897 179.228 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.427 ' HB2' ' O ' ' A' ' 10' ' ' LYS . 0.0 OUTLIER -75.95 -12.61 60.18 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.412 -0.805 . . . . 0.0 108.987 178.914 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -82.37 -40.33 21.48 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.64 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.07 -27.33 60.86 Favored 'General case' 0 C--N 1.306 -1.309 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 178.813 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.64 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.6 m-30 -72.1 -34.83 68.93 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.86 -0.792 . . . . 0.0 108.86 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.489 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 0.9 OUTLIER -73.34 -10.15 59.44 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.75 -0.594 . . . . 0.0 110.15 -179.84 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.5 -32.05 15.72 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 178.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.646 HG22 ' CE1' ' A' ' 70' ' ' PHE 0.251 60.3 mt -82.41 -35.36 12.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.668 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 178.043 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.749 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -71.84 -37.5 70.27 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.636 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.509 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 14.4 t70 -88.62 1.98 54.0 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.556 -0.715 . . . . 0.0 109.676 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -89.39 -6.82 56.27 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.308 -0.87 . . . . 0.0 108.722 178.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.044 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -107.5 -8.49 16.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.692 -0.63 . . . . 0.0 109.435 179.415 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.604 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 85.38 95.67 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.173 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 -178.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -72.26 147.77 48.26 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.205 1.634 . . . . 0.0 110.407 -179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.528 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 43.0 t -112.54 96.38 4.63 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.689 0 O-C-N 121.535 -0.728 . . . . 0.0 109.094 179.395 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.528 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.7 OUTLIER 66.1 9.96 6.67 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.514 -0.741 . . . . 0.0 109.397 -178.767 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.574 ' O ' ' CD1' ' A' ' 30' ' ' PHE . . . 108.58 28.93 4.36 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.626 -1.389 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.574 ' CD1' ' O ' ' A' ' 29' ' ' GLY . 30.4 m-85 -140.98 141.43 34.4 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.073 -1.251 . . . . 0.0 111.95 -179.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.044 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.7 mt -112.61 139.59 48.08 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 177.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.51 ' HA ' ' HG2' ' A' ' 64' ' ' MET . 20.9 p -92.43 144.88 24.92 Favored 'General case' 0 C--N 1.292 -1.924 0 C-N-CA 119.135 -1.026 . . . . 0.0 110.288 -179.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.537 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -42.33 -27.66 0.48 Allowed Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.729 -1.749 . . . . 0.0 108.729 179.512 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 32' ' ' SER . 54.2 m-20 -63.32 -26.23 68.67 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.461 -1.023 . . . . 0.0 109.972 179.36 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.517 ' HB3' ' CB ' ' A' ' 24' ' ' LEU . 16.5 mttt -95.21 -35.97 11.64 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 179.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.871 HG12 HD11 ' A' ' 40' ' ' LEU . 94.6 t -77.63 -48.81 23.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 C-N-CA 120.114 -0.634 . . . . 0.0 110.233 179.355 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.64 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 31.9 tttm -35.5 -56.1 1.06 Allowed Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.846 -0.534 . . . . 0.0 111.252 -178.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.9 Cg_endo -67.02 -35.79 24.49 Favored 'Trans proline' 0 C--N 1.308 -1.563 0 O-C-N 123.496 1.261 . . . . 0.0 110.073 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.684 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -63.28 -31.93 54.57 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.501 -0.75 . . . . 0.0 109.988 179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.091 ' HB3' HD22 ' A' ' 50' ' ' LEU . 18.3 mt -89.36 -25.52 21.54 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.174 -0.954 . . . . 0.0 110.087 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.475 HD11 ' HG3' ' A' ' 37' ' ' LYS . 41.8 mt -74.73 -12.52 60.43 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.078 -1.014 . . . . 0.0 109.049 179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -84.05 -8.04 59.23 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.7 -0.8 . . . . 0.0 109.714 179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.794 ' O ' HD21 ' A' ' 81' ' ' LEU . 1.0 OUTLIER -84.54 15.32 3.82 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.396 -0.815 . . . . 0.0 110.217 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 57.62 21.13 6.89 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.106 -0.996 . . . . 0.0 109.996 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.008 HD11 ' HB3' ' A' ' 80' ' ' ALA . 14.6 mt -99.7 153.11 37.94 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.377 -0.827 . . . . 0.0 110.019 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.581 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.1 Cg_endo -75.67 178.66 7.11 Favored 'Trans proline' 0 C--N 1.302 -1.919 0 O-C-N 123.998 1.525 . . . . 0.0 110.046 179.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.634 HG13 ' HB3' ' B' ' 111' ' ' PHE . 2.9 t -75.78 -2.73 4.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.37 -0.831 . . . . 0.0 109.331 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 13.6 t0 -83.83 -34.3 24.7 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.296 -0.878 . . . . 0.0 109.351 179.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.948 HG13 HD22 ' A' ' 45' ' ' LEU . 10.2 mm -80.73 -40.43 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 122.033 0.92 . . . . 0.0 108.522 178.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.091 HD22 ' HB3' ' A' ' 40' ' ' LEU . 32.8 mt -71.44 -27.55 63.35 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.536 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -69.83 -25.39 75.62 Favored Glycine 0 N--CA 1.488 2.119 0 N-CA-C 107.739 -2.144 . . . . 0.0 107.739 178.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.854 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.9 mtm-85 -101.28 -31.34 11.03 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.791 -0.829 . . . . 0.0 109.829 179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.634 HG11 ' CG2' ' A' ' 77' ' ' VAL . 7.5 t -67.7 -36.79 77.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.376 0 C-N-CA 119.289 -0.965 . . . . 0.0 109.217 179.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.578 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 3.7 t-105 -75.57 -51.63 12.45 Favored 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.189 -1.005 . . . . 0.0 109.809 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 41.0 mt-10 -57.7 -55.97 27.93 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.013 -1.054 . . . . 0.0 109.218 -178.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.855 ' O ' HD11 ' A' ' 90' ' ' LEU . 13.9 mt -59.55 -16.78 27.31 Favored 'General case' 0 C--N 1.297 -1.706 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 178.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.981 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 5.0 t -94.43 -25.5 16.89 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 177.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 5.7 t0 -73.73 98.95 3.02 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 121.234 0.54 . . . . 0.0 109.732 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.475 ' N ' ' OE1' ' A' ' 69' ' ' GLU . 20.9 mm -86.61 -36.78 10.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.221 -0.925 . . . . 0.0 110.171 -179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.514 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -96.87 -12.32 23.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.284 -0.885 . . . . 0.0 109.847 179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.509 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 40.4 m170 58.34 45.39 17.02 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.439 -0.788 . . . . 0.0 111.18 179.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.514 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 17.9 p-10 -107.22 28.91 7.61 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.089 -1.007 . . . . 0.0 109.599 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.451 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 61.24 30.37 73.78 Favored Glycine 0 N--CA 1.488 2.107 0 N-CA-C 108.765 -1.734 . . . . 0.0 108.765 -179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.521 ' HE2' ' HB3' ' A' ' 30' ' ' PHE . 86.7 mtp -151.96 160.21 43.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.32 -1.106 . . . . 0.0 110.696 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.85 HD12 HG11 ' A' ' 36' ' ' VAL . 12.8 mt -116.1 103.82 10.94 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 177.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.547 ' N ' ' HB2' ' A' ' 69' ' ' GLU . 0.4 OUTLIER -68.83 156.18 38.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.406 -0.809 . . . . 0.0 109.868 -178.949 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.543 ' HG3' ' N ' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -35.89 -40.12 0.18 Allowed 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.567 -0.708 . . . . 0.0 111.037 -179.476 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.543 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 9.5 t0 -81.5 -34.46 31.26 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.32 -0.862 . . . . 0.0 110.154 -179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.547 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 18.2 mt-10 -73.91 -42.77 60.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.306 -0.871 . . . . 0.0 109.065 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.961 ' CD2' HD12 ' A' ' 31' ' ' LEU . 15.6 t80 -59.35 -22.49 61.39 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 178.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.52 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -73.7 -48.91 28.55 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.828 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.822 ' O ' HD12 ' A' ' 76' ' ' LEU . 59.5 t -58.06 -27.98 32.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.361 -0.837 . . . . 0.0 109.452 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.981 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -91.5 -7.04 51.58 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.484 -0.76 . . . . 0.0 111.465 -179.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.593 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.9 mmt -82.26 -50.18 9.26 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.688 -1.257 . . . . 0.0 109.413 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.643 ' CZ ' ' CD1' ' A' ' 94' ' ' LEU . 1.7 p90 -71.72 -33.91 69.14 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 178.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.822 HD12 ' O ' ' A' ' 72' ' ' VAL . 7.1 mt -58.72 -22.06 56.62 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.779 HG23 ' O ' ' A' ' 73' ' ' ALA . 47.0 t -91.28 -64.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.444 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -55.18 -18.87 6.55 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 119.847 -0.741 . . . . 0.0 111.015 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.533 ' O ' ' N ' ' A' ' 84' ' ' GLU . 59.2 m -85.19 -10.88 56.14 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.05 -1.031 . . . . 0.0 109.586 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.008 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -89.72 -19.7 24.48 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.229 -0.92 . . . . 0.0 109.184 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.876 HD12 ' N ' ' A' ' 81' ' ' LEU . 5.4 mp -90.8 -38.46 12.98 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.447 -0.783 . . . . 0.0 109.951 179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.528 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -68.74 -61.6 1.74 Allowed 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.913 -0.715 . . . . 0.0 110.067 -179.599 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.528 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 177.74 35.98 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 C-N-CA 120.019 -0.672 . . . . 0.0 111.157 179.959 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -140.37 107.99 6.69 Favored Pre-proline 0 N--CA 1.495 1.787 0 O-C-N 120.75 -1.219 . . . . 0.0 110.864 -179.402 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.428 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 43.9 Cg_endo -70.76 -166.12 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.979 1.515 . . . . 0.0 110.28 179.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.527 ' CG1' ' HD2' ' A' ' 87' ' ' PRO . 51.0 t -125.02 148.45 60.15 Favored Pre-proline 0 N--CA 1.489 1.488 0 O-C-N 121.151 -0.968 . . . . 0.0 110.094 -179.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.534 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 48.2 Cg_endo -83.11 -162.3 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.007 1.53 . . . . 0.0 109.78 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 10.2 mtp -123.26 11.64 9.42 Favored 'General case' 0 C--N 1.299 -1.617 0 O-C-N 121.223 -0.923 . . . . 0.0 111.582 -179.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' O ' ' A' ' 90' ' ' LEU . 5.2 t -162.86 20.18 0.09 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 120.524 -1.36 . . . . 0.0 112.03 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.855 HD11 ' O ' ' A' ' 56' ' ' LEU . 2.5 mt 59.94 120.78 0.02 OUTLIER Pre-proline 0 C--N 1.28 -2.431 0 C-N-CA 120.116 -0.634 . . . . 0.0 111.037 178.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.812 ' HG2' HD23 ' A' ' 94' ' ' LEU . 38.4 Cg_endo -67.4 170.92 12.54 Favored 'Trans proline' 0 C--N 1.302 -1.899 0 O-C-N 123.962 1.506 . . . . 0.0 109.415 178.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -71.75 -18.68 28.35 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 123.649 1.342 . . . . 0.0 111.833 -178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.842 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -95.04 8.95 41.32 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.823 -1.173 . . . . 0.0 110.498 -179.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.842 HD22 ' C ' ' A' ' 93' ' ' ALA . 4.6 mm? -118.95 30.87 6.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.918 -1.114 . . . . 0.0 111.628 -179.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.48 HG13 HD13 ' A' ' 90' ' ' LEU . 0.0 OUTLIER -136.17 146.09 54.9 Favored Pre-proline 0 C--N 1.296 -1.734 0 O-C-N 121.078 -1.013 . . . . 0.0 109.337 179.441 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -64.37 172.24 6.82 Favored 'Trans proline' 0 C--N 1.302 -1.91 0 O-C-N 124.064 1.56 . . . . 0.0 109.95 179.83 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 42.4 Cg_endo -68.93 -5.3 15.3 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.922 1.485 . . . . 0.0 110.887 -178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.2 m -91.62 -30.92 16.09 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.015 -1.053 . . . . 0.0 109.282 179.35 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.19 14.76 28.3 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.563 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 1.1 mmt85 . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.475 -0.766 . . . . 0.0 110.563 -179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.49 1.572 0 CA-C-O 121.2 0.524 . . . . 0.0 110.135 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 6.3 t -115.39 -3.74 12.41 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.178 -0.951 . . . . 0.0 110.296 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.545 ' OD1' HD23 ' B' ' 112' ' ' LEU . 13.5 t-20 -126.96 138.13 32.03 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.95 -20.55 21.99 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.079 1.568 . . . . 0.0 110.68 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.655 ' HE2' HD12 ' A' ' 40' ' ' LEU . 80.7 m-85 -98.46 23.3 8.66 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.151 -0.968 . . . . 0.0 109.799 179.459 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.545 HD23 ' OD1' ' B' ' 109' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 118.052 -0.975 . . . . 0.0 110.171 179.858 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo . . . . . 0 N--CA 1.482 0.824 0 N-CA-C 109.816 -0.878 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.479 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.4 t90 -92.6 126.62 37.76 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.133 -0.979 . . . . 0.0 110.366 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.555 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -41.47 -31.22 0.24 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.376 -0.827 . . . . 0.0 110.438 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.514 HG22 ' CD2' ' A' ' 75' ' ' PHE . 40.7 t -87.01 157.16 3.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.245 -0.909 . . . . 0.0 110.143 -179.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.469 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 21.7 mmtm -110.56 166.22 11.18 Favored Pre-proline 0 N--CA 1.49 1.55 0 O-C-N 121.266 -0.897 . . . . 0.0 110.023 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.469 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 41.4 Cg_endo -68.29 -33.98 22.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.863 1.454 . . . . 0.0 109.669 179.426 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -75.52 -27.46 58.74 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 179.156 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.595 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 77.8 m-20 -81.38 -41.54 21.81 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.487 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 12.8 tptp -65.58 -25.21 67.31 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 119.628 -0.829 . . . . 0.0 109.068 178.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -67.41 -45.24 76.71 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.532 -0.73 . . . . 0.0 109.062 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.6 ptpt -73.53 -28.69 62.02 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 178.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.595 ' CD1' ' O ' ' A' ' 13' ' ' ASP . 8.0 m-30 -67.66 -37.62 82.64 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 178.388 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -74.71 -12.78 60.5 Favored 'General case' 0 N--CA 1.492 1.63 0 C-N-CA 120.246 -0.582 . . . . 0.0 110.468 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.84 -30.98 15.16 Favored 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 107.111 -1.44 . . . . 0.0 107.111 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.823 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 26.1 mt -81.46 -32.65 11.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.788 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -72.23 -36.99 69.26 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.541 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.3 t70 -89.02 1.43 55.55 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 121.681 -0.637 . . . . 0.0 109.833 179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -88.68 -8.32 54.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.242 -0.912 . . . . 0.0 109.086 178.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.08 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.1 mt -107.57 -7.0 16.65 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.552 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 0.2 OUTLIER 79.81 95.76 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.835 0 N-CA-C 109.165 -0.679 . . . . 0.0 109.165 -178.652 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 49.3 Cg_endo -75.62 152.21 37.69 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.165 1.613 . . . . 0.0 110.658 -179.064 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.497 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.0 t -118.44 114.93 46.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.497 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 27.0 t30 57.4 18.39 4.39 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.233 -0.917 . . . . 0.0 109.208 -178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.448 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 92.37 37.95 5.76 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.294 -1.523 . . . . 0.0 109.294 -179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.569 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 87.0 m-85 -150.5 148.3 28.55 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.188 -1.183 . . . . 0.0 111.902 -179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.08 ' CD1' HD12 ' A' ' 24' ' ' LEU . 12.0 mt -113.37 134.82 54.43 Favored 'General case' 0 C--N 1.299 -1.592 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 177.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.451 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 34.4 p -83.21 147.55 27.95 Favored 'General case' 0 C--N 1.287 -2.129 0 C-N-CA 118.865 -1.134 . . . . 0.0 109.881 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -44.87 -26.34 1.15 Allowed Glycine 0 N--CA 1.489 2.177 0 N-CA-C 108.291 -1.924 . . . . 0.0 108.291 179.449 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.423 ' N ' ' C ' ' A' ' 32' ' ' SER . 20.6 t70 -64.45 -24.08 67.5 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.634 -0.921 . . . . 0.0 109.972 179.405 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.499 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.8 mttt -98.8 -32.12 11.52 Favored 'General case' 0 C--N 1.308 -1.223 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 178.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.677 HG12 HD11 ' A' ' 40' ' ' LEU . 92.3 t -83.05 -46.21 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 C-N-CA 119.822 -0.751 . . . . 0.0 110.028 179.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.569 ' N ' ' HD2' ' A' ' 38' ' ' PRO . 39.1 tttt -41.18 -50.18 8.3 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.276 -0.89 . . . . 0.0 110.681 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.569 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 43.3 Cg_endo -69.36 -35.45 13.79 Favored 'Trans proline' 0 C--N 1.31 -1.452 0 O-C-N 123.231 1.122 . . . . 0.0 109.243 179.015 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.598 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.4 t -62.43 -36.47 74.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 CA-C-O 121.458 0.647 . . . . 0.0 109.526 179.135 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.059 ' HB3' HD22 ' A' ' 50' ' ' LEU . 42.3 mt -83.21 -21.58 33.39 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.384 -0.822 . . . . 0.0 109.65 179.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' HA ' ' A' ' 38' ' ' PRO . 34.2 mt -79.04 -13.21 59.91 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.533 -0.73 . . . . 0.0 109.324 179.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.417 ' O ' ' OD1' ' A' ' 42' ' ' ASN . 5.7 t30 -89.98 -3.77 57.82 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.724 -0.79 . . . . 0.0 110.051 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.577 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 94.6 p -86.11 16.85 3.94 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.289 -0.882 . . . . 0.0 110.14 -179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.43 16.06 6.03 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.267 -0.896 . . . . 0.0 109.709 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.066 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.3 mt -100.4 152.52 37.85 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.335 -0.853 . . . . 0.0 110.726 -179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.565 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 44.1 Cg_endo -76.46 168.75 23.21 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.116 1.587 . . . . 0.0 110.173 179.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.792 HG13 ' HB3' ' B' ' 111' ' ' PHE . 9.6 t -68.7 -5.86 5.11 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.386 -0.821 . . . . 0.0 109.682 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -80.23 -32.78 38.39 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.214 -0.928 . . . . 0.0 109.446 179.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.833 HG13 HD22 ' A' ' 45' ' ' LEU . 7.9 mm -82.47 -41.46 17.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 N-CA-C 108.399 -0.963 . . . . 0.0 108.399 178.645 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.059 HD22 ' HB3' ' A' ' 40' ' ' LEU . 14.6 mt -68.09 -28.12 67.08 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.47 -24.57 76.68 Favored Glycine 0 N--CA 1.485 1.909 0 N-CA-C 107.797 -2.121 . . . . 0.0 107.797 179.119 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.835 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.8 ttm180 -101.62 -31.63 10.74 Favored 'General case' 0 C--N 1.299 -1.624 0 O-C-N 121.899 -0.765 . . . . 0.0 110.293 179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.745 HG11 ' CG2' ' A' ' 77' ' ' VAL . 24.2 t -69.29 -37.26 75.55 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.304 0 C-N-CA 118.729 -1.188 . . . . 0.0 108.925 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.57 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 3.8 t-105 -67.6 -51.88 44.99 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 119.224 -0.99 . . . . 0.0 109.758 179.094 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.475 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 8.6 mt-10 -51.06 -59.99 3.57 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.423 -0.911 . . . . 0.0 110.16 -178.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.835 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.0 mt -62.07 -13.16 23.73 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.279 -0.968 . . . . 0.0 108.647 178.665 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.614 ' HB3' ' HB2' ' A' ' 73' ' ' ALA . 4.3 m -93.82 -27.2 16.58 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.551 -0.718 . . . . 0.0 110.147 179.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.536 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.3 t0 -79.25 70.67 5.69 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.193 -0.942 . . . . 0.0 110.006 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.532 HG12 ' HG2' ' A' ' 69' ' ' GLU . 46.2 mm -47.25 -33.71 2.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 121.3 -0.875 . . . . 0.0 110.296 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.478 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 12.5 m-20 -94.0 -25.41 17.25 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.205 -0.934 . . . . 0.0 110.122 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.437 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 25.5 m-70 64.62 45.27 3.59 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.237 -0.914 . . . . 0.0 110.142 -179.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.405 ' OD1' ' C ' ' A' ' 62' ' ' ASP . 2.7 p30 -110.89 0.62 17.21 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.191 -0.943 . . . . 0.0 110.549 -179.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.579 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 96.27 18.99 29.4 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.579 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.1 mmm -148.73 161.86 40.92 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.211 -1.17 . . . . 0.0 109.889 179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.655 HD12 HG11 ' A' ' 36' ' ' VAL . 15.9 mt -119.11 116.24 25.96 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.232 -0.918 . . . . 0.0 110.194 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 10.8 t0 -71.15 168.79 16.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.232 -0.917 . . . . 0.0 110.047 179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.558 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 1.5 ptt180 -53.48 -37.27 62.53 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.147 -0.971 . . . . 0.0 109.933 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.487 ' HA ' ' HE2' ' A' ' 14' ' ' LYS . 7.0 m-20 -85.16 -29.83 24.45 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.22 -0.925 . . . . 0.0 109.097 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.555 ' OE1' HD23 ' A' ' 65' ' ' LEU . 0.5 OUTLIER -74.4 -46.59 39.26 Favored 'General case' 0 C--N 1.303 -1.429 0 CA-C-O 121.562 0.696 . . . . 0.0 109.166 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.823 ' CZ ' HG22 ' A' ' 20' ' ' ILE . 50.2 t80 -59.11 -22.53 60.99 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 178.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -67.16 -50.1 62.34 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.963 0.887 . . . . 0.0 109.544 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.073 HG13 HD11 ' A' ' 94' ' ' LEU . 54.2 t -57.19 -26.24 25.01 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 CA-C-O 121.568 0.699 . . . . 0.0 110.105 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 57' ' ' SER . . . -85.11 -7.08 59.25 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.44 -0.788 . . . . 0.0 111.694 -178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.595 ' HB2' ' CE2' ' A' ' 17' ' ' TYR . 7.2 mmm -89.95 -40.4 12.39 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.614 -1.304 . . . . 0.0 110.233 -179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.856 ' CE2' HD13 ' A' ' 94' ' ' LEU . 1.9 p90 -77.24 -19.21 56.93 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 118.943 -1.103 . . . . 0.0 108.239 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.713 ' HB3' HG13 ' A' ' 53' ' ' VAL . 5.3 mt -77.54 -24.95 49.82 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 178.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.745 ' CG2' HG11 ' A' ' 53' ' ' VAL . 72.5 t -91.11 -34.7 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.637 -0.664 . . . . 0.0 110.133 179.535 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.411 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 1.8 m-85 -74.63 -26.09 59.66 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.429 -0.794 . . . . 0.0 110.386 -179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.478 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.3 m -80.18 -15.92 55.98 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.24 -0.913 . . . . 0.0 109.301 179.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.066 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.13 -8.88 54.76 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.313 -0.867 . . . . 0.0 108.936 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.71 HD23 ' N ' ' A' ' 81' ' ' LEU . 2.5 mt -89.97 -44.85 9.6 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.787 0.803 . . . . 0.0 109.337 179.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -69.93 -52.45 24.43 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 120.115 -0.634 . . . . 0.0 110.001 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.412 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.22 -27.57 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 119.395 -0.922 . . . . 0.0 111.211 -179.949 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.478 ' O ' ' O ' ' A' ' 79' ' ' CYS . 1.2 mt-10 -67.18 112.2 9.28 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.173 -0.954 . . . . 0.0 111.143 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 84' ' ' GLU . 42.5 Cg_endo -69.94 -176.13 1.43 Allowed 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.814 1.428 . . . . 0.0 109.636 179.092 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.521 HG13 HD22 ' A' ' 76' ' ' LEU . 61.1 t -128.73 120.73 20.72 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.003 -1.061 . . . . 0.0 110.887 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.709 ' O ' HD11 ' A' ' 56' ' ' LEU . 49.1 Cg_endo -84.69 -179.92 4.01 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.974 1.513 . . . . 0.0 109.122 178.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.812 ' C ' HD21 ' A' ' 56' ' ' LEU . 43.1 mtp -105.86 11.72 31.53 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.91 -1.119 . . . . 0.0 110.462 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.509 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 61.4 p -110.87 104.34 12.94 Favored 'General case' 0 C--N 1.298 -1.633 0 C-N-CA 118.494 -1.282 . . . . 0.0 112.023 -178.143 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.611 ' N ' ' CD2' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -54.89 104.99 0.47 Allowed Pre-proline 0 C--N 1.291 -1.946 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.15 179.099 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.612 ' HD2' HD23 ' A' ' 94' ' ' LEU . 42.3 Cg_endo -67.85 143.98 63.14 Favored 'Trans proline' 0 C--N 1.309 -1.55 0 O-C-N 123.654 1.344 . . . . 0.0 110.729 179.853 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.93 -5.58 17.37 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.198 1.63 . . . . 0.0 111.0 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.415 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -87.39 -4.36 59.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.175 -0.953 . . . . 0.0 109.505 179.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.073 HD11 HG13 ' A' ' 72' ' ' VAL . 0.1 OUTLIER -122.63 -1.81 8.96 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.655 -0.653 . . . . 0.0 109.787 -179.104 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.429 ' O ' ' NH2' ' A' ' 100' ' ' ARG . 64.8 t -93.73 135.86 24.59 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.39 -0.819 . . . . 0.0 110.715 -179.022 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -72.32 162.03 42.71 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 O-C-N 124.096 1.577 . . . . 0.0 110.09 179.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.74 -3.32 12.43 Favored 'Trans proline' 0 C--N 1.304 -1.772 0 O-C-N 123.894 1.47 . . . . 0.0 110.671 -179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 t -79.85 -30.56 40.36 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.09 -1.006 . . . . 0.0 109.712 179.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 99' ' ' LYS . 22.3 tptt -94.02 13.82 21.71 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.387 -0.821 . . . . 0.0 109.22 179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.429 ' NH2' ' O ' ' A' ' 95' ' ' VAL . 4.8 mtm180 . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.296 -0.878 . . . . 0.0 110.748 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.436 ' O ' ' N ' ' B' ' 109' ' ' ASN . 5.2 m . . . . . 0 N--CA 1.494 1.747 0 CA-C-O 121.225 0.536 . . . . 0.0 110.212 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.51 ' O ' ' NE1' ' A' ' 54' ' ' TRP . 73.1 p -63.43 80.58 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.308 -0.87 . . . . 0.0 109.881 179.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.527 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 9.8 t-20 -114.63 123.41 32.23 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.197 -0.939 . . . . 0.0 110.582 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -77.31 -10.23 17.6 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.982 1.517 . . . . 0.0 110.758 -179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.792 ' HB3' HG13 ' A' ' 47' ' ' VAL . 88.8 m-85 -99.65 -32.64 10.97 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.171 -0.955 . . . . 0.0 110.233 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 117.959 -1.02 . . . . 0.0 110.172 -179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo . . . . . 0 N--CA 1.484 0.948 0 N-CA-C 110.524 -0.606 . . . . 0.0 110.524 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.586 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 11.4 t90 -51.79 123.73 10.86 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.237 -0.914 . . . . 0.0 110.07 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.444 ' HB3' HD13 ' A' ' 94' ' ' LEU . . . -44.82 -25.21 0.27 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.682 179.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.586 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 51.2 t -97.26 126.78 49.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.386 -0.821 . . . . 0.0 110.065 -179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.545 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -95.52 -178.54 0.79 Allowed Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 121.35 -0.844 . . . . 0.0 109.889 -179.877 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.545 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 39.6 Cg_endo -66.38 -37.09 24.74 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.644 1.339 . . . . 0.0 109.781 179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.415 ' HG2' ' HB3' ' A' ' 10' ' ' LYS . 12.7 pt-20 -66.64 -33.83 76.52 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.226 -0.921 . . . . 0.0 109.037 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.584 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 46.8 m-20 -82.86 -41.49 18.93 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.038 -1.097 . . . . 0.0 108.038 178.492 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.516 ' HE2' ' HB2' ' A' ' 18' ' ' ASP . 0.0 OUTLIER -68.23 -15.71 63.68 Favored 'General case' 0 C--N 1.304 -1.39 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -83.67 -39.0 20.76 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.443 -0.785 . . . . 0.0 109.245 179.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.5 OUTLIER -81.63 -20.77 39.01 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 178.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.613 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.5 m-30 -81.35 -36.32 29.83 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.516 ' HB2' ' HE2' ' A' ' 14' ' ' LYS . 7.0 t70 -76.07 -8.64 57.45 Favored 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 120.139 -0.624 . . . . 0.0 110.207 -179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -93.23 -31.63 14.66 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 107.483 -1.302 . . . . 0.0 107.483 178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.517 HD13 ' SD ' ' A' ' 74' ' ' MET . 33.9 mt -79.84 -34.78 15.72 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 N-CA-C 107.768 -1.197 . . . . 0.0 107.768 177.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.759 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -66.91 -34.17 77.2 Favored 'General case' 0 N--CA 1.485 1.297 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.028 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.468 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.1 t0 -91.23 -7.56 50.91 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.394 -0.816 . . . . 0.0 110.011 179.186 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.477 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER -77.45 -14.54 59.67 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.285 -0.884 . . . . 0.0 108.792 179.219 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.084 HD12 ' CD1' ' A' ' 31' ' ' LEU . 12.7 mt -92.91 -55.38 3.38 Favored 'General case' 0 C--N 1.301 -1.512 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 179.396 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.656 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.3 m 140.36 97.15 0.0 OUTLIER Pre-proline 0 N--CA 1.508 2.473 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.64 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 52.5 Cg_endo -74.73 149.64 38.37 Favored 'Trans proline' 0 C--N 1.298 -2.111 0 O-C-N 123.828 1.436 . . . . 0.0 110.951 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 44.0 t -125.76 106.05 15.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.2 t30 58.0 18.12 4.88 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.388 -0.82 . . . . 0.0 109.588 -178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.41 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 97.17 36.04 5.07 Favored Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.725 -1.35 . . . . 0.0 109.725 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.497 ' CE1' ' HB2' ' A' ' 66' ' ' ASP . 82.9 m-85 -150.78 143.74 24.66 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.093 -1.239 . . . . 0.0 111.969 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.084 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.0 mt -111.2 137.32 49.05 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 177.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.466 ' O ' ' N ' ' A' ' 35' ' ' LYS . 0.8 OUTLIER -81.83 141.27 33.59 Favored 'General case' 0 C--N 1.291 -1.974 0 C-N-CA 118.791 -1.164 . . . . 0.0 110.139 -179.771 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.559 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.64 -27.53 0.33 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 32' ' ' SER . 24.7 t70 -64.77 -27.98 69.26 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.442 -1.034 . . . . 0.0 110.319 179.54 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.505 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 77.2 mttt -90.94 -34.63 15.11 Favored 'General case' 0 C--N 1.308 -1.207 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.857 ' CG1' HD11 ' A' ' 40' ' ' LEU . 77.1 t -74.97 -41.65 45.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.484 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.562 ' CG ' ' HB2' ' B' ' 110' ' ' PRO . 3.4 mtpt -36.67 -56.77 1.3 Allowed Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.795 -0.566 . . . . 0.0 110.914 -179.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.555 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -67.3 -35.5 23.95 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.919 1.483 . . . . 0.0 110.007 179.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.7 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -61.26 -27.45 41.85 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 O-C-N 121.379 -0.826 . . . . 0.0 109.553 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.926 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.0 mt -97.94 -33.52 11.18 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.376 -0.828 . . . . 0.0 110.432 -179.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.503 HD12 ' C ' ' A' ' 37' ' ' LYS . 14.0 mt -73.11 -9.14 58.41 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.325 -0.86 . . . . 0.0 109.171 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 15.4 m-20 -89.3 -9.01 52.15 Favored 'General case' 0 C--N 1.303 -1.426 0 C-N-CA 119.423 -0.911 . . . . 0.0 109.882 -179.763 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 1.008 ' O ' HD21 ' A' ' 81' ' ' LEU . 16.3 p -81.67 5.55 17.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.448 -0.782 . . . . 0.0 110.036 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.443 ' CB ' ' O ' ' A' ' 43' ' ' SER . 6.1 ttpt 66.98 19.1 10.62 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.3 -0.875 . . . . 0.0 109.931 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.884 HD22 HG13 ' A' ' 49' ' ' ILE . 15.7 mt -100.36 156.47 35.21 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.3 -0.875 . . . . 0.0 110.0 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.539 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.2 Cg_endo -75.44 167.98 25.48 Favored 'Trans proline' 0 C--N 1.301 -1.951 0 O-C-N 124.123 1.591 . . . . 0.0 110.233 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.699 HG13 ' O ' ' B' ' 111' ' ' PHE . 0.9 OUTLIER -67.35 -8.0 7.41 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.346 -0.846 . . . . 0.0 109.219 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -75.22 -31.63 60.92 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.113 -0.992 . . . . 0.0 109.067 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.884 HG13 HD22 ' A' ' 45' ' ' LEU . 8.5 mm -83.2 -37.19 13.45 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.812 179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.926 HD22 ' HB3' ' A' ' 40' ' ' LEU . 8.5 mt -74.19 -26.25 60.17 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-O 121.533 0.682 . . . . 0.0 109.371 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 55' ' ' GLU . . . -69.94 -29.06 71.07 Favored Glycine 0 N--CA 1.487 2.065 0 N-CA-C 107.656 -2.178 . . . . 0.0 107.656 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.794 ' O ' HD12 ' A' ' 56' ' ' LEU . 2.5 mtm180 -101.66 -31.88 10.6 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 122.251 -0.558 . . . . 0.0 110.462 179.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.75 ' CG2' HG21 ' A' ' 86' ' ' VAL . 5.6 t -64.57 -55.48 21.09 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 C-N-CA 119.061 -1.056 . . . . 0.0 108.195 179.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.559 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.0 t-105 -57.87 -52.18 66.56 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 177.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.548 ' OE1' ' ND2' ' B' ' 109' ' ' ASN . 0.2 OUTLIER -45.46 -66.29 0.42 Allowed 'General case' 0 C--N 1.299 -1.602 0 CA-C-O 121.577 0.703 . . . . 0.0 110.689 -179.895 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.937 HD11 ' O ' ' A' ' 87' ' ' PRO . 3.8 mt -60.54 -16.83 41.44 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.953 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.0 t -89.34 -14.61 35.28 Favored 'General case' 0 N--CA 1.486 1.325 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 178.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 54' ' ' TRP . 2.1 t0 -93.31 83.27 4.57 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.335 -0.853 . . . . 0.0 109.612 179.726 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.507 ' N ' ' OE2' ' A' ' 69' ' ' GLU . 31.9 mm -53.44 -38.84 33.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.374 -0.829 . . . . 0.0 110.804 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.525 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 4.8 p30 -103.72 -20.6 13.91 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.971 -1.081 . . . . 0.0 110.408 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.537 ' CE1' ' O ' ' A' ' 58' ' ' ASP . 19.8 m-70 67.19 42.12 2.39 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.33 -0.856 . . . . 0.0 110.122 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.403 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 1.4 p30 -95.67 1.05 53.34 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.15 -0.969 . . . . 0.0 110.059 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.422 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 94.25 25.12 17.27 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.514 -1.435 . . . . 0.0 109.514 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.556 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 23.2 mtp -152.76 161.79 42.11 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.153 -1.204 . . . . 0.0 111.17 179.56 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.717 HD12 HG21 ' A' ' 36' ' ' VAL . 21.9 mt -127.12 112.73 15.5 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.367 -0.833 . . . . 0.0 109.618 178.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.497 ' HB2' ' CE1' ' A' ' 30' ' ' PHE . 1.6 t70 -72.25 172.99 9.25 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.104 -0.998 . . . . 0.0 110.079 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.607 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -52.82 -41.58 64.33 Favored 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 119.569 -0.852 . . . . 0.0 110.202 -179.805 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.599 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.1 OUTLIER -81.15 -36.04 30.73 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.13 -0.981 . . . . 0.0 109.822 179.651 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.507 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 1.8 tt0 -72.02 -46.31 57.62 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.408 -0.807 . . . . 0.0 108.945 179.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.961 ' CD2' HD12 ' A' ' 31' ' ' LEU . 16.8 t80 -59.32 -17.37 28.68 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.599 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -72.69 -43.66 62.77 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-O 121.835 0.826 . . . . 0.0 109.35 179.059 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.929 HG13 HD12 ' A' ' 94' ' ' LEU . 41.8 t -60.02 -26.05 34.85 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.6 0 CA-C-O 121.498 0.666 . . . . 0.0 109.55 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.953 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.31 -6.33 55.23 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.309 -0.87 . . . . 0.0 111.315 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.61 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 12.2 mmt -83.64 -49.01 9.59 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 120.938 -1.101 . . . . 0.0 109.986 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.006 ' CZ ' HD11 ' A' ' 94' ' ' LEU . 5.4 p90 -73.97 -28.48 61.51 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.628 HD12 ' O ' ' A' ' 72' ' ' VAL . 10.2 mt -66.28 -22.21 66.29 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.984 ' O ' HD12 ' A' ' 81' ' ' LEU . 54.5 t -91.68 -45.45 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.315 0 O-C-N 121.642 -0.661 . . . . 0.0 110.164 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 4.8 m-85 -75.52 -23.37 56.69 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 121.285 -0.884 . . . . 0.0 110.573 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.589 ' HA ' ' HB2' ' A' ' 83' ' ' LYS . 88.6 m -84.3 -19.74 33.27 Favored 'General case' 0 C--N 1.302 -1.493 0 C-N-CA 119.334 -0.947 . . . . 0.0 109.601 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.72 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -77.74 -14.27 59.65 Favored 'General case' 0 C--N 1.305 -1.354 0 O-C-N 121.108 -0.995 . . . . 0.0 108.874 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.008 HD21 ' O ' ' A' ' 43' ' ' SER . 1.0 OUTLIER -92.29 -51.37 5.19 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.653 -0.654 . . . . 0.0 111.377 -179.592 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -118.09 -14.34 9.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 119.417 -0.913 . . . . 0.0 113.007 -177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.589 ' HB2' ' HA ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -108.58 -86.4 0.51 Allowed 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.178 -1.576 . . . . 0.0 112.071 -178.763 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 79' ' ' CYS . 33.9 mm-40 -131.54 155.01 82.01 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 120.968 -1.083 . . . . 0.0 110.738 -178.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -68.19 -159.31 0.05 OUTLIER 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.223 1.644 . . . . 0.0 110.51 179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.75 HG21 ' CG2' ' A' ' 53' ' ' VAL . 70.9 t -132.8 124.78 18.95 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.263 -0.898 . . . . 0.0 110.537 -179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.937 ' O ' HD11 ' A' ' 56' ' ' LEU . 48.7 Cg_endo -84.49 -159.96 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.825 1.434 . . . . 0.0 108.518 178.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.75 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -123.63 3.9 8.92 Favored 'General case' 0 C--N 1.291 -1.962 0 C-N-CA 119.368 -0.933 . . . . 0.0 110.581 179.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.593 ' N ' HD21 ' A' ' 56' ' ' LEU . 67.5 m -110.02 97.46 6.96 Favored 'General case' 0 C--N 1.291 -1.946 0 C-N-CA 118.789 -1.165 . . . . 0.0 112.264 -177.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.724 ' N ' HD23 ' A' ' 56' ' ' LEU . 0.4 OUTLIER -51.4 106.2 0.62 Allowed Pre-proline 0 C--N 1.292 -1.918 0 C-N-CA 120.13 -0.628 . . . . 0.0 109.524 178.056 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.766 ' HG2' HD23 ' A' ' 94' ' ' LEU . 43.3 Cg_endo -71.91 161.97 43.31 Favored 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 124.044 1.549 . . . . 0.0 110.952 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -74.62 -13.65 22.29 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 O-C-N 124.094 1.576 . . . . 0.0 110.791 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.498 ' C ' HD22 ' A' ' 94' ' ' LEU . . . -80.07 -5.02 55.13 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.214 -0.929 . . . . 0.0 109.286 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.006 HD11 ' CZ ' ' A' ' 75' ' ' PHE . 3.8 mm? -102.72 -19.2 14.84 Favored 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.403 -0.811 . . . . 0.0 110.112 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 49.0 t -65.88 116.02 28.38 Favored Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.277 -0.889 . . . . 0.0 110.479 -179.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.507 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 49.2 Cg_endo -78.02 176.0 10.5 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 124.042 1.548 . . . . 0.0 110.26 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.507 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 39.7 Cg_endo -66.47 -14.49 44.3 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.876 1.461 . . . . 0.0 110.015 179.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -63.18 -24.98 68.13 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.268 -0.895 . . . . 0.0 109.491 179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.3 tptt -89.21 9.18 26.67 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.421 -0.8 . . . . 0.0 109.281 179.181 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.52 -0.737 . . . . 0.0 109.598 179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 67.2 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.287 0.565 . . . . 0.0 110.127 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -159.42 38.32 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.243 -0.911 . . . . 0.0 109.814 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.548 ' ND2' ' OE1' ' A' ' 55' ' ' GLU . 14.7 t-20 -120.85 130.83 24.67 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.404 -0.81 . . . . 0.0 110.204 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.562 ' HB2' ' CG ' ' A' ' 37' ' ' LYS . 47.8 Cg_endo -75.05 -1.47 11.27 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.012 1.533 . . . . 0.0 110.837 -179.702 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.699 ' O ' HG13 ' A' ' 47' ' ' VAL . 86.8 m-85 -113.67 22.67 13.83 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.104 -0.998 . . . . 0.0 110.096 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 13.4 mt . . . . . 0 N--CA 1.491 1.577 0 O-C-N 120.957 -1.09 . . . . 0.0 110.18 179.885 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo . . . . . 0 N--CA 1.482 0.815 0 N-CA-C 110.376 -0.663 . . . . 0.0 110.376 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.563 ' CZ3' ' HG3' ' A' ' 14' ' ' LYS . 12.2 t90 -81.44 121.51 26.35 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.21 -0.931 . . . . 0.0 110.019 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.586 ' CB ' HD13 ' A' ' 94' ' ' LEU . . . -40.98 -29.69 0.11 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.412 -0.805 . . . . 0.0 110.053 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.49 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 84.9 t -93.92 146.47 6.56 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 O-C-N 121.568 -0.707 . . . . 0.0 109.531 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.478 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 1.6 mttp -103.56 175.27 2.3 Favored Pre-proline 0 C--N 1.302 -1.497 0 O-C-N 121.213 -0.929 . . . . 0.0 110.421 -179.116 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.478 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.1 Cg_endo -68.3 -33.82 22.92 Favored 'Trans proline' 0 C--N 1.303 -1.835 0 O-C-N 124.101 1.579 . . . . 0.0 109.708 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.5 mt-10 -75.45 -36.5 60.7 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.56 -0.713 . . . . 0.0 109.612 179.496 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.429 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -77.74 -36.36 50.83 Favored 'General case' 0 C--N 1.303 -1.424 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 179.036 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.563 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 1.5 tmtt? -72.26 -14.97 61.9 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.212 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -76.44 -42.35 44.33 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 179.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.621 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -73.18 -21.79 60.61 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 178.519 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.629 ' CE1' ' HB2' ' A' ' 74' ' ' MET . 8.6 m-30 -77.79 -34.78 52.06 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 178.621 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -76.13 -8.35 56.82 Favored 'General case' 0 N--CA 1.491 1.594 0 CA-C-O 121.395 0.616 . . . . 0.0 109.968 -179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.39 -34.73 14.04 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.67 HG22 ' CE1' ' A' ' 70' ' ' PHE . 18.1 mt -78.29 -29.35 15.18 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 178.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.763 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -74.54 -32.46 62.45 Favored 'General case' 0 N--CA 1.486 1.343 0 CA-C-O 121.562 0.696 . . . . 0.0 109.215 179.617 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.505 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.8 OUTLIER -90.28 -5.52 56.2 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.513 -0.742 . . . . 0.0 109.866 179.444 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 11.4 t -82.7 -10.75 58.77 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 109.108 179.073 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.067 HD12 ' CD1' ' A' ' 31' ' ' LEU . 4.0 mt -103.15 -13.99 16.57 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.609 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.8 t 88.78 101.46 0.03 OUTLIER Pre-proline 0 N--CA 1.5 2.069 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.468 -178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.3 Cg_endo -72.53 152.2 53.9 Favored 'Trans proline' 0 C--N 1.301 -1.947 0 O-C-N 124.348 1.709 . . . . 0.0 111.256 -178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.477 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 91.3 t -127.97 109.49 19.89 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.515 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 179.282 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 18.2 t30 57.47 24.07 9.83 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.353 -0.842 . . . . 0.0 109.282 -178.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.491 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 84.77 40.62 8.1 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.126 -1.589 . . . . 0.0 109.126 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.491 ' CD2' ' C ' ' A' ' 29' ' ' GLY . 87.7 m-85 -152.62 153.55 33.58 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.067 -1.255 . . . . 0.0 111.749 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.067 ' CD1' HD12 ' A' ' 24' ' ' LEU . 6.7 mt -121.8 147.15 46.33 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 177.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.468 ' O ' ' N ' ' A' ' 34' ' ' ASP . 58.8 p -95.16 143.21 26.77 Favored 'General case' 0 C--N 1.291 -1.935 0 C-N-CA 119.021 -1.072 . . . . 0.0 110.288 -179.5 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.621 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.87 -26.37 0.29 Allowed Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.189 -1.564 . . . . 0.0 109.189 179.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.468 ' N ' ' O ' ' A' ' 32' ' ' SER . 16.4 t0 -67.76 -26.04 65.91 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.379 -1.071 . . . . 0.0 110.134 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.486 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 84.7 mttt -91.1 -36.17 14.16 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 108.106 -1.072 . . . . 0.0 108.106 178.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.942 HG21 HD12 ' A' ' 65' ' ' LEU . 68.2 t -75.76 -50.04 24.58 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 C-N-CA 119.862 -0.735 . . . . 0.0 110.09 179.159 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.604 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 4.1 ttpt -34.61 -56.23 0.84 Allowed Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.743 -0.598 . . . . 0.0 111.013 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 37.5 Cg_endo -64.92 -33.51 51.83 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.326 1.172 . . . . 0.0 109.936 179.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.751 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.6 t -67.56 -29.08 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.531 -0.731 . . . . 0.0 110.002 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.03 ' HB3' HD22 ' A' ' 50' ' ' LEU . 24.7 mt -88.55 -27.1 21.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.148 -0.97 . . . . 0.0 110.204 -179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 38' ' ' PRO . 19.8 mt -73.65 -17.07 61.19 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.254 -0.904 . . . . 0.0 109.519 179.76 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 12.3 m-20 -73.03 -13.77 61.28 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 119.535 -0.866 . . . . 0.0 109.611 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.555 ' HB3' ' CG1' ' A' ' 77' ' ' VAL . 1.4 p -80.25 7.4 9.52 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.519 -0.738 . . . . 0.0 110.463 -179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 43' ' ' SER . 14.4 tptt 64.65 8.64 4.57 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.357 -0.839 . . . . 0.0 110.561 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.062 HD13 HG21 ' A' ' 49' ' ' ILE . 17.2 mt -88.75 153.72 50.03 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.13 -0.981 . . . . 0.0 110.123 179.794 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.56 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.3 Cg_endo -73.51 176.75 8.86 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 124.115 1.587 . . . . 0.0 110.696 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.838 HG22 ' HD1' ' B' ' 111' ' ' PHE . 1.9 t -71.04 -10.3 13.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.385 0 O-C-N 121.449 -0.782 . . . . 0.0 109.427 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 88.2 m-20 -76.83 -32.58 57.68 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.079 -1.013 . . . . 0.0 109.255 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 1.062 HG21 HD13 ' A' ' 45' ' ' LEU . 8.2 mm -81.98 -38.94 16.17 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.435 0 C-N-CA 119.515 -0.874 . . . . 0.0 108.892 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.03 HD22 ' HB3' ' A' ' 40' ' ' LEU . 26.7 mt -74.98 -29.69 60.97 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 109.06 -0.719 . . . . 0.0 109.06 179.321 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.547 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.77 -25.09 75.38 Favored Glycine 0 N--CA 1.485 1.96 0 N-CA-C 107.16 -2.376 . . . . 0.0 107.16 178.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.847 ' O ' HD12 ' A' ' 56' ' ' LEU . 8.5 ttm180 -101.05 -34.49 9.72 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 122.007 -0.702 . . . . 0.0 110.475 179.464 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.066 HG11 ' CG2' ' A' ' 77' ' ' VAL . 15.3 t -66.46 -41.76 89.17 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.335 0 C-N-CA 118.778 -1.169 . . . . 0.0 108.774 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.621 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 3.0 t-105 -65.17 -51.87 58.48 Favored 'General case' 0 C--N 1.302 -1.472 0 C-N-CA 119.197 -1.001 . . . . 0.0 109.702 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.491 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 3.0 mm-40 -50.9 -55.46 17.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.949 -1.094 . . . . 0.0 110.01 -178.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.929 HD21 ' C ' ' A' ' 88' ' ' MET . 2.5 mt -64.38 -12.78 46.15 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.195 -1.002 . . . . 0.0 108.843 179.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.854 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 38.5 m -94.39 -35.85 12.18 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.502 -0.749 . . . . 0.0 109.757 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.486 ' N ' ' O ' ' A' ' 54' ' ' TRP . 17.3 t0 -72.26 92.9 1.42 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.344 -0.848 . . . . 0.0 110.721 -179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.569 ' CG1' ' HG3' ' A' ' 69' ' ' GLU . 8.9 mm -72.55 -33.64 45.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.191 -0.943 . . . . 0.0 109.637 179.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.608 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 6.7 m-20 -92.43 -4.22 54.05 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.439 -0.788 . . . . 0.0 110.147 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.608 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 28.9 p80 38.73 54.98 1.98 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.661 -0.649 . . . . 0.0 110.644 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.507 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 36.7 p-10 -125.77 18.34 7.97 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.37 -0.831 . . . . 0.0 108.793 179.278 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' O ' ' HG3' ' A' ' 64' ' ' MET . . . 77.45 32.77 45.88 Favored Glycine 0 N--CA 1.486 2.008 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 -179.391 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.541 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 11.7 mtp -150.86 161.79 42.0 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.161 -1.199 . . . . 0.0 111.578 -179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.942 HD12 HG21 ' A' ' 36' ' ' VAL . 25.1 mt -135.42 110.4 8.82 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.462 -0.774 . . . . 0.0 110.022 179.229 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 27.1 t0 -70.0 169.32 13.56 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.087 -1.008 . . . . 0.0 110.666 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.559 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 12.1 ptt180 -49.06 -41.98 37.02 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.249 -0.907 . . . . 0.0 109.952 179.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.743 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -80.85 -35.92 32.14 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.322 -0.861 . . . . 0.0 109.152 179.416 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.569 ' HG3' ' CG1' ' A' ' 59' ' ' ILE . 1.7 tt0 -68.51 -55.35 12.0 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.915 0.864 . . . . 0.0 108.731 178.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.989 ' CD2' HD12 ' A' ' 31' ' ' LEU . 23.2 t80 -50.01 -24.72 2.78 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 108.266 -1.012 . . . . 0.0 108.266 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.743 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -64.58 -49.1 72.5 Favored 'General case' 0 N--CA 1.49 1.542 0 CA-C-O 121.669 0.747 . . . . 0.0 110.188 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.48 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 16.8 t -56.78 -25.96 22.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 O-C-N 121.571 -0.706 . . . . 0.0 110.178 -179.702 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.854 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -88.19 -8.37 55.43 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.884 . . . . 0.0 112.016 -178.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.629 ' HB2' ' CE1' ' A' ' 17' ' ' TYR . 8.7 mmm -89.87 -30.35 17.96 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.375 -1.453 . . . . 0.0 110.147 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.531 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -85.52 -21.14 28.75 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 120.981 -1.074 . . . . 0.0 109.008 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.558 ' O ' ' HB2' ' A' ' 80' ' ' ALA . 5.1 mt -83.53 -19.53 35.51 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.498 -0.751 . . . . 0.0 109.561 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.066 ' CG2' HG11 ' A' ' 53' ' ' VAL . 9.8 t -92.21 -44.04 14.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -0.895 . . . . 0.0 110.132 179.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.707 ' HA ' HD23 ' A' ' 81' ' ' LEU . 1.4 m-85 -70.28 -36.53 74.45 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.275 -0.891 . . . . 0.0 110.732 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.538 ' O ' ' CB ' ' A' ' 84' ' ' GLU . 80.6 m -82.71 -8.52 59.59 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.218 -0.926 . . . . 0.0 109.58 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.59 ' CB ' ' CG2' ' A' ' 86' ' ' VAL . . . -91.61 -30.39 16.38 Favored 'General case' 0 N--CA 1.489 1.511 0 CA-C-O 122.145 0.974 . . . . 0.0 109.174 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.707 HD23 ' HA ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -90.53 -22.84 21.12 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.554 -179.595 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.509 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 1.7 tp10 -72.33 -58.92 3.01 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.305 -0.872 . . . . 0.0 110.015 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.458 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.6 tttt -178.4 47.6 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.483 -0.761 . . . . 0.0 110.341 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.538 ' CB ' ' O ' ' A' ' 79' ' ' CYS . 2.9 tt0 -147.76 142.01 16.22 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.195 -0.94 . . . . 0.0 110.281 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.414 ' HD2' ' HG2' ' A' ' 84' ' ' GLU . 49.6 Cg_endo -78.53 152.44 26.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.042 1.548 . . . . 0.0 110.407 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.685 HG21 ' CG2' ' A' ' 49' ' ' ILE . 40.5 t -115.49 112.22 43.6 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.106 -0.996 . . . . 0.0 110.615 -179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.612 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.7 Cg_endo -83.57 178.05 5.88 Favored 'Trans proline' 0 C--N 1.306 -1.678 0 O-C-N 123.825 1.434 . . . . 0.0 110.025 179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.929 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -101.42 10.03 40.89 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.114 -0.991 . . . . 0.0 109.726 179.56 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.555 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.9 OUTLIER -94.82 117.27 29.87 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.174 -1.01 . . . . 0.0 111.817 -178.04 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.715 ' C ' HD12 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -104.36 85.44 1.11 Allowed Pre-proline 0 C--N 1.295 -1.783 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.652 ' HD2' HD23 ' A' ' 94' ' ' LEU . 39.8 Cg_endo -65.29 173.69 5.96 Favored 'Trans proline' 0 C--N 1.303 -1.868 0 O-C-N 123.672 1.354 . . . . 0.0 111.094 -178.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HD2' ' HB2' ' A' ' 91' ' ' PRO . 42.5 Cg_endo -68.45 -6.73 18.33 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.228 1.646 . . . . 0.0 110.905 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -77.72 -13.69 59.83 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.281 -0.887 . . . . 0.0 109.402 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.652 HD23 ' HD2' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -99.98 -10.61 21.43 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.217 -0.927 . . . . 0.0 110.12 179.599 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 79.3 t -89.16 129.95 46.01 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.147 -0.97 . . . . 0.0 110.608 -179.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.471 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 47.5 Cg_endo -73.82 174.54 12.14 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.872 1.459 . . . . 0.0 110.111 179.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.471 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 44.1 Cg_endo -71.05 -8.5 23.72 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.765 1.402 . . . . 0.0 110.439 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.84 -27.28 63.74 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.225 -0.922 . . . . 0.0 109.86 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.55 9.25 27.39 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.286 -0.884 . . . . 0.0 109.467 179.401 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.37 -0.832 . . . . 0.0 109.931 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.412 ' O ' ' C ' ' B' ' 108' ' ' THR . 0.4 OUTLIER . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.245 0.545 . . . . 0.0 110.125 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.412 ' C ' ' O ' ' B' ' 107' ' ' SER . 80.4 p 43.61 61.46 2.25 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.202 -0.936 . . . . 0.0 110.209 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.526 ' ND2' ' HD2' ' B' ' 110' ' ' PRO . 12.5 t-20 -115.46 129.18 25.33 Favored Pre-proline 0 N--CA 1.49 1.551 0 O-C-N 121.23 -0.919 . . . . 0.0 110.289 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.526 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.7 Cg_endo -74.93 -7.37 19.15 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.986 1.519 . . . . 0.0 111.076 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.838 ' HD1' HG22 ' A' ' 47' ' ' VAL . 69.5 m-85 -117.35 14.29 14.68 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.964 -1.085 . . . . 0.0 110.329 179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 27.1 mt . . . . . 0 N--CA 1.493 1.704 0 CA-C-O 118.033 -0.984 . . . . 0.0 110.182 179.9 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.416 ' O ' ' C ' ' A' ' 7' ' ' TRP . 47.4 Cg_endo . . . . . 0 N--CA 1.484 0.945 0 CA-C-O 121.563 0.568 . . . . 0.0 110.842 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.846 ' HE1' HD22 ' A' ' 94' ' ' LEU . 12.4 t90 -41.17 121.63 1.62 Allowed 'General case' 0 C--N 1.304 -1.377 0 O-C-N 121.504 -0.748 . . . . 0.0 109.92 179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.512 ' N ' ' O ' ' A' ' 93' ' ' ALA . . . -43.1 -24.88 0.09 Allowed 'General case' 0 C--N 1.303 -1.432 0 O-C-N 121.371 -0.831 . . . . 0.0 110.007 179.802 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 41.0 t -98.41 152.9 4.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.355 -0.841 . . . . 0.0 109.824 179.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.555 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -112.93 178.48 0.96 Allowed Pre-proline 0 N--CA 1.494 1.766 0 O-C-N 121.216 -0.927 . . . . 0.0 109.972 -179.8 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.555 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 44.2 Cg_endo -71.78 -35.86 7.04 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 O-C-N 123.961 1.506 . . . . 0.0 109.772 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -73.21 -30.5 63.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.31 -0.869 . . . . 0.0 109.215 179.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.512 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -78.81 -43.79 24.52 Favored 'General case' 0 C--N 1.305 -1.343 0 N-CA-C 108.374 -0.973 . . . . 0.0 108.374 178.912 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.465 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 13.5 tptp -65.32 -17.46 64.53 Favored 'General case' 0 C--N 1.302 -1.498 0 N-CA-C 108.887 -0.783 . . . . 0.0 108.887 178.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -77.96 -41.96 34.46 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 179.101 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.581 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 1.6 ptmt -79.27 -23.1 43.84 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 178.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.581 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 7.0 m-30 -75.43 -35.84 60.87 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 178.033 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.493 ' O ' ' HB3' ' A' ' 22' ' ' ASP . 52.9 t0 -77.66 -9.04 58.76 Favored 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 121.326 0.584 . . . . 0.0 109.715 179.658 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.46 -35.2 13.09 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 178.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.692 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 22.2 mt -76.75 -32.96 21.02 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.742 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -73.5 -39.22 64.99 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 178.617 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 5.7 t70 -86.65 4.23 41.3 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 121.605 -0.685 . . . . 0.0 109.684 179.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -91.88 -10.93 37.84 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.324 -0.86 . . . . 0.0 108.938 179.121 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.972 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.6 OUTLIER -100.57 -6.95 24.6 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 179.208 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.615 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 86.79 88.65 0.04 OUTLIER Pre-proline 0 N--CA 1.502 2.16 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 -178.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.539 ' HD3' ' HA ' ' A' ' 22' ' ' ASP . 50.1 Cg_endo -76.1 152.5 35.84 Favored 'Trans proline' 0 C--N 1.302 -1.891 0 O-C-N 124.486 1.782 . . . . 0.0 110.852 -178.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 38.4 t -117.72 108.38 24.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 O-C-N 121.575 -0.703 . . . . 0.0 109.171 179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 17.4 t30 57.96 16.22 3.59 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.372 -0.83 . . . . 0.0 109.644 -178.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.51 34.88 4.28 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.912 -1.275 . . . . 0.0 109.912 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.455 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 80.5 m-85 -145.96 146.24 30.96 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.048 -1.266 . . . . 0.0 111.959 -179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.972 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.7 mt -117.46 139.73 50.52 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 177.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.485 ' OG ' ' HG3' ' A' ' 35' ' ' LYS . 79.9 p -84.42 139.91 31.9 Favored 'General case' 0 C--N 1.294 -1.844 0 C-N-CA 118.973 -1.091 . . . . 0.0 110.236 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.599 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.08 -28.21 0.74 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 179.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.43 ' N ' ' O ' ' A' ' 32' ' ' SER . 9.1 t0 -65.84 -22.69 66.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.635 -0.92 . . . . 0.0 110.502 179.618 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.5 ' HD3' ' O ' ' A' ' 24' ' ' LEU . 10.6 mttm -95.94 -33.91 12.0 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 178.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.047 HG11 HD12 ' A' ' 65' ' ' LEU . 89.7 t -76.94 -42.28 32.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 C-N-CA 119.8 -0.76 . . . . 0.0 110.533 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.645 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 23.2 ttmt -42.34 -49.68 12.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.071 -1.018 . . . . 0.0 111.127 -179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.564 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 42.6 Cg_endo -69.56 -33.65 16.91 Favored 'Trans proline' 0 C--N 1.311 -1.421 0 O-C-N 123.099 1.052 . . . . 0.0 109.44 179.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.773 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -63.97 -35.38 73.26 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 CA-C-O 121.437 0.637 . . . . 0.0 109.601 179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.065 ' HB3' HD22 ' A' ' 50' ' ' LEU . 25.4 mt -87.89 -23.39 23.96 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.355 -0.841 . . . . 0.0 110.396 -179.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.459 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 35.2 mt -74.03 -14.44 61.01 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.351 -0.843 . . . . 0.0 109.18 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -85.31 -3.66 58.9 Favored 'General case' 0 C--N 1.303 -1.435 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.122 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.635 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.9 OUTLIER -85.9 15.3 5.03 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.336 -0.853 . . . . 0.0 110.527 -179.793 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.431 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.1 OUTLIER 64.24 13.23 7.76 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.11 -0.994 . . . . 0.0 109.757 -179.757 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.069 HD11 ' HB3' ' A' ' 80' ' ' ALA . 13.7 mt -100.23 153.95 37.47 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.583 -0.698 . . . . 0.0 110.717 -179.538 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.599 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 49.8 Cg_endo -78.45 -179.09 5.13 Favored 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 124.137 1.598 . . . . 0.0 110.12 179.225 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.815 HG22 ' HD1' ' B' ' 111' ' ' PHE . 10.8 t -78.47 -3.75 6.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 O-C-N 121.311 -0.868 . . . . 0.0 109.456 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -82.28 -35.5 27.99 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.259 -0.901 . . . . 0.0 109.439 179.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.774 HG13 HD22 ' A' ' 45' ' ' LEU . 9.4 mm -80.67 -38.77 17.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.065 HD22 ' HB3' ' A' ' 40' ' ' LEU . 33.9 mt -73.69 -25.99 60.5 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 179.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.56 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -71.84 -25.55 74.66 Favored Glycine 0 N--CA 1.486 1.988 0 N-CA-C 107.373 -2.291 . . . . 0.0 107.373 178.576 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.806 ' O ' HD12 ' A' ' 56' ' ' LEU . 9.4 ttm180 -101.42 -31.98 10.66 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.98 -0.718 . . . . 0.0 110.135 179.345 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.015 HG11 HG23 ' A' ' 77' ' ' VAL . 10.0 t -71.06 -34.68 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 118.996 -1.082 . . . . 0.0 108.526 179.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.599 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 2.5 t-105 -67.83 -53.18 28.95 Favored 'General case' 0 C--N 1.305 -1.339 0 C-N-CA 119.399 -0.92 . . . . 0.0 109.127 178.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.504 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 11.5 mt-10 -45.92 -58.92 3.15 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.025 -1.047 . . . . 0.0 110.004 -178.687 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.806 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.8 mt -62.15 -18.32 60.58 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.174 -0.954 . . . . 0.0 108.61 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 1.042 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 45.9 t -87.78 -24.21 23.84 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 178.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.557 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t0 -102.78 72.52 1.22 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.715 -0.616 . . . . 0.0 109.584 179.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 4.6 mt -60.62 -19.79 19.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.328 -0.857 . . . . 0.0 110.718 -179.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.511 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 46.9 p-10 -99.34 -18.16 17.67 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.919 -1.113 . . . . 0.0 109.481 179.026 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.514 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 20.9 m-70 58.59 46.83 14.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.441 -0.787 . . . . 0.0 110.985 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.463 ' CG ' ' HB2' ' A' ' 64' ' ' MET . 48.7 p-10 -106.37 21.03 18.08 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.253 -0.904 . . . . 0.0 108.777 178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.512 ' O ' ' HG2' ' A' ' 64' ' ' MET . . . 64.97 32.71 85.13 Favored Glycine 0 N--CA 1.487 2.096 0 N-CA-C 108.372 -1.891 . . . . 0.0 108.372 -179.042 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.519 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 1.9 mmt -147.59 162.15 39.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.549 -0.971 . . . . 0.0 110.849 -179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.047 HD12 HG11 ' A' ' 36' ' ' VAL . 12.7 mt -132.26 99.55 4.73 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.544 -0.723 . . . . 0.0 109.339 178.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.48 ' OD1' ' N ' ' A' ' 68' ' ' ASP . 1.2 p30 -72.31 164.77 25.74 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.195 -0.941 . . . . 0.0 110.671 -179.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.517 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 1.3 ptm180 -38.76 -43.82 0.95 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.448 -0.782 . . . . 0.0 111.601 -179.387 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 12.3 m-20 -80.26 -33.47 37.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.114 -0.992 . . . . 0.0 110.347 -179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' OE1' ' HA ' ' A' ' 58' ' ' ASP . 18.3 mt-10 -76.92 -48.1 19.15 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.243 -0.91 . . . . 0.0 108.852 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.917 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.0 t80 -59.33 -18.42 38.0 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -73.6 -54.0 9.19 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.032 0.92 . . . . 0.0 109.263 179.286 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.879 HG22 HD21 ' A' ' 94' ' ' LEU . 59.6 t -53.09 -22.66 4.77 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.684 0 CA-C-O 121.511 0.672 . . . . 0.0 110.039 179.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 1.042 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -86.14 -17.16 35.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.345 -0.847 . . . . 0.0 111.713 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.553 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 8.7 mmm -82.17 -42.16 19.4 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.363 -1.461 . . . . 0.0 110.731 -179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CE1' ' HG ' ' A' ' 76' ' ' LEU . 3.5 p90 -76.93 -18.44 58.27 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.004 -1.06 . . . . 0.0 108.773 179.407 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.641 HD22 HG13 ' A' ' 86' ' ' VAL . 7.2 mt -81.63 -24.76 36.16 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 121.631 0.729 . . . . 0.0 109.186 178.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.015 HG23 HG11 ' A' ' 53' ' ' VAL . 12.1 t -90.92 -34.61 6.53 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 121.597 -0.689 . . . . 0.0 110.195 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.444 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 0.8 OUTLIER -71.87 -29.57 64.51 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.383 -0.823 . . . . 0.0 110.843 -179.671 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.473 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.2 m -77.97 -17.04 57.64 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.138 -0.976 . . . . 0.0 109.613 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.069 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.31 -5.82 58.12 Favored 'General case' 0 C--N 1.302 -1.498 0 C-N-CA 119.645 -0.822 . . . . 0.0 109.01 179.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.675 HD23 ' N ' ' A' ' 81' ' ' LEU . 3.1 mt -90.36 -44.51 9.62 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.641 0.734 . . . . 0.0 109.029 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 1.7 mt-10 -70.9 -53.74 13.98 Favored 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.735 -0.786 . . . . 0.0 109.409 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 1.4 ttpt 178.41 -29.05 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.612 -0.68 . . . . 0.0 110.907 179.626 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.473 ' O ' ' O ' ' A' ' 79' ' ' CYS . 2.5 mt-10 -63.07 110.11 3.17 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.222 -0.924 . . . . 0.0 110.639 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 42.6 Cg_endo -69.15 175.3 7.78 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.918 1.483 . . . . 0.0 110.069 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.658 HG11 ' CG2' ' A' ' 53' ' ' VAL . 49.7 t -122.06 125.3 26.68 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.145 -0.972 . . . . 0.0 110.688 -179.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.656 ' O ' HD11 ' A' ' 56' ' ' LEU . 46.4 Cg_endo -85.76 -178.88 3.11 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.875 1.46 . . . . 0.0 108.831 179.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.742 ' HA ' HD11 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -111.88 12.98 20.89 Favored 'General case' 0 C--N 1.297 -1.703 0 O-C-N 121.05 -1.031 . . . . 0.0 110.324 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 68.8 m -105.4 104.88 14.7 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 119.164 -1.014 . . . . 0.0 111.959 -178.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.645 HD22 ' CG2' ' A' ' 95' ' ' VAL . 1.9 mt -52.35 106.22 0.63 Allowed Pre-proline 0 C--N 1.294 -1.842 0 C-N-CA 120.125 -0.63 . . . . 0.0 110.013 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 39.7 Cg_endo -70.47 142.72 45.5 Favored 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.747 1.393 . . . . 0.0 110.556 179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -70.58 -1.57 9.36 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.787 1.658 . . . . 0.0 111.795 -178.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' A' ' 8' ' ' ALA . . . -99.82 -10.15 22.12 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.177 -0.952 . . . . 0.0 109.635 -179.844 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.971 HD22 ' O ' ' A' ' 94' ' ' LEU . 0.2 OUTLIER -110.74 -14.99 13.93 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.554 0.692 . . . . 0.0 110.191 -179.227 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.645 ' CG2' HD22 ' A' ' 90' ' ' LEU . 54.3 t -87.7 137.46 31.96 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.901 -1.124 . . . . 0.0 111.099 -179.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.99 156.05 42.99 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 O-C-N 124.122 1.591 . . . . 0.0 110.178 179.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.577 ' HA ' ' CG ' ' A' ' 100' ' ' ARG . 49.2 Cg_endo -76.39 -2.34 12.53 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.981 1.516 . . . . 0.0 110.987 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 86.4 p -84.7 -30.9 24.41 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.042 -1.036 . . . . 0.0 110.186 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -89.78 7.32 37.56 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.338 -0.851 . . . . 0.0 109.608 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.577 ' CG ' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.736 0 O-C-N 121.314 -0.866 . . . . 0.0 110.096 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.202 0.525 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 13.7 t -102.35 -15.17 16.64 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.31 -0.869 . . . . 0.0 110.067 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.6 ' CB ' HD12 ' B' ' 112' ' ' LEU . 6.6 t-20 -46.22 148.77 1.45 Allowed Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.275 -0.89 . . . . 0.0 109.979 179.704 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.506 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 43.7 Cg_endo -72.96 -40.67 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.843 1.444 . . . . 0.0 110.98 -179.657 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.815 ' HD1' HG22 ' A' ' 47' ' ' VAL . 47.2 m-85 -67.65 -39.27 84.6 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.044 -1.035 . . . . 0.0 110.554 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.6 HD12 ' CB ' ' B' ' 109' ' ' ASN . 4.3 mt . . . . . 0 N--CA 1.493 1.704 0 O-C-N 121.042 -1.037 . . . . 0.0 110.248 -179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo . . . . . 0 N--CA 1.483 0.862 0 N-CA-C 110.275 -0.702 . . . . 0.0 110.275 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.57 ' CD1' ' HA ' ' A' ' 94' ' ' LEU . 10.1 t90 -47.24 126.68 9.69 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.336 -0.853 . . . . 0.0 109.802 179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.767 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -40.42 -28.99 0.07 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.371 -0.831 . . . . 0.0 109.306 179.619 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.532 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 3.6 t -89.92 124.98 42.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.401 ' HB2' ' CG ' ' A' ' 13' ' ' ASP . 1.5 mttm -74.91 162.7 72.4 Favored Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 120.938 -1.101 . . . . 0.0 110.674 -178.678 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -67.42 -29.92 37.07 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 124.118 1.589 . . . . 0.0 108.747 178.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -82.69 -20.86 35.33 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.583 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 6.8 m-20 -85.24 -42.72 14.41 Favored 'General case' 0 N--CA 1.485 1.289 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 178.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.515 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 5.5 tttt -69.1 -20.44 64.07 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.533 -0.73 . . . . 0.0 109.157 178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.32 -43.73 55.47 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.558 -0.714 . . . . 0.0 109.175 179.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.614 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 7.7 ptmt -73.65 -29.08 62.12 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.634 ' CZ ' ' HB2' ' A' ' 74' ' ' MET . 8.3 m-30 -67.45 -37.22 82.64 Favored 'General case' 0 N--CA 1.488 1.441 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 178.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -71.26 -10.4 59.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.685 -0.634 . . . . 0.0 110.201 -179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -92.76 -31.94 14.87 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 107.536 -1.283 . . . . 0.0 107.536 178.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.748 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 28.3 mt -81.26 -28.78 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.807 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.8 -38.54 58.1 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 108.512 -0.921 . . . . 0.0 108.512 178.666 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.452 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 4.0 t0 -87.78 -0.33 56.79 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.66 -0.65 . . . . 0.0 109.881 179.34 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.7 m -89.73 -3.83 58.0 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.243 -0.91 . . . . 0.0 108.884 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.086 HD12 ' CD1' ' A' ' 31' ' ' LEU . 1.6 mt -110.41 -8.94 14.63 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.509 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.585 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.0 t 83.79 98.4 0.03 OUTLIER Pre-proline 0 N--CA 1.498 1.958 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -178.636 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 47.3 Cg_endo -72.33 151.35 54.03 Favored 'Trans proline' 0 C--N 1.302 -1.877 0 O-C-N 124.613 1.849 . . . . 0.0 110.812 -179.115 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.489 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 50.2 t -122.93 104.67 14.81 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 179.316 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.489 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 20.7 t30 58.25 22.44 9.25 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.465 -0.772 . . . . 0.0 109.734 -178.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.451 ' O ' ' OD1' ' A' ' 66' ' ' ASP . . . 91.89 37.12 6.14 Favored Glycine 0 N--CA 1.491 2.339 0 N-CA-C 109.884 -1.287 . . . . 0.0 109.884 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.506 ' HA ' ' HA ' ' A' ' 66' ' ' ASP . 89.8 m-85 -151.16 151.62 32.19 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.19 -1.182 . . . . 0.0 111.737 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.086 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.9 mt -119.0 151.36 38.35 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 177.123 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.556 ' O ' ' N ' ' A' ' 35' ' ' LYS . 97.4 p -97.38 143.97 27.6 Favored 'General case' 0 C--N 1.291 -1.966 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.883 -179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.608 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.43 -27.65 0.16 Allowed Glycine 0 N--CA 1.493 2.443 0 N-CA-C 108.941 -1.664 . . . . 0.0 108.941 179.529 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.53 ' O ' ' CD ' ' A' ' 38' ' ' PRO . 1.2 m-20 -66.59 -30.59 70.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.373 -1.075 . . . . 0.0 110.264 179.251 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.556 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.0 mttt -85.09 -35.79 21.59 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 178.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.871 HG11 HD12 ' A' ' 65' ' ' LEU . 55.7 t -80.06 -45.18 22.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 CA-C-O 121.462 0.648 . . . . 0.0 110.316 179.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.644 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 5.2 tttt -40.65 -54.29 5.23 Favored Pre-proline 0 N--CA 1.49 1.528 0 O-C-N 121.597 -0.69 . . . . 0.0 110.789 -179.216 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.567 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -67.01 -33.46 32.09 Favored 'Trans proline' 0 C--N 1.31 -1.484 0 O-C-N 123.253 1.133 . . . . 0.0 109.796 179.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.517 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.7 -28.9 44.65 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.544 0 O-C-N 121.728 -0.607 . . . . 0.0 109.506 179.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.098 ' HB3' HD22 ' A' ' 50' ' ' LEU . 84.7 mt -88.05 -27.18 22.16 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.396 -0.815 . . . . 0.0 110.168 -179.521 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.482 HD12 ' HA ' ' A' ' 38' ' ' PRO . 23.9 mt -73.81 -12.76 60.79 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.266 -0.896 . . . . 0.0 109.378 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.469 ' OD1' ' O ' ' A' ' 39' ' ' VAL . 33.0 p-10 -80.09 -5.15 55.4 Favored 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.508 -0.877 . . . . 0.0 110.433 -179.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.541 ' OG ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -89.69 13.94 12.98 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.373 -0.83 . . . . 0.0 110.598 -179.307 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.51 13.63 4.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.058 -1.026 . . . . 0.0 109.95 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.895 HD22 HG13 ' A' ' 49' ' ' ILE . 16.2 mt -94.9 154.19 39.81 Favored Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.276 -0.89 . . . . 0.0 110.022 179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.9 Cg_endo -75.6 174.39 12.88 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 124.096 1.577 . . . . 0.0 110.652 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.709 HG13 ' HB3' ' B' ' 111' ' ' PHE . 6.8 t -71.95 -4.27 4.65 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.529 -0.732 . . . . 0.0 109.389 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 46.0 t0 -82.59 -35.4 27.12 Favored 'General case' 0 C--N 1.306 -1.322 0 O-C-N 121.218 -0.927 . . . . 0.0 109.449 179.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.895 HG13 HD22 ' A' ' 45' ' ' LEU . 7.8 mm -79.79 -38.69 19.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 C-N-CA 119.484 -0.886 . . . . 0.0 108.837 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.098 HD22 ' HB3' ' A' ' 40' ' ' LEU . 27.8 mt -70.41 -27.24 64.13 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.389 0.614 . . . . 0.0 109.403 179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.531 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.25 -24.03 76.92 Favored Glycine 0 N--CA 1.486 1.994 0 N-CA-C 107.632 -2.187 . . . . 0.0 107.632 179.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.963 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.6 ttm180 -101.54 -31.47 10.85 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.761 -0.846 . . . . 0.0 110.896 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.787 HG11 ' CG2' ' A' ' 77' ' ' VAL . 12.5 t -68.32 -39.36 80.84 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 120.965 -1.085 . . . . 0.0 109.048 -179.736 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.608 ' CZ3' ' HA2' ' A' ' 33' ' ' GLY . 1.7 t-105 -67.64 -50.29 58.68 Favored 'General case' 0 C--N 1.302 -1.476 0 C-N-CA 119.547 -0.861 . . . . 0.0 109.57 179.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.492 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 51.2 mt-10 -49.32 -56.81 8.26 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.056 -1.027 . . . . 0.0 109.956 -178.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.963 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -60.48 -16.2 34.36 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.247 -0.908 . . . . 0.0 108.731 178.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.792 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 66.2 m -93.02 -31.27 14.93 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.463 -0.773 . . . . 0.0 109.149 178.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 36.0 t0 -89.58 98.39 11.74 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 3.9 mt -93.78 -22.22 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.285 -0.884 . . . . 0.0 111.076 -178.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.524 ' OD1' ' N ' ' A' ' 61' ' ' HIS . 58.7 p-10 -90.76 -16.54 28.23 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.112 . . . . 0.0 110.067 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.524 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 4.0 m170 66.23 42.85 2.96 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.371 -0.83 . . . . 0.0 110.639 179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 64' ' ' MET . 23.3 p-10 -111.72 17.22 20.08 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.15 -0.969 . . . . 0.0 109.602 179.448 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 64.55 34.8 90.86 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.301 -1.52 . . . . 0.0 109.301 -179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 40.9 mtp -150.78 162.03 41.52 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.087 -1.243 . . . . 0.0 110.805 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.871 HD12 HG11 ' A' ' 36' ' ' VAL . 9.4 mt -126.22 106.27 9.42 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.261 -0.899 . . . . 0.0 109.735 178.795 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.506 ' HA ' ' HA ' ' A' ' 30' ' ' PHE . 2.3 t70 -69.86 172.12 8.21 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.127 -0.983 . . . . 0.0 110.29 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -51.81 -34.74 41.44 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.574 -0.704 . . . . 0.0 111.048 -179.606 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.505 ' HB3' ' HB3' ' A' ' 96' ' ' PRO . 11.6 m-20 -86.81 -34.56 19.5 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.04 -1.038 . . . . 0.0 110.019 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' HB3' ' O ' ' A' ' 57' ' ' SER . 25.1 mt-10 -76.89 -38.94 52.6 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.87 -0.789 . . . . 0.0 108.87 179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.965 ' CD2' HD12 ' A' ' 31' ' ' LEU . 38.6 t80 -63.01 -28.97 70.47 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.482 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -63.9 -51.49 64.29 Favored 'General case' 0 N--CA 1.493 1.689 0 CA-C-O 121.995 0.902 . . . . 0.0 109.663 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.928 HG13 ' CD1' ' A' ' 94' ' ' LEU . 41.9 t -52.7 -28.03 12.56 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 CA-C-O 121.494 0.664 . . . . 0.0 110.452 -179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.792 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -84.04 -13.61 52.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.319 -0.863 . . . . 0.0 111.862 -178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.634 ' HB2' ' CZ ' ' A' ' 17' ' ' TYR . 7.1 mmm -85.82 -32.84 21.54 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.503 -1.373 . . . . 0.0 111.146 -178.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.769 ' CZ ' HD13 ' A' ' 94' ' ' LEU . 4.4 p90 -84.47 -18.2 36.63 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 120.904 -1.123 . . . . 0.0 108.675 178.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.497 ' HB3' HG22 ' A' ' 53' ' ' VAL . 4.4 mt -83.9 -13.74 52.77 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.994 -0.743 . . . . 0.0 108.994 178.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.787 ' CG2' HG11 ' A' ' 53' ' ' VAL . 52.0 t -91.22 -47.82 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.49 -0.756 . . . . 0.0 110.261 179.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.576 ' HA ' ' CD2' ' A' ' 81' ' ' LEU . 8.2 m-85 -71.21 -29.89 65.7 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.338 -0.851 . . . . 0.0 110.279 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 31.2 t -82.09 -10.1 59.31 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.165 -0.959 . . . . 0.0 109.323 179.491 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.618 ' HB1' HG21 ' A' ' 49' ' ' ILE . . . -92.38 -35.76 13.52 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 122.186 0.994 . . . . 0.0 109.02 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.576 ' CD2' ' HA ' ' A' ' 78' ' ' TYR . 0.4 OUTLIER -90.57 -18.7 24.76 Favored 'General case' 0 C--N 1.297 -1.698 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.714 -179.452 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.454 ' N ' ' HG ' ' A' ' 81' ' ' LEU . 6.3 tt0 -69.94 -60.35 2.35 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.303 -0.873 . . . . 0.0 110.168 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 11.0 tttp -177.1 43.2 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.306 -0.871 . . . . 0.0 110.582 179.912 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.528 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.7 mt-10 -158.51 145.59 13.13 Favored Pre-proline 0 N--CA 1.493 1.684 0 O-C-N 121.253 -0.905 . . . . 0.0 110.298 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.0 -179.71 5.26 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.842 1.443 . . . . 0.0 109.596 179.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.544 ' CG2' ' HB2' ' A' ' 80' ' ' ALA . 92.7 t -131.22 117.28 16.84 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 120.963 -1.086 . . . . 0.0 110.745 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.477 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.5 Cg_endo -84.47 162.09 12.78 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.869 1.457 . . . . 0.0 109.551 178.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.898 ' C ' HD21 ' A' ' 56' ' ' LEU . 22.4 mtm -89.99 17.2 7.09 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.163 -0.961 . . . . 0.0 110.117 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.579 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 0.3 OUTLIER -98.56 114.9 27.51 Favored 'General case' 0 C--N 1.296 -1.735 0 C-N-CA 118.932 -1.107 . . . . 0.0 111.705 -178.144 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.873 HD22 ' O ' ' A' ' 56' ' ' LEU . 0.1 OUTLIER -103.18 84.76 0.74 Allowed Pre-proline 0 C--N 1.293 -1.874 0 N-CA-C 107.374 -1.343 . . . . 0.0 107.374 178.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.579 ' HD3' ' O ' ' A' ' 89' ' ' SER . 38.8 Cg_endo -64.57 165.48 20.37 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.776 1.409 . . . . 0.0 111.169 -178.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -70.31 -6.99 20.14 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.437 1.756 . . . . 0.0 110.655 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.83 -15.97 61.61 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.404 -0.81 . . . . 0.0 109.118 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.928 ' CD1' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -132.47 40.26 3.3 Favored 'General case' 0 C--N 1.304 -1.411 0 C-N-CA 119.377 -0.929 . . . . 0.0 110.897 -179.839 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.706 HG22 HD11 ' A' ' 90' ' ' LEU . 72.8 t -109.53 136.92 20.22 Favored Pre-proline 0 N--CA 1.492 1.656 0 O-C-N 121.103 -0.998 . . . . 0.0 110.116 179.692 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.505 ' HB3' ' HB3' ' A' ' 68' ' ' ASP . 47.4 Cg_endo -72.81 170.11 20.42 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.955 1.502 . . . . 0.0 110.544 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -76.62 -18.96 14.99 Favored 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.172 1.617 . . . . 0.0 110.559 179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -57.26 -23.66 49.65 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.122 -0.986 . . . . 0.0 110.172 -179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.6 tttm -90.49 8.82 31.94 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.266 -0.896 . . . . 0.0 109.672 179.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 7.9 mtt180 . . . . . 0 N--CA 1.493 1.684 0 O-C-N 121.399 -0.813 . . . . 0.0 110.432 -179.829 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.519 ' C ' ' CG2' ' B' ' 108' ' ' THR . 14.6 m . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.093 0.473 . . . . 0.0 110.02 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.519 ' CG2' ' C ' ' B' ' 107' ' ' SER . 0.0 OUTLIER 34.67 93.69 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 CA-C-O 121.326 0.584 . . . . 0.0 110.852 -179.93 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.534 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 16.1 t-20 -125.23 145.6 51.2 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.349 -0.844 . . . . 0.0 110.098 -179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 46.2 Cg_endo -73.5 -36.6 3.78 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.918 1.483 . . . . 0.0 110.713 -179.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.709 ' HB3' HG13 ' A' ' 47' ' ' VAL . 95.5 m-85 -71.5 -5.21 31.35 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.047 -1.033 . . . . 0.0 110.037 179.783 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 14.2 mt . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 117.964 -1.017 . . . . 0.0 110.352 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.882 0 N-CA-C 110.561 -0.592 . . . . 0.0 110.561 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.54 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 10.6 t90 -52.7 125.72 17.58 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.439 -0.788 . . . . 0.0 110.016 179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.706 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -43.53 -26.84 0.24 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.241 -0.912 . . . . 0.0 109.682 179.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.54 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 13.2 t -92.5 137.8 21.42 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.423 -0.798 . . . . 0.0 108.902 179.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.423 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 7.1 mttt -95.74 173.37 4.35 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 120.961 -1.087 . . . . 0.0 110.564 -179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.423 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 42.1 Cg_endo -70.99 -33.77 11.46 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.219 1.642 . . . . 0.0 109.993 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -80.03 -27.48 39.47 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.474 -0.766 . . . . 0.0 109.184 179.409 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.589 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.3 m-20 -79.72 -40.03 29.82 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 179.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.484 ' HE2' ' HA ' ' A' ' 68' ' ' ASP . 22.4 tptp -72.31 -20.77 61.44 Favored 'General case' 0 C--N 1.301 -1.516 0 C-N-CA 119.846 -0.742 . . . . 0.0 109.472 179.297 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.61 -42.32 71.11 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 179.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 3.0 ptpt -74.84 -30.31 61.33 Favored 'General case' 0 C--N 1.304 -1.403 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 178.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.636 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 8.7 m-30 -64.86 -40.94 95.94 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 178.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -72.4 -8.67 56.21 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.281 0.562 . . . . 0.0 110.432 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -95.33 -33.81 12.39 Favored 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 178.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.63 HG22 ' CE1' ' A' ' 70' ' ' PHE . 36.0 mt -79.68 -27.84 12.71 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.723 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -75.83 -39.17 57.21 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.647 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.456 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 20.7 t0 -87.36 0.02 56.08 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.814 -0.553 . . . . 0.0 110.05 179.711 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 0.6 OUTLIER -89.96 -7.55 53.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.292 -0.88 . . . . 0.0 109.238 179.164 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.11 HD12 ' CD1' ' A' ' 31' ' ' LEU . 3.9 mt -105.59 -14.38 15.3 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 109.106 -0.701 . . . . 0.0 109.106 179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.628 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 4.1 t 90.68 97.2 0.03 OUTLIER Pre-proline 0 N--CA 1.502 2.162 0 CA-C-O 121.211 0.529 . . . . 0.0 109.841 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.595 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.2 Cg_endo -74.65 151.75 41.79 Favored 'Trans proline' 0 C--N 1.301 -1.964 0 O-C-N 124.62 1.853 . . . . 0.0 110.701 -179.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.481 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 25.8 t -118.13 104.68 16.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.57 -0.706 . . . . 0.0 109.17 179.264 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.481 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 5.0 t30 58.56 15.02 3.35 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.442 -0.787 . . . . 0.0 109.678 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.9 32.24 3.89 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 110.083 -1.207 . . . . 0.0 110.083 179.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.604 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 87.9 m-85 -150.07 148.92 29.58 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.966 -1.314 . . . . 0.0 112.017 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.11 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.2 mt -114.41 136.39 53.05 Favored 'General case' 0 C--N 1.3 -1.549 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 177.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.438 ' O ' ' C ' ' A' ' 33' ' ' GLY . 0.3 OUTLIER -82.0 141.56 33.14 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.988 -1.085 . . . . 0.0 109.811 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.498 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -43.51 -27.56 0.84 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.627 -1.789 . . . . 0.0 108.627 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.4 t0 -63.66 -23.53 67.41 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.549 -0.971 . . . . 0.0 110.05 179.42 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.515 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 11.9 mttm -98.52 -35.64 10.17 Favored 'General case' 0 C--N 1.307 -1.274 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.052 HG11 HD12 ' A' ' 65' ' ' LEU . 99.2 t -76.93 -42.16 32.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 CA-C-O 121.569 0.7 . . . . 0.0 110.132 179.157 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.648 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 18.6 tttt -41.63 -53.94 7.06 Favored Pre-proline 0 C--N 1.303 -1.418 0 O-C-N 121.523 -0.736 . . . . 0.0 111.346 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.548 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.5 Cg_endo -68.31 -34.99 19.78 Favored 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.433 1.228 . . . . 0.0 109.907 179.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.792 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.7 t -60.57 -26.14 36.8 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.513 -0.742 . . . . 0.0 109.847 179.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.066 ' HB3' HD22 ' A' ' 50' ' ' LEU . 23.9 mt -96.9 -28.66 14.11 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.064 -1.022 . . . . 0.0 110.274 -179.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.467 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 62.7 mt -69.66 -17.27 63.48 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.28 -0.887 . . . . 0.0 108.629 179.196 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -80.36 -6.68 58.39 Favored 'General case' 0 C--N 1.302 -1.471 0 C-N-CA 119.515 -0.874 . . . . 0.0 109.575 179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.471 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -85.49 14.18 5.87 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.496 -0.753 . . . . 0.0 110.13 179.955 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 18.9 mmtt 58.71 16.17 4.23 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.254 -0.903 . . . . 0.0 110.2 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.037 HD11 ' HB3' ' A' ' 80' ' ' ALA . 15.9 mt -96.55 153.39 38.83 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.3 -0.875 . . . . 0.0 110.019 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.57 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.7 Cg_endo -76.02 176.32 10.19 Favored 'Trans proline' 0 C--N 1.3 -1.976 0 O-C-N 124.112 1.585 . . . . 0.0 109.897 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.577 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.4 t -73.85 -3.59 4.59 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.509 0 O-C-N 121.187 -0.946 . . . . 0.0 109.321 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.456 ' OD2' ' HB2' ' A' ' 46' ' ' PRO . 5.7 m-20 -81.11 -33.83 33.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.395 -0.816 . . . . 0.0 109.12 179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.96 HG13 HD22 ' A' ' 45' ' ' LEU . 9.0 mm -82.73 -40.04 16.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 178.859 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.066 HD22 ' HB3' ' A' ' 40' ' ' LEU . 21.9 mt -73.32 -28.99 62.38 Favored 'General case' 0 C--N 1.3 -1.562 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 179.038 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.613 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -66.1 -24.24 71.71 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 107.45 -2.26 . . . . 0.0 107.45 178.604 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.659 ' O ' HD12 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.47 -39.66 7.43 Favored 'General case' 0 C--N 1.297 -1.697 0 O-C-N 122.011 -0.7 . . . . 0.0 109.878 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.804 HG11 ' CG2' ' A' ' 77' ' ' VAL . 5.8 t -57.35 -45.41 85.27 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.041 -1.037 . . . . 0.0 109.751 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.538 ' O ' ' N ' ' A' ' 58' ' ' ASP . 4.3 t-105 -63.3 -53.14 57.51 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.809 -1.157 . . . . 0.0 109.336 179.425 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.488 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 85.7 mt-10 -54.87 -48.42 72.98 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 119.447 -0.901 . . . . 0.0 109.313 -179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 52' ' ' ARG . 7.8 mt -62.4 -22.88 66.49 Favored 'General case' 0 C--N 1.301 -1.54 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.913 ' HB2' ' HB2' ' A' ' 73' ' ' ALA . 41.7 t -89.62 -30.13 18.36 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.506 0.67 . . . . 0.0 109.291 178.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.2 OUTLIER -74.43 79.71 1.91 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.556 -0.715 . . . . 0.0 109.744 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.477 HG12 ' HG2' ' A' ' 69' ' ' GLU . 31.4 mm -60.43 -36.44 69.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.252 -0.905 . . . . 0.0 110.011 -179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 3.2 p30 -103.49 -20.09 14.16 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.0 110.372 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 33.2 m-70 69.41 41.8 1.26 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.455 -0.778 . . . . 0.0 110.54 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.449 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 2.7 p-10 -91.97 9.86 31.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.281 -0.887 . . . . 0.0 109.949 179.754 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.435 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 80.4 24.66 58.56 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.76 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.535 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 50.9 mtp -152.95 160.48 43.04 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.204 -1.174 . . . . 0.0 110.392 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 1.052 HD12 HG11 ' A' ' 36' ' ' VAL . 13.6 mt -119.28 100.5 7.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.336 -0.852 . . . . 0.0 109.293 178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.604 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.1 p30 -69.52 159.2 33.76 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.064 -1.022 . . . . 0.0 110.313 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.595 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 11.4 ptp180 -35.77 -43.91 0.32 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.707 -0.621 . . . . 0.0 111.251 -179.377 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.506 ' N ' ' HG3' ' A' ' 67' ' ' ARG . 35.8 t70 -75.89 -36.46 59.48 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.183 -0.948 . . . . 0.0 110.339 -179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.477 ' HG2' HG12 ' A' ' 59' ' ' ILE . 85.0 mt-10 -76.62 -43.11 39.73 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.216 -0.928 . . . . 0.0 109.004 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.967 ' CD2' HD12 ' A' ' 31' ' ' LEU . 22.1 t80 -59.54 -20.52 56.17 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.462 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -74.13 -49.83 22.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.412 -0.805 . . . . 0.0 109.519 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.939 HG13 ' CD1' ' A' ' 94' ' ' LEU . 55.8 t -58.31 -24.75 25.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.615 0 CA-C-O 121.351 0.596 . . . . 0.0 110.259 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.913 ' HB2' ' HB2' ' A' ' 57' ' ' SER . . . -88.27 -9.38 53.08 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.349 -0.845 . . . . 0.0 111.282 -179.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.601 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 3.3 mmt -85.29 -42.12 14.91 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.924 -1.11 . . . . 0.0 110.361 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.749 ' CE2' HD13 ' A' ' 94' ' ' LEU . 3.3 p90 -77.41 -26.72 51.93 Favored 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.013 -1.054 . . . . 0.0 108.256 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.736 ' HB3' HG22 ' A' ' 53' ' ' VAL . 14.3 mt -69.03 -23.02 64.02 Favored 'General case' 0 N--CA 1.486 1.35 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 178.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.804 ' CG2' HG11 ' A' ' 53' ' ' VAL . 57.6 t -92.3 -63.03 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.342 0 CA-C-O 121.49 0.662 . . . . 0.0 109.555 179.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.435 ' HA ' HD13 ' A' ' 81' ' ' LEU . 1.7 m-85 -47.17 -27.93 1.64 Allowed 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.554 -0.716 . . . . 0.0 111.637 -179.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.511 ' O ' ' O ' ' A' ' 84' ' ' GLU . 1.5 m -80.65 -16.16 54.73 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.84 -1.162 . . . . 0.0 109.95 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.037 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.3 -14.25 50.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.366 -0.833 . . . . 0.0 109.785 -179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.754 HD12 ' N ' ' A' ' 81' ' ' LEU . 6.4 mp -90.33 -42.26 11.05 Favored 'General case' 0 C--N 1.302 -1.462 0 CA-C-O 121.758 0.79 . . . . 0.0 109.345 179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.23 -55.42 10.61 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.987 -0.685 . . . . 0.0 109.73 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.65 -22.45 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.269 -0.894 . . . . 0.0 111.799 179.62 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.511 ' O ' ' O ' ' A' ' 79' ' ' CYS . 13.4 tt0 -79.84 113.57 38.93 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.909 -1.12 . . . . 0.0 111.378 -178.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -72.62 -171.25 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.763 1.402 . . . . 0.0 110.21 179.443 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.68 HG13 ' HD2' ' A' ' 87' ' ' PRO . 72.7 t -114.48 148.48 40.34 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.12 -0.987 . . . . 0.0 109.458 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.68 ' HD2' HG13 ' A' ' 86' ' ' VAL . 48.8 Cg_endo -77.66 -162.3 0.17 Allowed 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 123.753 1.396 . . . . 0.0 110.08 -179.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.428 ' HG2' ' O ' ' A' ' 88' ' ' MET . 3.1 ttt -108.39 -0.72 20.46 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.214 -0.929 . . . . 0.0 111.084 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.584 ' O ' ' O ' ' A' ' 90' ' ' LEU . 23.2 t -171.3 28.15 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.799 -1.188 . . . . 0.0 111.248 179.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.953 HD11 HG22 ' A' ' 95' ' ' VAL . 0.3 OUTLIER 46.04 123.14 0.0 OUTLIER Pre-proline 0 C--N 1.291 -1.943 0 CA-C-O 121.576 0.703 . . . . 0.0 111.494 178.639 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.754 ' O ' HD12 ' A' ' 90' ' ' LEU . 40.0 Cg_endo -66.9 164.79 28.31 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.274 1.144 . . . . 0.0 110.896 179.93 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -69.99 -3.2 11.68 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.099 1.579 . . . . 0.0 111.478 -179.091 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.14 -5.31 46.07 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.193 -0.942 . . . . 0.0 109.462 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.939 ' CD1' HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -141.95 42.33 1.69 Allowed 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 119.112 -1.035 . . . . 0.0 110.93 179.84 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.953 HG22 HD11 ' A' ' 90' ' ' LEU . 48.4 t -119.91 130.98 24.57 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.039 -1.038 . . . . 0.0 110.544 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.46 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 42.6 Cg_endo -69.47 174.29 9.48 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.867 1.457 . . . . 0.0 109.946 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.558 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 43.0 Cg_endo -69.33 176.42 6.47 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.78 1.411 . . . . 0.0 110.772 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 74.57 -49.74 0.67 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.505 -0.747 . . . . 0.0 110.134 -179.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.3 12.65 13.45 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.154 -0.966 . . . . 0.0 108.634 178.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.558 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 2.2 ptp180 . . . . . 0 N--CA 1.492 1.65 0 O-C-N 121.449 -0.782 . . . . 0.0 110.376 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.0 110.096 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 30.8 p -85.93 -27.67 24.8 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 110.212 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.452 ' OD1' ' HD2' ' B' ' 110' ' ' PRO . 48.1 t-20 -105.91 129.14 25.08 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.271 -0.893 . . . . 0.0 110.601 -179.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.452 ' HD2' ' OD1' ' B' ' 109' ' ' ASN . 46.6 Cg_endo -75.88 -28.4 7.81 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.938 1.494 . . . . 0.0 110.727 179.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.738 ' CE2' HD12 ' A' ' 40' ' ' LEU . 64.8 m-85 -86.08 -1.78 57.71 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.035 -1.041 . . . . 0.0 110.023 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.189 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo . . . . . 0 N--CA 1.483 0.91 0 N-CA-C 110.445 -0.637 . . . . 0.0 110.445 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.557 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 9.0 t90 -81.46 120.39 24.94 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.277 -0.89 . . . . 0.0 110.124 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.68 ' HB3' ' HB2' ' A' ' 94' ' ' LEU . . . -39.77 -29.01 0.05 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.445 -0.784 . . . . 0.0 110.322 -179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.557 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 14.4 t -92.84 128.38 44.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.485 -0.759 . . . . 0.0 109.373 179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.477 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 28.4 mttp -84.35 164.79 41.66 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.167 -0.958 . . . . 0.0 110.107 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.477 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 39.5 Cg_endo -67.64 -30.24 35.14 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 123.933 1.491 . . . . 0.0 109.476 179.319 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.0 mm-40 -85.13 -25.3 27.57 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.308 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.575 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 1.4 m-20 -77.59 -41.72 37.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 179.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.49 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 1.5 tmtt? -69.39 -23.63 63.75 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.798 -0.761 . . . . 0.0 109.071 179.103 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -65.11 -42.76 93.67 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 179.266 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.32 -38.81 65.69 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 178.177 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 5.3 m-30 -60.63 -21.98 63.3 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 106.816 -1.55 . . . . 0.0 106.816 177.286 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.455 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.1 OUTLIER -90.35 -12.09 38.71 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.312 0.577 . . . . 0.0 109.78 179.523 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.52 -33.38 15.19 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 178.575 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.789 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 41.2 mt -78.38 -29.88 15.25 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 177.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.864 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -76.81 -39.73 50.41 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.672 0.748 . . . . 0.0 108.992 179.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 7.8 t70 -86.44 1.98 49.39 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.599 -0.688 . . . . 0.0 109.583 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -90.24 -10.27 44.91 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.292 -0.88 . . . . 0.0 109.086 179.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.089 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.3 mt -105.44 -12.93 15.8 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 2.1 t 87.24 96.2 0.03 OUTLIER Pre-proline 0 N--CA 1.504 2.263 0 CA-C-O 121.379 0.609 . . . . 0.0 109.915 -179.028 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -75.49 152.38 38.45 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 124.509 1.794 . . . . 0.0 110.933 -179.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.5 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 26.3 t -116.65 107.8 23.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 7.6 t30 58.76 15.13 3.58 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.393 -0.817 . . . . 0.0 109.348 -178.605 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 102.94 32.26 4.78 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 179.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.59 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 86.4 m-85 -144.32 149.5 36.31 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.0 111.859 -179.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.089 ' CD1' HD12 ' A' ' 24' ' ' LEU . 8.8 mt -117.17 138.95 51.33 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 107.978 -1.119 . . . . 0.0 107.978 177.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 14.0 p -85.86 141.08 29.87 Favored 'General case' 0 C--N 1.292 -1.896 0 C-N-CA 118.731 -1.188 . . . . 0.0 110.069 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.451 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -41.33 -26.71 0.22 Allowed Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 29.1 t70 -61.25 -28.53 69.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.342 -1.093 . . . . 0.0 109.736 179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.579 ' HB3' HD13 ' A' ' 24' ' ' LEU . 46.8 mttm -94.11 -33.2 13.45 Favored 'General case' 0 C--N 1.305 -1.337 0 O-C-N 121.242 -0.911 . . . . 0.0 108.579 179.087 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.625 HG12 HD11 ' A' ' 40' ' ' LEU . 79.6 t -79.67 -44.3 23.31 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 C-N-CA 119.872 -0.731 . . . . 0.0 110.463 179.572 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.595 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 25.2 tttt -40.2 -54.02 4.84 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.889 -179.3 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 40.5 Cg_endo -66.83 -36.44 23.68 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 123.452 1.238 . . . . 0.0 109.683 179.272 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.668 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.3 t -59.74 -37.59 71.98 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.557 -0.714 . . . . 0.0 109.607 179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.996 ' HB3' HD22 ' A' ' 50' ' ' LEU . 34.9 mt -83.89 -29.02 27.52 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.411 -0.806 . . . . 0.0 109.845 -179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 29.4 mt -74.01 -12.48 60.64 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.399 -0.813 . . . . 0.0 109.512 179.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 28.5 m-20 -90.27 -4.98 56.82 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 119.507 -0.877 . . . . 0.0 110.125 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.582 ' CB ' HG13 ' A' ' 77' ' ' VAL . 60.5 p -84.13 8.87 14.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.383 -0.823 . . . . 0.0 110.256 -179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' CB ' ' O ' ' A' ' 43' ' ' SER . 0.2 OUTLIER 66.77 7.65 5.38 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.325 -0.859 . . . . 0.0 110.09 -179.731 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 1.04 HD11 ' HB3' ' A' ' 80' ' ' ALA . 18.8 mt -93.18 155.87 40.72 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.211 -0.931 . . . . 0.0 110.308 179.793 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.543 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 46.3 Cg_endo -74.55 167.78 26.33 Favored 'Trans proline' 0 C--N 1.301 -1.969 0 O-C-N 124.204 1.634 . . . . 0.0 109.975 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.817 HG13 ' HB3' ' B' ' 111' ' ' PHE . 17.5 t -66.63 -7.78 6.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.359 -0.838 . . . . 0.0 109.474 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' O ' ' OD1' ' A' ' 48' ' ' ASP . 47.4 t0 -77.33 -30.94 54.21 Favored 'General case' 0 C--N 1.307 -1.273 0 O-C-N 121.168 -0.957 . . . . 0.0 109.373 179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.831 HG13 HD22 ' A' ' 45' ' ' LEU . 9.1 mm -84.69 -36.61 11.7 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 CA-C-O 121.974 0.892 . . . . 0.0 108.943 179.01 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.996 HD22 ' HB3' ' A' ' 40' ' ' LEU . 11.5 mt -75.51 -25.59 57.38 Favored 'General case' 0 C--N 1.297 -1.693 0 N-CA-C 109.241 -0.651 . . . . 0.0 109.241 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.55 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -75.6 -25.03 68.63 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 107.708 -2.157 . . . . 0.0 107.708 179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.586 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.1 ttm180 -100.81 -29.67 12.12 Favored 'General case' 0 C--N 1.299 -1.599 0 N-CA-C 109.241 -0.652 . . . . 0.0 109.241 178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.014 HG11 HG23 ' A' ' 77' ' ' VAL . 17.0 t -69.67 -51.03 44.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.576 ' CZ3' ' HG ' ' A' ' 65' ' ' LEU . 1.5 t-105 -59.86 -53.63 55.62 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.452 -1.314 . . . . 0.0 107.452 177.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.523 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 0.0 OUTLIER -45.43 -65.7 0.5 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.924 0.869 . . . . 0.0 110.12 179.904 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.731 HD22 ' N ' ' A' ' 90' ' ' LEU . 22.2 mt -56.76 -18.27 12.07 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.997 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 3.3 t -91.66 -17.29 25.73 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 177.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.565 ' N ' ' O ' ' A' ' 54' ' ' TRP . 13.5 t70 -94.87 82.43 3.86 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.476 -0.765 . . . . 0.0 109.312 179.44 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 26.5 mt -87.0 -20.62 7.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.24 -0.913 . . . . 0.0 110.892 -178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' C ' ' CD2' ' A' ' 61' ' ' HIS . 5.8 p30 -94.52 -21.75 18.67 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.982 -1.074 . . . . 0.0 109.586 179.364 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.533 ' CD2' ' C ' ' A' ' 60' ' ' ASP . 25.0 m-70 70.86 40.29 0.96 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.465 -0.772 . . . . 0.0 110.673 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 32.1 p-10 -101.89 15.13 29.97 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.298 -0.876 . . . . 0.0 109.47 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.427 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 62.29 31.85 80.66 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 108.978 -1.649 . . . . 0.0 108.978 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.538 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 74.8 mtp -154.41 161.29 41.8 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.366 -1.079 . . . . 0.0 110.86 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.694 HD22 ' OG ' ' A' ' 57' ' ' SER . 9.0 mt -116.9 101.11 8.24 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.306 -0.871 . . . . 0.0 109.344 178.16 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.59 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 2.5 p30 -69.67 160.85 30.84 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.11 -0.994 . . . . 0.0 110.339 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.511 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.8 ptt85 -33.88 -45.41 0.19 Allowed 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.826 -0.546 . . . . 0.0 111.604 -179.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.627 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 22.6 m-20 -78.1 -41.25 35.76 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.234 -0.916 . . . . 0.0 110.437 -179.541 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.467 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 44.8 mt-10 -67.77 -48.1 67.3 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.266 -0.896 . . . . 0.0 109.316 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.846 ' CD2' HD12 ' A' ' 31' ' ' LEU . 10.2 t80 -57.88 -17.88 19.25 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 178.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 68' ' ' ASP . . . -75.37 -53.73 8.24 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.431 -0.793 . . . . 0.0 109.506 179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 1.04 HG13 HD11 ' A' ' 94' ' ' LEU . 55.4 t -55.39 -27.13 20.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 O-C-N 121.561 -0.712 . . . . 0.0 109.617 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.997 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.25 -2.84 58.06 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.395 -0.815 . . . . 0.0 110.816 -179.831 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.5 mmt -87.15 -50.02 6.9 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.662 -1.274 . . . . 0.0 110.066 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.859 ' CE2' HD13 ' A' ' 94' ' ' LEU . 4.2 p90 -74.51 -27.71 60.67 Favored 'General case' 0 C--N 1.299 -1.629 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 178.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.51 HD22 HG22 ' A' ' 86' ' ' VAL . 7.5 mt -62.95 -30.52 71.63 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.014 HG23 HG11 ' A' ' 53' ' ' VAL . 18.0 t -91.17 -23.8 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.382 0 O-C-N 121.896 -0.503 . . . . 0.0 109.942 179.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -89.43 -21.29 23.09 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.388 -0.82 . . . . 0.0 109.449 179.707 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.486 ' O ' ' O ' ' A' ' 84' ' ' GLU . 3.9 t -84.59 -18.23 36.22 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.437 -0.789 . . . . 0.0 109.493 179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 1.04 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -81.34 -14.88 56.78 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.358 -0.839 . . . . 0.0 109.076 179.207 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.572 HD21 ' CD1' ' A' ' 45' ' ' LEU . 5.7 mt -90.62 -39.71 12.34 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 121.677 0.751 . . . . 0.0 109.868 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.522 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 8.1 tp10 -69.08 -51.37 39.43 Favored 'General case' 0 C--N 1.3 -1.56 0 C-N-CA 120.108 -0.637 . . . . 0.0 109.968 -179.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 178.19 -24.02 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 C-N-CA 119.261 -0.976 . . . . 0.0 112.236 179.603 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.486 ' O ' ' O ' ' A' ' 79' ' ' CYS . 3.6 mm-40 -94.11 120.15 65.9 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 120.699 -1.251 . . . . 0.0 111.66 -178.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.97 -157.49 0.05 OUTLIER 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.937 1.493 . . . . 0.0 110.131 179.244 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.652 HG13 ' HD2' ' A' ' 87' ' ' PRO . 25.5 t -118.51 147.22 41.48 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.167 -0.958 . . . . 0.0 109.549 179.922 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.652 ' HD2' HG13 ' A' ' 86' ' ' VAL . 44.6 Cg_endo -80.34 -159.9 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.889 1.468 . . . . 0.0 110.02 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -125.37 12.58 8.16 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.359 -0.838 . . . . 0.0 111.341 -179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.478 ' O ' ' O ' ' A' ' 90' ' ' LEU . 22.9 t -165.15 23.1 0.05 Allowed 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 118.564 -1.254 . . . . 0.0 111.595 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.791 HD23 HD21 ' A' ' 94' ' ' LEU . 0.7 OUTLIER 55.55 115.21 0.01 OUTLIER Pre-proline 0 C--N 1.281 -2.393 0 C-N-CA 120.151 -0.62 . . . . 0.0 111.379 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.722 ' HG2' HD23 ' A' ' 94' ' ' LEU . 41.8 Cg_endo -69.9 157.36 60.37 Favored 'Trans proline' 0 C--N 1.302 -1.878 0 O-C-N 123.714 1.376 . . . . 0.0 109.563 178.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -71.5 -1.43 9.74 Favored 'Trans proline' 0 C--N 1.301 -1.959 0 O-C-N 124.029 1.542 . . . . 0.0 111.208 -179.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -84.35 0.42 49.35 Favored 'General case' 0 C--N 1.297 -1.695 0 O-C-N 121.355 -0.841 . . . . 0.0 110.0 -179.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.04 HD11 HG13 ' A' ' 72' ' ' VAL . 0.2 OUTLIER -150.68 38.5 0.69 Allowed 'General case' 0 C--N 1.304 -1.385 0 C-N-CA 118.891 -1.124 . . . . 0.0 111.558 179.958 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 77.1 t -121.34 133.27 24.16 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.008 -1.058 . . . . 0.0 110.21 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -73.42 171.7 17.16 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 124.043 1.549 . . . . 0.0 110.548 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.538 ' O ' ' CB ' ' A' ' 98' ' ' SER . 45.3 Cg_endo -71.91 -169.49 0.45 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.011 1.532 . . . . 0.0 110.244 179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.538 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.9 OUTLIER 76.21 -42.42 0.44 Allowed 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.495 -0.753 . . . . 0.0 110.489 -179.323 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.11 6.34 36.83 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.092 -1.005 . . . . 0.0 108.491 178.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.462 ' HD2' ' HA ' ' A' ' 97' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.437 0 O-C-N 121.432 -0.792 . . . . 0.0 110.442 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 8.3 p . . . . . 0 N--CA 1.492 1.657 0 CA-C-O 121.283 0.563 . . . . 0.0 110.243 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.503 ' O ' ' CE2' ' A' ' 54' ' ' TRP . 35.7 p -86.74 -28.29 23.14 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.948 . . . . 0.0 110.153 179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.548 ' CG ' HD23 ' B' ' 112' ' ' LEU . 1.1 t-20 -114.43 115.59 44.53 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.132 -179.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.505 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.5 Cg_endo -82.51 21.15 1.02 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.87 1.458 . . . . 0.0 111.056 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.916 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 78.8 m-85 -130.78 17.03 5.23 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.954 -1.092 . . . . 0.0 110.071 179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.548 HD23 ' CG ' ' B' ' 109' ' ' ASN . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.592 0 O-C-N 120.909 -1.119 . . . . 0.0 110.102 -179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.464 -0.629 . . . . 0.0 110.464 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.609 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 14.9 t90 -47.47 125.83 8.83 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.26 -0.9 . . . . 0.0 109.678 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.734 ' HB3' HD23 ' A' ' 94' ' ' LEU . . . -41.59 -26.02 0.06 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.385 -0.822 . . . . 0.0 110.161 179.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.609 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 49.3 t -106.13 157.91 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.28 -0.887 . . . . 0.0 110.195 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.587 ' HB3' ' HD2' ' A' ' 11' ' ' PRO . 13.2 mttt -108.15 170.56 5.4 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.231 -0.918 . . . . 0.0 109.384 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.587 ' HD2' ' HB3' ' A' ' 10' ' ' LYS . 38.1 Cg_endo -66.17 -32.69 42.25 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 123.665 1.35 . . . . 0.0 109.915 179.686 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.6 mt-10 -70.07 -32.03 69.93 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.454 -0.779 . . . . 0.0 109.402 179.232 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.404 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 2.4 m-20 -77.04 -40.94 44.52 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 179.059 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.495 ' HA ' ' HB2' ' A' ' 17' ' ' TYR . 8.2 tptm -65.3 -15.87 62.97 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.681 0.753 . . . . 0.0 109.073 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -80.07 -27.44 39.32 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.819 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.496 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 1.8 mtpt -90.72 -38.11 13.27 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 106.619 -1.623 . . . . 0.0 106.619 177.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.548 ' CD1' ' N ' ' A' ' 17' ' ' TYR . 4.9 m-30 -66.18 -27.07 67.72 Favored 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 107.547 -1.279 . . . . 0.0 107.547 178.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.494 ' HB3' ' O ' ' A' ' 14' ' ' LYS . 1.1 t70 -89.42 -12.72 39.45 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 120.121 -0.631 . . . . 0.0 109.843 -179.938 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -92.06 -28.24 17.28 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.055 -1.461 . . . . 0.0 107.055 178.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.773 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.255 54.0 mt -82.91 -35.31 12.19 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 N-CA-C 107.869 -1.159 . . . . 0.0 107.869 178.136 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.738 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -70.74 -39.44 73.31 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.751 0.786 . . . . 0.0 108.949 178.873 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -87.35 -1.65 58.07 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.801 -0.562 . . . . 0.0 110.121 179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 8.5 t -87.0 -11.37 50.65 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.267 -0.896 . . . . 0.0 109.01 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.975 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.0 mt -100.45 -10.7 20.86 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.616 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 87.72 97.08 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.179 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -178.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.592 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -74.9 149.52 37.31 Favored 'Trans proline' 0 C--N 1.304 -1.809 0 O-C-N 124.308 1.688 . . . . 0.0 110.752 -178.786 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.499 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 59.6 t -118.13 108.83 25.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.664 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.499 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 25.5 t30 58.91 22.29 10.12 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.354 -0.841 . . . . 0.0 109.583 -178.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.467 ' C ' ' CD2' ' A' ' 30' ' ' PHE . . . 87.62 39.56 7.11 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.54 ' HB3' ' CE ' ' A' ' 64' ' ' MET . 90.6 m-85 -151.16 154.6 37.22 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.305 -1.115 . . . . 0.0 111.615 -179.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.975 ' CD1' HD12 ' A' ' 24' ' ' LEU . 10.8 mt -123.07 137.21 54.99 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 108.448 -0.945 . . . . 0.0 108.448 177.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.494 ' CA ' ' SD ' ' A' ' 64' ' ' MET . 1.3 p -91.62 147.32 23.09 Favored 'General case' 0 C--N 1.289 -2.022 0 O-C-N 120.954 -1.091 . . . . 0.0 110.404 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.455 ' C ' ' O ' ' A' ' 32' ' ' SER . . . -41.72 -27.93 0.37 Allowed Glycine 0 N--CA 1.492 2.415 0 N-CA-C 108.712 -1.755 . . . . 0.0 108.712 179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' HB3' ' OG ' ' A' ' 32' ' ' SER . 13.3 t70 -62.09 -25.72 67.87 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.507 -0.996 . . . . 0.0 110.411 179.49 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 28.7 mttp -101.64 -28.41 12.52 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.04 -1.037 . . . . 0.0 108.856 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.743 ' CG1' HD12 ' A' ' 65' ' ' LEU . 91.6 t -83.81 -48.47 17.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.487 -0.758 . . . . 0.0 110.755 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.59 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 4.5 ttpp -41.53 -51.26 8.96 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.182 -0.949 . . . . 0.0 110.852 -179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.578 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.8 Cg_endo -67.83 -32.63 29.02 Favored 'Trans proline' 0 C--N 1.31 -1.448 0 O-C-N 123.142 1.075 . . . . 0.0 109.575 179.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.541 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.2 t -66.92 -36.61 77.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.686 -0.634 . . . . 0.0 109.62 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.088 ' HB3' HD22 ' A' ' 50' ' ' LEU . 58.0 mt -82.33 -25.43 33.92 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.395 -0.816 . . . . 0.0 109.812 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.464 ' CD1' ' HG2' ' A' ' 37' ' ' LYS . 39.4 mt -74.51 -11.56 60.25 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.36 -0.838 . . . . 0.0 109.32 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -84.12 -10.33 57.87 Favored 'General case' 0 C--N 1.304 -1.396 0 C-N-CA 119.584 -0.846 . . . . 0.0 110.078 -179.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.591 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.3 OUTLIER -81.71 8.91 8.77 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.312 -0.868 . . . . 0.0 109.732 179.622 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.404 ' CB ' ' O ' ' A' ' 43' ' ' SER . 1.3 ttmt 64.04 11.11 5.89 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.186 -0.946 . . . . 0.0 110.124 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.952 HD22 HG13 ' A' ' 49' ' ' ILE . 14.5 mt -88.84 154.14 49.99 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.333 -0.855 . . . . 0.0 110.016 179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.562 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.4 Cg_endo -75.0 172.32 16.61 Favored 'Trans proline' 0 C--N 1.302 -1.883 0 O-C-N 123.946 1.498 . . . . 0.0 109.652 179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.708 HG22 ' HD1' ' B' ' 111' ' ' PHE . 5.9 t -70.21 -5.59 5.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.422 -0.799 . . . . 0.0 109.725 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 42.7 m-20 -80.73 -33.09 35.43 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.234 -0.917 . . . . 0.0 109.386 179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.952 HG13 HD22 ' A' ' 45' ' ' LEU . 8.7 mm -81.5 -39.9 17.5 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.088 HD22 ' HB3' ' A' ' 40' ' ' LEU . 19.7 mt -70.01 -28.64 65.66 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.529 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -68.54 -24.45 75.21 Favored Glycine 0 N--CA 1.485 1.947 0 N-CA-C 107.539 -2.224 . . . . 0.0 107.539 178.737 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 1.003 ' O ' HD12 ' A' ' 56' ' ' LEU . 7.9 ttm-85 -101.99 -33.99 9.52 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.905 -0.762 . . . . 0.0 110.888 179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 1.107 HG11 ' CG2' ' A' ' 77' ' ' VAL . 22.7 t -67.84 -36.22 75.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.846 -1.159 . . . . 0.0 109.264 -179.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.568 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.1 t-105 -68.32 -49.88 57.25 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 119.281 -0.967 . . . . 0.0 109.435 178.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.5 mt-10 -56.01 -56.33 22.1 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.271 -0.893 . . . . 0.0 110.466 -178.504 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.003 HD12 ' O ' ' A' ' 52' ' ' ARG . 2.6 mt -59.38 -15.67 18.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.101 -1.0 . . . . 0.0 108.54 178.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.867 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 28.5 t -94.22 -30.99 14.3 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.562 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -85.42 98.22 10.45 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.692 -0.63 . . . . 0.0 110.08 179.785 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.516 HD12 ' HG2' ' A' ' 69' ' ' GLU . 3.3 mt -96.15 -21.23 5.56 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.237 -0.914 . . . . 0.0 110.917 -179.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.533 ' OD1' ' N ' ' A' ' 62' ' ' ASP . 3.2 p30 -95.28 -13.98 24.38 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.977 -1.077 . . . . 0.0 110.234 179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 60' ' ' ASP . 24.1 m170 61.4 44.4 9.53 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.415 -0.803 . . . . 0.0 110.787 179.452 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.533 ' N ' ' OD1' ' A' ' 60' ' ' ASP . 20.8 p-10 -106.83 18.56 21.68 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.442 -0.786 . . . . 0.0 109.135 179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.542 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 61.49 30.42 74.4 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.091 -1.604 . . . . 0.0 109.091 -179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.542 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 3.3 mmm -148.97 161.07 42.65 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.327 -1.102 . . . . 0.0 109.255 179.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.743 HD12 ' CG1' ' A' ' 36' ' ' VAL . 8.9 mt -111.86 107.81 16.98 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.852 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.569 ' OD1' ' N ' ' A' ' 66' ' ' ASP . 0.3 OUTLIER -68.21 148.99 50.08 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.153 -0.967 . . . . 0.0 109.131 179.932 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.509 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -39.57 -37.82 0.53 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.381 -0.824 . . . . 0.0 110.259 -179.897 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.417 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 0.4 OUTLIER -77.37 -36.62 53.46 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.391 -0.818 . . . . 0.0 109.264 179.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.554 ' HB2' ' N ' ' A' ' 66' ' ' ASP . 85.9 mt-10 -73.04 -51.21 19.01 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.866 ' CD2' HD12 ' A' ' 31' ' ' LEU . 27.2 t80 -50.0 -25.94 3.82 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.903 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.522 ' HA ' ' HB3' ' A' ' 17' ' ' TYR . . . -69.74 -54.58 13.06 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.178 -0.951 . . . . 0.0 110.071 179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.58 HG13 HD22 ' A' ' 94' ' ' LEU . 52.4 t -53.65 -22.65 6.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 O-C-N 121.507 -0.746 . . . . 0.0 109.85 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.867 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.24 -14.78 35.15 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.275 -0.89 . . . . 0.0 111.937 -178.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.539 ' SD ' ' CE1' ' A' ' 70' ' ' PHE . 7.3 mmm -81.77 -41.07 21.71 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.411 -1.431 . . . . 0.0 110.491 -179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.654 ' CZ ' ' CD2' ' A' ' 94' ' ' LEU . 3.4 p90 -76.79 -25.52 53.41 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.085 -1.046 . . . . 0.0 108.297 178.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.957 HD22 HG13 ' A' ' 86' ' ' VAL . 5.9 mt -72.35 -27.49 62.44 Favored 'General case' 0 N--CA 1.491 1.575 0 CA-C-O 121.514 0.673 . . . . 0.0 109.267 178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.107 ' CG2' HG11 ' A' ' 53' ' ' VAL . 33.3 t -91.59 -21.84 6.29 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.658 -0.652 . . . . 0.0 110.524 179.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -89.76 -22.08 22.34 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.322 -0.861 . . . . 0.0 109.473 179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.464 ' O ' ' O ' ' A' ' 84' ' ' GLU . 26.7 m -83.74 -17.4 41.37 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.473 -0.767 . . . . 0.0 109.481 179.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.917 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -86.11 -9.97 55.71 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.385 -0.822 . . . . 0.0 109.015 179.03 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.9 mt -90.86 -42.0 10.87 Favored 'General case' 0 N--CA 1.489 1.505 0 CA-C-O 121.685 0.755 . . . . 0.0 109.699 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.432 ' OE2' ' O ' ' A' ' 82' ' ' GLU . 6.3 tp10 -69.67 -51.95 30.07 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.64 -0.663 . . . . 0.0 109.856 -179.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.464 ' O ' ' HD3' ' A' ' 85' ' ' PRO . 0.0 OUTLIER 177.4 -26.58 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.186 -0.946 . . . . 0.0 111.441 179.9 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.464 ' O ' ' O ' ' A' ' 79' ' ' CYS . 4.6 tt0 -76.64 110.65 12.26 Favored Pre-proline 0 N--CA 1.493 1.705 0 O-C-N 121.092 -1.005 . . . . 0.0 111.017 -178.705 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 40.5 Cg_endo -67.18 -176.48 0.82 Allowed 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.946 1.498 . . . . 0.0 109.997 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.957 HG13 HD22 ' A' ' 76' ' ' LEU . 12.1 t -133.06 121.74 16.98 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 120.985 -1.072 . . . . 0.0 111.345 -179.094 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.596 ' O ' HD11 ' A' ' 56' ' ' LEU . 55.0 Cg_endo -84.8 -170.43 0.79 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 124.041 1.548 . . . . 0.0 109.564 178.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.699 ' C ' HD21 ' A' ' 56' ' ' LEU . 5.1 mtm -106.31 15.78 25.68 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.985 -1.072 . . . . 0.0 110.164 179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.585 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 1.9 m -100.08 115.01 28.78 Favored 'General case' 0 C--N 1.298 -1.673 0 C-N-CA 118.717 -1.193 . . . . 0.0 111.118 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.755 ' C ' HD12 ' A' ' 90' ' ' LEU . 0.1 OUTLIER -99.89 87.93 0.79 Allowed Pre-proline 0 C--N 1.295 -1.763 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.901 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.818 ' HG2' HD12 ' A' ' 94' ' ' LEU . 38.2 Cg_endo -63.81 165.36 18.8 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 121.296 1.33 . . . . 0.0 111.48 -179.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.94 -10.38 27.51 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.241 1.653 . . . . 0.0 110.813 -179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.54 -8.0 52.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.24 -0.912 . . . . 0.0 108.64 179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.818 HD12 ' HG2' ' A' ' 91' ' ' PRO . 4.3 mt -114.89 2.59 14.35 Favored 'General case' 0 C--N 1.306 -1.309 0 O-C-N 121.632 -0.668 . . . . 0.0 110.024 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 82.5 t -99.89 123.47 47.28 Favored Pre-proline 0 C--N 1.302 -1.46 0 O-C-N 121.391 -0.818 . . . . 0.0 110.696 -179.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.493 ' HG2' ' HG3' ' A' ' 99' ' ' LYS . 42.6 Cg_endo -68.92 167.25 23.83 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.958 1.504 . . . . 0.0 109.641 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.486 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 43.6 Cg_endo -71.32 -2.18 10.82 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.651 1.343 . . . . 0.0 110.755 -179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 5.7 p -102.48 -20.54 14.48 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.106 -0.996 . . . . 0.0 109.212 178.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.509 ' HB3' HG21 ' A' ' 59' ' ' ILE . 0.1 OUTLIER -100.5 6.96 44.39 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.567 -0.708 . . . . 0.0 109.224 178.881 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.486 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 6.8 ptp180 . . . . . 0 N--CA 1.494 1.76 0 O-C-N 121.082 -1.011 . . . . 0.0 110.655 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . 0.409 ' O ' ' C ' ' B' ' 108' ' ' THR . 34.1 p . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 121.201 0.524 . . . . 0.0 110.357 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . 0.409 ' C ' ' O ' ' B' ' 107' ' ' SER . 7.3 p 41.93 38.82 1.11 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 0.0 110.098 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.504 ' OD1' ' HA2' ' A' ' 51' ' ' GLY . 24.6 t-20 -90.13 133.08 34.2 Favored Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.366 -0.834 . . . . 0.0 110.162 -179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -80.63 27.62 0.56 Allowed 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.891 1.469 . . . . 0.0 111.869 -179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.708 ' HD1' HG22 ' A' ' 47' ' ' VAL . 62.6 m-85 -142.19 -56.97 0.45 Allowed 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.726 -1.234 . . . . 0.0 110.33 179.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 1.7 mt . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 118.012 -0.994 . . . . 0.0 110.291 -179.798 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo . . . . . 0 N--CA 1.482 0.843 0 N-CA-C 110.289 -0.696 . . . . 0.0 110.289 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.627 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 12.0 t90 -95.21 117.03 29.54 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.303 -0.873 . . . . 0.0 110.094 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.715 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -42.2 -28.56 0.2 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.245 -0.91 . . . . 0.0 110.463 -179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.66 HG13 ' HE2' ' A' ' 17' ' ' TYR . 22.9 t -96.02 112.14 27.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 O-C-N 121.404 -0.81 . . . . 0.0 110.601 -179.084 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.551 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -88.28 -177.53 0.87 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.406 -0.809 . . . . 0.0 109.955 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.551 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.8 Cg_endo -70.12 -37.44 8.31 Favored 'Trans proline' 0 C--N 1.308 -1.557 0 O-C-N 123.748 1.394 . . . . 0.0 109.789 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.442 ' HG3' ' N ' ' A' ' 13' ' ' ASP . 1.7 pt-20 -70.94 -30.22 66.46 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.234 -0.916 . . . . 0.0 109.576 179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.442 ' N ' ' HG3' ' A' ' 12' ' ' GLU . 5.8 m-20 -77.89 -42.44 33.31 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.686 ' CE ' ' HB2' ' A' ' 71' ' ' ALA . 0.0 OUTLIER -65.38 -33.82 76.85 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 178.28 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -51.18 -46.48 62.13 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.622 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.4 OUTLIER -72.31 -26.97 62.16 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.125 -1.065 . . . . 0.0 108.125 178.368 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.66 ' HE2' HG13 ' A' ' 9' ' ' VAL . 10.0 m-30 -74.03 -36.31 64.4 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-O 121.756 0.789 . . . . 0.0 109.147 178.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.485 ' N ' ' O ' ' A' ' 14' ' ' LYS . 5.9 t70 -74.69 -9.1 58.24 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.796 -0.565 . . . . 0.0 110.618 -179.492 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -94.75 -32.26 13.4 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.668 HG22 ' CZ ' ' A' ' 70' ' ' PHE . 72.5 mt -80.06 -31.46 13.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 N-CA-C 107.718 -1.215 . . . . 0.0 107.718 178.182 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.761 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.2 OUTLIER -72.9 -41.96 64.08 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 178.523 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.531 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 8.7 t70 -86.46 3.33 44.38 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.62 -0.675 . . . . 0.0 110.069 179.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.56 -7.49 50.12 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.313 -0.867 . . . . 0.0 109.182 179.218 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.072 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.2 mt -106.34 -8.85 17.03 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 109.184 -0.673 . . . . 0.0 109.184 179.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.593 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.3 m 83.06 92.2 0.04 OUTLIER Pre-proline 0 N--CA 1.5 2.055 0 N-CA-C 109.255 -0.646 . . . . 0.0 109.255 -178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.551 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 45.7 Cg_endo -72.76 151.09 51.16 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.303 1.686 . . . . 0.0 111.134 -179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.509 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 75.3 t -122.52 104.69 14.99 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.509 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 0.2 OUTLIER 67.66 22.61 8.97 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.387 -0.821 . . . . 0.0 108.962 -178.316 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.433 ' O ' ' CB ' ' A' ' 66' ' ' ASP . . . 83.84 37.84 11.17 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.109 -1.596 . . . . 0.0 109.109 -179.717 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.585 ' CD1' ' HB3' ' A' ' 66' ' ' ASP . 82.6 m-85 -148.7 147.27 28.69 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.3 -1.118 . . . . 0.0 111.513 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.072 ' CD1' HD12 ' A' ' 24' ' ' LEU . 15.5 mt -114.59 132.84 56.21 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 177.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.0 p -76.72 144.39 39.35 Favored 'General case' 0 C--N 1.288 -2.108 0 C-N-CA 119.018 -1.073 . . . . 0.0 109.815 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -41.56 -27.09 0.28 Allowed Glycine 0 N--CA 1.49 2.293 0 N-CA-C 108.915 -1.674 . . . . 0.0 108.915 179.624 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 32' ' ' SER . 13.9 t70 -66.41 -28.15 68.4 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.512 -0.993 . . . . 0.0 110.477 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.443 ' N ' ' O ' ' A' ' 32' ' ' SER . 22.5 mttp -90.84 -35.74 14.62 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 120.996 -1.065 . . . . 0.0 108.223 178.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.812 HG11 HD12 ' A' ' 65' ' ' LEU . 94.9 t -77.66 -45.11 28.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 C-N-CA 119.787 -0.765 . . . . 0.0 109.625 178.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.671 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 2.9 tttt -37.84 -54.63 2.35 Favored Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.708 -0.62 . . . . 0.0 110.951 -179.415 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.618 ' HA ' HD12 ' A' ' 41' ' ' LEU . 39.8 Cg_endo -67.05 -34.68 28.01 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.495 1.261 . . . . 0.0 110.028 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.678 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 2.1 t -61.99 -27.01 41.56 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 121.49 -0.756 . . . . 0.0 110.117 179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.092 ' HB3' HD22 ' A' ' 50' ' ' LEU . 24.1 mt -94.16 -29.03 15.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.205 -0.934 . . . . 0.0 110.873 -178.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.662 HD11 ' HG3' ' A' ' 37' ' ' LYS . 8.8 mt -74.84 -15.28 60.74 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.92 -1.112 . . . . 0.0 108.96 179.134 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -79.11 -13.57 59.66 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.637 -0.825 . . . . 0.0 109.944 -179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.581 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 27.4 p -82.87 11.7 5.75 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.418 -0.801 . . . . 0.0 110.326 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 61.8 12.21 4.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.174 -0.954 . . . . 0.0 110.31 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' A' ' 80' ' ' ALA . 16.0 mt -87.04 155.66 55.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.55 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 45.7 Cg_endo -77.4 168.95 22.03 Favored 'Trans proline' 0 C--N 1.301 -1.939 0 O-C-N 124.026 1.54 . . . . 0.0 109.548 179.167 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -69.77 -4.34 3.87 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.453 0 O-C-N 121.234 -0.916 . . . . 0.0 109.538 179.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -80.1 -30.74 39.2 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.311 -0.868 . . . . 0.0 109.103 179.608 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.795 HG13 HD22 ' A' ' 45' ' ' LEU . 11.4 mm -85.35 -36.99 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.319 0 CA-C-O 121.882 0.848 . . . . 0.0 108.884 178.731 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.092 HD22 ' HB3' ' A' ' 40' ' ' LEU . 15.7 mt -77.31 -26.17 51.98 Favored 'General case' 0 C--N 1.296 -1.724 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.572 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -70.16 -26.91 73.62 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 107.015 -2.434 . . . . 0.0 107.015 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 1.026 ' CZ ' HD11 ' A' ' 56' ' ' LEU . 0.2 OUTLIER -101.96 -36.93 8.44 Favored 'General case' 0 C--N 1.3 -1.582 0 O-C-N 122.039 -0.683 . . . . 0.0 110.566 179.412 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 49' ' ' ILE . 6.8 t -59.73 -41.44 85.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 O-C-N 121.044 -1.035 . . . . 0.0 110.128 -178.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' O ' ' N ' ' A' ' 58' ' ' ASP . 2.6 t-105 -66.98 -51.64 52.59 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.929 -1.107 . . . . 0.0 109.716 179.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.489 ' N ' ' CD1' ' A' ' 54' ' ' TRP . 5.6 mt-10 -52.3 -59.92 3.83 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.41 -0.806 . . . . 0.0 110.481 -177.853 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 1.026 HD11 ' CZ ' ' A' ' 52' ' ' ARG . 1.2 mt -59.95 -30.14 68.88 Favored 'General case' 0 C--N 1.297 -1.68 0 C-N-CA 119.166 -1.014 . . . . 0.0 108.751 179.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.971 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 44.3 t -75.29 -29.76 60.19 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.327 -0.858 . . . . 0.0 108.809 178.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.563 ' N ' ' O ' ' A' ' 54' ' ' TRP . 0.8 OUTLIER -70.42 62.41 0.24 Allowed 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.578 -0.701 . . . . 0.0 109.54 179.641 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.518 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 43.4 mm -43.21 -33.24 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 O-C-N 121.362 -0.836 . . . . 0.0 109.992 -179.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.443 ' OD2' ' OE2' ' A' ' 69' ' ' GLU . 1.6 m-20 -99.85 -20.7 16.05 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.244 -0.91 . . . . 0.0 110.263 -179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.525 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 44.3 m-70 59.33 38.47 23.05 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.254 -0.903 . . . . 0.0 110.244 -179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -97.6 -1.34 44.03 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.25 -0.906 . . . . 0.0 110.487 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.482 ' C ' ' CG ' ' A' ' 64' ' ' MET . . . 99.1 20.74 17.33 Favored Glycine 0 N--CA 1.492 2.43 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.586 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 8.6 mtp -153.26 161.3 42.54 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.302 -1.116 . . . . 0.0 110.593 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.812 HD12 HG11 ' A' ' 36' ' ' VAL . 12.6 mt -118.98 107.07 13.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.336 -0.853 . . . . 0.0 109.517 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.585 ' HB3' ' CD1' ' A' ' 30' ' ' PHE . 1.5 p30 -75.15 160.67 30.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.886 -1.134 . . . . 0.0 109.706 179.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.606 ' N ' ' CE2' ' A' ' 21' ' ' PHE . 2.2 ppt_? -36.88 -46.33 0.62 Allowed 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.671 -0.643 . . . . 0.0 111.741 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.466 ' O ' ' HB3' ' A' ' 71' ' ' ALA . 1.7 t70 -72.75 -38.87 67.22 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.096 -1.002 . . . . 0.0 110.268 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.518 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 50.7 mt-10 -71.33 -46.63 60.16 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.341 -0.849 . . . . 0.0 108.791 179.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.96 ' CD2' HD12 ' A' ' 31' ' ' LEU . 26.7 t80 -59.03 -18.6 36.13 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 178.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.686 ' HB2' ' CE ' ' A' ' 14' ' ' LYS . . . -76.01 -50.57 14.47 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.768 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.545 ' O ' HD12 ' A' ' 76' ' ' LEU . 55.1 t -59.89 -24.21 28.94 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.586 -0.696 . . . . 0.0 109.679 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.971 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.36 -4.99 56.72 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.289 -0.882 . . . . 0.0 110.877 -179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.578 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 10.5 mmt -84.44 -46.21 11.91 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.031 -1.043 . . . . 0.0 109.47 179.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.175 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 2.1 p90 -76.01 -29.36 58.12 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.545 HD12 ' O ' ' A' ' 72' ' ' VAL . 4.5 mt -60.42 -27.8 67.76 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 177.202 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.691 HG23 ' O ' ' A' ' 73' ' ' ALA . 77.2 t -92.55 -41.89 13.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.375 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.624 179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -75.39 -29.22 59.77 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.355 -0.841 . . . . 0.0 110.583 -179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.531 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 82.6 m -80.83 -11.82 59.53 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.231 -0.918 . . . . 0.0 109.591 179.868 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.799 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -84.96 -17.37 37.87 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.247 -0.908 . . . . 0.0 108.554 178.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.677 HD23 ' N ' ' A' ' 81' ' ' LEU . 0.9 OUTLIER -91.19 -39.36 12.16 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-O 121.891 0.853 . . . . 0.0 109.169 179.555 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.521 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.1 OUTLIER -69.91 -53.93 15.7 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.854 -0.529 . . . . 0.0 110.076 -179.836 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.521 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 178.93 -25.38 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 119.753 -0.779 . . . . 0.0 111.57 -179.995 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 0.8 OUTLIER -77.63 110.62 13.37 Favored Pre-proline 0 N--CA 1.496 1.849 0 O-C-N 121.112 -0.992 . . . . 0.0 110.825 -178.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' A' ' 83' ' ' LYS . 48.9 Cg_endo -75.79 -167.34 0.43 Allowed 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.818 1.431 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.552 HG21 HG23 ' A' ' 49' ' ' ILE . 60.2 t -109.47 144.53 30.01 Favored Pre-proline 0 C--N 1.303 -1.454 0 O-C-N 121.224 -0.922 . . . . 0.0 109.424 179.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HG3' ' HD3' ' A' ' 91' ' ' PRO . 45.8 Cg_endo -84.95 -155.58 0.06 OUTLIER 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.994 1.523 . . . . 0.0 110.552 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 52' ' ' ARG . 20.8 mtp -124.24 3.01 8.54 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.282 -0.886 . . . . 0.0 111.334 -179.563 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.503 ' N ' HH22 ' A' ' 52' ' ' ARG . 1.9 t -163.62 26.11 0.08 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.718 -1.239 . . . . 0.0 110.81 179.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.653 HD22 HG13 ' A' ' 95' ' ' VAL . 0.4 OUTLIER 52.42 113.96 0.01 OUTLIER Pre-proline 0 C--N 1.286 -2.174 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.722 178.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.866 ' HD2' HD12 ' A' ' 94' ' ' LEU . 47.0 Cg_endo -71.7 175.04 10.16 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.685 1.36 . . . . 0.0 109.348 178.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HA ' ' CG2' ' A' ' 95' ' ' VAL . 52.8 Cg_endo -81.1 -7.29 13.11 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 123.839 1.442 . . . . 0.0 111.96 -179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.722 ' O ' HD23 ' A' ' 94' ' ' LEU . . . -84.83 12.6 7.08 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 120.887 -1.133 . . . . 0.0 109.126 179.288 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.175 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 39.1 mt -133.41 -24.83 1.77 Allowed 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.513 -0.742 . . . . 0.0 111.244 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.653 HG13 HD22 ' A' ' 90' ' ' LEU . 4.6 m -93.67 148.86 36.16 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 120.977 -1.077 . . . . 0.0 110.425 -179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.505 ' O ' ' HB3' ' A' ' 100' ' ' ARG . 43.9 Cg_endo -69.75 171.51 14.32 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.247 1.656 . . . . 0.0 110.358 -179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.579 ' HA ' ' HB3' ' A' ' 100' ' ' ARG . 46.5 Cg_endo -72.63 -14.23 27.34 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.108 1.583 . . . . 0.0 110.971 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.439 ' OG ' ' N ' ' A' ' 99' ' ' LYS . 1.0 OUTLIER -74.65 -54.3 7.69 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.999 -1.063 . . . . 0.0 110.022 -179.866 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.439 ' N ' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -89.32 18.12 5.48 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.371 -0.831 . . . . 0.0 108.789 178.663 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.579 ' HB3' ' HA ' ' A' ' 97' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.543 0 O-C-N 121.618 -0.676 . . . . 0.0 110.314 -179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 42.5 t . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 121.262 0.553 . . . . 0.0 110.236 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 39.9 p -94.33 27.47 2.91 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.997 . . . . 0.0 110.214 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.515 ' ND2' ' HB3' ' A' ' 54' ' ' TRP . 18.2 t-20 -60.42 137.77 92.21 Favored Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.341 -0.849 . . . . 0.0 110.395 -179.83 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.598 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 46.9 Cg_endo -76.19 -29.36 6.49 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.096 1.577 . . . . 0.0 111.207 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 1.034 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 40.3 m-85 -80.9 -35.85 31.97 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.018 -1.051 . . . . 0.0 110.7 -179.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.512 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.749 0 O-C-N 121.047 -1.033 . . . . 0.0 110.149 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo . . . . . 0 N--CA 1.485 1.021 0 N-CA-C 110.766 -0.513 . . . . 0.0 110.766 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.816 ' HE1' HD22 ' A' ' 94' ' ' LEU . 13.2 t90 -64.19 126.8 28.91 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.423 -0.798 . . . . 0.0 109.666 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.539 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -41.12 -28.48 0.09 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.37 -0.831 . . . . 0.0 110.145 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.473 ' HB ' ' CE2' ' A' ' 7' ' ' TRP . 39.8 t -99.46 127.37 52.3 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.496 0 C-N-CA 119.792 -0.763 . . . . 0.0 109.602 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.523 ' CD ' ' HD2' ' A' ' 11' ' ' PRO . 0.0 OUTLIER -83.79 175.35 4.79 Favored Pre-proline 0 C--N 1.302 -1.484 0 O-C-N 121.263 -0.898 . . . . 0.0 110.05 -179.575 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.523 ' HD2' ' CD ' ' A' ' 10' ' ' LYS . 39.8 Cg_endo -67.71 -34.91 23.48 Favored 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.885 1.466 . . . . 0.0 109.412 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -74.09 -28.11 61.21 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.482 -0.761 . . . . 0.0 109.437 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 0.3 OUTLIER -82.21 -38.86 23.94 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.571 ' HG3' ' CZ3' ' A' ' 7' ' ' TRP . 8.2 tttt -70.43 -18.46 63.01 Favored 'General case' 0 C--N 1.303 -1.453 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.42 -44.93 61.75 Favored 'General case' 0 N--CA 1.486 1.369 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 179.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.637 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 5.1 ptmm? -73.66 -18.24 61.05 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 178.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.637 ' CD1' ' HG2' ' A' ' 16' ' ' LYS . 9.4 m-30 -83.33 -28.6 28.91 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 14' ' ' LYS . 0.4 OUTLIER -84.98 -9.68 57.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.695 -0.628 . . . . 0.0 110.452 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -91.82 -31.73 15.62 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 178.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.253 95.5 mt -80.82 -37.6 16.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 177.942 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.772 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -66.27 -33.89 76.77 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.885 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.52 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 0.6 OUTLIER -90.0 -6.44 55.6 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.638 -0.664 . . . . 0.0 109.806 179.518 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 29.7 t -83.46 -9.77 58.79 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 108.93 178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.819 HD12 ' CD1' ' A' ' 31' ' ' LEU . 2.7 mt -104.69 -11.53 16.83 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.594 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 1.4 m 84.37 99.59 0.03 OUTLIER Pre-proline 0 N--CA 1.503 2.201 0 CA-C-N 115.991 -0.55 . . . . 0.0 110.017 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.623 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 50.3 Cg_endo -76.06 152.37 35.85 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.149 1.605 . . . . 0.0 110.727 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.492 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 51.0 t -121.52 106.65 18.59 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.541 -0.725 . . . . 0.0 109.088 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.492 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 3.4 t30 60.62 17.58 7.6 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.296 -0.877 . . . . 0.0 109.306 -178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.447 ' O ' ' OD2' ' A' ' 66' ' ' ASP . . . 95.43 36.02 5.52 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.583 ' CE1' ' OD2' ' A' ' 66' ' ' ASP . 81.8 m-85 -150.38 144.42 25.45 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.255 -1.144 . . . . 0.0 111.964 -179.567 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.822 HD12 ' CD1' ' A' ' 70' ' ' PHE . 8.6 mt -109.07 143.33 38.54 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.533 -1.284 . . . . 0.0 107.533 177.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.458 ' HA ' ' SD ' ' A' ' 64' ' ' MET . 60.3 p -92.01 144.6 25.28 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 118.9 -1.12 . . . . 0.0 110.293 -179.649 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 37' ' ' LYS . . . -42.9 -26.21 0.43 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.12 -1.592 . . . . 0.0 109.12 -179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.448 ' N ' ' O ' ' A' ' 32' ' ' SER . 0.8 OUTLIER -69.8 -23.85 63.39 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.603 -0.939 . . . . 0.0 110.383 179.712 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.492 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 12.9 mttp -93.69 -35.01 13.03 Favored 'General case' 0 C--N 1.305 -1.351 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 179.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.788 HG12 HD11 ' A' ' 40' ' ' LEU . 95.7 t -75.94 -39.56 37.47 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.774 -0.77 . . . . 0.0 109.967 178.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.571 ' O ' HD12 ' A' ' 41' ' ' LEU . 0.0 OUTLIER -39.82 -56.65 3.0 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.233 -0.917 . . . . 0.0 110.95 -179.277 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 38.3 Cg_endo -65.92 -32.85 44.29 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.675 1.355 . . . . 0.0 109.696 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.882 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.6 t -65.18 -30.04 49.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.512 0 O-C-N 121.686 -0.634 . . . . 0.0 109.921 179.238 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 1.059 HD12 ' CZ ' ' B' ' 111' ' ' PHE . 22.5 mt -93.05 -36.24 12.81 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.135 -0.978 . . . . 0.0 110.501 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.571 HD12 ' O ' ' A' ' 37' ' ' LYS . 6.6 mt -70.88 -14.18 62.3 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.281 -0.887 . . . . 0.0 109.109 179.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 38' ' ' PRO . 0.6 OUTLIER -78.81 -13.93 59.54 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.205 -0.998 . . . . 0.0 109.459 179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.715 ' HB3' HD11 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -79.18 6.15 10.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.648 -0.658 . . . . 0.0 110.263 179.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.449 ' CB ' ' O ' ' A' ' 43' ' ' SER . 2.2 ttpt 67.39 15.7 9.93 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.273 -0.892 . . . . 0.0 109.864 -179.539 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.973 HD22 HG13 ' A' ' 49' ' ' ILE . 16.1 mt -96.7 154.38 38.43 Favored Pre-proline 0 N--CA 1.491 1.596 0 O-C-N 121.335 -0.853 . . . . 0.0 110.246 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.578 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 48.7 Cg_endo -76.6 178.92 6.96 Favored 'Trans proline' 0 C--N 1.299 -2.039 0 O-C-N 124.297 1.683 . . . . 0.0 109.957 179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.573 HG13 ' HB3' ' B' ' 111' ' ' PHE . 1.7 t -75.35 -1.96 3.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.228 -0.92 . . . . 0.0 109.437 179.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' OD1' HD13 ' A' ' 49' ' ' ILE . 1.0 OUTLIER -84.44 -32.84 23.85 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 121.231 -0.918 . . . . 0.0 109.326 -179.968 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.973 HG13 HD22 ' A' ' 45' ' ' LEU . 8.2 mm -84.85 -35.77 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 CA-C-O 121.989 0.9 . . . . 0.0 108.735 178.834 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 1.057 HD22 ' HB3' ' A' ' 40' ' ' LEU . 25.3 mt -79.76 -23.37 42.25 Favored 'General case' 0 C--N 1.298 -1.664 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.618 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.07 -24.78 75.12 Favored Glycine 0 N--CA 1.487 2.05 0 N-CA-C 107.586 -2.206 . . . . 0.0 107.586 178.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.933 ' O ' HD12 ' A' ' 56' ' ' LEU . 1.0 OUTLIER -101.28 -30.55 11.45 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.85 -0.794 . . . . 0.0 110.087 179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.946 HG11 HG23 ' A' ' 77' ' ' VAL . 24.6 t -69.25 -38.47 77.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 118.857 -1.137 . . . . 0.0 109.228 179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.583 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.8 t-105 -65.93 -50.79 63.18 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 118.957 -1.097 . . . . 0.0 109.08 178.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.482 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 7.7 mt-10 -56.84 -57.45 12.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.292 -178.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.933 HD12 ' O ' ' A' ' 52' ' ' ARG . 4.5 mt -59.87 -15.13 18.87 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 109.042 178.806 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.961 ' OG ' ' HB2' ' A' ' 73' ' ' ALA . 30.3 t -94.78 -36.76 11.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.516 -0.74 . . . . 0.0 109.941 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.583 ' OD1' ' CE2' ' A' ' 54' ' ' TRP . 0.1 OUTLIER -74.65 89.75 2.25 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.513 -0.742 . . . . 0.0 111.01 -179.061 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.901 HG23 ' HG3' ' A' ' 99' ' ' LYS . 15.7 mm -60.74 -32.24 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.13 -0.981 . . . . 0.0 109.384 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.606 ' O ' ' CG ' ' A' ' 61' ' ' HIS . 0.2 OUTLIER -101.67 -11.98 18.76 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.388 -0.82 . . . . 0.0 109.693 179.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.606 ' CG ' ' O ' ' A' ' 60' ' ' ASP . 30.1 p80 40.74 40.54 0.97 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 121.424 0.63 . . . . 0.0 110.57 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -90.51 0.43 57.33 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.323 -0.86 . . . . 0.0 109.042 178.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.56 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 101.62 18.85 17.27 Favored Glycine 0 N--CA 1.485 1.953 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 -179.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.56 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.5 mmm -146.89 160.85 41.81 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.148 -1.207 . . . . 0.0 109.818 179.467 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.648 HD12 HG11 ' A' ' 36' ' ' VAL . 12.4 mt -120.05 110.3 16.5 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.222 -0.924 . . . . 0.0 110.036 179.048 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.583 ' OD2' ' CE1' ' A' ' 30' ' ' PHE . 9.1 t70 -69.38 169.56 12.12 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.116 -0.99 . . . . 0.0 110.25 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.529 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 10.4 ptm180 -51.31 -40.34 58.8 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.359 -0.838 . . . . 0.0 109.775 179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.5 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 3.1 t70 -81.11 -28.85 35.0 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.347 -0.845 . . . . 0.0 109.252 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.532 ' OE2' ' N ' ' A' ' 59' ' ' ILE . 4.8 tt0 -74.51 -44.74 49.9 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.617 0.723 . . . . 0.0 109.198 179.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.882 ' CZ ' HG11 ' A' ' 39' ' ' VAL . 44.2 t80 -62.6 -18.56 62.43 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -74.37 -49.05 24.32 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 121.938 0.875 . . . . 0.0 109.145 179.157 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.989 ' CG1' HD11 ' A' ' 94' ' ' LEU . 30.2 t -55.6 -30.75 27.23 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.607 0 CA-C-O 121.469 0.652 . . . . 0.0 110.212 179.589 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.961 ' HB2' ' OG ' ' A' ' 57' ' ' SER . . . -90.09 -4.32 57.42 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.427 -0.795 . . . . 0.0 111.759 -178.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.604 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 7.2 mmt -85.39 -44.18 13.0 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.642 -1.287 . . . . 0.0 109.984 179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.513 ' CE1' ' O ' ' A' ' 72' ' ' VAL . 6.2 p90 -79.19 -23.13 44.07 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 178.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.652 ' HB3' HG13 ' A' ' 53' ' ' VAL . 4.3 mt -72.75 -25.41 61.19 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 177.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.946 HG23 HG11 ' A' ' 53' ' ' VAL . 44.6 t -89.93 -44.75 15.07 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . 0.474 ' HA ' ' HG ' ' A' ' 81' ' ' LEU . 1.4 m-85 -69.5 -27.86 65.55 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 120.158 -0.617 . . . . 0.0 110.798 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . . . . . . . . . 50.8 t -79.04 -15.16 58.61 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.042 -1.036 . . . . 0.0 109.282 179.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.71 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -91.05 -9.61 45.19 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.243 -0.911 . . . . 0.0 109.503 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.841 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.3 mt -90.03 -34.44 15.95 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 121.71 0.767 . . . . 0.0 109.227 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.515 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 0.5 OUTLIER -68.36 -60.06 2.73 Favored 'General case' 0 C--N 1.299 -1.619 0 C-N-CA 119.556 -0.858 . . . . 0.0 109.385 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 176.73 70.27 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 119.897 -0.721 . . . . 0.0 111.352 179.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.547 ' O ' ' HA ' ' A' ' 80' ' ' ALA . 1.2 mt-10 -172.79 136.05 0.77 Allowed Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.562 -1.336 . . . . 0.0 111.392 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -77.92 -171.59 1.24 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.796 1.419 . . . . 0.0 110.189 179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.54 ' CG1' ' HB3' ' A' ' 52' ' ' ARG . 43.7 t -130.47 131.65 23.49 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.308 -0.87 . . . . 0.0 109.72 179.593 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.909 ' O ' HD11 ' A' ' 56' ' ' LEU . 50.1 Cg_endo -82.91 -168.64 0.61 Allowed 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.811 1.427 . . . . 0.0 109.449 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.767 ' C ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -119.63 13.93 12.58 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.248 -0.908 . . . . 0.0 109.625 179.407 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.684 ' N ' HD21 ' A' ' 56' ' ' LEU . 19.9 m -115.31 97.63 6.29 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.828 -1.149 . . . . 0.0 110.933 -178.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.92 HD11 HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -59.48 109.01 1.6 Allowed Pre-proline 0 C--N 1.29 -2.016 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 178.851 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.514 ' HG2' ' HB3' ' A' ' 94' ' ' LEU . 38.9 Cg_endo -65.3 150.65 87.06 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.826 1.435 . . . . 0.0 111.966 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -76.33 -10.64 19.13 Favored 'Trans proline' 0 C--N 1.309 -1.546 0 O-C-N 124.415 1.745 . . . . 0.0 111.406 -179.324 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.68 -21.3 34.96 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.107 -0.996 . . . . 0.0 108.445 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.989 HD11 ' CG1' ' A' ' 72' ' ' VAL . 0.0 OUTLIER -103.32 -5.47 22.98 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 108.743 -0.836 . . . . 0.0 108.743 179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.92 HG23 HD11 ' A' ' 90' ' ' LEU . 0.5 OUTLIER -93.01 144.6 28.65 Favored Pre-proline 0 N--CA 1.493 1.71 0 O-C-N 120.974 -1.079 . . . . 0.0 110.938 -179.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 95' ' ' VAL . 47.4 Cg_endo -75.85 174.94 11.97 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 124.24 1.653 . . . . 0.0 110.407 179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.491 ' HD2' ' HB2' ' A' ' 96' ' ' PRO . 47.4 Cg_endo -72.89 -11.04 25.42 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.966 1.509 . . . . 0.0 110.59 179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 69.8 m -77.13 -19.99 56.19 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.041 -1.037 . . . . 0.0 109.535 179.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.901 ' HG3' HG23 ' A' ' 59' ' ' ILE . 0.0 OUTLIER -88.96 2.13 54.38 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.487 -0.758 . . . . 0.0 109.531 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . . . . . . . . . 4.1 ptp180 . . . . . 0 N--CA 1.49 1.567 0 O-C-N 121.253 -0.904 . . . . 0.0 110.162 179.828 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 25.0 p . . . . . 0 N--CA 1.49 1.536 0 CA-C-O 121.231 0.539 . . . . 0.0 110.167 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 57.3 p -62.1 -69.17 0.27 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.249 -0.907 . . . . 0.0 109.971 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.508 ' HB3' ' HB2' ' B' ' 112' ' ' LEU . 20.3 t-20 -94.09 131.66 31.1 Favored Pre-proline 0 C--N 1.3 -1.547 0 O-C-N 121.481 -0.762 . . . . 0.0 110.029 179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.582 ' HG2' ' CE1' ' B' ' 111' ' ' PHE . 47.5 Cg_endo -73.8 -25.46 14.49 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.953 1.502 . . . . 0.0 110.982 -179.608 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 1.059 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 71.5 m-85 -82.35 -46.72 13.21 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 120.992 -1.067 . . . . 0.0 110.509 -179.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.508 ' HB2' ' HB3' ' B' ' 109' ' ' ASN . 0.6 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.41 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo . . . . . 0 N--CA 1.483 0.911 0 N-CA-C 110.717 -0.532 . . . . 0.0 110.717 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.496 ' CD2' ' HB ' ' A' ' 9' ' ' VAL . 12.9 t90 -51.29 130.17 26.27 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.357 -0.839 . . . . 0.0 109.663 179.597 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.563 ' CB ' ' HB2' ' A' ' 94' ' ' LEU . . . -42.04 -26.34 0.09 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.174 -0.954 . . . . 0.0 110.324 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG22 ' CD2' ' A' ' 75' ' ' PHE . 44.0 t -95.79 155.0 3.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 0.0 109.621 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -90.17 163.96 29.58 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.073 -1.017 . . . . 0.0 109.923 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.64 -30.17 23.24 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.011 1.532 . . . . 0.0 109.683 179.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.492 ' O ' ' HG3' ' A' ' 16' ' ' LYS . 2.3 mt-10 -86.68 -18.63 30.78 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 121.475 0.655 . . . . 0.0 109.462 179.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.577 ' O ' ' CD1' ' A' ' 17' ' ' TYR . 3.6 m-20 -79.94 -43.98 21.16 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.987 -0.746 . . . . 0.0 108.987 179.333 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.567 ' HD3' ' HB2' ' A' ' 71' ' ' ALA . 7.2 tptp -67.53 -31.77 72.1 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.46 -38.72 74.92 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.492 ' HG3' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -78.04 -44.54 26.17 Favored 'General case' 0 C--N 1.301 -1.535 0 N-CA-C 107.088 -1.449 . . . . 0.0 107.088 178.479 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.608 ' CD1' ' CB ' ' A' ' 74' ' ' MET . 6.2 m-30 -54.73 -24.65 23.23 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -87.3 -14.57 40.5 Favored 'General case' 0 N--CA 1.492 1.644 0 C-N-CA 119.855 -0.738 . . . . 0.0 110.527 -179.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -93.87 -29.69 15.18 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.594 HG22 ' CZ ' ' A' ' 70' ' ' PHE 0.252 51.1 mt -80.03 -32.99 14.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 N-CA-C 107.715 -1.216 . . . . 0.0 107.715 177.846 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.69 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.1 OUTLIER -67.28 -36.65 82.0 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.639 0.733 . . . . 0.0 109.204 179.212 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.517 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 3.8 t70 -90.41 -8.56 50.29 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.71 -0.619 . . . . 0.0 110.294 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.2 -13.72 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.091 -1.006 . . . . 0.0 108.867 179.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 1.003 HD12 ' CD1' ' A' ' 31' ' ' LEU . 10.9 mt -93.68 -54.53 3.6 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 179.802 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.66 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 3.9 m 137.54 96.41 0.0 OUTLIER Pre-proline 0 N--CA 1.509 2.479 0 N-CA-C 108.554 -0.906 . . . . 0.0 108.554 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.633 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.2 Cg_endo -71.45 146.59 50.4 Favored 'Trans proline' 0 C--N 1.298 -2.088 0 O-C-N 123.948 1.499 . . . . 0.0 110.541 -179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.501 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 20.8 t -116.76 97.37 5.41 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 109.225 -0.658 . . . . 0.0 109.225 179.368 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.501 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 1.5 t30 60.56 11.32 2.98 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.378 -0.826 . . . . 0.0 109.68 -178.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.445 ' O ' ' CG ' ' A' ' 66' ' ' ASP . . . 110.79 33.49 2.41 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.524 ' CZ ' ' OD2' ' A' ' 66' ' ' ASP . 82.3 m-85 -150.68 150.04 30.59 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.181 -1.188 . . . . 0.0 112.228 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 1.003 ' CD1' HD12 ' A' ' 24' ' ' LEU . 9.0 mt -117.28 136.08 53.36 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 177.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.488 ' O ' ' N ' ' A' ' 34' ' ' ASP . 91.0 p -85.2 141.32 30.23 Favored 'General case' 0 C--N 1.289 -2.063 0 C-N-CA 118.925 -1.11 . . . . 0.0 110.261 -179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.478 ' HA2' ' CZ3' ' A' ' 54' ' ' TRP . . . -40.45 -27.93 0.17 Allowed Glycine 0 N--CA 1.495 2.599 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 32' ' ' SER . 5.9 t70 -62.43 -26.61 68.59 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.443 -1.034 . . . . 0.0 110.244 179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.429 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 53.2 mttt -96.53 -31.81 12.59 Favored 'General case' 0 C--N 1.308 -1.222 0 O-C-N 121.106 -0.996 . . . . 0.0 108.481 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.741 HG11 HD12 ' A' ' 65' ' ' LEU . 99.0 t -82.36 -46.88 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 C-N-CA 119.871 -0.732 . . . . 0.0 110.208 179.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.625 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 0.1 OUTLIER -42.79 -53.74 9.53 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 121.228 -0.92 . . . . 0.0 110.75 -179.68 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.573 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 39.3 Cg_endo -65.81 -34.03 41.46 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 N-CA-C 109.288 -1.081 . . . . 0.0 109.288 179.254 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.548 ' HB ' ' HA ' ' A' ' 36' ' ' VAL . 2.3 t -66.47 -30.43 49.78 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.493 0.663 . . . . 0.0 109.54 179.205 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.997 ' HB3' HD22 ' A' ' 50' ' ' LEU . 88.4 mt -86.72 -24.45 25.16 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.439 -0.788 . . . . 0.0 110.31 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.402 ' CD1' ' HD3' ' A' ' 37' ' ' LYS . 19.4 mt -79.31 -13.57 59.56 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.305 -0.872 . . . . 0.0 109.45 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -86.54 -6.88 58.77 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.829 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.588 ' CB ' ' CG1' ' A' ' 77' ' ' VAL . 0.7 OUTLIER -84.06 12.1 6.91 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.403 -0.811 . . . . 0.0 109.934 179.851 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.475 ' HB3' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER 64.71 17.77 11.1 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.202 -0.936 . . . . 0.0 109.98 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.904 HD22 HG13 ' A' ' 49' ' ' ILE . 15.1 mt -100.38 149.78 36.38 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.446 -0.784 . . . . 0.0 110.627 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.58 ' HD2' ' CG1' ' A' ' 49' ' ' ILE . 47.8 Cg_endo -75.88 175.34 11.44 Favored 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.059 1.557 . . . . 0.0 109.97 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.79 HG22 ' HD1' ' B' ' 111' ' ' PHE . 2.4 t -72.39 -2.52 3.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.268 -0.895 . . . . 0.0 109.648 -179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -84.25 -32.11 24.62 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.25 -0.906 . . . . 0.0 109.268 179.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.904 HG13 HD22 ' A' ' 45' ' ' LEU . 8.6 mm -84.35 -36.5 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 178.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.997 HD22 ' HB3' ' A' ' 40' ' ' LEU . 20.1 mt -75.62 -27.35 58.42 Favored 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.377 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.557 ' HA2' ' HB2' ' B' ' 111' ' ' PHE . . . -73.69 -24.06 75.37 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 107.238 -2.345 . . . . 0.0 107.238 178.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.826 ' O ' HD12 ' A' ' 56' ' ' LEU . 5.7 ttm105 -101.16 -33.96 9.89 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.942 -0.74 . . . . 0.0 109.935 179.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.848 HG11 HG23 ' A' ' 77' ' ' VAL . 38.0 t -69.26 -44.29 80.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.954 -1.091 . . . . 0.0 109.418 -179.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 2.0 t-105 -60.78 -45.99 92.23 Favored 'General case' 0 C--N 1.303 -1.433 0 C-N-CA 119.092 -1.043 . . . . 0.0 109.322 179.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.499 ' HG2' ' ND2' ' B' ' 109' ' ' ASN . 4.7 mm-40 -58.41 -55.81 30.18 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.035 -1.041 . . . . 0.0 110.243 -178.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.826 HD12 ' O ' ' A' ' 52' ' ' ARG . 3.8 mt -62.36 -14.42 39.68 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.073 -1.017 . . . . 0.0 108.575 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.932 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 1.4 t -95.14 -29.52 14.51 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.701 . . . . 0.0 109.348 178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 54' ' ' TRP . 6.0 t0 -77.58 82.15 4.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.55 -0.719 . . . . 0.0 110.097 -179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.482 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 38.3 mm -57.89 -35.41 51.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.089 -179.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.473 ' O ' ' HB2' ' A' ' 61' ' ' HIS . 15.8 m-20 -96.84 -18.76 19.35 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.309 -0.869 . . . . 0.0 110.475 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.549 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 86.5 m-70 57.34 48.82 14.17 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.294 -0.879 . . . . 0.0 109.988 -179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.6 p-10 -115.58 23.89 12.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.288 -0.883 . . . . 0.0 109.798 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.47 ' C ' ' HG3' ' A' ' 64' ' ' MET . . . 72.98 27.83 67.92 Favored Glycine 0 N--CA 1.488 2.113 0 N-CA-C 109.335 -1.506 . . . . 0.0 109.335 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.524 ' HA ' ' O ' ' A' ' 31' ' ' LEU . 10.0 mtt -151.17 160.94 43.56 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.249 -1.147 . . . . 0.0 110.377 179.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.741 HD12 HG11 ' A' ' 36' ' ' VAL . 10.9 mt -125.75 110.03 13.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.248 -0.907 . . . . 0.0 109.922 178.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.524 ' OD2' ' CZ ' ' A' ' 30' ' ' PHE . 7.5 t70 -69.55 168.51 14.53 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.915 -1.116 . . . . 0.0 109.357 179.366 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.554 ' HA ' ' CD2' ' A' ' 21' ' ' PHE . 7.3 ptt180 -50.74 -39.47 52.07 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.278 -0.889 . . . . 0.0 110.523 -179.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.443 ' N ' ' CG ' ' A' ' 67' ' ' ARG . 37.7 m-20 -79.78 -33.08 40.87 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.167 -0.958 . . . . 0.0 110.228 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.502 ' HG3' ' HB3' ' A' ' 66' ' ' ASP . 33.5 mt-10 -73.53 -42.99 61.02 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.233 -0.917 . . . . 0.0 109.211 179.413 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.884 ' CD2' HD12 ' A' ' 31' ' ' LEU . 35.9 t80 -58.62 -27.38 64.65 Favored 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 108.947 -0.76 . . . . 0.0 108.947 179.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.567 ' HB2' ' HD3' ' A' ' 14' ' ' LYS . . . -66.89 -46.86 73.6 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.358 -0.839 . . . . 0.0 110.092 179.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.946 HG13 HD11 ' A' ' 94' ' ' LEU . 61.6 t -58.62 -25.67 29.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-O 121.611 0.72 . . . . 0.0 109.86 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.932 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -89.67 -9.0 51.18 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.39 -0.818 . . . . 0.0 112.186 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.608 ' CB ' ' CD1' ' A' ' 17' ' ' TYR . 4.4 mmm -85.47 -44.1 13.01 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.602 -1.311 . . . . 0.0 110.386 -179.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.573 ' CZ ' ' HG ' ' A' ' 76' ' ' LEU . 3.9 p90 -76.67 -26.83 55.24 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.905 -1.118 . . . . 0.0 108.31 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.573 ' HG ' ' CZ ' ' A' ' 75' ' ' PHE . 8.3 mt -69.41 -23.99 63.78 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.17 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.848 HG23 HG11 ' A' ' 53' ' ' VAL . 61.8 t -91.4 -46.23 14.5 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.807 -0.558 . . . . 0.0 109.626 179.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -66.33 -28.71 68.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.7 -0.625 . . . . 0.0 110.908 -179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 84' ' ' GLU . 5.9 t -80.45 -14.96 57.86 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.171 -0.956 . . . . 0.0 109.969 -179.598 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.895 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -90.34 -8.43 50.78 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.135 -0.978 . . . . 0.0 109.068 179.183 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.806 HD23 ' N ' ' A' ' 81' ' ' LEU . 1.3 mt -90.75 -44.62 9.34 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.585 -0.697 . . . . 0.0 109.933 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.444 ' O ' ' CB ' ' A' ' 83' ' ' LYS . 0.2 OUTLIER -72.34 -54.39 9.61 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 119.181 -1.008 . . . . 0.0 110.344 -179.396 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.444 ' CB ' ' O ' ' A' ' 82' ' ' GLU . 0.0 OUTLIER 174.48 78.6 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.134 -0.979 . . . . 0.0 111.29 179.731 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 79' ' ' CYS . 0.0 OUTLIER -174.1 121.64 0.38 Allowed Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.45 -1.406 . . . . 0.0 111.325 179.734 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -73.84 168.57 24.45 Favored 'Trans proline' 0 C--N 1.31 -1.47 0 O-C-N 123.914 1.481 . . . . 0.0 110.161 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 0.523 ' O ' ' CD ' ' A' ' 52' ' ' ARG . 69.6 t -124.7 127.72 25.1 Favored Pre-proline 0 N--CA 1.492 1.652 0 O-C-N 121.077 -1.014 . . . . 0.0 110.98 -179.538 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.724 ' O ' HD11 ' A' ' 56' ' ' LEU . 52.5 Cg_endo -86.76 157.11 8.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.939 1.494 . . . . 0.0 109.794 179.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.737 ' C ' HD21 ' A' ' 56' ' ' LEU . 1.3 mmt -84.77 14.32 4.87 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.906 -1.121 . . . . 0.0 110.462 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.556 ' N ' HD21 ' A' ' 56' ' ' LEU . 10.8 m -111.87 103.63 11.89 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 118.685 -1.206 . . . . 0.0 110.88 -178.646 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.732 HD12 HD23 ' A' ' 94' ' ' LEU . 0.1 OUTLIER -65.57 108.69 2.31 Favored Pre-proline 0 C--N 1.292 -1.928 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 178.76 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.508 ' HD3' ' O ' ' A' ' 89' ' ' SER . 39.2 Cg_endo -64.21 149.39 90.37 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.748 1.394 . . . . 0.0 111.553 -178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -72.14 -9.46 24.5 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 124.347 1.709 . . . . 0.0 110.957 -179.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -92.45 20.59 6.06 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.946 HD11 HG13 ' A' ' 72' ' ' VAL 0.252 0.2 OUTLIER -138.75 3.47 2.27 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.481 0.658 . . . . 0.0 109.879 -178.014 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.663 HG22 HD11 ' A' ' 90' ' ' LEU . 16.9 t -93.28 115.7 65.4 Favored Pre-proline 0 N--CA 1.493 1.709 0 O-C-N 121.23 -0.919 . . . . 0.0 111.057 -179.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.439 ' HB2' ' HD2' ' A' ' 97' ' ' PRO . 49.6 Cg_endo -77.96 173.14 14.45 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.938 1.494 . . . . 0.0 110.115 179.303 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.449 ' HA ' ' HG2' ' A' ' 100' ' ' ARG . 44.8 Cg_endo -71.49 92.06 0.68 Allowed 'Trans proline' 0 C--N 1.303 -1.851 0 O-C-N 124.021 1.537 . . . . 0.0 111.137 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 t -154.37 -42.24 0.09 Allowed 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.473 -0.936 . . . . 0.0 108.473 178.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -89.48 5.26 46.19 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 177.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.449 ' HG2' ' HA ' ' A' ' 97' ' ' PRO . 2.1 mmt85 . . . . . 0 N--CA 1.491 1.623 0 C-N-CA 119.564 -0.855 . . . . 0.0 110.433 -179.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.236 0.541 . . . . 0.0 110.141 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 3.4 t -139.18 6.64 2.37 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.281 -0.887 . . . . 0.0 110.047 179.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.499 ' ND2' ' HG2' ' A' ' 55' ' ' GLU . 42.9 t-20 -122.89 128.63 25.29 Favored Pre-proline 0 N--CA 1.49 1.529 0 O-C-N 121.26 -0.9 . . . . 0.0 109.933 179.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.574 ' HG2' ' CE2' ' B' ' 111' ' ' PHE . 50.3 Cg_endo -75.88 9.74 2.24 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.832 1.438 . . . . 0.0 111.632 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.79 ' HD1' HG22 ' A' ' 47' ' ' VAL . 98.9 m-85 -132.42 41.51 3.2 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 120.778 -1.201 . . . . 0.0 110.366 179.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.463 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.064 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo . . . . . 0 N--CA 1.485 0.983 0 N-CA-C 110.504 -0.614 . . . . 0.0 110.504 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' TRP . . . . . 0.595 ' CE2' ' HB ' ' A' ' 9' ' ' VAL . 17.0 t90 -74.27 124.71 26.93 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.309 -0.869 . . . . 0.0 109.977 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 1.033 ' CB ' HD23 ' A' ' 94' ' ' LEU . . . -38.33 -30.32 0.04 OUTLIER 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.695 -0.628 . . . . 0.0 110.789 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.64 ' CG2' ' CD2' ' A' ' 75' ' ' PHE . 46.3 t -101.23 134.92 39.93 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.456 -0.777 . . . . 0.0 110.055 -179.294 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.561 ' CB ' ' HD2' ' A' ' 11' ' ' PRO . 0.1 OUTLIER -91.79 -179.11 1.02 Allowed Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.283 -0.886 . . . . 0.0 110.385 -179.362 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' CB ' ' A' ' 10' ' ' LYS . 41.7 Cg_endo -69.47 -36.47 11.53 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.941 1.495 . . . . 0.0 109.965 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -73.77 -27.12 61.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.366 -0.834 . . . . 0.0 109.957 179.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.471 ' O ' ' HG2' ' A' ' 16' ' ' LYS . 13.0 m-20 -80.93 -38.12 28.38 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.242 -0.911 . . . . 0.0 109.014 179.57 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . 2.2 tttt -77.13 -21.27 54.44 Favored 'General case' 0 C--N 1.301 -1.508 0 C-N-CA 119.693 -0.803 . . . . 0.0 108.948 178.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 11' ' ' PRO . . . -66.92 -39.35 87.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 179.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.613 ' HG2' ' CD1' ' A' ' 17' ' ' TYR . 0.0 OUTLIER -74.72 -24.47 58.74 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.776 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.632 ' CE1' ' HB3' ' A' ' 74' ' ' MET . 12.3 m-30 -76.96 -32.2 57.12 Favored 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 178.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.52 -11.7 60.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.682 -0.636 . . . . 0.0 110.029 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' SER . . . -89.6 -31.61 17.49 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 178.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.655 HG22 ' CE1' ' A' ' 70' ' ' PHE . 25.6 mt -81.47 -37.0 15.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 178.152 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.758 ' HA ' HD11 ' A' ' 31' ' ' LEU . 0.0 OUTLIER -68.26 -34.71 76.69 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.022 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 22' ' ' ASP . 6.8 t0 -90.49 -4.63 56.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.626 -0.672 . . . . 0.0 110.281 179.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 19' ' ' ALA . 25.8 t -85.99 -4.91 59.27 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.147 -0.97 . . . . 0.0 109.174 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.874 HD12 ' CD1' ' A' ' 31' ' ' LEU . 0.9 OUTLIER -109.47 -14.96 14.32 Favored 'General case' 0 C--N 1.303 -1.449 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 179.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.612 ' CB ' ' O ' ' A' ' 24' ' ' LEU . 5.1 t 91.22 101.24 0.02 OUTLIER Pre-proline 0 N--CA 1.506 2.333 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.237 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.62 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 51.8 Cg_endo -76.03 154.19 37.55 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 124.416 1.745 . . . . 0.0 110.607 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.485 ' O ' ' HB3' ' A' ' 28' ' ' ASN . 94.3 t -122.6 102.31 11.39 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.497 -0.752 . . . . 0.0 109.306 179.513 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.485 ' HB3' ' O ' ' A' ' 27' ' ' VAL . 12.4 t30 58.06 18.65 5.34 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.372 -0.83 . . . . 0.0 109.685 -178.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.532 ' O ' ' CG ' ' A' ' 30' ' ' PHE . . . 100.91 36.46 3.94 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' PHE . . . . . 0.532 ' CG ' ' O ' ' A' ' 29' ' ' GLY . 86.9 m-85 -153.28 145.44 23.83 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 120.848 -1.384 . . . . 0.0 112.003 -179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.898 HD12 ' CD2' ' A' ' 70' ' ' PHE . 10.1 mt -113.65 138.47 50.15 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.477 ' O ' ' N ' ' A' ' 34' ' ' ASP . 96.5 p -88.64 146.86 24.85 Favored 'General case' 0 C--N 1.291 -1.978 0 C-N-CA 118.825 -1.15 . . . . 0.0 110.276 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 37' ' ' LYS . . . -42.21 -26.11 0.32 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.864 -1.695 . . . . 0.0 108.864 179.659 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASP . . . . . 0.477 ' N ' ' O ' ' A' ' 32' ' ' SER . 56.9 m-20 -63.82 -26.13 68.49 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.459 -1.024 . . . . 0.0 109.947 179.562 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HB3' ' HB3' ' A' ' 24' ' ' LEU . 18.7 mttt -96.17 -35.75 11.2 Favored 'General case' 0 C--N 1.306 -1.288 0 O-C-N 121.091 -1.006 . . . . 0.0 108.507 179.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.914 HG11 HD12 ' A' ' 65' ' ' LEU . 63.0 t -79.18 -41.35 22.89 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 C-N-CA 120.146 -0.622 . . . . 0.0 110.156 179.478 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . 0.641 ' HA ' ' CZ ' ' B' ' 111' ' ' PHE . 3.1 ttpt -41.31 -55.39 5.28 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.0 110.652 -179.396 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PRO . . . . . 0.541 ' HD2' ' N ' ' A' ' 37' ' ' LYS . 41.3 Cg_endo -67.85 -34.72 23.21 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 O-C-N 123.559 1.294 . . . . 0.0 109.935 179.774 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.861 HG11 ' CZ ' ' A' ' 70' ' ' PHE . 4.1 t -59.71 -34.16 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 109.839 179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.966 ' HB3' HD22 ' A' ' 50' ' ' LEU . 20.5 mt -88.77 -27.25 21.27 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.256 -0.902 . . . . 0.0 109.804 179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.424 ' HG ' ' O ' ' A' ' 37' ' ' LYS . 61.1 mt -71.99 -12.26 61.16 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 121.283 -0.886 . . . . 0.0 109.128 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 -87.72 -4.52 58.9 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.41 -0.916 . . . . 0.0 109.989 -179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.503 ' O ' HD22 ' A' ' 81' ' ' LEU . 1.2 m -86.04 8.62 19.92 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.494 -0.754 . . . . 0.0 110.348 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 61.12 13.14 4.49 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.095 -1.003 . . . . 0.0 109.747 -179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.996 HD13 HG21 ' A' ' 49' ' ' ILE . 16.9 mt -95.56 156.42 37.51 Favored Pre-proline 0 N--CA 1.489 1.522 0 O-C-N 121.343 -0.848 . . . . 0.0 109.936 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PRO . . . . . 0.533 ' HG2' HG12 ' A' ' 49' ' ' ILE . 43.9 Cg_endo -73.26 167.64 26.81 Favored 'Trans proline' 0 C--N 1.301 -1.966 0 O-C-N 124.141 1.6 . . . . 0.0 109.888 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.642 HG22 ' HD1' ' B' ' 111' ' ' PHE . 1.2 t -65.11 -9.32 7.07 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.388 0 O-C-N 121.263 -0.898 . . . . 0.0 109.321 -179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 52' ' ' ARG . 44.3 m-20 -76.58 -30.46 57.02 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.344 -0.848 . . . . 0.0 109.214 -179.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.996 HG21 HD13 ' A' ' 45' ' ' LEU . 13.4 mm -84.58 -38.63 13.7 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 CA-C-O 122.002 0.906 . . . . 0.0 108.78 178.768 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.966 HD22 ' HB3' ' A' ' 40' ' ' LEU . 10.6 mt -78.5 -26.86 46.04 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.57 0.7 . . . . 0.0 109.252 179.782 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . 0.528 ' CA ' ' HB2' ' B' ' 111' ' ' PHE . . . -81.18 -24.21 57.69 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.598 -2.201 . . . . 0.0 107.598 179.241 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 1.079 ' NH2' HG12 ' A' ' 86' ' ' VAL . 0.1 OUTLIER -101.24 -26.16 13.74 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 122.147 -0.619 . . . . 0.0 110.045 179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.794 HG11 HG23 ' A' ' 77' ' ' VAL . 12.6 t -75.77 -43.23 40.39 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.774 -1.204 . . . . 0.0 107.869 178.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' TRP . . . . . 0.563 ' C ' ' CD1' ' A' ' 54' ' ' TRP . 1.5 t-105 -55.28 -49.04 73.12 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.289 -0.965 . . . . 0.0 108.442 178.166 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . 0.494 ' HG3' ' O ' ' A' ' 51' ' ' GLY . 5.0 mm-40 -53.75 -54.89 31.77 Favored 'General case' 0 C--N 1.305 -1.336 0 O-C-N 121.479 -0.763 . . . . 0.0 109.781 -179.261 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.74 HD23 ' CB ' ' A' ' 90' ' ' LEU . 8.2 mt -61.37 -15.85 40.48 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.149 -0.969 . . . . 0.0 108.718 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.832 ' CB ' ' HB2' ' A' ' 73' ' ' ALA . 31.8 m -94.07 -38.96 10.86 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.583 -0.698 . . . . 0.0 110.146 -179.999 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.541 ' N ' ' O ' ' A' ' 54' ' ' TRP . 4.8 t0 -60.94 100.57 0.12 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.289 -0.882 . . . . 0.0 110.026 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.531 ' CG1' ' HG2' ' A' ' 69' ' ' GLU . 34.2 mm -83.48 -20.82 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.284 -0.885 . . . . 0.0 110.372 -179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.453 ' HB2' ' OD2' ' A' ' 62' ' ' ASP . 19.5 m-20 -105.35 -16.31 14.79 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.143 -0.973 . . . . 0.0 110.438 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' HIS . . . . . 0.45 ' CD2' ' O ' ' A' ' 58' ' ' ASP . 6.9 m170 60.57 43.84 12.34 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.267 -0.895 . . . . 0.0 109.973 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' OD2' ' HB2' ' A' ' 60' ' ' ASP . 10.5 p30 -112.84 -6.82 13.8 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.251 -0.905 . . . . 0.0 110.527 -179.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.549 ' C ' ' HG2' ' A' ' 64' ' ' MET . . . 100.95 23.39 9.88 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' MET . . . . . 0.549 ' HG2' ' C ' ' A' ' 63' ' ' GLY . 2.0 mmm -147.57 161.16 41.69 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.222 -1.164 . . . . 0.0 109.374 179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.914 HD12 HG11 ' A' ' 36' ' ' VAL . 7.9 mt -121.36 107.76 12.88 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.083 -1.011 . . . . 0.0 110.325 179.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 67' ' ' ARG . 61.0 t0 -69.61 169.29 13.02 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.96 -1.088 . . . . 0.0 110.114 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ARG . . . . . 0.548 ' N ' ' OD1' ' A' ' 66' ' ' ASP . 8.1 ptt180 -50.56 -37.83 41.76 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.505 -0.747 . . . . 0.0 109.976 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.439 ' OD2' ' HG3' ' A' ' 67' ' ' ARG . 9.2 m-20 -78.65 -32.86 47.44 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.328 -0.857 . . . . 0.0 109.64 179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.531 ' HG2' ' CG1' ' A' ' 59' ' ' ILE . 39.3 mt-10 -76.71 -41.64 44.48 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.349 -0.844 . . . . 0.0 109.045 179.079 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . 0.898 ' CD2' HD12 ' A' ' 31' ' ' LEU . 9.3 t80 -61.21 -25.38 67.01 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.526 -0.734 . . . . 0.0 109.242 178.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.414 ' HA ' ' CD2' ' A' ' 17' ' ' TYR . . . -69.59 -47.08 64.76 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.377 -0.827 . . . . 0.0 109.794 179.664 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' VAL . . . . . 0.651 ' HA ' ' CE2' ' A' ' 75' ' ' PHE . 92.0 t -61.29 -23.87 31.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 121.416 -0.802 . . . . 0.0 110.103 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.832 ' HB2' ' CB ' ' A' ' 57' ' ' SER . . . -90.45 -2.95 57.96 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.479 -0.763 . . . . 0.0 110.835 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' MET . . . . . 0.632 ' HB3' ' CE1' ' A' ' 17' ' ' TYR . 16.1 mmt -89.59 -46.21 8.82 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.929 -1.107 . . . . 0.0 109.658 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 1.177 ' CZ ' HD22 ' A' ' 94' ' ' LEU . 2.0 p90 -77.61 -17.91 57.32 Favored 'General case' 0 C--N 1.299 -1.618 0 C-N-CA 119.051 -1.06 . . . . 0.0 108.244 178.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.597 ' HB3' HG13 ' A' ' 53' ' ' VAL . 9.6 mt -77.07 -26.5 53.53 Favored 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 177.41 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.794 HG23 HG11 ' A' ' 53' ' ' VAL . 79.6 t -91.87 -50.17 12.72 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.312 0 CA-C-O 121.386 0.612 . . . . 0.0 109.773 179.238 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -58.89 -33.52 70.61 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.607 -0.683 . . . . 0.0 111.54 -179.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' CYS . . . . . 0.512 ' HB3' ' HB3' ' A' ' 84' ' ' GLU . 55.6 m -77.48 -14.46 59.68 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.008 -1.057 . . . . 0.0 109.592 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.954 ' HB3' HD11 ' A' ' 45' ' ' LEU . . . -88.67 -10.34 48.85 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.373 -0.829 . . . . 0.0 109.57 179.195 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.534 HD23 ' N ' ' A' ' 81' ' ' LEU . 6.0 mt -90.88 -41.45 11.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.434 -0.791 . . . . 0.0 110.118 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.486 ' O ' ' HB2' ' A' ' 83' ' ' LYS . 4.7 mm-40 -69.79 -52.34 26.04 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.51 -0.876 . . . . 0.0 109.836 -179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 82' ' ' GLU . 0.1 OUTLIER 175.65 -23.88 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 119.537 -0.865 . . . . 0.0 111.277 179.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 79' ' ' CYS . 1.4 tt0 -59.45 131.66 88.09 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.081 -1.012 . . . . 0.0 111.179 -178.384 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -76.95 148.12 27.63 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.105 1.581 . . . . 0.0 109.866 179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' VAL . . . . . 1.079 HG12 ' NH2' ' A' ' 52' ' ' ARG . 0.5 OUTLIER -98.95 111.65 61.17 Favored Pre-proline 0 C--N 1.301 -1.5 0 O-C-N 121.148 -0.97 . . . . 0.0 109.011 -179.558 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.568 ' O ' ' NH2' ' A' ' 52' ' ' ARG . 48.0 Cg_endo -85.38 135.94 5.4 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 O-C-N 123.502 1.264 . . . . 0.0 109.665 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' MET . . . . . 0.686 ' O ' HD21 ' A' ' 56' ' ' LEU . 0.0 OUTLIER -62.84 -1.59 0.93 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.027 -1.046 . . . . 0.0 111.295 -178.993 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.589 ' O ' ' HD3' ' A' ' 91' ' ' PRO . 69.1 m -91.1 126.03 36.06 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 118.686 -1.206 . . . . 0.0 112.145 -177.489 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' LEU . . . . . 0.858 HD11 HG23 ' A' ' 95' ' ' VAL . 0.1 OUTLIER -103.25 85.23 0.83 Allowed Pre-proline 0 C--N 1.295 -1.774 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 177.998 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' A' ' 89' ' ' SER . 42.2 Cg_endo -67.67 165.66 26.79 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.612 1.322 . . . . 0.0 110.699 -179.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -71.99 -6.07 18.37 Favored 'Trans proline' 0 C--N 1.304 -1.815 0 O-C-N 124.165 1.613 . . . . 0.0 110.884 -179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 8' ' ' ALA . . . -76.72 -1.51 28.31 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.192 -0.943 . . . . 0.0 109.163 179.482 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 1.177 HD22 ' CZ ' ' A' ' 75' ' ' PHE . 3.6 mt -127.39 -0.96 6.3 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.482 -0.761 . . . . 0.0 109.679 179.92 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . 0.858 HG23 HD11 ' A' ' 90' ' ' LEU . 9.0 t -106.3 143.94 27.98 Favored Pre-proline 0 N--CA 1.488 1.437 0 O-C-N 121.429 -0.795 . . . . 0.0 110.211 -179.33 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.501 ' HD2' HG13 ' A' ' 95' ' ' VAL . 41.1 Cg_endo -67.2 174.9 6.37 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.062 1.559 . . . . 0.0 109.718 179.178 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' PRO . . . . . 0.545 ' O ' ' CB ' ' A' ' 98' ' ' SER . 42.3 Cg_endo -68.54 170.79 14.27 Favored 'Trans proline' 0 C--N 1.303 -1.856 0 O-C-N 123.844 1.444 . . . . 0.0 110.57 -179.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.545 ' CB ' ' O ' ' A' ' 97' ' ' PRO . 0.3 OUTLIER 77.3 -46.15 0.48 Allowed 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.777 -0.577 . . . . 0.0 110.314 -179.257 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . 0.506 ' O ' ' NZ ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER -88.22 9.45 22.94 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.172 -0.955 . . . . 0.0 108.801 179.079 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ARG . . . . . 0.408 ' C ' ' O ' ' A' ' 99' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.729 0 O-C-N 121.419 -0.8 . . . . 0.0 109.912 179.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 121.246 0.546 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' THR . . . . . . . . . . . . . 12.0 p -50.61 -33.16 21.11 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.362 -0.836 . . . . 0.0 110.383 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ASN . . . . . 0.542 ' OD1' HD12 ' B' ' 112' ' ' LEU . 5.4 t-20 -104.71 128.14 27.46 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.295 -0.878 . . . . 0.0 110.389 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . 0.529 ' HD2' ' ND2' ' B' ' 109' ' ' ASN . 48.5 Cg_endo -74.87 -21.52 16.09 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.93 1.49 . . . . 0.0 110.623 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' PHE . . . . . 0.925 ' CZ ' HD12 ' A' ' 40' ' ' LEU . 85.4 m-85 -83.85 -10.6 57.91 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.097 -1.002 . . . . 0.0 110.003 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' LEU . . . . . 0.542 HD12 ' OD1' ' B' ' 109' ' ' ASN . 41.8 mt . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.078 -0.963 . . . . 0.0 110.105 -179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_